data_2l0x_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l0x _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.177 0.513 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -139.94 136.79 34.2 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.724 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.63 ' HZ2' HE22 ' A' ' 57' ' ' GLN . 6.2 mttm -106.25 130.07 54.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -103.28 123.49 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-O 121.493 0.664 . . . . 0.0 110.49 -178.315 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.417 ' O ' HG21 ' A' ' 82' ' ' ILE . . . -84.53 134.38 34.42 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.304 -0.872 . . . . 0.0 111.325 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.2 mt -95.51 127.66 47.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.38 0.61 . . . . 0.0 111.65 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.0 tp -127.5 99.35 5.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.522 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -142.07 136.09 7.08 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.814 -178.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.1 OUTLIER -49.31 -177.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.217 0.532 . . . . 0.0 110.662 179.002 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -74.46 140.85 44.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.816 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.4 m 53.17 19.63 1.53 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.609 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.2 p -68.64 -17.13 21.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.417 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.449 ' C ' ' HG ' ' A' ' 21' ' ' SER . . . 103.82 29.25 5.62 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.7 mtmm -64.61 -62.49 1.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 110.369 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.96 -28.35 56.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.619 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.449 ' HG ' ' C ' ' A' ' 18' ' ' GLY . 94.6 p -68.2 -50.73 52.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.792 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.1 tp -77.4 -26.45 51.77 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.913 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.423 ' O ' ' CG1' ' A' ' 27' ' ' VAL . 33.9 m -60.32 -43.33 96.48 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 mp -77.89 -42.74 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.729 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.434 HE22 ' HB1' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -67.02 -32.13 73.14 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.358 -179.045 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -77.71 -62.59 1.62 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.374 0.607 . . . . 0.0 111.404 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.466 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 14.4 p -48.01 -47.52 12.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.268 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.466 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 2.2 tm-20 -83.53 -24.6 31.58 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.32 28.74 67.39 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.498 ' CA ' HD22 ' A' ' 153' ' ' ASN . 0.1 OUTLIER -144.94 125.67 14.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.07 0.462 . . . . 0.0 111.861 -178.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.516 ' O ' ' CG ' ' A' ' 31' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.346 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -178.68 174.05 1.22 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.509 0.671 . . . . 0.0 112.43 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.25 137.23 46.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.357 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -122.09 167.19 13.44 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.714 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.425 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -146.41 148.05 31.9 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.38 0.609 . . . . 0.0 112.319 -179.164 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.5 tttp -147.11 112.44 5.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.968 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.0 mp -106.44 120.28 41.5 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.095 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.504 ' N ' ' CD1' ' A' ' 47' ' ' ILE . 0.4 OUTLIER -145.47 165.31 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.42 -179.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.3 m -115.92 124.96 51.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.489 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.2 p -119.45 117.63 54.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.734 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 69.83 26.06 4.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.025 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.61 -9.41 55.7 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -89.99 132.04 35.57 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.96 145.58 40.25 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.621 0.724 . . . . 0.0 111.352 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -136.53 122.36 19.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.949 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 67.3 m170 -117.2 112.7 21.19 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -119.19 142.85 47.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.517 0.675 . . . . 0.0 111.831 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.63 HE22 ' HZ2' ' A' ' 8' ' ' LYS . 2.4 mt-30 -133.14 121.52 22.71 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.957 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.583 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.84 154.42 30.77 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 120.098 -0.641 . . . . 0.0 112.219 -178.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.14 144.87 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.686 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.05 107.48 12.68 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.872 -1.513 . . . . 0.0 108.178 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 121.12 0.486 . . . . 0.0 110.479 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 33.5 pt . . . . . 0 N--CA 1.436 -1.159 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -150.75 17.62 0.79 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.142 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -146.94 165.92 28.45 Favored Glycine 0 CA--C 1.516 0.143 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.584 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.1 122.4 7.23 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.956 -0.622 . . . . 0.0 110.812 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.417 HG21 ' O ' ' A' ' 10' ' ' ALA . 10.7 tt -125.54 103.38 11.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.618 ' CD2' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -96.28 125.82 41.06 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.737 -178.22 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.8 t -95.7 119.25 43.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.808 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.481 ' C ' ' CD1' ' A' ' 85' ' ' TYR . 4.1 p90 -109.7 145.41 36.61 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.651 ' HG ' ' H ' ' A' ' 88' ' ' THR . 0.8 OUTLIER -101.85 143.62 31.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.064 0.459 . . . . 0.0 111.752 -178.075 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.8 m -80.49 20.45 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.23 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.651 ' H ' ' HG ' ' A' ' 86' ' ' SER . 9.7 t -141.92 -15.94 0.79 Allowed 'General case' 0 C--O 1.232 0.141 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.544 ' C ' ' H ' ' A' ' 91' ' ' LYS . 38.8 t -113.71 94.21 4.74 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -176.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.5 mm -52.8 -14.74 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 176.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.544 ' H ' ' C ' ' A' ' 89' ' ' SER . 9.6 mttp -78.22 -46.61 19.95 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.192 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.648 ' HG ' ' H ' ' A' ' 86' ' ' SER . 88.0 p -61.9 -45.48 93.55 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.541 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -77.64 -37.27 50.36 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 119.248 -0.981 . . . . 0.0 112.652 -177.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -67.81 -43.89 78.59 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.43 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 91' ' ' LYS . 30.7 m -66.04 -38.16 81.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.85 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -58.92 -39.42 77.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -69.45 -26.75 64.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.126 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.9 t -77.29 -66.91 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.785 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.7 mp -41.07 -38.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.028 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.518 ' CE1' ' CD1' ' A' ' 141' ' ' TRP . 7.1 t-160 -64.4 -64.92 0.76 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.617 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.52 -57.75 1.46 Allowed Glycine 0 CA--C 1.517 0.212 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 105' ' ' ASP . 12.7 tptp -62.9 -64.72 0.83 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.915 -0.643 . . . . 0.0 110.713 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -36.95 -60.17 0.65 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.492 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -46.43 -48.07 18.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.471 178.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.92 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.419 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.925 0.393 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.486 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.8 OUTLIER -115.04 150.35 44.08 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.21 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -48.2 111.7 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.516 1.478 . . . . 0.0 112.32 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.486 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.5 mp -120.99 128.99 76.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 8.7 tpt -129.17 115.45 17.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.76 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mt -96.84 97.77 9.57 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.0 t -102.48 134.06 44.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 122.442 1.115 . . . . 0.0 110.471 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 146' ' ' LEU . . . -101.32 111.73 4.19 Favored Glycine 0 C--N 1.297 -1.595 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.509 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 46.3 t30 -96.95 173.72 7.14 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.415 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.509 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 24.4 mttt 59.57 58.59 2.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.507 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 32.0 tttm -64.41 -35.47 81.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.412 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.32 -10.6 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.04 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 125' ' ' MET . 9.1 mp -90.69 -29.93 17.42 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.598 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.1 OUTLIER -40.13 -23.97 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.889 178.499 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.598 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 3.6 mmt -45.24 -24.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.44 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -101.36 -37.81 8.31 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.068 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.41 ' NH1' ' OE2' ' A' ' 147' ' ' GLU . 1.9 tpt180 38.91 88.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.082 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.0 m -78.84 -38.21 20.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.586 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.409 HD13 ' H ' ' A' ' 130' ' ' SER . 6.7 tp -90.5 153.52 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.54 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 18.2 p -94.87 137.16 34.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.274 0.559 . . . . 0.0 112.087 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -54.95 -32.59 61.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.215 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -68.32 -65.83 0.65 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.964 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.54 ' H ' ' HG ' ' A' ' 130' ' ' SER . 41.0 mt-10 -42.09 -40.93 2.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.622 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.11 -34.29 64.74 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 132' ' ' GLU . 24.1 tttm -64.07 -55.5 21.68 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -55.6 -33.75 64.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.25 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.615 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -65.53 -62.99 1.2 Allowed 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.702 179.429 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -54.69 -34.99 63.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.364 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.56 -30.11 67.84 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.599 ' HG ' ' N ' ' A' ' 141' ' ' TRP . 23.4 p -64.3 -46.8 81.99 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.742 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.615 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 21.9 m95 -88.94 -5.71 57.78 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.089 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.4 ' O ' ' OE2' ' A' ' 166' ' ' GLU . 0.8 OUTLIER 75.91 25.49 1.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -89.24 169.16 11.69 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.894 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.47 133.81 49.61 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.214 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 6.6 t80 -96.83 122.49 39.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.005 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 118' ' ' GLY . 1.3 mm? -132.95 139.5 47.34 Favored 'General case' 0 C--O 1.209 -1.054 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.63 -176.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.423 ' OE1' ' OH ' ' A' ' 85' ' ' TYR . 5.5 tt0 -129.04 111.28 12.81 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 58.9 p -138.66 -177.15 4.74 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.734 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.549 ' H ' ' HG1' ' A' ' 155' ' ' THR . 0.1 OUTLIER -138.4 140.17 39.26 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.086 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.533 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -59.68 -43.07 94.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.157 0.503 . . . . 0.0 109.69 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.0 ttpp -65.38 5.64 0.38 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.381 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.533 ' H ' ' C ' ' A' ' 150' ' ' ALA . 3.4 tt0 -136.47 120.02 17.08 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.721 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.498 HD22 ' CA ' ' A' ' 30' ' ' GLN . 3.6 m120 -77.57 -56.86 4.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.961 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 153' ' ' ASN . 9.1 tt0 -36.97 -58.23 0.78 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.893 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.549 ' HG1' ' H ' ' A' ' 149' ' ' SER . 66.3 p -52.14 -50.16 62.29 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.126 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -49.75 -60.31 3.01 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.418 0.628 . . . . 0.0 109.717 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.1 t -40.92 -50.35 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.986 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -53.96 -32.6 54.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.661 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 156' ' ' ALA . 12.7 t -75.92 -26.74 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.247 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -71.45 -39.92 70.66 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.462 179.321 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.603 ' N ' ' CD1' ' A' ' 160' ' ' PHE . 36.2 ttm-85 -79.48 -47.73 15.12 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.163 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.6 mmm180 -57.75 -37.57 73.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.11 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.42 ' CG2' ' H ' ' A' ' 164' ' ' ILE . 11.6 tt -69.74 -58.18 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.438 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.42 ' H ' ' CG2' ' A' ' 163' ' ' ILE . 91.3 mt -46.2 -35.02 2.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.88 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -64.82 0.82 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.027 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.4 ' OE2' ' O ' ' A' ' 142' ' ' ASN . 2.1 tt0 -54.6 -37.99 66.22 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -49.56 -35.54 20.82 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -68.06 -52.65 32.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.085 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 3.6 ttpp -54.5 -61.07 2.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.529 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 33.7 mm -49.98 -32.98 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.62 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -39.59 89.05 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.102 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -61.9 -34.09 87.63 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.96 -80.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.67 0.271 . . . . 0.0 110.323 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 -0.141 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.817 179.824 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 121.352 0.596 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.69 135.41 33.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.256 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.619 ' HZ1' HE22 ' A' ' 57' ' ' GLN . 8.1 mttm -107.73 127.59 53.82 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -100.96 122.27 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 121.702 0.763 . . . . 0.0 110.808 -177.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.28 135.24 34.41 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.498 -0.751 . . . . 0.0 110.882 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.4 mt -96.97 131.74 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.554 0.692 . . . . 0.0 112.403 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.421 ' C ' ' CD2' ' A' ' 12' ' ' LEU . 5.0 tt -121.43 101.34 7.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.895 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -139.8 134.4 6.59 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.72 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.442 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -55.34 -158.35 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.368 0.604 . . . . 0.0 110.756 179.339 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.7 tpp85 -96.05 133.57 40.14 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.546 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.1 m 61.57 14.61 6.1 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.288 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.505 ' C ' ' HZ3' ' A' ' 120' ' ' LYS . 4.3 p -70.28 -13.32 17.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.502 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.4 21.65 47.5 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.747 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.4 pttm -68.17 -35.29 77.81 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.055 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.2 m -67.66 -42.21 82.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.545 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 m -60.42 -47.55 85.62 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.485 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.444 ' O ' ' CB ' ' A' ' 26' ' ' PHE . 45.4 tp -66.95 -26.94 67.08 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.547 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 97.2 m -63.06 -51.45 66.62 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.4 mm -65.3 -38.77 83.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.936 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.472 ' OE1' ' CB ' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -77.57 -25.67 50.21 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.541 -178.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.636 ' CZ ' ' CD2' ' A' ' 160' ' ' PHE . 37.1 t80 -77.78 -53.04 7.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.414 0.626 . . . . 0.0 110.614 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.457 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 14.9 p -59.61 -48.75 86.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.991 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.457 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 2.6 mt-10 -79.43 -24.41 42.51 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.416 ' O ' ' OD1' ' A' ' 153' ' ' ASN . . . 69.24 36.2 78.75 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -147.14 136.13 22.32 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.205 0.526 . . . . 0.0 111.179 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.24 179.29 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.42 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 7.2 pt-20 . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 1.2 m120 -172.85 176.08 3.18 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.576 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.434 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -108.26 152.95 23.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.577 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.45 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 25.3 m-85 -132.63 166.37 22.3 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.455 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.05 156.3 42.91 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.524 0.678 . . . . 0.0 112.823 -177.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -163.29 117.13 1.6 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.804 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mp -104.63 129.2 52.8 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.879 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 pp -147.1 160.31 9.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.935 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -114.97 123.28 48.71 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.974 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.26 129.87 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.014 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 63.74 7.26 3.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.019 0.438 . . . . 0.0 109.961 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.83 -11.76 59.17 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -89.15 135.02 33.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -77.13 147.12 36.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.606 0.717 . . . . 0.0 111.525 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.538 ' C ' ' HD1' ' A' ' 55' ' ' HIS . 13.7 m-85 -140.38 123.47 16.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.749 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.538 ' HD1' ' C ' ' A' ' 54' ' ' TYR . 1.2 m-70 -117.33 114.06 23.03 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.7 mp -118.88 143.88 46.72 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.785 0.802 . . . . 0.0 112.379 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.619 HE22 ' HZ1' ' A' ' 8' ' ' LYS . 2.9 mt-30 -135.63 122.15 20.71 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.198 -1.364 . . . . 0.0 109.95 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.637 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.78 153.53 33.28 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.53 -178.603 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -122.93 144.38 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-N 114.508 -1.224 . . . . 0.0 112.32 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.13 103.43 8.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.107 178.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 121.385 0.612 . . . . 0.0 110.513 -179.902 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 29.8 pt . . . . . 0 N--CA 1.429 -1.475 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -151.19 17.33 0.75 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.04 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -144.17 164.4 27.6 Favored Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.222 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.53 123.93 7.71 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.641 -0.78 . . . . 0.0 111.181 178.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.6 tt -128.71 113.79 30.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.2 mt -97.48 123.93 41.51 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.042 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -98.08 117.82 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.179 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.615 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 42.2 p90 -120.5 145.38 47.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.308 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.679 ' HG ' ' H ' ' A' ' 89' ' ' SER . 3.3 p -86.03 135.77 33.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.204 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.0 m -73.69 21.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.459 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.565 ' H ' ' HG ' ' A' ' 86' ' ' SER . 0.9 OUTLIER -136.9 -25.6 1.08 Allowed 'General case' 0 CA--C 1.52 -0.212 0 CA-C-O 121.003 0.43 . . . . 0.0 112.063 -178.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.679 ' H ' ' HG ' ' A' ' 86' ' ' SER . 60.8 p -97.77 100.06 11.42 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.067 -176.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.8 tp -59.37 -8.4 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 176.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.614 ' H ' ' C ' ' A' ' 89' ' ' SER . 21.8 mttp -77.05 -59.31 2.83 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.111 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.432 ' OG ' ' OG ' ' A' ' 89' ' ' SER . 83.1 p -52.22 -33.52 41.53 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.878 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.615 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -73.19 -49.76 26.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.721 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -65.98 -42.35 89.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.214 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.5 m -66.22 -41.56 89.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.254 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.4 mt -59.44 -34.51 54.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -71.0 -27.26 63.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.466 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.4 t -77.11 -67.27 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.263 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.4 tp -48.53 -29.53 2.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.684 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.616 ' CG ' ' CH2' ' A' ' 141' ' ' TRP . 35.6 t-80 -67.77 -63.58 1.03 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.235 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -39.58 -47.61 3.0 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 105' ' ' ASP . 37.6 tptt -62.81 -62.72 1.53 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.878 -0.661 . . . . 0.0 109.244 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -38.06 -51.09 1.39 Allowed 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.349 0.595 . . . . 0.0 109.498 178.686 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.485 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -52.4 -45.56 65.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.52 179.057 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.313 -0.983 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.035 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.486 ' N ' ' OE1' ' A' ' 111' ' ' GLN . 2.1 mm100 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 121.083 0.468 . . . . 0.0 111.367 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.61 161.21 62.32 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -51.83 101.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 120.953 1.102 . . . . 0.0 111.548 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.3 mt -116.22 120.97 66.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 8.5 tpt -121.84 113.73 20.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.033 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 79.8 mt -96.14 97.86 9.88 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.8 t -106.91 135.32 45.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 122.184 0.992 . . . . 0.0 111.696 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.403 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -105.45 116.08 5.1 Favored Glycine 0 C--N 1.308 -0.98 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.509 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 57.9 t30 -97.71 174.88 6.4 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.043 -178.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.509 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 7.2 mttp 62.09 58.19 1.9 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.048 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.44 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 2.9 tttm -58.92 -26.83 64.69 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -64.5 -13.98 54.9 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.97 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 125' ' ' MET . 11.0 mp -89.98 -30.03 18.07 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.61 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.1 OUTLIER -37.53 -25.78 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.132 178.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.61 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 7.2 mtp -49.26 -21.5 0.83 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.448 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -109.99 -38.84 5.22 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.139 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.48 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 19.6 ttm180 26.68 90.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.106 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.99 -32.98 56.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.437 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.6 tp -88.89 156.37 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.597 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.492 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 88.7 p -103.41 124.98 49.73 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.219 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.511 ' CE1' ' CE1' ' A' ' 145' ' ' PHE . 0.4 OUTLIER -39.23 -39.56 0.63 Allowed 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.064 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mp0 -61.33 -65.75 0.64 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.937 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.492 ' H ' ' HG ' ' A' ' 130' ' ' SER . 66.6 mt-10 -41.41 -46.18 3.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.076 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.78 -35.05 84.57 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 132' ' ' GLU . 12.1 ttpt -62.04 -55.27 30.81 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.0 -37.82 77.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.307 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.557 ' CD2' ' CE2' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -67.06 -64.78 0.78 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 120.905 0.384 . . . . 0.0 110.017 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -49.71 -32.45 13.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.304 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -67.12 -53.77 27.59 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.911 0.386 . . . . 0.0 110.11 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 88.8 p -62.32 -26.77 68.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.116 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.616 ' CH2' ' CG ' ' A' ' 100' ' ' HIS . 32.6 m0 -88.02 -8.78 55.11 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 65.9 20.61 11.38 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -101.04 166.65 10.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.776 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.01 133.96 48.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.916 -0.583 . . . . 0.0 112.252 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.511 ' CE1' ' CE1' ' A' ' 131' ' ' TYR . 4.5 t80 -97.1 122.92 40.63 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.529 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -135.79 138.89 43.06 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.592 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.48 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 2.3 tt0 -127.77 110.55 12.73 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.1 p -137.86 -176.79 4.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.164 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.71 139.85 38.54 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.857 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -59.78 -44.38 93.92 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 178.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -62.5 -0.5 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.184 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.51 ' H ' ' C ' ' A' ' 150' ' ' ALA . 1.3 mt-10 -136.42 97.98 3.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.627 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.455 ' O ' ' N ' ' A' ' 156' ' ' ALA . 11.2 t-20 -63.96 -47.71 79.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.969 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 153' ' ' ASN . 0.0 OUTLIER -37.06 -59.13 0.74 Allowed 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.104 0.478 . . . . 0.0 110.485 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 74.2 p -52.29 -44.98 65.3 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.847 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -55.19 -60.31 3.57 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.293 0.568 . . . . 0.0 109.959 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.1 t -41.63 -41.64 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.939 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.32 -39.56 94.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.891 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 156' ' ' ALA . 22.4 t -67.39 -31.33 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.371 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.636 ' CD2' ' CZ ' ' A' ' 26' ' ' PHE . 4.8 t80 -62.19 -66.94 0.46 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.67 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 26.3 ttm-85 -48.48 -53.15 19.05 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.849 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.46 -33.98 23.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.95 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -34.07 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.485 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 10.2 mt -68.06 -40.05 82.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.634 0.731 . . . . 0.0 110.244 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.37 -60.84 2.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.302 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.6 -32.29 65.11 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.546 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.0 -32.29 70.72 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -68.32 -55.98 10.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.96 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 18.4 ttpp -59.2 -62.33 1.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.931 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 67.1 mt -50.28 -33.14 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.111 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.13 -40.69 90.84 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.141 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.56 -32.71 84.21 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.94 -81.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.419 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.015 -179.96 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.52 ' OG ' ' ND1' ' A' ' 55' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 121.078 0.466 . . . . 0.0 110.159 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -139.9 136.7 34.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.602 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -106.36 133.47 51.0 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 1.3 mm -106.06 125.97 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-O 121.345 0.593 . . . . 0.0 110.232 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.74 134.0 34.76 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.124 -0.985 . . . . 0.0 110.631 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.0 mt -96.9 132.37 41.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.341 0.591 . . . . 0.0 112.121 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.2 tp -132.4 105.92 7.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.569 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -140.26 134.37 6.48 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -54.9 -159.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.371 0.605 . . . . 0.0 110.918 179.624 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -96.18 135.28 38.2 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.864 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.0 m 61.27 19.48 10.16 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.497 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.531 ' C ' ' HZ1' ' A' ' 120' ' ' LYS . 4.0 p -77.8 -19.66 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.852 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.436 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 93.38 23.28 24.67 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.424 ' O ' ' OG1' ' A' ' 23' ' ' THR . 9.6 pttm -69.32 -34.45 74.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.0 110.263 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.2 m -75.42 -36.16 60.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.086 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 78.3 p -60.42 -42.16 95.47 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.318 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.6 tp -77.44 -34.14 54.64 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.959 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 19' ' ' LYS . 27.0 m -52.98 -45.48 67.84 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.849 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.454 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 1.4 mp -74.42 -41.96 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.351 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.479 ' OE1' ' CB ' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -68.45 -28.9 67.45 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.334 -0.547 . . . . 0.0 110.961 -179.433 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.453 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 1.4 t80 -77.93 -64.05 1.25 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.336 0.588 . . . . 0.0 110.957 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 14.9 p -47.05 -48.41 8.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.727 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.449 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 0.5 OUTLIER -80.32 -24.95 39.58 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.157 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.431 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 74.09 24.02 74.7 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.154 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.32 125.88 14.13 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.657 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.239 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.224 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 . . . . . 0 N--CA 1.45 -0.447 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -172.33 -179.0 2.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.318 0.58 . . . . 0.0 111.837 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.3 m -126.7 143.27 51.29 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.151 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.429 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 14.2 m-85 -129.15 165.66 20.85 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.945 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.03 152.23 41.68 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.322 0.582 . . . . 0.0 112.148 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 tttp -156.47 113.14 3.09 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.868 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.9 mp -105.91 122.21 45.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.899 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.544 ' N ' ' CD1' ' A' ' 47' ' ' ILE . 0.3 OUTLIER -144.77 165.43 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.672 -179.145 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.6 m -115.23 125.89 53.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.266 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.0 p -120.61 117.25 52.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.885 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 69.88 25.9 4.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 110.118 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.38 -10.15 55.8 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -89.34 132.13 35.09 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -75.76 146.17 40.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.535 0.683 . . . . 0.0 111.203 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.417 ' OH ' ' OE2' ' A' ' 168' ' ' GLU . 5.1 m-85 -137.54 125.72 23.05 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.891 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.52 ' ND1' ' OG ' ' A' ' 6' ' ' SER . 1.3 t-80 -117.47 113.4 21.98 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mp -118.39 143.17 46.85 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.781 0.8 . . . . 0.0 111.822 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -140.44 120.52 13.73 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.047 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.64 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -115.85 154.33 29.89 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.331 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -130.89 144.15 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.267 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.41 102.93 7.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.449 -1.251 . . . . 0.0 108.306 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 121.38 0.61 . . . . 0.0 110.364 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.2 pt . . . . . 0 N--CA 1.434 -1.265 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.27 18.25 0.95 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.477 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -147.55 166.43 28.69 Favored Glycine 0 CA--C 1.519 0.339 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.622 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.9 123.08 7.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.851 -0.675 . . . . 0.0 111.2 178.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.6 tt -128.0 104.81 12.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.505 0.669 . . . . 0.0 109.296 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.625 ' H ' ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.53 122.17 40.28 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.144 -178.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -96.47 118.22 42.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.467 ' CZ ' ' CA ' ' A' ' 118' ' ' GLY . 25.5 p90 -112.12 144.69 41.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.465 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.635 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.5 p -86.94 135.7 33.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.844 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.6 m -72.35 19.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.991 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.553 ' H ' ' HG ' ' A' ' 86' ' ' SER . 5.5 t -136.65 -26.11 1.1 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.061 0.457 . . . . 0.0 112.099 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.635 ' H ' ' HG ' ' A' ' 86' ' ' SER . 18.3 t -93.14 93.74 8.45 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.095 -176.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 tp -60.45 -10.02 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.555 ' H ' ' C ' ' A' ' 89' ' ' SER . 15.6 mttp -75.48 -48.6 21.9 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 113.901 -1.5 . . . . 0.0 109.533 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.1 p -61.44 -30.92 70.88 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.906 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.427 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -73.24 -51.75 16.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.125 -179.437 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -62.77 -43.78 97.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.701 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.4 m -66.67 -34.51 70.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.084 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.8 mt -66.48 -36.08 76.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.591 -0.443 . . . . 0.0 109.904 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -70.07 -26.36 63.97 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.273 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.1 t -73.02 -67.03 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.895 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.5 tt -43.11 -40.37 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.214 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.614 ' CE1' ' CD1' ' A' ' 141' ' ' TRP . 1.1 t-160 -58.45 -63.57 1.23 Allowed 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.385 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -38.36 -58.42 1.68 Allowed Glycine 0 CA--C 1.519 0.3 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 105' ' ' ASP . 34.8 tptt -61.71 -62.75 1.58 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.953 -0.623 . . . . 0.0 110.365 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.64 -55.0 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.429 0.633 . . . . 0.0 109.579 179.375 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.46 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -49.17 -46.24 45.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.275 178.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.874 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.726 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.592 0.234 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.481 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.4 OUTLIER -138.3 148.2 58.62 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.098 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -48.7 114.59 1.28 Allowed 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 121.94 1.76 . . . . 0.0 112.824 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.481 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.2 mp -124.26 128.65 73.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 10.7 tpt -130.36 114.32 15.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.912 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.4 mt -97.65 98.66 10.07 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.3 t -104.98 129.45 57.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.944 0.878 . . . . 0.0 111.461 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.467 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -96.07 117.12 5.6 Favored Glycine 0 C--N 1.311 -0.83 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.485 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 58.7 t30 -97.47 174.14 6.82 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.994 -177.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.531 ' HZ1' ' C ' ' A' ' 17' ' ' VAL . 6.1 mttp 59.91 58.75 2.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.939 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.46 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 18.1 tttm -56.27 -26.05 50.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.568 -178.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.405 ' OD2' ' CD1' ' A' ' 123' ' ' LEU . 3.9 p-10 -72.72 -13.31 61.31 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.084 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.8 mp -91.18 -30.92 16.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.606 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.1 OUTLIER -38.93 -25.04 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.171 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.606 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 11.2 mtt -45.65 -23.95 0.3 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.473 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -105.17 -40.46 5.86 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.495 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.488 ' CZ ' ' OE1' ' A' ' 147' ' ' GLU . 2.6 tpp85 27.9 86.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.766 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.1 t -59.41 -32.6 49.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.396 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.29 153.04 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.531 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.543 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 78.3 p -96.89 121.94 39.32 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.304 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.402 ' HB2' HH12 ' A' ' 127' ' ' ARG . 13.8 t80 -37.01 -32.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.249 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.5 mp0 -70.51 -64.84 0.82 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.808 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.543 ' H ' ' HG ' ' A' ' 130' ' ' SER . 69.6 mt-10 -41.24 -42.52 2.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.724 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.15 -35.68 70.93 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 132' ' ' GLU . 4.2 tttt -61.97 -55.48 29.02 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.92 -35.72 69.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.821 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.61 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -66.27 -63.53 1.06 Allowed 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.85 -35.6 57.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.185 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -68.69 -32.35 72.11 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.173 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.664 ' HG ' ' N ' ' A' ' 141' ' ' TRP . 1.4 p -63.24 -46.24 87.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.792 -179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.664 ' N ' ' HG ' ' A' ' 140' ' ' SER . 30.9 m95 -88.51 -5.12 58.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.982 0.42 . . . . 0.0 110.335 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 141' ' ' TRP . 0.9 OUTLIER 77.41 23.69 0.85 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.384 0.611 . . . . 0.0 109.52 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.29 167.37 13.6 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.869 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -110.97 130.1 55.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.529 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -98.17 120.87 39.33 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.281 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.75 128.73 17.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.488 ' OE1' ' CZ ' ' A' ' 127' ' ' ARG . 6.4 mt-10 -100.28 119.76 38.89 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.043 0.449 . . . . 0.0 110.029 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 63.2 p -137.45 178.1 7.36 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.42 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.3 138.08 38.03 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.974 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.531 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -55.73 -49.82 72.01 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.143 0.497 . . . . 0.0 109.748 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.7 tttm -58.84 -3.12 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.284 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.531 ' H ' ' C ' ' A' ' 150' ' ' ALA . 6.7 tt0 -127.35 110.92 13.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.421 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -76.57 -47.21 23.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.684 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -41.3 -57.61 2.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.093 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.597 ' HG1' ' H ' ' A' ' 156' ' ' ALA . 78.0 p -52.74 -48.42 66.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.975 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.597 ' H ' ' HG1' ' A' ' 155' ' ' THR . . . -48.49 -60.56 2.59 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.516 0.674 . . . . 0.0 109.59 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 60.0 t -43.29 -49.58 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.088 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -53.76 -43.1 68.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.553 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.16 -44.12 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.304 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.412 ' O ' HG22 ' A' ' 163' ' ' ILE . 9.7 t80 -53.72 -40.48 66.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.168 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.3 ttt85 -77.09 -42.12 39.45 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.156 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -60.26 -34.44 73.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.189 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.457 HG22 ' H ' ' A' ' 164' ' ' ILE . 10.3 tt -70.73 -47.16 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 119.281 -0.968 . . . . 0.0 110.79 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.457 ' H ' HG22 ' A' ' 163' ' ' ILE . 85.5 mt -54.62 -32.07 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.289 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.21 -64.68 0.84 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.206 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -60.01 -29.67 68.64 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.493 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.33 -30.97 70.84 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.417 ' OE2' ' OH ' ' A' ' 54' ' ' TYR . 3.7 tp10 -68.06 -54.34 18.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.177 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -60.9 -61.09 2.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.884 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 74.2 mt -50.06 -36.96 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.814 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -70.86 -40.07 72.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.808 0.337 . . . . 0.0 110.605 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -55.16 -41.52 78.81 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.654 -0.979 . . . . 0.0 110.654 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.05 -61.99 1.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.756 0.313 . . . . 0.0 110.621 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.932 -179.832 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.516 ' OG ' ' ND1' ' A' ' 55' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 121.212 0.53 . . . . 0.0 110.185 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.22 136.05 34.58 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.489 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -106.16 132.28 52.41 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 1.1 mm -104.45 124.75 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-O 121.333 0.587 . . . . 0.0 110.242 -178.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.83 133.54 34.75 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.084 -1.01 . . . . 0.0 110.931 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.8 mt -95.56 133.72 35.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.657 0.741 . . . . 0.0 112.33 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.55 104.91 6.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.877 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -140.98 135.95 7.25 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.467 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -54.09 -158.18 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.769 0.795 . . . . 0.0 111.042 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -95.99 132.75 40.99 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.882 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.8 m 59.14 19.1 7.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.159 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.471 ' C ' ' NZ ' ' A' ' 120' ' ' LYS . 2.5 p -80.48 -10.76 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.801 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.42 7.66 51.23 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.402 ' CB ' ' NZ ' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -40.05 -59.26 1.26 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.118 0.485 . . . . 0.0 110.353 179.565 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -67.75 -26.97 66.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.449 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.0 m -64.39 -50.56 67.17 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.017 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.9 tp -75.83 -26.35 57.1 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.42 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.5 m -58.15 -50.9 71.89 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.4 mp -60.6 -43.73 95.28 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.406 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.541 ' OE1' ' N ' ' A' ' 31' ' ' PHE . 6.4 tt0 -69.69 -25.62 63.96 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.21 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -77.32 -49.94 13.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.246 0.546 . . . . 0.0 110.822 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.421 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 11.8 p -68.77 -45.1 81.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.139 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.421 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 2.8 tt0 -81.4 -24.94 36.61 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.466 ' O ' ' ND2' ' A' ' 153' ' ' ASN . . . 77.68 19.25 76.16 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.974 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.539 ' NE2' ' O ' ' A' ' 31' ' ' PHE . 16.8 tp60 -149.0 135.97 19.86 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.301 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.541 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 1.0 OUTLIER . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.567 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -161.97 -178.99 6.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.645 0.736 . . . . 0.0 112.95 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.2 m -137.43 144.3 42.28 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.11 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 12.3 m-85 -127.44 163.65 23.61 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.496 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.22 150.75 38.47 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.396 0.617 . . . . 0.0 112.661 -178.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.0 118.69 2.73 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.771 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.6 mp -105.82 129.3 54.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.654 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -147.65 165.83 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.798 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.4 m -115.79 126.4 53.97 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.197 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.403 ' CG1' ' CD1' ' A' ' 54' ' ' TYR . 7.2 p -121.28 118.95 57.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.94 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 71.27 17.36 5.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.12 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.37 -11.58 70.82 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -89.28 133.88 34.28 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.25 144.1 42.74 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.622 0.725 . . . . 0.0 111.163 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.419 ' OH ' ' OE2' ' A' ' 168' ' ' GLU . 6.6 m-85 -136.47 127.87 28.44 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.664 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.525 ' O ' ' ND1' ' A' ' 55' ' ' HIS . 1.2 t-80 -117.07 114.39 23.67 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 mp -117.69 143.72 45.92 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 122.078 0.942 . . . . 0.0 112.244 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -140.91 121.68 14.38 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 113.702 -1.59 . . . . 0.0 109.725 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.642 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -115.86 154.09 30.33 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.528 0.68 . . . . 0.0 112.347 -178.403 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.02 145.09 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-N 114.532 -1.213 . . . . 0.0 113.172 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.88 102.91 8.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.201 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.5 p . . . . . 0 N--CA 1.446 -0.661 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.07 -179.547 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 37.6 pt . . . . . 0 N--CA 1.438 -1.044 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.69 16.34 0.88 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.449 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -145.07 166.79 27.45 Favored Glycine 0 CA--C 1.519 0.319 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.317 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.82 122.5 7.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.911 -0.645 . . . . 0.0 111.28 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.425 ' O ' ' CG2' ' A' ' 82' ' ' ILE . 12.2 tt -127.55 101.04 6.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.562 0.696 . . . . 0.0 109.138 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.617 ' H ' ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -96.86 123.44 40.56 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.376 -178.52 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -96.84 119.67 45.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.97 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.635 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 32.1 p90 -121.64 144.72 48.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.675 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.584 ' HG ' ' H ' ' A' ' 88' ' ' THR . 1.7 p -87.82 143.28 27.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.735 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.8 m -80.67 20.32 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.778 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.584 ' H ' ' HG ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -131.05 -27.82 2.01 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.119 0.485 . . . . 0.0 111.936 -178.101 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.556 ' C ' ' H ' ' A' ' 91' ' ' LYS . 44.2 t -97.08 93.94 6.87 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.674 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 tp -58.58 -10.75 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.556 ' H ' ' C ' ' A' ' 89' ' ' SER . 2.6 mtpt -76.07 -50.82 13.7 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.052 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.477 ' O ' ' CG1' ' A' ' 96' ' ' ILE . 59.1 p -60.34 -31.88 70.73 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.01 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -75.56 -46.17 33.55 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.081 -179.337 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -66.02 -44.1 85.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.25 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.4 m -68.17 -39.8 81.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.621 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.477 ' CG1' ' O ' ' A' ' 92' ' ' SER . 1.4 mm -59.18 -42.45 86.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.289 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.49 -27.25 64.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.305 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.0 t -75.55 -66.97 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.166 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.6 mm -41.84 -45.49 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.043 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.443 ' ND1' ' C ' ' A' ' 100' ' ' HIS . 9.7 t-80 -56.53 -63.51 1.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.691 -0.403 . . . . 0.0 109.985 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.426 ' N ' ' HD1' ' A' ' 100' ' ' HIS . . . -40.63 -58.57 2.54 Favored Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 103' ' ' LEU . 14.0 tptp -55.8 -66.09 0.48 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.037 -0.582 . . . . 0.0 110.249 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.45 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.98 -59.84 0.8 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.275 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.481 ' CD2' ' CZ3' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -46.06 -47.72 17.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.577 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.313 -0.988 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.998 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 . . . . . 0 CA--C 1.52 -0.174 0 CA-C-O 120.941 0.401 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.454 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.7 OUTLIER -119.55 155.74 54.06 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.023 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -47.43 106.01 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.529 1.486 . . . . 0.0 112.335 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.454 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.8 mt -119.8 128.56 75.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 10.1 tpt -127.25 116.83 21.18 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.789 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 mt -96.02 97.25 9.45 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.5 t -103.72 133.19 48.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 122.406 1.098 . . . . 0.0 110.371 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.79 113.07 4.11 Favored Glycine 0 C--N 1.299 -1.509 0 CA-C-N 113.265 -1.789 . . . . 0.0 109.032 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.534 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 48.5 t30 -96.88 177.22 5.7 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.279 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.534 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 26.8 mttp 61.96 58.35 1.92 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.016 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.46 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 15.7 tttm -63.48 -31.27 72.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.495 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -63.58 -8.92 11.03 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.003 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 125' ' ' MET . 8.6 mp -93.67 -27.0 16.8 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.59 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.1 OUTLIER -39.3 -24.47 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.858 178.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.59 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 2.7 mmt -46.12 -22.27 0.21 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.502 ' CD ' ' HG1' ' A' ' 88' ' ' THR . 0.3 OUTLIER -106.67 -36.54 6.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.063 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.492 ' NH2' ' CD2' ' A' ' 131' ' ' TYR . 0.1 OUTLIER 33.11 88.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.851 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.6 t -72.05 -38.05 62.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.553 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 tp -89.92 155.63 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.427 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.467 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 62.0 p -103.03 125.44 49.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.949 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.492 ' CD2' ' NH2' ' A' ' 127' ' ' ARG . 0.8 OUTLIER -37.32 -35.91 0.13 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.574 179.13 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.6 mp0 -67.16 -64.75 0.79 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.054 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.467 ' H ' ' HG ' ' A' ' 130' ' ' SER . 64.6 mt-10 -41.21 -41.52 1.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.979 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.83 -36.3 65.91 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 132' ' ' GLU . 3.6 ttpp -61.69 -55.15 33.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.048 -0.576 . . . . 0.0 109.587 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.69 70.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.865 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.482 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -66.23 -61.66 1.9 Allowed 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.658 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -53.41 -35.78 60.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.34 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -68.85 -29.94 68.37 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.43 -46.65 82.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.715 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.482 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 33.0 m95 -89.35 -4.25 58.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.027 0.442 . . . . 0.0 110.194 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.409 ' O ' ' OE1' ' A' ' 166' ' ' GLU . 0.9 OUTLIER 76.52 22.46 1.22 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.403 -179.084 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -89.29 170.9 10.18 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.595 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -109.65 134.75 51.59 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.428 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 7.0 t80 -96.66 122.36 39.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.929 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -133.17 137.7 46.32 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.346 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.456 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 9.1 tt0 -127.38 110.64 13.01 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 36.3 p -136.56 -172.81 3.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.21 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.68 139.57 40.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.716 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.525 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -64.84 -30.97 72.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.287 0.565 . . . . 0.0 109.97 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -79.78 13.65 2.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.029 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -144.19 121.03 11.27 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.745 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 9.5 t-20 -77.59 -54.51 6.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.408 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 153' ' ' ASN . 7.6 tt0 -37.09 -55.33 0.96 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.823 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 60.2 p -57.01 -50.73 71.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.275 0.559 . . . . 0.0 110.158 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -47.68 -59.96 2.9 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.561 0.696 . . . . 0.0 109.574 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.9 t -41.28 -53.35 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.626 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -48.94 -33.1 10.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.733 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 156' ' ' ALA . 10.3 t -76.55 -28.54 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.608 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -68.55 -40.71 80.55 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.727 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.507 ' N ' ' CD1' ' A' ' 160' ' ' PHE . 27.6 ttm-85 -79.6 -50.57 10.48 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.196 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -54.53 -36.92 64.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.226 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 160' ' ' PHE . 11.9 tt -69.01 -58.25 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.322 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.424 ' H ' ' CG2' ' A' ' 163' ' ' ILE . 84.1 mt -46.68 -33.02 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.91 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.25 -64.62 0.87 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.295 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.409 ' OE1' ' O ' ' A' ' 142' ' ' ASN . 3.2 mm-40 -61.21 -26.47 67.75 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.454 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.1 -36.8 73.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.419 ' OE2' ' OH ' ' A' ' 54' ' ' TYR . 11.5 mm-40 -69.73 -52.06 28.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.273 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -54.59 -60.22 3.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.515 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 71.2 mt -50.0 -35.2 10.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.764 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.17 -39.92 90.13 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -60.4 -32.13 76.37 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.0 -76.59 0.09 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.168 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.061 179.871 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 121.166 0.508 . . . . 0.0 110.369 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.8 135.73 33.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.579 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -107.58 128.33 54.43 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 1.0 OUTLIER -101.97 121.66 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-O 121.535 0.684 . . . . 0.0 110.351 -178.469 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.99 135.55 34.4 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 121.426 -0.796 . . . . 0.0 111.062 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.8 mt -95.57 131.39 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.458 0.647 . . . . 0.0 112.226 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.412 ' C ' ' CD2' ' A' ' 12' ' ' LEU . 6.3 tt -130.58 103.67 6.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.215 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.08 135.32 6.84 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.734 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.478 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -53.72 -160.82 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.366 0.603 . . . . 0.0 110.535 179.168 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.404 ' NE ' ' OG ' ' A' ' 16' ' ' SER . 10.1 ttp180 -96.14 135.94 37.27 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.86 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.502 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 5.1 m 60.08 19.34 8.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.574 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.434 ' C ' ' NZ ' ' A' ' 120' ' ' LYS . 3.6 p -76.69 -19.75 14.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.737 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.34 21.63 26.67 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.531 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.7 pttm -68.17 -33.97 75.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.928 0.394 . . . . 0.0 110.016 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.7 m -73.16 -38.75 66.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.532 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.8 p -62.16 -40.4 95.86 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.402 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.7 tp -77.75 -25.44 49.17 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.26 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.4 m -63.67 -38.24 90.39 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.4 mp -74.92 -38.54 43.69 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.214 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.56 ' OE1' ' N ' ' A' ' 31' ' ' PHE . 5.9 tt0 -75.04 -25.48 58.72 Favored 'General case' 0 C--O 1.217 -0.618 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.154 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 23.1 t80 -76.59 -52.82 8.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.29 0.567 . . . . 0.0 110.766 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 11.3 p -62.28 -45.96 97.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.906 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.419 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 1.1 tm-20 -82.22 -24.54 34.81 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.466 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 77.24 18.01 78.79 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.799 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -146.68 134.19 20.89 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.56 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.47 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.428 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 2.3 pm0 . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.682 0.277 . . . . 0.0 110.381 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER 176.44 179.79 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.332 0.587 . . . . 0.0 111.962 -179.31 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.408 ' H ' ' HG1' ' A' ' 42' ' ' THR . 0.2 OUTLIER -107.69 140.49 40.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.666 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.418 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 12.1 m-85 -127.9 163.53 24.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.638 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.6 155.8 44.39 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.295 0.569 . . . . 0.0 112.363 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -160.97 111.68 1.76 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.899 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.1 mp -105.1 127.1 52.74 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.793 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -148.85 165.6 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.5 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.2 m -114.66 126.51 54.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.557 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.458 ' C ' ' H ' ' A' ' 51' ' ' GLY . 7.4 p -123.4 135.04 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.842 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 m120 62.6 3.97 1.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.029 0.442 . . . . 0.0 109.829 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 102.69 -13.23 56.52 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.423 ' NE2' ' H ' ' A' ' 53' ' ' GLU . 43.9 tp60 -90.29 140.37 29.76 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.423 ' H ' ' NE2' ' A' ' 52' ' ' GLN . 3.4 mt-10 -77.09 147.23 36.77 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.525 0.679 . . . . 0.0 111.303 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.542 ' C ' ' HD1' ' A' ' 55' ' ' HIS . 13.9 m-85 -139.76 123.04 17.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.799 -1.092 . . . . 0.0 109.911 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.542 ' HD1' ' C ' ' A' ' 54' ' ' TYR . 0.7 OUTLIER -117.48 113.79 22.54 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mp -118.84 145.9 45.3 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.641 0.734 . . . . 0.0 112.143 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -139.18 124.09 18.74 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.053 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.633 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.96 154.99 29.9 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.279 0.561 . . . . 0.0 112.463 -178.248 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.96 144.41 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.779 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.35 104.37 8.14 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.831 177.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.47 0 CA-C-O 121.128 0.489 . . . . 0.0 110.511 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 40.6 pt . . . . . 0 N--CA 1.439 -1.008 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.24 16.33 0.93 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.144 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.02 166.47 28.91 Favored Glycine 0 CA--C 1.516 0.152 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.73 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.98 123.17 7.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.711 -0.744 . . . . 0.0 111.481 178.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 10.8 tt -127.07 104.24 12.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.628 0.728 . . . . 0.0 109.064 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.603 ' H ' ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.32 123.29 41.09 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.784 -178.332 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -96.65 118.13 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.468 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.556 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 27.9 p90 -120.28 144.52 47.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.581 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.682 ' HG ' ' H ' ' A' ' 89' ' ' SER . 4.8 p -87.89 142.15 28.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.499 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.5 m -76.15 18.7 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.245 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.605 ' H ' ' HG ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -133.18 -23.38 1.94 Allowed 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.063 0.459 . . . . 0.0 111.752 -178.342 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.682 ' H ' ' HG ' ' A' ' 86' ' ' SER . 22.7 t -93.71 93.47 8.03 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.96 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 tp -59.69 -11.76 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.54 ' N ' ' C ' ' A' ' 89' ' ' SER . 9.3 mttp -78.07 -51.23 10.62 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.458 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.463 ' HG ' ' N ' ' A' ' 93' ' ' PHE . 83.0 p -56.48 -34.91 67.37 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.374 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.556 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.5 OUTLIER -70.8 -54.85 10.09 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.415 -179.278 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -63.0 -44.41 96.1 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.7 m -64.79 -34.4 69.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.034 -0.667 . . . . 0.0 110.186 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.8 mt -65.2 -35.61 75.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.087 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.0 tttp -69.97 -27.56 64.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.546 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.8 t -76.95 -67.27 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.281 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.6 mp -43.41 -45.31 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.4 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.402 ' CE1' ' CE2' ' A' ' 141' ' ' TRP . 6.6 t-80 -60.09 -58.36 8.88 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.504 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.68 -57.7 1.52 Allowed Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.866 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 105' ' ' ASP . 10.9 tptm -58.68 -66.65 0.46 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.274 -0.463 . . . . 0.0 110.574 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.7 OUTLIER -37.05 -62.25 0.51 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.479 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -42.86 -47.92 5.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.359 178.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.79 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.258 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 120.848 0.356 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.43 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -112.81 150.36 42.67 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.408 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -48.55 107.54 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.707 1.604 . . . . 0.0 112.857 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.43 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.9 mt -120.61 126.5 75.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 8.3 tpt -126.47 115.28 19.33 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.237 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.3 mt -96.02 97.82 9.89 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.58 132.56 49.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 122.135 0.969 . . . . 0.0 110.574 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.75 109.47 3.2 Favored Glycine 0 C--N 1.304 -1.239 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.517 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.6 t30 -97.24 175.62 6.21 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.182 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.517 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 2.9 mttp 66.25 59.54 0.66 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 122.026 0.917 . . . . 0.0 109.291 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.509 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 19.2 tttm -63.77 -37.88 89.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.053 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -60.45 -5.61 1.25 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.783 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 125' ' ' MET . 8.2 mp -91.95 -26.88 18.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.509 ' ND1' ' O ' ' A' ' 121' ' ' LYS . 13.2 p-80 -38.97 -24.97 0.01 OUTLIER 'General case' 0 C--N 1.339 0.124 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.719 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.536 ' N ' ' O ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -46.51 -22.89 0.31 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.293 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.479 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -110.38 -37.55 5.48 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.666 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.474 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 0.1 OUTLIER 29.65 91.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.886 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 46.1 t -72.37 -36.75 56.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.193 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.7 tp -89.57 154.74 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.634 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.503 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 99.5 p -101.55 127.24 48.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.742 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -40.63 -34.0 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.988 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -68.51 -65.42 0.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.988 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.503 ' H ' ' HG ' ' A' ' 130' ' ' SER . 63.6 mt-10 -41.38 -41.61 2.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.933 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.06 -34.7 64.72 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 132' ' ' GLU . 3.2 tttm -63.96 -55.27 23.72 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.28 -35.34 67.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.68 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.444 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -65.54 -62.09 1.72 Allowed 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -53.12 -38.41 62.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.226 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -33.28 75.51 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.736 0.303 . . . . 0.0 110.245 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.8 -46.11 86.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.828 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.444 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 42.2 m95 -89.09 1.04 56.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.695 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 6.5 m120 68.38 32.92 4.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.652 0.739 . . . . 0.0 109.58 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -100.84 169.04 9.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.862 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.14 133.79 51.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.305 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 5.2 t80 -96.9 123.39 40.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.814 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -134.74 137.14 43.2 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.862 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.474 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 6.2 tt0 -126.39 111.17 14.16 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 34.7 p -137.15 -173.85 3.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.134 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.0 136.09 34.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.919 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.517 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -63.79 -26.73 68.76 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.25 4.37 12.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.723 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -138.85 122.6 17.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.11 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 154' ' ' GLN . 4.8 t-20 -77.42 -55.48 5.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.614 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 153' ' ' ASN . 10.2 tt0 -36.91 -56.03 0.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.96 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 67.6 p -55.59 -46.12 77.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.021 0.439 . . . . 0.0 110.297 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -54.53 -62.08 1.89 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.952 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 61.5 t -43.0 -39.94 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.435 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.77 -33.11 75.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.59 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 156' ' ' ALA . 32.4 t -70.72 -35.38 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.954 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -64.32 -65.69 0.64 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.561 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.1 ttm-85 -48.41 -43.33 34.03 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.759 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -58.51 -33.37 69.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.456 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.27 -34.29 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.917 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.4 ' O ' ' CB ' ' A' ' 167' ' ' ALA . 11.1 mt -63.5 -48.18 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.267 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -55.47 -59.93 4.13 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.552 179.609 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.466 ' O ' ' CG1' ' A' ' 170' ' ' ILE . 4.5 tt0 -51.31 -24.03 4.2 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 164' ' ' ILE . . . -71.34 -31.14 67.03 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.935 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 165' ' ' LEU . 0.4 OUTLIER -70.74 -54.72 10.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.886 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -60.05 -50.23 74.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.068 0.461 . . . . 0.0 110.565 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.466 ' CG1' ' O ' ' A' ' 166' ' ' GLU . 3.1 mm -49.64 -42.98 18.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.966 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -66.29 -39.76 89.57 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.339 -179.579 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.37 -41.94 55.91 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.14 -79.88 0.06 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.754 0.312 . . . . 0.0 110.474 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.022 -179.904 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.171 0.51 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.97 135.64 32.96 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.647 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -107.21 128.53 54.5 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 1.0 OUTLIER -102.3 122.97 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 121.507 0.67 . . . . 0.0 110.469 -178.511 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.405 ' O ' HG21 ' A' ' 82' ' ' ILE . . . -83.9 134.27 34.69 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.373 -0.83 . . . . 0.0 111.606 -177.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.6 mt -95.44 130.16 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.523 0.678 . . . . 0.0 112.14 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.416 ' C ' ' CD2' ' A' ' 12' ' ' LEU . 5.1 tt -127.91 102.55 6.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.54 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.12 136.45 7.53 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.485 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -51.94 -161.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.676 0.751 . . . . 0.0 111.321 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -94.14 131.79 39.32 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.666 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.474 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 4.1 m 60.54 20.09 9.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.472 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 p -74.7 -19.59 16.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.606 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.452 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 98.13 20.17 21.56 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.472 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.1 pttm -69.2 -34.81 75.48 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.318 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.9 m -73.45 -30.39 63.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.419 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 65.5 p -67.8 -40.86 83.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.409 ' O ' ' CB ' ' A' ' 26' ' ' PHE . 46.1 tp -77.5 -26.49 51.27 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.759 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.5 m -62.77 -41.51 99.27 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.59 -41.6 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.606 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.499 ' OE1' ' CB ' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -71.88 -27.29 62.76 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.663 -179.42 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.409 ' CB ' ' O ' ' A' ' 22' ' ' LEU . 52.8 t80 -77.94 -62.05 1.8 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.303 0.573 . . . . 0.0 110.691 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.445 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 11.8 p -48.09 -48.9 12.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.804 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.445 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 2.4 mt-10 -80.42 -24.3 39.74 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.451 ' O ' ' ND2' ' A' ' 153' ' ' ASN . . . 72.76 25.47 73.86 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -150.29 126.63 10.73 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.732 0.301 . . . . 0.0 111.338 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.614 ' O ' ' CD1' ' A' ' 31' ' ' PHE . 0.1 OUTLIER . . . . . 0 CA--C 1.536 0.424 0 CA-C-O 122.02 0.915 . . . . 0.0 110.691 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -164.19 -176.69 4.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.236 0.541 . . . . 0.0 111.982 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.411 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 4.0 m -133.14 152.77 51.93 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.13 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.455 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 11.9 m-85 -133.17 162.94 30.42 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 111.008 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.61 152.34 43.91 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.537 0.684 . . . . 0.0 112.487 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -157.11 111.01 2.64 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.407 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.531 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 7.2 mp -105.2 127.28 52.85 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.491 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.61 165.13 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.708 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.4 m -114.61 126.67 55.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.924 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.95 123.35 65.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.819 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 70.95 19.79 5.56 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.91 -9.77 62.09 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -90.91 134.93 34.08 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.01 145.5 40.19 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.561 0.696 . . . . 0.0 111.058 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.459 ' C ' ' HD1' ' A' ' 55' ' ' HIS . 9.3 m-85 -139.44 125.14 19.47 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.778 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.459 ' HD1' ' C ' ' A' ' 54' ' ' TYR . 1.2 m-70 -117.44 113.65 22.36 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.47 ' CD2' ' N ' ' A' ' 56' ' ' LEU . 2.1 mm? -119.23 140.0 50.95 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 121.509 0.671 . . . . 0.0 111.629 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -136.76 124.98 23.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.777 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.645 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.13 148.86 39.87 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.916 -178.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -118.49 141.5 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 114.998 -1.001 . . . . 0.0 113.165 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -114.42 101.65 9.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.333 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.473 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.7 pt . . . . . 0 N--CA 1.437 -1.124 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.41 14.27 0.98 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.578 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -142.29 165.79 26.59 Favored Glycine 0 N--CA 1.454 -0.114 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.179 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.82 122.41 7.4 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.767 -0.717 . . . . 0.0 111.205 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.405 HG21 ' O ' ' A' ' 10' ' ' ALA . 11.3 tt -125.28 103.83 12.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.616 ' H ' ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -96.32 126.73 41.73 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.407 -177.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 t -96.07 113.68 31.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.43 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -110.37 146.05 36.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.734 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.717 ' HG ' ' H ' ' A' ' 88' ' ' THR . 1.0 OUTLIER -100.55 143.48 30.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.077 0.465 . . . . 0.0 111.881 -177.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.3 m -81.15 21.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.633 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.717 ' H ' ' HG ' ' A' ' 86' ' ' SER . 1.0 OUTLIER -140.55 -17.76 0.88 Allowed 'General case' 0 C--O 1.231 0.097 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.541 ' C ' ' N ' ' A' ' 91' ' ' LYS . 43.8 t -112.7 93.46 4.44 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.41 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 30.5 mm -50.84 -15.6 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.541 ' N ' ' C ' ' A' ' 89' ' ' SER . 0.4 OUTLIER -78.31 -49.14 14.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.244 179.287 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.592 ' HG ' ' H ' ' A' ' 86' ' ' SER . 85.7 p -59.74 -44.6 93.74 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.517 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -79.3 -34.02 42.79 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 119.354 -0.939 . . . . 0.0 112.533 -178.126 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.41 ' CG ' ' O ' ' A' ' 90' ' ' ILE . 8.9 mm-40 -69.84 -44.98 68.8 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.15 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 91' ' ' LYS . 28.1 m -64.99 -37.37 80.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.645 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.428 HG22 HD13 ' A' ' 96' ' ' ILE . 1.3 mt -61.74 -36.03 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -70.1 -25.79 63.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.333 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.5 t -76.1 -67.22 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.5 mp -42.81 -40.68 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.616 ' NE2' ' CD1' ' A' ' 141' ' ' TRP . 25.7 t-80 -60.32 -63.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.673 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.82 -50.6 2.0 Favored Glycine 0 CA--C 1.518 0.267 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 105' ' ' ASP . 12.7 tptm -66.03 -65.79 0.63 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.273 -0.464 . . . . 0.0 110.106 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.36 -58.75 0.81 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.496 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -47.0 -43.82 19.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.677 178.737 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.838 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.374 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.657 0.265 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.06 155.78 80.92 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -48.69 107.43 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.689 1.593 . . . . 0.0 112.174 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.6 mt -123.84 129.18 74.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 8.7 tpt -128.85 117.42 21.01 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.329 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.1 mt -97.34 97.59 9.26 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.7 t -104.45 134.22 46.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 122.196 0.998 . . . . 0.0 110.958 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -104.88 116.44 5.29 Favored Glycine 0 C--N 1.302 -1.313 0 CA-C-N 113.699 -1.592 . . . . 0.0 109.234 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.522 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 50.1 t30 -98.0 173.87 6.84 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.718 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.522 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 25.5 mttt 61.17 58.67 2.16 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.624 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.527 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -60.2 -35.24 74.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.282 -179.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -61.15 -13.63 19.11 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.488 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 125' ' ' MET . 9.8 mp -88.1 -31.37 19.25 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.527 ' ND1' ' O ' ' A' ' 121' ' ' LYS . 2.5 p-80 -37.67 -26.46 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.976 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.536 ' N ' ' O ' ' A' ' 123' ' ' LEU . 6.9 mmt -43.93 -24.64 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.454 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.3 OUTLIER -103.23 -34.94 8.63 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.815 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.458 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 1.6 tpt180 38.39 92.82 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.23 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.6 m -85.4 -35.43 9.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.312 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.48 130.0 39.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.523 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 92.4 p -77.1 122.19 24.62 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.946 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -40.56 -38.38 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.322 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -60.98 -64.21 1.03 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.011 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.523 ' H ' ' HG ' ' A' ' 130' ' ' SER . 64.2 mt-10 -41.11 -49.91 3.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.179 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.33 -25.72 74.56 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 132' ' ' GLU . 13.1 tttm -71.26 -55.98 6.98 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -55.95 -33.01 64.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.296 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.621 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -66.53 -62.97 1.18 Allowed 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.807 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -53.65 -36.89 62.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.312 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -69.56 -30.29 68.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.474 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.637 ' HG ' ' N ' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -63.63 -47.15 82.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.02 -178.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.637 ' N ' ' HG ' ' A' ' 140' ' ' SER . 8.4 m95 -91.52 -5.27 54.41 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.355 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 141' ' ' TRP . 0.9 OUTLIER 77.45 26.01 0.71 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.779 -179.271 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.45 170.11 11.19 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.218 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.19 133.39 50.03 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.906 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.451 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 6.5 t80 -97.06 122.96 40.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.767 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -133.12 138.81 46.8 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.939 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.458 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 4.9 tt0 -127.5 110.01 12.31 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.434 ' CB ' ' OG1' ' A' ' 155' ' ' THR . 0.1 OUTLIER -136.37 -178.38 5.14 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.676 -178.014 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.482 ' HG ' ' HZ1' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -138.77 132.79 31.24 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.39 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.513 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -54.41 -53.07 59.0 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.112 0.482 . . . . 0.0 109.843 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -51.28 -8.74 0.05 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.938 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.513 ' H ' ' C ' ' A' ' 150' ' ' ALA . 18.7 mt-10 -131.4 119.2 21.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.978 0.418 . . . . 0.0 110.657 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 10.2 t-20 -75.35 -48.25 23.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.195 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 153' ' ' ASN . 0.5 OUTLIER -36.71 -59.48 0.67 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.023 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.434 ' OG1' ' CB ' ' A' ' 148' ' ' SER . 1.5 p -54.43 -46.64 73.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.169 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.499 ' CB ' ' OE1' ' A' ' 25' ' ' GLN . . . -51.45 -59.4 4.28 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.524 0.678 . . . . 0.0 109.584 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 50.5 t -42.36 -48.43 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.67 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -54.02 -33.07 56.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.525 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 156' ' ' ALA . 11.6 t -77.06 -27.67 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.982 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.44 ' O ' HG22 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -68.64 -41.63 79.13 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.5 179.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.7 ttm-85 -79.86 -49.98 11.16 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.961 -0.695 . . . . 0.0 110.928 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -53.47 -37.88 63.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.31 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 160' ' ' PHE . 13.0 tt -68.39 -56.7 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.403 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.406 ' N ' ' CG2' ' A' ' 163' ' ' ILE . 84.7 mt -47.9 -33.87 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.975 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.8 -64.42 0.95 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.059 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -58.53 -28.57 65.59 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.532 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.56 -33.53 71.53 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.404 ' OE1' ' OH ' ' A' ' 54' ' ' TYR . 33.5 tp10 -68.73 -57.15 6.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.329 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 13.2 tttm -52.49 -56.72 13.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.636 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 66.3 mt -52.84 -34.2 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.137 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 172' ' ' GLY . 0.0 OUTLIER -68.9 -40.45 79.14 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.611 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.414 ' N ' ' OD1' ' A' ' 171' ' ' ASP . . . -60.3 -35.83 89.3 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.07 -60.77 2.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.803 0.335 . . . . 0.0 110.494 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.792 179.964 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 121.174 0.512 . . . . 0.0 110.445 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.84 136.39 33.95 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.611 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -106.66 121.28 44.03 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -98.95 117.2 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-O 121.824 0.821 . . . . 0.0 110.027 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.433 ' HB1' ' CE1' ' A' ' 81' ' ' TYR . . . -83.82 136.23 34.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.096 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.5 mt -95.27 132.81 38.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.23 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.423 ' C ' ' CD2' ' A' ' 12' ' ' LEU . 6.3 tt -127.65 104.05 7.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.392 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.39 134.87 6.51 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.691 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.446 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -55.05 -159.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.3 0.571 . . . . 0.0 110.582 179.187 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -92.61 133.28 36.12 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.952 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.513 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 7.7 m 56.58 19.46 4.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.546 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 p -69.85 -27.34 32.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.794 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.448 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 105.1 23.51 7.67 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.418 ' CE ' ' OD2' ' A' ' 60' ' ' ASP . 3.5 pttm -71.18 -33.59 70.13 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.356 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.2 m -75.75 -30.92 59.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.156 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 72.4 p -65.28 -54.15 33.53 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.056 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 23' ' ' THR . 24.7 tp -62.91 -52.06 64.53 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.731 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.442 ' C ' ' O ' ' A' ' 22' ' ' LEU . 9.2 m -36.47 -64.12 0.35 Allowed 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 122.976 0.172 . . . . 0.0 110.774 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -57.45 -41.72 79.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.144 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 30' ' ' GLN . 0.6 OUTLIER -66.99 -35.92 81.03 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.263 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.494 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.6 OUTLIER -77.54 -62.81 1.54 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.369 0.604 . . . . 0.0 110.705 -179.636 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.486 ' N ' ' CG ' ' A' ' 26' ' ' PHE . 9.1 p -44.77 -49.29 2.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.488 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.475 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 0.8 OUTLIER -79.78 -24.54 41.4 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.081 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 74.96 26.66 66.21 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.784 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 31' ' ' PHE . 10.6 tp60 -147.91 125.89 12.04 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.895 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.528 ' O ' ' NE2' ' A' ' 30' ' ' GLN . 1.2 t80 . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.606 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 2.6 pt-20 . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 1.4 m120 -177.47 174.48 1.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.235 0.541 . . . . 0.0 112.072 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.31 146.48 32.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.699 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.458 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 7.2 m-85 -131.7 164.16 26.55 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.318 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.84 156.67 42.96 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.328 0.585 . . . . 0.0 112.071 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -160.15 111.36 1.93 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.698 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mp -104.81 121.01 42.75 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.943 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.1 pp -147.72 165.16 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.595 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -111.82 127.97 55.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.99 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.43 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 2.5 p -128.16 124.86 63.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.526 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 49' ' ' VAL . 1.9 t-20 73.23 10.71 5.11 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.19 -11.87 71.04 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -91.21 137.84 32.06 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -76.4 146.06 38.94 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.578 0.704 . . . . 0.0 111.023 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.504 ' C ' ' HD1' ' A' ' 55' ' ' HIS . 8.2 m-85 -135.87 126.78 27.62 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.459 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.504 ' HD1' ' C ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -117.52 113.73 22.43 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.415 ' CD2' ' N ' ' A' ' 56' ' ' LEU . 2.9 mm? -119.39 138.61 52.97 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 121.356 0.598 . . . . 0.0 111.356 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -126.99 127.3 44.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.087 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 3.4 mp -114.43 154.83 27.45 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.098 0.475 . . . . 0.0 112.182 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.12 143.99 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 CA-C-O 122.035 0.921 . . . . 0.0 112.72 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.425 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -125.26 105.14 8.9 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.189 -1.369 . . . . 0.0 107.893 177.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.46 ' H ' ' HG1' ' A' ' 61' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.443 -0.819 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.51 -178.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 37.8 pt . . . . . 0 N--CA 1.433 -1.293 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.68 13.73 1.19 Allowed 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.41 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.24 163.29 28.92 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.487 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.433 ' CE1' ' HB1' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -151.45 123.46 8.15 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.787 -0.706 . . . . 0.0 111.094 177.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.5 tt -126.93 106.81 16.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.661 0.743 . . . . 0.0 109.146 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.32 122.5 40.42 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.459 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 t -97.04 114.53 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.456 ' CZ ' ' CA ' ' A' ' 118' ' ' GLY . 26.2 p90 -115.4 144.58 43.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.704 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.668 ' HG ' ' H ' ' A' ' 88' ' ' THR . 3.4 p -87.11 141.93 28.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.068 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.2 m -73.7 18.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.639 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.668 ' H ' ' HG ' ' A' ' 86' ' ' SER . 6.4 t -138.91 -22.07 0.96 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.666 ' H ' ' HG ' ' A' ' 86' ' ' SER . 22.9 t -90.83 93.07 9.07 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.201 -176.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.6 tp -59.11 -10.69 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.55 ' H ' ' C ' ' A' ' 89' ' ' SER . 6.9 mttm -77.84 -51.5 10.38 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.18 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.489 ' HG ' ' N ' ' A' ' 93' ' ' PHE . 53.5 p -57.68 -31.74 66.65 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.674 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.489 ' N ' ' HG ' ' A' ' 92' ' ' SER . 0.5 OUTLIER -75.39 -47.66 26.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.89 -179.541 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -63.35 -43.24 98.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.863 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.6 m -67.02 -38.97 82.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.197 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.2 mt -59.4 -38.47 75.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.1 tttp -73.13 -26.63 61.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.836 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 64.0 t -77.37 -67.15 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.985 0.422 . . . . 0.0 110.033 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.5 pp -45.23 -39.78 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.174 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.62 ' NE2' ' CE2' ' A' ' 141' ' ' TRP . 18.3 t60 -62.56 -61.34 2.5 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.235 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 100' ' ' HIS . . . -35.87 -48.68 1.05 Allowed Glycine 0 C--N 1.33 0.25 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 105' ' ' ASP . 1.9 tppt? -68.8 -66.68 0.54 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.429 -0.385 . . . . 0.0 110.03 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.87 -59.1 0.86 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.13 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.481 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -45.9 -45.39 15.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.487 178.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.706 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.833 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.79 0.328 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.476 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.4 OUTLIER -143.35 151.21 54.22 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.775 179.329 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -48.29 111.82 0.5 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.763 1.642 . . . . 0.0 112.407 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.476 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.8 mt -126.86 132.41 70.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.7 tpt -130.85 114.69 15.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.951 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.1 mt -96.74 98.13 9.91 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.2 t -105.03 130.79 55.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 122.153 0.978 . . . . 0.0 111.395 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.456 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -97.83 114.78 5.09 Favored Glycine 0 C--N 1.307 -1.043 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.522 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.9 t30 -97.49 173.99 6.89 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.025 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.522 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 23.2 mttt 60.4 58.87 2.42 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.712 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.498 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 17.3 tttm -60.48 -32.6 71.58 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -60.8 -18.05 53.07 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.956 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 125' ' ' MET . 11.0 mp -85.86 -26.39 25.68 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.6 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.1 OUTLIER -40.27 -24.63 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.854 179.094 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.6 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 15.1 mtt -46.72 -22.53 0.31 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.462 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -108.28 -42.5 4.59 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.564 -179.654 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.5 ' NE ' ' OE1' ' A' ' 147' ' ' GLU . 22.6 ttm180 26.44 83.61 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.868 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.5 m -62.91 -28.84 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.696 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.4 tp -89.54 155.65 3.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.566 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.53 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 57.9 p -97.66 120.51 38.18 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.996 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -39.85 -29.41 0.06 Allowed 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.4 mp0 -70.26 -63.75 1.03 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.895 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.53 ' H ' ' HG ' ' A' ' 130' ' ' SER . 57.7 mt-10 -41.2 -42.25 2.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.742 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.35 -34.89 63.69 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 132' ' ' GLU . 2.9 tttm -62.04 -55.03 33.26 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.02 -36.66 70.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.75 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.627 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -66.13 -62.87 1.25 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.159 0.504 . . . . 0.0 109.692 179.58 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.45 -35.12 51.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.122 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.03 -30.47 67.76 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.41 -46.86 84.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.757 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.627 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 15.0 m95 -90.5 -5.75 55.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.363 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 141' ' ' TRP . 1.1 t-20 78.73 24.8 0.55 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.008 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.31 167.6 13.4 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.712 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.65 128.83 54.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.975 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 5.9 t80 -97.95 121.38 39.79 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.768 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.08 126.4 14.85 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.5 ' OE1' ' NE ' ' A' ' 127' ' ' ARG . 7.8 mt-10 -99.16 117.26 33.24 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.2 p -137.47 -178.69 5.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.658 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 152' ' ' GLU . 0.1 OUTLIER -138.6 138.77 38.21 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.272 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -57.28 -48.0 80.02 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -55.83 -18.4 8.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.128 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 149' ' ' SER . 38.7 mt-10 -113.53 116.13 29.07 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.942 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 154' ' ' GLN . 6.4 t-20 -77.53 -50.34 12.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.78 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 153' ' ' ASN . 5.9 tt0 -39.92 -57.29 1.64 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.428 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 80.5 p -51.88 -44.28 63.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.48 ' CB ' ' OE1' ' A' ' 25' ' ' GLN . . . -55.41 -60.46 3.38 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.458 0.647 . . . . 0.0 109.626 178.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 57.7 t -41.82 -40.39 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.339 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -67.67 -36.57 80.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.623 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.478 ' N ' ' O ' ' A' ' 156' ' ' ALA . 22.0 t -70.29 -34.18 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.523 0.678 . . . . 0.0 109.612 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -66.13 -51.14 60.73 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.015 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.7 ttt85 -66.74 -36.96 83.7 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.223 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -64.28 -33.61 76.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.875 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.436 HG21 ' N ' ' A' ' 164' ' ' ILE . 15.3 tt -70.85 -39.75 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.167 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.436 ' N ' HG21 ' A' ' 163' ' ' ILE . 64.6 mt -62.52 -35.59 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.549 0.69 . . . . 0.0 109.231 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.35 -51.8 66.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.522 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -67.89 -26.48 66.02 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.526 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.07 -34.67 75.27 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.43 ' OE1' ' OH ' ' A' ' 54' ' ' TYR . 9.9 mm-40 -70.44 -55.98 7.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.647 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -54.81 -62.13 1.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.711 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 81.5 mt -52.99 -33.14 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.175 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -69.89 -40.35 75.71 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.752 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -60.71 -36.88 92.59 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.98 -62.81 1.22 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.569 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.722 179.988 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 121.262 0.553 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.05 136.13 33.34 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.984 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.532 ' HZ2' ' NE2' ' A' ' 57' ' ' GLN . 6.5 mttm -109.38 131.36 55.14 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 1.0 OUTLIER -104.1 125.4 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 CA-C-O 121.377 0.608 . . . . 0.0 110.674 -178.067 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.07 133.49 34.64 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.352 -0.843 . . . . 0.0 110.792 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.1 mt -96.58 133.21 38.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.645 0.736 . . . . 0.0 112.361 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.409 ' C ' ' CD2' ' A' ' 12' ' ' LEU . 5.3 tt -125.77 104.01 8.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.114 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -140.16 133.6 6.09 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.64 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.422 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.5 OUTLIER -56.94 -158.51 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.357 0.599 . . . . 0.0 110.605 179.221 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.494 ' HE ' ' HG ' ' A' ' 16' ' ' SER . 11.3 ttp180 -97.02 131.14 44.13 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.334 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.494 ' HG ' ' HE ' ' A' ' 15' ' ' ARG . 1.7 m 64.94 19.0 11.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.568 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.549 ' C ' ' HZ2' ' A' ' 120' ' ' LYS . 4.9 p -80.58 -15.74 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.83 0.348 . . . . 0.0 110.222 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.41 12.24 33.81 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.433 ' O ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -45.22 -52.58 9.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.938 0.399 . . . . 0.0 110.914 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 m -70.69 -26.69 63.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.491 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.4 m -68.71 -49.59 57.7 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.989 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 45.9 tp -73.8 -26.32 60.57 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 119.626 -0.829 . . . . 0.0 110.782 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 19' ' ' LYS . 35.1 m -63.38 -41.01 98.77 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -78.2 -37.03 21.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.754 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.64 ' NE2' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -77.06 -27.48 54.37 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.582 -179.131 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -77.22 -53.41 7.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.432 0.634 . . . . 0.0 110.563 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.42 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 14.2 p -58.46 -45.58 89.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.08 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.42 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 2.4 tt0 -82.59 -24.47 33.91 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.515 ' O ' ' ND2' ' A' ' 153' ' ' ASN . . . 71.72 27.5 70.79 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.488 ' CD ' ' N ' ' A' ' 31' ' ' PHE . 1.7 tp-100 -144.41 135.08 24.82 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.136 0.493 . . . . 0.0 111.637 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.64 ' N ' ' NE2' ' A' ' 25' ' ' GLN . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.917 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.29 170.36 4.29 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.351 -0.939 . . . . 0.0 113.34 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.78 143.43 44.02 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.61 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -122.71 169.17 11.34 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.367 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.413 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -146.99 147.56 30.82 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 120.008 -0.677 . . . . 0.0 112.605 -178.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.7 tttt -147.1 110.48 4.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.853 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.0 mp -106.4 122.83 47.06 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.254 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 pt -149.03 165.18 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.624 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 m -114.93 124.44 51.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.044 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.452 ' CG1' ' CD1' ' A' ' 54' ' ' TYR . 0.8 OUTLIER -121.95 126.03 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.649 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.12 21.45 10.11 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.14 -8.36 60.93 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.084 -1.207 . . . . 0.0 110.084 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -91.64 134.18 34.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -76.95 145.63 38.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.658 0.742 . . . . 0.0 111.785 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.452 ' CD1' ' CG1' ' A' ' 49' ' ' VAL . 13.5 m-85 -138.76 122.68 17.78 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.023 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 67.7 m170 -117.12 113.49 22.35 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mp -119.7 144.18 47.35 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.589 0.709 . . . . 0.0 112.04 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.532 ' NE2' ' HZ2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -134.92 125.26 26.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.919 178.72 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.631 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.66 154.19 32.04 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 120.01 -0.676 . . . . 0.0 112.065 -178.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.94 144.71 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.68 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.36 104.08 9.74 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.409 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 44.6 p . . . . . 0 N--CA 1.444 -0.737 0 CA-C-O 121.815 0.816 . . . . 0.0 111.152 -179.526 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 29.0 pt . . . . . 0 N--CA 1.439 -0.993 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.18 16.69 0.74 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.323 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -145.22 167.7 27.31 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.452 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.02 122.9 7.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.853 -0.674 . . . . 0.0 111.318 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 10.5 tt -126.52 105.72 14.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.651 ' H ' ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.51 122.47 40.61 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.179 -0.609 . . . . 0.0 111.434 -178.3 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -97.04 115.83 37.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.032 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.528 ' OH ' ' CZ ' ' A' ' 145' ' ' PHE . 53.8 p90 -109.76 144.69 37.82 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.502 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.0 OUTLIER -99.79 143.97 29.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.01 0.433 . . . . 0.0 111.47 -178.127 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.7 m -80.78 22.21 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.34 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.415 HG21 ' N ' ' A' ' 89' ' ' SER . 1.0 OUTLIER -140.22 -21.1 0.86 Allowed 'General case' 0 C--O 1.232 0.182 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -177.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.546 ' C ' ' N ' ' A' ' 91' ' ' LYS . 17.8 t -109.54 92.71 4.16 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.311 0.576 . . . . 0.0 111.694 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.438 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 1.0 OUTLIER -52.42 -15.24 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 176.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.546 ' N ' ' C ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -78.24 -39.33 40.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.177 179.182 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 89' ' ' SER . 79.4 p -69.87 -46.07 66.32 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.495 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -78.6 -32.84 47.72 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 119.473 -0.891 . . . . 0.0 112.489 -177.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.486 ' OE1' ' CE1' ' A' ' 93' ' ' PHE . 8.4 mm-40 -69.3 -45.19 70.17 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.277 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.7 m -66.05 -37.59 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 C-N-CA 120.141 -0.624 . . . . 0.0 109.976 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.427 HD11 HG23 ' A' ' 96' ' ' ILE . 2.0 mt -59.25 -40.54 81.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.986 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -70.1 -26.88 64.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.944 0.402 . . . . 0.0 110.411 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.3 t -75.53 -67.03 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.421 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.1 mt -47.37 -35.44 3.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.326 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.603 ' NE2' ' CD1' ' A' ' 141' ' ' TRP . 6.7 t-80 -62.38 -64.85 0.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.167 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -38.4 -57.62 1.79 Allowed Glycine 0 N--CA 1.453 -0.186 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.485 ' O ' ' N ' ' A' ' 105' ' ' ASP . 15.9 tptm -62.7 -65.14 0.73 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.059 -0.571 . . . . 0.0 110.641 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.05 -60.07 0.66 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.121 0.486 . . . . 0.0 109.849 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.512 ' CD2' ' CZ3' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -45.85 -46.81 15.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.543 0.687 . . . . 0.0 109.368 178.675 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.941 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.258 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 121.011 0.434 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.482 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.7 OUTLIER -115.83 156.55 46.35 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.401 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -49.22 109.15 0.24 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.636 1.557 . . . . 0.0 112.599 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.482 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.4 mt -121.66 128.6 75.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.4 tpt -131.69 112.7 12.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.575 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.9 mt -96.56 97.86 9.75 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.0 t -103.53 130.88 53.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 122.35 1.071 . . . . 0.0 111.364 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.466 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -98.26 106.55 3.3 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 113.593 -1.64 . . . . 0.0 109.082 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.506 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 55.0 t30 -96.78 174.91 6.56 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.527 -178.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.549 ' HZ2' ' C ' ' A' ' 17' ' ' VAL . 7.5 mttp 65.31 59.74 0.8 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.193 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.43 ' C ' ' H ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -65.73 -39.14 90.85 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -177.75 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -61.87 -3.5 1.18 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.047 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 125' ' ' MET . 9.7 mp -99.68 -30.17 12.25 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.494 ' O ' ' N ' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -39.93 -28.18 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.59 178.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.453 ' N ' ' O ' ' A' ' 123' ' ' LEU . 0.0 OUTLIER -41.18 -26.74 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.069 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -98.18 -36.18 10.14 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.822 179.495 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.577 HH12 ' CG2' ' A' ' 129' ' ' ILE . 7.0 tpt85 42.55 86.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.709 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.6 m -80.28 -39.98 19.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.654 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.577 ' CG2' HH12 ' A' ' 127' ' ' ARG . 0.8 OUTLIER -86.68 132.16 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.508 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 60.8 p -76.75 118.05 18.98 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.389 -0.525 . . . . 0.0 111.026 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -39.06 -29.48 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.28 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.4 mp0 -69.88 -63.07 1.15 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.874 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.508 ' H ' ' HG ' ' A' ' 130' ' ' SER . 52.9 mt-10 -41.09 -46.11 2.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.95 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.11 -31.73 72.34 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 132' ' ' GLU . 19.6 tttm -65.43 -56.62 11.47 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -54.94 -33.33 62.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.349 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.403 HD22 ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -66.11 -62.71 1.34 Allowed 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.892 179.574 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -56.95 -31.94 65.49 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.966 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.61 -35.28 72.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.771 0.319 . . . . 0.0 110.534 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.627 ' HG ' ' N ' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -64.2 -47.11 81.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.288 -178.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.627 ' N ' ' HG ' ' A' ' 140' ' ' SER . 18.6 m95 -91.2 -4.12 56.35 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.527 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 72.36 31.78 1.77 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.142 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.34 168.82 12.35 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.255 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -103.63 124.85 49.58 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.347 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.528 ' CZ ' ' OH ' ' A' ' 85' ' ' TYR . 7.3 t80 -97.8 123.19 41.65 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.863 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.52 123.67 12.91 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.471 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 2.8 mt-10 -98.72 114.82 27.5 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 5.0 p -136.33 -173.92 3.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.897 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.03 136.62 35.49 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.105 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.437 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -62.42 -43.63 98.37 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.132 0.491 . . . . 0.0 109.99 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.444 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 33.7 tttm -58.49 -7.03 0.8 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.519 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.437 ' H ' ' C ' ' A' ' 150' ' ' ALA . 25.1 mt-10 -126.9 128.4 46.42 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.769 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 2.5 t-20 -77.37 -56.01 4.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.09 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' A' ' 153' ' ' ASN . 0.0 OUTLIER -36.41 -59.02 0.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.135 0.493 . . . . 0.0 110.983 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 16.8 p -51.99 -51.34 57.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.649 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -52.31 -58.37 6.87 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.5 0.667 . . . . 0.0 109.713 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 53.7 t -42.21 -51.32 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.129 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -51.27 -36.43 42.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.053 0.454 . . . . 0.0 110.636 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.422 ' N ' ' O ' ' A' ' 156' ' ' ALA . 11.0 t -73.94 -31.15 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.261 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.439 ' CG ' ' N ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -68.77 -46.64 68.25 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.047 0.451 . . . . 0.0 112.119 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.439 ' N ' ' CG ' ' A' ' 160' ' ' PHE . 6.4 ttt180 -73.94 -34.56 64.35 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.751 -0.779 . . . . 0.0 111.152 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -65.65 -34.73 78.9 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.067 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 164' ' ' ILE . 14.1 tt -70.34 -43.16 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.861 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.454 ' N ' HG22 ' A' ' 163' ' ' ILE . 85.1 mt -59.58 -35.21 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.544 0.688 . . . . 0.0 109.611 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.21 -60.31 3.58 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.726 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -58.36 -34.9 71.18 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -55.98 -32.45 63.93 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 171' ' ' ASP . 6.0 tp10 -66.41 -59.65 3.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.359 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.51 -52.23 64.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.682 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 4.0 mm -50.45 -37.93 15.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.04 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 172' ' ' GLY . 0.0 OUTLIER -67.01 -40.13 87.24 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.028 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 171' ' ' ASP . . . -56.75 -36.41 72.04 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.72 -82.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.743 0.306 . . . . 0.0 110.213 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.838 179.937 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.322 0 CA-C-O 121.202 0.525 . . . . 0.0 110.651 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.71 136.04 33.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.526 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -106.0 128.5 53.87 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -102.82 122.95 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 121.416 0.627 . . . . 0.0 110.563 -178.023 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.465 ' O ' HG21 ' A' ' 82' ' ' ILE . . . -84.56 132.58 34.5 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.172 -0.955 . . . . 0.0 111.156 -178.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.7 mt -95.46 133.72 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-O 121.916 0.865 . . . . 0.0 112.721 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.6 mp -130.33 101.73 5.89 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.866 -1.515 . . . . 0.0 110.359 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.517 ' O ' ' NZ ' ' A' ' 19' ' ' LYS . . . -140.64 134.4 6.42 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.476 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.6 OUTLIER -56.16 -158.2 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.285 0.565 . . . . 0.0 110.736 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -98.93 133.76 42.75 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.485 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.6 m 64.25 19.29 11.72 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.721 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.512 ' C ' ' HZ1' ' A' ' 120' ' ' LYS . 4.9 p -85.91 -16.9 9.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.843 0.354 . . . . 0.0 110.561 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.591 ' CA ' ' HG ' ' A' ' 21' ' ' SER . . . 102.36 27.92 6.64 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.532 ' CB ' ' NZ ' ' A' ' 19' ' ' LYS . 4.8 ttpm? -61.2 -50.26 73.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.14 0.495 . . . . 0.0 110.435 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.21 -26.38 58.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.436 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.591 ' HG ' ' CA ' ' A' ' 18' ' ' GLY . 77.6 p -64.29 -43.38 94.94 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.856 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.9 tp -77.74 -39.51 44.13 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.851 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.404 ' O ' ' CG1' ' A' ' 27' ' ' VAL . 31.4 m -50.2 -43.87 52.83 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.68 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.4 mp -77.42 -41.58 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.635 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.443 ' NE2' ' O ' ' A' ' 152' ' ' GLU . 0.2 OUTLIER -67.78 -31.79 71.92 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.151 -179.016 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.632 ' CZ ' ' CE1' ' A' ' 160' ' ' PHE . 4.8 t80 -77.61 -64.03 1.24 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.404 0.621 . . . . 0.0 111.192 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.465 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 13.5 p -45.15 -49.17 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.996 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.465 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 0.7 OUTLIER -81.49 -25.12 36.26 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.28 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 153' ' ' ASN . . . 75.44 28.1 62.28 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.435 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.42 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 5.2 pt20 -146.38 128.05 15.2 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.943 0.878 . . . . 0.0 112.983 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.496 ' C ' ' CD1' ' A' ' 31' ' ' PHE . 0.7 OUTLIER . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.083 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.418 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 120.547 0.213 . . . . 0.0 110.532 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER 177.88 174.34 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.278 0.561 . . . . 0.0 112.278 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.04 142.92 37.47 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.426 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.432 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 12.5 m-85 -130.47 165.5 22.5 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.047 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.53 148.02 36.92 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.252 0.549 . . . . 0.0 112.046 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.94 116.1 4.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.978 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.522 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 7.4 mp -105.3 129.69 53.59 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.393 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.3 pt -147.39 160.97 8.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.47 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 m -117.01 123.56 47.19 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.173 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 p -118.42 125.48 74.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.984 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.7 m120 61.38 24.94 14.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 0.0 110.239 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.77 -9.52 65.27 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -88.77 130.48 35.35 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -76.96 146.12 37.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.582 0.706 . . . . 0.0 111.302 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.482 ' C ' ' HD1' ' A' ' 55' ' ' HIS . 9.3 m-85 -138.46 124.92 20.59 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.004 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.482 ' HD1' ' C ' ' A' ' 54' ' ' TYR . 0.4 OUTLIER -117.28 113.66 22.49 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mp -119.23 146.58 45.1 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.582 0.706 . . . . 0.0 112.132 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -136.35 123.53 21.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.983 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.641 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.12 154.91 30.22 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.541 0.686 . . . . 0.0 112.416 -178.371 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.85 145.14 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.785 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.16 103.89 8.52 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.019 -1.446 . . . . 0.0 107.92 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.516 -0.343 0 CA-C-O 121.312 0.577 . . . . 0.0 110.775 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 33.6 pt . . . . . 0 N--CA 1.433 -1.299 0 CA-C-O 121.319 0.581 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -151.11 18.41 0.76 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.115 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -146.69 167.75 28.11 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.15 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.97 123.21 7.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.136 -0.532 . . . . 0.0 111.806 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.47 ' CG2' ' O ' ' A' ' 82' ' ' ILE . 12.4 tt -128.06 98.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.797 0.808 . . . . 0.0 109.299 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.594 ' CD2' ' N ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -96.32 130.09 43.51 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.639 -178.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.93 132.81 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.885 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.509 ' CE1' ' CD2' ' A' ' 116' ' ' LEU . 2.2 m-85 -108.56 143.5 37.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.886 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -106.2 121.41 44.13 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.386 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.0 m -73.86 21.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.563 ' H ' ' C ' ' A' ' 86' ' ' SER . 9.7 t -142.72 -7.83 0.85 Allowed 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 114.212 1.189 . . . . 0.0 114.212 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.532 ' C ' ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -135.46 100.5 4.53 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 122.324 1.059 . . . . 0.0 112.077 -176.311 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.1 mm -56.08 -10.63 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 113.915 -1.493 . . . . 0.0 108.754 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.532 ' H ' ' C ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -79.3 -43.99 22.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.466 178.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.516 ' HG ' ' H ' ' A' ' 86' ' ' SER . 55.3 p -62.33 -45.89 91.19 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.151 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.57 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -76.48 -37.55 56.67 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 118.531 -1.267 . . . . 0.0 111.882 -178.312 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -69.66 -44.86 69.68 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.902 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 91' ' ' LYS . 23.5 m -63.1 -36.5 76.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.881 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.8 mt -72.42 -27.14 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.058 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -69.15 -29.17 67.14 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.8 t -76.29 -66.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.481 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.4 mp -39.16 -36.21 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.738 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.452 ' CE1' ' CE2' ' A' ' 141' ' ' TRP . 53.2 t-80 -66.95 -58.6 4.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.979 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.82 -49.16 1.95 Allowed Glycine 0 CA--C 1.518 0.259 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.804 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 105' ' ' ASP . 23.0 tptt -64.01 -66.31 0.56 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.424 -0.388 . . . . 0.0 110.393 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.7 OUTLIER -39.95 -57.17 1.67 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.627 179.058 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.492 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -46.84 -43.84 18.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.53 178.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.802 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.624 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.74 0.305 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.484 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -129.93 145.25 56.37 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.713 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -49.5 113.26 0.88 Allowed 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.624 1.55 . . . . 0.0 112.517 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.484 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.4 mp -123.99 132.99 70.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 9.4 tpt -133.18 115.3 14.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.011 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.509 ' CD2' ' CE1' ' A' ' 85' ' ' TYR . 4.2 mt -96.83 97.24 9.14 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.0 t -102.11 127.98 55.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.5 0.667 . . . . 0.0 111.753 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -94.73 114.68 4.89 Favored Glycine 0 C--N 1.311 -0.858 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.408 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 60.6 t30 -97.02 171.79 8.26 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.078 -0.649 . . . . 0.0 112.025 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.512 ' HZ1' ' C ' ' A' ' 17' ' ' VAL . 6.3 mtpp 61.73 55.47 2.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.629 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.556 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 8.8 tttm -57.41 -20.66 31.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.674 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -76.64 -20.48 56.65 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.991 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.9 mp -77.96 -31.63 50.96 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.621 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.3 OUTLIER -31.56 -32.56 0.01 OUTLIER 'General case' 0 C--N 1.339 0.141 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.029 178.196 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.621 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 2.2 mmt -42.02 -27.34 0.12 Allowed 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.487 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -101.17 -37.6 8.48 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.587 179.307 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.48 ' NH1' ' OE2' ' A' ' 147' ' ' GLU . 9.8 ttm180 32.01 85.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.449 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.2 m -72.66 -34.77 48.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.167 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 10.7 tp -91.4 153.82 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.691 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.429 ' OG ' ' OE1' ' A' ' 132' ' ' GLU . 3.8 t -95.16 130.19 41.98 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.86 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -50.39 -35.86 30.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.782 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -68.45 -62.21 1.49 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.743 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -40.72 -43.12 1.9 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.722 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.68 -36.1 67.11 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -62.08 -53.53 54.21 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.341 -0.43 . . . . 0.0 109.852 179.574 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -58.39 -38.04 76.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.76 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.625 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -66.43 -60.65 2.56 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.563 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -51.69 -37.16 49.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.984 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.83 -28.9 67.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.71 -47.37 78.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.155 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.625 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 17.1 m95 -91.0 -4.24 56.6 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.313 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 141' ' ' TRP . 0.8 OUTLIER 79.11 26.97 0.42 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.992 -179.434 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.61 168.81 12.24 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.69 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -111.69 127.73 55.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.043 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.406 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 9.9 t80 -98.01 120.81 39.05 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.314 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.53 128.23 17.21 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.338 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.48 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 1.7 mt-10 -100.2 116.74 32.92 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.007 0.432 . . . . 0.0 110.098 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.8 p -131.98 -177.97 4.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.596 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.21 131.79 30.82 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.563 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.499 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -56.44 -42.44 78.12 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.123 0.487 . . . . 0.0 110.084 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 38.1 tttt -58.2 -3.7 0.28 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.468 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.499 ' H ' ' C ' ' A' ' 150' ' ' ALA . 1.9 mt-10 -136.37 125.76 24.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.017 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 29' ' ' GLY . 5.3 t-20 -77.25 -48.95 16.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.831 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 153' ' ' ASN . 0.0 OUTLIER -38.5 -59.16 0.94 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.749 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 45.7 p -52.5 -49.55 64.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.188 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.419 ' HB1' HE22 ' A' ' 25' ' ' GLN . . . -50.63 -60.84 2.62 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.553 0.692 . . . . 0.0 110.285 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 49.0 t -45.76 -42.2 3.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.895 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.15 -41.62 98.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.664 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 11.5 t -63.38 -46.94 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.66 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.632 ' CE1' ' CZ ' ' A' ' 26' ' ' PHE . 10.4 m-85 -67.79 -22.81 65.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.105 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.24 -42.36 46.09 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.869 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -67.29 -32.35 73.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.132 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.458 HG21 ' O ' ' A' ' 160' ' ' PHE . 7.3 tt -69.14 -47.07 76.64 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.171 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.447 ' N ' ' CG2' ' A' ' 163' ' ' ILE . 95.4 mt -53.5 -37.53 30.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.05 -56.53 19.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.549 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -62.47 -28.73 70.02 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.309 -0.556 . . . . 0.0 109.573 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.23 -33.32 70.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.424 ' OE2' ' OH ' ' A' ' 54' ' ' TYR . 2.3 tp10 -68.83 -50.62 48.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.016 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -60.15 -64.29 1.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.741 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 50.6 mt -49.94 -31.75 7.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.952 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.84 -40.18 79.54 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.368 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -61.71 -35.63 91.5 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.29 -68.96 0.35 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.714 0.292 . . . . 0.0 110.427 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.715 179.927 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.308 0.575 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.59 134.96 32.84 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.22 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -107.25 126.0 51.86 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -100.17 122.03 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-O 121.566 0.698 . . . . 0.0 110.914 -177.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.62 134.84 34.78 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.464 -0.773 . . . . 0.0 110.903 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.3 mt -96.64 133.33 38.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.4 0.619 . . . . 0.0 112.382 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.435 ' C ' ' CD2' ' A' ' 12' ' ' LEU . 5.8 tt -128.61 105.67 8.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.494 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -142.03 134.33 6.11 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -52.99 172.6 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -73.37 131.61 42.07 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.231 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 m 67.1 19.97 10.38 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.698 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.6 p -79.72 -18.44 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.219 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.431 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 101.19 23.7 9.5 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.447 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.421 ' O ' ' OG1' ' A' ' 23' ' ' THR . 5.4 pttm -70.72 -33.44 70.85 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.423 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.8 m -77.2 -30.42 54.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.05 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 79.5 p -65.61 -41.91 92.21 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.125 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.0 tp -77.07 -44.05 32.07 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 119.754 -0.779 . . . . 0.0 110.648 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 19' ' ' LYS . 25.3 m -47.93 -42.37 27.13 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.226 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.15 -41.72 30.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 O-C-N 123.267 0.354 . . . . 0.0 111.272 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.477 ' OE1' ' CB ' ' A' ' 156' ' ' ALA . 0.3 OUTLIER -70.71 -28.69 64.92 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.969 -179.208 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.454 ' O ' ' N ' ' A' ' 29' ' ' GLY . 1.3 t80 -78.05 -63.63 1.35 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.231 0.539 . . . . 0.0 110.692 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.444 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 13.7 p -45.15 -49.59 2.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.419 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.444 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 2.5 tt0 -79.06 -24.45 43.55 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 71.5 28.21 69.93 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 114.471 -1.241 . . . . 0.0 110.024 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -149.73 125.8 10.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.49 -178.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.618 ' O ' ' CD1' ' A' ' 31' ' ' PHE . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.357 0 CA-C-O 122.318 1.056 . . . . 0.0 110.407 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.425 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.358 0 CA-C-O 120.683 0.278 . . . . 0.0 110.436 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 0.7 OUTLIER 177.49 176.68 0.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.185 0.517 . . . . 0.0 111.869 -179.383 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.9 147.47 30.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.873 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.442 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 11.6 m-85 -129.77 167.3 18.29 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.239 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.9 151.05 37.24 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.52 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.0 tmtp? -150.91 108.78 3.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.439 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.534 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 6.4 mp -106.48 121.4 44.2 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.938 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 pp -149.0 165.36 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.785 0.326 . . . . 0.0 110.647 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 m -108.81 127.6 54.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.173 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.451 ' C ' ' H ' ' A' ' 51' ' ' GLY . 7.6 p -126.39 138.32 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 62.06 5.95 1.61 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 97.39 -13.18 64.66 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -91.37 142.21 27.93 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -76.24 145.53 39.66 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.562 0.696 . . . . 0.0 111.073 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -136.34 124.8 23.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.134 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 62.3 m170 -116.74 113.98 23.35 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.43 ' CD2' ' N ' ' A' ' 56' ' ' LEU . 2.7 mm? -118.91 139.75 51.12 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 121.386 0.612 . . . . 0.0 111.34 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.36 122.41 23.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.91 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.649 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.19 154.6 30.84 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.345 0.593 . . . . 0.0 112.525 -178.139 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.8 145.29 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-N 114.672 -1.149 . . . . 0.0 113.05 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -123.61 106.5 10.61 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.067 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.516 -0.341 0 CA-C-O 121.614 0.721 . . . . 0.0 111.487 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 31.5 pt . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.77 19.33 0.7 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.022 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.02 165.08 28.92 Favored Glycine 0 CA--C 1.517 0.195 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.534 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.82 123.07 7.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.716 -0.742 . . . . 0.0 111.073 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.7 tt -126.19 107.62 17.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.9 0.857 . . . . 0.0 109.029 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.582 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 3.1 mp -97.27 126.67 42.63 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.979 -178.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -95.26 128.69 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.162 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.402 ' CD2' ' CE1' ' A' ' 93' ' ' PHE . 48.6 m-85 -110.69 144.44 39.62 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.172 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.696 ' HG ' ' H ' ' A' ' 89' ' ' SER . 0.9 OUTLIER -98.24 125.99 43.54 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.0 m -72.5 22.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.673 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.616 ' H ' ' HG ' ' A' ' 86' ' ' SER . 0.8 OUTLIER -138.79 -26.13 0.87 Allowed 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.696 ' H ' ' HG ' ' A' ' 86' ' ' SER . 4.1 t -98.0 93.98 6.6 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.378 -176.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.27 -11.57 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.535 ' N ' ' C ' ' A' ' 89' ' ' SER . 3.4 mptt -78.28 -57.22 3.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.456 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.481 ' H ' ' HG ' ' A' ' 89' ' ' SER . 69.6 p -49.6 -30.62 9.08 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.591 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.402 ' CE1' ' CD2' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -74.55 -48.29 27.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.838 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.39 -44.22 88.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.595 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.1 m -64.38 -35.84 75.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.145 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.7 mt -69.12 -29.44 42.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.882 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.03 -27.84 66.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.8 t -74.75 -66.73 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.2 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.6 mp -41.39 -48.64 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.514 ' CE1' ' CE2' ' A' ' 141' ' ' TRP . 51.8 t-80 -54.66 -64.84 0.7 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.669 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -38.07 -52.33 2.13 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 105' ' ' ASP . 17.7 tptm -65.87 -63.6 1.05 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.924 -0.638 . . . . 0.0 110.698 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -38.2 -59.24 0.89 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.215 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.48 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -47.05 -45.24 21.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.806 178.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.878 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.795 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.711 0.291 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.49 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.6 OUTLIER -130.07 153.68 81.12 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.685 179.419 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -48.02 114.69 1.2 Allowed 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.897 1.731 . . . . 0.0 112.572 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.49 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.4 mp -124.28 128.44 73.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 12.3 tpt -129.01 114.59 16.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.741 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 67.5 mt -97.21 98.91 10.41 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.387 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.83 131.16 57.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.865 0.84 . . . . 0.0 112.396 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -97.96 114.01 4.88 Favored Glycine 0 C--N 1.312 -0.773 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.478 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 57.7 t30 -96.84 172.79 7.65 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.952 -177.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.478 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 19.7 mttt 58.51 58.67 3.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.188 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -14.75 61.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.326 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -79.4 -13.03 59.87 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.633 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.661 ' O ' ' N ' ' A' ' 126' ' ' GLU . 10.9 mp -84.05 -26.57 28.95 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.553 ' O ' ' N ' ' A' ' 126' ' ' GLU . 10.3 t60 -22.76 -42.34 0.01 OUTLIER 'General case' 0 C--N 1.348 0.503 0 O-C-N 124.544 1.152 . . . . 0.0 111.289 178.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.567 ' N ' ' O ' ' A' ' 123' ' ' LEU . 0.7 OUTLIER -44.77 -19.04 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.416 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.661 ' N ' ' O ' ' A' ' 123' ' ' LEU . 19.8 mm-40 -89.74 -54.49 4.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.011 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.433 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 1.7 tpt85 35.85 71.24 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.269 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.71 -40.13 86.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.292 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 tp -88.44 155.12 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.582 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 132' ' ' GLU . 47.5 p -93.12 118.04 30.76 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.718 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -39.12 -28.66 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.645 0.736 . . . . 0.0 109.373 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.3 mp0 -70.06 -63.27 1.11 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.876 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.475 ' H ' ' HG ' ' A' ' 130' ' ' SER . 57.1 mt-10 -41.52 -41.73 2.19 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.16 -35.73 64.09 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 132' ' ' GLU . 2.4 tttm -60.72 -55.42 33.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.58 -33.97 66.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.075 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.35 -63.2 1.16 Allowed 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.836 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -51.67 -35.06 41.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.232 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -35.61 78.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.736 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.58 -47.32 76.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.59 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.514 ' CE2' ' CE1' ' A' ' 100' ' ' HIS . 25.7 m95 -92.72 2.52 56.69 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.719 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 60.77 39.94 16.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.526 0.679 . . . . 0.0 109.633 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -98.15 168.35 10.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.57 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.07 125.46 51.0 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.887 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.437 ' C ' ' CD1' ' A' ' 145' ' ' PHE . 4.0 t80 -98.4 122.03 41.08 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.262 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.01 126.43 15.83 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.433 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 2.7 mt-10 -100.49 114.89 28.86 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 21.0 p -134.77 -178.76 5.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.824 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.93 135.19 34.14 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.28 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -57.44 -46.52 83.5 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.883 0.373 . . . . 0.0 110.365 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -55.21 -6.29 0.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.33 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.508 ' H ' ' C ' ' A' ' 150' ' ' ALA . 2.1 tt0 -131.25 122.63 26.82 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.638 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.435 ' ND2' ' C ' ' A' ' 29' ' ' GLY . 10.4 t-20 -77.21 -52.02 9.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.167 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 153' ' ' ASN . 0.2 OUTLIER -36.77 -58.22 0.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.03 -179.632 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.403 ' HG1' ' N ' ' A' ' 156' ' ' ALA . 68.1 p -53.0 -45.1 67.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.127 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.477 ' CB ' ' OE1' ' A' ' 25' ' ' GLN . . . -55.44 -61.48 2.31 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.492 0.663 . . . . 0.0 110.121 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 57.4 t -43.22 -39.67 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.688 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -65.7 -42.81 90.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.199 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.3 t -61.93 -42.41 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.539 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.498 ' O ' ' N ' ' A' ' 163' ' ' ILE . 52.3 t80 -59.49 -66.76 0.46 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.216 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 160' ' ' PHE . 19.5 ttm-85 -41.62 -45.29 3.33 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.304 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -62.05 -30.35 70.92 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.754 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 160' ' ' PHE . 0.2 OUTLIER -66.41 -32.47 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.457 179.473 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.4 mt -68.39 -42.27 84.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.737 0.779 . . . . 0.0 109.665 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.62 -49.36 78.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.551 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -64.03 -32.56 74.15 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.08 -34.41 65.96 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.125 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.39 -55.39 10.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.682 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.62 -62.87 1.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.733 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 38.5 mm -53.32 -31.23 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.065 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -69.67 -40.38 76.47 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.633 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.53 -35.31 91.6 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.98 -62.71 1.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.688 0.28 . . . . 0.0 110.429 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.705 179.878 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 121.216 0.531 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.62 136.66 34.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.587 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.686 ' HZ3' HE22 ' A' ' 57' ' ' GLN . 11.0 mttm -108.51 127.49 53.97 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 1.0 OUTLIER -103.01 123.95 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-O 121.479 0.657 . . . . 0.0 111.13 -178.086 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.43 135.78 34.12 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.422 -0.799 . . . . 0.0 111.254 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.0 mt -95.77 133.84 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.24 100.69 5.93 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.349 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.71 133.73 5.87 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.69 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER -54.62 -167.08 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.034 0.445 . . . . 0.0 110.041 178.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.404 ' O ' ' CB ' ' A' ' 16' ' ' SER . 11.5 ttp180 -97.64 128.33 44.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.744 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER 76.24 8.79 3.32 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.125 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.469 ' C ' ' NZ ' ' A' ' 120' ' ' LYS . 7.3 p -77.63 -19.32 14.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.942 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.417 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 106.03 31.6 4.08 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.408 ' NZ ' ' CB ' ' A' ' 19' ' ' LYS . 2.6 ttmp? -59.5 -59.1 5.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.005 0.431 . . . . 0.0 110.406 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.07 -26.01 63.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.24 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.504 ' HG ' ' H ' ' A' ' 22' ' ' LEU . 89.1 p -63.78 -47.11 82.22 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.714 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.504 ' H ' ' HG ' ' A' ' 21' ' ' SER . 28.4 tp -71.39 -49.94 37.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.473 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.445 ' O ' ' CG1' ' A' ' 27' ' ' VAL . 48.7 m -43.79 -38.93 3.49 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.311 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.2 -43.68 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.94 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.622 ' NE2' ' N ' ' A' ' 31' ' ' PHE . 1.5 tp-100 -63.46 -40.53 97.37 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.756 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.636 ' CG ' ' CE1' ' A' ' 160' ' ' PHE . 2.2 t80 -74.87 -62.52 1.51 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.209 0.528 . . . . 0.0 111.825 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.488 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 7.4 p -44.0 -47.52 2.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.722 -178.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.481 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 2.0 tm-20 -83.91 -24.19 30.86 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.526 ' O ' ' ND2' ' A' ' 153' ' ' ASN . . . 75.11 25.5 68.71 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.075 -1.42 . . . . 0.0 110.348 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.547 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 1.9 tp-100 -152.01 130.1 11.87 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.687 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.622 ' N ' ' NE2' ' A' ' 25' ' ' GLN . 0.7 OUTLIER . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.684 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.421 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 2.2 pm0 . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 120.802 0.334 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 0.7 OUTLIER 177.11 175.33 0.4 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.624 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.81 127.61 53.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.294 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -110.02 174.05 6.04 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.968 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.5 161.7 37.75 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.488 ' NZ ' ' O ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -163.18 112.09 1.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.432 179.424 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.52 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 7.5 mp -105.17 127.93 53.15 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.727 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 pt -147.87 165.31 5.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.569 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.2 m -116.82 123.86 48.12 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.049 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.438 ' CG1' ' CD1' ' A' ' 54' ' ' TYR . 2.4 p -119.74 129.99 74.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.631 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.73 19.71 10.75 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.56 -9.43 71.04 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -90.0 135.6 33.55 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.49 147.28 37.93 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.584 0.706 . . . . 0.0 111.465 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.482 ' C ' ' HD1' ' A' ' 55' ' ' HIS . 5.8 m-85 -138.3 125.21 21.19 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.042 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.482 ' HD1' ' C ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -118.04 113.74 22.09 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.6 mp -118.62 143.21 46.96 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.629 0.728 . . . . 0.0 112.164 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.686 HE22 ' HZ3' ' A' ' 8' ' ' LYS . 1.2 mt-30 -133.96 122.6 23.31 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.93 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.636 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.38 153.52 31.89 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.063 -178.655 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.82 145.48 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-N 114.992 -1.004 . . . . 0.0 112.926 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -124.33 103.24 8.1 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.064 177.627 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.438 ' H ' ' HG1' ' A' ' 61' ' ' THR . 0.0 OUTLIER . . . . . 0 CA--C 1.513 -0.458 0 CA-C-O 121.374 0.607 . . . . 0.0 110.843 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 39.1 pt . . . . . 0 N--CA 1.439 -1.015 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -154.85 19.59 0.45 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.776 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.66 165.28 30.97 Favored Glycine 0 C--O 1.227 -0.323 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.873 -178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.78 122.31 7.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.689 -0.755 . . . . 0.0 110.691 178.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.6 tt -124.01 102.69 11.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.414 HD11 ' H ' ' A' ' 83' ' ' LEU . 0.3 OUTLIER -97.56 123.22 41.36 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.17 -178.253 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.9 t -95.38 130.54 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.135 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -111.25 143.94 41.23 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.538 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.568 ' HG ' ' H ' ' A' ' 89' ' ' SER . 0.5 OUTLIER -94.99 121.0 36.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.473 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.8 m -70.66 21.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.469 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.555 ' H ' ' C ' ' A' ' 86' ' ' SER . 1.1 t -136.27 -23.54 1.28 Allowed 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.568 ' H ' ' HG ' ' A' ' 86' ' ' SER . 8.3 t -100.45 94.1 5.98 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.482 -176.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.81 -11.41 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.555 ' H ' ' C ' ' A' ' 89' ' ' SER . 18.1 mttp -78.11 -56.35 4.55 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.141 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.543 ' H ' ' HG ' ' A' ' 89' ' ' SER . 85.4 p -49.83 -29.87 8.78 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.692 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -75.29 -50.22 16.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.92 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -64.68 -42.95 94.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.628 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.6 m -65.98 -37.62 80.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.469 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.1 mt -68.67 -28.58 40.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.567 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -70.4 -27.48 64.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.835 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 99' ' ' ILE . 17.0 t -74.34 -66.4 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.777 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' A' ' 98' ' ' VAL . 1.6 mp -39.97 -43.01 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.666 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.65 ' CE1' ' CE2' ' A' ' 141' ' ' TRP . 9.1 t60 -57.81 -59.38 5.32 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.616 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -36.39 -49.05 1.25 Allowed Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.716 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 105' ' ' ASP . 22.5 tptt -67.88 -66.03 0.62 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.32 -0.44 . . . . 0.0 110.367 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.46 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.5 OUTLIER -38.0 -59.65 0.82 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.479 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -44.29 -46.96 9.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.821 178.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.792 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.281 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.697 0.284 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.491 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -136.18 152.72 75.82 Favored Pre-proline 0 C--O 1.223 -0.328 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -48.3 108.18 0.17 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.929 1.753 . . . . 0.0 113.157 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.491 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.3 mt -121.22 127.07 75.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 11.0 tpt -127.99 114.5 17.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.913 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 62.7 mt -96.98 98.33 9.99 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.2 t -105.76 130.08 57.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.846 0.831 . . . . 0.0 112.774 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -97.63 112.51 4.48 Favored Glycine 0 C--N 1.312 -0.761 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.54 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 50.5 t30 -96.86 176.91 5.81 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.939 -0.705 . . . . 0.0 111.792 -177.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.54 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 36.5 mttp 58.61 57.76 3.62 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -59.72 -34.85 73.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.713 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 0.2 OUTLIER -60.56 -12.79 10.97 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.171 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.5 mp -92.58 -31.65 15.11 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.603 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -38.68 -25.58 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.226 178.694 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.603 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 3.8 mmt -43.33 -26.25 0.18 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.5 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -102.81 -39.68 6.89 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.133 179.062 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.449 ' NH1' ' OE2' ' A' ' 147' ' ' GLU . 29.1 ttm-85 34.52 72.31 0.09 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.717 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.431 ' CG2' ' N ' ' A' ' 129' ' ' ILE . 33.9 m -56.04 -48.19 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.545 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.431 ' N ' ' CG2' ' A' ' 128' ' ' VAL . 7.8 tp -86.88 152.55 3.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.473 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 1.9 p -99.13 125.5 44.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.465 0.65 . . . . 0.0 111.78 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.645 ' CD1' ' CE1' ' A' ' 145' ' ' PHE . 0.1 OUTLIER -52.7 -43.32 65.56 Favored 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.406 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 131' ' ' TYR . 1.4 mp0 -39.66 -62.75 0.65 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.95 178.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.473 ' H ' ' HG ' ' A' ' 130' ' ' SER . 14.9 mt-10 -50.74 -37.42 41.79 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 131' ' ' TYR . . . -70.84 -24.7 76.79 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 131' ' ' TYR . 31.4 tttm -73.68 -55.99 5.57 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -53.97 -35.47 61.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.505 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.53 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -68.15 -62.66 1.3 Allowed 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -47.24 -35.37 7.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.775 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.57 -33.37 72.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.154 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -63.95 -47.14 81.62 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.168 -179.246 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.65 ' CE2' ' CE1' ' A' ' 100' ' ' HIS . 29.7 m95 -90.44 -4.0 57.3 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.204 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 72.4 27.66 2.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.493 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -89.2 166.33 13.88 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.125 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -108.18 126.38 52.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.149 0.499 . . . . 0.0 111.47 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.645 ' CE1' ' CD1' ' A' ' 131' ' ' TYR . 11.3 t80 -98.63 122.0 41.3 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.863 -178.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.99 131.28 20.81 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.449 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 11.0 mt-10 -100.39 119.78 38.97 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.44 -178.95 5.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.736 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.04 137.9 39.86 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.968 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.555 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -59.92 -46.13 90.36 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -69.13 11.87 0.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.359 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.555 ' H ' ' C ' ' A' ' 150' ' ' ALA . 3.8 tt0 -137.68 117.79 13.48 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.231 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 10.1 t-20 -77.42 -56.71 4.31 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.43 ' OE1' ' OE2' ' A' ' 152' ' ' GLU . 0.0 OUTLIER -36.47 -59.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.051 0.453 . . . . 0.0 111.229 -179.036 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.2 p -52.35 -53.81 39.88 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.84 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -47.48 -59.51 3.19 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.598 0.714 . . . . 0.0 110.116 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 47.9 t -48.45 -42.76 12.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.733 -1.122 . . . . 0.0 110.865 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -60.45 -40.95 93.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.533 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.2 t -62.51 -46.27 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.21 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.636 ' CE1' ' CG ' ' A' ' 26' ' ' PHE . 15.2 m-85 -68.66 -24.04 64.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.365 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.8 ttm-85 -77.34 -41.11 41.74 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.01 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.2 mmm-85 -65.66 -33.93 77.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.978 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.473 ' CG2' ' N ' ' A' ' 164' ' ' ILE . 3.3 tt -68.93 -50.59 52.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.449 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.473 ' N ' ' CG2' ' A' ' 163' ' ' ILE . 94.3 mt -50.99 -35.96 15.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.181 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.23 -60.52 3.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.837 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -60.92 -26.7 67.66 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.704 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.64 -33.22 73.57 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.437 ' O ' ' OD2' ' A' ' 171' ' ' ASP . 2.7 tp10 -69.1 -50.13 50.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.417 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -62.37 -51.22 68.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.153 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 24.6 mt -53.59 -42.35 49.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.419 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.437 ' OD2' ' O ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -68.34 -38.58 81.65 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.482 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -54.6 -42.2 76.07 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.87 -73.88 0.15 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.738 0.304 . . . . 0.0 110.607 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.838 -179.727 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 121.11 0.481 . . . . 0.0 110.453 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.492 ' NH2' ' OD2' ' A' ' 171' ' ' ASP . 0.0 OUTLIER -139.7 134.92 32.62 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.657 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -106.26 125.51 51.09 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 0.8 OUTLIER -101.27 119.98 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 121.573 0.702 . . . . 0.0 110.442 -178.77 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.5 134.89 34.83 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.48 -0.763 . . . . 0.0 111.083 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.3 mt -95.9 125.65 48.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.294 0.569 . . . . 0.0 111.447 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.2 tp -124.49 104.28 8.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.532 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -139.65 135.89 7.49 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.494 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.1 OUTLIER -52.08 -160.97 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.518 0.675 . . . . 0.0 111.144 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.7 ttt-85 -93.52 135.14 35.06 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.407 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m 65.93 6.02 3.79 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.426 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.504 ' C ' ' HZ2' ' A' ' 120' ' ' LYS . 3.9 p -65.9 -17.97 23.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.813 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.2 25.29 37.42 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.445 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -65.26 -38.13 89.34 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.875 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.4 m -70.06 -35.52 74.29 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.2 m -60.45 -43.25 97.04 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.762 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 25' ' ' GLN . 22.8 tp -68.16 -56.42 8.85 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.271 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.476 ' O ' ' CG1' ' A' ' 27' ' ' VAL . 93.3 m -38.43 -36.65 0.25 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.51 -42.9 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.78 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.706 HE22 ' ND2' ' A' ' 153' ' ' ASN . 3.0 tp-100 -63.9 -38.32 90.64 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.135 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -76.48 -61.72 1.86 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.101 0.477 . . . . 0.0 111.668 -178.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 8.6 p -48.03 -47.9 12.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.672 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.499 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 2.0 tt0 -84.16 -23.56 30.57 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 75.01 23.4 74.67 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.532 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 11.7 mp0 -148.58 129.99 14.79 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.637 ' N ' ' NE2' ' A' ' 25' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.977 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.493 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 1.8 pm0 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -174.66 -177.0 1.1 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.465 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.08 124.35 32.59 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.686 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.15 174.66 5.79 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 120.993 0.425 . . . . 0.0 110.201 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.28 162.75 34.73 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.16 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -160.04 107.18 1.63 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.309 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.35 118.58 37.0 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.195 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.427 ' N ' ' CD1' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -149.38 165.14 3.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.575 -179.721 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.6 m -109.01 127.9 54.49 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.261 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.404 ' C ' ' H ' ' A' ' 51' ' ' GLY . 6.6 p -127.61 134.08 66.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.387 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.37 3.95 3.52 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.465 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 98.35 -12.89 63.33 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -91.71 141.23 28.92 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -76.68 144.83 39.15 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.55 0.691 . . . . 0.0 111.114 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.435 ' OH ' ' OE2' ' A' ' 168' ' ' GLU . 9.7 m-85 -135.89 124.21 23.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.203 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.415 ' HD1' ' C ' ' A' ' 54' ' ' TYR . 2.6 m-70 -118.05 113.37 21.54 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mp -123.59 146.44 48.15 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.601 0.715 . . . . 0.0 112.128 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -138.78 127.03 22.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.934 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.636 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.91 153.1 34.14 Favored 'General case' 0 CA--C 1.499 -1.018 0 C-N-CA 120.251 -0.579 . . . . 0.0 111.886 -178.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.53 144.46 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.718 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.96 105.35 9.91 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.344 -1.298 . . . . 0.0 107.961 177.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.479 0 CA-C-O 121.375 0.607 . . . . 0.0 110.445 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.4 pt . . . . . 0 N--CA 1.435 -1.177 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.07 15.67 1.06 Allowed 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.356 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -146.21 164.35 28.32 Favored Glycine 0 C--O 1.229 -0.214 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.473 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.11 125.1 8.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.068 -0.566 . . . . 0.0 111.475 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.8 tt -131.08 104.82 9.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.62 ' H ' ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -96.6 126.17 41.59 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.525 -177.847 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -96.6 130.75 44.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.091 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.609 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 37.2 p90 -128.99 144.5 51.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.444 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.578 ' HG ' ' H ' ' A' ' 89' ' ' SER . 4.1 p -87.27 142.83 27.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.211 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.8 m -71.28 12.69 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.776 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.564 ' H ' ' HG ' ' A' ' 86' ' ' SER . 8.6 t -132.86 -20.09 2.25 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 120.892 0.377 . . . . 0.0 111.904 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.578 ' H ' ' HG ' ' A' ' 86' ' ' SER . 33.1 t -90.13 92.63 9.04 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.758 -176.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 tp -61.12 -11.19 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.534 ' H ' ' C ' ' A' ' 89' ' ' SER . 3.3 mttp -78.04 -52.01 9.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 113.351 -1.75 . . . . 0.0 110.327 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 53.5 p -60.58 -33.58 72.93 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.643 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.609 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -74.06 -49.38 24.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.281 -179.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -65.23 -42.65 93.2 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.707 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.1 m -67.42 -38.51 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.652 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.6 mt -62.25 -38.12 80.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.347 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -69.43 -29.01 66.63 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.2 t -75.83 -67.03 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.208 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.1 tt -48.3 -40.12 9.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.615 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.467 ' CE1' ' CD2' ' A' ' 141' ' ' TRP . 12.3 t-80 -58.3 -64.54 0.88 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.484 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -42.64 -60.07 2.98 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 105' ' ' ASP . 14.6 tptp -57.31 -65.22 0.66 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.855 -0.672 . . . . 0.0 110.627 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -36.83 -55.87 0.88 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.237 0.542 . . . . 0.0 109.751 179.519 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.484 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -49.64 -47.75 49.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.73 0.776 . . . . 0.0 109.365 178.753 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.895 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.338 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.476 ' OE1' ' CB ' ' A' ' 173' ' ' ALA . 50.1 mt-30 . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 120.991 0.424 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.473 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -108.04 137.11 19.74 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.474 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -47.82 117.57 2.52 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.466 1.444 . . . . 0.0 112.313 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.473 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.5 mp -124.78 132.31 71.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 4.8 tpt -131.9 117.44 18.48 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.937 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.0 mt -95.75 97.4 9.67 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.0 t -103.91 133.15 48.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 122.327 1.061 . . . . 0.0 110.665 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.413 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -106.18 112.6 3.92 Favored Glycine 0 C--N 1.304 -1.229 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.188 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.524 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.1 t30 -96.98 176.94 5.78 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.898 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.524 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 8.7 mttp 63.41 58.79 1.31 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.221 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -65.03 -12.93 56.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.748 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.451 ' OD2' ' CD1' ' A' ' 123' ' ' LEU . 2.6 p-10 -81.3 -8.43 59.74 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.101 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.598 ' O ' ' N ' ' A' ' 126' ' ' GLU . 11.1 mp -98.52 -23.11 15.66 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.545 ' C ' ' H ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -26.88 -38.59 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.343 1.027 . . . . 0.0 111.284 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.543 ' N ' ' O ' ' A' ' 123' ' ' LEU . 2.0 mmt -46.85 -15.95 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.006 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 123' ' ' LEU . 18.6 mm-40 -92.58 -62.68 1.35 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.406 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.538 HH21 ' CD2' ' A' ' 124' ' ' HIS . 5.2 tpp85 26.18 65.74 0.07 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.008 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.9 t -49.01 -29.43 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.955 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.2 tp -88.82 156.36 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.877 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.523 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 74.9 p -97.85 123.09 41.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.348 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -37.77 -31.32 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.26 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.6 mp0 -71.66 -64.12 0.99 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.848 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.523 ' H ' ' HG ' ' A' ' 130' ' ' SER . 67.4 mt-10 -41.1 -40.95 1.63 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.952 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.91 -36.4 65.25 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 132' ' ' GLU . 13.8 tttm -62.39 -54.44 40.29 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.074 -0.563 . . . . 0.0 109.681 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.7 -35.76 71.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.794 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.18 -61.86 1.88 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.89 -38.01 61.25 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.17 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.43 -29.92 68.68 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.263 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.7 -46.67 81.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.989 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.479 ' CZ3' ' CD2' ' A' ' 104' ' ' LEU . 53.0 m95 -89.57 -3.49 58.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.143 0.496 . . . . 0.0 110.148 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 77.07 22.39 1.02 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.723 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.33 167.89 13.14 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.3 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.58 133.9 51.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.338 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 6.0 t80 -96.68 122.02 39.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.679 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -134.17 137.91 44.78 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.964 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.483 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 4.1 tt0 -126.24 111.5 14.65 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 27.5 p -137.66 -172.89 3.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.03 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.482 ' HG ' ' CD ' ' A' ' 152' ' ' GLU . 0.0 OUTLIER -137.98 141.48 40.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.221 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.513 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -61.66 -45.61 93.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.354 0.597 . . . . 0.0 109.4 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.445 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 15.7 tttp -65.81 5.22 0.5 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.644 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.513 ' H ' ' C ' ' A' ' 150' ' ' ALA . 43.9 mt-10 -133.85 120.4 20.39 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.836 0.351 . . . . 0.0 110.974 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.706 ' ND2' HE22 ' A' ' 25' ' ' GLN . 0.0 OUTLIER -77.57 -57.5 3.79 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.071 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 153' ' ' ASN . 9.0 tt0 -36.85 -58.43 0.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.976 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.8 p -52.06 -45.07 64.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.98 0.419 . . . . 0.0 110.045 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -56.16 -61.37 2.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.493 0.663 . . . . 0.0 109.869 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 59.7 t -40.83 -39.98 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.331 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -65.91 -38.33 88.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.149 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 156' ' ' ALA . 21.7 t -67.99 -37.31 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.55 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 160' ' ' PHE . 1.2 t80 -57.76 -65.32 0.66 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.338 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.445 ' O ' ' N ' ' A' ' 164' ' ' ILE . 1.1 ttt-85 -46.73 -64.9 0.65 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.117 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -41.66 -31.21 0.27 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.331 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -40.87 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 119.526 -0.869 . . . . 0.0 109.837 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.445 ' N ' ' O ' ' A' ' 161' ' ' ARG . 49.6 mt -63.92 -38.56 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.71 0.767 . . . . 0.0 109.961 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 168' ' ' GLU . 25.1 mt -57.63 -64.39 0.91 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.018 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -54.56 -25.39 25.79 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.53 -27.85 65.51 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 165' ' ' LEU . 3.0 tp10 -69.18 -57.85 4.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.019 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -57.76 -58.86 6.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.791 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 1.4 mp -52.86 -34.34 20.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.689 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.492 ' OD2' ' NH2' ' A' ' 7' ' ' ARG . 0.4 OUTLIER -67.39 -40.07 85.65 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.144 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -57.59 -39.6 91.21 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.476 ' CB ' ' OE1' ' A' ' 111' ' ' GLN . . . -69.41 -81.5 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.754 0.312 . . . . 0.0 110.243 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.832 179.923 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.88 0.371 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.19 137.42 34.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.057 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 5.5 mtpm? -103.48 134.36 46.97 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.93 129.01 73.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.744 -176.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.82 133.94 33.59 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.267 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.6 mt -97.58 133.87 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 120.695 0.284 . . . . 0.0 111.318 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.1 tt -130.45 97.67 4.46 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.459 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -141.18 133.41 5.81 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.431 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.9 -173.89 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -84.89 125.21 32.45 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.195 0.522 . . . . 0.0 111.427 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 75.31 12.1 3.33 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.593 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.14 -20.86 21.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.535 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.57 24.16 12.74 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.013 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.3 pttm -69.07 -36.49 77.69 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.322 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.1 m -71.86 -26.49 62.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.4 m -68.29 -43.45 77.69 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.163 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.2 tp -77.65 -41.41 38.41 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.897 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.3 m -52.56 -38.83 60.66 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -78.07 -38.4 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.038 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.554 ' CG ' ' ND2' ' A' ' 153' ' ' ASN . 0.1 OUTLIER -69.51 -33.65 73.15 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.398 -179.497 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -77.98 -61.14 2.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.197 0.522 . . . . 0.0 111.047 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.473 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 14.9 p -46.39 -48.05 6.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.77 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.473 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 2.2 tt0 -84.18 -24.74 30.0 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 77.97 22.91 67.67 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.252 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -153.02 127.14 9.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.721 ' H ' HD22 ' A' ' 153' ' ' ASN . 60.1 t80 . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.412 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.572 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 40' ' ' GLU . 3.9 m-20 166.88 -179.29 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.5 0.667 . . . . 0.0 112.504 -178.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.98 134.49 51.55 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.632 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -112.2 170.96 7.8 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.8 156.37 40.07 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -168.06 131.16 1.57 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.668 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.5 mp -105.97 133.29 50.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.533 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.31 165.4 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.897 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.7 m -133.24 131.16 39.97 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.802 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.468 ' C ' ' H ' ' A' ' 51' ' ' GLY . 7.6 p -133.89 136.44 53.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.296 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 61.51 2.94 0.73 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.224 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 105.18 -11.29 48.03 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -89.07 118.55 28.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.634 0.254 . . . . 0.0 110.687 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.26 144.23 28.24 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.278 0.561 . . . . 0.0 111.805 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.574 ' CD1' ' N ' ' A' ' 54' ' ' TYR . 0.5 OUTLIER -140.63 152.96 45.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.16 178.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -118.88 116.94 27.53 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.441 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.9 mp -117.38 139.36 50.96 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.748 0.785 . . . . 0.0 111.193 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -130.08 125.76 35.96 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.097 -1.41 . . . . 0.0 109.195 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.638 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -113.7 135.03 54.38 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.322 -178.747 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -118.99 139.95 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -118.83 112.97 20.37 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.626 178.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.3 p . . . . . 0 CA--C 1.512 -0.508 0 CA-C-O 121.316 0.579 . . . . 0.0 111.019 -179.663 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 8' ' ' LYS . 40.2 pt . . . . . 0 N--CA 1.43 -1.444 0 CA-C-O 121.297 0.57 . . . . 0.0 112.373 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -144.53 17.85 1.67 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.757 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.03 166.49 34.58 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.345 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.16 127.39 11.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.553 -0.823 . . . . 0.0 110.7 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.464 ' CG2' ' O ' ' A' ' 82' ' ' ILE . 12.3 tt -129.18 96.9 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.57 118.58 34.39 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.355 -177.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.95 111.02 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.273 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.511 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 4.1 p90 -110.66 142.39 42.61 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.416 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.63 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.5 p -88.94 141.17 28.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.429 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 19.1 m -77.58 18.05 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.771 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.59 ' H ' ' HG ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -133.99 -25.26 1.62 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.317 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.63 ' H ' ' HG ' ' A' ' 86' ' ' SER . 20.6 t -94.0 92.37 7.32 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.333 -176.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.3 tp -59.57 -10.43 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.531 ' H ' ' C ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -78.18 -54.96 5.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.247 179.004 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.1 p -55.13 -27.22 43.8 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.511 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -76.75 -39.58 51.26 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.625 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -68.23 -44.17 76.32 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.22 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.407 ' CG2' ' N ' ' A' ' 96' ' ' ILE . 2.3 m -69.37 -40.81 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.584 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.407 ' N ' ' CG2' ' A' ' 95' ' ' VAL . 18.0 mt -57.09 -51.28 71.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.292 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -72.35 -31.65 65.81 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.853 0.358 . . . . 0.0 111.412 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.8 t -73.46 -66.36 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.351 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.426 ' O ' ' C ' ' A' ' 100' ' ' HIS . 31.9 mt -48.16 -55.72 2.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.494 ' CE1' ' CE2' ' A' ' 141' ' ' TRP . 25.9 t-80 -41.16 -63.82 0.63 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.64 -52.0 1.9 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 103' ' ' LEU . 24.3 tptt -70.48 -66.66 0.57 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.386 -0.407 . . . . 0.0 111.106 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -36.71 -55.07 0.89 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.969 0.414 . . . . 0.0 109.946 179.718 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.49 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -51.91 -50.7 60.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.495 0.664 . . . . 0.0 109.449 179.157 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.454 ' N ' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.312 -1.027 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.032 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.842 0.353 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.479 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.8 OUTLIER -117.66 152.91 50.36 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.33 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -46.45 111.42 0.36 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 121.717 1.611 . . . . 0.0 112.338 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.479 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.9 mt -121.62 131.82 72.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.1 tpt -128.01 115.78 19.03 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.623 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.9 mt -95.25 97.55 9.96 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.4 133.31 47.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 122.298 1.047 . . . . 0.0 110.996 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.41 110.23 3.41 Favored Glycine 0 C--N 1.304 -1.231 0 CA-C-N 113.459 -1.7 . . . . 0.0 109.018 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.499 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 43.8 t30 -97.23 174.04 6.92 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.818 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.499 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 2.1 mttp 67.11 59.13 0.54 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.845 0.831 . . . . 0.0 109.226 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.37 -37.49 87.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.368 -178.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -59.88 -9.88 3.41 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.899 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.6 mp -93.99 -29.73 15.08 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.568 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -42.03 -22.77 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.805 178.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.568 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 3.5 mmt -46.65 -23.18 0.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.478 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.3 OUTLIER -103.34 -40.48 6.38 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.218 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.497 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 5.0 tpp85 33.16 83.29 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.199 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.0 m -67.87 -29.5 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.546 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.1 tp -89.42 155.07 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.497 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.505 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 82.0 p -94.7 122.54 37.41 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.838 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -41.35 -33.66 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.404 0.621 . . . . 0.0 109.52 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.5 mp0 -65.07 -64.71 0.8 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.932 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.505 ' H ' ' HG ' ' A' ' 130' ' ' SER . 65.4 mt-10 -41.26 -43.96 2.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.023 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.16 -32.97 69.0 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 132' ' ' GLU . 20.0 tttm -65.72 -55.26 18.27 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.08 -34.04 65.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.494 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.77 -62.7 1.36 Allowed 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.841 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -55.22 -34.71 64.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.543 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.15 -34.75 75.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.735 0.302 . . . . 0.0 110.55 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.04 -46.29 88.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.906 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.494 ' CE2' ' CE1' ' A' ' 100' ' ' HIS . 56.9 m95 -88.45 -4.51 58.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.977 0.418 . . . . 0.0 110.327 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 73.88 25.1 1.97 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.619 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -90.8 168.34 11.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.42 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.32 133.89 49.34 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.794 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.43 ' C ' ' CD1' ' A' ' 145' ' ' PHE . 4.6 t80 -96.65 121.37 38.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.182 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -134.71 137.07 43.19 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.624 -176.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.497 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 5.8 tt0 -124.62 111.01 15.12 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 10.7 p -135.5 -174.96 3.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.994 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.47 132.94 32.08 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.053 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.499 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -56.26 -53.04 61.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.283 0.563 . . . . 0.0 109.732 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -49.4 -12.38 0.06 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.786 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.499 ' H ' ' C ' ' A' ' 150' ' ' ALA . 31.8 mt-10 -122.64 124.17 42.83 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.64 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.721 HD22 ' H ' ' A' ' 31' ' ' PHE . 29.1 m120 -77.71 -53.21 7.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 153' ' ' ASN . 10.7 tt0 -38.81 -57.34 1.23 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.924 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 44.2 p -51.97 -44.89 64.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.987 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -55.89 -61.58 2.28 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.566 0.698 . . . . 0.0 109.868 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 61.3 t -41.62 -39.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.518 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -67.86 -36.98 81.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.633 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.477 ' N ' ' O ' ' A' ' 156' ' ' ALA . 35.5 t -66.61 -36.24 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -62.47 -65.69 0.65 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.691 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -44.09 -53.51 6.32 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.741 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -55.81 -29.45 59.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.914 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.64 -35.95 76.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.248 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 42.5 mt -67.54 -38.19 80.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.587 0.708 . . . . 0.0 109.948 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.13 -63.23 1.37 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.748 -178.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -57.59 -31.42 66.15 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.879 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.08 -32.3 70.83 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.475 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.49 -55.07 9.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.004 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -55.45 -63.11 1.27 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.091 0.472 . . . . 0.0 110.552 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 96.7 mt -51.23 -35.36 15.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.792 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.12 -40.0 86.77 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -57.38 -32.61 64.35 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.85 -79.43 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.727 0.299 . . . . 0.0 110.297 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.153 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.275 -179.889 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 CA-C-O 121.073 0.463 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -139.67 135.42 33.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.939 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -106.56 130.05 54.39 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 1.0 OUTLIER -103.77 123.04 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-O 121.426 0.631 . . . . 0.0 110.479 -178.586 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.19 134.86 34.95 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.113 -0.992 . . . . 0.0 110.216 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.9 mt -96.12 133.71 36.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.502 0.667 . . . . 0.0 111.905 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.0 tt -125.18 97.67 5.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.352 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -139.89 130.56 4.74 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.009 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.425 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -57.99 -155.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.04 139.36 31.5 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.752 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.7 m 56.8 10.8 0.79 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.986 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.68 -20.84 28.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.459 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.54 22.6 18.42 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 pttm -72.2 -34.44 68.38 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.856 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.5 m -77.25 -35.19 55.58 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.569 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.06 -36.14 81.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 29.4 tp -76.88 -46.58 24.01 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.471 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.417 ' O ' ' CG1' ' A' ' 27' ' ' VAL . 71.9 m -45.07 -41.5 7.75 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.92 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.62 -41.84 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.232 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.466 ' OE1' ' CB ' ' A' ' 156' ' ' ALA . 0.5 OUTLIER -69.43 -32.31 71.2 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.492 -178.781 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.46 ' CG ' ' N ' ' A' ' 27' ' ' VAL . 0.6 OUTLIER -77.92 -63.19 1.45 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.27 0.557 . . . . 0.0 110.805 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.471 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 11.3 p -44.38 -47.59 2.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.424 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.471 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 2.5 tt0 -83.14 -24.61 32.49 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 75.12 25.63 68.37 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.288 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 25' ' ' GLN . 0.6 OUTLIER -151.61 126.37 9.62 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 120.886 0.374 . . . . 0.0 111.691 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.1 t80 . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.95 178.48 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.426 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 1.4 pm0 . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 0.7 OUTLIER 178.99 -179.78 0.38 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.249 0.547 . . . . 0.0 112.079 -179.15 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.95 132.91 53.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.072 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -114.45 173.92 6.22 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.167 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.55 155.59 43.74 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -155.4 108.04 2.71 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.604 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.0 mp -105.36 122.45 45.98 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.725 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 pp -149.55 165.83 3.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.551 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.1 m -114.05 123.81 50.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.07 125.39 74.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-N 116.352 -0.386 . . . . 0.0 109.963 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 67.46 15.46 9.85 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.51 -9.95 76.02 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.37 135.71 33.51 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.39 146.99 40.37 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.597 0.713 . . . . 0.0 111.271 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.476 ' C ' ' HD1' ' A' ' 55' ' ' HIS . 4.9 m-85 -137.92 123.58 19.82 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.192 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.476 ' HD1' ' C ' ' A' ' 54' ' ' TYR . 0.4 OUTLIER -118.16 112.47 20.2 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -120.92 146.71 46.34 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.585 0.707 . . . . 0.0 112.24 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -137.56 126.93 24.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.01 178.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.644 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.72 154.51 31.57 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.253 -178.246 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.33 140.8 47.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.485 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.31 114.31 19.39 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.02 177.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.512 -0.495 0 CA-C-O 121.587 0.708 . . . . 0.0 111.029 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.7 pt . . . . . 0 N--CA 1.432 -1.348 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.39 20.35 0.84 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.137 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -147.95 164.79 28.89 Favored Glycine 0 CA--C 1.517 0.218 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.682 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.2 123.21 7.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.754 -0.723 . . . . 0.0 111.165 178.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.9 tt -126.85 110.37 22.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.577 ' CD2' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.79 119.1 36.97 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.236 -177.331 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.6 133.07 42.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.075 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.474 ' CD2' ' CE2' ' A' ' 93' ' ' PHE . 8.4 p90 -143.32 144.6 32.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.973 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.613 ' C ' ' H ' ' A' ' 88' ' ' THR . 2.2 t -88.24 143.25 27.15 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.853 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.2 m -67.18 14.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.972 0.415 . . . . 0.0 110.259 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.613 ' H ' ' C ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -127.78 -18.13 4.35 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.53 -178.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.697 ' HG ' ' H ' ' A' ' 92' ' ' SER . 8.6 t -94.95 92.02 6.68 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.447 -175.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.9 tp -62.97 -11.44 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 89' ' ' SER . 1.0 OUTLIER -78.32 -58.63 3.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 113.712 -1.585 . . . . 0.0 110.576 178.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.697 ' H ' ' HG ' ' A' ' 89' ' ' SER . 19.0 p -55.38 -31.62 61.94 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.398 0.618 . . . . 0.0 109.539 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.474 ' CE2' ' CD2' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -77.72 -38.1 47.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.195 179.677 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -69.21 -46.79 66.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.477 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.439 ' CG2' ' N ' ' A' ' 96' ' ' ILE . 2.8 m -67.8 -45.23 84.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.59 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.439 ' N ' ' CG2' ' A' ' 95' ' ' VAL . 33.3 mt -58.41 -46.14 89.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.24 -37.73 69.06 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.097 0.475 . . . . 0.0 111.06 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.0 t -72.11 -65.3 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.672 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.408 ' O ' ' C ' ' A' ' 100' ' ' HIS . 73.3 mt -42.3 -59.12 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.915 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.554 ' HD1' ' N ' ' A' ' 101' ' ' GLY . 4.3 t-80 -40.98 -64.98 0.47 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.752 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.554 ' N ' ' HD1' ' A' ' 100' ' ' HIS . . . -36.6 -56.71 1.25 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 103' ' ' LEU . 32.8 tptt -69.8 -66.5 0.58 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.472 -0.364 . . . . 0.0 111.611 -179.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.47 ' C ' ' O ' ' A' ' 102' ' ' LYS . 5.8 tp -36.98 -61.83 0.53 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.501 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -44.5 -50.67 9.38 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.787 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.474 ' N ' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.79 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.448 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 . . . . . 0 CA--C 1.521 -0.164 0 CA-C-O 120.932 0.396 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.476 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.8 OUTLIER -118.52 155.84 51.77 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.343 179.242 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -47.04 111.43 0.39 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.813 1.675 . . . . 0.0 112.254 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.476 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.7 mt -121.84 127.3 75.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 6.6 tpt -128.62 117.23 20.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.09 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.7 mt -95.95 97.79 9.9 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.413 ' O ' ' CE1' ' A' ' 85' ' ' TYR . 29.8 t -104.92 128.56 58.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 122.175 0.988 . . . . 0.0 111.319 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.457 ' CA ' ' CE2' ' A' ' 85' ' ' TYR . . . -102.65 114.5 4.91 Favored Glycine 0 C--N 1.307 -1.04 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.535 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 49.1 t30 -97.8 177.16 5.55 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.698 -178.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.535 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 19.4 mttt 61.91 59.17 1.77 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.071 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -64.92 -17.99 64.83 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -79.24 0.65 27.74 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.844 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 125' ' ' MET . 9.2 mp -95.88 -25.43 16.01 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.544 ' HD1' HH11 ' A' ' 127' ' ' ARG . 0.2 OUTLIER -37.39 -28.19 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.531 178.449 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.521 ' N ' ' O ' ' A' ' 123' ' ' LEU . 9.3 mtt -45.43 -23.58 0.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.519 ' CD ' ' HG1' ' A' ' 88' ' ' THR . 0.4 OUTLIER -108.98 -38.83 5.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.844 179.397 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.544 HH11 ' HD1' ' A' ' 124' ' ' HIS . 0.0 OUTLIER 28.68 86.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.173 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.9 m -72.79 -31.65 37.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.451 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.42 151.8 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.779 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.629 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 94.4 p -104.21 126.39 51.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.153 0.501 . . . . 0.0 111.417 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.455 ' CE1' ' CE1' ' A' ' 145' ' ' PHE . 0.8 OUTLIER -39.95 -38.86 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.313 178.738 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -63.21 -64.85 0.79 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.236 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.629 ' H ' ' HG ' ' A' ' 130' ' ' SER . 59.8 mt-10 -41.08 -46.54 2.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.116 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.42 -33.2 76.72 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 132' ' ' GLU . 21.4 tttm -63.87 -55.42 22.92 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.12 -35.75 69.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.674 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.416 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -66.79 -62.42 1.46 Allowed 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 121.18 0.514 . . . . 0.0 109.779 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.04 -36.61 50.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.288 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -68.12 -32.52 72.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.755 0.312 . . . . 0.0 110.26 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.64 ' HG ' ' N ' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -63.89 -46.15 86.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.844 -179.442 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.64 ' N ' ' HG ' ' A' ' 140' ' ' SER . 49.7 m95 -88.26 -4.51 58.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.345 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 74.63 27.52 1.31 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.399 0.618 . . . . 0.0 109.411 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -95.46 170.01 9.65 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.57 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.92 133.07 52.79 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.018 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.455 ' CE1' ' CE1' ' A' ' 131' ' ' TYR . 8.3 t80 -97.24 122.33 40.14 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.445 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -134.58 136.37 42.92 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.713 -176.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.467 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 5.8 tt0 -123.38 111.95 16.99 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.7 p -137.33 -175.74 4.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.752 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.26 136.51 35.01 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.908 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.456 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -57.49 -47.41 81.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.274 0.559 . . . . 0.0 109.827 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -56.08 -8.43 0.46 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.449 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.456 ' H ' ' C ' ' A' ' 150' ' ' ALA . 30.4 mt-10 -127.53 124.4 38.16 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.806 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 156' ' ' ALA . 5.4 t-20 -77.72 -55.87 4.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.02 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 153' ' ' ASN . 1.6 mt-30 -36.73 -57.74 0.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.103 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.8 p -52.88 -45.25 67.4 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.085 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.466 ' CB ' ' OE1' ' A' ' 25' ' ' GLN . . . -56.21 -61.67 2.24 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.595 0.712 . . . . 0.0 109.934 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 60.6 t -42.77 -39.18 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.534 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -68.77 -33.79 74.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.788 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.46 ' N ' ' O ' ' A' ' 156' ' ' ALA . 44.6 t -67.61 -39.38 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.074 0.464 . . . . 0.0 109.815 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.509 ' O ' ' N ' ' A' ' 163' ' ' ILE . 66.5 t80 -63.55 -66.24 0.57 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.779 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.0 ttt85 -43.34 -46.47 6.47 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.667 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -58.06 -32.64 68.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.16 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.509 ' N ' ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -66.22 -34.8 72.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.26 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.1 mt -63.78 -44.1 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.423 0.63 . . . . 0.0 111.295 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -58.79 -64.67 0.85 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.045 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.42 ' H ' HD21 ' A' ' 165' ' ' LEU . 0.4 OUTLIER -50.52 -23.83 2.77 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.676 -178.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.77 -31.18 66.35 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.559 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 165' ' ' LEU . 0.5 OUTLIER -70.29 -52.21 24.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.08 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -61.09 -63.56 1.25 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.883 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 96.4 mt -50.95 -32.7 12.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.94 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.02 -39.09 86.96 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.484 -0.487 . . . . 0.0 109.908 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -59.48 -35.54 85.78 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.403 ' O ' ' C ' ' A' ' 174' ' ' ALA . . . -68.39 -78.56 0.06 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 173' ' ' ALA . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.025 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 121.223 0.535 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -140.27 135.55 32.39 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.905 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.619 ' HZ3' ' NE2' ' A' ' 57' ' ' GLN . 15.2 mttm -107.3 127.63 53.72 Favored 'General case' 0 C--O 1.212 -0.896 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -103.02 118.47 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-O 121.691 0.758 . . . . 0.0 110.773 -178.352 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.431 ' O ' HG21 ' A' ' 82' ' ' ILE . . . -82.73 137.75 34.29 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.691 -0.631 . . . . 0.0 111.848 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.1 mt -92.92 125.82 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.183 0.516 . . . . 0.0 111.92 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tt -123.19 92.33 3.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.896 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -142.03 136.82 7.53 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -178.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.474 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.5 OUTLIER -53.09 -160.17 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.699 0.762 . . . . 0.0 111.31 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.8 tpp85 -97.11 136.0 38.28 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.701 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.3 m 63.28 11.5 5.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.567 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 p -71.94 -16.84 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.16 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.62 21.35 34.5 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -39.25 81.11 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.359 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.7 m -71.89 -28.65 63.65 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.3 m -63.73 -42.42 97.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.199 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.4 tp -75.53 -28.41 59.08 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.464 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.0 m -55.94 -49.92 72.18 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.477 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 1.4 mp -70.9 -41.04 77.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.075 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.467 ' OE1' ' CB ' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -65.67 -30.24 70.9 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.23 -179.169 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -77.79 -64.02 1.25 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.452 0.644 . . . . 0.0 111.353 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 14.1 p -49.65 -47.2 21.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.375 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.474 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 0.8 OUTLIER -83.66 -24.36 31.38 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.372 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.17 25.99 71.86 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -144.47 125.45 14.42 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.187 0.518 . . . . 0.0 112.297 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.625 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.801 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.553 0 CA-C-O 120.955 0.407 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -160.35 161.7 33.23 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.808 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.5 m -132.52 149.62 52.29 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.266 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 10.9 m-85 -129.63 164.48 23.79 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.72 150.36 35.22 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.148 0.499 . . . . 0.0 111.997 -178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -153.17 119.19 5.42 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.06 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.01 123.86 48.8 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.127 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -145.51 165.63 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.221 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.36 121.85 44.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.224 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.404 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 8.5 p -114.59 114.66 47.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.92 179.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 49' ' ' VAL . 4.3 t-20 73.72 11.83 4.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.398 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.82 -8.14 63.37 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.672 ' NE2' ' H ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -93.74 135.17 35.31 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.672 ' H ' ' NE2' ' A' ' 52' ' ' GLN . 2.4 mt-10 -74.35 145.48 43.81 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.577 0.704 . . . . 0.0 111.252 -178.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -136.18 127.07 27.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.183 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -117.63 112.87 21.11 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.0 mp -118.46 139.12 51.91 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.537 0.684 . . . . 0.0 111.575 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.619 ' NE2' ' HZ3' ' A' ' 8' ' ' LYS . 1.9 mt-30 -132.16 121.0 23.02 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.098 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.651 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -114.64 155.21 26.98 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.761 -178.214 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.12 145.95 31.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -177.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.494 ' O ' ' OG1' ' A' ' 61' ' ' THR . 0.3 OUTLIER -122.04 117.51 26.53 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 113.504 -1.68 . . . . 0.0 107.898 177.525 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 60' ' ' ASP . 20.3 p . . . . . 0 CA--C 1.497 -1.087 0 O-C-N 123.546 0.528 . . . . 0.0 109.771 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 8' ' ' LYS . 38.3 pt . . . . . 0 N--CA 1.439 -1.024 0 CA-C-O 121.405 0.622 . . . . 0.0 112.664 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.56 19.81 1.04 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.437 178.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.96 168.1 33.89 Favored Glycine 0 CA--C 1.521 0.45 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.187 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.15 122.76 7.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.985 -0.608 . . . . 0.0 110.709 177.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.431 HG21 ' O ' ' A' ' 10' ' ' ALA . 11.0 tt -125.34 102.3 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.716 0.77 . . . . 0.0 109.312 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.586 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.8 OUTLIER -97.15 125.72 41.84 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.794 -178.56 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -95.51 130.66 43.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.303 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -110.56 143.75 40.47 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.14 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.545 ' C ' ' H ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -98.21 124.13 42.63 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.1 m -72.51 23.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.71 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.545 ' H ' ' C ' ' A' ' 86' ' ' SER . 5.1 t -138.36 -25.57 0.93 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 91' ' ' LYS . 8.3 t -100.2 95.06 6.55 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.051 -176.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.1 tp -57.86 -11.66 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 175.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.563 ' H ' ' C ' ' A' ' 89' ' ' SER . 18.5 mttp -77.74 -61.51 1.97 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 113.936 -1.483 . . . . 0.0 110.23 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.44 ' O ' ' CD1' ' A' ' 96' ' ' ILE . 76.5 p -47.17 -29.59 2.4 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.723 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.41 ' CE2' ' CG2' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -74.07 -51.41 15.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.179 -179.365 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -65.79 -43.96 87.17 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.6 m -68.07 -36.5 75.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.12 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.44 ' CD1' ' O ' ' A' ' 92' ' ' SER . 19.2 mt -63.35 -38.84 83.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -69.68 -25.97 64.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.03 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 57.4 t -76.46 -66.47 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.338 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.5 mm -44.27 -54.36 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.431 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.637 ' ND1' ' CH2' ' A' ' 141' ' ' TRP . 2.0 t-80 -61.45 -64.51 0.92 Allowed 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.805 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.531 ' N ' ' ND1' ' A' ' 100' ' ' HIS . . . -35.39 -57.29 0.91 Allowed Glycine 0 N--CA 1.454 -0.141 0 CA-C-N 116.24 -0.437 . . . . 0.0 112.053 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 103' ' ' LEU . 15.4 tptm -69.69 -65.01 0.77 Allowed 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.359 -0.42 . . . . 0.0 110.736 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.45 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.7 OUTLIER -36.88 -60.87 0.59 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.097 0.475 . . . . 0.0 109.872 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.485 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -46.65 -47.01 20.26 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 178.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.83 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.56 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 . . . . . 0 CA--C 1.522 -0.13 0 CA-C-O 120.801 0.334 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.481 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.8 OUTLIER -118.62 153.67 52.25 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.233 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -48.04 117.06 2.26 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.582 1.521 . . . . 0.0 111.953 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.481 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.4 mp -122.81 126.45 73.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 8.4 tpt -122.31 112.53 18.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.497 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 73.2 mt -96.67 98.86 10.52 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.6 t -108.45 133.67 52.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 122.04 0.924 . . . . 0.0 112.62 -178.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -97.93 114.29 4.96 Favored Glycine 0 C--N 1.315 -0.615 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.429 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 50.5 t30 -98.09 170.08 9.17 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -177.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.429 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 25.8 mttt 61.02 57.37 2.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.274 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.526 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 9.2 ttpt -57.73 -29.06 64.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.418 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -67.5 -16.79 64.39 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.295 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.1 mp -82.01 -31.26 31.11 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.603 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.1 OUTLIER -37.74 -24.71 0.01 OUTLIER 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.366 178.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.603 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 2.7 mmt -48.24 -22.53 0.68 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.44 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -109.0 -37.68 5.76 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.827 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.445 ' NH1' ' OE1' ' A' ' 147' ' ' GLU . 0.2 OUTLIER 27.16 91.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.034 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 38.7 t -70.79 -45.81 71.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.055 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.41 ' CG2' ' CE2' ' A' ' 93' ' ' PHE . 8.7 tp -91.55 153.54 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.577 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.438 ' OG ' ' OE1' ' A' ' 133' ' ' GLU . 4.1 p -104.51 126.17 51.35 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.3 0.571 . . . . 0.0 111.329 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.638 ' CD1' ' CE1' ' A' ' 145' ' ' PHE . 0.7 OUTLIER -49.41 -43.67 44.71 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.815 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 131' ' ' TYR . 1.2 mp0 -39.07 -63.11 0.56 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.344 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.438 ' OE1' ' OG ' ' A' ' 130' ' ' SER . 11.7 mt-10 -52.24 -37.18 54.48 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 131' ' ' TYR . . . -72.27 -22.23 78.97 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 131' ' ' TYR . 0.3 OUTLIER -75.91 -54.68 6.53 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.478 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -54.49 -37.53 65.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.362 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.6 OUTLIER -69.61 -63.72 1.02 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -42.41 -32.95 0.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.27 -48.67 67.02 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.867 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -66.96 -27.82 67.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.475 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.637 ' CH2' ' ND1' ' A' ' 100' ' ' HIS . 22.8 m0 -86.67 -10.94 52.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.69 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.23 27.16 16.92 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -104.15 166.05 10.65 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.24 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -102.62 127.84 49.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.211 0.529 . . . . 0.0 112.115 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.638 ' CE1' ' CD1' ' A' ' 131' ' ' TYR . 11.3 t80 -99.36 118.67 36.52 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.109 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.03 133.12 22.88 Favored 'General case' 0 C--N 1.347 0.491 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.445 ' OE1' ' NH1' ' A' ' 127' ' ' ARG . 3.1 mt-10 -98.47 115.09 27.78 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.875 -0.515 . . . . 0.0 109.838 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.46 ' CB ' ' OG1' ' A' ' 155' ' ' THR . 0.5 OUTLIER -140.54 134.88 31.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.705 -179.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 152' ' ' GLU . 4.0 p -102.29 142.4 33.57 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.466 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -55.53 -55.28 33.67 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.688 178.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 31.3 tttt -46.84 -15.11 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.998 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.466 ' H ' ' C ' ' A' ' 150' ' ' ALA . 60.9 mt-10 -126.0 120.12 29.46 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.973 0.416 . . . . 0.0 110.868 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 154' ' ' GLN . 9.7 t-20 -77.1 -47.48 20.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 153' ' ' ASN . 1.4 mt-30 -36.92 -58.91 0.74 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.229 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.46 ' OG1' ' CB ' ' A' ' 148' ' ' SER . 1.2 p -56.49 -42.69 78.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.289 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.467 ' CB ' ' OE1' ' A' ' 25' ' ' GLN . . . -53.78 -60.75 2.92 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.555 0.693 . . . . 0.0 109.938 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 49.2 t -45.84 -44.12 4.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.561 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -53.9 -45.18 71.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.265 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.2 t -65.59 -49.48 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.423 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.479 ' O ' HG21 ' A' ' 163' ' ' ILE . 1.3 t80 -45.61 -37.5 5.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.807 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.1 ttt-85 -79.14 -50.27 11.28 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.375 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -34.29 69.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.278 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.479 HG21 ' O ' ' A' ' 160' ' ' PHE . 11.8 tt -67.9 -54.6 21.43 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.944 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.476 ' N ' ' CG2' ' A' ' 163' ' ' ILE . 90.8 mt -47.38 -34.6 3.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 119.219 -0.992 . . . . 0.0 109.425 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.66 -64.33 0.95 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.059 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -57.12 -30.64 64.56 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.227 -0.589 . . . . 0.0 109.42 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.96 -32.68 69.85 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.41 -53.14 25.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.383 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 12.6 tttm -59.14 -65.02 0.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.883 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 74.6 mt -48.74 -35.04 6.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.678 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -67.21 -37.33 83.43 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.03 -30.89 76.82 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.75 -79.54 0.05 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.191 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.768 179.88 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 121.265 0.555 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.23 136.68 33.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.312 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.42 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 22.6 mtmt -107.35 130.02 54.84 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 1.1 mm -108.77 121.07 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-O 121.342 0.592 . . . . 0.0 110.277 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.62 135.55 35.03 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.259 -0.9 . . . . 0.0 110.533 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.7 mt -95.54 131.69 41.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.415 0.626 . . . . 0.0 112.09 -178.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.408 ' C ' ' CD2' ' A' ' 12' ' ' LEU . 5.5 tt -132.34 99.09 4.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.719 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.87 135.57 6.81 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -52.45 -165.42 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.49 0.662 . . . . 0.0 110.791 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -100.33 138.09 37.86 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.487 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.52 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 1.3 m 67.66 20.52 9.56 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.36 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 p -90.08 -21.52 6.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.042 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.44 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 108.33 26.25 5.49 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.463 ' CB ' ' NZ ' ' A' ' 19' ' ' LYS . 1.3 ttmp? -60.76 -49.21 78.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.147 0.499 . . . . 0.0 110.094 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -75.98 -25.45 55.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.254 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 54.3 p -65.62 -44.99 84.8 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.453 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 23' ' ' THR . 20.4 tp -76.33 -58.39 3.31 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 119.784 -0.767 . . . . 0.0 110.975 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 22' ' ' LEU . 90.3 m -39.02 -48.68 1.65 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.961 -0.295 . . . . 0.0 110.705 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.488 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 1.3 mp -74.62 -35.31 37.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 123.356 0.41 . . . . 0.0 111.34 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.449 HE22 ' HB1' ' A' ' 156' ' ' ALA . 0.8 OUTLIER -69.6 -37.74 77.01 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.964 -178.589 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.631 ' CZ ' ' CD1' ' A' ' 160' ' ' PHE . 20.0 t80 -77.15 -59.55 2.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.291 0.567 . . . . 0.0 111.342 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 9.5 p -48.71 -47.19 15.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.57 -178.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.49 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 2.0 tt0 -85.13 -24.42 28.02 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.38 35.76 63.29 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -130.34 125.05 33.68 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.371 0.605 . . . . 0.0 111.641 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.718 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.742 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.66 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.443 ' CB ' ' O ' ' A' ' 60' ' ' ASP . 2.0 pt-20 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.783 0.325 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.409 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 1.3 m120 178.72 173.91 0.68 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.215 0.531 . . . . 0.0 111.83 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.91 143.4 36.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.567 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.441 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 12.3 m-85 -127.33 165.9 18.84 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.588 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.61 147.16 33.96 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 120.227 -0.589 . . . . 0.0 112.404 -178.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.425 ' C ' ' CD1' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -162.32 114.61 1.68 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.679 178.864 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.604 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -115.16 142.39 46.72 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.821 -1.082 . . . . 0.0 111.159 -177.688 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.77 165.73 2.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.274 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 m -108.33 124.04 49.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.758 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.94 122.76 68.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.139 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 69.65 12.98 8.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.043 0.449 . . . . 0.0 109.954 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.5 -11.37 70.23 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -89.55 133.25 34.69 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -77.39 147.43 36.05 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.522 0.677 . . . . 0.0 111.172 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -137.66 130.73 30.43 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.011 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -116.54 117.54 30.17 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.6 140.7 51.91 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.449 0.642 . . . . 0.0 112.019 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.52 124.41 22.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.097 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.641 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.25 154.95 30.3 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.152 0.501 . . . . 0.0 112.065 -178.717 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.27 145.47 35.28 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-N 115.125 -0.943 . . . . 0.0 113.01 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.443 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -123.34 102.66 8.04 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.009 177.646 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.668 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.036 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.42 ' HB ' ' O ' ' A' ' 8' ' ' LYS . 22.7 pt . . . . . 0 N--CA 1.438 -1.052 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -145.91 16.43 1.4 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.653 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.63 164.38 29.85 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.582 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.71 123.44 7.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.891 -0.655 . . . . 0.0 110.944 178.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 11.7 tt -127.26 104.83 13.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.552 0.691 . . . . 0.0 109.696 178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.406 ' H ' HD13 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -97.7 120.98 39.06 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.406 -178.684 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 t -97.19 114.14 33.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.675 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.505 ' CZ ' ' CA ' ' A' ' 118' ' ' GLY . 48.7 p90 -115.52 145.08 42.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.608 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.64 ' HG ' ' H ' ' A' ' 88' ' ' THR . 1.6 p -86.99 143.16 27.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.452 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.2 m -80.98 17.67 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 120.998 0.428 . . . . 0.0 110.256 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.64 ' H ' ' HG ' ' A' ' 86' ' ' SER . 7.4 t -130.26 -19.59 3.12 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.406 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.586 ' H ' ' HG ' ' A' ' 86' ' ' SER . 20.9 t -98.95 93.78 6.2 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.298 -176.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.7 tp -58.7 -11.82 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.573 ' H ' ' C ' ' A' ' 89' ' ' SER . 12.9 mttp -77.97 -54.39 6.35 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.442 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.1 p -53.93 -32.28 53.06 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.038 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.78 -51.0 17.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.025 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.28 -42.62 92.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.876 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.7 m -65.48 -40.12 87.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.307 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mt -63.0 -32.17 55.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.2 tttm -69.85 -26.47 64.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.101 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.4 t -77.24 -67.13 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.957 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.409 ' N ' ' CD1' ' A' ' 99' ' ' ILE . 1.6 mp -44.26 -38.18 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.245 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.636 ' CD2' ' CZ2' ' A' ' 141' ' ' TRP . 7.3 t60 -66.6 -64.22 0.9 Allowed 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.788 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.556 ' N ' ' CD2' ' A' ' 100' ' ' HIS . . . -35.69 -50.69 1.07 Allowed Glycine 0 C--N 1.329 0.159 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.431 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 17.5 tptm -70.73 -61.15 1.87 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.966 -0.617 . . . . 0.0 110.554 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -42.09 -60.23 1.5 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.462 0.648 . . . . 0.0 109.394 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.495 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -45.98 -44.29 14.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.23 178.51 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.756 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.943 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.722 0.296 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.432 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.5 OUTLIER -132.67 152.72 80.43 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.264 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -47.84 110.51 0.32 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.949 1.766 . . . . 0.0 112.478 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 3.0 mt -126.51 131.8 70.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 6.2 tpt -129.84 116.97 19.46 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.863 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.9 mt -95.69 98.11 10.23 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.5 t -102.41 126.15 56.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 122.066 0.936 . . . . 0.0 112.144 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.505 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -97.36 115.89 5.37 Favored Glycine 0 C--N 1.31 -0.913 0 N-CA-C 108.067 -2.013 . . . . 0.0 108.067 177.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.522 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 52.6 t30 -96.97 175.89 6.17 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.165 -0.614 . . . . 0.0 112.105 -177.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.522 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 15.6 mttt 58.84 58.2 3.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.632 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.546 ' O ' ' CG ' ' A' ' 124' ' ' HIS . 16.2 ttmt -58.73 -30.8 67.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.362 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -64.83 -27.07 68.63 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.199 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.4 mp -71.52 -29.88 65.28 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.624 ' ND1' ' N ' ' A' ' 125' ' ' MET . 0.6 OUTLIER -35.93 -29.23 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.498 179.207 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.624 ' N ' ' ND1' ' A' ' 124' ' ' HIS . 1.0 OUTLIER -45.11 -24.89 0.28 Allowed 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.709 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.483 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -103.64 -41.02 6.08 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.584 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.537 HH21 ' CB ' ' A' ' 124' ' ' HIS . 32.2 ttm-85 28.16 80.97 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.201 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.4 t -57.72 -53.93 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.055 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.5 tp -86.45 153.13 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.76 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.432 ' OG ' ' OE1' ' A' ' 133' ' ' GLU . 1.1 p -87.22 120.77 28.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.365 0.602 . . . . 0.0 111.407 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.621 ' CE1' ' CD1' ' A' ' 145' ' ' PHE . 0.3 OUTLIER -50.18 -47.32 54.57 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.389 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 131' ' ' TYR . 1.6 mp0 -40.28 -60.58 1.05 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.833 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.432 ' OE1' ' OG ' ' A' ' 130' ' ' SER . 26.9 mt-10 -50.61 -38.01 43.39 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.484 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 131' ' ' TYR . . . -69.23 -34.12 74.74 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -67.06 -54.65 19.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.76 -35.93 69.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.39 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.509 ' CD2' ' CE2' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -67.07 -64.32 0.88 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.516 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -45.82 -37.27 5.94 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.7 -40.82 88.64 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER -64.68 -34.15 77.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.231 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.636 ' CZ2' ' CD2' ' A' ' 100' ' ' HIS . 38.5 m0 -87.0 -7.23 58.35 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 70.51 25.32 4.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.988 -178.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -103.97 166.71 10.24 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.644 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.07 133.5 49.75 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.098 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.621 ' CD1' ' CE1' ' A' ' 131' ' ' TYR . 7.5 t80 -97.26 121.04 38.7 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.466 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -132.2 130.63 41.28 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.69 -177.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.503 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 4.5 mt-10 -110.27 112.34 24.23 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.942 0.401 . . . . 0.0 109.978 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 49.4 p -139.73 179.29 6.67 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.362 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 152' ' ' GLU . 6.0 p -139.17 133.92 32.08 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.501 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -54.91 -40.31 69.71 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -54.03 -42.11 68.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.059 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 149' ' ' SER . 13.3 tt0 -100.7 117.27 34.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.235 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 154' ' ' GLN . 0.7 OUTLIER -76.43 -42.58 43.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.185 -179.518 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 153' ' ' ASN . 5.3 tt0 -41.1 -47.83 3.25 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.099 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 63.2 p -62.83 -44.95 94.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.91 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.449 ' HB1' HE22 ' A' ' 25' ' ' GLN . . . -51.2 -64.36 0.84 Allowed 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.62 0.724 . . . . 0.0 109.465 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.0 t -45.12 -35.73 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.837 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -67.85 -41.03 83.58 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.551 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' A' ' 156' ' ' ALA . 19.4 t -62.69 -43.5 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-O 120.937 0.399 . . . . 0.0 110.399 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.631 ' CD1' ' CZ ' ' A' ' 26' ' ' PHE . 1.1 t80 -59.32 -61.23 2.79 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.727 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.53 -48.82 4.0 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.781 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.43 -26.87 68.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.534 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -68.26 -34.08 64.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.046 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 20.2 mt -71.41 -38.73 69.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.684 0.754 . . . . 0.0 109.787 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.31 -63.38 1.3 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.013 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -53.59 -36.21 61.68 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.462 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -55.95 -32.33 63.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -68.48 -57.69 5.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.671 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.77 -63.16 1.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.619 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 68.9 mt -50.37 -34.36 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.914 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.83 -40.31 75.93 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.468 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -58.15 -36.63 83.06 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.71 -65.63 0.68 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.758 0.313 . . . . 0.0 110.383 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.517 179.88 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 120.993 0.425 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -140.04 136.63 33.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.702 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -102.51 133.43 47.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -110.16 129.49 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.429 -177.325 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.28 133.32 33.7 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 121.627 -0.67 . . . . 0.0 110.144 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.2 mt -98.24 133.69 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.15 0.5 . . . . 0.0 112.123 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.424 ' C ' ' CD2' ' A' ' 12' ' ' LEU . 3.8 tt -126.4 99.43 5.83 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.341 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -140.3 133.21 5.86 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.5 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.68 -179.03 0.16 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.982 0.42 . . . . 0.0 110.003 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -76.33 131.88 39.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.026 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.4 m 63.81 16.28 9.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.721 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.532 ' C ' ' HZ3' ' A' ' 120' ' ' LYS . 10.5 p -72.42 -13.15 16.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.393 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.68 23.12 29.17 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.128 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.4 pttm -69.65 -30.34 68.02 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.969 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.8 m -77.5 -34.44 54.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.434 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 61.2 m -65.29 -42.41 93.17 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.635 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.0 tp -77.8 -36.7 50.02 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.3 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 97.2 m -55.45 -38.57 69.21 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -73.82 -39.42 52.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.223 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.582 ' CG ' HD21 ' A' ' 153' ' ' ASN . 5.2 tt0 -70.29 -27.63 64.56 Favored 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.933 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 1.3 t80 -77.46 -60.26 2.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.4 0.619 . . . . 0.0 110.875 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 14.9 p -52.71 -45.92 49.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.043 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.439 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 1.3 tm-20 -84.19 -24.61 30.04 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.474 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 78.77 19.61 72.81 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.748 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.546 ' NE2' ' O ' ' A' ' 31' ' ' PHE . 15.7 tp60 -154.26 134.06 12.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.161 -0.616 . . . . 0.0 112.258 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.546 ' O ' ' NE2' ' A' ' 30' ' ' GLN . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.453 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.505 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 1.8 pm0 . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -170.51 -178.45 2.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.455 0.645 . . . . 0.0 112.348 -178.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.93 131.93 46.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.22 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -108.47 171.33 7.48 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.464 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.3 150.95 37.55 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 37.8 tptt -154.12 116.44 4.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.84 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.527 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 7.0 mp -105.85 125.01 50.48 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.203 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.76 165.58 10.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.799 0.333 . . . . 0.0 110.585 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.4 m -117.7 123.82 47.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.878 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 p -127.15 132.12 70.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.67 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 70.59 7.35 6.18 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.05 -10.39 71.9 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -93.98 139.17 31.25 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -77.21 148.04 36.07 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.59 0.71 . . . . 0.0 111.41 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.467 ' C ' ' HD1' ' A' ' 55' ' ' HIS . 14.5 m-85 -139.35 124.47 18.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.215 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.467 ' HD1' ' C ' ' A' ' 54' ' ' TYR . 1.8 m-70 -117.32 114.15 23.17 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.2 mp -126.05 150.82 47.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.508 0.67 . . . . 0.0 111.67 -178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.29 133.15 36.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.941 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.637 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -114.64 144.28 43.68 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.639 -179.018 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.02 130.26 72.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.757 0.789 . . . . 0.0 112.89 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -123.23 106.4 10.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.349 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 N--CA 1.452 -0.367 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.302 -179.407 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.6 pt . . . . . 0 N--CA 1.43 -1.461 0 CA-C-O 121.186 0.517 . . . . 0.0 112.315 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -150.19 28.11 0.75 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.839 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.37 167.39 35.04 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.299 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.75 127.7 11.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.088 -0.556 . . . . 0.0 111.83 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.475 ' CG2' ' O ' ' A' ' 82' ' ' ILE . 13.2 tt -132.72 96.44 2.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.478 0.656 . . . . 0.0 109.35 177.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.573 ' H ' ' CD2' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -98.17 117.66 33.05 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.089 -178.795 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -96.44 117.69 41.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.345 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.448 ' CZ ' ' CA ' ' A' ' 118' ' ' GLY . 35.7 p90 -111.22 144.19 40.77 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.568 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.649 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.3 p -86.95 138.23 31.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.73 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.0 m -71.94 17.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.611 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.53 ' H ' ' C ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -138.11 -21.07 1.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.747 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.649 ' H ' ' HG ' ' A' ' 86' ' ' SER . 21.3 t -93.18 93.99 8.56 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.141 -176.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.8 tp -60.57 -8.36 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 176.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.586 ' H ' ' C ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -77.48 -59.55 2.73 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.755 179.181 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 86' ' ' SER . 18.9 p -54.12 -29.39 44.81 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.335 0.588 . . . . 0.0 109.566 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.2 -39.87 47.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.669 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -68.59 -42.98 77.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.263 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 m -67.38 -40.41 84.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.562 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.2 mt -55.05 -43.65 70.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 121.212 -0.195 . . . . 0.0 110.686 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -69.23 -35.03 75.74 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.239 0.543 . . . . 0.0 110.761 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.419 ' O ' ' C ' ' A' ' 99' ' ' ILE . 58.4 t -71.58 -65.63 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.319 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.419 ' C ' ' O ' ' A' ' 98' ' ' VAL . 1.4 mp -38.02 -54.38 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.026 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.483 ' CE1' ' CG ' ' A' ' 141' ' ' TRP . 1.1 t-160 -46.4 -64.06 0.85 Allowed 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.457 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 100' ' ' HIS . . . -35.14 -58.45 0.8 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.467 ' O ' ' C ' ' A' ' 103' ' ' LEU . 16.5 tptp -69.82 -65.83 0.67 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.355 -0.422 . . . . 0.0 110.992 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.467 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -36.48 -63.02 0.42 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.021 0.438 . . . . 0.0 109.895 179.671 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.479 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -44.35 -50.83 8.95 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.47 ' N ' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.76 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.373 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 120.848 0.356 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.482 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -108.57 132.02 21.4 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.569 179.553 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -48.2 123.04 8.32 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.384 1.39 . . . . 0.0 111.901 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.482 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.5 mp -123.91 130.83 73.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 6.7 tpt -128.4 117.27 21.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.793 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 mt -95.83 97.82 9.96 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.1 t -105.5 128.4 59.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 122.136 0.969 . . . . 0.0 111.446 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.448 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -100.25 111.84 4.28 Favored Glycine 0 C--N 1.308 -1.006 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.504 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 53.4 t30 -97.75 173.56 7.05 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.684 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.532 ' HZ3' ' C ' ' A' ' 17' ' ' VAL . 5.9 mtpp 61.96 58.38 1.91 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.909 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.534 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 0.5 OUTLIER -60.28 -25.51 65.78 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.568 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -67.53 -9.87 46.5 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.204 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 125' ' ' MET . 11.2 mp -97.2 -25.35 15.32 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.534 ' ND1' ' O ' ' A' ' 121' ' ' LYS . 2.3 p-80 -36.94 -28.57 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.66 178.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.525 ' N ' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -44.39 -23.14 0.09 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.519 ' CD ' ' HG1' ' A' ' 88' ' ' THR . 0.2 OUTLIER -107.66 -40.68 5.24 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.69 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.462 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 22.1 ttm180 24.63 84.33 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.192 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 46.2 t -53.77 -35.35 26.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.308 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.4 tp -88.61 155.92 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.68 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.611 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 89.1 p -100.89 126.68 47.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.682 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -39.54 -33.29 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.796 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.6 mp0 -69.73 -65.3 0.73 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.73 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.611 ' H ' ' HG ' ' A' ' 130' ' ' SER . 62.4 mt-10 -41.41 -40.12 1.66 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.731 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.69 -37.54 67.25 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 132' ' ' GLU . 4.0 tmtt? -61.15 -55.32 33.71 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.66 -36.34 69.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.77 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.54 -61.78 1.9 Allowed 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.19 -37.36 54.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.109 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.01 -34.83 79.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.597 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.58 -46.4 86.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.891 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.483 ' CG ' ' CE1' ' A' ' 100' ' ' HIS . 66.5 m95 -90.58 4.79 50.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.523 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 62.69 31.01 16.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.637 0.732 . . . . 0.0 109.623 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -94.33 167.82 11.29 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.283 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -106.53 132.97 51.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.272 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.432 ' C ' ' CD1' ' A' ' 145' ' ' PHE . 6.4 t80 -96.89 121.59 38.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.478 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -134.69 137.36 43.49 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.872 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.462 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 2.4 mt-10 -125.4 111.56 15.27 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 20.8 p -137.43 -176.29 4.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.039 -178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.0 135.26 34.1 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.063 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.525 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -61.95 -29.47 70.26 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.25 0.548 . . . . 0.0 109.643 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -69.39 0.92 4.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.139 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.416 ' H ' ' C ' ' A' ' 150' ' ' ALA . 25.1 mt-10 -141.54 128.51 20.68 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.728 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.582 HD21 ' CG ' ' A' ' 25' ' ' GLN . 6.1 t-20 -77.52 -54.32 6.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.198 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 153' ' ' ASN . 1.1 mt-30 -36.75 -56.19 0.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.092 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 50.5 p -56.14 -42.69 77.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.031 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 153' ' ' ASN . . . -57.7 -61.39 2.55 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.441 0.639 . . . . 0.0 110.196 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 59.7 t -42.55 -40.15 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.582 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -66.74 -36.61 82.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.783 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.435 ' N ' ' O ' ' A' ' 156' ' ' ALA . 25.7 t -66.14 -41.29 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.007 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.447 ' O ' ' N ' ' A' ' 163' ' ' ILE . 22.7 t80 -59.66 -65.51 0.66 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.647 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.81 -55.82 2.91 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.789 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -51.83 -31.46 27.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.821 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -66.5 -37.21 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.416 -179.6 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.5 mt -68.97 -31.97 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 121.421 0.629 . . . . 0.0 110.133 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.53 -59.79 4.68 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.719 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 114' ' ' ILE . 6.1 pt-20 -59.24 -30.25 68.12 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.515 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.46 -32.24 71.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.442 ' O ' ' OD1' ' A' ' 171' ' ' ASP . 0.0 OUTLIER -71.33 -41.4 69.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.04 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 15.7 tptt -70.19 -58.67 3.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.314 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.47 -52.17 49.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.321 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 172' ' ' GLY . 1.6 p-10 -67.58 -26.78 66.44 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.363 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 171' ' ' ASP . . . -60.28 -44.44 97.5 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.38 -67.97 0.46 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.806 0.336 . . . . 0.0 110.497 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.715 -179.795 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 120.974 0.416 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.402 ' NH2' ' OD1' ' A' ' 171' ' ' ASP . 0.0 OUTLIER -139.87 135.97 33.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.457 -179.392 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -104.16 122.39 45.24 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -104.02 118.54 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-O 121.617 0.722 . . . . 0.0 109.917 -179.068 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.452 ' HB1' ' CE1' ' A' ' 81' ' ' TYR . . . -84.02 134.68 34.62 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 121.191 -0.943 . . . . 0.0 111.339 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.0 mt -95.36 126.88 47.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.705 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.2 tp -127.02 102.0 6.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.499 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -139.21 135.31 7.22 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -53.84 -161.04 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.418 0.628 . . . . 0.0 110.804 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -96.01 130.96 42.87 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.854 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m 67.45 14.6 9.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.748 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.48 ' C ' ' NZ ' ' A' ' 120' ' ' LYS . 7.6 p -76.93 -12.76 14.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.483 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.535 ' CA ' ' HG ' ' A' ' 21' ' ' SER . . . 102.21 12.35 34.01 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.42 ' CB ' ' NZ ' ' A' ' 19' ' ' LYS . 0.8 OUTLIER -46.82 -48.71 20.77 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.678 0.275 . . . . 0.0 111.122 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -76.99 -26.45 53.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.924 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.535 ' HG ' ' CA ' ' A' ' 18' ' ' GLY . 78.3 p -68.49 -49.4 59.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.549 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.6 tp -78.15 -30.7 49.37 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.271 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.1 m -62.59 -47.86 81.95 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 mp -68.28 -34.87 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.981 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 150' ' ' ALA . 2.9 tt0 -74.2 -25.39 59.66 Favored 'General case' 0 C--O 1.215 -0.718 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.639 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 1.4 t80 -76.69 -57.97 3.55 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.473 0.654 . . . . 0.0 110.398 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 11.5 p -57.17 -49.19 80.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.425 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.458 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 1.2 tm-20 -80.13 -24.81 40.23 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.463 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 77.75 23.49 66.96 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.822 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.412 ' OE1' ' O ' ' A' ' 31' ' ' PHE . 1.7 pp0? -153.32 138.43 17.34 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 119.345 -0.942 . . . . 0.0 112.72 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.491 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 27.6 t80 . . . . . 0 C--N 1.317 -0.824 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.456 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.419 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 4.2 pt-20 . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 120.599 0.237 . . . . 0.0 110.438 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 1.8 m120 -170.94 179.03 3.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.543 0.687 . . . . 0.0 112.6 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.444 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 0.8 OUTLIER -127.09 145.89 50.57 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.165 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.529 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 7.3 m-85 -133.5 163.75 28.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.991 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.27 149.87 36.99 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -149.03 112.48 5.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.016 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.586 ' CD2' ' HD1' ' A' ' 55' ' ' HIS . 6.4 mp -108.02 120.95 43.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.068 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 pp -147.59 165.56 5.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.795 0.331 . . . . 0.0 111.009 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 m -112.46 126.77 55.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.637 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.457 ' C ' ' H ' ' A' ' 51' ' ' GLY . 7.6 p -124.07 133.83 68.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.809 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 63.5 3.85 1.59 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.114 0.483 . . . . 0.0 109.722 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 103.11 -14.05 55.52 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.609 ' NE2' ' N ' ' A' ' 53' ' ' GLU . 35.3 tp60 -90.1 141.28 28.84 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.609 ' N ' ' NE2' ' A' ' 52' ' ' GLN . 2.1 mt-10 -76.96 149.89 35.94 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.401 0.619 . . . . 0.0 111.051 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -141.23 124.18 16.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.114 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.586 ' HD1' ' CD2' ' A' ' 46' ' ' LEU . 9.7 t60 -117.69 113.89 22.54 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.1 mp -120.66 140.81 51.06 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.695 0.76 . . . . 0.0 111.637 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -133.07 123.39 25.68 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.251 -1.341 . . . . 0.0 109.502 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.633 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.89 154.02 31.53 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.04 -178.656 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.92 145.13 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.264 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.66 103.27 10.53 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.708 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 68.8 p . . . . . 0 CA--C 1.51 -0.594 0 CA-C-O 121.769 0.795 . . . . 0.0 110.45 179.717 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 31.3 pt . . . . . 0 N--CA 1.438 -1.05 0 CA-C-O 121.586 0.708 . . . . 0.0 112.902 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -152.0 16.76 0.66 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.78 164.07 32.98 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.966 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.452 ' CE1' ' HB1' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -152.29 122.86 7.33 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.672 -0.764 . . . . 0.0 110.589 178.107 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 8.8 tt -122.6 98.5 5.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.617 ' H ' ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.37 126.57 42.69 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.174 -178.261 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -95.51 121.03 45.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.845 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.536 ' C ' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -110.06 147.5 33.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.276 -0.874 . . . . 0.0 108.994 179.356 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.713 ' HG ' ' H ' ' A' ' 88' ' ' THR . 0.3 OUTLIER -108.29 144.19 36.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.99 0.424 . . . . 0.0 112.051 -177.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.2 m -81.45 15.86 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.255 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.713 ' H ' ' HG ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -136.7 -16.1 1.54 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -177.223 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 91' ' ' LYS . 28.9 t -112.35 93.5 4.47 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-O 121.378 0.608 . . . . 0.0 110.304 -177.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.3 tp -54.84 -13.54 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.563 ' H ' ' C ' ' A' ' 89' ' ' SER . 0.6 OUTLIER -79.1 -45.88 19.15 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.421 178.549 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.584 ' HG ' ' H ' ' A' ' 86' ' ' SER . 89.1 p -59.05 -46.71 87.56 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.483 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -79.14 -32.91 44.55 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 119.0 -1.08 . . . . 0.0 112.215 -178.439 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -66.3 -47.18 74.43 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.908 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.3 m -65.28 -34.82 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.457 -0.497 . . . . 0.0 109.881 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 96' ' ' ILE . 2.0 mt -60.94 -36.83 74.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.701 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -70.52 -29.26 65.71 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.996 0.427 . . . . 0.0 109.94 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 99' ' ' ILE . 14.0 t -72.23 -66.63 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.4 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.437 ' C ' ' O ' ' A' ' 98' ' ' VAL . 1.3 mp -38.55 -60.26 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.612 ' CE1' ' CG ' ' A' ' 141' ' ' TRP . 12.8 t-80 -43.05 -64.9 0.55 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.125 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -36.77 -66.51 0.48 Allowed Glycine 0 CA--C 1.518 0.233 0 CA-C-O 121.521 0.511 . . . . 0.0 112.047 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 103' ' ' LEU . 21.2 tptm -60.92 -61.08 2.84 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.765 -0.717 . . . . 0.0 110.527 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 102' ' ' LYS . 7.4 tp -36.14 -67.24 0.17 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.379 0.609 . . . . 0.0 109.6 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.566 ' CD2' ' CZ3' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -42.88 -48.62 5.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.57 179.027 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.922 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.456 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.875 0.369 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.6 mt -109.96 134.6 20.64 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.526 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -46.71 109.21 0.19 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.238 1.292 . . . . 0.0 112.295 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.5 mt -123.17 135.75 62.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.538 ' SD ' ' O ' ' A' ' 144' ' ' ALA . 2.4 tpp -137.65 123.59 20.17 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.394 0.616 . . . . 0.0 110.873 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.499 ' N ' ' SD ' ' A' ' 115' ' ' MET . 5.4 mt -97.88 107.3 19.76 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.623 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.7 t -103.23 127.74 56.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 121.863 0.84 . . . . 0.0 112.181 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.419 ' CA ' ' CE2' ' A' ' 85' ' ' TYR . . . -97.03 103.63 2.92 Favored Glycine 0 C--N 1.311 -0.831 0 N-CA-C 107.816 -2.113 . . . . 0.0 107.816 176.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.484 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.7 t30 -96.8 173.89 7.08 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.049 -177.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.484 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 7.1 mtpp 63.64 59.29 1.2 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.228 -178.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.46 ' HZ1' ' HG ' ' A' ' 149' ' ' SER . 0.0 OUTLIER -68.63 0.15 4.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.348 -178.449 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -82.59 -37.32 25.21 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.449 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.537 ' CD2' ' N ' ' A' ' 123' ' ' LEU . 1.0 OUTLIER -83.87 -18.11 38.58 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.081 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.526 ' C ' ' ND1' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -39.13 -27.92 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.002 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.504 ' N ' ' O ' ' A' ' 123' ' ' LEU . 9.5 mtt -42.1 -31.27 0.35 Allowed 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.41 ' N ' ' C ' ' A' ' 124' ' ' HIS . 1.3 pt-20 -87.8 -42.41 12.59 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.295 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 124' ' ' HIS . 6.0 tpt85 55.94 72.3 0.5 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.267 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.7 t -52.7 -64.35 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.57 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 10.7 tp -86.89 153.22 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.44 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 35.8 p -88.24 137.67 32.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.278 0.561 . . . . 0.0 112.343 -178.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -53.5 -33.24 53.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.139 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -69.06 -65.8 0.66 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.194 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.44 ' H ' ' HG ' ' A' ' 130' ' ' SER . 45.3 mt-10 -42.83 -40.12 2.76 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.63 -35.02 62.67 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 132' ' ' GLU . 3.5 tptm -62.0 -57.29 12.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -55.28 -36.18 65.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.783 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.412 ' O ' ' OG ' ' A' ' 140' ' ' SER . 0.7 OUTLIER -65.45 -61.13 2.28 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.419 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.56 -40.62 62.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.932 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.62 -30.86 71.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.654 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 137' ' ' LEU . 24.8 p -63.72 -46.79 83.83 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.965 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.612 ' CG ' ' CE1' ' A' ' 100' ' ' HIS . 34.3 m95 -91.15 -0.58 57.73 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.778 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 3.5 m120 72.5 36.13 1.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.952 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -100.05 163.3 12.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.423 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.538 ' O ' ' SD ' ' A' ' 115' ' ' MET . . . -102.18 128.34 48.72 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.501 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.429 ' C ' ' CD1' ' A' ' 145' ' ' PHE . 6.2 t80 -98.09 118.43 34.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.755 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -131.76 126.83 35.41 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.41 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 1.8 mt-10 -109.12 112.79 25.16 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.13 0.491 . . . . 0.0 110.197 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.1 p -136.43 -173.16 3.33 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.647 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.46 ' HG ' ' HZ1' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -139.03 141.6 38.26 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.068 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.544 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -65.66 -49.15 69.66 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -49.42 -10.27 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.841 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.504 ' H ' ' C ' ' A' ' 150' ' ' ALA . 23.7 tt0 -129.04 127.27 41.23 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.813 0.339 . . . . 0.0 110.916 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.466 HD21 ' CG ' ' A' ' 25' ' ' GLN . 4.0 t-20 -77.78 -55.43 5.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.116 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 153' ' ' ASN . 10.3 tt0 -37.94 -53.13 1.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.932 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 54.9 p -56.74 -41.54 77.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.97 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 153' ' ' ASN . . . -57.38 -62.94 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.624 0.726 . . . . 0.0 109.993 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.1 t -44.95 -37.55 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.443 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -62.29 -42.78 99.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.575 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 11.9 t -60.06 -45.28 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.696 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.434 ' O ' ' N ' ' A' ' 163' ' ' ILE . 53.6 t80 -56.66 -65.38 0.62 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.084 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.1 ttm-85 -41.44 -58.05 2.0 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.178 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.79 -31.65 17.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.755 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 160' ' ' PHE . 0.3 OUTLIER -69.18 -34.21 62.16 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.392 -179.758 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 12.6 mt -63.07 -38.07 81.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.937 0.875 . . . . 0.0 109.102 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -64.72 0.82 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.284 -1.325 . . . . 0.0 111.543 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.71 -33.37 70.11 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.464 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.38 -31.48 67.7 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -67.86 -56.07 10.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.428 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 13.5 tttm -59.03 -63.74 1.19 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.954 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 72.2 mt -47.26 -37.15 4.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.59 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.402 ' OD1' ' NH2' ' A' ' 7' ' ' ARG . 11.6 t70 -69.25 -40.17 78.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.147 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.89 -40.42 57.48 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.37 -77.5 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.329 . . . . 0.0 110.26 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.026 -179.99 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 121.186 0.517 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.506 ' NH2' ' OD2' ' A' ' 171' ' ' ASP . 12.0 mtt180 -139.94 136.12 33.51 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.784 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -105.99 129.49 54.1 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 0.8 OUTLIER -101.36 121.28 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-O 121.393 0.616 . . . . 0.0 110.647 -178.435 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.432 ' O ' HG21 ' A' ' 82' ' ' ILE . . . -83.12 135.04 34.96 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.469 -0.77 . . . . 0.0 110.742 -178.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.9 mt -95.08 128.6 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 CA-C-O 121.759 0.79 . . . . 0.0 111.353 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mp -127.26 94.52 4.02 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 113.975 -1.466 . . . . 0.0 110.252 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -140.54 136.01 7.38 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 -179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.494 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.1 OUTLIER -51.69 -161.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.395 0.617 . . . . 0.0 110.823 179.513 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.22 137.46 33.37 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.138 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.5 m 59.78 19.45 8.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.809 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 p -76.05 -21.64 15.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.876 0.369 . . . . 0.0 110.386 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.95 25.39 11.46 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -71.75 -32.09 67.35 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.353 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.9 m -78.12 -35.83 48.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.777 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.5 p -62.02 -48.3 80.91 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.475 ' O ' ' N ' ' A' ' 25' ' ' GLN . 15.5 tp -63.44 -53.34 53.75 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.656 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 22' ' ' LEU . 50.4 m -38.07 -40.82 0.52 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.43 -40.8 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.053 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.585 ' OE1' ' N ' ' A' ' 31' ' ' PHE . 3.1 tp-100 -62.65 -41.06 98.84 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.535 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.512 ' C ' ' CD1' ' A' ' 26' ' ' PHE . 0.4 OUTLIER -76.67 -60.7 2.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.169 0.509 . . . . 0.0 111.828 -178.048 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.454 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 13.2 p -45.51 -44.03 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.037 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.454 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 2.1 mm-40 -92.01 -23.7 19.45 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.433 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 71.34 26.02 74.26 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -148.99 142.03 24.84 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.585 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.924 177.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 173.93 174.42 0.16 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 119.439 -0.904 . . . . 0.0 113.043 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.14 147.31 32.67 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.291 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -121.58 173.84 7.16 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.428 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.52 161.0 43.0 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -178.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -162.67 110.59 1.31 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.892 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.0 mp -106.9 119.69 40.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.664 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 pp -147.95 166.09 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.663 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.3 m -111.28 126.15 54.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.239 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.481 ' C ' ' H ' ' A' ' 51' ' ' GLY . 14.9 p -122.06 135.92 60.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.724 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 62.12 3.9 1.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.042 0.449 . . . . 0.0 109.839 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 102.3 -13.31 57.08 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.617 ' NE2' ' H ' ' A' ' 53' ' ' GLU . 39.5 tp60 -91.49 141.75 28.39 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.617 ' H ' ' NE2' ' A' ' 52' ' ' GLN . 1.8 mt-10 -76.5 146.19 38.65 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.416 0.626 . . . . 0.0 111.229 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.549 ' C ' ' HD1' ' A' ' 55' ' ' HIS . 11.7 m-85 -138.71 123.47 18.69 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.142 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.549 ' HD1' ' C ' ' A' ' 54' ' ' TYR . 1.6 m-70 -117.64 113.92 22.63 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mp -118.72 144.22 46.38 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.617 0.722 . . . . 0.0 112.374 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -134.1 124.29 25.89 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.09 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.642 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.65 155.1 30.47 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 120.264 -0.574 . . . . 0.0 112.402 -178.214 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.82 144.82 35.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.429 ' O ' ' OG1' ' A' ' 61' ' ' THR . 0.4 OUTLIER -121.86 124.68 44.7 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.073 178.314 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 60' ' ' ASP . 31.4 p . . . . . 0 CA--C 1.512 -0.506 0 CA-C-O 121.627 0.727 . . . . 0.0 110.381 -179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 31.7 pt . . . . . 0 N--CA 1.427 -1.623 0 CA-C-O 121.286 0.565 . . . . 0.0 112.25 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -153.32 26.81 0.52 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.745 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.92 165.02 30.13 Favored Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.076 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.96 124.84 8.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.918 -0.641 . . . . 0.0 111.522 178.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.432 HG21 ' O ' ' A' ' 10' ' ' ALA . 12.0 tt -132.89 104.63 7.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.447 0.641 . . . . 0.0 109.693 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.4 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.7 OUTLIER -96.89 124.55 40.9 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.434 -178.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -97.86 133.58 39.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.112 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.574 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 26.4 p90 -137.16 145.48 43.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.717 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.594 ' HG ' ' H ' ' A' ' 88' ' ' THR . 1.0 OUTLIER -87.25 143.88 27.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.697 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.1 m -71.94 13.42 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.31 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.594 ' H ' ' HG ' ' A' ' 86' ' ' SER . 0.6 OUTLIER -135.13 -19.28 1.74 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.911 0.386 . . . . 0.0 111.737 -178.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.543 ' C ' ' H ' ' A' ' 91' ' ' LYS . 23.0 t -89.28 92.65 9.25 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.05 -176.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.74 -9.69 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 176.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.543 ' H ' ' C ' ' A' ' 89' ' ' SER . 0.1 OUTLIER -76.86 -53.21 8.19 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.284 178.278 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 25.6 p -59.6 -34.21 72.46 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.289 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.574 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -72.06 -56.71 5.15 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.173 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.22 -40.51 97.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.031 -178.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.409 ' CG2' ' O ' ' A' ' 91' ' ' LYS . 17.0 m -68.85 -33.95 61.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.676 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 mt -65.17 -40.86 90.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.335 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -70.22 -29.12 65.86 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.043 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.1 t -74.84 -66.92 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.6 mm -41.76 -66.09 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.532 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.484 ' HD1' ' N ' ' A' ' 101' ' ' GLY . 8.6 t-80 -42.24 -64.98 0.51 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.192 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.484 ' N ' ' HD1' ' A' ' 100' ' ' HIS . . . -35.06 -65.31 0.41 Allowed Glycine 0 CA--C 1.517 0.175 0 CA-C-O 121.337 0.41 . . . . 0.0 112.357 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 14.8 tptm -67.97 -63.53 1.04 Allowed 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.071 -0.565 . . . . 0.0 111.189 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.5 OUTLIER -36.05 -58.3 0.66 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.047 0.451 . . . . 0.0 110.146 -179.426 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.477 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -51.39 -51.32 55.75 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.457 ' N ' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.313 -1.019 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.263 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 . . . . . 0 CA--C 1.52 -0.189 0 CA-C-O 120.955 0.407 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.1 pt -117.64 150.39 46.75 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.17 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -45.03 121.03 3.28 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.716 1.611 . . . . 0.0 112.014 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.4 mt -125.0 126.0 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.4 tpt -127.15 117.68 22.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.773 -178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mt -96.19 97.91 9.91 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.0 t -105.07 126.57 60.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 122.249 1.023 . . . . 0.0 111.294 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.43 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -97.83 107.81 3.53 Favored Glycine 0 C--N 1.308 -1.005 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.528 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 52.6 t30 -97.26 176.74 5.8 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.662 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.528 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 41.2 mttt 62.75 60.76 1.25 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.689 0.757 . . . . 0.0 108.977 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.1 tttm -67.01 -24.12 65.99 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -73.91 2.47 8.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 118.751 -1.179 . . . . 0.0 111.545 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 126' ' ' GLU . 8.1 mp -94.39 -25.77 16.8 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 176.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.55 ' C ' ' N ' ' A' ' 126' ' ' GLU . 7.6 t60 -27.12 -38.63 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.403 1.065 . . . . 0.0 111.457 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.515 ' N ' ' O ' ' A' ' 123' ' ' LEU . 2.8 mmt -46.98 -16.41 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.851 0.834 . . . . 0.0 108.777 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 123' ' ' LEU . 21.1 mm-40 -98.41 -57.53 2.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.994 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.517 HH11 ' HD1' ' A' ' 124' ' ' HIS . 0.0 OUTLIER 32.81 67.77 0.16 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.458 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.9 m -61.55 -32.1 52.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.828 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.5 tp -88.93 154.97 3.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.474 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.484 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 92.7 p -103.02 129.09 49.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.242 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -42.18 -35.32 0.92 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.564 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.6 mt-10 -66.34 -65.54 0.67 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.052 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.484 ' H ' ' HG ' ' A' ' 130' ' ' SER . 63.6 mt-10 -41.29 -41.43 1.9 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.925 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.08 -35.91 64.33 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 132' ' ' GLU . 15.4 tttm -62.34 -54.94 33.15 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.066 -0.567 . . . . 0.0 109.601 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.87 69.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.561 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.73 -60.75 2.57 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -54.54 -36.66 64.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.422 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -68.37 -31.77 71.39 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.487 ' HG ' ' N ' ' A' ' 141' ' ' TRP . 13.1 p -63.88 -46.5 84.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.855 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.487 ' N ' ' HG ' ' A' ' 140' ' ' SER . 67.7 m95 -89.23 -3.53 58.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.935 0.398 . . . . 0.0 110.315 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 76.18 23.35 1.25 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.72 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -90.59 168.13 12.04 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.83 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.41 134.13 50.91 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.045 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.429 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 5.7 t80 -96.51 122.53 39.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.739 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -134.55 136.95 43.41 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.603 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.466 ' CD ' ' CZ ' ' A' ' 127' ' ' ARG . 5.8 tt0 -123.48 112.23 17.25 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 24.2 p -138.99 -177.16 4.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.052 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 152' ' ' GLU . 0.0 OUTLIER -139.91 130.4 25.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.087 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 152' ' ' GLU . . . -49.24 -64.87 0.68 Allowed 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 150' ' ' ALA . 40.4 tttm -33.88 -30.7 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.217 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 150' ' ' ALA . 34.3 mt-10 -111.71 103.63 11.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.57 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -64.9 -49.4 70.6 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.345 -179.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' A' ' 153' ' ' ASN . 4.1 mt-30 -37.27 -53.32 1.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.883 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 80.8 p -58.16 -40.45 81.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.726 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 153' ' ' ASN . . . -58.2 -61.85 2.26 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.439 0.638 . . . . 0.0 109.978 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 55.1 t -41.32 -41.67 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.719 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.65 -39.53 93.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.528 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' A' ' 156' ' ' ALA . 29.5 t -63.04 -37.52 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.018 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 163' ' ' ILE . 52.6 t80 -61.41 -65.18 0.73 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.753 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.45 -53.79 3.29 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.985 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -29.79 65.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.846 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.469 ' N ' ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -67.9 -33.89 64.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.387 -179.551 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.7 mt -69.85 -36.53 69.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 121.594 0.711 . . . . 0.0 109.784 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.28 -65.12 0.74 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.862 -178.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -58.06 -33.51 69.1 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.531 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.17 -31.55 67.37 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -68.44 -57.11 6.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.617 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -54.88 -64.84 0.71 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.844 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 96.6 mt -50.57 -34.51 12.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.007 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.506 ' OD2' ' NH2' ' A' ' 7' ' ' ARG . 1.2 t70 -67.26 -40.05 86.19 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -57.91 -31.88 65.39 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.37 -79.14 0.06 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 -0.12 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.86 179.689 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 121.35 0.595 . . . . 0.0 110.54 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.509 ' NH2' ' OD2' ' A' ' 171' ' ' ASP . 0.0 OUTLIER -139.72 135.5 33.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.233 179.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -109.09 129.23 55.47 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -102.96 125.06 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-O 121.282 0.563 . . . . 0.0 110.967 -177.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.433 ' O ' HG21 ' A' ' 82' ' ' ILE . . . -84.03 133.08 34.68 Favored 'General case' 0 C--O 1.218 -0.566 0 O-C-N 121.463 -0.773 . . . . 0.0 111.303 -178.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.2 mt -95.81 133.97 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 121.795 0.807 . . . . 0.0 112.307 -179.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tp -130.45 102.26 6.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.339 -1.301 . . . . 0.0 110.627 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.67 135.75 6.97 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.4 OUTLIER -53.87 -164.44 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.349 0.595 . . . . 0.0 110.417 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.42 ' NH1' ' OG ' ' A' ' 16' ' ' SER . 9.1 ttt-85 -98.7 134.04 42.17 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.92 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.522 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 1.3 m 67.47 19.85 9.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.572 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 p -87.3 -15.25 9.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.685 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.34 10.53 35.98 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -41.79 -55.53 2.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.015 0.436 . . . . 0.0 110.718 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -69.47 -31.13 69.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.386 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 m -58.08 -44.03 87.35 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.117 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.7 tp -77.63 -48.41 16.91 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.167 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 86.9 m -45.68 -54.67 7.45 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.547 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.4 mp -59.49 -42.61 88.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.079 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.622 ' NE2' ' ND2' ' A' ' 153' ' ' ASN . 0.0 OUTLIER -65.09 -33.39 75.91 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.919 -179.301 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.464 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 1.6 t80 -76.83 -62.29 1.69 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.265 0.555 . . . . 0.0 111.858 -178.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.445 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 14.9 p -48.6 -46.46 15.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.597 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.445 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 12.4 mt-10 -85.33 -24.1 27.79 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.35 43.73 45.02 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.72 -174.22 3.65 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.566 0.698 . . . . 0.0 110.368 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.611 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.494 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.717 178.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.517 -0.313 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -165.6 179.01 6.3 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 119.653 -0.819 . . . . 0.0 113.06 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.51 145.91 51.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.879 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.45 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 13.6 m-85 -129.08 166.48 19.18 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.724 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.89 153.28 39.95 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.565 -178.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.441 ' NZ ' ' O ' ' A' ' 27' ' ' VAL . 29.4 tptt -156.82 112.03 2.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.455 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.529 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 6.7 mp -106.48 120.29 41.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.663 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.65 165.71 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.622 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 m -111.34 128.46 55.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.359 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.9 p -127.31 135.66 62.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.16 12.83 6.36 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.28 -11.54 69.35 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -90.45 139.16 30.94 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -76.71 145.15 38.87 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.638 0.733 . . . . 0.0 111.32 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.413 ' OH ' ' OE1' ' A' ' 168' ' ' GLU . 10.3 m-85 -137.08 122.83 19.92 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.995 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -116.9 113.61 22.7 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.0 mp -119.57 143.4 47.64 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.657 0.741 . . . . 0.0 112.214 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -135.32 124.86 25.04 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.698 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.63 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.83 154.5 30.62 Favored 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 120.034 -0.666 . . . . 0.0 112.218 -178.452 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.17 145.93 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.87 -178.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.73 103.31 8.78 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.049 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.1 p . . . . . 0 N--CA 1.446 -0.634 0 CA-C-O 121.773 0.797 . . . . 0.0 111.562 -179.147 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 29.1 pt . . . . . 0 N--CA 1.438 -1.032 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -151.84 17.86 0.69 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.197 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -146.65 166.57 28.25 Favored Glycine 0 CA--C 1.518 0.232 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.38 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.68 121.69 7.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.951 -0.624 . . . . 0.0 110.763 178.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.433 HG21 ' O ' ' A' ' 10' ' ' ALA . 10.0 tt -123.9 103.31 12.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.64 ' H ' ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -95.9 131.95 41.71 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.456 -0.897 . . . . 0.0 110.447 -178.266 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.483 ' O ' ' CD1' ' A' ' 96' ' ' ILE . 1.2 t -92.34 130.87 40.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.963 -178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -108.04 143.21 37.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.978 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.522 ' HG ' ' H ' ' A' ' 88' ' ' THR . 47.8 t -109.88 130.21 55.55 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.889 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.1 m -81.34 18.35 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.004 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.522 ' H ' ' HG ' ' A' ' 86' ' ' SER . 1.4 t -143.54 -3.3 0.92 Allowed 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -177.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.539 ' C ' ' H ' ' A' ' 91' ' ' LYS . 1.0 OUTLIER -134.31 97.94 3.97 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 119.416 -0.914 . . . . 0.0 112.843 -175.566 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.465 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 18.1 mm -56.13 -10.9 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 114.155 -1.384 . . . . 0.0 107.859 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.539 ' H ' ' C ' ' A' ' 89' ' ' SER . 0.1 OUTLIER -79.13 -42.03 27.2 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.091 178.686 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.62 -47.49 75.46 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.051 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.55 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -76.3 -35.39 58.86 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 119.105 -1.038 . . . . 0.0 112.186 -178.034 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.526 ' OE2' ' CE1' ' A' ' 93' ' ' PHE . 14.0 mm-40 -66.46 -47.95 71.48 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.901 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.6 m -64.17 -37.49 80.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.023 0.439 . . . . 0.0 110.292 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.483 ' CD1' ' O ' ' A' ' 84' ' ' VAL . 31.8 mt -69.02 -31.28 49.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.887 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.73 -26.42 63.38 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.18 0.514 . . . . 0.0 109.709 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 7.3 t -70.44 -64.98 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.755 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.8 tt -43.29 -47.95 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.647 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.58 ' NE2' ' CD1' ' A' ' 141' ' ' TRP . 15.1 t-80 -44.96 -64.79 0.63 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.852 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -39.43 -57.44 2.24 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 111.931 -0.468 . . . . 0.0 111.931 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 105' ' ' ASP . 13.5 tptp -62.96 -65.77 0.64 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.177 -0.511 . . . . 0.0 111.061 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.476 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -36.52 -56.69 0.8 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.731 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.481 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -46.34 -47.66 18.49 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.635 178.522 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.825 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.317 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.882 0.372 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.485 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.5 OUTLIER -136.17 154.6 77.45 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.407 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -49.89 110.14 0.35 Allowed 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.772 1.648 . . . . 0.0 112.546 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.485 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.2 mp -121.67 127.84 75.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.2 tpt -130.68 115.84 17.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.669 -178.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.2 mt -96.71 97.52 9.41 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.8 t -105.64 130.34 57.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.632 0.729 . . . . 0.0 110.977 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -102.02 116.33 5.49 Favored Glycine 0 C--N 1.306 -1.136 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.514 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.7 t30 -97.04 173.92 7.02 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.557 -178.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.522 ' NZ ' ' O ' ' A' ' 16' ' ' SER . 18.0 mttt 60.2 58.25 2.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.545 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.46 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 20.5 tttm -63.76 -29.5 70.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.955 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -70.96 -6.8 41.48 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.953 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 125' ' ' MET . 8.6 mp -94.31 -29.85 14.83 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.609 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.1 OUTLIER -38.61 -24.79 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.927 177.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.609 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 19.1 mtp -44.73 -24.11 0.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.472 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.3 OUTLIER -101.83 -37.63 8.19 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.33 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.425 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 1.2 tpt180 37.08 87.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.794 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.5 m -80.22 -32.36 13.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.15 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 11.1 tp -91.23 154.7 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.21 178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.444 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 6.5 p -97.36 134.37 40.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.424 0.631 . . . . 0.0 112.226 -178.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -58.42 -30.63 67.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.095 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mp0 -68.53 -65.66 0.67 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.989 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.444 ' H ' ' HG ' ' A' ' 130' ' ' SER . 43.5 mt-10 -41.42 -41.26 1.98 Allowed 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.83 -36.33 65.93 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 132' ' ' GLU . 3.5 tttm -60.92 -55.72 29.6 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.56 -33.98 66.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.289 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.61 -62.94 1.23 Allowed 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.832 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -54.27 -33.67 59.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.655 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.43 -38.15 80.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.703 0.287 . . . . 0.0 110.872 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.41 -47.43 79.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.428 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.58 ' CD1' ' NE2' ' A' ' 100' ' ' HIS . 23.7 m95 -91.64 2.68 56.3 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.352 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 13.4 m120 60.67 35.56 19.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.099 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -92.05 166.71 12.54 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.946 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -103.29 125.5 49.96 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.052 -0.659 . . . . 0.0 112.012 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.418 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 6.7 t80 -98.13 121.22 39.79 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.977 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.31 125.98 15.1 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.418 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.425 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 11.7 tt0 -102.01 110.8 22.86 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.482 ' HG ' ' CG2' ' A' ' 159' ' ' VAL . 0.1 OUTLIER -123.07 -176.52 3.44 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.245 -178.787 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.85 138.9 37.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.524 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.537 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -71.88 -11.22 60.69 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.476 0.655 . . . . 0.0 109.361 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.54 -5.57 59.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.004 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.46 ' O ' ' OE1' ' A' ' 25' ' ' GLN . 51.9 mt-10 -138.97 125.91 21.06 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.474 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.622 ' ND2' ' NE2' ' A' ' 25' ' ' GLN . 4.2 m120 -75.51 -48.43 22.55 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 153' ' ' ASN . 0.0 OUTLIER -36.54 -56.88 0.79 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.998 0.427 . . . . 0.0 110.716 -179.166 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.2 p -52.57 -47.8 66.6 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.354 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -55.38 -60.35 3.53 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.338 0.589 . . . . 0.0 110.178 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.1 t -41.98 -40.75 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.403 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.3 -32.53 72.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.994 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.487 ' N ' ' O ' ' A' ' 156' ' ' ALA . 22.0 t -73.78 -36.53 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 121.038 0.447 . . . . 0.0 109.996 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.424 ' O ' HG21 ' A' ' 163' ' ' ILE . 25.5 t80 -69.22 -35.63 76.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.038 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -77.4 -45.21 26.6 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.135 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -34.39 74.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.067 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 164' ' ' ILE . 14.0 tt -68.83 -50.46 54.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.365 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.448 ' N ' ' CG2' ' A' ' 163' ' ' ILE . 86.5 mt -50.76 -33.63 12.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 119.064 -1.055 . . . . 0.0 108.885 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.93 -63.61 1.16 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.861 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -57.77 -29.08 64.54 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.63 -32.52 71.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.413 ' OE1' ' OH ' ' A' ' 54' ' ' TYR . 1.7 tp10 -68.93 -57.79 5.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.315 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -53.61 -62.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.689 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 74.7 mt -51.89 -34.33 16.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.011 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.509 ' OD2' ' NH2' ' A' ' 7' ' ' ARG . 1.9 t70 -69.64 -38.49 77.19 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.679 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -63.21 -35.41 92.04 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.98 -65.48 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.348 . . . . 0.0 110.686 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.691 -179.928 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.177 0.513 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -139.94 136.79 34.2 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.724 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.63 ' HZ2' HE22 ' A' ' 57' ' ' GLN . 6.2 mttm -106.25 130.07 54.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -103.28 123.49 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-O 121.493 0.664 . . . . 0.0 110.49 -178.315 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.417 ' O ' HG21 ' A' ' 82' ' ' ILE . . . -84.53 134.38 34.42 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.304 -0.872 . . . . 0.0 111.325 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.2 mt -95.51 127.66 47.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.38 0.61 . . . . 0.0 111.65 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.0 tp -127.5 99.35 5.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.522 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -142.07 136.09 7.08 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.814 -178.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.1 OUTLIER -49.31 -177.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.217 0.532 . . . . 0.0 110.662 179.002 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -74.46 140.85 44.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.816 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.434 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 9.4 m 53.17 19.63 1.53 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.609 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.2 p -68.64 -17.13 21.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.417 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.449 ' C ' ' HG ' ' A' ' 21' ' ' SER . . . 103.82 29.25 5.62 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.7 mtmm -64.61 -62.49 1.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 110.369 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.96 -28.35 56.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.619 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.449 ' HG ' ' C ' ' A' ' 18' ' ' GLY . 94.6 p -68.2 -50.73 52.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.792 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.1 tp -77.4 -26.45 51.77 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.913 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.423 ' O ' ' CG1' ' A' ' 27' ' ' VAL . 33.9 m -60.32 -43.33 96.48 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 mp -77.89 -42.74 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.729 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.434 HE22 ' HB1' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -67.02 -32.13 73.14 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.358 -179.045 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -77.71 -62.59 1.62 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.374 0.607 . . . . 0.0 111.404 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.466 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 14.4 p -48.01 -47.52 12.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.268 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.466 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 2.2 tm-20 -83.53 -24.6 31.58 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.32 28.74 67.39 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.498 ' CA ' HD22 ' A' ' 153' ' ' ASN . 0.1 OUTLIER -144.94 125.67 14.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.07 0.462 . . . . 0.0 111.861 -178.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.516 ' O ' ' CG ' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -72.97 94.11 1.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.346 178.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.474 ' CG2' ' N ' ' A' ' 33' ' ' ASP . 13.6 p -96.7 167.3 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.892 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.474 ' N ' ' CG2' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -37.05 -50.85 0.93 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.919 -179.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 33' ' ' ASP . 7.0 p 33.21 96.28 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.431 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -150.68 41.87 0.79 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.599 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.427 ' O ' ' O ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -95.09 172.77 5.05 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.083 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 36' ' ' ASP . 44.6 Cg_exo -57.33 -139.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.507 2.138 . . . . 0.0 111.881 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.462 ' O ' ' CG2' ' A' ' 38' ' ' THR . 10.6 t -130.28 62.89 1.57 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.697 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 tp -82.94 144.81 9.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.282 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.11 148.49 23.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.258 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -178.68 174.05 1.22 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.509 0.671 . . . . 0.0 112.43 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.25 137.23 46.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.357 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -122.09 167.19 13.44 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.714 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.425 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -146.41 148.05 31.9 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.38 0.609 . . . . 0.0 112.319 -179.164 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.5 tttp -147.11 112.44 5.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.968 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.0 mp -106.44 120.28 41.5 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.095 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.504 ' N ' ' CD1' ' A' ' 47' ' ' ILE . 0.4 OUTLIER -145.47 165.31 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.42 -179.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.3 m -115.92 124.96 51.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.489 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.2 p -119.45 117.63 54.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.734 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 69.83 26.06 4.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.025 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.61 -9.41 55.7 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -89.99 132.04 35.57 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.96 145.58 40.25 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.621 0.724 . . . . 0.0 111.352 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -136.53 122.36 19.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.949 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 67.3 m170 -117.2 112.7 21.19 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mp -119.19 142.85 47.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.517 0.675 . . . . 0.0 111.831 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.63 HE22 ' HZ2' ' A' ' 8' ' ' LYS . 2.4 mt-30 -133.14 121.52 22.71 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.957 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.583 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.84 154.42 30.77 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 120.098 -0.641 . . . . 0.0 112.219 -178.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.14 144.87 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.686 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.05 107.48 12.68 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.872 -1.513 . . . . 0.0 108.178 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.94 160.03 39.86 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.12 0.486 . . . . 0.0 110.479 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 63' ' ' GLY . . . -144.79 34.37 1.13 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.959 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 62' ' ' ALA . . . -23.52 -77.12 0.01 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 123.862 0.726 . . . . 0.0 112.37 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -123.26 -79.52 0.61 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.378 0.609 . . . . 0.0 110.759 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.552 ' CG ' ' H ' ' A' ' 66' ' ' GLU . 2.7 t70 -76.64 -178.1 4.57 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.49 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.552 ' H ' ' CG ' ' A' ' 65' ' ' ASP . 20.1 mp0 -45.2 -16.2 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.574 ' CG ' ' O ' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -175.56 -4.81 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.531 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.54 ' HG ' ' H ' ' A' ' 65' ' ' ASP . 1.8 m 52.49 119.86 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.338 0.59 . . . . 0.0 112.39 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.574 ' N ' ' CD1' ' A' ' 69' ' ' ILE . 1.6 mp -85.09 -39.52 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.991 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.26 158.49 79.42 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.974 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -41.56 123.24 2.11 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.609 2.206 . . . . 0.0 112.39 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.447 ' O ' ' CB ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -174.59 50.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.031 179.586 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.447 ' CB ' ' O ' ' A' ' 72' ' ' GLN . 0.2 OUTLIER 77.34 -6.67 1.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.392 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.49 ' CD2' ' O ' ' A' ' 67' ' ' TYR . 25.8 m-85 -90.11 8.94 30.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.429 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 76' ' ' ILE . 8.7 p -81.65 28.7 0.4 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.744 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -51.87 -170.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.138 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 3.4 p-10 -132.52 49.8 2.29 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.204 0.526 . . . . 0.0 109.816 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 33.5 pt -80.13 -174.14 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.051 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -150.75 17.62 0.79 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.142 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -146.94 165.92 28.45 Favored Glycine 0 CA--C 1.516 0.143 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.584 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.1 122.4 7.23 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.956 -0.622 . . . . 0.0 110.812 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.417 HG21 ' O ' ' A' ' 10' ' ' ALA . 10.7 tt -125.54 103.38 11.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.618 ' CD2' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -96.28 125.82 41.06 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.737 -178.22 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.8 t -95.7 119.25 43.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.808 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.481 ' C ' ' CD1' ' A' ' 85' ' ' TYR . 4.1 p90 -109.7 145.41 36.61 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.651 ' HG ' ' H ' ' A' ' 88' ' ' THR . 0.8 OUTLIER -101.85 143.62 31.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.064 0.459 . . . . 0.0 111.752 -178.075 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.8 m -80.49 20.45 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.23 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.651 ' H ' ' HG ' ' A' ' 86' ' ' SER . 9.7 t -141.92 -15.94 0.79 Allowed 'General case' 0 C--O 1.232 0.141 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.544 ' C ' ' H ' ' A' ' 91' ' ' LYS . 38.8 t -113.71 94.21 4.74 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -176.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.5 mm -52.8 -14.74 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 176.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.544 ' H ' ' C ' ' A' ' 89' ' ' SER . 9.6 mttp -78.22 -46.61 19.95 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.192 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.648 ' HG ' ' H ' ' A' ' 86' ' ' SER . 88.0 p -61.9 -45.48 93.55 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.541 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -77.64 -37.27 50.36 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 119.248 -0.981 . . . . 0.0 112.652 -177.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -67.81 -43.89 78.59 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.43 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 91' ' ' LYS . 30.7 m -66.04 -38.16 81.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.85 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -58.92 -39.42 77.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -69.45 -26.75 64.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.126 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.9 t -77.29 -66.91 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.785 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.7 mp -41.07 -38.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.028 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.518 ' CE1' ' CD1' ' A' ' 141' ' ' TRP . 7.1 t-160 -64.4 -64.92 0.76 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.617 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.52 -57.75 1.46 Allowed Glycine 0 CA--C 1.517 0.212 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 105' ' ' ASP . 12.7 tptp -62.9 -64.72 0.83 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.915 -0.643 . . . . 0.0 110.713 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.481 ' CD1' ' OH ' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -36.95 -60.17 0.65 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.492 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -46.43 -48.07 18.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.471 178.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -60.1 -31.4 70.0 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.419 -179.237 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.447 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 58.2 ttp -73.16 -51.34 18.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.42 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.7 m -75.48 -24.58 17.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.508 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.03 35.28 0.96 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -93.33 -155.15 0.43 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.154 0.502 . . . . 0.0 111.555 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.55 -171.39 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.94 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -66.79 118.59 10.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.839 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.486 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.8 OUTLIER -115.04 150.35 44.08 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.21 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -48.2 111.7 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.516 1.478 . . . . 0.0 112.32 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.486 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.5 mp -120.99 128.99 76.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 8.7 tpt -129.17 115.45 17.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.76 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mt -96.84 97.77 9.57 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.0 t -102.48 134.06 44.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 122.442 1.115 . . . . 0.0 110.471 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 146' ' ' LEU . . . -101.32 111.73 4.19 Favored Glycine 0 C--N 1.297 -1.595 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.509 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 46.3 t30 -96.95 173.72 7.14 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.415 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.509 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 24.4 mttt 59.57 58.59 2.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.507 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 32.0 tttm -64.41 -35.47 81.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.412 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.419 ' CG ' HN21 ' A' ' 186' ' ' GDP . 6.1 p-10 -60.32 -10.6 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.04 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 125' ' ' MET . 9.1 mp -90.69 -29.93 17.42 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.598 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.1 OUTLIER -40.13 -23.97 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.889 178.499 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.598 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 3.6 mmt -45.24 -24.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.44 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -101.36 -37.81 8.31 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.068 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.41 ' NH1' ' OE2' ' A' ' 147' ' ' GLU . 1.9 tpt180 38.91 88.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.082 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.0 m -78.84 -38.21 20.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.586 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.409 HD13 ' H ' ' A' ' 130' ' ' SER . 6.7 tp -90.5 153.52 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.54 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 18.2 p -94.87 137.16 34.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.274 0.559 . . . . 0.0 112.087 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -54.95 -32.59 61.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.215 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -68.32 -65.83 0.65 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.964 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.54 ' H ' ' HG ' ' A' ' 130' ' ' SER . 41.0 mt-10 -42.09 -40.93 2.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.622 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.11 -34.29 64.74 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 132' ' ' GLU . 24.1 tttm -64.07 -55.5 21.68 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -55.6 -33.75 64.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.25 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.615 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -65.53 -62.99 1.2 Allowed 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.702 179.429 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -54.69 -34.99 63.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.364 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.56 -30.11 67.84 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.599 ' HG ' ' N ' ' A' ' 141' ' ' TRP . 23.4 p -64.3 -46.8 81.99 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.742 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.615 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 21.9 m95 -88.94 -5.71 57.78 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.089 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.4 ' O ' ' OE2' ' A' ' 166' ' ' GLU . 0.8 OUTLIER 75.91 25.49 1.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -89.24 169.16 11.69 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.894 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.47 133.81 49.61 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.214 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 6.6 t80 -96.83 122.49 39.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.005 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 118' ' ' GLY . 1.3 mm? -132.95 139.5 47.34 Favored 'General case' 0 C--O 1.209 -1.054 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.63 -176.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.423 ' OE1' ' OH ' ' A' ' 85' ' ' TYR . 5.5 tt0 -129.04 111.28 12.81 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 58.9 p -138.66 -177.15 4.74 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.734 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.549 ' H ' ' HG1' ' A' ' 155' ' ' THR . 0.1 OUTLIER -138.4 140.17 39.26 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.086 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.533 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -59.68 -43.07 94.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.157 0.503 . . . . 0.0 109.69 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.0 ttpp -65.38 5.64 0.38 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.381 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.533 ' H ' ' C ' ' A' ' 150' ' ' ALA . 3.4 tt0 -136.47 120.02 17.08 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.721 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.498 HD22 ' CA ' ' A' ' 30' ' ' GLN . 3.6 m120 -77.57 -56.86 4.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.961 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 153' ' ' ASN . 9.1 tt0 -36.97 -58.23 0.78 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.893 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.549 ' HG1' ' H ' ' A' ' 149' ' ' SER . 66.3 p -52.14 -50.16 62.29 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.126 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -49.75 -60.31 3.01 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.418 0.628 . . . . 0.0 109.717 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.1 t -40.92 -50.35 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.986 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -53.96 -32.6 54.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.661 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 156' ' ' ALA . 12.7 t -75.92 -26.74 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.247 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -71.45 -39.92 70.66 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.462 179.321 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.603 ' N ' ' CD1' ' A' ' 160' ' ' PHE . 36.2 ttm-85 -79.48 -47.73 15.12 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.163 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.6 mmm180 -57.75 -37.57 73.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.11 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.42 ' CG2' ' H ' ' A' ' 164' ' ' ILE . 11.6 tt -69.74 -58.18 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.438 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.42 ' H ' ' CG2' ' A' ' 163' ' ' ILE . 91.3 mt -46.2 -35.02 2.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.88 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -64.82 0.82 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.027 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.4 ' OE2' ' O ' ' A' ' 142' ' ' ASN . 2.1 tt0 -54.6 -37.99 66.22 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -49.56 -35.54 20.82 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -68.06 -52.65 32.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.085 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 3.6 ttpp -54.5 -61.07 2.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.529 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 33.7 mm -49.98 -32.98 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.62 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -39.59 89.05 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.102 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -61.9 -34.09 87.63 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.96 -80.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.67 0.271 . . . . 0.0 110.323 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 -0.141 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.817 179.824 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GDP . . . . . 0.434 " H5'" ' HA ' ' A' ' 16' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 121.352 0.596 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.69 135.41 33.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.256 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.619 ' HZ1' HE22 ' A' ' 57' ' ' GLN . 8.1 mttm -107.73 127.59 53.82 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -100.96 122.27 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 121.702 0.763 . . . . 0.0 110.808 -177.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.28 135.24 34.41 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.498 -0.751 . . . . 0.0 110.882 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.4 mt -96.97 131.74 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.554 0.692 . . . . 0.0 112.403 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.421 ' C ' ' CD2' ' A' ' 12' ' ' LEU . 5.0 tt -121.43 101.34 7.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.895 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -139.8 134.4 6.59 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.72 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.442 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -55.34 -158.35 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.368 0.604 . . . . 0.0 110.756 179.339 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.7 tpp85 -96.05 133.57 40.14 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.546 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.401 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 4.1 m 61.57 14.61 6.1 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.288 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.505 ' C ' ' HZ3' ' A' ' 120' ' ' LYS . 4.3 p -70.28 -13.32 17.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.502 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.4 21.65 47.5 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.747 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.4 pttm -68.17 -35.29 77.81 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.055 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.2 m -67.66 -42.21 82.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.545 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 m -60.42 -47.55 85.62 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.485 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.444 ' O ' ' CB ' ' A' ' 26' ' ' PHE . 45.4 tp -66.95 -26.94 67.08 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.547 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 97.2 m -63.06 -51.45 66.62 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.4 mm -65.3 -38.77 83.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.936 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.472 ' OE1' ' CB ' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -77.57 -25.67 50.21 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.541 -178.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.636 ' CZ ' ' CD2' ' A' ' 160' ' ' PHE . 37.1 t80 -77.78 -53.04 7.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.414 0.626 . . . . 0.0 110.614 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.457 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 14.9 p -59.61 -48.75 86.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.991 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.457 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 2.6 mt-10 -79.43 -24.41 42.51 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.416 ' O ' ' OD1' ' A' ' 153' ' ' ASN . . . 69.24 36.2 78.75 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -147.14 136.13 22.32 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.205 0.526 . . . . 0.0 111.179 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -39.88 122.09 1.39 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.24 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.458 ' CG2' ' N ' ' A' ' 33' ' ' ASP . 14.5 p -93.56 166.13 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.785 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.458 ' N ' ' CG2' ' A' ' 32' ' ' VAL . 0.3 OUTLIER -87.52 10.16 18.65 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.377 -179.172 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.0 p 42.09 41.26 1.95 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.8 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.51 ' O ' ' CG ' ' A' ' 35' ' ' TYR . 21.5 t80 -158.04 85.91 0.89 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.581 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -162.32 158.85 20.69 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.531 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.624 ' C ' ' H ' ' A' ' 39' ' ' ILE . 94.8 Cg_exo -26.69 84.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.158 0 C-N-CA 124.326 3.35 . . . . 0.0 113.163 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 36' ' ' ASP . 13.2 t -68.65 35.05 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.665 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.624 ' H ' ' C ' ' A' ' 37' ' ' PRO . 1.7 tp -84.33 166.24 2.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.408 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.42 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 7.2 pt-20 -81.31 132.92 35.36 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.964 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 1.2 m120 -172.85 176.08 3.18 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.576 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.434 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -108.26 152.95 23.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.577 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.45 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 25.3 m-85 -132.63 166.37 22.3 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.455 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.05 156.3 42.91 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.524 0.678 . . . . 0.0 112.823 -177.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -163.29 117.13 1.6 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.804 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mp -104.63 129.2 52.8 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.879 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 pp -147.1 160.31 9.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.935 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -114.97 123.28 48.71 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.974 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.26 129.87 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.014 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 63.74 7.26 3.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.019 0.438 . . . . 0.0 109.961 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.83 -11.76 59.17 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -89.15 135.02 33.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -77.13 147.12 36.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.606 0.717 . . . . 0.0 111.525 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.538 ' C ' ' HD1' ' A' ' 55' ' ' HIS . 13.7 m-85 -140.38 123.47 16.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.749 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.538 ' HD1' ' C ' ' A' ' 54' ' ' TYR . 1.2 m-70 -117.33 114.06 23.03 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.7 mp -118.88 143.88 46.72 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.785 0.802 . . . . 0.0 112.379 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.619 HE22 ' HZ1' ' A' ' 8' ' ' LYS . 2.9 mt-30 -135.63 122.15 20.71 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.198 -1.364 . . . . 0.0 109.95 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.637 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.78 153.53 33.28 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.53 -178.603 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -122.93 144.38 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-N 114.508 -1.224 . . . . 0.0 112.32 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.13 103.43 8.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.107 178.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.417 ' CG2' ' CD2' ' A' ' 74' ' ' TYR . 1.5 p -70.84 143.54 51.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.385 0.612 . . . . 0.0 110.513 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.66 12.88 2.31 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.644 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -105.21 -63.85 0.65 Allowed Glycine 0 CA--C 1.527 0.784 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.571 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.5 ' OE1' ' NE2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -84.02 -164.63 0.96 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.285 0.564 . . . . 0.0 111.324 -179.321 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.626 ' O ' ' N ' ' A' ' 67' ' ' TYR . 1.8 p30 -76.11 -172.8 2.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.078 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.526 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -21.82 -41.61 0.0 OUTLIER 'General case' 0 C--N 1.344 0.33 0 O-C-N 124.051 0.845 . . . . 0.0 110.778 -179.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 65' ' ' ASP . 4.4 t80 -178.86 5.0 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.64 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.55 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 67.0 m 36.67 93.97 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.699 0.285 . . . . 0.0 111.738 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -44.21 139.9 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.445 ' CD2' ' O ' ' A' ' 70' ' ' PHE . 66.1 t80 53.95 64.94 5.92 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.729 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -51.4 163.58 1.03 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.632 2.221 . . . . 0.0 112.215 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.5 ' NE2' ' OE1' ' A' ' 64' ' ' GLN . 8.0 mp0 -91.35 -43.9 9.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.313 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.1 m -131.51 -1.26 3.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.228 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.417 ' CD2' ' CG2' ' A' ' 61' ' ' THR . 0.2 OUTLIER -100.88 10.83 40.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.408 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 76' ' ' ILE . 5.4 m -83.58 57.55 4.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.247 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -50.53 -169.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.583 -179.57 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -117.29 54.28 0.89 Allowed 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 29.8 pt -78.86 -176.97 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-N 114.479 -1.237 . . . . 0.0 113.238 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -151.19 17.33 0.75 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.04 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -144.17 164.4 27.6 Favored Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.222 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.533 ' OH ' ' CG ' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -152.53 123.93 7.71 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.641 -0.78 . . . . 0.0 111.181 178.458 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.6 tt -128.71 113.79 30.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.2 mt -97.48 123.93 41.51 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.042 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -98.08 117.82 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.179 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.615 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 42.2 p90 -120.5 145.38 47.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.308 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.679 ' HG ' ' H ' ' A' ' 89' ' ' SER . 3.3 p -86.03 135.77 33.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.204 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.0 m -73.69 21.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.459 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.565 ' H ' ' HG ' ' A' ' 86' ' ' SER . 0.9 OUTLIER -136.9 -25.6 1.08 Allowed 'General case' 0 CA--C 1.52 -0.212 0 CA-C-O 121.003 0.43 . . . . 0.0 112.063 -178.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.679 ' H ' ' HG ' ' A' ' 86' ' ' SER . 60.8 p -97.77 100.06 11.42 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.067 -176.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.8 tp -59.37 -8.4 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 176.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.614 ' H ' ' C ' ' A' ' 89' ' ' SER . 21.8 mttp -77.05 -59.31 2.83 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.111 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.432 ' OG ' ' OG ' ' A' ' 89' ' ' SER . 83.1 p -52.22 -33.52 41.53 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.878 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.615 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -73.19 -49.76 26.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.721 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -65.98 -42.35 89.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.214 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.5 m -66.22 -41.56 89.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.254 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.4 mt -59.44 -34.51 54.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -71.0 -27.26 63.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.466 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.4 t -77.11 -67.27 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.263 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.4 tp -48.53 -29.53 2.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.684 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.616 ' CG ' ' CH2' ' A' ' 141' ' ' TRP . 35.6 t-80 -67.77 -63.58 1.03 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.235 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -39.58 -47.61 3.0 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 105' ' ' ASP . 37.6 tptt -62.81 -62.72 1.53 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.878 -0.661 . . . . 0.0 109.244 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -38.06 -51.09 1.39 Allowed 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.349 0.595 . . . . 0.0 109.498 178.686 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.485 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -52.4 -45.56 65.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.52 179.057 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -61.27 -32.7 72.52 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.035 -179.593 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.529 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 23.7 ttp -77.07 -46.48 23.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.18 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.8 m -76.86 -11.19 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.623 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.488 ' O ' ' CB ' ' A' ' 109' ' ' LYS . . . 81.32 4.14 90.51 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.543 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 108' ' ' GLY . 5.9 tttp 83.85 94.51 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.137 0.494 . . . . 0.0 111.709 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.5 t -144.34 139.09 24.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.467 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.486 ' N ' ' OE1' ' A' ' 111' ' ' GLN . 2.1 mm100 -73.1 113.66 10.4 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.367 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.61 161.21 62.32 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -51.83 101.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 120.953 1.102 . . . . 0.0 111.548 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.3 mt -116.22 120.97 66.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 8.5 tpt -121.84 113.73 20.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.033 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 79.8 mt -96.14 97.86 9.88 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.8 t -106.91 135.32 45.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 122.184 0.992 . . . . 0.0 111.696 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.403 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -105.45 116.08 5.1 Favored Glycine 0 C--N 1.308 -0.98 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.509 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 57.9 t30 -97.71 174.88 6.4 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.043 -178.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.509 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 7.2 mttp 62.09 58.19 1.9 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.048 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.44 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 2.9 tttm -58.92 -26.83 64.69 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.633 ' CG ' HN22 ' A' ' 186' ' ' GDP . 3.1 p-10 -64.5 -13.98 54.9 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.97 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 125' ' ' MET . 11.0 mp -89.98 -30.03 18.07 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.61 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.1 OUTLIER -37.53 -25.78 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.132 178.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.61 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 7.2 mtp -49.26 -21.5 0.83 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.448 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -109.99 -38.84 5.22 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.139 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.48 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 19.6 ttm180 26.68 90.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.106 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.99 -32.98 56.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.437 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.6 tp -88.89 156.37 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.597 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.492 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 88.7 p -103.41 124.98 49.73 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.219 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.511 ' CE1' ' CE1' ' A' ' 145' ' ' PHE . 0.4 OUTLIER -39.23 -39.56 0.63 Allowed 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.064 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mp0 -61.33 -65.75 0.64 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.937 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.492 ' H ' ' HG ' ' A' ' 130' ' ' SER . 66.6 mt-10 -41.41 -46.18 3.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.076 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.78 -35.05 84.57 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 132' ' ' GLU . 12.1 ttpt -62.04 -55.27 30.81 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.0 -37.82 77.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.307 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.557 ' CD2' ' CE2' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -67.06 -64.78 0.78 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 120.905 0.384 . . . . 0.0 110.017 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -49.71 -32.45 13.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.304 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -67.12 -53.77 27.59 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.911 0.386 . . . . 0.0 110.11 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 88.8 p -62.32 -26.77 68.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.116 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.616 ' CH2' ' CG ' ' A' ' 100' ' ' HIS . 32.6 m0 -88.02 -8.78 55.11 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 65.9 20.61 11.38 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -101.04 166.65 10.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.776 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.01 133.96 48.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.916 -0.583 . . . . 0.0 112.252 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.511 ' CE1' ' CE1' ' A' ' 131' ' ' TYR . 4.5 t80 -97.1 122.92 40.63 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.529 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -135.79 138.89 43.06 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.592 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.48 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 2.3 tt0 -127.77 110.55 12.73 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.1 p -137.86 -176.79 4.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.164 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.71 139.85 38.54 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.857 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -59.78 -44.38 93.92 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 178.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -62.5 -0.5 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.184 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.51 ' H ' ' C ' ' A' ' 150' ' ' ALA . 1.3 mt-10 -136.42 97.98 3.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.627 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.455 ' O ' ' N ' ' A' ' 156' ' ' ALA . 11.2 t-20 -63.96 -47.71 79.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.969 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 153' ' ' ASN . 0.0 OUTLIER -37.06 -59.13 0.74 Allowed 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.104 0.478 . . . . 0.0 110.485 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 74.2 p -52.29 -44.98 65.3 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.847 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -55.19 -60.31 3.57 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.293 0.568 . . . . 0.0 109.959 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.1 t -41.63 -41.64 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.939 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.32 -39.56 94.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.891 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 156' ' ' ALA . 22.4 t -67.39 -31.33 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.371 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.636 ' CD2' ' CZ ' ' A' ' 26' ' ' PHE . 4.8 t80 -62.19 -66.94 0.46 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.67 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 26.3 ttm-85 -48.48 -53.15 19.05 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.849 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.46 -33.98 23.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.95 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -34.07 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.485 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 10.2 mt -68.06 -40.05 82.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.634 0.731 . . . . 0.0 110.244 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.37 -60.84 2.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.302 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.6 -32.29 65.11 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.546 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.0 -32.29 70.72 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -68.32 -55.98 10.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.96 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 18.4 ttpp -59.2 -62.33 1.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.931 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 67.1 mt -50.28 -33.14 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.111 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.13 -40.69 90.84 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.141 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.56 -32.71 84.21 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.94 -81.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.419 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.015 -179.96 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GDP . . . . . 0.633 HN22 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.52 ' OG ' ' ND1' ' A' ' 55' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 121.078 0.466 . . . . 0.0 110.159 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -139.9 136.7 34.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.602 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -106.36 133.47 51.0 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 1.3 mm -106.06 125.97 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-O 121.345 0.593 . . . . 0.0 110.232 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.74 134.0 34.76 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.124 -0.985 . . . . 0.0 110.631 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.0 mt -96.9 132.37 41.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.341 0.591 . . . . 0.0 112.121 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.2 tp -132.4 105.92 7.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.569 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -140.26 134.37 6.48 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -54.9 -159.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.371 0.605 . . . . 0.0 110.918 179.624 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -96.18 135.28 38.2 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.864 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.0 m 61.27 19.48 10.16 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.497 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.531 ' C ' ' HZ1' ' A' ' 120' ' ' LYS . 4.0 p -77.8 -19.66 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.852 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.436 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 93.38 23.28 24.67 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.424 ' O ' ' OG1' ' A' ' 23' ' ' THR . 9.6 pttm -69.32 -34.45 74.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.0 110.263 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.2 m -75.42 -36.16 60.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.086 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 78.3 p -60.42 -42.16 95.47 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.318 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.6 tp -77.44 -34.14 54.64 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.959 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 19' ' ' LYS . 27.0 m -52.98 -45.48 67.84 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.849 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.454 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 1.4 mp -74.42 -41.96 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.351 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.479 ' OE1' ' CB ' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -68.45 -28.9 67.45 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.334 -0.547 . . . . 0.0 110.961 -179.433 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.453 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 1.4 t80 -77.93 -64.05 1.25 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.336 0.588 . . . . 0.0 110.957 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 14.9 p -47.05 -48.41 8.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.727 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.449 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 0.5 OUTLIER -80.32 -24.95 39.58 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.157 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.431 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 74.09 24.02 74.7 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.154 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.32 125.88 14.13 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.657 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -68.05 92.37 0.38 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.224 178.697 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.468 ' CG2' ' N ' ' A' ' 33' ' ' ASP . 14.7 p -101.33 166.51 2.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.186 0.517 . . . . 0.0 110.581 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.468 ' N ' ' CG2' ' A' ' 32' ' ' VAL . 1.2 t70 -73.0 26.75 0.06 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.01 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 32' ' ' VAL . 4.2 p -64.62 64.05 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.016 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.497 ' O ' ' CG ' ' A' ' 35' ' ' TYR . 0.6 OUTLIER -91.04 105.79 18.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.648 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.444 ' O ' ' O ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -137.37 172.37 6.98 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.208 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 36' ' ' ASP . 49.0 Cg_exo -56.68 -137.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.485 2.123 . . . . 0.0 111.763 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.438 ' O ' ' CG2' ' A' ' 38' ' ' THR . 10.9 t -129.68 60.85 1.57 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.608 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 tp -83.17 149.17 4.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.223 -0.898 . . . . 0.0 111.158 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -87.49 147.33 25.42 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.149 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -172.33 -179.0 2.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.318 0.58 . . . . 0.0 111.837 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.3 m -126.7 143.27 51.29 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.151 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.429 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 14.2 m-85 -129.15 165.66 20.85 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.945 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.03 152.23 41.68 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.322 0.582 . . . . 0.0 112.148 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 tttp -156.47 113.14 3.09 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.868 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.9 mp -105.91 122.21 45.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.899 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.544 ' N ' ' CD1' ' A' ' 47' ' ' ILE . 0.3 OUTLIER -144.77 165.43 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.672 -179.145 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.6 m -115.23 125.89 53.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.266 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.0 p -120.61 117.25 52.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.885 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 69.88 25.9 4.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 110.118 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.38 -10.15 55.8 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -89.34 132.13 35.09 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -75.76 146.17 40.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.535 0.683 . . . . 0.0 111.203 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.417 ' OH ' ' OE2' ' A' ' 168' ' ' GLU . 5.1 m-85 -137.54 125.72 23.05 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.891 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.52 ' ND1' ' OG ' ' A' ' 6' ' ' SER . 1.3 t-80 -117.47 113.4 21.98 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mp -118.39 143.17 46.85 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.781 0.8 . . . . 0.0 111.822 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -140.44 120.52 13.73 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.047 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.64 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -115.85 154.33 29.89 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.331 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -130.89 144.15 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.267 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.41 102.93 7.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.449 -1.251 . . . . 0.0 108.306 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.14 153.96 45.37 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.38 0.61 . . . . 0.0 110.364 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 64' ' ' GLN . . . -143.17 21.01 1.92 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.319 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -38.84 -25.42 0.04 OUTLIER Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.599 ' CG ' ' H ' ' A' ' 65' ' ' ASP . 0.5 OUTLIER -145.31 -125.3 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.476 0.655 . . . . 0.0 110.888 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.599 ' H ' ' CG ' ' A' ' 64' ' ' GLN . 5.9 p30 -76.33 -170.27 1.42 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.816 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.52 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 1.0 OUTLIER -61.63 56.0 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 O-C-N 124.045 0.841 . . . . 0.0 110.223 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.573 ' CE1' ' CD1' ' A' ' 74' ' ' TYR . 31.9 t80 76.5 71.67 0.07 Allowed 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.574 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 24.1 m -47.22 122.93 4.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.3 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.625 ' CD1' ' H ' ' A' ' 69' ' ' ILE . 2.6 mp -55.33 -63.68 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.023 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.534 ' O ' ' N ' ' A' ' 72' ' ' GLN . 7.1 m-85 -32.14 97.02 0.1 Allowed Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 114.271 -1.332 . . . . 0.0 110.915 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.19 82.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.071 1.847 . . . . 0.0 112.401 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -111.24 -69.9 0.84 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.991 179.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.45 ' OG1' ' NE2' ' A' ' 72' ' ' GLN . 3.7 m -100.54 -20.42 15.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.683 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.573 ' CD1' ' CE1' ' A' ' 67' ' ' TYR . 79.6 m-85 -88.23 49.52 1.81 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.21 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.484 ' H ' ' HG ' ' A' ' 75' ' ' SER . 3.7 p -80.71 11.04 4.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.172 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.416 ' O ' ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -49.68 -178.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 120.938 0.399 . . . . 0.0 110.968 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.74 51.43 1.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 45.2 pt -78.4 -173.5 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 115.415 -0.812 . . . . 0.0 112.725 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.27 18.25 0.95 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.477 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -147.55 166.43 28.69 Favored Glycine 0 CA--C 1.519 0.339 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.622 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.54 ' OH ' ' CD2' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -151.9 123.08 7.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.851 -0.675 . . . . 0.0 111.2 178.399 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.6 tt -128.0 104.81 12.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.505 0.669 . . . . 0.0 109.296 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.625 ' H ' ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.53 122.17 40.28 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.144 -178.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -96.47 118.22 42.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.467 ' CZ ' ' CA ' ' A' ' 118' ' ' GLY . 25.5 p90 -112.12 144.69 41.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.465 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.635 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.5 p -86.94 135.7 33.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.844 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.6 m -72.35 19.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.991 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.553 ' H ' ' HG ' ' A' ' 86' ' ' SER . 5.5 t -136.65 -26.11 1.1 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.061 0.457 . . . . 0.0 112.099 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.635 ' H ' ' HG ' ' A' ' 86' ' ' SER . 18.3 t -93.14 93.74 8.45 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.095 -176.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 tp -60.45 -10.02 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.555 ' H ' ' C ' ' A' ' 89' ' ' SER . 15.6 mttp -75.48 -48.6 21.9 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 113.901 -1.5 . . . . 0.0 109.533 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.1 p -61.44 -30.92 70.88 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.906 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.427 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -73.24 -51.75 16.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.125 -179.437 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -62.77 -43.78 97.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.701 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.4 m -66.67 -34.51 70.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.084 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.8 mt -66.48 -36.08 76.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.591 -0.443 . . . . 0.0 109.904 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -70.07 -26.36 63.97 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.273 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.1 t -73.02 -67.03 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.895 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.5 tt -43.11 -40.37 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.214 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.614 ' CE1' ' CD1' ' A' ' 141' ' ' TRP . 1.1 t-160 -58.45 -63.57 1.23 Allowed 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.385 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -38.36 -58.42 1.68 Allowed Glycine 0 CA--C 1.519 0.3 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 105' ' ' ASP . 34.8 tptt -61.71 -62.75 1.58 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.953 -0.623 . . . . 0.0 110.365 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.64 -55.0 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.429 0.633 . . . . 0.0 109.579 179.375 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.46 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -49.17 -46.24 45.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.275 178.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -60.47 -36.12 77.52 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.726 -179.577 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.518 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 2.0 ttm -59.4 -57.96 10.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.135 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.548 ' C ' ' H ' ' A' ' 109' ' ' LYS . 19.1 m -77.07 -13.31 14.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.584 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.26 -24.83 0.1 OUTLIER Glycine 0 CA--C 1.53 1.028 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.65 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.548 ' H ' ' C ' ' A' ' 107' ' ' VAL . 7.9 tttp -173.9 -134.58 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 117.663 0.731 . . . . 0.0 111.689 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.513 ' H ' ' CG ' ' A' ' 109' ' ' LYS . 5.1 t 52.85 120.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.719 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -75.14 136.4 41.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.732 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.481 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.4 OUTLIER -138.3 148.2 58.62 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.098 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -48.7 114.59 1.28 Allowed 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 121.94 1.76 . . . . 0.0 112.824 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.481 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.2 mp -124.26 128.65 73.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 10.7 tpt -130.36 114.32 15.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.912 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.4 mt -97.65 98.66 10.07 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.3 t -104.98 129.45 57.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.944 0.878 . . . . 0.0 111.461 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.467 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -96.07 117.12 5.6 Favored Glycine 0 C--N 1.311 -0.83 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.485 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 58.7 t30 -97.47 174.14 6.82 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.994 -177.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.531 ' HZ1' ' C ' ' A' ' 17' ' ' VAL . 6.1 mttp 59.91 58.75 2.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.939 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.46 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 18.1 tttm -56.27 -26.05 50.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.568 -178.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.621 ' CG ' HN22 ' A' ' 186' ' ' GDP . 3.9 p-10 -72.72 -13.31 61.31 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.084 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.8 mp -91.18 -30.92 16.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.606 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.1 OUTLIER -38.93 -25.04 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.171 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.606 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 11.2 mtt -45.65 -23.95 0.3 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.473 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -105.17 -40.46 5.86 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.495 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.488 ' CZ ' ' OE1' ' A' ' 147' ' ' GLU . 2.6 tpp85 27.9 86.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.766 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.1 t -59.41 -32.6 49.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.396 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.29 153.04 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.531 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.543 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 78.3 p -96.89 121.94 39.32 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.304 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.402 ' HB2' HH12 ' A' ' 127' ' ' ARG . 13.8 t80 -37.01 -32.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.249 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.5 mp0 -70.51 -64.84 0.82 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.808 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.543 ' H ' ' HG ' ' A' ' 130' ' ' SER . 69.6 mt-10 -41.24 -42.52 2.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.724 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.15 -35.68 70.93 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 132' ' ' GLU . 4.2 tttt -61.97 -55.48 29.02 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.92 -35.72 69.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.821 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.61 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -66.27 -63.53 1.06 Allowed 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.85 -35.6 57.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.185 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -68.69 -32.35 72.11 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.173 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.664 ' HG ' ' N ' ' A' ' 141' ' ' TRP . 1.4 p -63.24 -46.24 87.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.792 -179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.664 ' N ' ' HG ' ' A' ' 140' ' ' SER . 30.9 m95 -88.51 -5.12 58.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.982 0.42 . . . . 0.0 110.335 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 141' ' ' TRP . 0.9 OUTLIER 77.41 23.69 0.85 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.384 0.611 . . . . 0.0 109.52 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.29 167.37 13.6 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.869 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -110.97 130.1 55.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.529 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -98.17 120.87 39.33 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.281 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.75 128.73 17.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.488 ' OE1' ' CZ ' ' A' ' 127' ' ' ARG . 6.4 mt-10 -100.28 119.76 38.89 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.043 0.449 . . . . 0.0 110.029 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 63.2 p -137.45 178.1 7.36 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.42 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.3 138.08 38.03 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.974 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.531 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -55.73 -49.82 72.01 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.143 0.497 . . . . 0.0 109.748 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.7 tttm -58.84 -3.12 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.284 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.531 ' H ' ' C ' ' A' ' 150' ' ' ALA . 6.7 tt0 -127.35 110.92 13.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.421 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -76.57 -47.21 23.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.684 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -41.3 -57.61 2.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.093 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.597 ' HG1' ' H ' ' A' ' 156' ' ' ALA . 78.0 p -52.74 -48.42 66.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.975 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.597 ' H ' ' HG1' ' A' ' 155' ' ' THR . . . -48.49 -60.56 2.59 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.516 0.674 . . . . 0.0 109.59 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 60.0 t -43.29 -49.58 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.088 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -53.76 -43.1 68.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.553 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.16 -44.12 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.304 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.412 ' O ' HG22 ' A' ' 163' ' ' ILE . 9.7 t80 -53.72 -40.48 66.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.168 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.3 ttt85 -77.09 -42.12 39.45 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.156 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -60.26 -34.44 73.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.189 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.457 HG22 ' H ' ' A' ' 164' ' ' ILE . 10.3 tt -70.73 -47.16 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 119.281 -0.968 . . . . 0.0 110.79 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.457 ' H ' HG22 ' A' ' 163' ' ' ILE . 85.5 mt -54.62 -32.07 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.289 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.21 -64.68 0.84 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.206 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -60.01 -29.67 68.64 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.493 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.33 -30.97 70.84 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.417 ' OE2' ' OH ' ' A' ' 54' ' ' TYR . 3.7 tp10 -68.06 -54.34 18.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.177 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -60.9 -61.09 2.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.884 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 74.2 mt -50.06 -36.96 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.814 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -70.86 -40.07 72.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.808 0.337 . . . . 0.0 110.605 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -55.16 -41.52 78.81 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.654 -0.979 . . . . 0.0 110.654 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.05 -61.99 1.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.756 0.313 . . . . 0.0 110.621 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.932 -179.832 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GDP . . . . . 0.621 HN22 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.516 ' OG ' ' ND1' ' A' ' 55' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 121.212 0.53 . . . . 0.0 110.185 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.22 136.05 34.58 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.489 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -106.16 132.28 52.41 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 1.1 mm -104.45 124.75 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-O 121.333 0.587 . . . . 0.0 110.242 -178.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.83 133.54 34.75 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.084 -1.01 . . . . 0.0 110.931 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.8 mt -95.56 133.72 35.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.657 0.741 . . . . 0.0 112.33 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.55 104.91 6.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.877 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -140.98 135.95 7.25 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.467 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -54.09 -158.18 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.769 0.795 . . . . 0.0 111.042 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -95.99 132.75 40.99 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.882 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.467 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 5.8 m 59.14 19.1 7.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.159 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.471 ' C ' ' NZ ' ' A' ' 120' ' ' LYS . 2.5 p -80.48 -10.76 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.801 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.42 7.66 51.23 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.402 ' CB ' ' NZ ' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -40.05 -59.26 1.26 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.118 0.485 . . . . 0.0 110.353 179.565 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -67.75 -26.97 66.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.449 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.506 ' OG ' ' H8 ' ' A' ' 186' ' ' GDP . 8.0 m -64.39 -50.56 67.17 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.017 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.9 tp -75.83 -26.35 57.1 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.42 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.5 m -58.15 -50.9 71.89 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.4 mp -60.6 -43.73 95.28 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.406 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.541 ' OE1' ' N ' ' A' ' 31' ' ' PHE . 6.4 tt0 -69.69 -25.62 63.96 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.21 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -77.32 -49.94 13.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.246 0.546 . . . . 0.0 110.822 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.421 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 11.8 p -68.77 -45.1 81.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.139 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.421 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 2.8 tt0 -81.4 -24.94 36.61 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.466 ' O ' ' ND2' ' A' ' 153' ' ' ASN . . . 77.68 19.25 76.16 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.974 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.539 ' NE2' ' O ' ' A' ' 31' ' ' PHE . 16.8 tp60 -149.0 135.97 19.86 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.301 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.541 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 1.0 OUTLIER -71.76 93.96 1.34 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.567 178.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 33' ' ' ASP . 13.9 p -111.68 166.49 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.094 0.473 . . . . 0.0 110.46 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.451 ' N ' ' CG2' ' A' ' 32' ' ' VAL . 0.4 OUTLIER -62.68 -14.41 43.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.479 -178.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 33' ' ' ASP . 29.4 p 49.8 173.39 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.399 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -152.81 13.59 0.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.117 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 37' ' ' PRO . 2.2 m-20 -113.88 95.28 37.08 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.664 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 36' ' ' ASP . 66.4 Cg_exo -54.82 -130.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.568 2.179 . . . . 0.0 112.256 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.3 t -109.95 46.25 1.04 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.181 0.515 . . . . 0.0 112.046 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.434 ' CG2' ' OD1' ' A' ' 41' ' ' ASN . 1.5 tp -84.59 165.22 2.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.469 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.98 124.56 28.81 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.434 ' OD1' ' CG2' ' A' ' 39' ' ' ILE . 1.2 m120 -161.97 -178.99 6.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.645 0.736 . . . . 0.0 112.95 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.2 m -137.43 144.3 42.28 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.11 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 12.3 m-85 -127.44 163.65 23.61 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.496 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.22 150.75 38.47 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.396 0.617 . . . . 0.0 112.661 -178.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.0 118.69 2.73 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.771 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.6 mp -105.82 129.3 54.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.654 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -147.65 165.83 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.798 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.4 m -115.79 126.4 53.97 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.197 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.403 ' CG1' ' CD1' ' A' ' 54' ' ' TYR . 7.2 p -121.28 118.95 57.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.94 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 71.27 17.36 5.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.12 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.37 -11.58 70.82 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -89.28 133.88 34.28 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.25 144.1 42.74 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.622 0.725 . . . . 0.0 111.163 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.419 ' OH ' ' OE2' ' A' ' 168' ' ' GLU . 6.6 m-85 -136.47 127.87 28.44 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.664 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.525 ' O ' ' ND1' ' A' ' 55' ' ' HIS . 1.2 t-80 -117.07 114.39 23.67 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 mp -117.69 143.72 45.92 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 122.078 0.942 . . . . 0.0 112.244 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -140.91 121.68 14.38 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 113.702 -1.59 . . . . 0.0 109.725 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.642 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -115.86 154.09 30.33 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.528 0.68 . . . . 0.0 112.347 -178.403 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.02 145.09 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-N 114.532 -1.213 . . . . 0.0 113.172 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -120.88 102.91 8.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.201 178.016 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.5 p -70.51 150.85 45.72 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.07 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 63' ' ' GLY . . . -121.31 23.83 10.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.714 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 62' ' ' ALA . . . -51.55 -164.92 0.01 OUTLIER Glycine 0 CA--C 1.529 0.951 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.485 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.42 ' NE2' ' O ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -83.22 -64.48 1.16 Allowed 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.391 0.615 . . . . 0.0 111.023 -179.618 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.548 ' CG ' ' H ' ' A' ' 66' ' ' GLU . 4.0 t70 -76.26 -178.8 4.7 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.633 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.548 ' H ' ' CG ' ' A' ' 65' ' ' ASP . 0.6 OUTLIER -45.04 -19.6 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.604 ' CG ' ' O ' ' A' ' 67' ' ' TYR . 11.3 t80 -178.06 4.14 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.959 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.4 m 38.93 81.33 0.03 OUTLIER 'General case' 0 C--O 1.232 0.15 0 O-C-N 122.121 -0.362 . . . . 0.0 111.266 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -42.65 140.22 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.337 0.064 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.4 t80 68.16 63.72 0.65 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.164 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.508 ' C ' ' H ' ' A' ' 73' ' ' THR . 51.0 Cg_exo -47.11 -42.09 26.49 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.7 2.267 . . . . 0.0 112.423 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.3 13.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.077 0.465 . . . . 0.0 109.959 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.508 ' H ' ' C ' ' A' ' 71' ' ' PRO . 87.6 m -135.87 -35.51 0.78 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.193 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.16 -65.74 0.69 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.999 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 t 73.64 49.14 0.14 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.928 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -81.95 172.73 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.48 0.657 . . . . 0.0 111.551 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.49 52.46 1.06 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.052 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 37.6 pt -80.69 -173.08 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.69 16.34 0.88 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.449 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -145.07 166.79 27.45 Favored Glycine 0 CA--C 1.519 0.319 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.317 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.82 122.5 7.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.911 -0.645 . . . . 0.0 111.28 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.425 ' O ' ' CG2' ' A' ' 82' ' ' ILE . 12.2 tt -127.55 101.04 6.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.562 0.696 . . . . 0.0 109.138 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.617 ' H ' ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -96.86 123.44 40.56 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.376 -178.52 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -96.84 119.67 45.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.97 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.635 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 32.1 p90 -121.64 144.72 48.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.675 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.584 ' HG ' ' H ' ' A' ' 88' ' ' THR . 1.7 p -87.82 143.28 27.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.735 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.8 m -80.67 20.32 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.778 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.584 ' H ' ' HG ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -131.05 -27.82 2.01 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.119 0.485 . . . . 0.0 111.936 -178.101 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.556 ' C ' ' H ' ' A' ' 91' ' ' LYS . 44.2 t -97.08 93.94 6.87 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.674 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 tp -58.58 -10.75 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.556 ' H ' ' C ' ' A' ' 89' ' ' SER . 2.6 mtpt -76.07 -50.82 13.7 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.052 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.477 ' O ' ' CG1' ' A' ' 96' ' ' ILE . 59.1 p -60.34 -31.88 70.73 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.01 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -75.56 -46.17 33.55 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.081 -179.337 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -66.02 -44.1 85.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.25 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.4 m -68.17 -39.8 81.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.621 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.477 ' CG1' ' O ' ' A' ' 92' ' ' SER . 1.4 mm -59.18 -42.45 86.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.289 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.49 -27.25 64.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.305 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.0 t -75.55 -66.97 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.166 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.6 mm -41.84 -45.49 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.043 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.443 ' ND1' ' C ' ' A' ' 100' ' ' HIS . 9.7 t-80 -56.53 -63.51 1.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.691 -0.403 . . . . 0.0 109.985 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.426 ' N ' ' HD1' ' A' ' 100' ' ' HIS . . . -40.63 -58.57 2.54 Favored Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 103' ' ' LEU . 14.0 tptp -55.8 -66.09 0.48 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.037 -0.582 . . . . 0.0 110.249 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.45 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.98 -59.84 0.8 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.275 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.481 ' CD2' ' CZ3' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -46.06 -47.72 17.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.577 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -59.91 -30.13 68.83 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.998 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.481 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 3.9 ttm -77.81 -48.53 16.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.723 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.4 m -75.98 -24.87 16.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.674 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 40.87 37.18 1.29 Allowed Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.36 -158.17 0.63 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.221 0.534 . . . . 0.0 111.63 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.47 -170.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.96 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -67.34 117.21 9.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.995 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.454 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.7 OUTLIER -119.55 155.74 54.06 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.023 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -47.43 106.01 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.529 1.486 . . . . 0.0 112.335 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.454 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.8 mt -119.8 128.56 75.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 10.1 tpt -127.25 116.83 21.18 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.789 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 mt -96.02 97.25 9.45 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.5 t -103.72 133.19 48.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 122.406 1.098 . . . . 0.0 110.371 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.79 113.07 4.11 Favored Glycine 0 C--N 1.299 -1.509 0 CA-C-N 113.265 -1.789 . . . . 0.0 109.032 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.534 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 48.5 t30 -96.88 177.22 5.7 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.279 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.534 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 26.8 mttp 61.96 58.35 1.92 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.016 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.46 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 15.7 tttm -63.48 -31.27 72.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.495 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -63.58 -8.92 11.03 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.003 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 125' ' ' MET . 8.6 mp -93.67 -27.0 16.8 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.59 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.1 OUTLIER -39.3 -24.47 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.858 178.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.59 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 2.7 mmt -46.12 -22.27 0.21 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.502 ' CD ' ' HG1' ' A' ' 88' ' ' THR . 0.3 OUTLIER -106.67 -36.54 6.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.063 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.492 ' NH2' ' CD2' ' A' ' 131' ' ' TYR . 0.1 OUTLIER 33.11 88.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.851 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.6 t -72.05 -38.05 62.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.553 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 tp -89.92 155.63 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.427 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.467 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 62.0 p -103.03 125.44 49.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.949 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.492 ' CD2' ' NH2' ' A' ' 127' ' ' ARG . 0.8 OUTLIER -37.32 -35.91 0.13 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.574 179.13 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.6 mp0 -67.16 -64.75 0.79 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.054 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.467 ' H ' ' HG ' ' A' ' 130' ' ' SER . 64.6 mt-10 -41.21 -41.52 1.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.979 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.83 -36.3 65.91 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 132' ' ' GLU . 3.6 ttpp -61.69 -55.15 33.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.048 -0.576 . . . . 0.0 109.587 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.69 70.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.865 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.482 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -66.23 -61.66 1.9 Allowed 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.658 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -53.41 -35.78 60.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.34 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -68.85 -29.94 68.37 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.43 -46.65 82.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.715 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.482 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 33.0 m95 -89.35 -4.25 58.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.027 0.442 . . . . 0.0 110.194 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.409 ' O ' ' OE1' ' A' ' 166' ' ' GLU . 0.9 OUTLIER 76.52 22.46 1.22 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.403 -179.084 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -89.29 170.9 10.18 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.595 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -109.65 134.75 51.59 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.428 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.442 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 7.0 t80 -96.66 122.36 39.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.929 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -133.17 137.7 46.32 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.346 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.456 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 9.1 tt0 -127.38 110.64 13.01 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 36.3 p -136.56 -172.81 3.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.21 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.68 139.57 40.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.716 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.525 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -64.84 -30.97 72.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.287 0.565 . . . . 0.0 109.97 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -79.78 13.65 2.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.029 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -144.19 121.03 11.27 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.745 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 9.5 t-20 -77.59 -54.51 6.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.408 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 153' ' ' ASN . 7.6 tt0 -37.09 -55.33 0.96 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.823 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 60.2 p -57.01 -50.73 71.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.275 0.559 . . . . 0.0 110.158 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -47.68 -59.96 2.9 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.561 0.696 . . . . 0.0 109.574 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.9 t -41.28 -53.35 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.626 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -48.94 -33.1 10.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.733 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 156' ' ' ALA . 10.3 t -76.55 -28.54 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.608 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -68.55 -40.71 80.55 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.727 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.507 ' N ' ' CD1' ' A' ' 160' ' ' PHE . 27.6 ttm-85 -79.6 -50.57 10.48 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.196 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -54.53 -36.92 64.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.226 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 160' ' ' PHE . 11.9 tt -69.01 -58.25 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.322 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.424 ' H ' ' CG2' ' A' ' 163' ' ' ILE . 84.1 mt -46.68 -33.02 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.91 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.25 -64.62 0.87 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.295 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.409 ' OE1' ' O ' ' A' ' 142' ' ' ASN . 3.2 mm-40 -61.21 -26.47 67.75 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.454 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.1 -36.8 73.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.419 ' OE2' ' OH ' ' A' ' 54' ' ' TYR . 11.5 mm-40 -69.73 -52.06 28.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.273 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -54.59 -60.22 3.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.515 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 71.2 mt -50.0 -35.2 10.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.764 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.17 -39.92 90.13 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -60.4 -32.13 76.37 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.0 -76.59 0.09 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.168 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.061 179.871 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GDP . . . . . 0.506 ' H8 ' ' OG ' ' A' ' 21' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 121.166 0.508 . . . . 0.0 110.369 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.8 135.73 33.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.579 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -107.58 128.33 54.43 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 1.0 OUTLIER -101.97 121.66 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-O 121.535 0.684 . . . . 0.0 110.351 -178.469 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.99 135.55 34.4 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 121.426 -0.796 . . . . 0.0 111.062 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.8 mt -95.57 131.39 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.458 0.647 . . . . 0.0 112.226 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.412 ' C ' ' CD2' ' A' ' 12' ' ' LEU . 6.3 tt -130.58 103.67 6.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.215 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.08 135.32 6.84 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.734 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.478 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -53.72 -160.82 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.366 0.603 . . . . 0.0 110.535 179.168 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.404 ' NE ' ' OG ' ' A' ' 16' ' ' SER . 10.1 ttp180 -96.14 135.94 37.27 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.86 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.502 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 5.1 m 60.08 19.34 8.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.574 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.434 ' C ' ' NZ ' ' A' ' 120' ' ' LYS . 3.6 p -76.69 -19.75 14.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.737 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.34 21.63 26.67 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.531 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.7 pttm -68.17 -33.97 75.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.928 0.394 . . . . 0.0 110.016 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.7 m -73.16 -38.75 66.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.532 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.8 p -62.16 -40.4 95.86 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.402 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.7 tp -77.75 -25.44 49.17 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.26 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.4 m -63.67 -38.24 90.39 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.4 mp -74.92 -38.54 43.69 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.214 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.56 ' OE1' ' N ' ' A' ' 31' ' ' PHE . 5.9 tt0 -75.04 -25.48 58.72 Favored 'General case' 0 C--O 1.217 -0.618 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.154 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 23.1 t80 -76.59 -52.82 8.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.29 0.567 . . . . 0.0 110.766 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 11.3 p -62.28 -45.96 97.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.906 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.419 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 1.1 tm-20 -82.22 -24.54 34.81 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.466 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 77.24 18.01 78.79 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.799 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -146.68 134.19 20.89 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.56 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 0.6 OUTLIER -68.57 93.8 0.53 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.47 178.116 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.467 ' CG2' ' N ' ' A' ' 33' ' ' ASP . 12.3 p -109.07 166.15 4.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.12 0.486 . . . . 0.0 110.586 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.488 ' C ' ' HG ' ' A' ' 34' ' ' SER . 0.2 OUTLIER -61.94 -12.17 16.93 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.135 -179.229 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.488 ' HG ' ' C ' ' A' ' 33' ' ' ASP . 52.7 p 49.1 177.03 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.03 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -150.91 0.33 0.4 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.781 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 37' ' ' PRO . 9.5 m-20 -118.86 87.12 32.43 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.853 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 36' ' ' ASP . 67.7 Cg_exo -54.11 -129.44 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.867 2.378 . . . . 0.0 112.32 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.0 t -78.45 38.63 0.31 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.223 0.535 . . . . 0.0 110.914 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.45 ' H ' ' C ' ' A' ' 37' ' ' PRO . 1.5 tp -84.12 143.83 11.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.013 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.428 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 2.3 pm0 -91.94 144.03 25.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.381 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER 176.44 179.79 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.332 0.587 . . . . 0.0 111.962 -179.31 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.408 ' H ' ' HG1' ' A' ' 42' ' ' THR . 0.2 OUTLIER -107.69 140.49 40.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.666 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.418 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 12.1 m-85 -127.9 163.53 24.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.638 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.6 155.8 44.39 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.295 0.569 . . . . 0.0 112.363 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -160.97 111.68 1.76 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.899 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.1 mp -105.1 127.1 52.74 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.793 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -148.85 165.6 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.5 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.2 m -114.66 126.51 54.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.557 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.458 ' C ' ' H ' ' A' ' 51' ' ' GLY . 7.4 p -123.4 135.04 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.842 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 m120 62.6 3.97 1.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.029 0.442 . . . . 0.0 109.829 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 102.69 -13.23 56.52 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.423 ' NE2' ' H ' ' A' ' 53' ' ' GLU . 43.9 tp60 -90.29 140.37 29.76 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.423 ' H ' ' NE2' ' A' ' 52' ' ' GLN . 3.4 mt-10 -77.09 147.23 36.77 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.525 0.679 . . . . 0.0 111.303 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.542 ' C ' ' HD1' ' A' ' 55' ' ' HIS . 13.9 m-85 -139.76 123.04 17.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.799 -1.092 . . . . 0.0 109.911 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.542 ' HD1' ' C ' ' A' ' 54' ' ' TYR . 0.7 OUTLIER -117.48 113.79 22.54 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mp -118.84 145.9 45.3 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.641 0.734 . . . . 0.0 112.143 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -139.18 124.09 18.74 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.053 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.633 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.96 154.99 29.9 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.279 0.561 . . . . 0.0 112.463 -178.248 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.96 144.41 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.779 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.35 104.37 8.14 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.831 177.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.37 166.57 11.53 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.128 0.489 . . . . 0.0 110.511 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 63' ' ' GLY . . . -135.68 29.46 3.21 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.857 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 62' ' ' ALA . . . -30.35 -63.6 0.17 Allowed Glycine 0 CA--C 1.528 0.899 0 O-C-N 123.84 0.712 . . . . 0.0 111.421 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -144.51 -93.16 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.607 0.717 . . . . 0.0 110.208 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 68' ' ' SER . 3.9 p30 -77.0 -172.07 2.21 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.963 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.542 ' O ' ' CB ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -63.77 46.98 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.385 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.542 ' CB ' ' O ' ' A' ' 66' ' ' GLU . 10.9 t80 91.5 69.2 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.103 0 O-C-N 124.003 0.815 . . . . 0.0 109.888 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.564 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.7 OUTLIER -61.03 147.82 42.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.065 -178.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.608 ' CG2' ' H ' ' A' ' 70' ' ' PHE . 18.1 mm -98.06 -132.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.082 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.608 ' H ' ' CG2' ' A' ' 69' ' ' ILE . 0.2 OUTLIER 61.67 127.84 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.499 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.435 ' O ' ' O ' ' A' ' 70' ' ' PHE . 77.3 Cg_exo -42.25 171.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.004 1.802 . . . . 0.0 112.745 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 65.73 -51.71 0.38 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.764 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.9 m -40.85 -60.13 1.25 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.586 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.1 95.24 3.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.417 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.434 ' H ' ' HG ' ' A' ' 75' ' ' SER . 12.6 p -83.62 51.51 2.03 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.436 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -81.99 175.68 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.426 0.631 . . . . 0.0 111.703 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 6.3 p-10 -145.54 48.0 1.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.263 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 40.6 pt -81.33 -172.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.822 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.24 16.33 0.93 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.144 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.02 166.47 28.91 Favored Glycine 0 CA--C 1.516 0.152 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.73 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.518 ' OH ' ' CD1' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -151.98 123.17 7.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.711 -0.744 . . . . 0.0 111.481 178.193 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 10.8 tt -127.07 104.24 12.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.628 0.728 . . . . 0.0 109.064 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.603 ' H ' ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.32 123.29 41.09 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.784 -178.332 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -96.65 118.13 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.468 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.556 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 27.9 p90 -120.28 144.52 47.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.581 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.682 ' HG ' ' H ' ' A' ' 89' ' ' SER . 4.8 p -87.89 142.15 28.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.499 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.5 m -76.15 18.7 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.245 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.605 ' H ' ' HG ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -133.18 -23.38 1.94 Allowed 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.063 0.459 . . . . 0.0 111.752 -178.342 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.682 ' H ' ' HG ' ' A' ' 86' ' ' SER . 22.7 t -93.71 93.47 8.03 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.96 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 tp -59.69 -11.76 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.54 ' N ' ' C ' ' A' ' 89' ' ' SER . 9.3 mttp -78.07 -51.23 10.62 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.458 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.463 ' HG ' ' N ' ' A' ' 93' ' ' PHE . 83.0 p -56.48 -34.91 67.37 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.374 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.556 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.5 OUTLIER -70.8 -54.85 10.09 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.415 -179.278 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -63.0 -44.41 96.1 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.7 m -64.79 -34.4 69.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.034 -0.667 . . . . 0.0 110.186 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.8 mt -65.2 -35.61 75.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.087 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.0 tttp -69.97 -27.56 64.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.546 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.8 t -76.95 -67.27 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.281 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.6 mp -43.41 -45.31 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.4 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.402 ' CE1' ' CE2' ' A' ' 141' ' ' TRP . 6.6 t-80 -60.09 -58.36 8.88 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.504 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.68 -57.7 1.52 Allowed Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.866 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 105' ' ' ASP . 10.9 tptm -58.68 -66.65 0.46 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.274 -0.463 . . . . 0.0 110.574 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 106' ' ' MET . 0.7 OUTLIER -37.05 -62.25 0.51 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.479 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -42.86 -47.92 5.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.359 178.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -62.57 -30.66 71.48 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.258 -179.353 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 103' ' ' LEU . 58.8 ttp -75.86 -47.28 26.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.723 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.6 m -75.39 -26.62 18.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.482 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 40.61 35.79 0.92 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.09 -157.93 0.64 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.281 0.563 . . . . 0.0 111.806 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.05 -167.54 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.158 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -66.6 116.43 7.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.896 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.43 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -112.81 150.36 42.67 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.408 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -48.55 107.54 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.707 1.604 . . . . 0.0 112.857 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.43 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.9 mt -120.61 126.5 75.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 8.3 tpt -126.47 115.28 19.33 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.237 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.3 mt -96.02 97.82 9.89 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.58 132.56 49.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 122.135 0.969 . . . . 0.0 110.574 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.75 109.47 3.2 Favored Glycine 0 C--N 1.304 -1.239 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.517 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.6 t30 -97.24 175.62 6.21 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.182 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.517 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 2.9 mttp 66.25 59.54 0.66 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 122.026 0.917 . . . . 0.0 109.291 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.509 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 19.2 tttm -63.77 -37.88 89.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.053 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.606 ' CG ' HN22 ' A' ' 186' ' ' GDP . 5.0 p-10 -60.45 -5.61 1.25 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.783 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 125' ' ' MET . 8.2 mp -91.95 -26.88 18.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.509 ' ND1' ' O ' ' A' ' 121' ' ' LYS . 13.2 p-80 -38.97 -24.97 0.01 OUTLIER 'General case' 0 C--N 1.339 0.124 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.719 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.536 ' N ' ' O ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -46.51 -22.89 0.31 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.293 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.479 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -110.38 -37.55 5.48 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.666 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.474 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 0.1 OUTLIER 29.65 91.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.886 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 46.1 t -72.37 -36.75 56.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.193 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.7 tp -89.57 154.74 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.634 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.503 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 99.5 p -101.55 127.24 48.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.742 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -40.63 -34.0 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.988 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -68.51 -65.42 0.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.988 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.503 ' H ' ' HG ' ' A' ' 130' ' ' SER . 63.6 mt-10 -41.38 -41.61 2.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.933 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.06 -34.7 64.72 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 132' ' ' GLU . 3.2 tttm -63.96 -55.27 23.72 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.28 -35.34 67.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.68 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.444 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -65.54 -62.09 1.72 Allowed 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -53.12 -38.41 62.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.226 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -33.28 75.51 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.736 0.303 . . . . 0.0 110.245 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.8 -46.11 86.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.828 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.444 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 42.2 m95 -89.09 1.04 56.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.695 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 6.5 m120 68.38 32.92 4.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.652 0.739 . . . . 0.0 109.58 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -100.84 169.04 9.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.862 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.14 133.79 51.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.305 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.447 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 5.2 t80 -96.9 123.39 40.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.814 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -134.74 137.14 43.2 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.862 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.474 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 6.2 tt0 -126.39 111.17 14.16 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 34.7 p -137.15 -173.85 3.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.134 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.0 136.09 34.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.919 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.517 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -63.79 -26.73 68.76 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.25 4.37 12.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.723 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -138.85 122.6 17.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.11 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 154' ' ' GLN . 4.8 t-20 -77.42 -55.48 5.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.614 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 153' ' ' ASN . 10.2 tt0 -36.91 -56.03 0.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.96 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 67.6 p -55.59 -46.12 77.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.021 0.439 . . . . 0.0 110.297 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -54.53 -62.08 1.89 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.952 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 61.5 t -43.0 -39.94 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.435 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.77 -33.11 75.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.59 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 156' ' ' ALA . 32.4 t -70.72 -35.38 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.954 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -64.32 -65.69 0.64 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.561 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.1 ttm-85 -48.41 -43.33 34.03 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.759 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -58.51 -33.37 69.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.456 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.27 -34.29 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.917 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.4 ' O ' ' CB ' ' A' ' 167' ' ' ALA . 11.1 mt -63.5 -48.18 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.267 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -55.47 -59.93 4.13 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.552 179.609 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.466 ' O ' ' CG1' ' A' ' 170' ' ' ILE . 4.5 tt0 -51.31 -24.03 4.2 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 164' ' ' ILE . . . -71.34 -31.14 67.03 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.935 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 165' ' ' LEU . 0.4 OUTLIER -70.74 -54.72 10.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.886 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -60.05 -50.23 74.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.068 0.461 . . . . 0.0 110.565 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.466 ' CG1' ' O ' ' A' ' 166' ' ' GLU . 3.1 mm -49.64 -42.98 18.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.966 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -66.29 -39.76 89.57 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.339 -179.579 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.37 -41.94 55.91 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.14 -79.88 0.06 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.754 0.312 . . . . 0.0 110.474 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.022 -179.904 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GDP . . . . . 0.606 HN22 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.171 0.51 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.97 135.64 32.96 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.647 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -107.21 128.53 54.5 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 1.0 OUTLIER -102.3 122.97 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 121.507 0.67 . . . . 0.0 110.469 -178.511 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.405 ' O ' HG21 ' A' ' 82' ' ' ILE . . . -83.9 134.27 34.69 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.373 -0.83 . . . . 0.0 111.606 -177.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.6 mt -95.44 130.16 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.523 0.678 . . . . 0.0 112.14 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.416 ' C ' ' CD2' ' A' ' 12' ' ' LEU . 5.1 tt -127.91 102.55 6.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.54 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.12 136.45 7.53 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.485 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -51.94 -161.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.676 0.751 . . . . 0.0 111.321 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -94.14 131.79 39.32 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.666 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.474 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 4.1 m 60.54 20.09 9.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.472 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 p -74.7 -19.59 16.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.606 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.452 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 98.13 20.17 21.56 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.472 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.519 ' HZ3' ' PB ' ' A' ' 186' ' ' GDP . 15.1 pttm -69.2 -34.81 75.48 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.318 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.9 m -73.45 -30.39 63.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.419 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.465 ' OG ' ' N7 ' ' A' ' 186' ' ' GDP . 65.5 p -67.8 -40.86 83.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.409 ' O ' ' CB ' ' A' ' 26' ' ' PHE . 46.1 tp -77.5 -26.49 51.27 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.759 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.5 m -62.77 -41.51 99.27 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.59 -41.6 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.606 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.499 ' OE1' ' CB ' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -71.88 -27.29 62.76 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.663 -179.42 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.409 ' CB ' ' O ' ' A' ' 22' ' ' LEU . 52.8 t80 -77.94 -62.05 1.8 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.303 0.573 . . . . 0.0 110.691 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.445 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 11.8 p -48.09 -48.9 12.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.804 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.445 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 2.4 mt-10 -80.42 -24.3 39.74 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.451 ' O ' ' ND2' ' A' ' 153' ' ' ASN . . . 72.76 25.47 73.86 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -150.29 126.63 10.73 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.732 0.301 . . . . 0.0 111.338 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.614 ' O ' ' CD1' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -64.96 91.85 0.1 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 122.02 0.915 . . . . 0.0 110.691 178.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.411 ' CG2' ' N ' ' A' ' 33' ' ' ASP . 11.4 p -109.2 166.34 4.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.838 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -74.36 -41.52 60.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.958 -179.687 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 33' ' ' ASP . 4.2 p 43.5 -170.16 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.961 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -149.9 52.68 0.92 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.453 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 37' ' ' PRO . 9.7 t70 -131.95 81.85 61.31 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.293 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 36' ' ' ASP . 52.1 Cg_exo -57.08 -132.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.869 2.379 . . . . 0.0 111.806 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.4 t -96.25 43.05 1.08 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.167 0.508 . . . . 0.0 111.311 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.544 ' CG2' ' ND2' ' A' ' 41' ' ' ASN . 1.5 tp -84.5 163.64 2.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.901 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -86.5 124.79 33.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.637 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.544 ' ND2' ' CG2' ' A' ' 39' ' ' ILE . 31.7 m-20 -164.19 -176.69 4.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.236 0.541 . . . . 0.0 111.982 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.411 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 4.0 m -133.14 152.77 51.93 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.13 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.455 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 11.9 m-85 -133.17 162.94 30.42 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 111.008 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.61 152.34 43.91 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.537 0.684 . . . . 0.0 112.487 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -157.11 111.01 2.64 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.407 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.531 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 7.2 mp -105.2 127.28 52.85 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.491 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.61 165.13 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.708 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.4 m -114.61 126.67 55.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.924 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.95 123.35 65.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.819 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 70.95 19.79 5.56 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.91 -9.77 62.09 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -90.91 134.93 34.08 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.01 145.5 40.19 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.561 0.696 . . . . 0.0 111.058 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.459 ' C ' ' HD1' ' A' ' 55' ' ' HIS . 9.3 m-85 -139.44 125.14 19.47 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.778 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.459 ' HD1' ' C ' ' A' ' 54' ' ' TYR . 1.2 m-70 -117.44 113.65 22.36 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.47 ' CD2' ' N ' ' A' ' 56' ' ' LEU . 2.1 mm? -119.23 140.0 50.95 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 121.509 0.671 . . . . 0.0 111.629 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -136.76 124.98 23.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.777 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.645 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.13 148.86 39.87 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.916 -178.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -118.49 141.5 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 114.998 -1.001 . . . . 0.0 113.165 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -114.42 101.65 9.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.333 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.531 ' OG1' ' CZ ' ' A' ' 74' ' ' TYR . 0.9 OUTLIER -149.32 156.74 42.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.473 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 64' ' ' GLN . . . -126.03 7.72 7.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.007 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 62' ' ' ALA . . . 33.78 -94.2 0.01 OUTLIER Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.507 ' H ' ' HG ' ' A' ' 68' ' ' SER . 0.0 OUTLIER -115.25 -54.33 2.55 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.757 0.789 . . . . 0.0 109.547 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.636 ' O ' ' N ' ' A' ' 67' ' ' TYR . 2.1 p30 -112.16 -172.94 2.14 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.045 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.54 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -28.84 -30.7 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.144 0 O-C-N 123.591 0.557 . . . . 0.0 111.222 -178.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.636 ' N ' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -170.36 1.08 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.929 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.617 ' HG ' ' H ' ' A' ' 65' ' ' ASP . 2.2 m 54.48 98.3 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.89 -35.25 63.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-O 121.423 0.63 . . . . 0.0 109.45 178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.89 152.78 59.82 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.723 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -42.44 144.61 1.17 Allowed 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.346 2.031 . . . . 0.0 112.335 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -173.82 -73.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.605 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.9 m -153.73 16.05 0.51 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.205 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.531 ' CZ ' ' OG1' ' A' ' 61' ' ' THR . 0.2 OUTLIER -113.98 28.99 8.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.356 -179.142 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.5 p -78.95 22.49 0.38 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.229 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.04 -173.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 111.146 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.69 52.42 1.88 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.378 0.608 . . . . 0.0 109.363 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 35.7 pt -77.44 -172.5 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.723 -178.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.41 14.27 0.98 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.578 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -142.29 165.79 26.59 Favored Glycine 0 N--CA 1.454 -0.114 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.179 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.556 ' OH ' ' CE1' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -151.82 122.41 7.4 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.767 -0.717 . . . . 0.0 111.205 178.27 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.405 HG21 ' O ' ' A' ' 10' ' ' ALA . 11.3 tt -125.28 103.83 12.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.616 ' H ' ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -96.32 126.73 41.73 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.407 -177.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 t -96.07 113.68 31.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.43 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -110.37 146.05 36.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.734 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.717 ' HG ' ' H ' ' A' ' 88' ' ' THR . 1.0 OUTLIER -100.55 143.48 30.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.077 0.465 . . . . 0.0 111.881 -177.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.3 m -81.15 21.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.633 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.717 ' H ' ' HG ' ' A' ' 86' ' ' SER . 1.0 OUTLIER -140.55 -17.76 0.88 Allowed 'General case' 0 C--O 1.231 0.097 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.541 ' C ' ' N ' ' A' ' 91' ' ' LYS . 43.8 t -112.7 93.46 4.44 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.41 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 30.5 mm -50.84 -15.6 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.541 ' N ' ' C ' ' A' ' 89' ' ' SER . 0.4 OUTLIER -78.31 -49.14 14.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.244 179.287 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.592 ' HG ' ' H ' ' A' ' 86' ' ' SER . 85.7 p -59.74 -44.6 93.74 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.517 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -79.3 -34.02 42.79 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 119.354 -0.939 . . . . 0.0 112.533 -178.126 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.41 ' CG ' ' O ' ' A' ' 90' ' ' ILE . 8.9 mm-40 -69.84 -44.98 68.8 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.15 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 91' ' ' LYS . 28.1 m -64.99 -37.37 80.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.645 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.428 HG22 HD13 ' A' ' 96' ' ' ILE . 1.3 mt -61.74 -36.03 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -70.1 -25.79 63.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.333 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.5 t -76.1 -67.22 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.5 mp -42.81 -40.68 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.616 ' NE2' ' CD1' ' A' ' 141' ' ' TRP . 25.7 t-80 -60.32 -63.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.673 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.82 -50.6 2.0 Favored Glycine 0 CA--C 1.518 0.267 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 105' ' ' ASP . 12.7 tptm -66.03 -65.79 0.63 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.273 -0.464 . . . . 0.0 110.106 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.36 -58.75 0.81 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.496 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -47.0 -43.82 19.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.677 178.737 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -62.36 -34.25 76.33 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.374 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.517 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 12.6 ttm -61.57 -55.9 25.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.99 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.511 ' C ' ' H ' ' A' ' 109' ' ' LYS . 18.1 m -77.28 -12.9 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.16 0.505 . . . . 0.0 110.249 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.16 -25.23 0.16 Allowed Glycine 0 CA--C 1.53 1.01 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.949 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.599 ' CG ' ' H ' ' A' ' 110' ' ' VAL . 3.4 tptt -173.92 -128.82 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 117.803 0.802 . . . . 0.0 112.016 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.599 ' H ' ' CG ' ' A' ' 109' ' ' LYS . 6.6 t 52.09 116.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.757 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -77.81 124.76 28.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.891 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.06 155.78 80.92 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -48.69 107.43 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.689 1.593 . . . . 0.0 112.174 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.6 mt -123.84 129.18 74.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 8.7 tpt -128.85 117.42 21.01 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.329 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.1 mt -97.34 97.59 9.26 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.7 t -104.45 134.22 46.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 122.196 0.998 . . . . 0.0 110.958 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -104.88 116.44 5.29 Favored Glycine 0 C--N 1.302 -1.313 0 CA-C-N 113.699 -1.592 . . . . 0.0 109.234 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.522 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 50.1 t30 -98.0 173.87 6.84 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.718 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.522 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 25.5 mttt 61.17 58.67 2.16 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.624 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.527 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -60.2 -35.24 74.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.282 -179.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.622 ' CG ' HN22 ' A' ' 186' ' ' GDP . 5.1 p-10 -61.15 -13.63 19.11 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.488 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 125' ' ' MET . 9.8 mp -88.1 -31.37 19.25 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.527 ' ND1' ' O ' ' A' ' 121' ' ' LYS . 2.5 p-80 -37.67 -26.46 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.976 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.536 ' N ' ' O ' ' A' ' 123' ' ' LEU . 6.9 mmt -43.93 -24.64 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.454 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.3 OUTLIER -103.23 -34.94 8.63 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.815 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.458 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 1.6 tpt180 38.39 92.82 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.23 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.6 m -85.4 -35.43 9.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.312 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.48 130.0 39.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.523 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 92.4 p -77.1 122.19 24.62 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.946 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -40.56 -38.38 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.322 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -60.98 -64.21 1.03 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.011 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.523 ' H ' ' HG ' ' A' ' 130' ' ' SER . 64.2 mt-10 -41.11 -49.91 3.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.179 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.33 -25.72 74.56 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 132' ' ' GLU . 13.1 tttm -71.26 -55.98 6.98 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -55.95 -33.01 64.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.296 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.621 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -66.53 -62.97 1.18 Allowed 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.807 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -53.65 -36.89 62.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.312 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -69.56 -30.29 68.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.474 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.637 ' HG ' ' N ' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -63.63 -47.15 82.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.02 -178.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.637 ' N ' ' HG ' ' A' ' 140' ' ' SER . 8.4 m95 -91.52 -5.27 54.41 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.355 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 141' ' ' TRP . 0.9 OUTLIER 77.45 26.01 0.71 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.779 -179.271 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.45 170.11 11.19 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.218 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.19 133.39 50.03 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.906 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.451 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 6.5 t80 -97.06 122.96 40.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.767 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -133.12 138.81 46.8 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.939 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.458 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 4.9 tt0 -127.5 110.01 12.31 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.434 ' CB ' ' OG1' ' A' ' 155' ' ' THR . 0.1 OUTLIER -136.37 -178.38 5.14 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.676 -178.014 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.482 ' HG ' ' HZ1' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -138.77 132.79 31.24 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.39 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.513 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -54.41 -53.07 59.0 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.112 0.482 . . . . 0.0 109.843 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -51.28 -8.74 0.05 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.938 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.513 ' H ' ' C ' ' A' ' 150' ' ' ALA . 18.7 mt-10 -131.4 119.2 21.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.978 0.418 . . . . 0.0 110.657 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 10.2 t-20 -75.35 -48.25 23.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.195 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 153' ' ' ASN . 0.5 OUTLIER -36.71 -59.48 0.67 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.023 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.434 ' OG1' ' CB ' ' A' ' 148' ' ' SER . 1.5 p -54.43 -46.64 73.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.169 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.499 ' CB ' ' OE1' ' A' ' 25' ' ' GLN . . . -51.45 -59.4 4.28 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.524 0.678 . . . . 0.0 109.584 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 50.5 t -42.36 -48.43 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.67 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -54.02 -33.07 56.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.525 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 156' ' ' ALA . 11.6 t -77.06 -27.67 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.982 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.44 ' O ' HG22 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -68.64 -41.63 79.13 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.5 179.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.7 ttm-85 -79.86 -49.98 11.16 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.961 -0.695 . . . . 0.0 110.928 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -53.47 -37.88 63.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.31 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 160' ' ' PHE . 13.0 tt -68.39 -56.7 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.403 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.406 ' N ' ' CG2' ' A' ' 163' ' ' ILE . 84.7 mt -47.9 -33.87 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.975 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.8 -64.42 0.95 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.059 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -58.53 -28.57 65.59 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.532 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.56 -33.53 71.53 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.404 ' OE1' ' OH ' ' A' ' 54' ' ' TYR . 33.5 tp10 -68.73 -57.15 6.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.329 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 13.2 tttm -52.49 -56.72 13.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.636 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 66.3 mt -52.84 -34.2 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.137 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 172' ' ' GLY . 0.0 OUTLIER -68.9 -40.45 79.14 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.611 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.414 ' N ' ' OD1' ' A' ' 171' ' ' ASP . . . -60.3 -35.83 89.3 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.07 -60.77 2.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.803 0.335 . . . . 0.0 110.494 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.792 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GDP . . . . . 0.622 HN22 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 121.174 0.512 . . . . 0.0 110.445 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.84 136.39 33.95 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.611 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -106.66 121.28 44.03 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -98.95 117.2 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-O 121.824 0.821 . . . . 0.0 110.027 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.433 ' HB1' ' CE1' ' A' ' 81' ' ' TYR . . . -83.82 136.23 34.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.096 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.5 mt -95.27 132.81 38.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.23 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.423 ' C ' ' CD2' ' A' ' 12' ' ' LEU . 6.3 tt -127.65 104.05 7.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.392 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.39 134.87 6.51 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.691 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.446 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -55.05 -159.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.3 0.571 . . . . 0.0 110.582 179.187 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -92.61 133.28 36.12 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.952 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.513 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 7.7 m 56.58 19.46 4.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.546 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 p -69.85 -27.34 32.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.794 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.448 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 105.1 23.51 7.67 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.418 ' CE ' ' OD2' ' A' ' 60' ' ' ASP . 3.5 pttm -71.18 -33.59 70.13 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.356 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.2 m -75.75 -30.92 59.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.156 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.453 ' OG ' ' N7 ' ' A' ' 186' ' ' GDP . 72.4 p -65.28 -54.15 33.53 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.056 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 23' ' ' THR . 24.7 tp -62.91 -52.06 64.53 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.731 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.442 ' C ' ' O ' ' A' ' 22' ' ' LEU . 9.2 m -36.47 -64.12 0.35 Allowed 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 122.976 0.172 . . . . 0.0 110.774 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -57.45 -41.72 79.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.144 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 30' ' ' GLN . 0.6 OUTLIER -66.99 -35.92 81.03 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.263 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.494 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.6 OUTLIER -77.54 -62.81 1.54 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.369 0.604 . . . . 0.0 110.705 -179.636 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.486 ' N ' ' CG ' ' A' ' 26' ' ' PHE . 9.1 p -44.77 -49.29 2.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.488 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.475 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 0.8 OUTLIER -79.78 -24.54 41.4 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.081 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 74.96 26.66 66.21 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.784 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 31' ' ' PHE . 10.6 tp60 -147.91 125.89 12.04 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.895 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.528 ' O ' ' NE2' ' A' ' 30' ' ' GLN . 1.2 t80 -66.76 96.37 0.4 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.606 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.556 ' C ' ' H ' ' A' ' 34' ' ' SER . 13.4 p -99.25 166.94 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.18 0.514 . . . . 0.0 110.768 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.465 ' N ' ' CG2' ' A' ' 32' ' ' VAL . 0.4 OUTLIER -64.18 12.5 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.018 -178.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.556 ' H ' ' C ' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -39.48 115.12 0.47 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.85 0.357 . . . . 0.0 110.792 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -151.48 85.02 1.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.592 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -133.48 176.63 2.76 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.054 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 36' ' ' ASP . 42.3 Cg_exo -57.31 -138.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.575 2.183 . . . . 0.0 111.371 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.443 ' O ' ' CG2' ' A' ' 38' ' ' THR . 11.0 t -130.34 61.8 1.59 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.867 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 tp -83.2 147.06 6.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.075 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 2.6 pt-20 -88.11 152.29 22.11 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.045 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 1.4 m120 -177.47 174.48 1.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.235 0.541 . . . . 0.0 112.072 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.31 146.48 32.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.699 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.458 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 7.2 m-85 -131.7 164.16 26.55 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.318 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.84 156.67 42.96 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.328 0.585 . . . . 0.0 112.071 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -160.15 111.36 1.93 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.698 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mp -104.81 121.01 42.75 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.943 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.1 pp -147.72 165.16 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.595 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -111.82 127.97 55.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.99 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.43 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 2.5 p -128.16 124.86 63.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.526 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 49' ' ' VAL . 1.9 t-20 73.23 10.71 5.11 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.19 -11.87 71.04 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -91.21 137.84 32.06 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -76.4 146.06 38.94 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.578 0.704 . . . . 0.0 111.023 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.504 ' C ' ' HD1' ' A' ' 55' ' ' HIS . 8.2 m-85 -135.87 126.78 27.62 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.459 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.504 ' HD1' ' C ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -117.52 113.73 22.43 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.415 ' CD2' ' N ' ' A' ' 56' ' ' LEU . 2.9 mm? -119.39 138.61 52.97 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 121.356 0.598 . . . . 0.0 111.356 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -126.99 127.3 44.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.087 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 3.4 mp -114.43 154.83 27.45 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.098 0.475 . . . . 0.0 112.182 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.12 143.99 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 CA-C-O 122.035 0.921 . . . . 0.0 112.72 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.425 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -125.26 105.14 8.9 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.189 -1.369 . . . . 0.0 107.893 177.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.46 ' H ' ' HG1' ' A' ' 61' ' ' THR . 0.8 OUTLIER -99.34 153.63 18.82 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.51 -178.086 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.32 8.91 3.43 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.144 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.72 -55.35 25.8 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -112.02 -139.1 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.386 0.612 . . . . 0.0 110.818 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -74.95 -175.96 2.75 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.927 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.439 ' N ' ' CG ' ' A' ' 65' ' ' ASP . 0.9 OUTLIER -33.9 -31.9 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.252 0.549 . . . . 0.0 109.797 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.605 ' CG ' ' O ' ' A' ' 67' ' ' TYR . 2.9 t80 166.8 82.93 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.423 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.52 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 1.4 m -67.71 123.79 21.49 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.977 -178.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.591 ' CD1' ' CE2' ' A' ' 67' ' ' TYR . 6.5 mm -62.08 -131.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.56 ' H ' ' CG2' ' A' ' 69' ' ' ILE . 40.7 t80 41.42 80.83 0.26 Allowed Pre-proline 0 C--N 1.331 -0.223 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.603 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.462 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 47.1 Cg_exo -52.28 -161.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.674 2.249 . . . . 0.0 112.434 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.462 ' CB ' ' O ' ' A' ' 71' ' ' PRO . 1.1 tt0 81.02 -35.21 0.11 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.269 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.421 ' H ' ' C ' ' A' ' 71' ' ' PRO . 17.5 m -101.46 -20.67 15.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.255 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -94.66 -28.85 15.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.564 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.6 t 49.32 49.48 19.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.915 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.455 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 0.9 OUTLIER -77.55 -97.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 120.839 0.352 . . . . 0.0 110.906 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 3.0 m-20 87.11 33.57 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 37.8 pt -83.95 -169.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 CA-C-N 114.51 -1.223 . . . . 0.0 112.554 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.68 13.73 1.19 Allowed 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.41 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.24 163.29 28.92 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.487 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.55 ' OH ' ' CD2' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -151.45 123.46 8.15 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.787 -0.706 . . . . 0.0 111.094 177.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.5 tt -126.93 106.81 16.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.661 0.743 . . . . 0.0 109.146 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.32 122.5 40.42 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.459 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 t -97.04 114.53 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.456 ' CZ ' ' CA ' ' A' ' 118' ' ' GLY . 26.2 p90 -115.4 144.58 43.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.704 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.668 ' HG ' ' H ' ' A' ' 88' ' ' THR . 3.4 p -87.11 141.93 28.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.068 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.2 m -73.7 18.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.639 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.668 ' H ' ' HG ' ' A' ' 86' ' ' SER . 6.4 t -138.91 -22.07 0.96 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.666 ' H ' ' HG ' ' A' ' 86' ' ' SER . 22.9 t -90.83 93.07 9.07 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.201 -176.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.6 tp -59.11 -10.69 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.55 ' H ' ' C ' ' A' ' 89' ' ' SER . 6.9 mttm -77.84 -51.5 10.38 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.18 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.489 ' HG ' ' N ' ' A' ' 93' ' ' PHE . 53.5 p -57.68 -31.74 66.65 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.674 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.489 ' N ' ' HG ' ' A' ' 92' ' ' SER . 0.5 OUTLIER -75.39 -47.66 26.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.89 -179.541 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -63.35 -43.24 98.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.863 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.6 m -67.02 -38.97 82.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.197 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.2 mt -59.4 -38.47 75.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.1 tttp -73.13 -26.63 61.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.836 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 64.0 t -77.37 -67.15 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.985 0.422 . . . . 0.0 110.033 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.5 pp -45.23 -39.78 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.174 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.62 ' NE2' ' CE2' ' A' ' 141' ' ' TRP . 18.3 t60 -62.56 -61.34 2.5 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.235 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 100' ' ' HIS . . . -35.87 -48.68 1.05 Allowed Glycine 0 C--N 1.33 0.25 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 105' ' ' ASP . 1.9 tppt? -68.8 -66.68 0.54 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.429 -0.385 . . . . 0.0 110.03 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.87 -59.1 0.86 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.13 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.481 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -45.9 -45.39 15.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.487 178.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -59.18 -39.02 81.25 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.833 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 5.8 ttm -61.67 -56.65 17.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.816 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.572 ' C ' ' H ' ' A' ' 109' ' ' LYS . 18.5 m -77.07 -12.55 14.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.035 0.445 . . . . 0.0 110.773 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.04 -25.11 0.06 OUTLIER Glycine 0 CA--C 1.534 1.228 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.891 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.572 ' H ' ' C ' ' A' ' 107' ' ' VAL . 3.9 tttm -174.27 -126.63 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.758 0.779 . . . . 0.0 111.482 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.491 ' H ' ' CG ' ' A' ' 109' ' ' LYS . 6.4 t 52.06 118.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.886 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -77.27 137.52 38.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.97 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.476 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.4 OUTLIER -143.35 151.21 54.22 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.775 179.329 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -48.29 111.82 0.5 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.763 1.642 . . . . 0.0 112.407 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.476 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.8 mt -126.86 132.41 70.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.7 tpt -130.85 114.69 15.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.951 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.1 mt -96.74 98.13 9.91 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.2 t -105.03 130.79 55.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 122.153 0.978 . . . . 0.0 111.395 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.456 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -97.83 114.78 5.09 Favored Glycine 0 C--N 1.307 -1.043 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.522 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.9 t30 -97.49 173.99 6.89 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.025 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.522 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 23.2 mttt 60.4 58.87 2.42 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.712 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.498 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 17.3 tttm -60.48 -32.6 71.58 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.611 ' CG ' HN22 ' A' ' 186' ' ' GDP . 3.5 p-10 -60.8 -18.05 53.07 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.956 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 125' ' ' MET . 11.0 mp -85.86 -26.39 25.68 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.6 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.1 OUTLIER -40.27 -24.63 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.854 179.094 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.6 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 15.1 mtt -46.72 -22.53 0.31 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.462 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -108.28 -42.5 4.59 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.564 -179.654 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.5 ' NE ' ' OE1' ' A' ' 147' ' ' GLU . 22.6 ttm180 26.44 83.61 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.868 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.5 m -62.91 -28.84 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.696 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.4 tp -89.54 155.65 3.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.566 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.53 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 57.9 p -97.66 120.51 38.18 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.996 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -39.85 -29.41 0.06 Allowed 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.4 mp0 -70.26 -63.75 1.03 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.895 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.53 ' H ' ' HG ' ' A' ' 130' ' ' SER . 57.7 mt-10 -41.2 -42.25 2.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.742 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.35 -34.89 63.69 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 132' ' ' GLU . 2.9 tttm -62.04 -55.03 33.26 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.02 -36.66 70.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.75 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.627 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -66.13 -62.87 1.25 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.159 0.504 . . . . 0.0 109.692 179.58 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.45 -35.12 51.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.122 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.03 -30.47 67.76 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.41 -46.86 84.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.757 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.627 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 15.0 m95 -90.5 -5.75 55.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.363 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 141' ' ' TRP . 1.1 t-20 78.73 24.8 0.55 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.008 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.31 167.6 13.4 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.712 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.65 128.83 54.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.975 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 5.9 t80 -97.95 121.38 39.79 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.768 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.08 126.4 14.85 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.5 ' OE1' ' NE ' ' A' ' 127' ' ' ARG . 7.8 mt-10 -99.16 117.26 33.24 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.2 p -137.47 -178.69 5.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.658 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 152' ' ' GLU . 0.1 OUTLIER -138.6 138.77 38.21 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.272 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -57.28 -48.0 80.02 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -55.83 -18.4 8.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.128 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 149' ' ' SER . 38.7 mt-10 -113.53 116.13 29.07 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.942 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 154' ' ' GLN . 6.4 t-20 -77.53 -50.34 12.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.78 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 153' ' ' ASN . 5.9 tt0 -39.92 -57.29 1.64 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.428 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 80.5 p -51.88 -44.28 63.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.48 ' CB ' ' OE1' ' A' ' 25' ' ' GLN . . . -55.41 -60.46 3.38 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.458 0.647 . . . . 0.0 109.626 178.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 57.7 t -41.82 -40.39 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.339 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -67.67 -36.57 80.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.623 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.478 ' N ' ' O ' ' A' ' 156' ' ' ALA . 22.0 t -70.29 -34.18 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.523 0.678 . . . . 0.0 109.612 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -66.13 -51.14 60.73 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.015 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.7 ttt85 -66.74 -36.96 83.7 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.223 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -64.28 -33.61 76.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.875 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.436 HG21 ' N ' ' A' ' 164' ' ' ILE . 15.3 tt -70.85 -39.75 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.167 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.436 ' N ' HG21 ' A' ' 163' ' ' ILE . 64.6 mt -62.52 -35.59 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.549 0.69 . . . . 0.0 109.231 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.35 -51.8 66.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.522 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -67.89 -26.48 66.02 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.526 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.07 -34.67 75.27 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.43 ' OE1' ' OH ' ' A' ' 54' ' ' TYR . 9.9 mm-40 -70.44 -55.98 7.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.647 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -54.81 -62.13 1.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.711 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 81.5 mt -52.99 -33.14 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.175 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -69.89 -40.35 75.71 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.752 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -60.71 -36.88 92.59 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.98 -62.81 1.22 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.569 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.722 179.988 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GDP . . . . . 0.611 HN22 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 121.262 0.553 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.05 136.13 33.34 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.984 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.532 ' HZ2' ' NE2' ' A' ' 57' ' ' GLN . 6.5 mttm -109.38 131.36 55.14 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 1.0 OUTLIER -104.1 125.4 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 CA-C-O 121.377 0.608 . . . . 0.0 110.674 -178.067 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.07 133.49 34.64 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.352 -0.843 . . . . 0.0 110.792 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.1 mt -96.58 133.21 38.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.645 0.736 . . . . 0.0 112.361 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.409 ' C ' ' CD2' ' A' ' 12' ' ' LEU . 5.3 tt -125.77 104.01 8.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.114 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -140.16 133.6 6.09 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.64 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.422 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.5 OUTLIER -56.94 -158.51 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.357 0.599 . . . . 0.0 110.605 179.221 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.494 ' HE ' ' HG ' ' A' ' 16' ' ' SER . 11.3 ttp180 -97.02 131.14 44.13 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.334 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.494 ' HG ' ' HE ' ' A' ' 15' ' ' ARG . 1.7 m 64.94 19.0 11.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.568 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.549 ' C ' ' HZ2' ' A' ' 120' ' ' LYS . 4.9 p -80.58 -15.74 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.83 0.348 . . . . 0.0 110.222 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.41 12.24 33.81 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.433 ' O ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -45.22 -52.58 9.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.938 0.399 . . . . 0.0 110.914 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 m -70.69 -26.69 63.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.491 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.492 ' OG ' ' H8 ' ' A' ' 186' ' ' GDP . 60.4 m -68.71 -49.59 57.7 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.989 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 45.9 tp -73.8 -26.32 60.57 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 119.626 -0.829 . . . . 0.0 110.782 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 19' ' ' LYS . 35.1 m -63.38 -41.01 98.77 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -78.2 -37.03 21.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.754 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.64 ' NE2' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -77.06 -27.48 54.37 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.582 -179.131 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -77.22 -53.41 7.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.432 0.634 . . . . 0.0 110.563 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.42 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 14.2 p -58.46 -45.58 89.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.08 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.42 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 2.4 tt0 -82.59 -24.47 33.91 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.515 ' O ' ' ND2' ' A' ' 153' ' ' ASN . . . 71.72 27.5 70.79 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.488 ' CD ' ' N ' ' A' ' 31' ' ' PHE . 1.7 tp-100 -144.41 135.08 24.82 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.136 0.493 . . . . 0.0 111.637 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.64 ' N ' ' NE2' ' A' ' 25' ' ' GLN . 0.7 OUTLIER -73.07 94.46 1.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.917 179.027 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.463 ' CG2' ' N ' ' A' ' 33' ' ' ASP . 14.7 p -100.0 166.52 2.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.016 0.436 . . . . 0.0 110.559 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.463 ' N ' ' CG2' ' A' ' 32' ' ' VAL . 0.7 OUTLIER -41.49 -40.46 1.81 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.6 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.413 ' O ' ' O ' ' A' ' 33' ' ' ASP . 5.0 p 35.29 95.04 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.363 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -152.72 69.83 0.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.85 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.79 174.14 3.25 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.12 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -63.23 -149.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.3 2.0 . . . . 0.0 111.263 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.447 ' O ' ' CG2' ' A' ' 38' ' ' THR . 13.3 t -130.38 57.59 1.71 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.795 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 tp -83.7 159.28 3.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.414 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.58 138.08 31.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.955 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.29 170.36 4.29 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.351 -0.939 . . . . 0.0 113.34 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.78 143.43 44.02 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.61 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -122.71 169.17 11.34 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.367 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.413 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -146.99 147.56 30.82 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 120.008 -0.677 . . . . 0.0 112.605 -178.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.7 tttt -147.1 110.48 4.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.853 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.0 mp -106.4 122.83 47.06 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.254 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 pt -149.03 165.18 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.624 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 m -114.93 124.44 51.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.044 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.452 ' CG1' ' CD1' ' A' ' 54' ' ' TYR . 0.8 OUTLIER -121.95 126.03 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.649 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.12 21.45 10.11 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.14 -8.36 60.93 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.084 -1.207 . . . . 0.0 110.084 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -91.64 134.18 34.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -76.95 145.63 38.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.658 0.742 . . . . 0.0 111.785 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.452 ' CD1' ' CG1' ' A' ' 49' ' ' VAL . 13.5 m-85 -138.76 122.68 17.78 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.023 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 67.7 m170 -117.12 113.49 22.35 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mp -119.7 144.18 47.35 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.589 0.709 . . . . 0.0 112.04 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.532 ' NE2' ' HZ2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -134.92 125.26 26.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.919 178.72 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.631 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.66 154.19 32.04 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 120.01 -0.676 . . . . 0.0 112.065 -178.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.94 144.71 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.68 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.36 104.08 9.74 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.409 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 44.6 p -68.61 139.27 55.51 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.815 0.816 . . . . 0.0 111.152 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -144.1 14.32 1.67 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.299 -1.318 . . . . 0.0 108.461 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -104.38 -18.53 13.0 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.048 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -139.09 -148.65 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.678 0.751 . . . . 0.0 111.74 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.601 ' C ' ' H ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -75.7 -170.4 1.29 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.162 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 67' ' ' TYR . 0.3 OUTLIER -64.25 41.74 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.15 0 O-C-N 123.277 0.361 . . . . 0.0 110.172 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.601 ' H ' ' C ' ' A' ' 65' ' ' ASP . 16.0 t80 96.22 84.15 0.01 OUTLIER 'General case' 0 C--N 1.339 0.132 0 O-C-N 124.109 0.881 . . . . 0.0 108.854 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.564 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 5.6 m -65.77 111.7 3.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.216 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.605 ' CD1' ' H ' ' A' ' 69' ' ' ILE . 2.1 mp -41.42 150.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.98 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.529 ' CD2' ' O ' ' A' ' 70' ' ' PHE . 61.3 t80 54.9 65.78 4.62 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.872 0.368 . . . . 0.0 110.313 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -47.08 99.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.785 2.323 . . . . 0.0 112.178 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.06 -24.2 23.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.352 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.25 -30.93 10.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.741 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.96 102.24 13.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.891 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.1 m -87.94 52.77 2.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.867 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -87.46 172.88 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.497 0.665 . . . . 0.0 112.149 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 4.9 p-10 -145.89 57.04 1.21 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.611 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 29.0 pt -78.72 -175.82 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.18 16.69 0.74 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.323 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -145.22 167.7 27.31 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.452 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.545 ' OH ' ' CD1' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -152.02 122.9 7.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.853 -0.674 . . . . 0.0 111.318 178.44 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 10.5 tt -126.52 105.72 14.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.651 ' H ' ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.51 122.47 40.61 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.179 -0.609 . . . . 0.0 111.434 -178.3 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -97.04 115.83 37.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.032 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.528 ' OH ' ' CZ ' ' A' ' 145' ' ' PHE . 53.8 p90 -109.76 144.69 37.82 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.502 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.0 OUTLIER -99.79 143.97 29.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.01 0.433 . . . . 0.0 111.47 -178.127 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.7 m -80.78 22.21 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.34 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.415 HG21 ' N ' ' A' ' 89' ' ' SER . 1.0 OUTLIER -140.22 -21.1 0.86 Allowed 'General case' 0 C--O 1.232 0.182 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -177.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.546 ' C ' ' N ' ' A' ' 91' ' ' LYS . 17.8 t -109.54 92.71 4.16 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.311 0.576 . . . . 0.0 111.694 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.438 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 1.0 OUTLIER -52.42 -15.24 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 176.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.546 ' N ' ' C ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -78.24 -39.33 40.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.177 179.182 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 89' ' ' SER . 79.4 p -69.87 -46.07 66.32 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.495 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -78.6 -32.84 47.72 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 119.473 -0.891 . . . . 0.0 112.489 -177.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.486 ' OE1' ' CE1' ' A' ' 93' ' ' PHE . 8.4 mm-40 -69.3 -45.19 70.17 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.277 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.7 m -66.05 -37.59 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 C-N-CA 120.141 -0.624 . . . . 0.0 109.976 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.427 HD11 HG23 ' A' ' 96' ' ' ILE . 2.0 mt -59.25 -40.54 81.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.986 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -70.1 -26.88 64.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.944 0.402 . . . . 0.0 110.411 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.3 t -75.53 -67.03 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.421 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.1 mt -47.37 -35.44 3.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.326 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.603 ' NE2' ' CD1' ' A' ' 141' ' ' TRP . 6.7 t-80 -62.38 -64.85 0.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.167 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -38.4 -57.62 1.79 Allowed Glycine 0 N--CA 1.453 -0.186 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.485 ' O ' ' N ' ' A' ' 105' ' ' ASP . 15.9 tptm -62.7 -65.14 0.73 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.059 -0.571 . . . . 0.0 110.641 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.05 -60.07 0.66 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.121 0.486 . . . . 0.0 109.849 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.512 ' CD2' ' CZ3' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -45.85 -46.81 15.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.543 0.687 . . . . 0.0 109.368 178.675 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -61.96 -31.87 72.25 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.258 -179.356 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.524 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 48.8 ttp -69.18 -50.95 42.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.4 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.9 m -76.47 -24.49 15.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.544 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.15 37.08 1.43 Allowed Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.17 -155.78 0.48 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.163 0.506 . . . . 0.0 111.575 -178.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.14 -170.42 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.774 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -65.24 115.82 5.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.896 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.482 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.7 OUTLIER -115.83 156.55 46.35 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.401 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -49.22 109.15 0.24 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.636 1.557 . . . . 0.0 112.599 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.482 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.4 mt -121.66 128.6 75.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.4 tpt -131.69 112.7 12.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.575 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.9 mt -96.56 97.86 9.75 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.0 t -103.53 130.88 53.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 122.35 1.071 . . . . 0.0 111.364 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.466 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -98.26 106.55 3.3 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 113.593 -1.64 . . . . 0.0 109.082 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.506 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 55.0 t30 -96.78 174.91 6.56 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.527 -178.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.549 ' HZ2' ' C ' ' A' ' 17' ' ' VAL . 7.5 mttp 65.31 59.74 0.8 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.193 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.43 ' C ' ' H ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -65.73 -39.14 90.85 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -177.75 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.646 ' CG ' HN22 ' A' ' 186' ' ' GDP . 5.9 p-10 -61.87 -3.5 1.18 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.047 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 125' ' ' MET . 9.7 mp -99.68 -30.17 12.25 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.494 ' O ' ' N ' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -39.93 -28.18 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.59 178.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.453 ' N ' ' O ' ' A' ' 123' ' ' LEU . 0.0 OUTLIER -41.18 -26.74 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.069 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -98.18 -36.18 10.14 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.822 179.495 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.577 HH12 ' CG2' ' A' ' 129' ' ' ILE . 7.0 tpt85 42.55 86.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.709 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.6 m -80.28 -39.98 19.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.654 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.577 ' CG2' HH12 ' A' ' 127' ' ' ARG . 0.8 OUTLIER -86.68 132.16 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.508 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 60.8 p -76.75 118.05 18.98 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.389 -0.525 . . . . 0.0 111.026 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -39.06 -29.48 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.28 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.4 mp0 -69.88 -63.07 1.15 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.874 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.508 ' H ' ' HG ' ' A' ' 130' ' ' SER . 52.9 mt-10 -41.09 -46.11 2.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.95 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.11 -31.73 72.34 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 132' ' ' GLU . 19.6 tttm -65.43 -56.62 11.47 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -54.94 -33.33 62.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.349 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.403 HD22 ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -66.11 -62.71 1.34 Allowed 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.892 179.574 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -56.95 -31.94 65.49 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.966 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.61 -35.28 72.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.771 0.319 . . . . 0.0 110.534 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.627 ' HG ' ' N ' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -64.2 -47.11 81.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.288 -178.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.627 ' N ' ' HG ' ' A' ' 140' ' ' SER . 18.6 m95 -91.2 -4.12 56.35 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.527 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 72.36 31.78 1.77 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.142 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.34 168.82 12.35 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.255 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -103.63 124.85 49.58 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.347 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.528 ' CZ ' ' OH ' ' A' ' 85' ' ' TYR . 7.3 t80 -97.8 123.19 41.65 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.863 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.52 123.67 12.91 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.471 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 2.8 mt-10 -98.72 114.82 27.5 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 5.0 p -136.33 -173.92 3.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.897 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.03 136.62 35.49 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.105 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.437 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -62.42 -43.63 98.37 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.132 0.491 . . . . 0.0 109.99 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.444 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 33.7 tttm -58.49 -7.03 0.8 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.519 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.437 ' H ' ' C ' ' A' ' 150' ' ' ALA . 25.1 mt-10 -126.9 128.4 46.42 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.769 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 2.5 t-20 -77.37 -56.01 4.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.09 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' A' ' 153' ' ' ASN . 0.0 OUTLIER -36.41 -59.02 0.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.135 0.493 . . . . 0.0 110.983 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 16.8 p -51.99 -51.34 57.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.649 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -52.31 -58.37 6.87 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.5 0.667 . . . . 0.0 109.713 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 53.7 t -42.21 -51.32 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.129 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -51.27 -36.43 42.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.053 0.454 . . . . 0.0 110.636 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.422 ' N ' ' O ' ' A' ' 156' ' ' ALA . 11.0 t -73.94 -31.15 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.261 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.439 ' CG ' ' N ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -68.77 -46.64 68.25 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.047 0.451 . . . . 0.0 112.119 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.439 ' N ' ' CG ' ' A' ' 160' ' ' PHE . 6.4 ttt180 -73.94 -34.56 64.35 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.751 -0.779 . . . . 0.0 111.152 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -65.65 -34.73 78.9 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.067 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 164' ' ' ILE . 14.1 tt -70.34 -43.16 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.861 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.454 ' N ' HG22 ' A' ' 163' ' ' ILE . 85.1 mt -59.58 -35.21 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.544 0.688 . . . . 0.0 109.611 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.21 -60.31 3.58 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.726 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -58.36 -34.9 71.18 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -55.98 -32.45 63.93 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 171' ' ' ASP . 6.0 tp10 -66.41 -59.65 3.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.359 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.51 -52.23 64.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.682 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 4.0 mm -50.45 -37.93 15.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.04 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 172' ' ' GLY . 0.0 OUTLIER -67.01 -40.13 87.24 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.028 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 171' ' ' ASP . . . -56.75 -36.41 72.04 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.72 -82.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.743 0.306 . . . . 0.0 110.213 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.838 179.937 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GDP . . . . . 0.646 HN22 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.322 0 CA-C-O 121.202 0.525 . . . . 0.0 110.651 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.71 136.04 33.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.526 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -106.0 128.5 53.87 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -102.82 122.95 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 121.416 0.627 . . . . 0.0 110.563 -178.023 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.465 ' O ' HG21 ' A' ' 82' ' ' ILE . . . -84.56 132.58 34.5 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.172 -0.955 . . . . 0.0 111.156 -178.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.7 mt -95.46 133.72 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-O 121.916 0.865 . . . . 0.0 112.721 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.6 mp -130.33 101.73 5.89 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.866 -1.515 . . . . 0.0 110.359 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.517 ' O ' ' NZ ' ' A' ' 19' ' ' LYS . . . -140.64 134.4 6.42 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.476 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.6 OUTLIER -56.16 -158.2 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.285 0.565 . . . . 0.0 110.736 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -98.93 133.76 42.75 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.485 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.441 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 2.6 m 64.25 19.29 11.72 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.721 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.512 ' C ' ' HZ1' ' A' ' 120' ' ' LYS . 4.9 p -85.91 -16.9 9.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.843 0.354 . . . . 0.0 110.561 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.591 ' CA ' ' HG ' ' A' ' 21' ' ' SER . . . 102.36 27.92 6.64 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.532 ' CB ' ' NZ ' ' A' ' 19' ' ' LYS . 4.8 ttpm? -61.2 -50.26 73.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.14 0.495 . . . . 0.0 110.435 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.21 -26.38 58.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.436 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.591 ' HG ' ' CA ' ' A' ' 18' ' ' GLY . 77.6 p -64.29 -43.38 94.94 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.856 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.9 tp -77.74 -39.51 44.13 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.851 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.404 ' O ' ' CG1' ' A' ' 27' ' ' VAL . 31.4 m -50.2 -43.87 52.83 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.68 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.4 mp -77.42 -41.58 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.635 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.443 ' NE2' ' O ' ' A' ' 152' ' ' GLU . 0.2 OUTLIER -67.78 -31.79 71.92 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.151 -179.016 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.632 ' CZ ' ' CE1' ' A' ' 160' ' ' PHE . 4.8 t80 -77.61 -64.03 1.24 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.404 0.621 . . . . 0.0 111.192 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.465 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 13.5 p -45.15 -49.17 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.996 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.465 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 0.7 OUTLIER -81.49 -25.12 36.26 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.28 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 153' ' ' ASN . . . 75.44 28.1 62.28 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.435 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.42 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 5.2 pt20 -146.38 128.05 15.2 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.943 0.878 . . . . 0.0 112.983 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.496 ' C ' ' CD1' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -69.66 95.86 0.9 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.083 178.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.59 ' C ' ' H ' ' A' ' 34' ' ' SER . 14.2 p -98.69 166.98 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.483 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.471 ' N ' ' CG2' ' A' ' 32' ' ' VAL . 1.8 t70 -63.87 16.87 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.109 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.59 ' H ' ' C ' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -38.92 119.13 0.84 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.831 0.348 . . . . 0.0 110.898 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -152.7 34.78 0.49 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.586 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -83.44 172.47 9.25 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.434 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 36' ' ' ASP . 46.9 Cg_exo -56.81 -138.25 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.551 2.168 . . . . 0.0 111.902 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.454 ' O ' ' CG2' ' A' ' 38' ' ' THR . 10.4 t -130.23 62.8 1.56 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.745 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 tp -82.89 144.68 9.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.176 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.418 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -90.0 152.16 21.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.532 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER 177.88 174.34 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.278 0.561 . . . . 0.0 112.278 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.04 142.92 37.47 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.426 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.432 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 12.5 m-85 -130.47 165.5 22.5 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.047 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.53 148.02 36.92 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.252 0.549 . . . . 0.0 112.046 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.94 116.1 4.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.978 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.522 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 7.4 mp -105.3 129.69 53.59 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.393 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.3 pt -147.39 160.97 8.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.47 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 m -117.01 123.56 47.19 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.173 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 p -118.42 125.48 74.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.984 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.7 m120 61.38 24.94 14.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 0.0 110.239 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.77 -9.52 65.27 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -88.77 130.48 35.35 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -76.96 146.12 37.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.582 0.706 . . . . 0.0 111.302 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.482 ' C ' ' HD1' ' A' ' 55' ' ' HIS . 9.3 m-85 -138.46 124.92 20.59 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.004 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.482 ' HD1' ' C ' ' A' ' 54' ' ' TYR . 0.4 OUTLIER -117.28 113.66 22.49 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mp -119.23 146.58 45.1 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.582 0.706 . . . . 0.0 112.132 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -136.35 123.53 21.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.983 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.641 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.12 154.91 30.22 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.541 0.686 . . . . 0.0 112.416 -178.371 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.85 145.14 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.785 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.16 103.89 8.52 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.019 -1.446 . . . . 0.0 107.92 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.46 152.25 46.67 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.312 0.577 . . . . 0.0 110.775 -178.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 63' ' ' GLY . . . -138.67 30.53 2.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.462 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.463 ' N ' ' OH ' ' A' ' 74' ' ' TYR . . . -30.22 -43.21 0.06 OUTLIER Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -144.1 -100.06 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.455 0.645 . . . . 0.0 109.973 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.566 ' C ' ' H ' ' A' ' 67' ' ' TYR . 4.3 p30 -76.92 -173.59 2.75 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.56 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.545 ' O ' ' CB ' ' A' ' 67' ' ' TYR . 1.0 OUTLIER -65.69 45.93 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.566 ' H ' ' C ' ' A' ' 65' ' ' ASP . 21.2 t80 96.69 79.15 0.0 OUTLIER 'General case' 0 C--N 1.343 0.311 0 O-C-N 124.469 1.106 . . . . 0.0 109.784 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.557 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.7 OUTLIER -69.7 124.7 24.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.937 -178.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.514 ' CG2' ' H ' ' A' ' 70' ' ' PHE . 20.7 mm -72.35 -125.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.514 ' H ' ' CG2' ' A' ' 69' ' ' ILE . 86.7 t80 52.3 86.72 0.15 Allowed Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 120.294 -0.563 . . . . 0.0 109.525 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -41.4 112.45 0.21 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.255 1.97 . . . . 0.0 112.8 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.429 ' NE2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -162.75 -60.82 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.528 179.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.429 ' OG1' ' NE2' ' A' ' 72' ' ' GLN . 1.9 m -144.08 10.15 1.51 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.371 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.463 ' OH ' ' N ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -122.57 -8.9 8.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.472 -179.739 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.519 ' H ' ' HG ' ' A' ' 75' ' ' SER . 1.4 p -84.98 63.06 7.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.189 0.519 . . . . 0.0 110.592 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -52.41 -165.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.164 -179.814 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.39 44.36 2.48 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.218 0.533 . . . . 0.0 110.171 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 33.6 pt -81.51 -173.79 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.38 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -151.11 18.41 0.76 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.115 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -146.69 167.75 28.11 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.15 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.527 ' OH ' ' CE2' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -151.97 123.21 7.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.136 -0.532 . . . . 0.0 111.806 178.156 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.47 ' CG2' ' O ' ' A' ' 82' ' ' ILE . 12.4 tt -128.06 98.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.797 0.808 . . . . 0.0 109.299 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.594 ' CD2' ' N ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -96.32 130.09 43.51 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.639 -178.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.93 132.81 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.885 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.509 ' CE1' ' CD2' ' A' ' 116' ' ' LEU . 2.2 m-85 -108.56 143.5 37.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.886 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -106.2 121.41 44.13 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.386 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.0 m -73.86 21.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.563 ' H ' ' C ' ' A' ' 86' ' ' SER . 9.7 t -142.72 -7.83 0.85 Allowed 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 114.212 1.189 . . . . 0.0 114.212 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.532 ' C ' ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -135.46 100.5 4.53 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 122.324 1.059 . . . . 0.0 112.077 -176.311 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.1 mm -56.08 -10.63 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 113.915 -1.493 . . . . 0.0 108.754 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.532 ' H ' ' C ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -79.3 -43.99 22.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.466 178.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.516 ' HG ' ' H ' ' A' ' 86' ' ' SER . 55.3 p -62.33 -45.89 91.19 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.151 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.57 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -76.48 -37.55 56.67 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 118.531 -1.267 . . . . 0.0 111.882 -178.312 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -69.66 -44.86 69.68 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.902 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 91' ' ' LYS . 23.5 m -63.1 -36.5 76.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.881 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.8 mt -72.42 -27.14 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.058 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -69.15 -29.17 67.14 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.8 t -76.29 -66.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.481 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.4 mp -39.16 -36.21 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.738 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.452 ' CE1' ' CE2' ' A' ' 141' ' ' TRP . 53.2 t-80 -66.95 -58.6 4.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.979 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.82 -49.16 1.95 Allowed Glycine 0 CA--C 1.518 0.259 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.804 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 105' ' ' ASP . 23.0 tptt -64.01 -66.31 0.56 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.424 -0.388 . . . . 0.0 110.393 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.7 OUTLIER -39.95 -57.17 1.67 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.627 179.058 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.492 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -46.84 -43.84 18.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.53 178.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -61.99 -32.89 73.39 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.624 -179.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 8.3 ttm -66.89 -53.72 29.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.713 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.578 ' C ' ' H ' ' A' ' 109' ' ' LYS . 15.9 m -77.19 -14.53 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.938 0.399 . . . . 0.0 110.569 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.5 -24.42 0.04 OUTLIER Glycine 0 CA--C 1.532 1.134 0 CA-C-N 115.87 -0.605 . . . . 0.0 113.132 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.578 ' H ' ' C ' ' A' ' 107' ' ' VAL . 24.0 tttt -172.02 -130.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 117.92 0.86 . . . . 0.0 111.601 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.534 ' H ' ' CG ' ' A' ' 109' ' ' LYS . 5.2 t 53.14 119.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.488 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -74.62 124.42 26.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.949 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.484 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -129.93 145.25 56.37 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.713 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -49.5 113.26 0.88 Allowed 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.624 1.55 . . . . 0.0 112.517 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.484 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.4 mp -123.99 132.99 70.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 9.4 tpt -133.18 115.3 14.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.011 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.509 ' CD2' ' CE1' ' A' ' 85' ' ' TYR . 4.2 mt -96.83 97.24 9.14 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.0 t -102.11 127.98 55.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.5 0.667 . . . . 0.0 111.753 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -94.73 114.68 4.89 Favored Glycine 0 C--N 1.311 -0.858 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.408 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 60.6 t30 -97.02 171.79 8.26 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.078 -0.649 . . . . 0.0 112.025 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.512 ' HZ1' ' C ' ' A' ' 17' ' ' VAL . 6.3 mtpp 61.73 55.47 2.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.629 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.556 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 8.8 tttm -57.41 -20.66 31.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.674 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.61 ' CG ' HN22 ' A' ' 186' ' ' GDP . 3.4 p-10 -76.64 -20.48 56.65 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.991 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.9 mp -77.96 -31.63 50.96 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.621 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.3 OUTLIER -31.56 -32.56 0.01 OUTLIER 'General case' 0 C--N 1.339 0.141 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.029 178.196 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.621 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 2.2 mmt -42.02 -27.34 0.12 Allowed 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.487 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -101.17 -37.6 8.48 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.587 179.307 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.48 ' NH1' ' OE2' ' A' ' 147' ' ' GLU . 9.8 ttm180 32.01 85.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.449 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.2 m -72.66 -34.77 48.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.167 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 10.7 tp -91.4 153.82 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.691 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.429 ' OG ' ' OE1' ' A' ' 132' ' ' GLU . 3.8 t -95.16 130.19 41.98 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.86 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -50.39 -35.86 30.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.782 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -68.45 -62.21 1.49 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.743 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -40.72 -43.12 1.9 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.722 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.68 -36.1 67.11 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -62.08 -53.53 54.21 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.341 -0.43 . . . . 0.0 109.852 179.574 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -58.39 -38.04 76.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.76 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.625 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -66.43 -60.65 2.56 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.563 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -51.69 -37.16 49.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.984 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.83 -28.9 67.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.71 -47.37 78.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.155 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.625 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 17.1 m95 -91.0 -4.24 56.6 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.313 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 141' ' ' TRP . 0.8 OUTLIER 79.11 26.97 0.42 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.992 -179.434 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.61 168.81 12.24 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.69 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -111.69 127.73 55.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.043 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.406 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 9.9 t80 -98.01 120.81 39.05 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.314 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.53 128.23 17.21 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.338 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.48 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 1.7 mt-10 -100.2 116.74 32.92 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.007 0.432 . . . . 0.0 110.098 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.8 p -131.98 -177.97 4.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.596 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.21 131.79 30.82 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.563 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.499 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -56.44 -42.44 78.12 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.123 0.487 . . . . 0.0 110.084 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 38.1 tttt -58.2 -3.7 0.28 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.468 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.499 ' H ' ' C ' ' A' ' 150' ' ' ALA . 1.9 mt-10 -136.37 125.76 24.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.017 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 29' ' ' GLY . 5.3 t-20 -77.25 -48.95 16.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.831 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 153' ' ' ASN . 0.0 OUTLIER -38.5 -59.16 0.94 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.749 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 45.7 p -52.5 -49.55 64.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.188 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.419 ' HB1' HE22 ' A' ' 25' ' ' GLN . . . -50.63 -60.84 2.62 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.553 0.692 . . . . 0.0 110.285 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 49.0 t -45.76 -42.2 3.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.895 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.15 -41.62 98.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.664 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 11.5 t -63.38 -46.94 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.66 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.632 ' CE1' ' CZ ' ' A' ' 26' ' ' PHE . 10.4 m-85 -67.79 -22.81 65.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.105 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.24 -42.36 46.09 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.869 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -67.29 -32.35 73.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.132 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.458 HG21 ' O ' ' A' ' 160' ' ' PHE . 7.3 tt -69.14 -47.07 76.64 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.171 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.447 ' N ' ' CG2' ' A' ' 163' ' ' ILE . 95.4 mt -53.5 -37.53 30.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.05 -56.53 19.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.549 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -62.47 -28.73 70.02 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.309 -0.556 . . . . 0.0 109.573 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.23 -33.32 70.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.424 ' OE2' ' OH ' ' A' ' 54' ' ' TYR . 2.3 tp10 -68.83 -50.62 48.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.016 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -60.15 -64.29 1.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.741 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 50.6 mt -49.94 -31.75 7.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.952 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.84 -40.18 79.54 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.368 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -61.71 -35.63 91.5 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.29 -68.96 0.35 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.714 0.292 . . . . 0.0 110.427 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.715 179.927 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GDP . . . . . 0.61 HN22 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.308 0.575 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.59 134.96 32.84 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.22 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -107.25 126.0 51.86 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -100.17 122.03 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-O 121.566 0.698 . . . . 0.0 110.914 -177.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.62 134.84 34.78 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.464 -0.773 . . . . 0.0 110.903 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.3 mt -96.64 133.33 38.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.4 0.619 . . . . 0.0 112.382 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.435 ' C ' ' CD2' ' A' ' 12' ' ' LEU . 5.8 tt -128.61 105.67 8.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.494 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -142.03 134.33 6.11 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -52.99 172.6 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -73.37 131.61 42.07 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.231 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 m 67.1 19.97 10.38 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.698 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.6 p -79.72 -18.44 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.219 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.431 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 101.19 23.7 9.5 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.447 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.421 ' O ' ' OG1' ' A' ' 23' ' ' THR . 5.4 pttm -70.72 -33.44 70.85 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.423 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.8 m -77.2 -30.42 54.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.05 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.45 ' OG ' ' N7 ' ' A' ' 186' ' ' GDP . 79.5 p -65.61 -41.91 92.21 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.125 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.0 tp -77.07 -44.05 32.07 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 119.754 -0.779 . . . . 0.0 110.648 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 19' ' ' LYS . 25.3 m -47.93 -42.37 27.13 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.226 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.15 -41.72 30.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 O-C-N 123.267 0.354 . . . . 0.0 111.272 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.477 ' OE1' ' CB ' ' A' ' 156' ' ' ALA . 0.3 OUTLIER -70.71 -28.69 64.92 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.969 -179.208 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.454 ' O ' ' N ' ' A' ' 29' ' ' GLY . 1.3 t80 -78.05 -63.63 1.35 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.231 0.539 . . . . 0.0 110.692 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.444 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 13.7 p -45.15 -49.59 2.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.419 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.444 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 2.5 tt0 -79.06 -24.45 43.55 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 71.5 28.21 69.93 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 114.471 -1.241 . . . . 0.0 110.024 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -149.73 125.8 10.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.49 -178.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.618 ' O ' ' CD1' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -67.45 91.63 0.27 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.318 1.056 . . . . 0.0 110.407 178.643 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.467 ' CG2' ' N ' ' A' ' 33' ' ' ASP . 14.9 p -98.85 166.44 2.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.006 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.467 ' N ' ' CG2' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -46.37 -30.01 1.93 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.101 -179.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.2 p 37.74 93.27 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.41 -38.98 18.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.122 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -37.34 101.01 0.21 Allowed Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.72 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.493 ' O ' ' O ' ' A' ' 36' ' ' ASP . 76.5 Cg_exo -53.72 -128.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.358 2.038 . . . . 0.0 112.164 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.6 t -102.39 46.92 0.91 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.121 0.486 . . . . 0.0 111.137 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 tp -83.69 145.59 8.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.016 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.425 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -90.14 146.36 24.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.436 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 0.7 OUTLIER 177.49 176.68 0.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.185 0.517 . . . . 0.0 111.869 -179.383 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.9 147.47 30.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.873 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.442 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 11.6 m-85 -129.77 167.3 18.29 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.239 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.9 151.05 37.24 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.52 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.0 tmtp? -150.91 108.78 3.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.439 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.534 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 6.4 mp -106.48 121.4 44.2 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.938 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 pp -149.0 165.36 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.785 0.326 . . . . 0.0 110.647 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 m -108.81 127.6 54.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.173 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.451 ' C ' ' H ' ' A' ' 51' ' ' GLY . 7.6 p -126.39 138.32 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 62.06 5.95 1.61 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 97.39 -13.18 64.66 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -91.37 142.21 27.93 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -76.24 145.53 39.66 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.562 0.696 . . . . 0.0 111.073 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -136.34 124.8 23.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.134 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 62.3 m170 -116.74 113.98 23.35 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.43 ' CD2' ' N ' ' A' ' 56' ' ' LEU . 2.7 mm? -118.91 139.75 51.12 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 121.386 0.612 . . . . 0.0 111.34 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.36 122.41 23.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.91 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.649 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.19 154.6 30.84 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.345 0.593 . . . . 0.0 112.525 -178.139 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.8 145.29 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-N 114.672 -1.149 . . . . 0.0 113.05 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -123.61 106.5 10.61 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.067 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.67 148.62 49.81 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.614 0.721 . . . . 0.0 111.487 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.481 ' O ' ' N ' ' A' ' 64' ' ' GLN . . . -138.37 15.53 2.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.867 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.433 ' N ' ' OH ' ' A' ' 74' ' ' TYR . . . -38.46 -26.68 0.04 OUTLIER Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.108 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.548 ' CG ' ' H ' ' A' ' 65' ' ' ASP . 1.5 tp60 -145.09 -121.24 0.08 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.554 0.693 . . . . 0.0 110.405 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' A' ' 68' ' ' SER . 0.0 OUTLIER -75.17 -173.82 2.12 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.751 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 67' ' ' TYR . 1.5 mp0 -65.11 47.03 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.257 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.556 ' H ' ' C ' ' A' ' 65' ' ' ASP . 4.0 t80 93.67 80.66 0.0 OUTLIER 'General case' 0 C--O 1.232 0.146 0 O-C-N 124.157 0.911 . . . . 0.0 109.143 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.567 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 12.1 m -68.8 134.43 49.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.611 -178.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.639 ' CD1' ' H ' ' A' ' 69' ' ' ILE . 2.6 mp -69.07 97.15 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.478 ' O ' ' N ' ' A' ' 72' ' ' GLN . 18.6 t80 -158.03 76.85 3.63 Favored Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.355 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.18 83.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.658 2.239 . . . . 0.0 111.863 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.499 ' NE2' ' OG1' ' A' ' 73' ' ' THR . 1.1 tt0 -169.72 -52.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.684 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.499 ' OG1' ' NE2' ' A' ' 72' ' ' GLN . 1.2 m -135.0 4.09 3.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.64 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.531 ' O ' ' CZ ' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -130.02 5.24 4.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.622 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -155.08 86.17 1.1 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.377 0.608 . . . . 0.0 109.813 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.554 ' CG2' ' H ' ' A' ' 77' ' ' ASP . 6.9 mm -56.63 -132.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.845 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.554 ' H ' ' CG2' ' A' ' 76' ' ' ILE . 0.8 OUTLIER -118.34 48.26 1.46 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.384 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 31.5 pt -77.26 -177.65 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 114.572 -1.194 . . . . 0.0 112.838 -177.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.77 19.33 0.7 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.022 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.02 165.08 28.92 Favored Glycine 0 CA--C 1.517 0.195 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.534 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.531 ' OH ' ' CD1' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -151.82 123.07 7.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.716 -0.742 . . . . 0.0 111.073 177.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.7 tt -126.19 107.62 17.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.9 0.857 . . . . 0.0 109.029 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.582 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 3.1 mp -97.27 126.67 42.63 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.979 -178.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -95.26 128.69 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.162 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.402 ' CD2' ' CE1' ' A' ' 93' ' ' PHE . 48.6 m-85 -110.69 144.44 39.62 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.172 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.696 ' HG ' ' H ' ' A' ' 89' ' ' SER . 0.9 OUTLIER -98.24 125.99 43.54 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.0 m -72.5 22.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.673 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.616 ' H ' ' HG ' ' A' ' 86' ' ' SER . 0.8 OUTLIER -138.79 -26.13 0.87 Allowed 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.696 ' H ' ' HG ' ' A' ' 86' ' ' SER . 4.1 t -98.0 93.98 6.6 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.378 -176.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.27 -11.57 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.535 ' N ' ' C ' ' A' ' 89' ' ' SER . 3.4 mptt -78.28 -57.22 3.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.456 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.481 ' H ' ' HG ' ' A' ' 89' ' ' SER . 69.6 p -49.6 -30.62 9.08 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.591 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.402 ' CE1' ' CD2' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -74.55 -48.29 27.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.838 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.39 -44.22 88.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.595 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.1 m -64.38 -35.84 75.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.145 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.7 mt -69.12 -29.44 42.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.882 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.03 -27.84 66.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.8 t -74.75 -66.73 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.2 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.6 mp -41.39 -48.64 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.514 ' CE1' ' CE2' ' A' ' 141' ' ' TRP . 51.8 t-80 -54.66 -64.84 0.7 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.669 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -38.07 -52.33 2.13 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 105' ' ' ASP . 17.7 tptm -65.87 -63.6 1.05 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.924 -0.638 . . . . 0.0 110.698 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -38.2 -59.24 0.89 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.215 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.48 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -47.05 -45.24 21.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.806 178.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -61.06 -36.07 78.62 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.795 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.517 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 5.2 ttm -60.48 -55.67 30.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.206 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.54 ' C ' ' H ' ' A' ' 109' ' ' LYS . 17.7 m -77.21 -13.8 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.18 0.514 . . . . 0.0 110.243 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 63.67 -24.76 0.09 OUTLIER Glycine 0 CA--C 1.531 1.033 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.999 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.54 ' H ' ' C ' ' A' ' 107' ' ' VAL . 20.8 tttt -172.85 -135.01 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 117.784 0.792 . . . . 0.0 111.832 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.527 ' H ' ' CG ' ' A' ' 109' ' ' LYS . 5.6 t 52.77 118.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.665 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -76.15 126.97 31.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.022 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.49 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.6 OUTLIER -130.07 153.68 81.12 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.685 179.419 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -48.02 114.69 1.2 Allowed 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.897 1.731 . . . . 0.0 112.572 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.49 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.4 mp -124.28 128.44 73.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 12.3 tpt -129.01 114.59 16.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.741 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 67.5 mt -97.21 98.91 10.41 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.387 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.83 131.16 57.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.865 0.84 . . . . 0.0 112.396 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -97.96 114.01 4.88 Favored Glycine 0 C--N 1.312 -0.773 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.478 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 57.7 t30 -96.84 172.79 7.65 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.952 -177.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.478 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 19.7 mttt 58.51 58.67 3.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.188 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -14.75 61.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.326 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.621 ' CG ' HN22 ' A' ' 186' ' ' GDP . 3.9 p-10 -79.4 -13.03 59.87 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.633 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.661 ' O ' ' N ' ' A' ' 126' ' ' GLU . 10.9 mp -84.05 -26.57 28.95 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.553 ' O ' ' N ' ' A' ' 126' ' ' GLU . 10.3 t60 -22.76 -42.34 0.01 OUTLIER 'General case' 0 C--N 1.348 0.503 0 O-C-N 124.544 1.152 . . . . 0.0 111.289 178.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.567 ' N ' ' O ' ' A' ' 123' ' ' LEU . 0.7 OUTLIER -44.77 -19.04 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.416 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.661 ' N ' ' O ' ' A' ' 123' ' ' LEU . 19.8 mm-40 -89.74 -54.49 4.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.011 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.433 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 1.7 tpt85 35.85 71.24 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.269 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.71 -40.13 86.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.292 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 tp -88.44 155.12 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.582 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 132' ' ' GLU . 47.5 p -93.12 118.04 30.76 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.718 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -39.12 -28.66 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.645 0.736 . . . . 0.0 109.373 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.3 mp0 -70.06 -63.27 1.11 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.876 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.475 ' H ' ' HG ' ' A' ' 130' ' ' SER . 57.1 mt-10 -41.52 -41.73 2.19 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.16 -35.73 64.09 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 132' ' ' GLU . 2.4 tttm -60.72 -55.42 33.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.58 -33.97 66.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.075 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.35 -63.2 1.16 Allowed 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.836 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -51.67 -35.06 41.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.232 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -35.61 78.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.736 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.58 -47.32 76.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.59 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.514 ' CE2' ' CE1' ' A' ' 100' ' ' HIS . 25.7 m95 -92.72 2.52 56.69 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.719 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 60.77 39.94 16.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.526 0.679 . . . . 0.0 109.633 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -98.15 168.35 10.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.57 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.07 125.46 51.0 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.887 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.437 ' C ' ' CD1' ' A' ' 145' ' ' PHE . 4.0 t80 -98.4 122.03 41.08 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.262 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.01 126.43 15.83 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.433 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 2.7 mt-10 -100.49 114.89 28.86 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 21.0 p -134.77 -178.76 5.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.824 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.93 135.19 34.14 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.28 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -57.44 -46.52 83.5 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.883 0.373 . . . . 0.0 110.365 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -55.21 -6.29 0.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.33 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.508 ' H ' ' C ' ' A' ' 150' ' ' ALA . 2.1 tt0 -131.25 122.63 26.82 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.638 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.435 ' ND2' ' C ' ' A' ' 29' ' ' GLY . 10.4 t-20 -77.21 -52.02 9.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.167 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 153' ' ' ASN . 0.2 OUTLIER -36.77 -58.22 0.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.03 -179.632 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.403 ' HG1' ' N ' ' A' ' 156' ' ' ALA . 68.1 p -53.0 -45.1 67.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.127 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.477 ' CB ' ' OE1' ' A' ' 25' ' ' GLN . . . -55.44 -61.48 2.31 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.492 0.663 . . . . 0.0 110.121 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 57.4 t -43.22 -39.67 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.688 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -65.7 -42.81 90.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.199 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.3 t -61.93 -42.41 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.539 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.498 ' O ' ' N ' ' A' ' 163' ' ' ILE . 52.3 t80 -59.49 -66.76 0.46 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.216 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 160' ' ' PHE . 19.5 ttm-85 -41.62 -45.29 3.33 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.304 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -62.05 -30.35 70.92 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.754 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 160' ' ' PHE . 0.2 OUTLIER -66.41 -32.47 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.457 179.473 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.4 mt -68.39 -42.27 84.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.737 0.779 . . . . 0.0 109.665 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.62 -49.36 78.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.551 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -64.03 -32.56 74.15 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.08 -34.41 65.96 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.125 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.39 -55.39 10.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.682 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.62 -62.87 1.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.733 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 38.5 mm -53.32 -31.23 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.065 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -69.67 -40.38 76.47 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.633 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.53 -35.31 91.6 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.98 -62.71 1.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.688 0.28 . . . . 0.0 110.429 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.705 179.878 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GDP . . . . . 0.621 HN22 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 121.216 0.531 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.62 136.66 34.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.587 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.686 ' HZ3' HE22 ' A' ' 57' ' ' GLN . 11.0 mttm -108.51 127.49 53.97 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 1.0 OUTLIER -103.01 123.95 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-O 121.479 0.657 . . . . 0.0 111.13 -178.086 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.43 135.78 34.12 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.422 -0.799 . . . . 0.0 111.254 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.0 mt -95.77 133.84 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.24 100.69 5.93 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.349 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.71 133.73 5.87 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.69 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER -54.62 -167.08 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.034 0.445 . . . . 0.0 110.041 178.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.404 ' O ' ' CB ' ' A' ' 16' ' ' SER . 11.5 ttp180 -97.64 128.33 44.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.744 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.41 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 0.7 OUTLIER 76.24 8.79 3.32 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.125 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.469 ' C ' ' NZ ' ' A' ' 120' ' ' LYS . 7.3 p -77.63 -19.32 14.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.942 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.417 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 106.03 31.6 4.08 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.408 ' NZ ' ' CB ' ' A' ' 19' ' ' LYS . 2.6 ttmp? -59.5 -59.1 5.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.005 0.431 . . . . 0.0 110.406 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.07 -26.01 63.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.24 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.504 ' HG ' ' H ' ' A' ' 22' ' ' LEU . 89.1 p -63.78 -47.11 82.22 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.714 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.504 ' H ' ' HG ' ' A' ' 21' ' ' SER . 28.4 tp -71.39 -49.94 37.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.473 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.445 ' O ' ' CG1' ' A' ' 27' ' ' VAL . 48.7 m -43.79 -38.93 3.49 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.311 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.2 -43.68 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.94 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.622 ' NE2' ' N ' ' A' ' 31' ' ' PHE . 1.5 tp-100 -63.46 -40.53 97.37 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.756 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.636 ' CG ' ' CE1' ' A' ' 160' ' ' PHE . 2.2 t80 -74.87 -62.52 1.51 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.209 0.528 . . . . 0.0 111.825 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.488 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 7.4 p -44.0 -47.52 2.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.722 -178.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.481 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 2.0 tm-20 -83.91 -24.19 30.86 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.526 ' O ' ' ND2' ' A' ' 153' ' ' ASN . . . 75.11 25.5 68.71 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.075 -1.42 . . . . 0.0 110.348 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.547 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 1.9 tp-100 -152.01 130.1 11.87 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.687 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.622 ' N ' ' NE2' ' A' ' 25' ' ' GLN . 0.7 OUTLIER -67.05 93.82 0.3 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.684 178.461 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.3 p -105.73 165.85 3.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.098 0.475 . . . . 0.0 110.393 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -75.66 -32.78 60.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.374 -179.023 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 33' ' ' ASP . 10.0 p 43.0 -168.91 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.855 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.408 ' O ' ' C ' ' A' ' 36' ' ' ASP . 3.6 t80 -149.04 -39.47 0.15 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.21 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 37' ' ' PRO . 4.9 m-20 -36.73 100.11 0.19 Allowed Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.665 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 36' ' ' ASP . 66.4 Cg_exo -54.55 -129.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.319 2.013 . . . . 0.0 112.236 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.8 t -103.17 47.63 0.88 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.227 0.537 . . . . 0.0 111.215 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 tp -83.29 144.68 9.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.444 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.421 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 2.2 pm0 -90.59 145.45 24.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.889 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 0.7 OUTLIER 177.11 175.33 0.4 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.624 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.81 127.61 53.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.294 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -110.02 174.05 6.04 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.968 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.5 161.7 37.75 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.488 ' NZ ' ' O ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -163.18 112.09 1.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.432 179.424 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.52 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 7.5 mp -105.17 127.93 53.15 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.727 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 pt -147.87 165.31 5.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.569 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.2 m -116.82 123.86 48.12 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.049 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.438 ' CG1' ' CD1' ' A' ' 54' ' ' TYR . 2.4 p -119.74 129.99 74.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.631 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.73 19.71 10.75 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.56 -9.43 71.04 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -90.0 135.6 33.55 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.49 147.28 37.93 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.584 0.706 . . . . 0.0 111.465 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.482 ' C ' ' HD1' ' A' ' 55' ' ' HIS . 5.8 m-85 -138.3 125.21 21.19 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.042 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.482 ' HD1' ' C ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -118.04 113.74 22.09 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.6 mp -118.62 143.21 46.96 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.629 0.728 . . . . 0.0 112.164 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.686 HE22 ' HZ3' ' A' ' 8' ' ' LYS . 1.2 mt-30 -133.96 122.6 23.31 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.93 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.636 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.38 153.52 31.89 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.063 -178.655 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.82 145.48 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-N 114.992 -1.004 . . . . 0.0 112.926 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -124.33 103.24 8.1 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.064 177.627 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.549 ' C ' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -93.06 -70.1 0.72 Allowed 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.374 0.607 . . . . 0.0 110.843 -179.201 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 50.43 9.9 0.05 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.317 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 61' ' ' THR . . . -50.44 -70.48 0.82 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -83.82 -113.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.421 0.629 . . . . 0.0 110.614 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.588 ' OD1' ' N ' ' A' ' 68' ' ' SER . 0.0 OUTLIER -75.35 -173.91 2.22 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.048 179.525 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.538 ' N ' ' CG ' ' A' ' 65' ' ' ASP . 2.9 mp0 -66.04 44.71 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.628 ' CZ ' ' CZ ' ' A' ' 74' ' ' TYR . 3.4 t80 91.75 73.47 0.0 OUTLIER 'General case' 0 C--N 1.339 0.122 0 O-C-N 124.196 0.935 . . . . 0.0 108.788 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.588 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.9 OUTLIER -72.9 120.51 18.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.964 -178.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.621 ' CG2' ' H ' ' A' ' 70' ' ' PHE . 31.4 mm -61.5 -126.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.621 ' H ' ' CG2' ' A' ' 69' ' ' ILE . 87.8 t80 49.35 80.64 0.29 Allowed Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 120.379 -0.528 . . . . 0.0 109.683 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -46.54 117.92 2.3 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.53 2.153 . . . . 0.0 112.503 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -171.9 -37.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.612 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.3 m -108.19 -24.0 11.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.618 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.628 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 16.5 m-85 -77.2 -55.19 5.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.078 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 t 74.63 -48.5 0.65 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.35 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.97 173.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.072 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.566 ' O ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -131.2 -15.47 3.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.08 -179.654 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.566 ' O ' ' O ' ' A' ' 77' ' ' ASP . 39.1 pt 33.67 -170.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 177.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -154.85 19.59 0.45 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.776 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.66 165.28 30.97 Favored Glycine 0 C--O 1.227 -0.323 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.873 -178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.78 122.31 7.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.689 -0.755 . . . . 0.0 110.691 178.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.6 tt -124.01 102.69 11.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.414 HD11 ' H ' ' A' ' 83' ' ' LEU . 0.3 OUTLIER -97.56 123.22 41.36 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.17 -178.253 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.9 t -95.38 130.54 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.135 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -111.25 143.94 41.23 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.538 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.568 ' HG ' ' H ' ' A' ' 89' ' ' SER . 0.5 OUTLIER -94.99 121.0 36.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.473 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.8 m -70.66 21.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.469 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.555 ' H ' ' C ' ' A' ' 86' ' ' SER . 1.1 t -136.27 -23.54 1.28 Allowed 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.568 ' H ' ' HG ' ' A' ' 86' ' ' SER . 8.3 t -100.45 94.1 5.98 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.482 -176.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -56.81 -11.41 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.555 ' H ' ' C ' ' A' ' 89' ' ' SER . 18.1 mttp -78.11 -56.35 4.55 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.141 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.543 ' H ' ' HG ' ' A' ' 89' ' ' SER . 85.4 p -49.83 -29.87 8.78 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.692 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -75.29 -50.22 16.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.92 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -64.68 -42.95 94.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.628 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.6 m -65.98 -37.62 80.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.469 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.1 mt -68.67 -28.58 40.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.567 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -70.4 -27.48 64.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.835 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 99' ' ' ILE . 17.0 t -74.34 -66.4 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.777 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' A' ' 98' ' ' VAL . 1.6 mp -39.97 -43.01 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.666 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.65 ' CE1' ' CE2' ' A' ' 141' ' ' TRP . 9.1 t60 -57.81 -59.38 5.32 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.616 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -36.39 -49.05 1.25 Allowed Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.716 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 105' ' ' ASP . 22.5 tptt -67.88 -66.03 0.62 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.32 -0.44 . . . . 0.0 110.367 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.46 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.5 OUTLIER -38.0 -59.65 0.82 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.479 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -44.29 -46.96 9.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.821 178.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -59.94 -33.39 71.84 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.281 -179.159 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.514 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 21.1 ttm -69.44 -54.98 11.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.07 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.592 ' C ' ' H ' ' A' ' 109' ' ' LYS . 28.9 m -77.25 -15.55 14.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.829 -179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.87 -24.94 0.05 OUTLIER Glycine 0 CA--C 1.533 1.2 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.688 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.592 ' H ' ' C ' ' A' ' 107' ' ' VAL . 1.2 pttt -176.03 -126.69 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.573 0.687 . . . . 0.0 111.004 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 109' ' ' LYS . 5.8 t 52.2 121.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 121.346 0.593 . . . . 0.0 111.889 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -75.17 125.26 28.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.033 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.491 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -136.18 152.72 75.82 Favored Pre-proline 0 C--O 1.223 -0.328 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -48.3 108.18 0.17 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.929 1.753 . . . . 0.0 113.157 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.491 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.3 mt -121.22 127.07 75.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 11.0 tpt -127.99 114.5 17.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.913 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 62.7 mt -96.98 98.33 9.99 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.2 t -105.76 130.08 57.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.846 0.831 . . . . 0.0 112.774 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -97.63 112.51 4.48 Favored Glycine 0 C--N 1.312 -0.761 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.54 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 50.5 t30 -96.86 176.91 5.81 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.939 -0.705 . . . . 0.0 111.792 -177.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.54 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 36.5 mttp 58.61 57.76 3.62 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -59.72 -34.85 73.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.713 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 0.2 OUTLIER -60.56 -12.79 10.97 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.171 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.5 mp -92.58 -31.65 15.11 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.603 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -38.68 -25.58 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.226 178.694 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.603 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 3.8 mmt -43.33 -26.25 0.18 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.5 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -102.81 -39.68 6.89 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.133 179.062 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.449 ' NH1' ' OE2' ' A' ' 147' ' ' GLU . 29.1 ttm-85 34.52 72.31 0.09 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.717 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.431 ' CG2' ' N ' ' A' ' 129' ' ' ILE . 33.9 m -56.04 -48.19 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.545 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.431 ' N ' ' CG2' ' A' ' 128' ' ' VAL . 7.8 tp -86.88 152.55 3.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.473 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 1.9 p -99.13 125.5 44.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.465 0.65 . . . . 0.0 111.78 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.645 ' CD1' ' CE1' ' A' ' 145' ' ' PHE . 0.1 OUTLIER -52.7 -43.32 65.56 Favored 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.406 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 131' ' ' TYR . 1.4 mp0 -39.66 -62.75 0.65 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.95 178.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.473 ' H ' ' HG ' ' A' ' 130' ' ' SER . 14.9 mt-10 -50.74 -37.42 41.79 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 131' ' ' TYR . . . -70.84 -24.7 76.79 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 131' ' ' TYR . 31.4 tttm -73.68 -55.99 5.57 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -53.97 -35.47 61.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.505 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.53 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -68.15 -62.66 1.3 Allowed 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -47.24 -35.37 7.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.775 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.57 -33.37 72.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.154 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -63.95 -47.14 81.62 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.168 -179.246 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.65 ' CE2' ' CE1' ' A' ' 100' ' ' HIS . 29.7 m95 -90.44 -4.0 57.3 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.204 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 72.4 27.66 2.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.493 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -89.2 166.33 13.88 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.125 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -108.18 126.38 52.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.149 0.499 . . . . 0.0 111.47 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.645 ' CE1' ' CD1' ' A' ' 131' ' ' TYR . 11.3 t80 -98.63 122.0 41.3 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.863 -178.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.99 131.28 20.81 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.449 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 11.0 mt-10 -100.39 119.78 38.97 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.44 -178.95 5.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.736 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.04 137.9 39.86 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.968 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.555 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -59.92 -46.13 90.36 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -69.13 11.87 0.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.359 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.555 ' H ' ' C ' ' A' ' 150' ' ' ALA . 3.8 tt0 -137.68 117.79 13.48 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.231 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 10.1 t-20 -77.42 -56.71 4.31 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.43 ' OE1' ' OE2' ' A' ' 152' ' ' GLU . 0.0 OUTLIER -36.47 -59.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.051 0.453 . . . . 0.0 111.229 -179.036 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.2 p -52.35 -53.81 39.88 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.84 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -47.48 -59.51 3.19 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.598 0.714 . . . . 0.0 110.116 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 47.9 t -48.45 -42.76 12.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.733 -1.122 . . . . 0.0 110.865 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -60.45 -40.95 93.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.533 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.2 t -62.51 -46.27 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.21 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.636 ' CE1' ' CG ' ' A' ' 26' ' ' PHE . 15.2 m-85 -68.66 -24.04 64.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.365 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.8 ttm-85 -77.34 -41.11 41.74 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.01 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.2 mmm-85 -65.66 -33.93 77.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.978 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.473 ' CG2' ' N ' ' A' ' 164' ' ' ILE . 3.3 tt -68.93 -50.59 52.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.449 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.473 ' N ' ' CG2' ' A' ' 163' ' ' ILE . 94.3 mt -50.99 -35.96 15.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.181 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.23 -60.52 3.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.837 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -60.92 -26.7 67.66 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.704 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.64 -33.22 73.57 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.437 ' O ' ' OD2' ' A' ' 171' ' ' ASP . 2.7 tp10 -69.1 -50.13 50.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.417 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -62.37 -51.22 68.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.153 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 24.6 mt -53.59 -42.35 49.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.419 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.437 ' OD2' ' O ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -68.34 -38.58 81.65 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.482 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -54.6 -42.2 76.07 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.87 -73.88 0.15 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.738 0.304 . . . . 0.0 110.607 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.838 -179.727 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GDP . . . . . 0.41 " H5'" ' HA ' ' A' ' 16' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 121.11 0.481 . . . . 0.0 110.453 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.492 ' NH2' ' OD2' ' A' ' 171' ' ' ASP . 0.0 OUTLIER -139.7 134.92 32.62 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.657 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -106.26 125.51 51.09 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 0.8 OUTLIER -101.27 119.98 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 121.573 0.702 . . . . 0.0 110.442 -178.77 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.5 134.89 34.83 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.48 -0.763 . . . . 0.0 111.083 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.3 mt -95.9 125.65 48.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.294 0.569 . . . . 0.0 111.447 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.2 tp -124.49 104.28 8.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.532 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -139.65 135.89 7.49 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.494 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.1 OUTLIER -52.08 -160.97 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.518 0.675 . . . . 0.0 111.144 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.7 ttt-85 -93.52 135.14 35.06 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.407 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.412 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 1.8 m 65.93 6.02 3.79 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.426 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.504 ' C ' ' HZ2' ' A' ' 120' ' ' LYS . 3.9 p -65.9 -17.97 23.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.813 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.2 25.29 37.42 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.445 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -65.26 -38.13 89.34 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.875 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.4 m -70.06 -35.52 74.29 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.464 ' OG ' ' H8 ' ' A' ' 186' ' ' GDP . 69.2 m -60.45 -43.25 97.04 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.762 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 25' ' ' GLN . 22.8 tp -68.16 -56.42 8.85 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.271 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.476 ' O ' ' CG1' ' A' ' 27' ' ' VAL . 93.3 m -38.43 -36.65 0.25 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.51 -42.9 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.78 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.706 HE22 ' ND2' ' A' ' 153' ' ' ASN . 3.0 tp-100 -63.9 -38.32 90.64 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.135 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -76.48 -61.72 1.86 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.101 0.477 . . . . 0.0 111.668 -178.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 8.6 p -48.03 -47.9 12.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.672 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.499 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 2.0 tt0 -84.16 -23.56 30.57 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 75.01 23.4 74.67 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.532 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 11.7 mp0 -148.58 129.99 14.79 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.637 ' N ' ' NE2' ' A' ' 25' ' ' GLN . 0.8 OUTLIER -61.47 94.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.977 178.512 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.445 HG22 ' H ' ' A' ' 33' ' ' ASP . 7.2 p -141.57 165.38 18.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.451 ' O ' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -97.75 -12.94 21.73 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.184 0.516 . . . . 0.0 110.358 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 33' ' ' ASP . 18.5 p 47.09 178.3 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.323 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.19 24.24 1.63 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.116 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.419 ' O ' ' O ' ' A' ' 37' ' ' PRO . 1.4 m-20 -139.36 79.87 24.23 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.324 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.535 ' C ' ' H ' ' A' ' 39' ' ' ILE . 52.0 Cg_exo -56.87 -130.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.94 2.427 . . . . 0.0 111.949 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.2 t -72.79 34.36 0.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.025 0.44 . . . . 0.0 111.239 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.535 ' H ' ' C ' ' A' ' 37' ' ' PRO . 1.5 tp -84.1 148.55 4.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.993 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.493 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 1.8 pm0 -87.37 140.81 29.16 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.723 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -174.66 -177.0 1.1 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.465 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.08 124.35 32.59 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.686 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.15 174.66 5.79 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 120.993 0.425 . . . . 0.0 110.201 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.28 162.75 34.73 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.16 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -160.04 107.18 1.63 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.309 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.35 118.58 37.0 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.195 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.427 ' N ' ' CD1' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -149.38 165.14 3.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.575 -179.721 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.6 m -109.01 127.9 54.49 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.261 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.404 ' C ' ' H ' ' A' ' 51' ' ' GLY . 6.6 p -127.61 134.08 66.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.387 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.37 3.95 3.52 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.465 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 98.35 -12.89 63.33 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -91.71 141.23 28.92 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -76.68 144.83 39.15 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.55 0.691 . . . . 0.0 111.114 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.435 ' OH ' ' OE2' ' A' ' 168' ' ' GLU . 9.7 m-85 -135.89 124.21 23.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.203 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.415 ' HD1' ' C ' ' A' ' 54' ' ' TYR . 2.6 m-70 -118.05 113.37 21.54 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mp -123.59 146.44 48.15 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.601 0.715 . . . . 0.0 112.128 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -138.78 127.03 22.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.934 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.636 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.91 153.1 34.14 Favored 'General case' 0 CA--C 1.499 -1.018 0 C-N-CA 120.251 -0.579 . . . . 0.0 111.886 -178.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.53 144.46 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.718 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.96 105.35 9.91 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.344 -1.298 . . . . 0.0 107.961 177.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.85 153.02 51.73 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.375 0.607 . . . . 0.0 110.445 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 64' ' ' GLN . . . -141.32 17.65 2.23 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.054 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -40.51 -26.67 0.13 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 62' ' ' ALA . 10.7 mm100 -140.21 -144.98 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.48 0.657 . . . . 0.0 110.919 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.765 ' O ' ' N ' ' A' ' 67' ' ' TYR . 1.4 p30 -74.68 -170.47 1.06 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.209 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.531 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 1.4 pm0 -44.73 72.38 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 124.342 1.026 . . . . 0.0 110.409 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.765 ' N ' ' O ' ' A' ' 65' ' ' ASP . 15.9 t80 64.47 3.86 2.04 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.682 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.52 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 5.4 m 35.41 100.94 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.174 0.511 . . . . 0.0 112.27 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 70' ' ' PHE . 2.4 mp -41.67 -73.32 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-O 121.496 0.665 . . . . 0.0 110.04 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.482 ' O ' ' O ' ' A' ' 71' ' ' PRO . 0.3 OUTLIER -42.36 167.59 0.06 OUTLIER Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.321 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.492 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 52.9 Cg_exo -52.38 -137.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.968 0 C-N-CA 122.614 2.209 . . . . 0.0 113.0 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.492 ' CB ' ' O ' ' A' ' 71' ' ' PRO . 3.5 tt0 84.89 57.54 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.492 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.463 ' CB ' ' O ' ' A' ' 72' ' ' GLN . 0.2 OUTLIER 79.82 -31.1 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.634 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.426 ' H ' ' C ' ' A' ' 72' ' ' GLN . 30.9 m-85 -78.41 8.43 5.12 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.567 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 76' ' ' ILE . 1.1 p -82.89 29.58 0.46 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.986 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.424 ' O ' ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -50.44 -174.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.324 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.96 50.76 2.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.464 0.65 . . . . 0.0 109.416 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.4 pt -79.03 -170.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.985 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.07 15.67 1.06 Allowed 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.356 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -146.21 164.35 28.32 Favored Glycine 0 C--O 1.229 -0.214 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.473 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.531 ' OH ' ' CD1' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -152.11 125.1 8.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.068 -0.566 . . . . 0.0 111.475 178.146 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.8 tt -131.08 104.82 9.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.62 ' H ' ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -96.6 126.17 41.59 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.525 -177.847 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -96.6 130.75 44.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.091 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.609 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 37.2 p90 -128.99 144.5 51.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.444 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.578 ' HG ' ' H ' ' A' ' 89' ' ' SER . 4.1 p -87.27 142.83 27.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.211 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.8 m -71.28 12.69 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.776 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.564 ' H ' ' HG ' ' A' ' 86' ' ' SER . 8.6 t -132.86 -20.09 2.25 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 120.892 0.377 . . . . 0.0 111.904 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.578 ' H ' ' HG ' ' A' ' 86' ' ' SER . 33.1 t -90.13 92.63 9.04 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.758 -176.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 tp -61.12 -11.19 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.534 ' H ' ' C ' ' A' ' 89' ' ' SER . 3.3 mttp -78.04 -52.01 9.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 113.351 -1.75 . . . . 0.0 110.327 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 53.5 p -60.58 -33.58 72.93 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.643 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.609 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -74.06 -49.38 24.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.281 -179.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -65.23 -42.65 93.2 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.707 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.1 m -67.42 -38.51 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.652 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.6 mt -62.25 -38.12 80.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.347 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -69.43 -29.01 66.63 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.2 t -75.83 -67.03 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.208 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.1 tt -48.3 -40.12 9.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.615 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.467 ' CE1' ' CD2' ' A' ' 141' ' ' TRP . 12.3 t-80 -58.3 -64.54 0.88 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.484 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -42.64 -60.07 2.98 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 105' ' ' ASP . 14.6 tptp -57.31 -65.22 0.66 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.855 -0.672 . . . . 0.0 110.627 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -36.83 -55.87 0.88 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.237 0.542 . . . . 0.0 109.751 179.519 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.484 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -49.64 -47.75 49.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.73 0.776 . . . . 0.0 109.365 178.753 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -61.65 -31.58 71.69 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.338 -179.252 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.506 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 50.7 ttp -67.57 -52.28 40.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.334 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.1 m -76.87 -22.93 14.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.42 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.32 28.58 0.32 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.41 -153.16 0.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.11 0.481 . . . . 0.0 111.55 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.73 -170.56 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.79 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.476 ' OE1' ' CB ' ' A' ' 173' ' ' ALA . 50.1 mt-30 -65.04 117.82 8.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.833 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.473 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -108.04 137.11 19.74 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.474 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -47.82 117.57 2.52 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.466 1.444 . . . . 0.0 112.313 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.473 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.5 mp -124.78 132.31 71.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 4.8 tpt -131.9 117.44 18.48 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.937 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.0 mt -95.75 97.4 9.67 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.0 t -103.91 133.15 48.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 122.327 1.061 . . . . 0.0 110.665 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.413 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -106.18 112.6 3.92 Favored Glycine 0 C--N 1.304 -1.229 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.188 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.524 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.1 t30 -96.98 176.94 5.78 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.898 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.524 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 8.7 mttp 63.41 58.79 1.31 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.221 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -65.03 -12.93 56.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.748 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.451 ' OD2' ' CD1' ' A' ' 123' ' ' LEU . 2.6 p-10 -81.3 -8.43 59.74 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.101 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.598 ' O ' ' N ' ' A' ' 126' ' ' GLU . 11.1 mp -98.52 -23.11 15.66 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.545 ' C ' ' H ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -26.88 -38.59 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.343 1.027 . . . . 0.0 111.284 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.543 ' N ' ' O ' ' A' ' 123' ' ' LEU . 2.0 mmt -46.85 -15.95 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.006 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 123' ' ' LEU . 18.6 mm-40 -92.58 -62.68 1.35 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.406 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.538 HH21 ' CD2' ' A' ' 124' ' ' HIS . 5.2 tpp85 26.18 65.74 0.07 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.008 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.9 t -49.01 -29.43 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.955 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.2 tp -88.82 156.36 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.877 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.523 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 74.9 p -97.85 123.09 41.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.348 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -37.77 -31.32 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.26 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.6 mp0 -71.66 -64.12 0.99 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.848 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.523 ' H ' ' HG ' ' A' ' 130' ' ' SER . 67.4 mt-10 -41.1 -40.95 1.63 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.952 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.91 -36.4 65.25 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 132' ' ' GLU . 13.8 tttm -62.39 -54.44 40.29 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.074 -0.563 . . . . 0.0 109.681 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.7 -35.76 71.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.794 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.18 -61.86 1.88 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.89 -38.01 61.25 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.17 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.43 -29.92 68.68 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.263 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.7 -46.67 81.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.989 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.479 ' CZ3' ' CD2' ' A' ' 104' ' ' LEU . 53.0 m95 -89.57 -3.49 58.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.143 0.496 . . . . 0.0 110.148 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 77.07 22.39 1.02 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.723 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.33 167.89 13.14 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.3 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.58 133.9 51.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.338 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 6.0 t80 -96.68 122.02 39.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.679 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -134.17 137.91 44.78 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.964 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.483 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 4.1 tt0 -126.24 111.5 14.65 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 27.5 p -137.66 -172.89 3.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.03 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.482 ' HG ' ' CD ' ' A' ' 152' ' ' GLU . 0.0 OUTLIER -137.98 141.48 40.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.221 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.513 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -61.66 -45.61 93.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.354 0.597 . . . . 0.0 109.4 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.445 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 15.7 tttp -65.81 5.22 0.5 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.644 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.513 ' H ' ' C ' ' A' ' 150' ' ' ALA . 43.9 mt-10 -133.85 120.4 20.39 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.836 0.351 . . . . 0.0 110.974 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.706 ' ND2' HE22 ' A' ' 25' ' ' GLN . 0.0 OUTLIER -77.57 -57.5 3.79 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.071 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 153' ' ' ASN . 9.0 tt0 -36.85 -58.43 0.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.976 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.8 p -52.06 -45.07 64.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.98 0.419 . . . . 0.0 110.045 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -56.16 -61.37 2.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.493 0.663 . . . . 0.0 109.869 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 59.7 t -40.83 -39.98 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.331 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -65.91 -38.33 88.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.149 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 156' ' ' ALA . 21.7 t -67.99 -37.31 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.55 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.402 ' CD1' ' C ' ' A' ' 160' ' ' PHE . 1.2 t80 -57.76 -65.32 0.66 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.338 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.445 ' O ' ' N ' ' A' ' 164' ' ' ILE . 1.1 ttt-85 -46.73 -64.9 0.65 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.117 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -41.66 -31.21 0.27 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.331 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -40.87 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 119.526 -0.869 . . . . 0.0 109.837 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.445 ' N ' ' O ' ' A' ' 161' ' ' ARG . 49.6 mt -63.92 -38.56 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.71 0.767 . . . . 0.0 109.961 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 168' ' ' GLU . 25.1 mt -57.63 -64.39 0.91 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.018 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -54.56 -25.39 25.79 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.53 -27.85 65.51 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 165' ' ' LEU . 3.0 tp10 -69.18 -57.85 4.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.019 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -57.76 -58.86 6.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.791 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 1.4 mp -52.86 -34.34 20.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.689 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.492 ' OD2' ' NH2' ' A' ' 7' ' ' ARG . 0.4 OUTLIER -67.39 -40.07 85.65 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.144 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -57.59 -39.6 91.21 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.476 ' CB ' ' OE1' ' A' ' 111' ' ' GLN . . . -69.41 -81.5 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.754 0.312 . . . . 0.0 110.243 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.832 179.923 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GDP . . . . . 0.464 ' H8 ' ' OG ' ' A' ' 21' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.88 0.371 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.19 137.42 34.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.057 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 5.5 mtpm? -103.48 134.36 46.97 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.93 129.01 73.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.744 -176.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.82 133.94 33.59 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.267 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.6 mt -97.58 133.87 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 120.695 0.284 . . . . 0.0 111.318 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.1 tt -130.45 97.67 4.46 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.459 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -141.18 133.41 5.81 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.431 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.9 -173.89 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -84.89 125.21 32.45 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.195 0.522 . . . . 0.0 111.427 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 75.31 12.1 3.33 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.593 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.14 -20.86 21.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.535 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.57 24.16 12.74 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.013 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.3 pttm -69.07 -36.49 77.69 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.322 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.1 m -71.86 -26.49 62.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.468 ' OG ' ' H8 ' ' A' ' 186' ' ' GDP . 55.4 m -68.29 -43.45 77.69 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.163 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.2 tp -77.65 -41.41 38.41 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.897 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.3 m -52.56 -38.83 60.66 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -78.07 -38.4 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.038 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.554 ' CG ' ' ND2' ' A' ' 153' ' ' ASN . 0.1 OUTLIER -69.51 -33.65 73.15 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.398 -179.497 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -77.98 -61.14 2.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.197 0.522 . . . . 0.0 111.047 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.473 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 14.9 p -46.39 -48.05 6.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.77 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.473 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 2.2 tt0 -84.18 -24.74 30.0 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 77.97 22.91 67.67 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.252 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -153.02 127.14 9.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.721 ' H ' HD22 ' A' ' 153' ' ' ASN . 60.1 t80 -59.5 94.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.412 178.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.9 p -123.4 166.03 18.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.983 0.42 . . . . 0.0 110.101 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 34' ' ' SER . 0.2 OUTLIER -78.01 -37.8 46.23 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.211 -179.281 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 33' ' ' ASP . 25.1 p 53.83 148.26 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.857 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -87.29 29.39 0.86 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.63 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -143.41 72.07 17.78 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.795 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 39' ' ' ILE . 46.1 Cg_exo -58.75 -131.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 123.152 2.568 . . . . 0.0 111.64 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.9 t -74.32 46.07 0.25 Allowed 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 121.77 0.795 . . . . 0.0 110.372 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.488 ' H ' ' C ' ' A' ' 37' ' ' PRO . 1.5 tp -82.76 139.75 17.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.094 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.572 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -83.48 130.44 35.02 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.821 -178.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 40' ' ' GLU . 3.9 m-20 166.88 -179.29 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.5 0.667 . . . . 0.0 112.504 -178.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.98 134.49 51.55 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.632 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -112.2 170.96 7.8 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.8 156.37 40.07 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -168.06 131.16 1.57 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.668 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.5 mp -105.97 133.29 50.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.533 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.31 165.4 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.897 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.7 m -133.24 131.16 39.97 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.802 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.468 ' C ' ' H ' ' A' ' 51' ' ' GLY . 7.6 p -133.89 136.44 53.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.296 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 61.51 2.94 0.73 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.224 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 105.18 -11.29 48.03 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -89.07 118.55 28.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.634 0.254 . . . . 0.0 110.687 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.26 144.23 28.24 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.278 0.561 . . . . 0.0 111.805 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.574 ' CD1' ' N ' ' A' ' 54' ' ' TYR . 0.5 OUTLIER -140.63 152.96 45.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.16 178.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -118.88 116.94 27.53 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.441 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.9 mp -117.38 139.36 50.96 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.748 0.785 . . . . 0.0 111.193 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -130.08 125.76 35.96 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.097 -1.41 . . . . 0.0 109.195 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.638 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -113.7 135.03 54.38 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.322 -178.747 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.487 ' CG1' ' OH ' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -118.99 139.95 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -118.83 112.97 20.37 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.626 178.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.3 p 41.96 -118.78 0.44 Allowed 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.316 0.579 . . . . 0.0 111.019 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 59.69 33.99 22.02 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.592 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.36 -158.63 27.94 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.53 ' O ' ' CD1' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -82.01 115.74 21.3 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.021 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 68' ' ' SER . 7.6 p-10 -136.72 -174.17 3.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.038 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.617 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -45.51 -46.78 14.11 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -43.39 -24.35 0.09 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.305 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 65' ' ' ASP . 81.4 p -156.64 86.26 0.99 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.742 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.531 ' O ' ' CB ' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -51.66 130.36 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.462 179.196 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.554 ' O ' ' CG ' ' A' ' 70' ' ' PHE . 6.6 t80 146.81 76.87 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.837 0 O-C-N 124.097 0.873 . . . . 0.0 109.852 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 45.3 Cg_exo -54.47 -142.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 122.97 2.447 . . . . 0.0 112.958 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.5 ' CB ' ' O ' ' A' ' 71' ' ' PRO . 0.5 OUTLIER 89.67 -8.67 0.39 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.065 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 m -158.67 15.82 0.19 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.827 0.346 . . . . 0.0 110.915 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.53 ' CD1' ' O ' ' A' ' 64' ' ' GLN . 8.3 t80 -110.19 -25.09 10.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.158 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 m 43.61 80.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.82 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.442 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 30.9 pt -70.46 -135.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.507 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 1.9 m-20 83.7 34.8 0.05 OUTLIER 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 8' ' ' LYS . 40.2 pt -83.22 -171.91 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.373 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -144.53 17.85 1.67 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.757 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.03 166.49 34.58 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.345 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.43 ' OH ' ' OE1' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -150.16 127.39 11.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.553 -0.823 . . . . 0.0 110.7 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.464 ' CG2' ' O ' ' A' ' 82' ' ' ILE . 12.3 tt -129.18 96.9 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.57 118.58 34.39 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.355 -177.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.95 111.02 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.273 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.511 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 4.1 p90 -110.66 142.39 42.61 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.416 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.63 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.5 p -88.94 141.17 28.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.429 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 19.1 m -77.58 18.05 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.771 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.59 ' H ' ' HG ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -133.99 -25.26 1.62 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.317 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.63 ' H ' ' HG ' ' A' ' 86' ' ' SER . 20.6 t -94.0 92.37 7.32 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.333 -176.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.3 tp -59.57 -10.43 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.531 ' H ' ' C ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -78.18 -54.96 5.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.247 179.004 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.1 p -55.13 -27.22 43.8 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.511 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -76.75 -39.58 51.26 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.625 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -68.23 -44.17 76.32 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.22 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.407 ' CG2' ' N ' ' A' ' 96' ' ' ILE . 2.3 m -69.37 -40.81 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.584 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.407 ' N ' ' CG2' ' A' ' 95' ' ' VAL . 18.0 mt -57.09 -51.28 71.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.292 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -72.35 -31.65 65.81 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.853 0.358 . . . . 0.0 111.412 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.8 t -73.46 -66.36 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.351 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.426 ' O ' ' C ' ' A' ' 100' ' ' HIS . 31.9 mt -48.16 -55.72 2.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.494 ' CE1' ' CE2' ' A' ' 141' ' ' TRP . 25.9 t-80 -41.16 -63.82 0.63 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.64 -52.0 1.9 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 103' ' ' LEU . 24.3 tptt -70.48 -66.66 0.57 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.386 -0.407 . . . . 0.0 111.106 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -36.71 -55.07 0.89 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.969 0.414 . . . . 0.0 109.946 179.718 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.49 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -51.91 -50.7 60.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.495 0.664 . . . . 0.0 109.449 179.157 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -51.38 -29.67 16.42 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.032 -179.382 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.467 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 17.6 ttp -77.49 -48.67 16.51 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.9 m -75.44 -25.75 18.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.781 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 40.84 37.34 1.32 Allowed Glycine 0 CA--C 1.531 1.076 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.564 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.25 -157.99 0.53 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 117.224 0.512 . . . . 0.0 111.543 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.19 -177.56 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.762 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -67.49 118.74 11.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.71 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.479 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.8 OUTLIER -117.66 152.91 50.36 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.33 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -46.45 111.42 0.36 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 121.717 1.611 . . . . 0.0 112.338 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.479 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.9 mt -121.62 131.82 72.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.1 tpt -128.01 115.78 19.03 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.623 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.9 mt -95.25 97.55 9.96 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.4 133.31 47.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 122.298 1.047 . . . . 0.0 110.996 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.41 110.23 3.41 Favored Glycine 0 C--N 1.304 -1.231 0 CA-C-N 113.459 -1.7 . . . . 0.0 109.018 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.499 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 43.8 t30 -97.23 174.04 6.92 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.818 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.499 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 2.1 mttp 67.11 59.13 0.54 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.845 0.831 . . . . 0.0 109.226 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.37 -37.49 87.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.368 -178.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.613 ' CG ' HN22 ' A' ' 186' ' ' GDP . 3.6 p-10 -59.88 -9.88 3.41 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.899 -178.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.6 mp -93.99 -29.73 15.08 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.568 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -42.03 -22.77 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.805 178.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.568 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 3.5 mmt -46.65 -23.18 0.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.478 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.3 OUTLIER -103.34 -40.48 6.38 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.218 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.497 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 5.0 tpp85 33.16 83.29 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.199 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.0 m -67.87 -29.5 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.546 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.1 tp -89.42 155.07 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.497 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.505 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 82.0 p -94.7 122.54 37.41 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.838 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -41.35 -33.66 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.404 0.621 . . . . 0.0 109.52 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.5 mp0 -65.07 -64.71 0.8 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.932 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.505 ' H ' ' HG ' ' A' ' 130' ' ' SER . 65.4 mt-10 -41.26 -43.96 2.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.023 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.16 -32.97 69.0 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 132' ' ' GLU . 20.0 tttm -65.72 -55.26 18.27 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.08 -34.04 65.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.494 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.77 -62.7 1.36 Allowed 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.841 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -55.22 -34.71 64.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.543 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.15 -34.75 75.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.735 0.302 . . . . 0.0 110.55 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.04 -46.29 88.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.906 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.494 ' CE2' ' CE1' ' A' ' 100' ' ' HIS . 56.9 m95 -88.45 -4.51 58.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.977 0.418 . . . . 0.0 110.327 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 73.88 25.1 1.97 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.619 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -90.8 168.34 11.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.42 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.32 133.89 49.34 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.794 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.43 ' C ' ' CD1' ' A' ' 145' ' ' PHE . 4.6 t80 -96.65 121.37 38.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.182 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -134.71 137.07 43.19 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.624 -176.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.497 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 5.8 tt0 -124.62 111.01 15.12 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 10.7 p -135.5 -174.96 3.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.994 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.47 132.94 32.08 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.053 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.499 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -56.26 -53.04 61.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.283 0.563 . . . . 0.0 109.732 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -49.4 -12.38 0.06 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.786 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.499 ' H ' ' C ' ' A' ' 150' ' ' ALA . 31.8 mt-10 -122.64 124.17 42.83 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.64 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.721 HD22 ' H ' ' A' ' 31' ' ' PHE . 29.1 m120 -77.71 -53.21 7.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 153' ' ' ASN . 10.7 tt0 -38.81 -57.34 1.23 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.924 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 44.2 p -51.97 -44.89 64.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.987 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -55.89 -61.58 2.28 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.566 0.698 . . . . 0.0 109.868 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 61.3 t -41.62 -39.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.518 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -67.86 -36.98 81.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.633 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.477 ' N ' ' O ' ' A' ' 156' ' ' ALA . 35.5 t -66.61 -36.24 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -62.47 -65.69 0.65 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.691 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -44.09 -53.51 6.32 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.741 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -55.81 -29.45 59.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.914 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.64 -35.95 76.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.248 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 42.5 mt -67.54 -38.19 80.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.587 0.708 . . . . 0.0 109.948 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.13 -63.23 1.37 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.748 -178.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -57.59 -31.42 66.15 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.879 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.08 -32.3 70.83 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.475 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.49 -55.07 9.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.004 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -55.45 -63.11 1.27 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.091 0.472 . . . . 0.0 110.552 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 96.7 mt -51.23 -35.36 15.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.792 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.12 -40.0 86.77 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -57.38 -32.61 64.35 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.85 -79.43 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.727 0.299 . . . . 0.0 110.297 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.153 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.275 -179.889 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GDP . . . . . 0.613 HN22 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 CA-C-O 121.073 0.463 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -139.67 135.42 33.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.939 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -106.56 130.05 54.39 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 1.0 OUTLIER -103.77 123.04 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-O 121.426 0.631 . . . . 0.0 110.479 -178.586 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.19 134.86 34.95 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.113 -0.992 . . . . 0.0 110.216 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.9 mt -96.12 133.71 36.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.502 0.667 . . . . 0.0 111.905 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.0 tt -125.18 97.67 5.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.352 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -139.89 130.56 4.74 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.009 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.425 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -57.99 -155.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.04 139.36 31.5 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.752 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.7 m 56.8 10.8 0.79 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.986 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.68 -20.84 28.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.459 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.54 22.6 18.42 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 pttm -72.2 -34.44 68.38 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.856 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.5 m -77.25 -35.19 55.58 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.569 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.06 -36.14 81.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 29.4 tp -76.88 -46.58 24.01 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.471 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.417 ' O ' ' CG1' ' A' ' 27' ' ' VAL . 71.9 m -45.07 -41.5 7.75 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.92 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.62 -41.84 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.232 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.466 ' OE1' ' CB ' ' A' ' 156' ' ' ALA . 0.5 OUTLIER -69.43 -32.31 71.2 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.492 -178.781 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.46 ' CG ' ' N ' ' A' ' 27' ' ' VAL . 0.6 OUTLIER -77.92 -63.19 1.45 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.27 0.557 . . . . 0.0 110.805 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.471 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 11.3 p -44.38 -47.59 2.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.424 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.471 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 2.5 tt0 -83.14 -24.61 32.49 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 75.12 25.63 68.37 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.288 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 25' ' ' GLN . 0.6 OUTLIER -151.61 126.37 9.62 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 120.886 0.374 . . . . 0.0 111.691 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -63.57 93.71 0.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.95 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.469 ' CG2' ' N ' ' A' ' 33' ' ' ASP . 12.7 p -107.4 165.87 4.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.26 0.553 . . . . 0.0 110.986 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.469 ' N ' ' CG2' ' A' ' 32' ' ' VAL . 0.2 OUTLIER -49.87 -13.89 0.12 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.993 -178.536 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 33' ' ' ASP . 17.5 p 42.68 97.98 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.147 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -84.71 12.09 7.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.084 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 37' ' ' PRO . 1.2 m-20 -119.84 86.71 36.52 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.033 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 36' ' ' ASP . 68.5 Cg_exo -54.29 -128.42 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.898 2.398 . . . . 0.0 112.302 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.9 t -91.84 45.44 1.22 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.311 0.577 . . . . 0.0 111.246 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 tp -84.02 142.6 13.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.654 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.426 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 1.4 pm0 -90.77 135.65 33.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.382 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 0.7 OUTLIER 178.99 -179.78 0.38 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.249 0.547 . . . . 0.0 112.079 -179.15 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.95 132.91 53.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.072 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -114.45 173.92 6.22 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.167 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.55 155.59 43.74 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -155.4 108.04 2.71 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.604 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.0 mp -105.36 122.45 45.98 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.725 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 pp -149.55 165.83 3.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.551 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.1 m -114.05 123.81 50.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.07 125.39 74.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-N 116.352 -0.386 . . . . 0.0 109.963 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 67.46 15.46 9.85 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.51 -9.95 76.02 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.37 135.71 33.51 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.39 146.99 40.37 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.597 0.713 . . . . 0.0 111.271 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.476 ' C ' ' HD1' ' A' ' 55' ' ' HIS . 4.9 m-85 -137.92 123.58 19.82 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.192 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.476 ' HD1' ' C ' ' A' ' 54' ' ' TYR . 0.4 OUTLIER -118.16 112.47 20.2 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -120.92 146.71 46.34 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.585 0.707 . . . . 0.0 112.24 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -137.56 126.93 24.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.01 178.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.644 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.72 154.51 31.57 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.253 -178.246 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.33 140.8 47.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.485 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.31 114.31 19.39 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.02 177.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.41 ' O ' ' OD2' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -131.53 172.96 11.6 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.587 0.708 . . . . 0.0 111.029 -178.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -143.61 13.04 1.72 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.985 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.426 ' O ' ' OG ' ' A' ' 68' ' ' SER . . . -92.23 -121.11 2.78 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.505 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 10.9 mp0 -82.77 72.18 9.85 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 68' ' ' SER . 35.3 p-10 -138.06 -172.3 3.23 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.091 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.547 ' OE1' ' N ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -50.66 -38.1 44.61 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.547 ' N ' ' OE1' ' A' ' 66' ' ' GLU . 41.4 t80 -48.62 -17.61 0.18 Allowed 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.535 ' N ' ' C ' ' A' ' 66' ' ' GLU . 78.9 p -160.27 84.28 0.71 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.748 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.545 ' O ' ' CD2' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -42.72 127.95 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.585 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 69' ' ' ILE . 0.6 OUTLIER 169.27 81.42 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.829 -179.733 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.92 110.24 0.38 Allowed 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.333 2.022 . . . . 0.0 112.224 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.4 -56.31 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.663 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -105.1 -19.75 13.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.666 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.502 ' C ' ' H ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -87.33 24.38 1.63 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.12 0.486 . . . . 0.0 109.822 179.534 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -77.66 23.42 0.23 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.292 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.502 ' H ' ' C ' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -51.21 -172.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.888 179.729 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.83 49.6 2.21 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.7 pt -78.73 -174.88 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.691 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.39 20.35 0.84 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.137 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -147.95 164.79 28.89 Favored Glycine 0 CA--C 1.517 0.218 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.682 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.2 123.21 7.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.754 -0.723 . . . . 0.0 111.165 178.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.9 tt -126.85 110.37 22.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.577 ' CD2' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.79 119.1 36.97 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.236 -177.331 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.6 133.07 42.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.075 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.474 ' CD2' ' CE2' ' A' ' 93' ' ' PHE . 8.4 p90 -143.32 144.6 32.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.973 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.613 ' C ' ' H ' ' A' ' 88' ' ' THR . 2.2 t -88.24 143.25 27.15 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.853 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.2 m -67.18 14.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.972 0.415 . . . . 0.0 110.259 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.613 ' H ' ' C ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -127.78 -18.13 4.35 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.53 -178.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.697 ' HG ' ' H ' ' A' ' 92' ' ' SER . 8.6 t -94.95 92.02 6.68 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.447 -175.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.9 tp -62.97 -11.44 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 89' ' ' SER . 1.0 OUTLIER -78.32 -58.63 3.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 113.712 -1.585 . . . . 0.0 110.576 178.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.697 ' H ' ' HG ' ' A' ' 89' ' ' SER . 19.0 p -55.38 -31.62 61.94 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.398 0.618 . . . . 0.0 109.539 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.474 ' CE2' ' CD2' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -77.72 -38.1 47.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.195 179.677 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -69.21 -46.79 66.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.477 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.439 ' CG2' ' N ' ' A' ' 96' ' ' ILE . 2.8 m -67.8 -45.23 84.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.59 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.439 ' N ' ' CG2' ' A' ' 95' ' ' VAL . 33.3 mt -58.41 -46.14 89.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.24 -37.73 69.06 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.097 0.475 . . . . 0.0 111.06 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 56.0 t -72.11 -65.3 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.672 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.408 ' O ' ' C ' ' A' ' 100' ' ' HIS . 73.3 mt -42.3 -59.12 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.915 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.554 ' HD1' ' N ' ' A' ' 101' ' ' GLY . 4.3 t-80 -40.98 -64.98 0.47 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.752 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.554 ' N ' ' HD1' ' A' ' 100' ' ' HIS . . . -36.6 -56.71 1.25 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 103' ' ' LEU . 32.8 tptt -69.8 -66.5 0.58 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.472 -0.364 . . . . 0.0 111.611 -179.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 106' ' ' MET . 5.8 tp -36.98 -61.83 0.53 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.501 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -44.5 -50.67 9.38 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.787 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.474 ' N ' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -53.6 -26.65 22.76 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.448 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 103' ' ' LEU . 3.9 tpp -72.96 -53.72 10.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.903 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.0 m -77.31 -20.87 14.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.384 -0.527 . . . . 0.0 110.837 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 42.07 37.89 2.41 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.593 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.2 tptp -84.44 -154.65 0.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.178 0.513 . . . . 0.0 111.46 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.62 -173.83 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.993 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -67.95 116.97 9.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.689 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.476 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.8 OUTLIER -118.52 155.84 51.77 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.343 179.242 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -47.04 111.43 0.39 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.813 1.675 . . . . 0.0 112.254 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.476 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.7 mt -121.84 127.3 75.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 6.6 tpt -128.62 117.23 20.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.09 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.7 mt -95.95 97.79 9.9 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.413 ' O ' ' CE1' ' A' ' 85' ' ' TYR . 29.8 t -104.92 128.56 58.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 122.175 0.988 . . . . 0.0 111.319 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.457 ' CA ' ' CE2' ' A' ' 85' ' ' TYR . . . -102.65 114.5 4.91 Favored Glycine 0 C--N 1.307 -1.04 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.535 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 49.1 t30 -97.8 177.16 5.55 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.698 -178.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.535 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 19.4 mttt 61.91 59.17 1.77 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.071 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -64.92 -17.99 64.83 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.639 ' CG ' HN22 ' A' ' 186' ' ' GDP . 5.5 p-10 -79.24 0.65 27.74 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.844 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 125' ' ' MET . 9.2 mp -95.88 -25.43 16.01 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.544 ' HD1' HH11 ' A' ' 127' ' ' ARG . 0.2 OUTLIER -37.39 -28.19 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.531 178.449 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.521 ' N ' ' O ' ' A' ' 123' ' ' LEU . 9.3 mtt -45.43 -23.58 0.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.519 ' CD ' ' HG1' ' A' ' 88' ' ' THR . 0.4 OUTLIER -108.98 -38.83 5.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.844 179.397 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.544 HH11 ' HD1' ' A' ' 124' ' ' HIS . 0.0 OUTLIER 28.68 86.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.173 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.9 m -72.79 -31.65 37.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.451 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.42 151.8 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.779 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.629 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 94.4 p -104.21 126.39 51.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.153 0.501 . . . . 0.0 111.417 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.455 ' CE1' ' CE1' ' A' ' 145' ' ' PHE . 0.8 OUTLIER -39.95 -38.86 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.313 178.738 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -63.21 -64.85 0.79 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.236 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.629 ' H ' ' HG ' ' A' ' 130' ' ' SER . 59.8 mt-10 -41.08 -46.54 2.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.116 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.42 -33.2 76.72 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 132' ' ' GLU . 21.4 tttm -63.87 -55.42 22.92 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.12 -35.75 69.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.674 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.416 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -66.79 -62.42 1.46 Allowed 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 121.18 0.514 . . . . 0.0 109.779 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.04 -36.61 50.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.288 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -68.12 -32.52 72.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.755 0.312 . . . . 0.0 110.26 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.64 ' HG ' ' N ' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -63.89 -46.15 86.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.844 -179.442 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.64 ' N ' ' HG ' ' A' ' 140' ' ' SER . 49.7 m95 -88.26 -4.51 58.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.345 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 74.63 27.52 1.31 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.399 0.618 . . . . 0.0 109.411 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -95.46 170.01 9.65 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.57 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.92 133.07 52.79 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.018 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.455 ' CE1' ' CE1' ' A' ' 131' ' ' TYR . 8.3 t80 -97.24 122.33 40.14 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.445 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -134.58 136.37 42.92 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.713 -176.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.467 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 5.8 tt0 -123.38 111.95 16.99 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.7 p -137.33 -175.74 4.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.752 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.26 136.51 35.01 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.908 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.459 ' N ' ' O6 ' ' A' ' 186' ' ' GDP . . . -57.49 -47.41 81.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.274 0.559 . . . . 0.0 109.827 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -56.08 -8.43 0.46 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.449 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.456 ' H ' ' C ' ' A' ' 150' ' ' ALA . 30.4 mt-10 -127.53 124.4 38.16 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.806 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 156' ' ' ALA . 5.4 t-20 -77.72 -55.87 4.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.02 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 153' ' ' ASN . 1.6 mt-30 -36.73 -57.74 0.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.103 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 58.8 p -52.88 -45.25 67.4 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.085 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.466 ' CB ' ' OE1' ' A' ' 25' ' ' GLN . . . -56.21 -61.67 2.24 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.595 0.712 . . . . 0.0 109.934 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 60.6 t -42.77 -39.18 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.534 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -68.77 -33.79 74.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.788 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.46 ' N ' ' O ' ' A' ' 156' ' ' ALA . 44.6 t -67.61 -39.38 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.074 0.464 . . . . 0.0 109.815 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.509 ' O ' ' N ' ' A' ' 163' ' ' ILE . 66.5 t80 -63.55 -66.24 0.57 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.779 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.0 ttt85 -43.34 -46.47 6.47 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.667 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -58.06 -32.64 68.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.16 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.509 ' N ' ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -66.22 -34.8 72.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.26 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.1 mt -63.78 -44.1 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.423 0.63 . . . . 0.0 111.295 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -58.79 -64.67 0.85 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.045 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.42 ' H ' HD21 ' A' ' 165' ' ' LEU . 0.4 OUTLIER -50.52 -23.83 2.77 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.676 -178.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.77 -31.18 66.35 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.559 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 165' ' ' LEU . 0.5 OUTLIER -70.29 -52.21 24.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.08 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -61.09 -63.56 1.25 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.883 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 96.4 mt -50.95 -32.7 12.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.94 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.02 -39.09 86.96 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.484 -0.487 . . . . 0.0 109.908 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -59.48 -35.54 85.78 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.403 ' O ' ' C ' ' A' ' 174' ' ' ALA . . . -68.39 -78.56 0.06 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 173' ' ' ALA . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.025 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GDP . . . . . 0.639 HN22 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 121.223 0.535 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -140.27 135.55 32.39 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.905 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.619 ' HZ3' ' NE2' ' A' ' 57' ' ' GLN . 15.2 mttm -107.3 127.63 53.72 Favored 'General case' 0 C--O 1.212 -0.896 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -103.02 118.47 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-O 121.691 0.758 . . . . 0.0 110.773 -178.352 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.431 ' O ' HG21 ' A' ' 82' ' ' ILE . . . -82.73 137.75 34.29 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.691 -0.631 . . . . 0.0 111.848 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.1 mt -92.92 125.82 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.183 0.516 . . . . 0.0 111.92 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tt -123.19 92.33 3.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.896 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 66' ' ' GLU . . . -142.03 136.82 7.53 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -178.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.474 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.5 OUTLIER -53.09 -160.17 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.699 0.762 . . . . 0.0 111.31 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.8 tpp85 -97.11 136.0 38.28 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.701 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.3 m 63.28 11.5 5.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.567 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 p -71.94 -16.84 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.16 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.62 21.35 34.5 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -39.25 81.11 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.359 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.7 m -71.89 -28.65 63.65 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.464 ' OG ' ' H8 ' ' A' ' 186' ' ' GDP . 60.3 m -63.73 -42.42 97.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.199 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.4 tp -75.53 -28.41 59.08 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.464 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.0 m -55.94 -49.92 72.18 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.477 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 1.4 mp -70.9 -41.04 77.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.075 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.467 ' OE1' ' CB ' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -65.67 -30.24 70.9 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.23 -179.169 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -77.79 -64.02 1.25 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.452 0.644 . . . . 0.0 111.353 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 14.1 p -49.65 -47.2 21.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.375 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.474 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 0.8 OUTLIER -83.66 -24.36 31.38 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.372 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.17 25.99 71.86 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -144.47 125.45 14.42 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.187 0.518 . . . . 0.0 112.297 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.625 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -71.65 92.53 1.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.801 179.164 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.464 ' CG2' ' N ' ' A' ' 33' ' ' ASP . 12.5 p -117.05 165.83 12.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.206 0.527 . . . . 0.0 110.568 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.464 ' N ' ' CG2' ' A' ' 32' ' ' VAL . 1.0 OUTLIER -87.51 20.51 2.86 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.295 -179.052 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 33' ' ' ASP . 5.0 p -30.03 131.46 0.08 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.798 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.73 100.58 12.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.336 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -166.62 82.95 0.94 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.524 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -58.42 -135.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.753 2.302 . . . . 0.0 112.127 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.471 ' O ' ' CG2' ' A' ' 38' ' ' THR . 1.6 t -101.24 46.06 0.95 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.986 0.898 . . . . 0.0 111.385 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 tp -82.48 167.1 2.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.228 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.22 116.78 14.16 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.019 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -160.35 161.7 33.23 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.808 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.5 m -132.52 149.62 52.29 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.266 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 10.9 m-85 -129.63 164.48 23.79 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.72 150.36 35.22 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.148 0.499 . . . . 0.0 111.997 -178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -153.17 119.19 5.42 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.06 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.01 123.86 48.8 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.127 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -145.51 165.63 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.221 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.36 121.85 44.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.224 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.404 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 8.5 p -114.59 114.66 47.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.92 179.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 49' ' ' VAL . 4.3 t-20 73.72 11.83 4.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.398 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.82 -8.14 63.37 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.672 ' NE2' ' H ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -93.74 135.17 35.31 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.672 ' H ' ' NE2' ' A' ' 52' ' ' GLN . 2.4 mt-10 -74.35 145.48 43.81 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.577 0.704 . . . . 0.0 111.252 -178.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -136.18 127.07 27.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.183 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -117.63 112.87 21.11 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.0 mp -118.46 139.12 51.91 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.537 0.684 . . . . 0.0 111.575 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.619 ' NE2' ' HZ3' ' A' ' 8' ' ' LYS . 1.9 mt-30 -132.16 121.0 23.02 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.098 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.651 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -114.64 155.21 26.98 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.761 -178.214 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.12 145.95 31.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -177.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.494 ' O ' ' OG1' ' A' ' 61' ' ' THR . 0.3 OUTLIER -122.04 117.51 26.53 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 113.504 -1.68 . . . . 0.0 107.898 177.525 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.645 ' C ' ' H ' ' A' ' 63' ' ' GLY . 20.3 p 55.88 178.7 0.04 OUTLIER 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 123.546 0.528 . . . . 0.0 109.771 -177.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 52.85 12.48 0.27 Allowed 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.645 ' H ' ' C ' ' A' ' 61' ' ' THR . . . -150.22 -157.75 7.89 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 113.9 -1.5 . . . . 0.0 111.681 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.561 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 6.8 mp0 -86.23 86.95 7.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.235 0.54 . . . . 0.0 110.73 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.458 ' H ' ' HG ' ' A' ' 68' ' ' SER . 21.3 p-10 -139.71 -176.67 4.65 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.977 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.525 ' OE1' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -60.36 -9.24 3.29 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.53 ' CD2' ' OH ' ' A' ' 74' ' ' TYR . 32.3 t80 -94.67 12.17 28.65 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.458 ' HG ' ' H ' ' A' ' 65' ' ' ASP . 1.3 p -158.13 152.22 24.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.218 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.402 ' H ' ' H ' ' A' ' 70' ' ' PHE . 3.9 tt -166.23 -11.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 121.815 0.817 . . . . 0.0 109.386 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 70' ' ' PHE . 28.5 t80 -116.59 85.22 16.27 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.477 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.481 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 51.3 Cg_exo -51.66 -163.25 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.551 2.167 . . . . 0.0 112.516 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.481 ' CB ' ' O ' ' A' ' 71' ' ' PRO . 1.8 tt0 81.29 -20.06 0.39 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.288 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.5 m -128.73 -15.41 4.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.65 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.549 ' CD2' ' O ' ' A' ' 63' ' ' GLY . 0.8 OUTLIER -94.93 -22.39 18.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.507 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 75' ' ' SER . 0.4 OUTLIER 55.25 87.32 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.459 179.448 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.427 ' HB ' HE21 ' A' ' 64' ' ' GLN . 1.1 pt -92.46 173.6 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 121.022 0.439 . . . . 0.0 111.274 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 170.35 29.13 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.076 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 8' ' ' LYS . 38.3 pt -85.56 -171.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-O 121.405 0.622 . . . . 0.0 112.664 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.56 19.81 1.04 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.437 178.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.96 168.1 33.89 Favored Glycine 0 CA--C 1.521 0.45 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.187 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.15 122.76 7.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.985 -0.608 . . . . 0.0 110.709 177.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.431 HG21 ' O ' ' A' ' 10' ' ' ALA . 11.0 tt -125.34 102.3 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.716 0.77 . . . . 0.0 109.312 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.586 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.8 OUTLIER -97.15 125.72 41.84 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.794 -178.56 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -95.51 130.66 43.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.303 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -110.56 143.75 40.47 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.14 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.545 ' C ' ' H ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -98.21 124.13 42.63 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.1 m -72.51 23.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.71 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.545 ' H ' ' C ' ' A' ' 86' ' ' SER . 5.1 t -138.36 -25.57 0.93 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 91' ' ' LYS . 8.3 t -100.2 95.06 6.55 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.051 -176.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.1 tp -57.86 -11.66 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 175.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.563 ' H ' ' C ' ' A' ' 89' ' ' SER . 18.5 mttp -77.74 -61.51 1.97 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 113.936 -1.483 . . . . 0.0 110.23 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.44 ' O ' ' CD1' ' A' ' 96' ' ' ILE . 76.5 p -47.17 -29.59 2.4 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.723 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.41 ' CE2' ' CG2' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -74.07 -51.41 15.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.179 -179.365 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -65.79 -43.96 87.17 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.6 m -68.07 -36.5 75.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.12 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.44 ' CD1' ' O ' ' A' ' 92' ' ' SER . 19.2 mt -63.35 -38.84 83.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -69.68 -25.97 64.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.03 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 57.4 t -76.46 -66.47 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.338 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.5 mm -44.27 -54.36 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.431 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.637 ' ND1' ' CH2' ' A' ' 141' ' ' TRP . 2.0 t-80 -61.45 -64.51 0.92 Allowed 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.805 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.531 ' N ' ' ND1' ' A' ' 100' ' ' HIS . . . -35.39 -57.29 0.91 Allowed Glycine 0 N--CA 1.454 -0.141 0 CA-C-N 116.24 -0.437 . . . . 0.0 112.053 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 103' ' ' LEU . 15.4 tptm -69.69 -65.01 0.77 Allowed 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.359 -0.42 . . . . 0.0 110.736 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.45 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.7 OUTLIER -36.88 -60.87 0.59 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.097 0.475 . . . . 0.0 109.872 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.485 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -46.65 -47.01 20.26 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 178.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -59.27 -30.68 68.48 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.56 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.477 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 2.1 tpp -65.18 -55.02 20.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.84 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.2 m -76.59 -23.21 15.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.451 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.45 37.64 1.83 Allowed Glycine 0 CA--C 1.531 1.059 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.607 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -152.88 0.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.156 0.503 . . . . 0.0 111.46 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.33 -174.75 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.767 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -66.96 117.14 8.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.72 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.481 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.8 OUTLIER -118.62 153.67 52.25 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.233 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -48.04 117.06 2.26 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.582 1.521 . . . . 0.0 111.953 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.481 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.4 mp -122.81 126.45 73.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 8.4 tpt -122.31 112.53 18.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.497 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 73.2 mt -96.67 98.86 10.52 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.6 t -108.45 133.67 52.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 122.04 0.924 . . . . 0.0 112.62 -178.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -97.93 114.29 4.96 Favored Glycine 0 C--N 1.315 -0.615 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.429 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 50.5 t30 -98.09 170.08 9.17 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -177.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.429 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 25.8 mttt 61.02 57.37 2.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.274 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.526 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 9.2 ttpt -57.73 -29.06 64.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.418 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.611 ' CG ' HN22 ' A' ' 186' ' ' GDP . 4.8 p-10 -67.5 -16.79 64.39 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.295 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.1 mp -82.01 -31.26 31.11 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.603 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.1 OUTLIER -37.74 -24.71 0.01 OUTLIER 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.366 178.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.603 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 2.7 mmt -48.24 -22.53 0.68 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.44 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -109.0 -37.68 5.76 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.827 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.445 ' NH1' ' OE1' ' A' ' 147' ' ' GLU . 0.2 OUTLIER 27.16 91.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.034 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 38.7 t -70.79 -45.81 71.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.055 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.41 ' CG2' ' CE2' ' A' ' 93' ' ' PHE . 8.7 tp -91.55 153.54 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.577 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.438 ' OG ' ' OE1' ' A' ' 133' ' ' GLU . 4.1 p -104.51 126.17 51.35 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.3 0.571 . . . . 0.0 111.329 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.638 ' CD1' ' CE1' ' A' ' 145' ' ' PHE . 0.7 OUTLIER -49.41 -43.67 44.71 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.815 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 131' ' ' TYR . 1.2 mp0 -39.07 -63.11 0.56 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.344 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.438 ' OE1' ' OG ' ' A' ' 130' ' ' SER . 11.7 mt-10 -52.24 -37.18 54.48 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 131' ' ' TYR . . . -72.27 -22.23 78.97 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 131' ' ' TYR . 0.3 OUTLIER -75.91 -54.68 6.53 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.478 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -54.49 -37.53 65.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.362 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.6 OUTLIER -69.61 -63.72 1.02 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -42.41 -32.95 0.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.27 -48.67 67.02 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.867 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -66.96 -27.82 67.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.475 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.637 ' CH2' ' ND1' ' A' ' 100' ' ' HIS . 22.8 m0 -86.67 -10.94 52.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.69 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.23 27.16 16.92 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -104.15 166.05 10.65 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.24 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -102.62 127.84 49.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.211 0.529 . . . . 0.0 112.115 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.638 ' CE1' ' CD1' ' A' ' 131' ' ' TYR . 11.3 t80 -99.36 118.67 36.52 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.109 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.03 133.12 22.88 Favored 'General case' 0 C--N 1.347 0.491 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.445 ' OE1' ' NH1' ' A' ' 127' ' ' ARG . 3.1 mt-10 -98.47 115.09 27.78 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.875 -0.515 . . . . 0.0 109.838 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.46 ' CB ' ' OG1' ' A' ' 155' ' ' THR . 0.5 OUTLIER -140.54 134.88 31.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.705 -179.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 152' ' ' GLU . 4.0 p -102.29 142.4 33.57 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.466 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -55.53 -55.28 33.67 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.688 178.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 31.3 tttt -46.84 -15.11 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.998 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.466 ' H ' ' C ' ' A' ' 150' ' ' ALA . 60.9 mt-10 -126.0 120.12 29.46 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.973 0.416 . . . . 0.0 110.868 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 154' ' ' GLN . 9.7 t-20 -77.1 -47.48 20.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 153' ' ' ASN . 1.4 mt-30 -36.92 -58.91 0.74 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.229 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.46 ' OG1' ' CB ' ' A' ' 148' ' ' SER . 1.2 p -56.49 -42.69 78.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.289 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.467 ' CB ' ' OE1' ' A' ' 25' ' ' GLN . . . -53.78 -60.75 2.92 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.555 0.693 . . . . 0.0 109.938 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 49.2 t -45.84 -44.12 4.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.561 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -53.9 -45.18 71.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.265 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.2 t -65.59 -49.48 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.423 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.479 ' O ' HG21 ' A' ' 163' ' ' ILE . 1.3 t80 -45.61 -37.5 5.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.807 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.1 ttt-85 -79.14 -50.27 11.28 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.375 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -34.29 69.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.278 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.479 HG21 ' O ' ' A' ' 160' ' ' PHE . 11.8 tt -67.9 -54.6 21.43 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.944 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.476 ' N ' ' CG2' ' A' ' 163' ' ' ILE . 90.8 mt -47.38 -34.6 3.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 119.219 -0.992 . . . . 0.0 109.425 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.66 -64.33 0.95 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.059 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -57.12 -30.64 64.56 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.227 -0.589 . . . . 0.0 109.42 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.96 -32.68 69.85 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.41 -53.14 25.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.383 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 12.6 tttm -59.14 -65.02 0.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.883 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 74.6 mt -48.74 -35.04 6.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.678 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -67.21 -37.33 83.43 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.03 -30.89 76.82 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.75 -79.54 0.05 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.191 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.768 179.88 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GDP . . . . . 0.611 HN22 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 121.265 0.555 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.23 136.68 33.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.312 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.42 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 22.6 mtmt -107.35 130.02 54.84 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 1.1 mm -108.77 121.07 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-O 121.342 0.592 . . . . 0.0 110.277 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.62 135.55 35.03 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.259 -0.9 . . . . 0.0 110.533 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.7 mt -95.54 131.69 41.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.415 0.626 . . . . 0.0 112.09 -178.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.408 ' C ' ' CD2' ' A' ' 12' ' ' LEU . 5.5 tt -132.34 99.09 4.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.719 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.87 135.57 6.81 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -52.45 -165.42 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.49 0.662 . . . . 0.0 110.791 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -100.33 138.09 37.86 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.487 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.52 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 1.3 m 67.66 20.52 9.56 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.36 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 p -90.08 -21.52 6.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.042 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.44 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 108.33 26.25 5.49 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.463 ' CB ' ' NZ ' ' A' ' 19' ' ' LYS . 1.3 ttmp? -60.76 -49.21 78.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.147 0.499 . . . . 0.0 110.094 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -75.98 -25.45 55.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.254 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 54.3 p -65.62 -44.99 84.8 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.453 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 23' ' ' THR . 20.4 tp -76.33 -58.39 3.31 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 119.784 -0.767 . . . . 0.0 110.975 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 22' ' ' LEU . 90.3 m -39.02 -48.68 1.65 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.961 -0.295 . . . . 0.0 110.705 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.488 ' N ' ' CD1' ' A' ' 24' ' ' ILE . 1.3 mp -74.62 -35.31 37.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 123.356 0.41 . . . . 0.0 111.34 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.449 HE22 ' HB1' ' A' ' 156' ' ' ALA . 0.8 OUTLIER -69.6 -37.74 77.01 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.964 -178.589 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.631 ' CZ ' ' CD1' ' A' ' 160' ' ' PHE . 20.0 t80 -77.15 -59.55 2.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.291 0.567 . . . . 0.0 111.342 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 9.5 p -48.71 -47.19 15.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.57 -178.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.49 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 2.0 tt0 -85.13 -24.42 28.02 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.38 35.76 63.29 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -130.34 125.05 33.68 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.371 0.605 . . . . 0.0 111.641 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.718 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -73.19 94.13 1.93 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.66 -179.633 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.9 165.42 14.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.326 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.437 ' O ' ' O ' ' A' ' 34' ' ' SER . 0.5 OUTLIER -107.96 18.3 21.4 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.161 -179.2 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 33' ' ' ASP . 32.6 p 50.05 175.23 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.661 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -152.08 -60.82 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.941 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -53.72 167.89 0.45 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.366 -179.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 36' ' ' ASP . 52.9 Cg_exo -56.4 -135.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.475 2.117 . . . . 0.0 112.068 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.475 ' O ' ' CG2' ' A' ' 38' ' ' THR . 8.9 t -129.72 65.81 1.48 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.46 0.648 . . . . 0.0 110.107 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.8 tp -82.46 157.62 3.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.605 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.443 ' CB ' ' O ' ' A' ' 60' ' ' ASP . 2.0 pt-20 -90.61 153.27 20.45 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.34 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.409 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 1.3 m120 178.72 173.91 0.68 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.215 0.531 . . . . 0.0 111.83 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.91 143.4 36.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.567 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.441 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 12.3 m-85 -127.33 165.9 18.84 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.588 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.61 147.16 33.96 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 120.227 -0.589 . . . . 0.0 112.404 -178.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.425 ' C ' ' CD1' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -162.32 114.61 1.68 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.679 178.864 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.604 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -115.16 142.39 46.72 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.821 -1.082 . . . . 0.0 111.159 -177.688 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -150.77 165.73 2.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.274 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 m -108.33 124.04 49.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.758 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.94 122.76 68.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.139 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 69.65 12.98 8.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.043 0.449 . . . . 0.0 109.954 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.5 -11.37 70.23 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -89.55 133.25 34.69 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -77.39 147.43 36.05 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.522 0.677 . . . . 0.0 111.172 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -137.66 130.73 30.43 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.011 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -116.54 117.54 30.17 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.6 140.7 51.91 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.449 0.642 . . . . 0.0 112.019 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.52 124.41 22.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.097 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.641 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.25 154.95 30.3 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.152 0.501 . . . . 0.0 112.065 -178.717 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.27 145.47 35.28 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-N 115.125 -0.943 . . . . 0.0 113.01 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.443 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -123.34 102.66 8.04 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.009 177.646 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.452 ' OG1' ' OH ' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -98.64 161.29 13.74 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.036 -178.708 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 63' ' ' GLY . . . -132.21 20.75 4.43 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.278 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 62' ' ' ALA . . . -31.94 -72.6 0.07 OUTLIER Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.373 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -144.64 -90.47 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.661 0.743 . . . . 0.0 110.459 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.565 ' OD1' ' N ' ' A' ' 68' ' ' SER . 4.1 p30 -77.37 -173.64 2.96 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.535 -1.212 . . . . 0.0 110.118 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.553 ' O ' ' CB ' ' A' ' 67' ' ' TYR . 3.5 mm-40 -62.89 43.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.918 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.564 ' H ' ' C ' ' A' ' 65' ' ' ASP . 26.1 t80 97.05 74.85 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 O-C-N 124.368 1.043 . . . . 0.0 109.38 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.565 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 1.7 m -60.6 130.58 47.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.456 -178.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.665 ' CD1' ' H ' ' A' ' 69' ' ' ILE . 3.2 mp -61.32 -127.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.269 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.621 ' H ' ' CG2' ' A' ' 69' ' ' ILE . 5.2 m-85 40.24 81.25 0.25 Allowed Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 120.884 -0.327 . . . . 0.0 110.353 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -47.1 -7.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.419 2.08 . . . . 0.0 112.484 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.535 ' H ' ' C ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -42.03 -68.47 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.827 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.416 ' N ' HE21 ' A' ' 72' ' ' GLN . 0.0 OUTLIER -78.11 -33.9 50.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.692 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.452 ' OH ' ' OG1' ' A' ' 61' ' ' THR . 0.3 OUTLIER -93.28 103.6 15.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.568 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.5 m -81.37 55.98 2.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.456 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.1 pt -49.69 163.25 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-O 121.324 0.583 . . . . 0.0 111.747 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 p30 175.52 29.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.953 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.42 ' HB ' ' O ' ' A' ' 8' ' ' LYS . 22.7 pt -87.45 -167.66 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -145.91 16.43 1.4 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.653 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.63 164.38 29.85 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.582 -178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.477 ' OH ' ' CD2' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -151.71 123.44 7.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.891 -0.655 . . . . 0.0 110.944 178.268 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 11.7 tt -127.26 104.83 13.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.552 0.691 . . . . 0.0 109.696 178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.406 ' H ' HD13 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -97.7 120.98 39.06 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.406 -178.684 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 t -97.19 114.14 33.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.675 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.505 ' CZ ' ' CA ' ' A' ' 118' ' ' GLY . 48.7 p90 -115.52 145.08 42.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.608 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.64 ' HG ' ' H ' ' A' ' 88' ' ' THR . 1.6 p -86.99 143.16 27.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.452 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.2 m -80.98 17.67 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 120.998 0.428 . . . . 0.0 110.256 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.64 ' H ' ' HG ' ' A' ' 86' ' ' SER . 7.4 t -130.26 -19.59 3.12 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.406 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.586 ' H ' ' HG ' ' A' ' 86' ' ' SER . 20.9 t -98.95 93.78 6.2 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.298 -176.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.7 tp -58.7 -11.82 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.573 ' H ' ' C ' ' A' ' 89' ' ' SER . 12.9 mttp -77.97 -54.39 6.35 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.442 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.1 p -53.93 -32.28 53.06 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.038 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.78 -51.0 17.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.025 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.28 -42.62 92.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.876 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 17.7 m -65.48 -40.12 87.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.307 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mt -63.0 -32.17 55.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.2 tttm -69.85 -26.47 64.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.101 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.4 t -77.24 -67.13 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.957 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.409 ' N ' ' CD1' ' A' ' 99' ' ' ILE . 1.6 mp -44.26 -38.18 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.245 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.636 ' CD2' ' CZ2' ' A' ' 141' ' ' TRP . 7.3 t60 -66.6 -64.22 0.9 Allowed 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.788 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.556 ' N ' ' CD2' ' A' ' 100' ' ' HIS . . . -35.69 -50.69 1.07 Allowed Glycine 0 C--N 1.329 0.159 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.431 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 17.5 tptm -70.73 -61.15 1.87 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.966 -0.617 . . . . 0.0 110.554 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 106' ' ' MET . 0.6 OUTLIER -42.09 -60.23 1.5 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.462 0.648 . . . . 0.0 109.394 179.638 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.495 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -45.98 -44.29 14.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.23 178.51 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -60.52 -32.67 71.69 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.943 179.812 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.495 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 4.6 ttm -58.93 -56.65 19.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.727 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.529 ' C ' ' H ' ' A' ' 109' ' ' LYS . 16.9 m -77.11 -13.55 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.251 0.548 . . . . 0.0 109.865 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.45 -24.99 0.1 OUTLIER Glycine 0 CA--C 1.53 0.989 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.92 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.541 ' CG ' ' H ' ' A' ' 110' ' ' VAL . 7.2 tttp -173.28 -131.88 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 117.705 0.753 . . . . 0.0 111.732 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.541 ' H ' ' CG ' ' A' ' 109' ' ' LYS . 6.7 t 52.34 116.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.61 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -77.63 126.06 30.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.007 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.432 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.5 OUTLIER -132.67 152.72 80.43 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.264 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -47.84 110.51 0.32 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.949 1.766 . . . . 0.0 112.478 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 3.0 mt -126.51 131.8 70.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 6.2 tpt -129.84 116.97 19.46 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.863 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.9 mt -95.69 98.11 10.23 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.5 t -102.41 126.15 56.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 122.066 0.936 . . . . 0.0 112.144 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.505 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -97.36 115.89 5.37 Favored Glycine 0 C--N 1.31 -0.913 0 N-CA-C 108.067 -2.013 . . . . 0.0 108.067 177.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.522 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 52.6 t30 -96.97 175.89 6.17 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.165 -0.614 . . . . 0.0 112.105 -177.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.522 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 15.6 mttt 58.84 58.2 3.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.632 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.546 ' O ' ' CG ' ' A' ' 124' ' ' HIS . 16.2 ttmt -58.73 -30.8 67.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.362 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.599 ' CG ' HN22 ' A' ' 186' ' ' GDP . 5.1 p-10 -64.83 -27.07 68.63 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.199 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.4 mp -71.52 -29.88 65.28 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.624 ' ND1' ' N ' ' A' ' 125' ' ' MET . 0.6 OUTLIER -35.93 -29.23 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.498 179.207 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.624 ' N ' ' ND1' ' A' ' 124' ' ' HIS . 1.0 OUTLIER -45.11 -24.89 0.28 Allowed 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.709 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.483 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -103.64 -41.02 6.08 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.584 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.537 HH21 ' CB ' ' A' ' 124' ' ' HIS . 32.2 ttm-85 28.16 80.97 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.201 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.4 t -57.72 -53.93 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.055 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.5 tp -86.45 153.13 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.76 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.432 ' OG ' ' OE1' ' A' ' 133' ' ' GLU . 1.1 p -87.22 120.77 28.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.365 0.602 . . . . 0.0 111.407 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.621 ' CE1' ' CD1' ' A' ' 145' ' ' PHE . 0.3 OUTLIER -50.18 -47.32 54.57 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.389 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 131' ' ' TYR . 1.6 mp0 -40.28 -60.58 1.05 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.833 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.432 ' OE1' ' OG ' ' A' ' 130' ' ' SER . 26.9 mt-10 -50.61 -38.01 43.39 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.484 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 131' ' ' TYR . . . -69.23 -34.12 74.74 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -67.06 -54.65 19.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.76 -35.93 69.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.39 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.509 ' CD2' ' CE2' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -67.07 -64.32 0.88 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.516 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -45.82 -37.27 5.94 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.7 -40.82 88.64 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER -64.68 -34.15 77.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.231 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.636 ' CZ2' ' CD2' ' A' ' 100' ' ' HIS . 38.5 m0 -87.0 -7.23 58.35 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 70.51 25.32 4.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.988 -178.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -103.97 166.71 10.24 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.644 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.07 133.5 49.75 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.098 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.621 ' CD1' ' CE1' ' A' ' 131' ' ' TYR . 7.5 t80 -97.26 121.04 38.7 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.466 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -132.2 130.63 41.28 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.69 -177.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.503 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 4.5 mt-10 -110.27 112.34 24.23 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.942 0.401 . . . . 0.0 109.978 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 49.4 p -139.73 179.29 6.67 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.362 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 152' ' ' GLU . 6.0 p -139.17 133.92 32.08 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.501 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.426 ' N ' ' O6 ' ' A' ' 186' ' ' GDP . . . -54.91 -40.31 69.71 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -54.03 -42.11 68.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.059 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 149' ' ' SER . 13.3 tt0 -100.7 117.27 34.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.235 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 154' ' ' GLN . 0.7 OUTLIER -76.43 -42.58 43.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.185 -179.518 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 153' ' ' ASN . 5.3 tt0 -41.1 -47.83 3.25 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.099 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 63.2 p -62.83 -44.95 94.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.91 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.449 ' HB1' HE22 ' A' ' 25' ' ' GLN . . . -51.2 -64.36 0.84 Allowed 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.62 0.724 . . . . 0.0 109.465 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.0 t -45.12 -35.73 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.837 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -67.85 -41.03 83.58 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.551 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' A' ' 156' ' ' ALA . 19.4 t -62.69 -43.5 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-O 120.937 0.399 . . . . 0.0 110.399 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.631 ' CD1' ' CZ ' ' A' ' 26' ' ' PHE . 1.1 t80 -59.32 -61.23 2.79 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.727 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.53 -48.82 4.0 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.781 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.43 -26.87 68.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.534 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -68.26 -34.08 64.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.046 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 20.2 mt -71.41 -38.73 69.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.684 0.754 . . . . 0.0 109.787 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.31 -63.38 1.3 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.013 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -53.59 -36.21 61.68 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.462 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -55.95 -32.33 63.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -68.48 -57.69 5.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.671 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.77 -63.16 1.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.619 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 68.9 mt -50.37 -34.36 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.914 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.83 -40.31 75.93 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.468 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -58.15 -36.63 83.06 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.71 -65.63 0.68 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.758 0.313 . . . . 0.0 110.383 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.517 179.88 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GDP . . . . . 0.599 HN22 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 120.993 0.425 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -140.04 136.63 33.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.702 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -102.51 133.43 47.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -110.16 129.49 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.429 -177.325 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.28 133.32 33.7 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 121.627 -0.67 . . . . 0.0 110.144 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.2 mt -98.24 133.69 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.15 0.5 . . . . 0.0 112.123 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.424 ' C ' ' CD2' ' A' ' 12' ' ' LEU . 3.8 tt -126.4 99.43 5.83 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.341 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -140.3 133.21 5.86 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.5 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.68 -179.03 0.16 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.982 0.42 . . . . 0.0 110.003 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -76.33 131.88 39.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.026 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.4 m 63.81 16.28 9.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.721 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.532 ' C ' ' HZ3' ' A' ' 120' ' ' LYS . 10.5 p -72.42 -13.15 16.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.393 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.68 23.12 29.17 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.128 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.488 ' HZ1' ' HG1' ' A' ' 38' ' ' THR . 19.4 pttm -69.65 -30.34 68.02 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.969 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.8 m -77.5 -34.44 54.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.434 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 61.2 m -65.29 -42.41 93.17 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.635 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.0 tp -77.8 -36.7 50.02 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.3 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 97.2 m -55.45 -38.57 69.21 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -73.82 -39.42 52.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.223 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.582 ' CG ' HD21 ' A' ' 153' ' ' ASN . 5.2 tt0 -70.29 -27.63 64.56 Favored 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.933 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 1.3 t80 -77.46 -60.26 2.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.4 0.619 . . . . 0.0 110.875 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 14.9 p -52.71 -45.92 49.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.043 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.439 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 1.3 tm-20 -84.19 -24.61 30.04 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.474 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 78.77 19.61 72.81 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.748 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.546 ' NE2' ' O ' ' A' ' 31' ' ' PHE . 15.7 tp60 -154.26 134.06 12.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.161 -0.616 . . . . 0.0 112.258 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.546 ' O ' ' NE2' ' A' ' 30' ' ' GLN . 1.0 OUTLIER -65.54 93.81 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.453 178.576 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 34' ' ' SER . 10.6 p -107.29 166.08 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.212 0.53 . . . . 0.0 110.485 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.471 ' N ' ' CG2' ' A' ' 32' ' ' VAL . 0.2 OUTLIER -44.66 -14.34 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.944 -178.642 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 32' ' ' VAL . 15.3 p 39.78 86.34 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.208 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -86.99 27.0 1.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.373 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 37' ' ' PRO . 3.8 t70 -115.92 92.02 33.18 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.246 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 36' ' ' ASP . 60.0 Cg_exo -54.5 -131.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.644 2.229 . . . . 0.0 112.407 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.488 ' HG1' ' HZ1' ' A' ' 19' ' ' LYS . 13.4 t -112.86 50.11 0.9 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.338 0.59 . . . . 0.0 111.696 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 tp -84.26 158.39 3.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.409 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.505 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 1.8 pm0 -85.52 124.22 31.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.819 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -170.51 -178.45 2.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.455 0.645 . . . . 0.0 112.348 -178.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.93 131.93 46.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.22 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -108.47 171.33 7.48 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.464 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.3 150.95 37.55 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 37.8 tptt -154.12 116.44 4.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.84 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.527 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 7.0 mp -105.85 125.01 50.48 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.203 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.76 165.58 10.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.799 0.333 . . . . 0.0 110.585 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.4 m -117.7 123.82 47.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.878 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 p -127.15 132.12 70.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.67 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 70.59 7.35 6.18 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.05 -10.39 71.9 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -93.98 139.17 31.25 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -77.21 148.04 36.07 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.59 0.71 . . . . 0.0 111.41 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.467 ' C ' ' HD1' ' A' ' 55' ' ' HIS . 14.5 m-85 -139.35 124.47 18.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.215 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.467 ' HD1' ' C ' ' A' ' 54' ' ' TYR . 1.8 m-70 -117.32 114.15 23.17 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.2 mp -126.05 150.82 47.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.508 0.67 . . . . 0.0 111.67 -178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.29 133.15 36.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.941 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.637 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -114.64 144.28 43.68 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.639 -179.018 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.02 130.26 72.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.757 0.789 . . . . 0.0 112.89 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -123.23 106.4 10.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.349 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.481 ' CG2' ' OH ' ' A' ' 74' ' ' TYR . 21.3 p -129.21 -166.86 1.7 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.302 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -148.6 23.69 1.0 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.102 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.431 ' O ' ' OG ' ' A' ' 68' ' ' SER . . . -94.62 -132.6 6.76 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.668 ' NE2' ' H ' ' A' ' 64' ' ' GLN . 0.9 OUTLIER -83.66 66.46 9.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.529 0.68 . . . . 0.0 110.356 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.663 ' O ' ' N ' ' A' ' 68' ' ' SER . 8.5 p-10 -138.57 -177.22 4.76 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.442 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.535 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 1.2 pm0 -37.95 -31.9 0.05 Allowed 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.183 0.516 . . . . 0.0 109.814 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.528 ' CG ' ' O ' ' A' ' 67' ' ' TYR . 2.6 t80 -54.27 -13.85 0.99 Allowed 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.897 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.663 ' N ' ' O ' ' A' ' 65' ' ' ASP . 16.4 p -165.5 -7.49 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.535 ' N ' ' O ' ' A' ' 65' ' ' ASP . 0.4 OUTLIER 45.13 115.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.925 0.869 . . . . 0.0 111.122 -177.766 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' A' ' 69' ' ' ILE . 0.8 OUTLIER -178.17 87.79 0.23 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.358 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.88 131.9 35.69 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.396 2.064 . . . . 0.0 112.559 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -172.89 -72.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.449 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.9 m -141.16 12.24 2.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.82 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.481 ' OH ' ' CG2' ' A' ' 61' ' ' THR . 0.3 OUTLIER -111.24 4.63 19.33 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.873 -179.526 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -82.28 -15.62 52.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.409 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.499 ' O ' ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER 26.87 -153.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 178.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.3 p30 -130.28 51.62 2.09 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.6 pt -75.55 173.85 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.315 -178.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -150.19 28.11 0.75 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.839 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.37 167.39 35.04 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.299 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.75 127.7 11.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.088 -0.556 . . . . 0.0 111.83 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.475 ' CG2' ' O ' ' A' ' 82' ' ' ILE . 13.2 tt -132.72 96.44 2.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.478 0.656 . . . . 0.0 109.35 177.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.573 ' H ' ' CD2' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -98.17 117.66 33.05 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.089 -178.795 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -96.44 117.69 41.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.345 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.448 ' CZ ' ' CA ' ' A' ' 118' ' ' GLY . 35.7 p90 -111.22 144.19 40.77 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.568 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.649 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.3 p -86.95 138.23 31.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.73 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.0 m -71.94 17.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.611 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.53 ' H ' ' C ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -138.11 -21.07 1.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.747 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.649 ' H ' ' HG ' ' A' ' 86' ' ' SER . 21.3 t -93.18 93.99 8.56 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.141 -176.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.8 tp -60.57 -8.36 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 176.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.586 ' H ' ' C ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -77.48 -59.55 2.73 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.755 179.181 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 86' ' ' SER . 18.9 p -54.12 -29.39 44.81 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.335 0.588 . . . . 0.0 109.566 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.2 -39.87 47.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.669 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -68.59 -42.98 77.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.263 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 m -67.38 -40.41 84.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.562 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.2 mt -55.05 -43.65 70.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 121.212 -0.195 . . . . 0.0 110.686 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -69.23 -35.03 75.74 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.239 0.543 . . . . 0.0 110.761 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.419 ' O ' ' C ' ' A' ' 99' ' ' ILE . 58.4 t -71.58 -65.63 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.319 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.419 ' C ' ' O ' ' A' ' 98' ' ' VAL . 1.4 mp -38.02 -54.38 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.026 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.483 ' CE1' ' CG ' ' A' ' 141' ' ' TRP . 1.1 t-160 -46.4 -64.06 0.85 Allowed 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.457 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 100' ' ' HIS . . . -35.14 -58.45 0.8 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.467 ' O ' ' C ' ' A' ' 103' ' ' LEU . 16.5 tptp -69.82 -65.83 0.67 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.355 -0.422 . . . . 0.0 110.992 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 106' ' ' MET . 0.2 OUTLIER -36.48 -63.02 0.42 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.021 0.438 . . . . 0.0 109.895 179.671 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.479 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -44.35 -50.83 8.95 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -52.26 -31.3 31.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.373 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.481 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 3.9 ttm -65.68 -51.44 59.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.378 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.558 ' C ' ' H ' ' A' ' 109' ' ' LYS . 24.2 m -76.6 -13.78 14.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.83 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 63.39 -23.91 0.08 OUTLIER Glycine 0 CA--C 1.532 1.104 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.911 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.558 ' H ' ' C ' ' A' ' 107' ' ' VAL . 3.6 tptp -171.77 -142.08 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.67 0.735 . . . . 0.0 111.444 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.54 ' H ' ' CG ' ' A' ' 109' ' ' LYS . 4.7 t 52.96 120.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.51 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -73.96 117.98 16.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.756 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.482 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -108.57 132.02 21.4 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.569 179.553 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -48.2 123.04 8.32 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.384 1.39 . . . . 0.0 111.901 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.482 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.5 mp -123.91 130.83 73.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 6.7 tpt -128.4 117.27 21.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.793 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 mt -95.83 97.82 9.96 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.1 t -105.5 128.4 59.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 122.136 0.969 . . . . 0.0 111.446 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.448 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -100.25 111.84 4.28 Favored Glycine 0 C--N 1.308 -1.006 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.504 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 53.4 t30 -97.75 173.56 7.05 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.684 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.532 ' HZ3' ' C ' ' A' ' 17' ' ' VAL . 5.9 mtpp 61.96 58.38 1.91 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.909 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.534 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 0.5 OUTLIER -60.28 -25.51 65.78 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.568 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.609 ' CG ' HN22 ' A' ' 186' ' ' GDP . 4.2 p-10 -67.53 -9.87 46.5 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.204 -179.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 125' ' ' MET . 11.2 mp -97.2 -25.35 15.32 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.534 ' ND1' ' O ' ' A' ' 121' ' ' LYS . 2.3 p-80 -36.94 -28.57 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.66 178.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.525 ' N ' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -44.39 -23.14 0.09 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.519 ' CD ' ' HG1' ' A' ' 88' ' ' THR . 0.2 OUTLIER -107.66 -40.68 5.24 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.69 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.462 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 22.1 ttm180 24.63 84.33 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.192 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 46.2 t -53.77 -35.35 26.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.308 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.4 tp -88.61 155.92 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.68 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.611 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 89.1 p -100.89 126.68 47.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.682 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -39.54 -33.29 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.796 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.6 mp0 -69.73 -65.3 0.73 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.73 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.611 ' H ' ' HG ' ' A' ' 130' ' ' SER . 62.4 mt-10 -41.41 -40.12 1.66 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.731 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.69 -37.54 67.25 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 132' ' ' GLU . 4.0 tmtt? -61.15 -55.32 33.71 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.66 -36.34 69.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.77 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.54 -61.78 1.9 Allowed 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.19 -37.36 54.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.109 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.01 -34.83 79.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.597 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.58 -46.4 86.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.891 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.483 ' CG ' ' CE1' ' A' ' 100' ' ' HIS . 66.5 m95 -90.58 4.79 50.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.523 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 62.69 31.01 16.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.637 0.732 . . . . 0.0 109.623 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -94.33 167.82 11.29 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.283 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -106.53 132.97 51.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.272 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.432 ' C ' ' CD1' ' A' ' 145' ' ' PHE . 6.4 t80 -96.89 121.59 38.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.478 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -134.69 137.36 43.49 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.872 -176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.462 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 2.4 mt-10 -125.4 111.56 15.27 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 20.8 p -137.43 -176.29 4.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.039 -178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.0 135.26 34.1 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.063 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.525 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -61.95 -29.47 70.26 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.25 0.548 . . . . 0.0 109.643 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -69.39 0.92 4.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.139 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.416 ' H ' ' C ' ' A' ' 150' ' ' ALA . 25.1 mt-10 -141.54 128.51 20.68 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.728 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.582 HD21 ' CG ' ' A' ' 25' ' ' GLN . 6.1 t-20 -77.52 -54.32 6.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.198 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 153' ' ' ASN . 1.1 mt-30 -36.75 -56.19 0.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.092 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 50.5 p -56.14 -42.69 77.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.031 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 153' ' ' ASN . . . -57.7 -61.39 2.55 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.441 0.639 . . . . 0.0 110.196 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 59.7 t -42.55 -40.15 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.582 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -66.74 -36.61 82.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.783 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.435 ' N ' ' O ' ' A' ' 156' ' ' ALA . 25.7 t -66.14 -41.29 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.007 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.447 ' O ' ' N ' ' A' ' 163' ' ' ILE . 22.7 t80 -59.66 -65.51 0.66 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.647 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.81 -55.82 2.91 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.789 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -51.83 -31.46 27.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.821 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -66.5 -37.21 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.416 -179.6 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.5 mt -68.97 -31.97 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 121.421 0.629 . . . . 0.0 110.133 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.53 -59.79 4.68 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.719 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 114' ' ' ILE . 6.1 pt-20 -59.24 -30.25 68.12 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.515 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.46 -32.24 71.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.442 ' O ' ' OD1' ' A' ' 171' ' ' ASP . 0.0 OUTLIER -71.33 -41.4 69.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.04 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 15.7 tptt -70.19 -58.67 3.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.314 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.47 -52.17 49.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.321 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 172' ' ' GLY . 1.6 p-10 -67.58 -26.78 66.44 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.363 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 171' ' ' ASP . . . -60.28 -44.44 97.5 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.38 -67.97 0.46 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.806 0.336 . . . . 0.0 110.497 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.715 -179.795 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GDP . . . . . 0.609 HN22 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 120.974 0.416 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.402 ' NH2' ' OD1' ' A' ' 171' ' ' ASP . 0.0 OUTLIER -139.87 135.97 33.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.457 -179.392 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -104.16 122.39 45.24 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -104.02 118.54 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-O 121.617 0.722 . . . . 0.0 109.917 -179.068 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.452 ' HB1' ' CE1' ' A' ' 81' ' ' TYR . . . -84.02 134.68 34.62 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 121.191 -0.943 . . . . 0.0 111.339 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.0 mt -95.36 126.88 47.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.705 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.2 tp -127.02 102.0 6.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.499 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -139.21 135.31 7.22 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -53.84 -161.04 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.418 0.628 . . . . 0.0 110.804 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -96.01 130.96 42.87 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.854 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m 67.45 14.6 9.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.748 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.48 ' C ' ' NZ ' ' A' ' 120' ' ' LYS . 7.6 p -76.93 -12.76 14.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.483 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.535 ' CA ' ' HG ' ' A' ' 21' ' ' SER . . . 102.21 12.35 34.01 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.42 ' CB ' ' NZ ' ' A' ' 19' ' ' LYS . 0.8 OUTLIER -46.82 -48.71 20.77 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.678 0.275 . . . . 0.0 111.122 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -76.99 -26.45 53.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.924 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.535 ' HG ' ' CA ' ' A' ' 18' ' ' GLY . 78.3 p -68.49 -49.4 59.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.549 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.6 tp -78.15 -30.7 49.37 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.271 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.1 m -62.59 -47.86 81.95 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.5 mp -68.28 -34.87 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.981 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 150' ' ' ALA . 2.9 tt0 -74.2 -25.39 59.66 Favored 'General case' 0 C--O 1.215 -0.718 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.639 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 1.4 t80 -76.69 -57.97 3.55 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.473 0.654 . . . . 0.0 110.398 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 11.5 p -57.17 -49.19 80.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.425 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.458 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 1.2 tm-20 -80.13 -24.81 40.23 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.463 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 77.75 23.49 66.96 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.822 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.412 ' OE1' ' O ' ' A' ' 31' ' ' PHE . 1.7 pp0? -153.32 138.43 17.34 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 119.345 -0.942 . . . . 0.0 112.72 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.491 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 27.6 t80 -58.8 118.21 5.47 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.456 178.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.47 ' CG2' ' N ' ' A' ' 33' ' ' ASP . 12.4 p -94.04 166.48 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.917 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.47 ' N ' ' CG2' ' A' ' 32' ' ' VAL . 0.4 OUTLIER -49.16 -26.41 2.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.935 -179.536 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.8 p 39.7 77.57 0.05 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.174 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -152.4 34.71 0.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.593 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.65 172.92 3.15 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.285 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -63.62 -147.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.247 1.965 . . . . 0.0 111.247 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.454 ' O ' ' CG2' ' A' ' 38' ' ' THR . 11.7 t -131.02 61.01 1.64 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.164 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.8 tp -82.93 158.5 3.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.255 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.419 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 4.2 pt-20 -86.27 149.36 25.12 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.438 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 1.8 m120 -170.94 179.03 3.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.543 0.687 . . . . 0.0 112.6 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.444 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 0.8 OUTLIER -127.09 145.89 50.57 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.165 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.529 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 7.3 m-85 -133.5 163.75 28.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.991 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.27 149.87 36.99 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -149.03 112.48 5.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.016 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.586 ' CD2' ' HD1' ' A' ' 55' ' ' HIS . 6.4 mp -108.02 120.95 43.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.068 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 pp -147.59 165.56 5.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.795 0.331 . . . . 0.0 111.009 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 m -112.46 126.77 55.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.637 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.457 ' C ' ' H ' ' A' ' 51' ' ' GLY . 7.6 p -124.07 133.83 68.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.809 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 63.5 3.85 1.59 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.114 0.483 . . . . 0.0 109.722 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 103.11 -14.05 55.52 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.609 ' NE2' ' N ' ' A' ' 53' ' ' GLU . 35.3 tp60 -90.1 141.28 28.84 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.609 ' N ' ' NE2' ' A' ' 52' ' ' GLN . 2.1 mt-10 -76.96 149.89 35.94 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.401 0.619 . . . . 0.0 111.051 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -141.23 124.18 16.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.114 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.586 ' HD1' ' CD2' ' A' ' 46' ' ' LEU . 9.7 t60 -117.69 113.89 22.54 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.1 mp -120.66 140.81 51.06 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.695 0.76 . . . . 0.0 111.637 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -133.07 123.39 25.68 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.251 -1.341 . . . . 0.0 109.502 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.633 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.89 154.02 31.53 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.04 -178.656 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.92 145.13 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.264 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.66 103.27 10.53 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.708 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.548 ' C ' ' H ' ' A' ' 63' ' ' GLY . 68.8 p -59.46 -99.61 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.769 0.795 . . . . 0.0 110.45 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.433 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . 70.24 -10.49 0.66 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.186 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.548 ' H ' ' C ' ' A' ' 61' ' ' THR . . . -77.0 -10.57 86.19 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.539 HE22 ' CG ' ' A' ' 71' ' ' PRO . 20.9 mt-30 -142.49 -148.69 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.168 0.509 . . . . 0.0 110.138 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.619 ' O ' ' N ' ' A' ' 67' ' ' TYR . 2.5 p30 -76.86 -172.84 2.43 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.601 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.531 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -59.77 71.33 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.688 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.619 ' N ' ' O ' ' A' ' 65' ' ' ASP . 62.8 t80 57.94 64.68 1.47 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.937 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.577 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 1.1 m -40.97 134.68 1.91 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.55 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.537 ' N ' ' CD1' ' A' ' 69' ' ' ILE . 1.9 mp -88.7 83.28 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER 179.62 -54.62 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.862 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.539 ' CG ' HE22 ' A' ' 64' ' ' GLN . 83.8 Cg_exo -40.72 139.64 1.24 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.186 1.924 . . . . 0.0 112.316 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.57 -40.14 9.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.36 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 m -82.36 -20.22 37.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.365 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.6 35.58 3.28 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.37 0.605 . . . . 0.0 110.458 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 76' ' ' ILE . 8.7 t -153.98 -18.55 0.13 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.98 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.486 ' O ' ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER 28.83 -155.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 178.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.591 ' O ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -119.36 -24.75 6.27 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.528 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.591 ' O ' ' O ' ' A' ' 77' ' ' ASP . 31.3 pt 29.65 -164.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 O-C-N 124.148 0.905 . . . . 0.0 112.902 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -152.0 16.76 0.66 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.78 164.07 32.98 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.966 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.542 ' OH ' ' CG ' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -152.29 122.86 7.33 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.672 -0.764 . . . . 0.0 110.589 178.107 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 8.8 tt -122.6 98.5 5.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.617 ' H ' ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.37 126.57 42.69 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.174 -178.261 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -95.51 121.03 45.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.845 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.536 ' C ' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -110.06 147.5 33.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.276 -0.874 . . . . 0.0 108.994 179.356 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.713 ' HG ' ' H ' ' A' ' 88' ' ' THR . 0.3 OUTLIER -108.29 144.19 36.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.99 0.424 . . . . 0.0 112.051 -177.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.2 m -81.45 15.86 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.255 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.713 ' H ' ' HG ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -136.7 -16.1 1.54 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -177.223 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 91' ' ' LYS . 28.9 t -112.35 93.5 4.47 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-O 121.378 0.608 . . . . 0.0 110.304 -177.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.3 tp -54.84 -13.54 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.563 ' H ' ' C ' ' A' ' 89' ' ' SER . 0.6 OUTLIER -79.1 -45.88 19.15 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.421 178.549 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.584 ' HG ' ' H ' ' A' ' 86' ' ' SER . 89.1 p -59.05 -46.71 87.56 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.483 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -79.14 -32.91 44.55 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 119.0 -1.08 . . . . 0.0 112.215 -178.439 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -66.3 -47.18 74.43 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.908 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.3 m -65.28 -34.82 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.457 -0.497 . . . . 0.0 109.881 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 96' ' ' ILE . 2.0 mt -60.94 -36.83 74.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.701 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -70.52 -29.26 65.71 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.996 0.427 . . . . 0.0 109.94 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 99' ' ' ILE . 14.0 t -72.23 -66.63 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.4 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.437 ' C ' ' O ' ' A' ' 98' ' ' VAL . 1.3 mp -38.55 -60.26 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.612 ' CE1' ' CG ' ' A' ' 141' ' ' TRP . 12.8 t-80 -43.05 -64.9 0.55 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.125 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -36.77 -66.51 0.48 Allowed Glycine 0 CA--C 1.518 0.233 0 CA-C-O 121.521 0.511 . . . . 0.0 112.047 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 103' ' ' LEU . 21.2 tptm -60.92 -61.08 2.84 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.765 -0.717 . . . . 0.0 110.527 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 102' ' ' LYS . 7.4 tp -36.14 -67.24 0.17 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.379 0.609 . . . . 0.0 109.6 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.566 ' CD2' ' CZ3' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -42.88 -48.62 5.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.57 179.027 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -59.39 -31.22 69.05 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.456 -179.179 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.436 ' N ' ' O ' ' A' ' 103' ' ' LEU . 41.7 ttp -69.57 -49.85 50.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.584 -178.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.4 m -76.99 -25.47 15.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.536 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 40.71 37.22 1.24 Allowed Glycine 0 CA--C 1.53 0.999 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.56 -156.19 0.56 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.262 0.553 . . . . 0.0 111.888 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -82.62 -167.6 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.921 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -68.98 119.82 13.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.678 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.6 mt -109.96 134.6 20.64 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.526 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -46.71 109.21 0.19 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.238 1.292 . . . . 0.0 112.295 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.5 mt -123.17 135.75 62.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.538 ' SD ' ' O ' ' A' ' 144' ' ' ALA . 2.4 tpp -137.65 123.59 20.17 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.394 0.616 . . . . 0.0 110.873 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.499 ' N ' ' SD ' ' A' ' 115' ' ' MET . 5.4 mt -97.88 107.3 19.76 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.623 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.7 t -103.23 127.74 56.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 121.863 0.84 . . . . 0.0 112.181 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.419 ' CA ' ' CE2' ' A' ' 85' ' ' TYR . . . -97.03 103.63 2.92 Favored Glycine 0 C--N 1.311 -0.831 0 N-CA-C 107.816 -2.113 . . . . 0.0 107.816 176.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.484 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.7 t30 -96.8 173.89 7.08 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.049 -177.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.484 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 7.1 mtpp 63.64 59.29 1.2 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.228 -178.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.46 ' HZ1' ' HG ' ' A' ' 149' ' ' SER . 0.0 OUTLIER -68.63 0.15 4.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.348 -178.449 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -82.59 -37.32 25.21 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.449 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.537 ' CD2' ' N ' ' A' ' 123' ' ' LEU . 1.0 OUTLIER -83.87 -18.11 38.58 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.081 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.526 ' C ' ' ND1' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -39.13 -27.92 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.002 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.504 ' N ' ' O ' ' A' ' 123' ' ' LEU . 9.5 mtt -42.1 -31.27 0.35 Allowed 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.41 ' N ' ' C ' ' A' ' 124' ' ' HIS . 1.3 pt-20 -87.8 -42.41 12.59 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.295 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 124' ' ' HIS . 6.0 tpt85 55.94 72.3 0.5 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.267 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.7 t -52.7 -64.35 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.57 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 10.7 tp -86.89 153.22 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.44 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 35.8 p -88.24 137.67 32.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.278 0.561 . . . . 0.0 112.343 -178.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -53.5 -33.24 53.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.139 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -69.06 -65.8 0.66 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.194 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.44 ' H ' ' HG ' ' A' ' 130' ' ' SER . 45.3 mt-10 -42.83 -40.12 2.76 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.63 -35.02 62.67 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 132' ' ' GLU . 3.5 tptm -62.0 -57.29 12.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -55.28 -36.18 65.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.783 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.412 ' O ' ' OG ' ' A' ' 140' ' ' SER . 0.7 OUTLIER -65.45 -61.13 2.28 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.419 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.56 -40.62 62.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.932 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.62 -30.86 71.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.654 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 137' ' ' LEU . 24.8 p -63.72 -46.79 83.83 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.965 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.612 ' CG ' ' CE1' ' A' ' 100' ' ' HIS . 34.3 m95 -91.15 -0.58 57.73 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.778 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 3.5 m120 72.5 36.13 1.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.952 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -100.05 163.3 12.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.423 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.538 ' O ' ' SD ' ' A' ' 115' ' ' MET . . . -102.18 128.34 48.72 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.501 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.429 ' C ' ' CD1' ' A' ' 145' ' ' PHE . 6.2 t80 -98.09 118.43 34.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.755 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -131.76 126.83 35.41 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.41 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 1.8 mt-10 -109.12 112.79 25.16 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.13 0.491 . . . . 0.0 110.197 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.1 p -136.43 -173.16 3.33 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.647 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.46 ' HG ' ' HZ1' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -139.03 141.6 38.26 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.068 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.544 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -65.66 -49.15 69.66 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -49.42 -10.27 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.841 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.504 ' H ' ' C ' ' A' ' 150' ' ' ALA . 23.7 tt0 -129.04 127.27 41.23 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.813 0.339 . . . . 0.0 110.916 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.466 HD21 ' CG ' ' A' ' 25' ' ' GLN . 4.0 t-20 -77.78 -55.43 5.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.116 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 153' ' ' ASN . 10.3 tt0 -37.94 -53.13 1.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.932 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 54.9 p -56.74 -41.54 77.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.97 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 153' ' ' ASN . . . -57.38 -62.94 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.624 0.726 . . . . 0.0 109.993 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.1 t -44.95 -37.55 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.443 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -62.29 -42.78 99.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.575 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 11.9 t -60.06 -45.28 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.696 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.434 ' O ' ' N ' ' A' ' 163' ' ' ILE . 53.6 t80 -56.66 -65.38 0.62 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.084 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.1 ttm-85 -41.44 -58.05 2.0 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.178 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.79 -31.65 17.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.755 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 160' ' ' PHE . 0.3 OUTLIER -69.18 -34.21 62.16 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.392 -179.758 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 12.6 mt -63.07 -38.07 81.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.937 0.875 . . . . 0.0 109.102 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -64.72 0.82 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.284 -1.325 . . . . 0.0 111.543 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.71 -33.37 70.11 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.464 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.38 -31.48 67.7 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -67.86 -56.07 10.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.428 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 13.5 tttm -59.03 -63.74 1.19 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.954 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 72.2 mt -47.26 -37.15 4.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.59 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.402 ' OD1' ' NH2' ' A' ' 7' ' ' ARG . 11.6 t70 -69.25 -40.17 78.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.147 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.89 -40.42 57.48 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.37 -77.5 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.329 . . . . 0.0 110.26 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.026 -179.99 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GDP . . . . . 0.444 ' O1A' ' N ' ' A' ' 21' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 121.186 0.517 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.506 ' NH2' ' OD2' ' A' ' 171' ' ' ASP . 12.0 mtt180 -139.94 136.12 33.51 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.784 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -105.99 129.49 54.1 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 0.8 OUTLIER -101.36 121.28 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-O 121.393 0.616 . . . . 0.0 110.647 -178.435 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.432 ' O ' HG21 ' A' ' 82' ' ' ILE . . . -83.12 135.04 34.96 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.469 -0.77 . . . . 0.0 110.742 -178.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.9 mt -95.08 128.6 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 CA-C-O 121.759 0.79 . . . . 0.0 111.353 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mp -127.26 94.52 4.02 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 113.975 -1.466 . . . . 0.0 110.252 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -140.54 136.01 7.38 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 -179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.494 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.1 OUTLIER -51.69 -161.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.395 0.617 . . . . 0.0 110.823 179.513 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.22 137.46 33.37 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.138 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.5 m 59.78 19.45 8.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.809 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 p -76.05 -21.64 15.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.876 0.369 . . . . 0.0 110.386 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.95 25.39 11.46 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -71.75 -32.09 67.35 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.353 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.9 m -78.12 -35.83 48.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.777 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.519 ' OG ' ' N7 ' ' A' ' 186' ' ' GDP . 79.5 p -62.02 -48.3 80.91 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.475 ' O ' ' N ' ' A' ' 25' ' ' GLN . 15.5 tp -63.44 -53.34 53.75 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.656 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 22' ' ' LEU . 50.4 m -38.07 -40.82 0.52 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.43 -40.8 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.053 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.585 ' OE1' ' N ' ' A' ' 31' ' ' PHE . 3.1 tp-100 -62.65 -41.06 98.84 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.535 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.512 ' C ' ' CD1' ' A' ' 26' ' ' PHE . 0.4 OUTLIER -76.67 -60.7 2.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.169 0.509 . . . . 0.0 111.828 -178.048 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.454 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 13.2 p -45.51 -44.03 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.037 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.454 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 2.1 mm-40 -92.01 -23.7 19.45 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.433 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 71.34 26.02 74.26 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -148.99 142.03 24.84 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.585 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 0.6 OUTLIER -78.13 93.65 4.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.924 177.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.521 ' C ' ' H ' ' A' ' 34' ' ' SER . 9.3 p -109.04 166.35 4.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.212 0.529 . . . . 0.0 110.869 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.463 ' N ' ' CG2' ' A' ' 32' ' ' VAL . 0.3 OUTLIER -50.06 -8.59 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.8 -178.766 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.521 ' H ' ' C ' ' A' ' 32' ' ' VAL . 6.4 p 38.53 83.27 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.213 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -86.02 22.71 1.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.519 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 10.8 t0 -139.21 76.49 32.17 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.301 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.476 ' C ' ' H ' ' A' ' 39' ' ' ILE . 25.4 Cg_exo -64.1 -138.11 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 123.052 2.501 . . . . 0.0 112.026 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.9 t -74.93 47.41 0.34 Allowed 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.895 0.855 . . . . 0.0 110.513 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.476 ' H ' ' C ' ' A' ' 37' ' ' PRO . 1.5 tp -82.18 143.86 11.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 114.263 -1.335 . . . . 0.0 107.969 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.22 120.32 23.56 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.721 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 173.93 174.42 0.16 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 119.439 -0.904 . . . . 0.0 113.043 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.14 147.31 32.67 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.291 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -121.58 173.84 7.16 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.428 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.52 161.0 43.0 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -178.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -162.67 110.59 1.31 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.892 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.0 mp -106.9 119.69 40.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.664 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 pp -147.95 166.09 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.663 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.3 m -111.28 126.15 54.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.239 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.481 ' C ' ' H ' ' A' ' 51' ' ' GLY . 14.9 p -122.06 135.92 60.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.724 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 62.12 3.9 1.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.042 0.449 . . . . 0.0 109.839 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 102.3 -13.31 57.08 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.617 ' NE2' ' H ' ' A' ' 53' ' ' GLU . 39.5 tp60 -91.49 141.75 28.39 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.617 ' H ' ' NE2' ' A' ' 52' ' ' GLN . 1.8 mt-10 -76.5 146.19 38.65 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.416 0.626 . . . . 0.0 111.229 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.549 ' C ' ' HD1' ' A' ' 55' ' ' HIS . 11.7 m-85 -138.71 123.47 18.69 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.142 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.549 ' HD1' ' C ' ' A' ' 54' ' ' TYR . 1.6 m-70 -117.64 113.92 22.63 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mp -118.72 144.22 46.38 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.617 0.722 . . . . 0.0 112.374 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -134.1 124.29 25.89 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.09 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.642 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.65 155.1 30.47 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 120.264 -0.574 . . . . 0.0 112.402 -178.214 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.82 144.82 35.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.429 ' O ' ' OG1' ' A' ' 61' ' ' THR . 0.4 OUTLIER -121.86 124.68 44.7 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.073 178.314 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 60' ' ' ASP . 31.4 p 50.46 -113.2 0.66 Allowed 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.627 0.727 . . . . 0.0 110.381 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 41.36 34.65 0.36 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.727 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.36 -113.9 0.59 Allowed Glycine 0 CA--C 1.523 0.584 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.374 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.557 ' O ' ' CG ' ' A' ' 74' ' ' TYR . 19.4 mm100 -118.84 126.24 51.37 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.739 0.78 . . . . 0.0 110.286 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.543 ' C ' ' N ' ' A' ' 67' ' ' TYR . 23.1 p-10 -139.52 -169.58 2.72 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.961 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.492 ' CD ' ' N ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -50.7 -14.2 0.18 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.482 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.543 ' N ' ' C ' ' A' ' 65' ' ' ASP . 4.8 t80 -67.43 -29.47 68.97 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.222 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.529 ' OG ' ' NE2' ' A' ' 64' ' ' GLN . 7.1 p -138.99 167.73 21.41 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.869 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.7 tt -127.89 3.92 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.024 0.44 . . . . 0.0 110.859 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -103.81 103.68 38.38 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.44 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.96 122.78 8.81 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.291 1.994 . . . . 0.0 112.876 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.503 ' O ' ' CB ' ' A' ' 73' ' ' THR . 5.1 mm-40 -145.33 74.36 1.39 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.554 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.503 ' CB ' ' O ' ' A' ' 72' ' ' GLN . 0.6 OUTLIER 86.73 -22.97 0.15 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.336 -179.3 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.557 ' CG ' ' O ' ' A' ' 64' ' ' GLN . 19.3 t80 -63.88 -10.12 19.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.274 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 76' ' ' ILE . 4.0 p -78.21 46.08 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.465 ' O ' ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -51.78 -163.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.447 -179.377 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 2.9 p-10 -112.08 47.24 1.07 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 31.7 pt -79.98 178.99 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.25 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -153.32 26.81 0.52 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.745 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.92 165.02 30.13 Favored Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.076 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.96 124.84 8.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.918 -0.641 . . . . 0.0 111.522 178.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.432 HG21 ' O ' ' A' ' 10' ' ' ALA . 12.0 tt -132.89 104.63 7.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.447 0.641 . . . . 0.0 109.693 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.4 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.7 OUTLIER -96.89 124.55 40.9 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.434 -178.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -97.86 133.58 39.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.112 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.574 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 26.4 p90 -137.16 145.48 43.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.717 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.594 ' HG ' ' H ' ' A' ' 88' ' ' THR . 1.0 OUTLIER -87.25 143.88 27.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.697 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.1 m -71.94 13.42 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.31 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.594 ' H ' ' HG ' ' A' ' 86' ' ' SER . 0.6 OUTLIER -135.13 -19.28 1.74 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.911 0.386 . . . . 0.0 111.737 -178.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.543 ' C ' ' H ' ' A' ' 91' ' ' LYS . 23.0 t -89.28 92.65 9.25 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.05 -176.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.74 -9.69 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 176.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.543 ' H ' ' C ' ' A' ' 89' ' ' SER . 0.1 OUTLIER -76.86 -53.21 8.19 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.284 178.278 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 25.6 p -59.6 -34.21 72.46 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.289 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.574 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -72.06 -56.71 5.15 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.173 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.22 -40.51 97.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.031 -178.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.409 ' CG2' ' O ' ' A' ' 91' ' ' LYS . 17.0 m -68.85 -33.95 61.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.676 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 mt -65.17 -40.86 90.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.335 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -70.22 -29.12 65.86 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.043 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.1 t -74.84 -66.92 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.6 mm -41.76 -66.09 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.532 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.484 ' HD1' ' N ' ' A' ' 101' ' ' GLY . 8.6 t-80 -42.24 -64.98 0.51 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.192 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.484 ' N ' ' HD1' ' A' ' 100' ' ' HIS . . . -35.06 -65.31 0.41 Allowed Glycine 0 CA--C 1.517 0.175 0 CA-C-O 121.337 0.41 . . . . 0.0 112.357 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 14.8 tptm -67.97 -63.53 1.04 Allowed 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.071 -0.565 . . . . 0.0 111.189 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.5 OUTLIER -36.05 -58.3 0.66 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.047 0.451 . . . . 0.0 110.146 -179.426 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.477 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -51.39 -51.32 55.75 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -52.09 -29.54 22.03 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.263 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.47 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 4.3 tpp -67.74 -53.63 25.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.711 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.8 m -77.2 -20.27 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.698 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 42.27 38.16 2.66 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.232 178.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.32 -159.47 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.396 0.598 . . . . 0.0 111.346 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.73 -175.01 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.67 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -66.61 114.4 5.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.472 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.1 pt -117.64 150.39 46.75 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.17 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -45.03 121.03 3.28 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.716 1.611 . . . . 0.0 112.014 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.4 mt -125.0 126.0 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.4 tpt -127.15 117.68 22.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.773 -178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mt -96.19 97.91 9.91 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.0 t -105.07 126.57 60.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 122.249 1.023 . . . . 0.0 111.294 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.43 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -97.83 107.81 3.53 Favored Glycine 0 C--N 1.308 -1.005 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.528 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 52.6 t30 -97.26 176.74 5.8 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.662 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.528 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 41.2 mttt 62.75 60.76 1.25 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.689 0.757 . . . . 0.0 108.977 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.1 tttm -67.01 -24.12 65.99 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.621 ' CG ' HN22 ' A' ' 186' ' ' GDP . 1.3 p-10 -73.91 2.47 8.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 118.751 -1.179 . . . . 0.0 111.545 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 126' ' ' GLU . 8.1 mp -94.39 -25.77 16.8 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 176.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.55 ' C ' ' N ' ' A' ' 126' ' ' GLU . 7.6 t60 -27.12 -38.63 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.403 1.065 . . . . 0.0 111.457 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.515 ' N ' ' O ' ' A' ' 123' ' ' LEU . 2.8 mmt -46.98 -16.41 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.851 0.834 . . . . 0.0 108.777 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 123' ' ' LEU . 21.1 mm-40 -98.41 -57.53 2.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.994 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.517 HH11 ' HD1' ' A' ' 124' ' ' HIS . 0.0 OUTLIER 32.81 67.77 0.16 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.458 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.9 m -61.55 -32.1 52.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.828 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.5 tp -88.93 154.97 3.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.474 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.484 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 92.7 p -103.02 129.09 49.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.242 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -42.18 -35.32 0.92 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.564 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.6 mt-10 -66.34 -65.54 0.67 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.052 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.484 ' H ' ' HG ' ' A' ' 130' ' ' SER . 63.6 mt-10 -41.29 -41.43 1.9 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.925 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.08 -35.91 64.33 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 132' ' ' GLU . 15.4 tttm -62.34 -54.94 33.15 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.066 -0.567 . . . . 0.0 109.601 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.87 69.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.561 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.73 -60.75 2.57 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -54.54 -36.66 64.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.422 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -68.37 -31.77 71.39 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.487 ' HG ' ' N ' ' A' ' 141' ' ' TRP . 13.1 p -63.88 -46.5 84.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.855 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.487 ' N ' ' HG ' ' A' ' 140' ' ' SER . 67.7 m95 -89.23 -3.53 58.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.935 0.398 . . . . 0.0 110.315 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 76.18 23.35 1.25 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.72 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -90.59 168.13 12.04 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.83 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.41 134.13 50.91 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.045 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.429 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 5.7 t80 -96.51 122.53 39.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.739 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -134.55 136.95 43.41 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.603 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.466 ' CD ' ' CZ ' ' A' ' 127' ' ' ARG . 5.8 tt0 -123.48 112.23 17.25 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 24.2 p -138.99 -177.16 4.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.052 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 152' ' ' GLU . 0.0 OUTLIER -139.91 130.4 25.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.087 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 152' ' ' GLU . . . -49.24 -64.87 0.68 Allowed 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 150' ' ' ALA . 40.4 tttm -33.88 -30.7 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.217 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 150' ' ' ALA . 34.3 mt-10 -111.71 103.63 11.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.57 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -64.9 -49.4 70.6 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.345 -179.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' A' ' 153' ' ' ASN . 4.1 mt-30 -37.27 -53.32 1.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.883 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 80.8 p -58.16 -40.45 81.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.726 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 153' ' ' ASN . . . -58.2 -61.85 2.26 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.439 0.638 . . . . 0.0 109.978 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 55.1 t -41.32 -41.67 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.719 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.65 -39.53 93.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.528 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' A' ' 156' ' ' ALA . 29.5 t -63.04 -37.52 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.018 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 163' ' ' ILE . 52.6 t80 -61.41 -65.18 0.73 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.753 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.45 -53.79 3.29 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.985 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -29.79 65.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.846 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.469 ' N ' ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -67.9 -33.89 64.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.387 -179.551 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 41.7 mt -69.85 -36.53 69.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 121.594 0.711 . . . . 0.0 109.784 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.28 -65.12 0.74 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.862 -178.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -58.06 -33.51 69.1 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.531 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.17 -31.55 67.37 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -68.44 -57.11 6.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.617 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -54.88 -64.84 0.71 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.844 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 96.6 mt -50.57 -34.51 12.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.007 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.506 ' OD2' ' NH2' ' A' ' 7' ' ' ARG . 1.2 t70 -67.26 -40.05 86.19 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -57.91 -31.88 65.39 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.37 -79.14 0.06 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 -0.12 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.86 179.689 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GDP . . . . . 0.621 HN22 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 121.35 0.595 . . . . 0.0 110.54 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.509 ' NH2' ' OD2' ' A' ' 171' ' ' ASP . 0.0 OUTLIER -139.72 135.5 33.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.233 179.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -109.09 129.23 55.47 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -102.96 125.06 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-O 121.282 0.563 . . . . 0.0 110.967 -177.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.433 ' O ' HG21 ' A' ' 82' ' ' ILE . . . -84.03 133.08 34.68 Favored 'General case' 0 C--O 1.218 -0.566 0 O-C-N 121.463 -0.773 . . . . 0.0 111.303 -178.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.2 mt -95.81 133.97 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 121.795 0.807 . . . . 0.0 112.307 -179.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tp -130.45 102.26 6.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.339 -1.301 . . . . 0.0 110.627 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.67 135.75 6.97 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.4 OUTLIER -53.87 -164.44 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.349 0.595 . . . . 0.0 110.417 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.42 ' NH1' ' OG ' ' A' ' 16' ' ' SER . 9.1 ttt-85 -98.7 134.04 42.17 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.92 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.522 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 1.3 m 67.47 19.85 9.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.572 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 p -87.3 -15.25 9.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.685 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.34 10.53 35.98 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -41.79 -55.53 2.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.015 0.436 . . . . 0.0 110.718 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -69.47 -31.13 69.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.386 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.493 ' OG ' ' H8 ' ' A' ' 186' ' ' GDP . 1.6 m -58.08 -44.03 87.35 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.117 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.7 tp -77.63 -48.41 16.91 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.167 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 86.9 m -45.68 -54.67 7.45 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.547 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.4 mp -59.49 -42.61 88.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.079 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.622 ' NE2' ' ND2' ' A' ' 153' ' ' ASN . 0.0 OUTLIER -65.09 -33.39 75.91 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.919 -179.301 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.464 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 1.6 t80 -76.83 -62.29 1.69 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.265 0.555 . . . . 0.0 111.858 -178.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.445 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 14.9 p -48.6 -46.46 15.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.597 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.445 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 12.4 mt-10 -85.33 -24.1 27.79 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.35 43.73 45.02 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.72 -174.22 3.65 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.566 0.698 . . . . 0.0 110.368 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.611 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -135.39 89.49 2.51 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.717 178.515 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.5 p -107.98 166.13 4.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.633 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 34' ' ' SER . 0.5 OUTLIER -66.26 -28.92 69.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.611 -179.096 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.539 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 3.9 p 34.94 51.4 0.52 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.085 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -88.6 64.43 7.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.868 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.75 176.68 1.51 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.731 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -65.42 -153.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.12 1.88 . . . . 0.0 111.169 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.473 ' O ' ' CG2' ' A' ' 38' ' ' THR . 11.3 t -131.69 64.9 1.58 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.923 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 tp -82.58 161.95 3.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.267 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.05 136.24 33.66 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.717 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -165.6 179.01 6.3 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 119.653 -0.819 . . . . 0.0 113.06 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.51 145.91 51.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.879 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.45 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 13.6 m-85 -129.08 166.48 19.18 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.724 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.89 153.28 39.95 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.565 -178.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.441 ' NZ ' ' O ' ' A' ' 27' ' ' VAL . 29.4 tptt -156.82 112.03 2.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.455 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.529 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 6.7 mp -106.48 120.29 41.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.663 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.65 165.71 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.622 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 m -111.34 128.46 55.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.359 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.9 p -127.31 135.66 62.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 m120 63.16 12.83 6.36 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.28 -11.54 69.35 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -90.45 139.16 30.94 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -76.71 145.15 38.87 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.638 0.733 . . . . 0.0 111.32 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.413 ' OH ' ' OE1' ' A' ' 168' ' ' GLU . 10.3 m-85 -137.08 122.83 19.92 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.995 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -116.9 113.61 22.7 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.0 mp -119.57 143.4 47.64 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.657 0.741 . . . . 0.0 112.214 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -135.32 124.86 25.04 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.698 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.63 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.83 154.5 30.62 Favored 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 120.034 -0.666 . . . . 0.0 112.218 -178.452 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.17 145.93 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.87 -178.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.73 103.31 8.78 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.049 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.1 p -68.98 137.49 53.77 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.773 0.797 . . . . 0.0 111.562 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -144.71 13.85 1.53 Allowed 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.188 -1.369 . . . . 0.0 108.639 178.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.85 -2.4 30.35 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.523 ' N ' ' OE1' ' A' ' 64' ' ' GLN . 13.2 mp0 -142.14 -153.0 0.44 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.543 0.687 . . . . 0.0 111.107 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.566 ' CG ' ' H ' ' A' ' 66' ' ' GLU . 2.3 t70 -74.46 -177.38 3.08 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.507 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.566 ' H ' ' CG ' ' A' ' 65' ' ' ASP . 3.8 mp0 -43.39 -18.47 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 68' ' ' SER . 17.2 p90 -172.01 -22.73 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.751 -178.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.58 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 1.4 m 41.36 93.02 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.536 0.208 . . . . 0.0 111.439 -178.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.535 ' CD1' ' H ' ' A' ' 70' ' ' PHE . 0.5 OUTLIER -56.94 156.53 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.355 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.535 ' H ' ' CD1' ' A' ' 69' ' ' ILE . 29.0 t80 58.82 65.89 2.67 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.89 0.376 . . . . 0.0 110.383 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -46.6 109.9 0.24 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.729 2.286 . . . . 0.0 111.988 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -97.7 -6.81 32.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.623 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.41 -26.83 2.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.569 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.64 101.6 11.62 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.515 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.0 m -86.93 51.9 2.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.8 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -86.15 172.36 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 121.562 0.696 . . . . 0.0 112.056 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 5.1 p-10 -147.56 57.53 1.12 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.565 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 29.1 pt -79.01 -176.56 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -177.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -151.84 17.86 0.69 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.197 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -146.65 166.57 28.25 Favored Glycine 0 CA--C 1.518 0.232 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.38 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.68 121.69 7.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.951 -0.624 . . . . 0.0 110.763 178.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.433 HG21 ' O ' ' A' ' 10' ' ' ALA . 10.0 tt -123.9 103.31 12.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.64 ' H ' ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -95.9 131.95 41.71 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.456 -0.897 . . . . 0.0 110.447 -178.266 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.483 ' O ' ' CD1' ' A' ' 96' ' ' ILE . 1.2 t -92.34 130.87 40.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.963 -178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -108.04 143.21 37.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.978 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.522 ' HG ' ' H ' ' A' ' 88' ' ' THR . 47.8 t -109.88 130.21 55.55 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.889 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.1 m -81.34 18.35 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.004 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.522 ' H ' ' HG ' ' A' ' 86' ' ' SER . 1.4 t -143.54 -3.3 0.92 Allowed 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -177.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.539 ' C ' ' H ' ' A' ' 91' ' ' LYS . 1.0 OUTLIER -134.31 97.94 3.97 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 119.416 -0.914 . . . . 0.0 112.843 -175.566 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.465 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 18.1 mm -56.13 -10.9 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 114.155 -1.384 . . . . 0.0 107.859 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.539 ' H ' ' C ' ' A' ' 89' ' ' SER . 0.1 OUTLIER -79.13 -42.03 27.2 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.091 178.686 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.62 -47.49 75.46 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.051 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.55 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -76.3 -35.39 58.86 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 119.105 -1.038 . . . . 0.0 112.186 -178.034 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.526 ' OE2' ' CE1' ' A' ' 93' ' ' PHE . 14.0 mm-40 -66.46 -47.95 71.48 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.901 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.6 m -64.17 -37.49 80.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.023 0.439 . . . . 0.0 110.292 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.483 ' CD1' ' O ' ' A' ' 84' ' ' VAL . 31.8 mt -69.02 -31.28 49.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.887 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.73 -26.42 63.38 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.18 0.514 . . . . 0.0 109.709 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 7.3 t -70.44 -64.98 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.755 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.8 tt -43.29 -47.95 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.647 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.58 ' NE2' ' CD1' ' A' ' 141' ' ' TRP . 15.1 t-80 -44.96 -64.79 0.63 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.852 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -39.43 -57.44 2.24 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 111.931 -0.468 . . . . 0.0 111.931 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 105' ' ' ASP . 13.5 tptp -62.96 -65.77 0.64 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.177 -0.511 . . . . 0.0 111.061 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.476 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -36.52 -56.69 0.8 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.731 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.481 ' CD1' ' C ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -46.34 -47.66 18.49 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.635 178.522 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -56.83 -33.76 67.07 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.317 -179.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.529 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 2.4 tpp -67.99 -55.74 11.56 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.869 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.593 ' C ' ' H ' ' A' ' 109' ' ' LYS . 16.5 m -77.03 -12.82 14.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.016 -178.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.29 -24.87 0.04 OUTLIER Glycine 0 CA--C 1.534 1.227 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.853 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.593 ' H ' ' C ' ' A' ' 107' ' ' VAL . 1.4 tptt -173.45 -128.73 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.856 0.828 . . . . 0.0 111.533 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.577 ' H ' ' CG ' ' A' ' 109' ' ' LYS . 7.8 t 51.1 118.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.909 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -76.14 131.6 39.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.086 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.485 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.5 OUTLIER -136.17 154.6 77.45 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.407 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -49.89 110.14 0.35 Allowed 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.772 1.648 . . . . 0.0 112.546 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.485 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.2 mp -121.67 127.84 75.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.2 tpt -130.68 115.84 17.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.669 -178.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 28.2 mt -96.71 97.52 9.41 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.8 t -105.64 130.34 57.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.632 0.729 . . . . 0.0 110.977 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -102.02 116.33 5.49 Favored Glycine 0 C--N 1.306 -1.136 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.514 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.7 t30 -97.04 173.92 7.02 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.557 -178.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.522 ' NZ ' ' O ' ' A' ' 16' ' ' SER . 18.0 mttt 60.2 58.25 2.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.545 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.46 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 20.5 tttm -63.76 -29.5 70.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.955 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -70.96 -6.8 41.48 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.953 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 125' ' ' MET . 8.6 mp -94.31 -29.85 14.83 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.609 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.1 OUTLIER -38.61 -24.79 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.927 177.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.609 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 19.1 mtp -44.73 -24.11 0.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.472 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.3 OUTLIER -101.83 -37.63 8.19 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.33 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.425 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 1.2 tpt180 37.08 87.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.794 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.5 m -80.22 -32.36 13.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.15 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 11.1 tp -91.23 154.7 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.21 178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.444 ' HG ' ' H ' ' A' ' 133' ' ' GLU . 6.5 p -97.36 134.37 40.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.424 0.631 . . . . 0.0 112.226 -178.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -58.42 -30.63 67.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.095 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mp0 -68.53 -65.66 0.67 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.989 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.444 ' H ' ' HG ' ' A' ' 130' ' ' SER . 43.5 mt-10 -41.42 -41.26 1.98 Allowed 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.83 -36.33 65.93 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 132' ' ' GLU . 3.5 tttm -60.92 -55.72 29.6 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.56 -33.98 66.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.289 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.61 -62.94 1.23 Allowed 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.832 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -54.27 -33.67 59.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.655 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.43 -38.15 80.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.703 0.287 . . . . 0.0 110.872 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.41 -47.43 79.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.428 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.58 ' CD1' ' NE2' ' A' ' 100' ' ' HIS . 23.7 m95 -91.64 2.68 56.3 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.352 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 13.4 m120 60.67 35.56 19.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.099 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -92.05 166.71 12.54 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.946 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -103.29 125.5 49.96 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.052 -0.659 . . . . 0.0 112.012 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.418 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 6.7 t80 -98.13 121.22 39.79 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.977 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.31 125.98 15.1 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.418 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.425 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 11.7 tt0 -102.01 110.8 22.86 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.482 ' HG ' ' CG2' ' A' ' 159' ' ' VAL . 0.1 OUTLIER -123.07 -176.52 3.44 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.245 -178.787 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.85 138.9 37.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.524 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.537 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -71.88 -11.22 60.69 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.476 0.655 . . . . 0.0 109.361 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.54 -5.57 59.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.004 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.46 ' O ' ' OE1' ' A' ' 25' ' ' GLN . 51.9 mt-10 -138.97 125.91 21.06 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.474 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.622 ' ND2' ' NE2' ' A' ' 25' ' ' GLN . 4.2 m120 -75.51 -48.43 22.55 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 153' ' ' ASN . 0.0 OUTLIER -36.54 -56.88 0.79 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.998 0.427 . . . . 0.0 110.716 -179.166 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.2 p -52.57 -47.8 66.6 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.354 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -55.38 -60.35 3.53 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.338 0.589 . . . . 0.0 110.178 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.1 t -41.98 -40.75 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.403 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.3 -32.53 72.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.994 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.487 ' N ' ' O ' ' A' ' 156' ' ' ALA . 22.0 t -73.78 -36.53 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 121.038 0.447 . . . . 0.0 109.996 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.424 ' O ' HG21 ' A' ' 163' ' ' ILE . 25.5 t80 -69.22 -35.63 76.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.038 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -77.4 -45.21 26.6 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.135 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -34.39 74.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.067 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 164' ' ' ILE . 14.0 tt -68.83 -50.46 54.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.365 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.448 ' N ' ' CG2' ' A' ' 163' ' ' ILE . 86.5 mt -50.76 -33.63 12.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 119.064 -1.055 . . . . 0.0 108.885 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.93 -63.61 1.16 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.861 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -57.77 -29.08 64.54 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.63 -32.52 71.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.413 ' OE1' ' OH ' ' A' ' 54' ' ' TYR . 1.7 tp10 -68.93 -57.79 5.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.315 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -53.61 -62.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.689 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 74.7 mt -51.89 -34.33 16.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.011 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.509 ' OD2' ' NH2' ' A' ' 7' ' ' ARG . 1.9 t70 -69.64 -38.49 77.19 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.679 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -63.21 -35.41 92.04 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.98 -65.48 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.348 . . . . 0.0 110.686 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.691 -179.928 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GDP . . . . . 0.493 ' H8 ' ' OG ' ' A' ' 21' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.177 0.513 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.732 ' NH2' ' HB1' ' A' ' 167' ' ' ALA . 23.2 mtm180 -139.94 136.79 34.2 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.724 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.494 ' HB2' HG22 ' A' ' 78' ' ' ILE . 6.2 mttm -106.25 130.07 54.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.774 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.9 OUTLIER -103.28 123.49 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-O 121.493 0.664 . . . . 0.0 110.49 -178.315 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.53 134.38 34.42 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.304 -0.872 . . . . 0.0 111.325 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.2 mt -95.51 127.66 47.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.38 0.61 . . . . 0.0 111.65 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.617 HD22 HG21 ' A' ' 99' ' ' ILE . 13.0 tp -127.5 99.35 5.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.522 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -142.07 136.09 7.08 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.814 -178.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.1 OUTLIER -49.31 -177.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.217 0.532 . . . . 0.0 110.662 179.002 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -74.46 140.85 44.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.816 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.4 m 53.17 19.63 1.53 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.609 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.2 p -68.64 -17.13 21.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.417 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.429 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 103.82 29.25 5.62 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.403 ' HG3' ' HZ3' ' A' ' 19' ' ' LYS . 6.7 mtmm -64.61 -62.49 1.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 110.369 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.504 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.9 OUTLIER -55.96 -28.35 56.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.619 -179.149 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 94.6 p -68.2 -50.73 52.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.792 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.1 tp -77.4 -26.45 51.77 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.913 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.622 ' O ' HG12 ' A' ' 27' ' ' VAL . 33.9 m -60.32 -43.33 96.48 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.504 HD13 ' O ' ' A' ' 20' ' ' SER . 1.2 mp -77.89 -42.74 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.729 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.534 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -67.02 -32.13 73.14 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.358 -179.045 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -77.71 -62.59 1.62 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.374 0.607 . . . . 0.0 111.404 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 23' ' ' THR . 14.4 p -48.01 -47.52 12.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.268 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.612 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.2 tm-20 -83.53 -24.6 31.58 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.32 28.74 67.39 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.525 ' CA ' HD21 ' A' ' 153' ' ' ASN . 0.1 OUTLIER -144.94 125.67 14.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.07 0.462 . . . . 0.0 111.861 -178.643 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.516 ' CG ' ' O ' ' A' ' 31' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.346 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -178.68 174.05 1.22 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.509 0.671 . . . . 0.0 112.43 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.548 HG23 HG23 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -108.25 137.23 46.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.357 179.61 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -122.09 167.19 13.44 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.714 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -146.41 148.05 31.9 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.38 0.609 . . . . 0.0 112.319 -179.164 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.5 tttp -147.11 112.44 5.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.968 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.498 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.0 mp -106.44 120.28 41.5 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.095 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.812 HD12 ' H ' ' A' ' 47' ' ' ILE . 0.4 OUTLIER -145.47 165.31 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.42 -179.687 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.3 m -115.92 124.96 51.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.489 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.586 ' O ' HG13 ' A' ' 49' ' ' VAL . 13.2 p -119.45 117.63 54.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.734 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.563 ' OD1' HG22 ' A' ' 49' ' ' VAL . 0.8 OUTLIER 69.83 26.06 4.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.025 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.61 -9.41 55.7 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -89.99 132.04 35.57 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.96 145.58 40.25 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.621 0.724 . . . . 0.0 111.352 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.666 ' CE2' HG23 ' A' ' 164' ' ' ILE . 5.5 m-85 -136.53 122.36 19.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.949 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.573 ' C ' HD12 ' A' ' 56' ' ' LEU . 67.3 m170 -117.2 112.7 21.19 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.573 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.4 mp -119.19 142.85 47.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.517 0.675 . . . . 0.0 111.831 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.743 ' C ' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -133.14 121.52 22.71 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.957 178.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.892 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.84 154.42 30.77 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 120.098 -0.641 . . . . 0.0 112.219 -178.286 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.548 HG23 HG23 ' A' ' 42' ' ' THR . 0.3 OUTLIER -128.14 144.87 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.686 -179.503 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.05 107.48 12.68 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.872 -1.513 . . . . 0.0 108.178 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 121.12 0.486 . . . . 0.0 110.479 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.494 HG22 ' HB2' ' A' ' 8' ' ' LYS . 33.5 pt . . . . . 0 N--CA 1.436 -1.159 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -150.75 17.62 0.79 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.142 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.489 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -146.94 165.92 28.45 Favored Glycine 0 CA--C 1.516 0.143 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.584 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.1 122.4 7.23 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.956 -0.622 . . . . 0.0 110.812 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.614 ' O ' HG23 ' A' ' 82' ' ' ILE . 10.7 tt -125.54 103.38 11.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.803 ' N ' HD23 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -96.28 125.82 41.06 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.737 -178.22 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.476 ' O ' HD11 ' A' ' 96' ' ' ILE . 1.8 t -95.7 119.25 43.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.808 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.481 ' C ' ' CD1' ' A' ' 85' ' ' TYR . 4.1 p90 -109.7 145.41 36.61 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.421 ' OG ' ' N ' ' A' ' 89' ' ' SER . 0.8 OUTLIER -101.85 143.62 31.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.064 0.459 . . . . 0.0 111.752 -178.075 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.597 HG21 ' N ' ' A' ' 124' ' ' HIS . 17.8 m -80.49 20.45 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.23 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.7 t -141.92 -15.94 0.79 Allowed 'General case' 0 C--O 1.232 0.141 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.538 ' C ' ' N ' ' A' ' 91' ' ' LYS . 38.8 t -113.71 94.21 4.74 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -176.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.524 HG22 ' CD ' ' A' ' 94' ' ' GLU . 22.5 mm -52.8 -14.74 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 176.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.775 ' O ' HG22 ' A' ' 95' ' ' VAL . 9.6 mttp -78.22 -46.61 19.95 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.192 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.0 p -61.9 -45.48 93.55 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.575 ' CE2' HD13 ' A' ' 129' ' ' ILE . 0.1 OUTLIER -77.64 -37.27 50.36 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 119.248 -0.981 . . . . 0.0 112.652 -177.831 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.524 ' CD ' HG22 ' A' ' 90' ' ' ILE . 88.5 mt-10 -67.81 -43.89 78.59 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.43 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.775 HG22 ' O ' ' A' ' 91' ' ' LYS . 30.7 m -66.04 -38.16 81.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.85 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.476 HD11 ' O ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -58.92 -39.42 77.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.632 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -69.45 -26.75 64.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.126 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 94' ' ' GLU . 60.9 t -77.29 -66.91 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.785 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.617 HG21 HD22 ' A' ' 12' ' ' LEU . 1.7 mp -41.07 -38.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.028 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -64.4 -64.92 0.76 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.617 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.52 -57.75 1.46 Allowed Glycine 0 CA--C 1.517 0.212 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 105' ' ' ASP . 12.7 tptp -62.9 -64.72 0.83 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.915 -0.643 . . . . 0.0 110.713 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -36.95 -60.17 0.65 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.734 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.747 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -46.43 -48.07 18.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.471 178.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.92 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.419 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.413 ' HB3' HG23 ' A' ' 170' ' ' ILE . 61.7 mt-30 . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.925 0.393 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.716 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.8 OUTLIER -115.04 150.35 44.08 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.21 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -48.2 111.7 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.516 1.478 . . . . 0.0 112.32 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.486 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.5 mp -120.99 128.99 76.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 8.7 tpt -129.17 115.45 17.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.76 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mt -96.84 97.77 9.57 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.0 t -102.48 134.06 44.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 122.442 1.115 . . . . 0.0 110.471 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 146' ' ' LEU . . . -101.32 111.73 4.19 Favored Glycine 0 C--N 1.297 -1.595 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.478 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 46.3 t30 -96.95 173.72 7.14 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.415 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.478 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 24.4 mttt 59.57 58.59 2.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.507 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.418 ' H ' ' HB3' ' A' ' 149' ' ' SER . 32.0 tttm -64.41 -35.47 81.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.412 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.32 -10.6 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.04 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 125' ' ' MET . 9.1 mp -90.69 -29.93 17.42 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.597 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.7 OUTLIER -40.13 -23.97 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.889 178.499 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.519 ' N ' ' O ' ' A' ' 123' ' ' LEU . 3.6 mmt -45.24 -24.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.44 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -101.36 -37.81 8.31 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.068 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.41 ' NH1' ' OE2' ' A' ' 147' ' ' GLU . 1.9 tpt180 38.91 88.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.082 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.474 HG23 ' N ' ' A' ' 129' ' ' ILE . 17.0 m -78.84 -38.21 20.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.586 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.575 HD13 ' CE2' ' A' ' 93' ' ' PHE . 6.7 tp -90.5 153.52 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.562 ' HG ' ' HB2' ' A' ' 133' ' ' GLU . 18.2 p -94.87 137.16 34.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.274 0.559 . . . . 0.0 112.087 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -54.95 -32.59 61.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.215 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -68.32 -65.83 0.65 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.964 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.562 ' HB2' ' HG ' ' A' ' 130' ' ' SER . 41.0 mt-10 -42.09 -40.93 2.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.622 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.11 -34.29 64.74 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 132' ' ' GLU . 24.1 tttm -64.07 -55.5 21.68 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -55.6 -33.75 64.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.25 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.646 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -65.53 -62.99 1.2 Allowed 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.702 179.429 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -54.69 -34.99 63.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.364 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.56 -30.11 67.84 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.4 p -64.3 -46.8 81.99 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.742 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.646 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 21.9 m95 -88.94 -5.71 57.78 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.089 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.4 ' O ' ' OE2' ' A' ' 166' ' ' GLU . 0.8 OUTLIER 75.91 25.49 1.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.703 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -89.24 169.16 11.69 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.894 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.47 133.81 49.61 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.214 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.633 ' O ' HD22 ' A' ' 146' ' ' LEU . 6.6 t80 -96.83 122.49 39.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.005 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.829 HD12 HG22 ' A' ' 159' ' ' VAL . 1.3 mm? -132.95 139.5 47.34 Favored 'General case' 0 C--O 1.209 -1.054 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.63 -176.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.41 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 5.5 tt0 -129.04 111.28 12.81 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 58.9 p -138.66 -177.15 4.74 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.734 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.418 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -138.4 140.17 39.26 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.086 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -59.68 -43.07 94.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.157 0.503 . . . . 0.0 109.69 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.0 ttpp -65.38 5.64 0.38 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.381 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 150' ' ' ALA . 3.4 tt0 -136.47 120.02 17.08 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.721 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.525 HD21 ' CA ' ' A' ' 30' ' ' GLN . 3.6 m120 -77.57 -56.86 4.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.961 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 153' ' ' ASN . 9.1 tt0 -36.97 -58.23 0.78 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.893 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 159' ' ' VAL . 66.3 p -52.14 -50.16 62.29 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.126 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.534 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -49.75 -60.31 3.01 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.418 0.628 . . . . 0.0 109.717 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.1 t -40.92 -50.35 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.986 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -53.96 -32.6 54.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.661 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.829 HG22 HD12 ' A' ' 146' ' ' LEU . 12.7 t -75.92 -26.74 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.247 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -71.45 -39.92 70.66 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.462 179.321 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.603 ' N ' ' CD1' ' A' ' 160' ' ' PHE . 36.2 ttm-85 -79.48 -47.73 15.12 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.163 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.6 mmm180 -57.75 -37.57 73.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.11 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.628 HG23 ' N ' ' A' ' 164' ' ' ILE . 11.6 tt -69.74 -58.18 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.438 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.666 HG23 ' CE2' ' A' ' 54' ' ' TYR . 91.3 mt -46.2 -35.02 2.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.88 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -64.82 0.82 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.027 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.4 ' OE2' ' O ' ' A' ' 142' ' ' ASN . 2.1 tt0 -54.6 -37.99 66.22 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.732 ' HB1' ' NH2' ' A' ' 7' ' ' ARG . . . -49.56 -35.54 20.82 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -68.06 -52.65 32.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.085 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 3.6 ttpp -54.5 -61.07 2.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.529 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.716 HG21 ' C ' ' A' ' 112' ' ' ILE . 33.7 mm -49.98 -32.98 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.62 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -39.59 89.05 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.102 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -61.9 -34.09 87.63 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.96 -80.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.67 0.271 . . . . 0.0 110.323 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 -0.141 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.817 179.824 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 121.352 0.596 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.69 135.41 33.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.256 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.548 ' HB2' HG22 ' A' ' 78' ' ' ILE . 8.1 mttm -107.73 127.59 53.82 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.733 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.9 OUTLIER -100.96 122.27 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 121.702 0.763 . . . . 0.0 110.808 -177.899 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.28 135.24 34.41 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.498 -0.751 . . . . 0.0 110.882 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.4 mt -96.97 131.74 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.554 0.692 . . . . 0.0 112.403 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.91 HD11 HG21 ' A' ' 99' ' ' ILE . 5.0 tt -121.43 101.34 7.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.895 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -139.8 134.4 6.59 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.72 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.442 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -55.34 -158.35 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.368 0.604 . . . . 0.0 110.756 179.339 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.7 tpp85 -96.05 133.57 40.14 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.546 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.1 m 61.57 14.61 6.1 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.288 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.473 ' C ' ' HZ2' ' A' ' 120' ' ' LYS . 4.3 p -70.28 -13.32 17.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.502 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.4 21.65 47.5 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.747 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.4 pttm -68.17 -35.29 77.81 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.055 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.2 m -67.66 -42.21 82.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.545 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 m -60.42 -47.55 85.62 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.485 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.444 ' O ' ' CB ' ' A' ' 26' ' ' PHE . 45.4 tp -66.95 -26.94 67.08 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.547 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.576 ' O ' HG12 ' A' ' 27' ' ' VAL . 97.2 m -63.06 -51.45 66.62 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.4 mm -65.3 -38.77 83.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.936 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.579 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -77.57 -25.67 50.21 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.541 -178.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.636 ' CZ ' ' CD2' ' A' ' 160' ' ' PHE . 37.1 t80 -77.78 -53.04 7.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.414 0.626 . . . . 0.0 110.614 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.605 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.9 p -59.61 -48.75 86.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.991 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.605 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.6 mt-10 -79.43 -24.41 42.51 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.569 ' O ' ' ND2' ' A' ' 153' ' ' ASN . . . 69.24 36.2 78.75 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -147.14 136.13 22.32 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.205 0.526 . . . . 0.0 111.179 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.24 179.29 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.42 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 7.2 pt-20 . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 1.2 m120 -172.85 176.08 3.18 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.576 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.434 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -108.26 152.95 23.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.577 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 25.3 m-85 -132.63 166.37 22.3 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.455 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -147.05 156.3 42.91 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.524 0.678 . . . . 0.0 112.823 -177.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -163.29 117.13 1.6 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.804 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 46' ' ' LEU . 8.2 mp -104.63 129.2 52.8 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.879 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 pp -147.1 160.31 9.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.935 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -114.97 123.28 48.71 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.974 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.26 129.87 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.014 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 63.74 7.26 3.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.019 0.438 . . . . 0.0 109.961 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.83 -11.76 59.17 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -89.15 135.02 33.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -77.13 147.12 36.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.606 0.717 . . . . 0.0 111.525 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -140.38 123.47 16.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.749 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.593 ' C ' HD12 ' A' ' 56' ' ' LEU . 1.2 m-70 -117.33 114.06 23.03 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.593 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.7 mp -118.88 143.88 46.72 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.785 0.802 . . . . 0.0 112.379 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.747 ' C ' HD13 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -135.63 122.15 20.71 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.198 -1.364 . . . . 0.0 109.95 178.794 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.952 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.78 153.53 33.28 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.53 -178.603 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -122.93 144.38 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-N 114.508 -1.224 . . . . 0.0 112.32 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.13 103.43 8.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.107 178.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 121.385 0.612 . . . . 0.0 110.513 -179.902 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.548 HG22 ' HB2' ' A' ' 8' ' ' LYS . 29.8 pt . . . . . 0 N--CA 1.429 -1.475 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -151.19 17.33 0.75 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.04 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -144.17 164.4 27.6 Favored Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.222 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.53 123.93 7.71 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.641 -0.78 . . . . 0.0 111.181 178.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.504 ' O ' HG23 ' A' ' 82' ' ' ILE . 7.6 tt -128.71 113.79 30.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.2 mt -97.48 123.93 41.51 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.042 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -98.08 117.82 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.179 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.615 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 42.2 p90 -120.5 145.38 47.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.308 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 88' ' ' THR . 3.3 p -86.03 135.77 33.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.204 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.535 HG21 ' N ' ' A' ' 124' ' ' HIS . 18.0 m -73.69 21.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.459 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.495 ' H ' ' C ' ' A' ' 86' ' ' SER . 0.9 OUTLIER -136.9 -25.6 1.08 Allowed 'General case' 0 CA--C 1.52 -0.212 0 CA-C-O 121.003 0.43 . . . . 0.0 112.063 -178.237 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 91' ' ' LYS . 60.8 p -97.77 100.06 11.42 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.067 -176.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.8 tp -59.37 -8.4 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 176.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.563 ' H ' ' C ' ' A' ' 89' ' ' SER . 21.8 mttp -77.05 -59.31 2.83 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.111 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.432 ' OG ' ' OG ' ' A' ' 89' ' ' SER . 83.1 p -52.22 -33.52 41.53 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.878 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.615 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -73.19 -49.76 26.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.721 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -65.98 -42.35 89.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.214 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 91' ' ' LYS . 19.5 m -66.22 -41.56 89.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.254 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.508 ' N ' HG23 ' A' ' 95' ' ' VAL . 1.4 mt -59.44 -34.51 54.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -71.0 -27.26 63.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.466 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.4 t -77.11 -67.27 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.263 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.91 HG21 HD11 ' A' ' 12' ' ' LEU . 1.4 tp -48.53 -29.53 2.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.684 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.616 ' CG ' ' CH2' ' A' ' 141' ' ' TRP . 35.6 t-80 -67.77 -63.58 1.03 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.235 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -39.58 -47.61 3.0 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 105' ' ' ASP . 37.6 tptt -62.81 -62.72 1.53 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.878 -0.661 . . . . 0.0 109.244 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -38.06 -51.09 1.39 Allowed 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.349 0.595 . . . . 0.0 109.498 178.686 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.735 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -52.4 -45.56 65.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.52 179.057 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.313 -0.983 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.035 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.762 ' O ' ' HB2' ' A' ' 174' ' ' ALA . 2.1 mm100 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 121.083 0.468 . . . . 0.0 111.367 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.67 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.2 OUTLIER -130.61 161.21 62.32 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.585 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -51.83 101.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 120.953 1.102 . . . . 0.0 111.548 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.3 mt -116.22 120.97 66.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.404 ' CE ' HD23 ' A' ' 146' ' ' LEU . 8.5 tpt -121.84 113.73 20.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.033 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 79.8 mt -96.14 97.86 9.88 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.8 t -106.91 135.32 45.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 122.184 0.992 . . . . 0.0 111.696 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.403 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -105.45 116.08 5.1 Favored Glycine 0 C--N 1.308 -0.98 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.476 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 57.9 t30 -97.71 174.88 6.4 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.043 -178.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.476 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 7.2 mttp 62.09 58.19 1.9 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.048 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.44 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 2.9 tttm -58.92 -26.83 64.69 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -64.5 -13.98 54.9 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.97 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 125' ' ' MET . 11.0 mp -89.98 -30.03 18.07 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.61 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.1 OUTLIER -37.53 -25.78 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.132 178.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.61 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 7.2 mtp -49.26 -21.5 0.83 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.448 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -109.99 -38.84 5.22 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.139 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.484 ' HE ' ' HB2' ' A' ' 124' ' ' HIS . 19.6 ttm180 26.68 90.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.106 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.99 -32.98 56.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.437 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.6 tp -88.89 156.37 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.597 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.562 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 88.7 p -103.41 124.98 49.73 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.219 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.511 ' CE1' ' CE1' ' A' ' 145' ' ' PHE . 0.4 OUTLIER -39.23 -39.56 0.63 Allowed 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.064 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mp0 -61.33 -65.75 0.64 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.937 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.562 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 66.6 mt-10 -41.41 -46.18 3.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.076 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.78 -35.05 84.57 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 132' ' ' GLU . 12.1 ttpt -62.04 -55.27 30.81 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.0 -37.82 77.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.307 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.557 ' CD2' ' CE2' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -67.06 -64.78 0.78 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 120.905 0.384 . . . . 0.0 110.017 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -49.71 -32.45 13.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.304 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -67.12 -53.77 27.59 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.911 0.386 . . . . 0.0 110.11 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 88.8 p -62.32 -26.77 68.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.116 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.616 ' CH2' ' CG ' ' A' ' 100' ' ' HIS . 32.6 m0 -88.02 -8.78 55.11 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 65.9 20.61 11.38 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -101.04 166.65 10.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.776 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.01 133.96 48.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.916 -0.583 . . . . 0.0 112.252 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.71 ' O ' HD22 ' A' ' 146' ' ' LEU . 4.5 t80 -97.1 122.92 40.63 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.529 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.913 HD12 HG22 ' A' ' 159' ' ' VAL . 1.2 mm? -135.79 138.89 43.06 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.592 -176.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.48 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 2.3 tt0 -127.77 110.55 12.73 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.1 p -137.86 -176.79 4.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.164 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.71 139.85 38.54 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.857 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.484 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -59.78 -44.38 93.92 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 178.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -62.5 -0.5 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.184 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.484 ' H ' ' C ' ' A' ' 150' ' ' ALA . 1.3 mt-10 -136.42 97.98 3.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.627 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.569 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 39.2 t30 -63.96 -47.71 79.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.969 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 153' ' ' ASN . 0.0 OUTLIER -37.06 -59.13 0.74 Allowed 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.104 0.478 . . . . 0.0 110.485 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.588 ' O ' HG23 ' A' ' 159' ' ' VAL . 74.2 p -52.29 -44.98 65.3 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.847 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.579 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -55.19 -60.31 3.57 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.293 0.568 . . . . 0.0 109.959 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.1 t -41.63 -41.64 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.939 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.32 -39.56 94.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.891 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.913 HG22 HD12 ' A' ' 146' ' ' LEU . 22.4 t -67.39 -31.33 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.371 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.636 ' CD2' ' CZ ' ' A' ' 26' ' ' PHE . 4.8 t80 -62.19 -66.94 0.46 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.67 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 26.3 ttm-85 -48.48 -53.15 19.05 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.849 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.46 -33.98 23.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.95 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.521 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -65.76 -34.07 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.485 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.434 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 10.2 mt -68.06 -40.05 82.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.634 0.731 . . . . 0.0 110.244 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.37 -60.84 2.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.302 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.6 -32.29 65.11 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.546 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -60.0 -32.29 70.72 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -68.32 -55.98 10.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.96 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 18.4 ttpp -59.2 -62.33 1.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.931 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.67 HG21 ' C ' ' A' ' 112' ' ' ILE . 67.1 mt -50.28 -33.14 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.111 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.13 -40.69 90.84 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.141 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.56 -32.71 84.21 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.94 -81.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.419 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.762 ' HB2' ' O ' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.015 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.476 ' HG ' ' CE1' ' A' ' 55' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 121.078 0.466 . . . . 0.0 110.159 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.454 ' NH1' ' HB1' ' A' ' 167' ' ' ALA . 2.1 ptp180 -139.9 136.7 34.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.602 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.546 ' HB2' HG22 ' A' ' 78' ' ' ILE . 4.1 mptt -106.36 133.47 51.0 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.755 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.3 mm -106.06 125.97 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-O 121.345 0.593 . . . . 0.0 110.232 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.445 ' HB2' ' CD1' ' A' ' 78' ' ' ILE . . . -83.74 134.0 34.76 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.124 -0.985 . . . . 0.0 110.631 -178.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 58' ' ' LEU . 17.0 mt -96.9 132.37 41.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.341 0.591 . . . . 0.0 112.121 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.2 tp -132.4 105.92 7.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.569 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -140.26 134.37 6.48 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -54.9 -159.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.371 0.605 . . . . 0.0 110.918 179.624 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -96.18 135.28 38.2 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.864 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.0 m 61.27 19.48 10.16 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.497 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 p -77.8 -19.66 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.852 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.38 23.28 24.67 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.6 pttm -69.32 -34.45 74.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.0 110.263 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.2 m -75.42 -36.16 60.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.086 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.3 p -60.42 -42.16 95.47 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.318 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.6 tp -77.44 -34.14 54.64 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.959 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.596 ' O ' HG12 ' A' ' 27' ' ' VAL . 27.0 m -52.98 -45.48 67.84 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.849 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.47 HD12 ' N ' ' A' ' 24' ' ' ILE . 1.4 mp -74.42 -41.96 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.351 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.618 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -68.45 -28.9 67.45 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.334 -0.547 . . . . 0.0 110.961 -179.433 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.453 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 1.4 t80 -77.93 -64.05 1.25 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.336 0.588 . . . . 0.0 110.957 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.9 p -47.05 -48.41 8.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.727 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.61 ' N ' HG13 ' A' ' 27' ' ' VAL . 0.5 OUTLIER -80.32 -24.95 39.58 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.157 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.431 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 74.09 24.02 74.7 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.154 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -145.32 125.88 14.13 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.657 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.239 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.224 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 . . . . . 0 N--CA 1.45 -0.447 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -172.33 -179.0 2.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.318 0.58 . . . . 0.0 111.837 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.3 m -126.7 143.27 51.29 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.151 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.457 ' CE2' HD11 ' A' ' 24' ' ' ILE . 14.2 m-85 -129.15 165.66 20.85 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.945 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.515 HG23 ' HB2' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -143.03 152.23 41.68 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.322 0.582 . . . . 0.0 112.148 -178.964 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 tttp -156.47 113.14 3.09 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.868 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.9 mp -105.91 122.21 45.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.899 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.895 HD12 ' H ' ' A' ' 47' ' ' ILE . 0.3 OUTLIER -144.77 165.43 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.672 -179.145 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.6 m -115.23 125.89 53.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.266 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.562 ' O ' HG13 ' A' ' 49' ' ' VAL . 8.0 p -120.61 117.25 52.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.885 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.512 ' CG ' HG22 ' A' ' 49' ' ' VAL . 0.9 OUTLIER 69.88 25.9 4.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 110.118 -179.17 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.38 -10.15 55.8 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -89.34 132.13 35.09 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -75.76 146.17 40.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.535 0.683 . . . . 0.0 111.203 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.559 ' CD1' HG12 ' A' ' 49' ' ' VAL . 5.1 m-85 -137.54 125.72 23.05 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.891 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.517 ' ND1' ' O ' ' A' ' 55' ' ' HIS . 1.3 t-80 -117.47 113.4 21.98 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.497 HD12 ' C ' ' A' ' 55' ' ' HIS . 9.5 mp -118.39 143.17 46.85 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.781 0.8 . . . . 0.0 111.822 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.806 ' C ' HD13 ' A' ' 58' ' ' LEU . 3.2 tt0 -140.44 120.52 13.73 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.047 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.973 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -115.85 154.33 29.89 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.331 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -130.89 144.15 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.267 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.41 102.93 7.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.449 -1.251 . . . . 0.0 108.306 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 121.38 0.61 . . . . 0.0 110.364 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 8' ' ' LYS . 45.2 pt . . . . . 0 N--CA 1.434 -1.265 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.27 18.25 0.95 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.477 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.425 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -147.55 166.43 28.69 Favored Glycine 0 CA--C 1.519 0.339 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.622 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.9 123.08 7.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.851 -0.675 . . . . 0.0 111.2 178.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.621 ' O ' HG23 ' A' ' 82' ' ' ILE . 9.6 tt -128.0 104.81 12.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.505 0.669 . . . . 0.0 109.296 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 1.008 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.53 122.17 40.28 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.144 -178.894 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.405 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.9 OUTLIER -96.47 118.22 42.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.376 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.467 ' CZ ' ' CA ' ' A' ' 118' ' ' GLY . 25.5 p90 -112.12 144.69 41.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.465 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.49 ' C ' ' H ' ' A' ' 88' ' ' THR . 1.5 p -86.94 135.7 33.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.844 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.564 HG21 ' N ' ' A' ' 124' ' ' HIS . 17.6 m -72.35 19.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.991 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.49 ' H ' ' C ' ' A' ' 86' ' ' SER . 5.5 t -136.65 -26.11 1.1 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.061 0.457 . . . . 0.0 112.099 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.545 ' C ' ' N ' ' A' ' 91' ' ' LYS . 18.3 t -93.14 93.74 8.45 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.095 -176.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 tp -60.45 -10.02 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.545 ' N ' ' C ' ' A' ' 89' ' ' SER . 15.6 mttp -75.48 -48.6 21.9 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 113.901 -1.5 . . . . 0.0 109.533 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.1 p -61.44 -30.92 70.88 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.906 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.446 ' CE2' HG21 ' A' ' 129' ' ' ILE . 0.6 OUTLIER -73.24 -51.75 16.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.125 -179.437 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -62.77 -43.78 97.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.701 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 91' ' ' LYS . 14.4 m -66.67 -34.51 70.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.084 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.8 mt -66.48 -36.08 76.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.591 -0.443 . . . . 0.0 109.904 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -70.07 -26.36 63.97 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.273 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.1 t -73.02 -67.03 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.895 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.423 HG23 ' N ' ' A' ' 100' ' ' HIS . 2.5 tt -43.11 -40.37 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.214 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.423 ' N ' HG23 ' A' ' 99' ' ' ILE . 0.9 OUTLIER -58.45 -63.57 1.23 Allowed 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.385 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -38.36 -58.42 1.68 Allowed Glycine 0 CA--C 1.519 0.3 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 105' ' ' ASP . 34.8 tptt -61.71 -62.75 1.58 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.953 -0.623 . . . . 0.0 110.365 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.64 -55.0 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.429 0.633 . . . . 0.0 109.579 179.375 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -49.17 -46.24 45.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.275 178.712 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.874 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.726 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.458 ' HB3' HG23 ' A' ' 170' ' ' ILE . 23.0 mt-30 . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.592 0.234 . . . . 0.0 110.732 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.602 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.4 OUTLIER -138.3 148.2 58.62 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.098 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -48.7 114.59 1.28 Allowed 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 121.94 1.76 . . . . 0.0 112.824 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.513 ' HB ' ' HB2' ' A' ' 143' ' ' ALA . 2.2 mp -124.26 128.65 73.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.542 ' O ' HD12 ' A' ' 83' ' ' LEU . 10.7 tpt -130.36 114.32 15.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.912 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.4 mt -97.65 98.66 10.07 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.3 t -104.98 129.45 57.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.944 0.878 . . . . 0.0 111.461 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.467 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -96.07 117.12 5.6 Favored Glycine 0 C--N 1.311 -0.83 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.445 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 58.7 t30 -97.47 174.14 6.82 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.994 -177.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.445 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 6.1 mttp 59.91 58.75 2.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.939 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 18.1 tttm -56.27 -26.05 50.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.568 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.405 ' OD2' ' CD1' ' A' ' 123' ' ' LEU . 3.9 p-10 -72.72 -13.31 61.31 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.084 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.8 mp -91.18 -30.92 16.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.564 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -38.93 -25.04 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.171 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.519 ' N ' ' O ' ' A' ' 123' ' ' LEU . 11.2 mtt -45.65 -23.95 0.3 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.473 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -105.17 -40.46 5.86 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.495 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.488 ' CZ ' ' OE1' ' A' ' 147' ' ' GLU . 2.6 tpp85 27.9 86.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.766 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.1 t -59.41 -32.6 49.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.396 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.446 HG21 ' CE2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -88.29 153.04 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.531 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.501 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 78.3 p -96.89 121.94 39.32 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.304 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.411 ' HB2' HH12 ' A' ' 127' ' ' ARG . 13.8 t80 -37.01 -32.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.249 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.5 mp0 -70.51 -64.84 0.82 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.808 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.501 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 69.6 mt-10 -41.24 -42.52 2.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.724 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.15 -35.68 70.93 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 132' ' ' GLU . 4.2 tttt -61.97 -55.48 29.02 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.92 -35.72 69.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.821 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.644 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -66.27 -63.53 1.06 Allowed 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.85 -35.6 57.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.185 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -68.69 -32.35 72.11 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.173 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 p -63.24 -46.24 87.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.792 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.644 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 30.9 m95 -88.51 -5.12 58.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.982 0.42 . . . . 0.0 110.335 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 141' ' ' TRP . 0.9 OUTLIER 77.41 23.69 0.85 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.384 0.611 . . . . 0.0 109.52 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.29 167.37 13.6 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.869 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.432 ' HB3' ' SD ' ' A' ' 115' ' ' MET . . . -110.97 130.1 55.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.529 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -98.17 120.87 39.33 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.281 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.75 128.73 17.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.488 ' OE1' ' CZ ' ' A' ' 127' ' ' ARG . 6.4 mt-10 -100.28 119.76 38.89 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.043 0.449 . . . . 0.0 110.029 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 63.2 p -137.45 178.1 7.36 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.42 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.3 138.08 38.03 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.974 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -55.73 -49.82 72.01 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.143 0.497 . . . . 0.0 109.748 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.7 tttm -58.84 -3.12 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.284 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 150' ' ' ALA . 6.7 tt0 -127.35 110.92 13.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.421 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.515 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 7.7 t-20 -76.57 -47.21 23.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.684 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -41.3 -57.61 2.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.093 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.644 ' O ' HG23 ' A' ' 159' ' ' VAL . 78.0 p -52.74 -48.42 66.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.975 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.618 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -48.49 -60.56 2.59 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.516 0.674 . . . . 0.0 109.59 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 60.0 t -43.29 -49.58 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.088 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -53.76 -43.1 68.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.553 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 155' ' ' THR . 3.2 t -68.16 -44.12 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.304 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.758 ' CE1' HD11 ' A' ' 164' ' ' ILE . 9.7 t80 -53.72 -40.48 66.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.168 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.3 ttt85 -77.09 -42.12 39.45 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.156 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -60.26 -34.44 73.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.189 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 160' ' ' PHE . 10.3 tt -70.73 -47.16 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 119.281 -0.968 . . . . 0.0 110.79 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.758 HD11 ' CE1' ' A' ' 160' ' ' PHE . 85.5 mt -54.62 -32.07 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.289 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.404 ' HA ' HD13 ' A' ' 165' ' ' LEU . 0.4 OUTLIER -63.21 -64.68 0.84 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.206 -179.419 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -60.01 -29.67 68.64 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.493 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.454 ' HB1' ' NH1' ' A' ' 7' ' ' ARG . . . -61.33 -30.97 70.84 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.417 ' OE2' ' OH ' ' A' ' 54' ' ' TYR . 3.7 tp10 -68.06 -54.34 18.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.177 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -60.9 -61.09 2.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.884 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.602 HG21 ' C ' ' A' ' 112' ' ' ILE . 74.2 mt -50.06 -36.96 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.814 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -70.86 -40.07 72.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.808 0.337 . . . . 0.0 110.605 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -55.16 -41.52 78.81 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.654 -0.979 . . . . 0.0 110.654 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.05 -61.99 1.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.756 0.313 . . . . 0.0 110.621 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.932 -179.832 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 121.212 0.53 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.22 136.05 34.58 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.489 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.543 ' HB2' HG22 ' A' ' 78' ' ' ILE . 1.9 mptt -106.16 132.28 52.41 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.776 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.1 mm -104.45 124.75 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-O 121.333 0.587 . . . . 0.0 110.242 -178.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.475 ' HB2' ' CD1' ' A' ' 78' ' ' ILE . . . -83.83 133.54 34.75 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.084 -1.01 . . . . 0.0 110.931 -177.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 58' ' ' LEU . 14.8 mt -95.56 133.72 35.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.657 0.741 . . . . 0.0 112.33 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.55 104.91 6.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.877 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -140.98 135.95 7.25 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.467 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -54.09 -158.18 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.769 0.795 . . . . 0.0 111.042 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -95.99 132.75 40.99 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.882 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.8 m 59.14 19.1 7.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.159 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 17' ' ' VAL . 2.5 p -80.48 -10.76 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.801 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.42 7.66 51.23 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.414 ' HE3' ' H ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -40.05 -59.26 1.26 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.118 0.485 . . . . 0.0 110.353 179.565 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -67.75 -26.97 66.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.449 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.0 m -64.39 -50.56 67.17 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.017 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.9 tp -75.83 -26.35 57.1 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.42 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.492 ' O ' HG12 ' A' ' 27' ' ' VAL . 55.5 m -58.15 -50.9 71.89 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.4 mp -60.6 -43.73 95.28 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.406 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.541 ' OE1' ' N ' ' A' ' 31' ' ' PHE . 6.4 tt0 -69.69 -25.62 63.96 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.21 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -77.32 -49.94 13.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.246 0.546 . . . . 0.0 110.822 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.591 HG13 ' N ' ' A' ' 28' ' ' GLU . 11.8 p -68.77 -45.1 81.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.139 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.591 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.8 tt0 -81.4 -24.94 36.61 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 77.68 19.25 76.16 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.974 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.539 ' NE2' ' O ' ' A' ' 31' ' ' PHE . 16.8 tp60 -149.0 135.97 19.86 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.301 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.541 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 1.0 OUTLIER . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.567 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -161.97 -178.99 6.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.645 0.736 . . . . 0.0 112.95 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.2 m -137.43 144.3 42.28 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.11 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 12.3 m-85 -127.44 163.65 23.61 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.496 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.528 HG23 ' HB2' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -144.22 150.75 38.47 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.396 0.617 . . . . 0.0 112.661 -178.609 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.0 118.69 2.73 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.771 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.6 mp -105.82 129.3 54.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.654 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.444 HD12 ' HE2' ' A' ' 160' ' ' PHE . 1.0 OUTLIER -147.65 165.83 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.798 -179.095 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.4 m -115.79 126.4 53.97 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.197 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.594 HG12 ' CD1' ' A' ' 54' ' ' TYR . 7.2 p -121.28 118.95 57.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.94 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 71.27 17.36 5.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.12 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.37 -11.58 70.82 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -89.28 133.88 34.28 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.25 144.1 42.74 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.622 0.725 . . . . 0.0 111.163 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.594 ' CD1' HG12 ' A' ' 49' ' ' VAL . 6.6 m-85 -136.47 127.87 28.44 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.664 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 55' ' ' HIS . 1.2 t-80 -117.07 114.39 23.67 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.449 HD12 ' C ' ' A' ' 55' ' ' HIS . 8.4 mp -117.69 143.72 45.92 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 122.078 0.942 . . . . 0.0 112.244 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.772 ' C ' HD13 ' A' ' 58' ' ' LEU . 3.0 tt0 -140.91 121.68 14.38 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 113.702 -1.59 . . . . 0.0 109.725 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.946 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -115.86 154.09 30.33 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.528 0.68 . . . . 0.0 112.347 -178.403 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.02 145.09 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-N 114.532 -1.213 . . . . 0.0 113.172 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.88 102.91 8.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.201 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.5 p . . . . . 0 N--CA 1.446 -0.661 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.07 -179.547 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.543 HG22 ' HB2' ' A' ' 8' ' ' LYS . 37.6 pt . . . . . 0 N--CA 1.438 -1.044 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.69 16.34 0.88 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.449 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -145.07 166.79 27.45 Favored Glycine 0 CA--C 1.519 0.319 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.317 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.82 122.5 7.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.911 -0.645 . . . . 0.0 111.28 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.698 ' O ' HG23 ' A' ' 82' ' ' ILE . 12.2 tt -127.55 101.04 6.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.562 0.696 . . . . 0.0 109.138 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.968 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -96.86 123.44 40.56 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.376 -178.52 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -96.84 119.67 45.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.97 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.635 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 32.1 p90 -121.64 144.72 48.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.675 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.7 p -87.82 143.28 27.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.735 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.59 HG21 ' N ' ' A' ' 124' ' ' HIS . 15.8 m -80.67 20.32 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.778 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.609 ' HB ' HD23 ' A' ' 123' ' ' LEU . 0.7 OUTLIER -131.05 -27.82 2.01 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.119 0.485 . . . . 0.0 111.936 -178.101 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.543 ' C ' ' N ' ' A' ' 91' ' ' LYS . 44.2 t -97.08 93.94 6.87 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.674 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 tp -58.58 -10.75 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.567 ' O ' HG22 ' A' ' 95' ' ' VAL . 2.6 mtpt -76.07 -50.82 13.7 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.052 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.477 ' O ' ' CG1' ' A' ' 96' ' ' ILE . 59.1 p -60.34 -31.88 70.73 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.01 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -75.56 -46.17 33.55 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.081 -179.337 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -66.02 -44.1 85.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.25 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 91' ' ' LYS . 16.4 m -68.17 -39.8 81.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.621 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.494 ' N ' HG23 ' A' ' 95' ' ' VAL . 1.4 mm -59.18 -42.45 86.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.289 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.49 -27.25 64.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.305 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.0 t -75.55 -66.97 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.166 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.6 mm -41.84 -45.49 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.043 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.443 ' ND1' ' C ' ' A' ' 100' ' ' HIS . 9.7 t-80 -56.53 -63.51 1.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.691 -0.403 . . . . 0.0 109.985 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -40.63 -58.57 2.54 Favored Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 103' ' ' LEU . 14.0 tptp -55.8 -66.09 0.48 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.037 -0.582 . . . . 0.0 110.249 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.45 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.98 -59.84 0.8 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.275 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -46.06 -47.72 17.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.577 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.439 ' N ' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.313 -0.988 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.998 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 . . . . . 0 CA--C 1.52 -0.174 0 CA-C-O 120.941 0.401 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.635 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.7 OUTLIER -119.55 155.74 54.06 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.023 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -47.43 106.01 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.529 1.486 . . . . 0.0 112.335 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.454 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.8 mt -119.8 128.56 75.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.564 ' O ' HD12 ' A' ' 83' ' ' LEU . 10.1 tpt -127.25 116.83 21.18 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.789 -178.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 mt -96.02 97.25 9.45 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.5 t -103.72 133.19 48.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 122.406 1.098 . . . . 0.0 110.371 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.79 113.07 4.11 Favored Glycine 0 C--N 1.299 -1.509 0 CA-C-N 113.265 -1.789 . . . . 0.0 109.032 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.509 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 48.5 t30 -96.88 177.22 5.7 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.279 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.509 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 26.8 mttp 61.96 58.35 1.92 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.016 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -63.48 -31.27 72.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.495 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -63.58 -8.92 11.03 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.003 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.609 HD23 ' HB ' ' A' ' 88' ' ' THR . 8.6 mp -93.67 -27.0 16.8 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.59 ' N ' HG21 ' A' ' 87' ' ' VAL . 1.1 p-80 -39.3 -24.47 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.858 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.518 ' N ' ' O ' ' A' ' 123' ' ' LEU . 2.7 mmt -46.12 -22.27 0.21 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.473 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.3 OUTLIER -106.67 -36.54 6.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.063 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.492 ' NH2' ' CD2' ' A' ' 131' ' ' TYR . 0.1 OUTLIER 33.11 88.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.851 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.6 t -72.05 -38.05 62.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.553 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 tp -89.92 155.63 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.427 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.484 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 62.0 p -103.03 125.44 49.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.949 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.492 ' CD2' ' NH2' ' A' ' 127' ' ' ARG . 0.8 OUTLIER -37.32 -35.91 0.13 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.574 179.13 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.6 mp0 -67.16 -64.75 0.79 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.054 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.484 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 64.6 mt-10 -41.21 -41.52 1.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.979 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.83 -36.3 65.91 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 132' ' ' GLU . 3.6 ttpp -61.69 -55.15 33.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.048 -0.576 . . . . 0.0 109.587 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.69 70.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.865 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.518 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -66.23 -61.66 1.9 Allowed 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.658 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -53.41 -35.78 60.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.34 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -68.85 -29.94 68.37 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.43 -46.65 82.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.715 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.518 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 33.0 m95 -89.35 -4.25 58.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.027 0.442 . . . . 0.0 110.194 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.409 ' O ' ' OE1' ' A' ' 166' ' ' GLU . 0.9 OUTLIER 76.52 22.46 1.22 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.403 -179.084 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -89.29 170.9 10.18 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.595 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.409 ' HB3' ' SD ' ' A' ' 115' ' ' MET . . . -109.65 134.75 51.59 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.428 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.627 ' O ' HD22 ' A' ' 146' ' ' LEU . 7.0 t80 -96.66 122.36 39.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.929 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.782 HD12 HG22 ' A' ' 159' ' ' VAL . 1.2 mm? -133.17 137.7 46.32 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.346 -176.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.456 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 9.1 tt0 -127.38 110.64 13.01 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 36.3 p -136.56 -172.81 3.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.21 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.68 139.57 40.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.716 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.525 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -64.84 -30.97 72.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.287 0.565 . . . . 0.0 109.97 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -79.78 13.65 2.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.029 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -144.19 121.03 11.27 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.745 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 154' ' ' GLN . 41.3 t30 -77.59 -54.51 6.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.408 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 153' ' ' ASN . 7.6 tt0 -37.09 -55.33 0.96 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.823 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 159' ' ' VAL . 60.2 p -57.01 -50.73 71.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.275 0.559 . . . . 0.0 110.158 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -47.68 -59.96 2.9 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.561 0.696 . . . . 0.0 109.574 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.9 t -41.28 -53.35 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.626 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -48.94 -33.1 10.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.733 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.782 HG22 HD12 ' A' ' 146' ' ' LEU . 10.3 t -76.55 -28.54 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.608 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -68.55 -40.71 80.55 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.727 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.507 ' N ' ' CD1' ' A' ' 160' ' ' PHE . 27.6 ttm-85 -79.6 -50.57 10.48 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.196 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -54.53 -36.92 64.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.226 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.627 HG23 ' N ' ' A' ' 164' ' ' ILE . 11.9 tt -69.01 -58.25 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.322 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.627 ' N ' HG23 ' A' ' 163' ' ' ILE . 84.1 mt -46.68 -33.02 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.91 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.25 -64.62 0.87 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.295 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.409 ' OE1' ' O ' ' A' ' 142' ' ' ASN . 3.2 mm-40 -61.21 -26.47 67.75 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.454 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -58.1 -36.8 73.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.419 ' OE2' ' OH ' ' A' ' 54' ' ' TYR . 11.5 mm-40 -69.73 -52.06 28.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.273 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -54.59 -60.22 3.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.515 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.635 HG21 ' C ' ' A' ' 112' ' ' ILE . 71.2 mt -50.0 -35.2 10.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.764 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.17 -39.92 90.13 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -60.4 -32.13 76.37 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.0 -76.59 0.09 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.168 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.061 179.871 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 121.166 0.508 . . . . 0.0 110.369 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.413 ' NH1' ' HB1' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -139.8 135.73 33.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.579 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.426 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 18.3 mttt -107.58 128.33 54.43 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.762 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -101.97 121.66 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-O 121.535 0.684 . . . . 0.0 110.351 -178.469 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.99 135.55 34.4 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 121.426 -0.796 . . . . 0.0 111.062 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.8 mt -95.57 131.39 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.458 0.647 . . . . 0.0 112.226 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.632 HD23 ' C ' ' A' ' 12' ' ' LEU . 6.3 tt -130.58 103.67 6.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.215 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.08 135.32 6.84 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.734 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.478 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -53.72 -160.82 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.366 0.603 . . . . 0.0 110.535 179.168 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.404 ' NE ' ' OG ' ' A' ' 16' ' ' SER . 10.1 ttp180 -96.14 135.94 37.27 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.86 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.404 ' OG ' ' NE ' ' A' ' 15' ' ' ARG . 5.1 m 60.08 19.34 8.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.574 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.477 ' C ' ' HZ2' ' A' ' 120' ' ' LYS . 3.6 p -76.69 -19.75 14.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.737 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.34 21.63 26.67 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.531 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.7 pttm -68.17 -33.97 75.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.928 0.394 . . . . 0.0 110.016 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.7 m -73.16 -38.75 66.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.532 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.8 p -62.16 -40.4 95.86 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.402 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.7 tp -77.75 -25.44 49.17 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.26 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.564 ' O ' HG12 ' A' ' 27' ' ' VAL . 58.4 m -63.67 -38.24 90.39 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.4 mp -74.92 -38.54 43.69 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.214 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.56 ' OE1' ' N ' ' A' ' 31' ' ' PHE . 5.9 tt0 -75.04 -25.48 58.72 Favored 'General case' 0 C--O 1.217 -0.618 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.154 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 23.1 t80 -76.59 -52.82 8.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.29 0.567 . . . . 0.0 110.766 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.593 HG13 ' N ' ' A' ' 28' ' ' GLU . 11.3 p -62.28 -45.96 97.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.906 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.593 ' N ' HG13 ' A' ' 27' ' ' VAL . 1.1 tm-20 -82.22 -24.54 34.81 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.466 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 77.24 18.01 78.79 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.799 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -146.68 134.19 20.89 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.56 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.47 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.428 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 2.3 pm0 . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.682 0.277 . . . . 0.0 110.381 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER 176.44 179.79 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.332 0.587 . . . . 0.0 111.962 -179.31 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.514 HG23 HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -107.69 140.49 40.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.666 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 12.1 m-85 -127.9 163.53 24.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.638 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -143.6 155.8 44.39 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.295 0.569 . . . . 0.0 112.363 -178.52 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.465 ' HD2' HD11 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -160.97 111.68 1.76 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.899 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 46' ' ' LEU . 8.1 mp -105.1 127.1 52.74 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.793 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.81 HD12 ' CZ ' ' A' ' 160' ' ' PHE . 0.9 OUTLIER -148.85 165.6 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.5 179.338 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.2 m -114.66 126.51 54.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.557 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.594 HG21 HG21 ' A' ' 164' ' ' ILE . 7.4 p -123.4 135.04 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.842 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.517 ' CG ' HG22 ' A' ' 49' ' ' VAL . 7.7 m-20 62.6 3.97 1.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.029 0.442 . . . . 0.0 109.829 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 102.69 -13.23 56.52 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -90.29 140.37 29.76 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -77.09 147.23 36.77 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.525 0.679 . . . . 0.0 111.303 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.552 ' CD1' HG12 ' A' ' 49' ' ' VAL . 13.9 m-85 -139.76 123.04 17.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.799 -1.092 . . . . 0.0 109.911 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.626 ' C ' HD12 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -117.48 113.79 22.54 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.626 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.9 mp -118.84 145.9 45.3 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.641 0.734 . . . . 0.0 112.143 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.811 ' C ' HD13 ' A' ' 58' ' ' LEU . 12.4 tt0 -139.18 124.09 18.74 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.053 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.939 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.96 154.99 29.9 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.279 0.561 . . . . 0.0 112.463 -178.248 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.514 HG23 HG23 ' A' ' 42' ' ' THR . 0.3 OUTLIER -133.96 144.41 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.779 -179.495 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.35 104.37 8.14 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.831 177.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.47 0 CA-C-O 121.128 0.489 . . . . 0.0 110.511 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.428 HD12 ' O ' ' A' ' 80' ' ' GLY . 40.6 pt . . . . . 0 N--CA 1.439 -1.008 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.24 16.33 0.93 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.144 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.428 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -148.02 166.47 28.91 Favored Glycine 0 CA--C 1.516 0.152 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.73 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.98 123.17 7.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.711 -0.744 . . . . 0.0 111.481 178.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.624 ' O ' HG23 ' A' ' 82' ' ' ILE . 10.8 tt -127.07 104.24 12.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.628 0.728 . . . . 0.0 109.064 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.989 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.32 123.29 41.09 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.784 -178.332 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -96.65 118.13 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.468 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.556 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 27.9 p90 -120.28 144.52 47.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.581 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.482 ' HG ' ' H ' ' A' ' 89' ' ' SER . 4.8 p -87.89 142.15 28.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.499 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.562 HG21 ' N ' ' A' ' 124' ' ' HIS . 16.5 m -76.15 18.7 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.245 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.551 ' HB ' HD23 ' A' ' 123' ' ' LEU . 0.7 OUTLIER -133.18 -23.38 1.94 Allowed 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.063 0.459 . . . . 0.0 111.752 -178.342 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.54 ' C ' ' N ' ' A' ' 91' ' ' LYS . 22.7 t -93.71 93.47 8.03 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.96 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 tp -59.69 -11.76 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.648 ' O ' HG22 ' A' ' 95' ' ' VAL . 9.3 mttp -78.07 -51.23 10.62 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.458 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.0 p -56.48 -34.91 67.37 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.374 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.556 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.5 OUTLIER -70.8 -54.85 10.09 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.415 -179.278 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -63.0 -44.41 96.1 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.648 HG22 ' O ' ' A' ' 91' ' ' LYS . 17.7 m -64.79 -34.4 69.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.034 -0.667 . . . . 0.0 110.186 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.441 ' CG1' HD22 ' A' ' 12' ' ' LEU . 1.8 mt -65.2 -35.61 75.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.087 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.0 tttp -69.97 -27.56 64.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.546 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.8 t -76.95 -67.27 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.281 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.6 mp -43.41 -45.31 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.4 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.435 ' CD2' ' N ' ' A' ' 101' ' ' GLY . 24.1 t60 -60.09 -58.36 8.88 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.504 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.435 ' N ' ' CD2' ' A' ' 100' ' ' HIS . . . -37.68 -57.7 1.52 Allowed Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.866 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 105' ' ' ASP . 10.9 tptm -58.68 -66.65 0.46 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.274 -0.463 . . . . 0.0 110.574 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.7 OUTLIER -37.05 -62.25 0.51 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.72 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -42.86 -47.92 5.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.359 178.695 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.79 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.258 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 120.848 0.356 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.43 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -112.81 150.36 42.67 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.408 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -48.55 107.54 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.707 1.604 . . . . 0.0 112.857 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.458 ' HB ' ' HB2' ' A' ' 143' ' ' ALA . 2.9 mt -120.61 126.5 75.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.48 ' O ' HD12 ' A' ' 83' ' ' LEU . 8.3 tpt -126.47 115.28 19.33 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.237 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.3 mt -96.02 97.82 9.89 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.58 132.56 49.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 122.135 0.969 . . . . 0.0 110.574 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.75 109.47 3.2 Favored Glycine 0 C--N 1.304 -1.239 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.475 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.6 t30 -97.24 175.62 6.21 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.182 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.477 ' HZ2' ' C ' ' A' ' 17' ' ' VAL . 2.9 mttp 66.25 59.54 0.66 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 122.026 0.917 . . . . 0.0 109.291 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.509 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 19.2 tttm -63.77 -37.88 89.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.053 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -60.45 -5.61 1.25 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.783 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.551 HD23 ' HB ' ' A' ' 88' ' ' THR . 8.2 mp -91.95 -26.88 18.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.562 ' N ' HG21 ' A' ' 87' ' ' VAL . 13.2 p-80 -38.97 -24.97 0.01 OUTLIER 'General case' 0 C--N 1.339 0.124 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.719 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.536 ' N ' ' O ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -46.51 -22.89 0.31 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.293 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.479 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -110.38 -37.55 5.48 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.666 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.474 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 0.1 OUTLIER 29.65 91.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.886 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 46.1 t -72.37 -36.75 56.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.193 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.7 tp -89.57 154.74 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.634 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.494 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 99.5 p -101.55 127.24 48.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.742 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -40.63 -34.0 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.988 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -68.51 -65.42 0.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.988 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.494 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 63.6 mt-10 -41.38 -41.61 2.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.933 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.06 -34.7 64.72 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 132' ' ' GLU . 3.2 tttm -63.96 -55.27 23.72 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.28 -35.34 67.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.68 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.48 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -65.54 -62.09 1.72 Allowed 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -53.12 -38.41 62.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.226 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -33.28 75.51 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.736 0.303 . . . . 0.0 110.245 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.8 -46.11 86.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.828 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.48 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 42.2 m95 -89.09 1.04 56.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.695 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 6.5 m120 68.38 32.92 4.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.652 0.739 . . . . 0.0 109.58 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -100.84 169.04 9.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.862 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.14 133.79 51.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.305 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.699 ' O ' HD22 ' A' ' 146' ' ' LEU . 5.2 t80 -96.9 123.39 40.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.814 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.699 HD22 ' O ' ' A' ' 145' ' ' PHE . 1.3 mm? -134.74 137.14 43.2 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.862 -176.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.474 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 6.2 tt0 -126.39 111.17 14.16 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 34.7 p -137.15 -173.85 3.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.134 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.0 136.09 34.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.919 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.517 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -63.79 -26.73 68.76 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.25 4.37 12.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.723 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -138.85 122.6 17.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.11 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 154' ' ' GLN . 65.6 t30 -77.42 -55.48 5.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.614 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 153' ' ' ASN . 10.2 tt0 -36.91 -56.03 0.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.96 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.617 ' O ' HG23 ' A' ' 159' ' ' VAL . 67.6 p -55.59 -46.12 77.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.021 0.439 . . . . 0.0 110.297 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -54.53 -62.08 1.89 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.952 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 61.5 t -43.0 -39.94 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.435 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.77 -33.11 75.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.59 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.691 HG22 HD12 ' A' ' 146' ' ' LEU . 32.4 t -70.72 -35.38 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.954 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.81 ' CZ ' HD12 ' A' ' 47' ' ' ILE . 23.5 t80 -64.32 -65.69 0.64 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.561 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.582 HH22 HG23 ' A' ' 49' ' ' VAL . 9.1 ttm-85 -48.41 -43.33 34.03 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.759 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.574 ' HE ' HD21 ' A' ' 146' ' ' LEU . 11.4 mmm180 -58.51 -33.37 69.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.456 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -66.27 -34.29 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.917 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.78 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 11.1 mt -63.5 -48.18 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.267 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -55.47 -59.93 4.13 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.552 179.609 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.476 ' H ' HD23 ' A' ' 165' ' ' LEU . 4.5 tt0 -51.31 -24.03 4.2 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.78 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -71.34 -31.14 67.03 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.935 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 165' ' ' LEU . 0.4 OUTLIER -70.74 -54.72 10.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.886 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -60.05 -50.23 74.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.068 0.461 . . . . 0.0 110.565 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.466 ' CG1' ' O ' ' A' ' 166' ' ' GLU . 3.1 mm -49.64 -42.98 18.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.966 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -66.29 -39.76 89.57 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.339 -179.579 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.37 -41.94 55.91 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.14 -79.88 0.06 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.754 0.312 . . . . 0.0 110.474 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.022 -179.904 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.171 0.51 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.97 135.64 32.96 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.647 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.518 ' HB2' HG22 ' A' ' 78' ' ' ILE . 17.0 mttt -107.21 128.53 54.5 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.784 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -102.3 122.97 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 121.507 0.67 . . . . 0.0 110.469 -178.511 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.481 ' HB2' ' CD1' ' A' ' 78' ' ' ILE . . . -83.9 134.27 34.69 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.373 -0.83 . . . . 0.0 111.606 -177.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.6 mt -95.44 130.16 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.523 0.678 . . . . 0.0 112.14 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.604 HD23 ' C ' ' A' ' 12' ' ' LEU . 5.1 tt -127.91 102.55 6.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.54 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.12 136.45 7.53 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.485 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -51.94 -161.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.676 0.751 . . . . 0.0 111.321 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -94.14 131.79 39.32 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.666 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.452 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 4.1 m 60.54 20.09 9.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.472 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 p -74.7 -19.59 16.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.606 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.413 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 98.13 20.17 21.56 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.472 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.1 pttm -69.2 -34.81 75.48 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.318 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.9 m -73.45 -30.39 63.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.419 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 65.5 p -67.8 -40.86 83.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.409 ' O ' ' CB ' ' A' ' 26' ' ' PHE . 46.1 tp -77.5 -26.49 51.27 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.759 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.623 ' O ' HG12 ' A' ' 27' ' ' VAL . 57.5 m -62.77 -41.51 99.27 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.59 -41.6 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.606 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.535 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -71.88 -27.29 62.76 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.663 -179.42 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.409 ' CB ' ' O ' ' A' ' 22' ' ' LEU . 52.8 t80 -77.94 -62.05 1.8 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.303 0.573 . . . . 0.0 110.691 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.623 HG12 ' O ' ' A' ' 23' ' ' THR . 11.8 p -48.09 -48.9 12.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.804 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.612 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.4 mt-10 -80.42 -24.3 39.74 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.402 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 72.76 25.47 73.86 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -150.29 126.63 10.73 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.732 0.301 . . . . 0.0 111.338 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.614 ' CD1' ' O ' ' A' ' 31' ' ' PHE . 0.1 OUTLIER . . . . . 0 CA--C 1.536 0.424 0 CA-C-O 122.02 0.915 . . . . 0.0 110.691 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -164.19 -176.69 4.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.236 0.541 . . . . 0.0 111.982 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.411 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 4.0 m -133.14 152.77 51.93 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.13 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 11.9 m-85 -133.17 162.94 30.42 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 111.008 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.61 152.34 43.91 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.537 0.684 . . . . 0.0 112.487 -179.223 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.591 ' C ' HD12 ' A' ' 46' ' ' LEU . 25.8 tttp -157.11 111.01 2.64 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.407 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.718 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.2 mp -105.2 127.28 52.85 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.491 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.484 HD12 ' CE1' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -148.61 165.13 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.708 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.4 m -114.61 126.67 55.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.924 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.701 HG11 HG21 ' A' ' 164' ' ' ILE . 1.5 p -124.95 123.35 65.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.819 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 70.95 19.79 5.56 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.91 -9.77 62.09 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -90.91 134.93 34.08 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.01 145.5 40.19 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.561 0.696 . . . . 0.0 111.058 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.404 ' OH ' ' OE1' ' A' ' 168' ' ' GLU . 9.3 m-85 -139.44 125.14 19.47 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.778 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.605 ' C ' HD22 ' A' ' 56' ' ' LEU . 1.2 m-70 -117.44 113.65 22.36 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.703 ' N ' HD22 ' A' ' 56' ' ' LEU . 2.1 mm? -119.23 140.0 50.95 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 121.509 0.671 . . . . 0.0 111.629 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.828 ' C ' HD13 ' A' ' 58' ' ' LEU . 1.1 mt-30 -136.76 124.98 23.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.777 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.984 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.13 148.86 39.87 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.916 -178.368 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -118.49 141.5 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 114.998 -1.001 . . . . 0.0 113.165 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -114.42 101.65 9.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.333 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.473 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.518 HG22 ' HB2' ' A' ' 8' ' ' LYS . 35.7 pt . . . . . 0 N--CA 1.437 -1.124 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.41 14.27 0.98 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.578 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -142.29 165.79 26.59 Favored Glycine 0 N--CA 1.454 -0.114 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.179 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.407 ' CD1' ' HB3' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -151.82 122.41 7.4 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.767 -0.717 . . . . 0.0 111.205 178.27 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.628 ' O ' HG23 ' A' ' 82' ' ' ILE . 11.3 tt -125.28 103.83 12.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.973 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -96.32 126.73 41.73 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.407 -177.798 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.447 ' O ' HG12 ' A' ' 84' ' ' VAL . 2.0 t -96.07 113.68 31.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.43 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -110.37 146.05 36.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.734 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.558 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.0 OUTLIER -100.55 143.48 30.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.077 0.465 . . . . 0.0 111.881 -177.624 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.575 HG21 ' N ' ' A' ' 124' ' ' HIS . 17.3 m -81.15 21.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.633 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.407 ' HB ' HD23 ' A' ' 123' ' ' LEU . 1.0 OUTLIER -140.55 -17.76 0.88 Allowed 'General case' 0 C--O 1.231 0.097 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.605 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.558 ' H ' ' HG ' ' A' ' 86' ' ' SER . 43.8 t -112.7 93.46 4.44 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 94' ' ' GLU . 30.5 mm -50.84 -15.6 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.793 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.4 OUTLIER -78.31 -49.14 14.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.244 179.287 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.7 p -59.74 -44.6 93.74 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.517 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -79.3 -34.02 42.79 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 119.354 -0.939 . . . . 0.0 112.533 -178.126 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.416 ' HG3' HG22 ' A' ' 90' ' ' ILE . 8.9 mm-40 -69.84 -44.98 68.8 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.15 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 91' ' ' LYS . 28.1 m -64.99 -37.37 80.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.645 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.405 ' N ' HG23 ' A' ' 95' ' ' VAL . 1.3 mt -61.74 -36.03 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -70.1 -25.79 63.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.333 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.5 t -76.1 -67.22 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.5 mp -42.81 -40.68 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.616 ' NE2' ' CD1' ' A' ' 141' ' ' TRP . 25.7 t-80 -60.32 -63.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.673 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.82 -50.6 2.0 Favored Glycine 0 CA--C 1.518 0.267 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 105' ' ' ASP . 12.7 tptm -66.03 -65.79 0.63 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.273 -0.464 . . . . 0.0 110.106 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.36 -58.75 0.81 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.933 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.749 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -47.0 -43.82 19.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.677 178.737 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.838 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.374 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.563 ' OE1' ' HB1' ' A' ' 173' ' ' ALA . 8.6 mt-30 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.657 0.265 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.667 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.2 OUTLIER -132.06 155.78 80.92 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.308 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -48.69 107.43 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.689 1.593 . . . . 0.0 112.174 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.6 mt -123.84 129.18 74.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.508 ' O ' HD12 ' A' ' 83' ' ' LEU . 8.7 tpt -128.85 117.42 21.01 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.329 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.1 mt -97.34 97.59 9.26 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.7 t -104.45 134.22 46.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 122.196 0.998 . . . . 0.0 110.958 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -104.88 116.44 5.29 Favored Glycine 0 C--N 1.302 -1.313 0 CA-C-N 113.699 -1.592 . . . . 0.0 109.234 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.487 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 50.1 t30 -98.0 173.87 6.84 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.718 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.487 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 25.5 mttt 61.17 58.67 2.16 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.624 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.527 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -60.2 -35.24 74.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.282 -179.168 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -61.15 -13.63 19.11 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.488 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 125' ' ' MET . 9.8 mp -88.1 -31.37 19.25 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.575 ' N ' HG21 ' A' ' 87' ' ' VAL . 2.5 p-80 -37.67 -26.46 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.976 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.536 ' N ' ' O ' ' A' ' 123' ' ' LEU . 6.9 mmt -43.93 -24.64 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.454 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.3 OUTLIER -103.23 -34.94 8.63 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.815 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.458 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 1.6 tpt180 38.39 92.82 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.23 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.535 HG22 ' C ' ' A' ' 87' ' ' VAL . 19.6 m -85.4 -35.43 9.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.312 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -89.48 130.0 39.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.159 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.408 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 92.4 p -77.1 122.19 24.62 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.946 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -40.56 -38.38 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.322 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -60.98 -64.21 1.03 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.011 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.408 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 64.2 mt-10 -41.11 -49.91 3.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.179 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.33 -25.72 74.56 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 132' ' ' GLU . 13.1 tttm -71.26 -55.98 6.98 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -55.95 -33.01 64.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.296 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.652 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -66.53 -62.97 1.18 Allowed 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.807 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -53.65 -36.89 62.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.312 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -69.56 -30.29 68.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.474 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.526 ' OG ' ' CD2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -63.63 -47.15 82.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.02 -178.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.652 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 8.4 m95 -91.52 -5.27 54.41 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.355 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 141' ' ' TRP . 0.9 OUTLIER 77.45 26.01 0.71 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.779 -179.271 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.45 170.11 11.19 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.218 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.19 133.39 50.03 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.906 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.64 ' O ' HD22 ' A' ' 146' ' ' LEU . 6.5 t80 -97.06 122.96 40.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.767 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.895 HD12 HG22 ' A' ' 159' ' ' VAL . 1.2 mm? -133.12 138.81 46.8 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.939 -176.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.458 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 4.9 tt0 -127.5 110.01 12.31 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.518 ' OG ' HG21 ' A' ' 159' ' ' VAL . 0.1 OUTLIER -136.37 -178.38 5.14 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.676 -178.014 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 152' ' ' GLU . 0.0 OUTLIER -138.77 132.79 31.24 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.39 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.479 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -54.41 -53.07 59.0 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.112 0.482 . . . . 0.0 109.843 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -51.28 -8.74 0.05 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.938 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.479 ' H ' ' C ' ' A' ' 150' ' ' ALA . 18.7 mt-10 -131.4 119.2 21.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.978 0.418 . . . . 0.0 110.657 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.454 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 39.5 t30 -75.35 -48.25 23.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.195 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 153' ' ' ASN . 3.3 mt-30 -36.71 -59.48 0.67 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.023 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.5 p -54.43 -46.64 73.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.169 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.535 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -51.45 -59.4 4.28 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.524 0.678 . . . . 0.0 109.584 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 50.5 t -42.36 -48.43 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.67 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -54.02 -33.07 56.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.525 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.895 HG22 HD12 ' A' ' 146' ' ' LEU . 11.6 t -77.06 -27.67 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.982 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.484 ' CE1' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -68.64 -41.63 79.13 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.5 179.779 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.7 ttm-85 -79.86 -49.98 11.16 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.961 -0.695 . . . . 0.0 110.928 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -53.47 -37.88 63.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.31 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 159' ' ' VAL . 13.0 tt -68.39 -56.7 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.403 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.701 HG21 HG11 ' A' ' 49' ' ' VAL . 84.7 mt -47.9 -33.87 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.975 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.8 -64.42 0.95 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.059 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -58.53 -28.57 65.59 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.532 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -59.56 -33.53 71.53 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.404 ' OE1' ' OH ' ' A' ' 54' ' ' TYR . 33.5 tp10 -68.73 -57.15 6.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.329 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 13.2 tttm -52.49 -56.72 13.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.636 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.667 HG21 ' C ' ' A' ' 112' ' ' ILE . 66.3 mt -52.84 -34.2 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.137 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 172' ' ' GLY . 0.0 OUTLIER -68.9 -40.45 79.14 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.611 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.414 ' N ' ' OD1' ' A' ' 171' ' ' ASP . . . -60.3 -35.83 89.3 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.563 ' HB1' ' OE1' ' A' ' 111' ' ' GLN . . . -68.07 -60.77 2.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.803 0.335 . . . . 0.0 110.494 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.792 179.964 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 121.174 0.512 . . . . 0.0 110.445 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.84 136.39 33.95 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.611 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.435 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 4.0 mptt -106.66 121.28 44.03 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.551 HD11 HD12 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -98.95 117.2 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-O 121.824 0.821 . . . . 0.0 110.027 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.82 136.23 34.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.096 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.5 mt -95.27 132.81 38.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.23 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.645 HD23 ' C ' ' A' ' 12' ' ' LEU . 6.3 tt -127.65 104.05 7.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.392 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.39 134.87 6.51 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.691 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.446 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -55.05 -159.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.3 0.571 . . . . 0.0 110.582 179.187 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -92.61 133.28 36.12 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.952 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.454 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 7.7 m 56.58 19.46 4.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.546 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.415 ' H ' HG12 ' A' ' 17' ' ' VAL . 2.8 p -69.85 -27.34 32.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.794 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.409 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 105.1 23.51 7.67 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.418 ' CE ' ' OD2' ' A' ' 60' ' ' ASP . 3.5 pttm -71.18 -33.59 70.13 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.356 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.2 m -75.75 -30.92 59.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.156 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 72.4 p -65.28 -54.15 33.53 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.056 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 23' ' ' THR . 24.7 tp -62.91 -52.06 64.53 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.731 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.49 ' O ' HG12 ' A' ' 27' ' ' VAL . 9.2 m -36.47 -64.12 0.35 Allowed 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 122.976 0.172 . . . . 0.0 110.774 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -57.45 -41.72 79.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.144 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.663 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -66.99 -35.92 81.03 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.263 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.494 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.6 OUTLIER -77.54 -62.81 1.54 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.369 0.604 . . . . 0.0 110.705 -179.636 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.569 HG13 ' N ' ' A' ' 28' ' ' GLU . 9.1 p -44.77 -49.29 2.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.488 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.569 ' N ' HG13 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -79.78 -24.54 41.4 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.081 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 74.96 26.66 66.21 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.784 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 31' ' ' PHE . 10.6 tp60 -147.91 125.89 12.04 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.895 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.528 ' O ' ' NE2' ' A' ' 30' ' ' GLN . 1.2 t80 . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.606 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 2.6 pt-20 . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 1.4 m120 -177.47 174.48 1.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.235 0.541 . . . . 0.0 112.072 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.31 146.48 32.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.699 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 7.2 m-85 -131.7 164.16 26.55 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.318 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.84 156.67 42.96 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.328 0.585 . . . . 0.0 112.071 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -160.15 111.36 1.93 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.698 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.9 mp -104.81 121.01 42.75 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.943 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.534 ' O ' HD12 ' A' ' 47' ' ' ILE . 1.1 pp -147.72 165.16 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.595 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -111.82 127.97 55.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.99 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.735 HG11 HG21 ' A' ' 164' ' ' ILE . 2.5 p -128.16 124.86 63.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.526 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 49' ' ' VAL . 1.9 t-20 73.23 10.71 5.11 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.19 -11.87 71.04 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -91.21 137.84 32.06 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -76.4 146.06 38.94 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.578 0.704 . . . . 0.0 111.023 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.43 ' OH ' ' OE1' ' A' ' 168' ' ' GLU . 8.2 m-85 -135.87 126.78 27.62 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.459 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.646 ' C ' HD22 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -117.52 113.73 22.43 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.646 HD22 ' C ' ' A' ' 55' ' ' HIS . 2.9 mm? -119.39 138.61 52.97 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 121.356 0.598 . . . . 0.0 111.356 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.453 ' O ' HD12 ' A' ' 58' ' ' LEU . 5.3 mt-30 -126.99 127.3 44.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.087 177.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.546 HD11 ' CG1' ' A' ' 9' ' ' ILE . 3.4 mp -114.43 154.83 27.45 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.098 0.475 . . . . 0.0 112.182 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.12 143.99 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 CA-C-O 122.035 0.921 . . . . 0.0 112.72 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.425 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -125.26 105.14 8.9 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.189 -1.369 . . . . 0.0 107.893 177.64 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.443 -0.819 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.51 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.53 HD12 ' O ' ' A' ' 80' ' ' GLY . 37.8 pt . . . . . 0 N--CA 1.433 -1.293 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.68 13.73 1.19 Allowed 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.41 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.53 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -148.24 163.29 28.92 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.487 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.45 123.46 8.15 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.787 -0.706 . . . . 0.0 111.094 177.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.558 ' O ' HG23 ' A' ' 82' ' ' ILE . 9.5 tt -126.93 106.81 16.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.661 0.743 . . . . 0.0 109.146 178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.715 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -97.32 122.5 40.42 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.459 -178.123 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.405 ' O ' HG12 ' A' ' 84' ' ' VAL . 1.7 t -97.04 114.53 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.456 ' CZ ' ' CA ' ' A' ' 118' ' ' GLY . 26.2 p90 -115.4 144.58 43.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.704 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.477 ' C ' ' H ' ' A' ' 88' ' ' THR . 3.4 p -87.11 141.93 28.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.068 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.63 HG21 ' N ' ' A' ' 124' ' ' HIS . 16.2 m -73.7 18.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.639 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.477 ' H ' ' C ' ' A' ' 86' ' ' SER . 6.4 t -138.91 -22.07 0.96 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.508 ' C ' ' N ' ' A' ' 91' ' ' LYS . 22.9 t -90.83 93.07 9.07 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.201 -176.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.6 tp -59.11 -10.69 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.539 ' O ' HG22 ' A' ' 95' ' ' VAL . 6.9 mttm -77.84 -51.5 10.38 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.18 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 53.5 p -57.68 -31.74 66.65 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.674 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -75.39 -47.66 26.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.89 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.513 ' O ' HG23 ' A' ' 98' ' ' VAL . 6.1 mt-10 -63.35 -43.24 98.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.863 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 91' ' ' LYS . 31.6 m -67.02 -38.97 82.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.197 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.418 ' N ' HG23 ' A' ' 95' ' ' VAL . 5.2 mt -59.4 -38.47 75.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.1 tttp -73.13 -26.63 61.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.836 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 94' ' ' GLU . 64.0 t -77.37 -67.15 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.985 0.422 . . . . 0.0 110.033 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.515 HD12 ' N ' ' A' ' 100' ' ' HIS . 2.5 pp -45.23 -39.78 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.174 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.62 ' NE2' ' CE2' ' A' ' 141' ' ' TRP . 18.3 t60 -62.56 -61.34 2.5 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.235 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 100' ' ' HIS . . . -35.87 -48.68 1.05 Allowed Glycine 0 C--N 1.33 0.25 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 105' ' ' ASP . 1.9 tppt? -68.8 -66.68 0.54 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.429 -0.385 . . . . 0.0 110.03 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.87 -59.1 0.86 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.13 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.721 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -45.9 -45.39 15.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.487 178.631 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.706 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.833 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.513 ' OE1' ' HB1' ' A' ' 173' ' ' ALA . 9.8 mt-30 . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.79 0.328 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.651 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.4 OUTLIER -143.35 151.21 54.22 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.775 179.329 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -48.29 111.82 0.5 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.763 1.642 . . . . 0.0 112.407 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' A' ' 143' ' ' ALA . 2.8 mt -126.86 132.41 70.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.7 tpt -130.85 114.69 15.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.951 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.1 mt -96.74 98.13 9.91 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.2 t -105.03 130.79 55.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 122.153 0.978 . . . . 0.0 111.395 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.456 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -97.83 114.78 5.09 Favored Glycine 0 C--N 1.307 -1.043 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.486 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.9 t30 -97.49 173.99 6.89 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.025 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.486 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 23.2 mttt 60.4 58.87 2.42 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.712 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.3 tttm -60.48 -32.6 71.58 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -60.8 -18.05 53.07 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.956 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 125' ' ' MET . 11.0 mp -85.86 -26.39 25.68 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.63 ' N ' HG21 ' A' ' 87' ' ' VAL . 1.0 OUTLIER -40.27 -24.63 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.854 179.094 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 123' ' ' LEU . 15.1 mtt -46.72 -22.53 0.31 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.462 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -108.28 -42.5 4.59 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.564 -179.654 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.5 ' NE ' ' OE1' ' A' ' 147' ' ' GLU . 22.6 ttm180 26.44 83.61 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.868 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.5 m -62.91 -28.84 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.696 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.4 tp -89.54 155.65 3.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.566 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.445 ' C ' ' N ' ' A' ' 132' ' ' GLU . 57.9 p -97.66 120.51 38.18 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.996 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -39.85 -29.41 0.06 Allowed 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.4 mp0 -70.26 -63.75 1.03 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.895 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.43 ' OE1' ' OG ' ' A' ' 130' ' ' SER . 57.7 mt-10 -41.2 -42.25 2.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.742 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.35 -34.89 63.69 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 132' ' ' GLU . 2.9 tttm -62.04 -55.03 33.26 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.02 -36.66 70.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.75 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.657 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -66.13 -62.87 1.25 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.159 0.504 . . . . 0.0 109.692 179.58 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.45 -35.12 51.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.122 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.03 -30.47 67.76 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.41 -46.86 84.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.757 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.657 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 15.0 m95 -90.5 -5.75 55.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.363 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 141' ' ' TRP . 1.1 t-20 78.73 24.8 0.55 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.008 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.31 167.6 13.4 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.712 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.65 128.83 54.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.975 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 5.9 t80 -97.95 121.38 39.79 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.768 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.08 126.4 14.85 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.5 ' OE1' ' NE ' ' A' ' 127' ' ' ARG . 7.8 mt-10 -99.16 117.26 33.24 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.2 p -137.47 -178.69 5.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.658 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 152' ' ' GLU . 0.1 OUTLIER -138.6 138.77 38.21 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.272 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -57.28 -48.0 80.02 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -55.83 -18.4 8.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.128 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 149' ' ' SER . 38.7 mt-10 -113.53 116.13 29.07 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.942 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.541 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 6.4 t-20 -77.53 -50.34 12.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.78 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 153' ' ' ASN . 5.9 tt0 -39.92 -57.29 1.64 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.428 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.704 ' O ' HG23 ' A' ' 159' ' ' VAL . 80.5 p -51.88 -44.28 63.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.663 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -55.41 -60.46 3.38 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.458 0.647 . . . . 0.0 109.626 178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 57.7 t -41.82 -40.39 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.339 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -67.67 -36.57 80.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.623 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 155' ' ' THR . 22.0 t -70.29 -34.18 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.523 0.678 . . . . 0.0 109.612 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.741 ' CE1' HD11 ' A' ' 164' ' ' ILE . 7.7 t80 -66.13 -51.14 60.73 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.015 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.7 ttt85 -66.74 -36.96 83.7 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.223 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -64.28 -33.61 76.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.875 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.694 HG22 ' O ' ' A' ' 160' ' ' PHE . 15.3 tt -70.85 -39.75 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.167 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.741 HD11 ' CE1' ' A' ' 160' ' ' PHE . 64.6 mt -62.52 -35.59 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.549 0.69 . . . . 0.0 109.231 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.35 -51.8 66.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.522 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -67.89 -26.48 66.02 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.526 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -61.07 -34.67 75.27 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.43 ' OE1' ' OH ' ' A' ' 54' ' ' TYR . 9.9 mm-40 -70.44 -55.98 7.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.647 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -54.81 -62.13 1.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.711 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.651 HG21 ' C ' ' A' ' 112' ' ' ILE . 81.5 mt -52.99 -33.14 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.175 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -69.89 -40.35 75.71 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.752 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -60.71 -36.88 92.59 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.513 ' HB1' ' OE1' ' A' ' 111' ' ' GLN . . . -68.98 -62.81 1.22 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.569 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.722 179.988 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 121.262 0.553 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.465 ' NH1' ' HB1' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -140.05 136.13 33.34 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.984 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.53 ' HB2' HG22 ' A' ' 78' ' ' ILE . 6.5 mttm -109.38 131.36 55.14 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.75 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -104.1 125.4 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 CA-C-O 121.377 0.608 . . . . 0.0 110.674 -178.067 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.07 133.49 34.64 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.352 -0.843 . . . . 0.0 110.792 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.1 mt -96.58 133.21 38.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.645 0.736 . . . . 0.0 112.361 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.602 HD23 ' C ' ' A' ' 12' ' ' LEU . 5.3 tt -125.77 104.01 8.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.114 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -140.16 133.6 6.09 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.64 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.422 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.5 OUTLIER -56.94 -158.51 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.357 0.599 . . . . 0.0 110.605 179.221 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -97.02 131.14 44.13 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.334 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 m 64.94 19.0 11.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.568 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 17' ' ' VAL . 4.9 p -80.58 -15.74 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.83 0.348 . . . . 0.0 110.222 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.41 12.24 33.81 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.428 ' NZ ' ' CB ' ' A' ' 19' ' ' LYS . 0.6 OUTLIER -45.22 -52.58 9.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.938 0.399 . . . . 0.0 110.914 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.545 ' O ' HD13 ' A' ' 24' ' ' ILE . 2.1 m -70.69 -26.69 63.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.491 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.4 m -68.71 -49.59 57.7 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.989 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 45.9 tp -73.8 -26.32 60.57 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 119.626 -0.829 . . . . 0.0 110.782 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.545 ' O ' HG12 ' A' ' 27' ' ' VAL . 35.1 m -63.38 -41.01 98.77 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.545 HD13 ' O ' ' A' ' 20' ' ' SER . 1.3 mp -78.2 -37.03 21.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.754 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.644 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 0.6 OUTLIER -77.06 -27.48 54.37 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.582 -179.131 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -77.22 -53.41 7.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.432 0.634 . . . . 0.0 110.563 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.573 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.2 p -58.46 -45.58 89.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.08 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.573 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.4 tt0 -82.59 -24.47 33.91 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.72 27.5 70.79 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.52 ' N ' ' NE2' ' A' ' 25' ' ' GLN . 1.7 tp-100 -144.41 135.08 24.82 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.136 0.493 . . . . 0.0 111.637 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.917 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.29 170.36 4.29 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.351 -0.939 . . . . 0.0 113.34 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.78 143.43 44.02 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.61 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -122.71 169.17 11.34 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.367 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -146.99 147.56 30.82 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 120.008 -0.677 . . . . 0.0 112.605 -178.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.7 tttt -147.1 110.48 4.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.853 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.0 mp -106.4 122.83 47.06 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.254 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.437 HD12 ' CE1' ' A' ' 160' ' ' PHE . 1.2 pt -149.03 165.18 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.624 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 m -114.93 124.44 51.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.044 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.576 HG11 HG21 ' A' ' 164' ' ' ILE . 0.8 OUTLIER -121.95 126.03 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.649 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.12 21.45 10.11 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.14 -8.36 60.93 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.084 -1.207 . . . . 0.0 110.084 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -91.64 134.18 34.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -76.95 145.63 38.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.658 0.742 . . . . 0.0 111.785 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.452 ' CD1' ' CG1' ' A' ' 49' ' ' VAL . 13.5 m-85 -138.76 122.68 17.78 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.023 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.666 ' C ' HD12 ' A' ' 56' ' ' LEU . 67.7 m170 -117.12 113.49 22.35 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.666 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.9 mp -119.7 144.18 47.35 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.589 0.709 . . . . 0.0 112.04 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.756 ' C ' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -134.92 125.26 26.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.919 178.72 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.913 HD22 ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.66 154.19 32.04 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 120.01 -0.676 . . . . 0.0 112.065 -178.59 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.94 144.71 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.68 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.36 104.08 9.74 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.409 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 44.6 p . . . . . 0 N--CA 1.444 -0.737 0 CA-C-O 121.815 0.816 . . . . 0.0 111.152 -179.526 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.53 HG22 ' HB2' ' A' ' 8' ' ' LYS . 29.0 pt . . . . . 0 N--CA 1.439 -0.993 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.18 16.69 0.74 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.323 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -145.22 167.7 27.31 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.452 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.02 122.9 7.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.853 -0.674 . . . . 0.0 111.318 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.613 ' O ' HG23 ' A' ' 82' ' ' ILE . 10.5 tt -126.52 105.72 14.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 1.047 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.51 122.47 40.61 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.179 -0.609 . . . . 0.0 111.434 -178.3 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 84' ' ' VAL . 1.6 t -97.04 115.83 37.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.032 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.504 ' OH ' ' CZ ' ' A' ' 145' ' ' PHE . 53.8 p90 -109.76 144.69 37.82 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.494 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.0 OUTLIER -99.79 143.97 29.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.01 0.433 . . . . 0.0 111.47 -178.127 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.661 HG21 ' N ' ' A' ' 124' ' ' HIS . 14.7 m -80.78 22.21 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.34 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.22 -21.1 0.86 Allowed 'General case' 0 C--O 1.232 0.182 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.546 ' C ' ' N ' ' A' ' 91' ' ' LYS . 17.8 t -109.54 92.71 4.16 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.311 0.576 . . . . 0.0 111.694 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.438 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 1.0 OUTLIER -52.42 -15.24 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 176.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.698 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -78.24 -39.33 40.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.177 179.182 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 89' ' ' SER . 79.4 p -69.87 -46.07 66.32 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.495 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -78.6 -32.84 47.72 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 119.473 -0.891 . . . . 0.0 112.489 -177.821 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.486 ' OE1' ' CE1' ' A' ' 93' ' ' PHE . 8.4 mm-40 -69.3 -45.19 70.17 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.277 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 91' ' ' LYS . 27.7 m -66.05 -37.59 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 C-N-CA 120.141 -0.624 . . . . 0.0 109.976 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.583 ' CG1' HD22 ' A' ' 12' ' ' LEU . 2.0 mt -59.25 -40.54 81.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.986 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -70.1 -26.88 64.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.944 0.402 . . . . 0.0 110.411 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.3 t -75.53 -67.03 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.421 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.1 mt -47.37 -35.44 3.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.326 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.603 ' NE2' ' CD1' ' A' ' 141' ' ' TRP . 6.7 t-80 -62.38 -64.85 0.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.167 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -38.4 -57.62 1.79 Allowed Glycine 0 N--CA 1.453 -0.186 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.485 ' O ' ' N ' ' A' ' 105' ' ' ASP . 15.9 tptm -62.7 -65.14 0.73 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.059 -0.571 . . . . 0.0 110.641 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.05 -60.07 0.66 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.121 0.486 . . . . 0.0 109.849 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.758 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -45.85 -46.81 15.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.543 0.687 . . . . 0.0 109.368 178.675 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.941 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.258 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 121.011 0.434 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.482 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.7 OUTLIER -115.83 156.55 46.35 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.401 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -49.22 109.15 0.24 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.636 1.557 . . . . 0.0 112.599 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.482 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.4 mt -121.66 128.6 75.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.523 ' O ' HD12 ' A' ' 83' ' ' LEU . 7.4 tpt -131.69 112.7 12.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.575 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.9 mt -96.56 97.86 9.75 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.0 t -103.53 130.88 53.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 122.35 1.071 . . . . 0.0 111.364 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.466 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -98.26 106.55 3.3 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 113.593 -1.64 . . . . 0.0 109.082 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.482 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 55.0 t30 -96.78 174.91 6.56 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.527 -178.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.482 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 7.5 mttp 65.31 59.74 0.8 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.193 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.73 -39.14 90.85 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -61.87 -3.5 1.18 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.047 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 125' ' ' MET . 9.7 mp -99.68 -30.17 12.25 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.661 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -39.93 -28.18 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.59 178.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.453 ' N ' ' O ' ' A' ' 123' ' ' LEU . 0.0 OUTLIER -41.18 -26.74 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.069 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -98.18 -36.18 10.14 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.822 179.495 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.563 HH12 ' CG2' ' A' ' 129' ' ' ILE . 7.0 tpt85 42.55 86.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.709 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.578 HG22 ' C ' ' A' ' 87' ' ' VAL . 30.6 m -80.28 -39.98 19.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.654 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.563 ' CG2' HH12 ' A' ' 127' ' ' ARG . 0.8 OUTLIER -86.68 132.16 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 132' ' ' GLU . 60.8 p -76.75 118.05 18.98 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.389 -0.525 . . . . 0.0 111.026 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -39.06 -29.48 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.28 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.4 mp0 -69.88 -63.07 1.15 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.874 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 132' ' ' GLU . 52.9 mt-10 -41.09 -46.11 2.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.95 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.11 -31.73 72.34 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 132' ' ' GLU . 19.6 tttm -65.43 -56.62 11.47 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -54.94 -33.33 62.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.349 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.11 -62.71 1.34 Allowed 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.892 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -56.95 -31.94 65.49 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.966 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.61 -35.28 72.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.771 0.319 . . . . 0.0 110.534 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -47.11 81.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.288 -178.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.603 ' CD1' ' NE2' ' A' ' 100' ' ' HIS . 18.6 m95 -91.2 -4.12 56.35 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.527 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 72.36 31.78 1.77 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.142 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.34 168.82 12.35 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.255 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -103.63 124.85 49.58 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.347 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.504 ' CZ ' ' OH ' ' A' ' 85' ' ' TYR . 7.3 t80 -97.8 123.19 41.65 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.863 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.52 123.67 12.91 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.471 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 2.8 mt-10 -98.72 114.82 27.5 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 5.0 p -136.33 -173.92 3.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.897 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.03 136.62 35.49 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.105 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.42 -43.63 98.37 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.132 0.491 . . . . 0.0 109.99 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.444 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 33.7 tttm -58.49 -7.03 0.8 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.519 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -126.9 128.4 46.42 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.769 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 154' ' ' GLN . 48.9 t30 -77.37 -56.01 4.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.09 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' A' ' 153' ' ' ASN . 1.7 mt-30 -36.41 -59.02 0.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.135 0.493 . . . . 0.0 110.983 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.586 ' O ' HG23 ' A' ' 159' ' ' VAL . 16.8 p -51.99 -51.34 57.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.649 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -52.31 -58.37 6.87 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.5 0.667 . . . . 0.0 109.713 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 53.7 t -42.21 -51.32 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.129 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -51.27 -36.43 42.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.053 0.454 . . . . 0.0 110.636 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 155' ' ' THR . 11.0 t -73.94 -31.15 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.261 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.529 ' O ' HG22 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -68.77 -46.64 68.25 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.047 0.451 . . . . 0.0 112.119 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.439 ' N ' ' CG ' ' A' ' 160' ' ' PHE . 6.4 ttt180 -73.94 -34.56 64.35 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.751 -0.779 . . . . 0.0 111.152 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -65.65 -34.73 78.9 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.067 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 160' ' ' PHE . 14.1 tt -70.34 -43.16 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.861 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.576 HG21 HG11 ' A' ' 49' ' ' VAL . 85.1 mt -59.58 -35.21 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.544 0.688 . . . . 0.0 109.611 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.421 ' HA ' HD13 ' A' ' 165' ' ' LEU . 0.4 OUTLIER -63.21 -60.31 3.58 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.726 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -58.36 -34.9 71.18 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.465 ' HB1' ' NH1' ' A' ' 7' ' ' ARG . . . -55.98 -32.45 63.93 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 171' ' ' ASP . 6.0 tp10 -66.41 -59.65 3.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.359 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.51 -52.23 64.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.682 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 4.0 mm -50.45 -37.93 15.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.04 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 172' ' ' GLY . 0.0 OUTLIER -67.01 -40.13 87.24 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.028 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 171' ' ' ASP . . . -56.75 -36.41 72.04 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.72 -82.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.743 0.306 . . . . 0.0 110.213 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.838 179.937 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.322 0 CA-C-O 121.202 0.525 . . . . 0.0 110.651 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.606 ' NH1' ' HB1' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -139.71 136.04 33.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.526 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.434 ' HB2' HG22 ' A' ' 78' ' ' ILE . 12.5 mttp -106.0 128.5 53.87 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.752 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.9 OUTLIER -102.82 122.95 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 121.416 0.627 . . . . 0.0 110.563 -178.023 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.439 ' HB3' ' CE1' ' A' ' 81' ' ' TYR . . . -84.56 132.58 34.5 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.172 -0.955 . . . . 0.0 111.156 -178.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.666 ' O ' HD12 ' A' ' 12' ' ' LEU . 11.7 mt -95.46 133.72 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-O 121.916 0.865 . . . . 0.0 112.721 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.666 HD12 ' O ' ' A' ' 11' ' ' ILE . 2.6 mp -130.33 101.73 5.89 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.866 -1.515 . . . . 0.0 110.359 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.517 ' O ' ' NZ ' ' A' ' 19' ' ' LYS . . . -140.64 134.4 6.42 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.476 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.6 OUTLIER -56.16 -158.2 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.285 0.565 . . . . 0.0 110.736 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -98.93 133.76 42.75 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.485 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.6 m 64.25 19.29 11.72 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.721 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 p -85.91 -16.9 9.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.843 0.354 . . . . 0.0 110.561 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.36 27.92 6.64 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.61 ' HB2' ' HZ2' ' A' ' 19' ' ' LYS . 4.8 ttpm? -61.2 -50.26 73.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.14 0.495 . . . . 0.0 110.435 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.21 -26.38 58.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.436 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.6 p -64.29 -43.38 94.94 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.856 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.9 tp -77.74 -39.51 44.13 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.851 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.61 ' O ' HG12 ' A' ' 27' ' ' VAL . 31.4 m -50.2 -43.87 52.83 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.68 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.4 mp -77.42 -41.58 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.635 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.475 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -67.78 -31.79 71.92 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.151 -179.016 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.632 ' CZ ' ' CE1' ' A' ' 160' ' ' PHE . 4.8 t80 -77.61 -64.03 1.24 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.404 0.621 . . . . 0.0 111.192 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.619 HG13 ' N ' ' A' ' 28' ' ' GLU . 13.5 p -45.15 -49.17 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.996 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.619 ' N ' HG13 ' A' ' 27' ' ' VAL . 0.7 OUTLIER -81.49 -25.12 36.26 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.28 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.575 ' O ' ' ND2' ' A' ' 153' ' ' ASN . . . 75.44 28.1 62.28 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.435 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.42 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 5.1 pt20 -146.38 128.05 15.2 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.943 0.878 . . . . 0.0 112.983 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.496 ' CD1' ' C ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.083 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.418 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 120.547 0.213 . . . . 0.0 110.532 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER 177.88 174.34 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.278 0.561 . . . . 0.0 112.278 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.447 HG23 HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -108.04 142.92 37.47 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.426 179.319 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 12.5 m-85 -130.47 165.5 22.5 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.047 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.602 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -142.53 148.02 36.92 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.252 0.549 . . . . 0.0 112.046 -178.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.583 ' C ' HD12 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -151.94 116.1 4.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.978 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.4 mp -105.3 129.69 53.59 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.393 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.3 pt -147.39 160.97 8.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.47 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 m -117.01 123.56 47.19 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.173 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.764 HG11 HG21 ' A' ' 164' ' ' ILE . 1.7 p -118.42 125.48 74.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.984 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.442 ' ND2' HG22 ' A' ' 49' ' ' VAL . 7.8 m-20 61.38 24.94 14.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 0.0 110.239 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.77 -9.52 65.27 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -88.77 130.48 35.35 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -76.96 146.12 37.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.582 0.706 . . . . 0.0 111.302 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.424 ' OH ' ' OE2' ' A' ' 168' ' ' GLU . 9.3 m-85 -138.46 124.92 20.59 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.004 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.656 ' C ' HD12 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -117.28 113.66 22.49 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.656 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.9 mp -119.23 146.58 45.1 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.582 0.706 . . . . 0.0 112.132 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.791 ' C ' HD13 ' A' ' 58' ' ' LEU . 4.9 tt0 -136.35 123.53 21.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.983 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.949 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.12 154.91 30.22 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.541 0.686 . . . . 0.0 112.416 -178.371 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.447 HG23 HG23 ' A' ' 42' ' ' THR . 0.3 OUTLIER -131.85 145.14 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.785 -178.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.16 103.89 8.52 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.019 -1.446 . . . . 0.0 107.92 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.516 -0.343 0 CA-C-O 121.312 0.577 . . . . 0.0 110.775 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.434 HG22 ' HB2' ' A' ' 8' ' ' LYS . 33.6 pt . . . . . 0 N--CA 1.433 -1.299 0 CA-C-O 121.319 0.581 . . . . 0.0 112.38 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -151.11 18.41 0.76 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.115 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -146.69 167.75 28.11 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.15 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.439 ' CE1' ' HB3' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -151.97 123.21 7.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.136 -0.532 . . . . 0.0 111.806 178.156 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.744 ' O ' HG23 ' A' ' 82' ' ' ILE . 12.4 tt -128.06 98.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.797 0.808 . . . . 0.0 109.299 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.787 ' N ' HD23 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -96.32 130.09 43.51 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.639 -178.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.93 132.81 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.885 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.509 ' CE1' ' CD2' ' A' ' 116' ' ' LEU . 2.2 m-85 -108.56 143.5 37.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.886 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.552 ' C ' ' H ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -106.2 121.41 44.13 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.386 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.484 HG11 HH21 ' A' ' 127' ' ' ARG . 12.0 m -73.86 21.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.552 ' H ' ' C ' ' A' ' 86' ' ' SER . 9.7 t -142.72 -7.83 0.85 Allowed 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 114.212 1.189 . . . . 0.0 114.212 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.501 ' N ' ' OG ' ' A' ' 86' ' ' SER . 0.0 OUTLIER -135.46 100.5 4.53 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 122.324 1.059 . . . . 0.0 112.077 -176.311 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.458 HG22 ' CD ' ' A' ' 94' ' ' GLU . 17.1 mm -56.08 -10.63 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 113.915 -1.493 . . . . 0.0 108.754 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.77 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -79.3 -43.99 22.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.466 178.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 55.3 p -62.33 -45.89 91.19 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.151 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.837 ' CD2' HD13 ' A' ' 129' ' ' ILE . 0.1 OUTLIER -76.48 -37.55 56.67 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 118.531 -1.267 . . . . 0.0 111.882 -178.312 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.458 ' CD ' HG22 ' A' ' 90' ' ' ILE . 91.5 mt-10 -69.66 -44.86 69.68 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.902 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 91' ' ' LYS . 23.5 m -63.1 -36.5 76.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.881 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.444 ' N ' HG23 ' A' ' 95' ' ' VAL . 47.8 mt -72.42 -27.14 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.058 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -69.15 -29.17 67.14 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.8 t -76.29 -66.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.481 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.502 HG21 HD21 ' A' ' 12' ' ' LEU . 1.4 mp -39.16 -36.21 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.738 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -66.95 -58.6 4.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.979 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.82 -49.16 1.95 Allowed Glycine 0 CA--C 1.518 0.259 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.804 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 105' ' ' ASP . 23.0 tptt -64.01 -66.31 0.56 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.424 -0.388 . . . . 0.0 110.393 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.7 OUTLIER -39.95 -57.17 1.67 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.627 179.058 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -46.84 -43.84 18.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.53 178.686 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.802 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.624 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.74 0.305 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.484 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -129.93 145.25 56.37 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.713 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -49.5 113.26 0.88 Allowed 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.624 1.55 . . . . 0.0 112.517 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.512 ' HB ' ' HB2' ' A' ' 143' ' ' ALA . 2.4 mp -123.99 132.99 70.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.473 ' SD ' ' HB3' ' A' ' 144' ' ' ALA . 9.4 tpt -133.18 115.3 14.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.011 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.509 ' CD2' ' CE1' ' A' ' 85' ' ' TYR . 4.2 mt -96.83 97.24 9.14 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.0 t -102.11 127.98 55.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.5 0.667 . . . . 0.0 111.753 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -94.73 114.68 4.89 Favored Glycine 0 C--N 1.311 -0.858 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -97.02 171.79 8.26 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.078 -0.649 . . . . 0.0 112.025 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 6.3 mtpp 61.73 55.47 2.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.629 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -57.41 -20.66 31.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.674 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -76.64 -20.48 56.65 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.991 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.9 mp -77.96 -31.63 50.96 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.522 ' CE1' ' HG2' ' A' ' 125' ' ' MET . 3.2 p-80 -31.56 -32.56 0.01 OUTLIER 'General case' 0 C--N 1.339 0.141 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.029 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.552 ' N ' ' O ' ' A' ' 123' ' ' LEU . 2.2 mmt -42.02 -27.34 0.12 Allowed 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.487 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -101.17 -37.6 8.48 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.587 179.307 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.484 HH21 HG11 ' A' ' 87' ' ' VAL . 9.8 ttm180 32.01 85.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.449 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.2 m -72.66 -34.77 48.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.167 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.837 HD13 ' CD2' ' A' ' 93' ' ' PHE . 10.7 tp -91.4 153.82 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.691 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.4 ' OG ' ' OE1' ' A' ' 132' ' ' GLU . 3.8 t -95.16 130.19 41.98 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.86 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -50.39 -35.86 30.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.782 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -68.45 -62.21 1.49 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.743 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -40.72 -43.12 1.9 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.722 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.68 -36.1 67.11 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -62.08 -53.53 54.21 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.341 -0.43 . . . . 0.0 109.852 179.574 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -58.39 -38.04 76.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.76 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.649 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -66.43 -60.65 2.56 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.563 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -51.69 -37.16 49.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.984 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.83 -28.9 67.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.71 -47.37 78.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.155 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.649 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 17.1 m95 -91.0 -4.24 56.6 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.313 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 141' ' ' TRP . 0.8 OUTLIER 79.11 26.97 0.42 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.992 -179.434 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.61 168.81 12.24 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.69 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.473 ' HB3' ' SD ' ' A' ' 115' ' ' MET . . . -111.69 127.73 55.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.043 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.406 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 9.9 t80 -98.01 120.81 39.05 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.314 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.53 128.23 17.21 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.338 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.48 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 1.7 mt-10 -100.2 116.74 32.92 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.007 0.432 . . . . 0.0 110.098 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.433 ' OG ' HG21 ' A' ' 159' ' ' VAL . 11.8 p -131.98 -177.97 4.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.596 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.21 131.79 30.82 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.563 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.479 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -56.44 -42.44 78.12 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.123 0.487 . . . . 0.0 110.084 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 38.1 tttt -58.2 -3.7 0.28 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.468 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.479 ' H ' ' C ' ' A' ' 150' ' ' ALA . 1.9 mt-10 -136.37 125.76 24.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.017 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.575 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 66.0 t30 -77.25 -48.95 16.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.831 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 153' ' ' ASN . 1.2 mt-30 -38.5 -59.16 0.94 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.749 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.661 ' O ' HG23 ' A' ' 159' ' ' VAL . 45.7 p -52.5 -49.55 64.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.188 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.475 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -50.63 -60.84 2.62 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.553 0.692 . . . . 0.0 110.285 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 49.0 t -45.76 -42.2 3.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.895 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.15 -41.62 98.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.664 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 155' ' ' THR . 11.5 t -63.38 -46.94 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.66 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.632 ' CE1' ' CZ ' ' A' ' 26' ' ' PHE . 10.4 m-85 -67.79 -22.81 65.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.105 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.428 ' NH1' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -76.24 -42.36 46.09 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.869 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -67.29 -32.35 73.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.132 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 160' ' ' PHE . 7.3 tt -69.14 -47.07 76.64 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.171 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.764 HG21 HG11 ' A' ' 49' ' ' VAL . 95.4 mt -53.5 -37.53 30.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.05 -56.53 19.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.549 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -62.47 -28.73 70.02 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.309 -0.556 . . . . 0.0 109.573 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.606 ' HB1' ' NH1' ' A' ' 7' ' ' ARG . . . -59.23 -33.32 70.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.424 ' OE2' ' OH ' ' A' ' 54' ' ' TYR . 2.3 tp10 -68.83 -50.62 48.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.016 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -60.15 -64.29 1.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.741 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 50.6 mt -49.94 -31.75 7.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.952 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.84 -40.18 79.54 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.368 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -61.71 -35.63 91.5 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.29 -68.96 0.35 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.714 0.292 . . . . 0.0 110.427 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.715 179.927 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.308 0.575 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.526 ' NH1' ' HB1' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -139.59 134.96 32.84 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.22 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.52 ' HB2' HG22 ' A' ' 78' ' ' ILE . 35.5 mttt -107.25 126.0 51.86 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.751 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.9 OUTLIER -100.17 122.03 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-O 121.566 0.698 . . . . 0.0 110.914 -177.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.62 134.84 34.78 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.464 -0.773 . . . . 0.0 110.903 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.3 mt -96.64 133.33 38.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.4 0.619 . . . . 0.0 112.382 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.647 HD23 ' C ' ' A' ' 12' ' ' LEU . 5.8 tt -128.61 105.67 8.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.494 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -142.03 134.33 6.11 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -52.99 172.6 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -73.37 131.61 42.07 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.231 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 m 67.1 19.97 10.38 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.698 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.6 p -79.72 -18.44 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.219 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.401 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 101.19 23.7 9.5 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.447 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.4 pttm -70.72 -33.44 70.85 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.423 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.496 ' O ' HD13 ' A' ' 24' ' ' ILE . 39.8 m -77.2 -30.42 54.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.05 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 79.5 p -65.61 -41.91 92.21 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.125 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.0 tp -77.07 -44.05 32.07 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 119.754 -0.779 . . . . 0.0 110.648 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.605 ' O ' HG12 ' A' ' 27' ' ' VAL . 25.3 m -47.93 -42.37 27.13 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.226 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.496 HD13 ' O ' ' A' ' 20' ' ' SER . 1.3 mp -77.15 -41.72 30.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 O-C-N 123.267 0.354 . . . . 0.0 111.272 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.541 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.3 OUTLIER -70.71 -28.69 64.92 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.969 -179.208 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.454 ' O ' ' N ' ' A' ' 29' ' ' GLY . 1.3 t80 -78.05 -63.63 1.35 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.231 0.539 . . . . 0.0 110.692 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.608 HG13 ' N ' ' A' ' 28' ' ' GLU . 13.7 p -45.15 -49.59 2.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.419 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.608 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.5 tt0 -79.06 -24.45 43.55 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.519 ' O ' ' ND2' ' A' ' 153' ' ' ASN . . . 71.5 28.21 69.93 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 114.471 -1.241 . . . . 0.0 110.024 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -149.73 125.8 10.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.49 -178.98 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.618 ' CD1' ' O ' ' A' ' 31' ' ' PHE . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.357 0 CA-C-O 122.318 1.056 . . . . 0.0 110.407 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.425 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.358 0 CA-C-O 120.683 0.278 . . . . 0.0 110.436 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 0.7 OUTLIER 177.49 176.68 0.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.185 0.517 . . . . 0.0 111.869 -179.383 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.9 147.47 30.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.873 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 11.6 m-85 -129.77 167.3 18.29 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.239 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.537 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -145.9 151.05 37.24 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.52 -178.668 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.594 ' C ' HD12 ' A' ' 46' ' ' LEU . 5.0 tmtp? -150.91 108.78 3.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.439 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.748 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.4 mp -106.48 121.4 44.2 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.938 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 pp -149.0 165.36 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.785 0.326 . . . . 0.0 110.647 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 m -108.81 127.6 54.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.173 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.631 HG11 HG21 ' A' ' 164' ' ' ILE . 7.6 p -126.39 138.32 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.615 ' OD1' HG22 ' A' ' 49' ' ' VAL . 4.7 m-20 62.06 5.95 1.61 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 97.39 -13.18 64.66 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -91.37 142.21 27.93 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -76.24 145.53 39.66 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.562 0.696 . . . . 0.0 111.073 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.499 ' CD1' HG12 ' A' ' 49' ' ' VAL . 8.0 m-85 -136.34 124.8 23.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.134 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.643 ' C ' HD22 ' A' ' 56' ' ' LEU . 62.3 m170 -116.74 113.98 23.35 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.655 ' N ' HD22 ' A' ' 56' ' ' LEU . 2.7 mm? -118.91 139.75 51.12 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 121.386 0.612 . . . . 0.0 111.34 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.75 ' C ' HD13 ' A' ' 58' ' ' LEU . 1.9 mt-30 -133.36 122.41 23.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.91 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.924 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.19 154.6 30.84 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.345 0.593 . . . . 0.0 112.525 -178.139 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.8 145.29 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-N 114.672 -1.149 . . . . 0.0 113.05 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -123.61 106.5 10.61 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.067 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.516 -0.341 0 CA-C-O 121.614 0.721 . . . . 0.0 111.487 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.52 HG22 ' HB2' ' A' ' 8' ' ' LYS . 31.5 pt . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.77 19.33 0.7 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.022 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.402 ' HA3' HD13 ' A' ' 9' ' ' ILE . . . -148.02 165.08 28.92 Favored Glycine 0 CA--C 1.517 0.195 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.534 -178.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.82 123.07 7.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.716 -0.742 . . . . 0.0 111.073 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.569 ' O ' HG23 ' A' ' 82' ' ' ILE . 9.7 tt -126.19 107.62 17.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.9 0.857 . . . . 0.0 109.029 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.818 ' N ' HD12 ' A' ' 83' ' ' LEU . 3.1 mp -97.27 126.67 42.63 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.979 -178.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -95.26 128.69 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.162 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.707 ' CZ ' HG21 ' A' ' 96' ' ' ILE . 48.6 m-85 -110.69 144.44 39.62 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.172 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.506 ' HG ' ' H ' ' A' ' 89' ' ' SER . 0.9 OUTLIER -98.24 125.99 43.54 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.218 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.487 HG21 ' N ' ' A' ' 124' ' ' HIS . 11.0 m -72.5 22.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.673 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.501 ' H ' ' C ' ' A' ' 86' ' ' SER . 0.8 OUTLIER -138.79 -26.13 0.87 Allowed 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.263 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.535 ' C ' ' N ' ' A' ' 91' ' ' LYS . 4.1 t -98.0 93.98 6.6 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.378 -176.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.477 HD13 ' O ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -58.27 -11.57 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.314 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.535 ' N ' ' C ' ' A' ' 89' ' ' SER . 3.4 mptt -78.28 -57.22 3.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.456 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 69.6 p -49.6 -30.62 9.08 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.591 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.402 ' CE1' ' CD2' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -74.55 -48.29 27.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.838 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.39 -44.22 88.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.595 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 91' ' ' LYS . 4.1 m -64.38 -35.84 75.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.145 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.707 HG21 ' CZ ' ' A' ' 85' ' ' TYR . 44.7 mt -69.12 -29.44 42.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.882 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.03 -27.84 66.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.8 t -74.75 -66.73 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.2 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.6 mp -41.39 -48.64 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.514 ' CE1' ' CE2' ' A' ' 141' ' ' TRP . 51.8 t-80 -54.66 -64.84 0.7 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.669 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -38.07 -52.33 2.13 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 105' ' ' ASP . 17.7 tptm -65.87 -63.6 1.05 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.924 -0.638 . . . . 0.0 110.698 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -38.2 -59.24 0.89 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.215 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.736 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -47.05 -45.24 21.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.806 178.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.878 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.795 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.538 ' OE1' ' HB1' ' A' ' 173' ' ' ALA . 8.2 mt-30 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.711 0.291 . . . . 0.0 111.022 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.721 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.6 OUTLIER -130.07 153.68 81.12 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.685 179.419 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -48.02 114.69 1.2 Allowed 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.897 1.731 . . . . 0.0 112.572 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.49 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.4 mp -124.28 128.44 73.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.54 ' SD ' ' HB3' ' A' ' 144' ' ' ALA . 12.3 tpt -129.01 114.59 16.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.741 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 138' ' ' ALA . 67.5 mt -97.21 98.91 10.41 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.387 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.83 131.16 57.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.865 0.84 . . . . 0.0 112.396 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -97.96 114.01 4.88 Favored Glycine 0 C--N 1.312 -0.773 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.448 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 57.7 t30 -96.84 172.79 7.65 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.952 -177.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.448 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 19.7 mttt 58.51 58.67 3.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.188 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -14.75 61.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.326 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -79.4 -13.03 59.87 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.633 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.661 ' O ' ' N ' ' A' ' 126' ' ' GLU . 10.9 mp -84.05 -26.57 28.95 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.553 ' C ' ' N ' ' A' ' 126' ' ' GLU . 3.6 t-80 -22.76 -42.34 0.01 OUTLIER 'General case' 0 C--N 1.348 0.503 0 O-C-N 124.544 1.152 . . . . 0.0 111.289 178.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.567 ' N ' ' O ' ' A' ' 123' ' ' LEU . 0.7 OUTLIER -44.77 -19.04 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.416 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.661 ' N ' ' O ' ' A' ' 123' ' ' LEU . 19.8 mm-40 -89.74 -54.49 4.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.011 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.433 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 1.7 tpt85 35.85 71.24 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.269 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.71 -40.13 86.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.292 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 tp -88.44 155.12 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.582 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 132' ' ' GLU . 47.5 p -93.12 118.04 30.76 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.718 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -39.12 -28.66 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.645 0.736 . . . . 0.0 109.373 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.3 mp0 -70.06 -63.27 1.11 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.876 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.4 ' CG ' ' OG ' ' A' ' 130' ' ' SER . 57.1 mt-10 -41.52 -41.73 2.19 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.16 -35.73 64.09 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 132' ' ' GLU . 2.4 tttm -60.72 -55.42 33.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.58 -33.97 66.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.075 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.35 -63.2 1.16 Allowed 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.836 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 143' ' ' ALA . . . -51.67 -35.06 41.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.232 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -35.61 78.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.736 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.58 -47.32 76.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.59 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.558 ' CH2' HD22 ' A' ' 104' ' ' LEU . 25.7 m95 -92.72 2.52 56.69 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.719 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 60.77 39.94 16.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.526 0.679 . . . . 0.0 109.633 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.46 ' O ' ' HB1' ' A' ' 138' ' ' ALA . . . -98.15 168.35 10.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.57 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.54 ' HB3' ' SD ' ' A' ' 115' ' ' MET . . . -105.07 125.46 51.0 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.887 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.437 ' C ' ' CD1' ' A' ' 145' ' ' PHE . 4.0 t80 -98.4 122.03 41.08 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.262 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.01 126.43 15.83 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.433 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 2.7 mt-10 -100.49 114.89 28.86 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.404 ' OG ' HG21 ' A' ' 159' ' ' VAL . 21.0 p -134.77 -178.76 5.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.824 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.93 135.19 34.14 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.28 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -57.44 -46.52 83.5 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.883 0.373 . . . . 0.0 110.365 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -55.21 -6.29 0.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.33 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.481 ' H ' ' C ' ' A' ' 150' ' ' ALA . 2.1 tt0 -131.25 122.63 26.82 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.638 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 48.8 t30 -77.21 -52.02 9.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.167 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 153' ' ' ASN . 2.8 mt-30 -36.77 -58.22 0.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.03 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.678 ' O ' HG23 ' A' ' 159' ' ' VAL . 68.1 p -53.0 -45.1 67.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.127 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.541 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -55.44 -61.48 2.31 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.492 0.663 . . . . 0.0 110.121 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 57.4 t -43.22 -39.67 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.688 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -65.7 -42.81 90.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.199 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 155' ' ' THR . 14.3 t -61.93 -42.41 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.539 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.537 ' O ' HG22 ' A' ' 163' ' ' ILE . 52.3 t80 -59.49 -66.76 0.46 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.216 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 160' ' ' PHE . 19.5 ttm-85 -41.62 -45.29 3.33 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.304 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -62.05 -30.35 70.92 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.754 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.2 OUTLIER -66.41 -32.47 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.457 179.473 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.631 HG21 HG11 ' A' ' 49' ' ' VAL . 7.4 mt -68.39 -42.27 84.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.737 0.779 . . . . 0.0 109.665 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.62 -49.36 78.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.551 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -64.03 -32.56 74.15 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -56.08 -34.41 65.96 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.125 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.39 -55.39 10.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.682 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.62 -62.87 1.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.733 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.721 HG21 ' C ' ' A' ' 112' ' ' ILE . 38.5 mm -53.32 -31.23 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.065 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -69.67 -40.38 76.47 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.633 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.53 -35.31 91.6 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.538 ' HB1' ' OE1' ' A' ' 111' ' ' GLN . . . -67.98 -62.71 1.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.688 0.28 . . . . 0.0 110.429 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.705 179.878 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 121.216 0.531 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.62 136.66 34.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.587 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.534 ' HB2' HG22 ' A' ' 78' ' ' ILE . 11.0 mttm -108.51 127.49 53.97 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.741 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -103.01 123.95 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-O 121.479 0.657 . . . . 0.0 111.13 -178.086 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.43 135.78 34.12 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.422 -0.799 . . . . 0.0 111.254 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.0 mt -95.77 133.84 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.24 100.69 5.93 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.349 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.71 133.73 5.87 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.69 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER -54.62 -167.08 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.034 0.445 . . . . 0.0 110.041 178.822 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.404 ' O ' ' CB ' ' A' ' 16' ' ' SER . 11.5 ttp180 -97.64 128.33 44.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.744 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER 76.24 8.79 3.32 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.125 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.488 ' C ' ' HZ2' ' A' ' 120' ' ' LYS . 7.3 p -77.63 -19.32 14.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.942 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.417 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 106.03 31.6 4.08 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.408 ' NZ ' ' CB ' ' A' ' 19' ' ' LYS . 2.6 ttmp? -59.5 -59.1 5.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.005 0.431 . . . . 0.0 110.406 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.07 -26.01 63.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.24 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 89.1 p -63.78 -47.11 82.22 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.714 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 28.4 tp -71.39 -49.94 37.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.473 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.551 ' O ' HG12 ' A' ' 27' ' ' VAL . 48.7 m -43.79 -38.93 3.49 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.311 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.2 -43.68 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.94 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.622 ' NE2' ' N ' ' A' ' 31' ' ' PHE . 1.5 tp-100 -63.46 -40.53 97.37 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.756 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.636 ' CG ' ' CE1' ' A' ' 160' ' ' PHE . 2.2 t80 -74.87 -62.52 1.51 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.209 0.528 . . . . 0.0 111.825 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.576 HG13 ' N ' ' A' ' 28' ' ' GLU . 7.4 p -44.0 -47.52 2.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.722 -178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.576 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.0 tm-20 -83.91 -24.19 30.86 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.467 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 75.11 25.5 68.71 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.075 -1.42 . . . . 0.0 110.348 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.547 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 1.9 tp-100 -152.01 130.1 11.87 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.687 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.622 ' N ' ' NE2' ' A' ' 25' ' ' GLN . 0.7 OUTLIER . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.684 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.571 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 2.2 pm0 . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 120.802 0.334 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.571 ' ND2' ' O ' ' A' ' 40' ' ' GLU . 1.0 OUTLIER 177.11 175.33 0.4 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.624 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.81 127.61 53.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.294 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -110.02 174.05 6.04 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.968 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.531 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -143.5 161.7 37.75 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.399 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.595 ' C ' HD12 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -163.18 112.09 1.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.432 179.424 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.699 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.5 mp -105.17 127.93 53.15 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.727 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 pt -147.87 165.31 5.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.569 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.2 m -116.82 123.86 48.12 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.049 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.713 HG11 HG21 ' A' ' 164' ' ' ILE . 2.4 p -119.74 129.99 74.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.631 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.505 ' CG ' HG22 ' A' ' 49' ' ' VAL . 9.2 m-20 61.73 19.71 10.75 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.56 -9.43 71.04 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -90.0 135.6 33.55 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.49 147.28 37.93 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.584 0.706 . . . . 0.0 111.465 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.438 ' CD1' ' CG1' ' A' ' 49' ' ' VAL . 5.8 m-85 -138.3 125.21 21.19 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.042 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.618 ' C ' HD12 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -118.04 113.74 22.09 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.618 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.6 mp -118.62 143.21 46.96 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.629 0.728 . . . . 0.0 112.164 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.806 ' C ' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -133.96 122.6 23.31 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.93 178.834 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.976 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.38 153.52 31.89 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.063 -178.655 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.82 145.48 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-N 114.992 -1.004 . . . . 0.0 112.926 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -124.33 103.24 8.1 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.064 177.627 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.513 -0.458 0 CA-C-O 121.374 0.607 . . . . 0.0 110.843 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.554 HD12 ' O ' ' A' ' 80' ' ' GLY . 39.1 pt . . . . . 0 N--CA 1.439 -1.015 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -154.85 19.59 0.45 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.776 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.554 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -152.66 165.28 30.97 Favored Glycine 0 C--O 1.227 -0.323 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.873 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.78 122.31 7.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.689 -0.755 . . . . 0.0 110.691 178.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.599 ' O ' HG23 ' A' ' 82' ' ' ILE . 9.6 tt -124.01 102.69 11.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.685 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -97.56 123.22 41.36 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.17 -178.253 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.9 t -95.38 130.54 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.135 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.656 ' CZ ' HG21 ' A' ' 96' ' ' ILE . 69.6 m-85 -111.25 143.94 41.23 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.538 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.583 ' HG ' ' H ' ' A' ' 89' ' ' SER . 0.5 OUTLIER -94.99 121.0 36.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.473 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.52 HG21 ' N ' ' A' ' 124' ' ' HIS . 13.8 m -70.66 21.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.469 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.522 ' H ' ' C ' ' A' ' 86' ' ' SER . 1.1 t -136.27 -23.54 1.28 Allowed 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.583 ' H ' ' HG ' ' A' ' 86' ' ' SER . 8.3 t -100.45 94.1 5.98 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.482 -176.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -56.81 -11.41 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 175.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.555 ' N ' ' C ' ' A' ' 89' ' ' SER . 18.1 mttp -78.11 -56.35 4.55 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.141 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.4 p -49.83 -29.87 8.78 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.692 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.868 ' CE2' HG21 ' A' ' 129' ' ' ILE . 0.3 OUTLIER -75.29 -50.22 16.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.92 -179.305 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -64.68 -42.95 94.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.628 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 91' ' ' LYS . 4.6 m -65.98 -37.62 80.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.469 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.656 HG21 ' CZ ' ' A' ' 85' ' ' TYR . 41.1 mt -68.67 -28.58 40.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.567 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -70.4 -27.48 64.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.835 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 99' ' ' ILE . 17.0 t -74.34 -66.4 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.777 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' A' ' 98' ' ' VAL . 1.6 mp -39.97 -43.01 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.666 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.65 ' CE1' ' CE2' ' A' ' 141' ' ' TRP . 9.1 t60 -57.81 -59.38 5.32 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.616 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -36.39 -49.05 1.25 Allowed Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.716 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 105' ' ' ASP . 22.5 tptt -67.88 -66.03 0.62 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.32 -0.44 . . . . 0.0 110.367 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.48 HD13 ' C ' ' A' ' 103' ' ' LEU . 0.5 OUTLIER -38.0 -59.65 0.82 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.882 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -44.29 -46.96 9.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.821 178.632 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.792 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.281 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.697 0.284 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.491 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -136.18 152.72 75.82 Favored Pre-proline 0 C--O 1.223 -0.328 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -48.3 108.18 0.17 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.929 1.753 . . . . 0.0 113.157 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.491 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.3 mt -121.22 127.07 75.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 11.0 tpt -127.99 114.5 17.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.913 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.437 HD12 ' HB2' ' A' ' 138' ' ' ALA . 62.7 mt -96.98 98.33 9.99 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.2 t -105.76 130.08 57.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.846 0.831 . . . . 0.0 112.774 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -97.63 112.51 4.48 Favored Glycine 0 C--N 1.312 -0.761 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.522 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 50.5 t30 -96.86 176.91 5.81 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.939 -0.705 . . . . 0.0 111.792 -177.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.522 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 36.5 mttp 58.61 57.76 3.62 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -59.72 -34.85 73.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.713 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.56 -12.79 10.97 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.171 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.5 mp -92.58 -31.65 15.11 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.52 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.5 OUTLIER -38.68 -25.58 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.226 178.694 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.518 ' N ' ' O ' ' A' ' 123' ' ' LEU . 3.8 mmt -43.33 -26.25 0.18 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.5 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -102.81 -39.68 6.89 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.133 179.062 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.474 HH21 ' HB2' ' A' ' 124' ' ' HIS . 29.1 ttm-85 34.52 72.31 0.09 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.717 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.613 HG23 ' N ' ' A' ' 129' ' ' ILE . 33.9 m -56.04 -48.19 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.545 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.868 HG21 ' CE2' ' A' ' 93' ' ' PHE . 7.8 tp -86.88 152.55 3.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.422 ' OG ' ' OE1' ' A' ' 133' ' ' GLU . 1.9 p -99.13 125.5 44.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.465 0.65 . . . . 0.0 111.78 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.645 ' CD1' ' CE1' ' A' ' 145' ' ' PHE . 0.1 OUTLIER -52.7 -43.32 65.56 Favored 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.406 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 131' ' ' TYR . 1.4 mp0 -39.66 -62.75 0.65 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.95 178.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.422 ' OE1' ' OG ' ' A' ' 130' ' ' SER . 14.9 mt-10 -50.74 -37.42 41.79 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 131' ' ' TYR . . . -70.84 -24.7 76.79 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 131' ' ' TYR . 31.4 tttm -73.68 -55.99 5.57 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -53.97 -35.47 61.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.505 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.608 HD21 ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -68.15 -62.66 1.3 Allowed 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -47.24 -35.37 7.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.775 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.57 -33.37 72.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.154 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -63.95 -47.14 81.62 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.168 -179.246 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.65 ' CE2' ' CE1' ' A' ' 100' ' ' HIS . 29.7 m95 -90.44 -4.0 57.3 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.204 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 72.4 27.66 2.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.493 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -89.2 166.33 13.88 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.125 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -108.18 126.38 52.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.149 0.499 . . . . 0.0 111.47 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.645 ' CE1' ' CD1' ' A' ' 131' ' ' TYR . 11.3 t80 -98.63 122.0 41.3 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.863 -178.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.99 131.28 20.81 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.449 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 11.0 mt-10 -100.39 119.78 38.97 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.491 ' OG ' HG21 ' A' ' 159' ' ' VAL . 0.8 OUTLIER -134.44 -178.95 5.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.736 -179.507 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.04 137.9 39.86 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.968 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.526 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -59.92 -46.13 90.36 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -69.13 11.87 0.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.359 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 150' ' ' ALA . 3.8 tt0 -137.68 117.79 13.48 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.231 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 154' ' ' GLN . 41.0 t30 -77.42 -56.71 4.31 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.43 ' OE1' ' OE2' ' A' ' 152' ' ' GLU . 0.0 OUTLIER -36.47 -59.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.051 0.453 . . . . 0.0 111.229 -179.036 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.621 ' O ' HG23 ' A' ' 159' ' ' VAL . 3.2 p -52.35 -53.81 39.88 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.84 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -47.48 -59.51 3.19 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.598 0.714 . . . . 0.0 110.116 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 47.9 t -48.45 -42.76 12.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.733 -1.122 . . . . 0.0 110.865 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -60.45 -40.95 93.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.533 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 155' ' ' THR . 14.2 t -62.51 -46.27 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.21 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.636 ' CE1' ' CG ' ' A' ' 26' ' ' PHE . 15.2 m-85 -68.66 -24.04 64.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.365 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.8 ttm-85 -77.34 -41.11 41.74 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.01 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.2 mmm-85 -65.66 -33.93 77.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.978 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 164' ' ' ILE . 3.3 tt -68.93 -50.59 52.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.449 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.713 HG21 HG11 ' A' ' 49' ' ' VAL . 94.3 mt -50.99 -35.96 15.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.181 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.23 -60.52 3.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.837 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -60.92 -26.7 67.66 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.704 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -61.64 -33.22 73.57 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.437 ' O ' ' OD2' ' A' ' 171' ' ' ASP . 2.7 tp10 -69.1 -50.13 50.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.417 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -62.37 -51.22 68.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.153 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 24.6 mt -53.59 -42.35 49.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.419 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.437 ' OD2' ' O ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -68.34 -38.58 81.65 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.482 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -54.6 -42.2 76.07 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.87 -73.88 0.15 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.738 0.304 . . . . 0.0 110.607 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.838 -179.727 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 121.11 0.481 . . . . 0.0 110.453 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.492 ' NH2' ' OD2' ' A' ' 171' ' ' ASP . 0.0 OUTLIER -139.7 134.92 32.62 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.657 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.436 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 5.0 mtmm -106.26 125.51 51.09 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.762 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -101.27 119.98 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 121.573 0.702 . . . . 0.0 110.442 -178.77 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.5 134.89 34.83 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.48 -0.763 . . . . 0.0 111.083 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.477 HD13 ' OG1' ' A' ' 23' ' ' THR . 18.3 mt -95.9 125.65 48.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.294 0.569 . . . . 0.0 111.447 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.492 ' CD2' HD13 ' A' ' 99' ' ' ILE . 13.2 tp -124.49 104.28 8.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.532 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -139.65 135.89 7.49 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.494 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.1 OUTLIER -52.08 -160.97 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.518 0.675 . . . . 0.0 111.144 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.7 ttt-85 -93.52 135.14 35.06 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.407 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m 65.93 6.02 3.79 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.426 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.503 ' C ' ' HZ2' ' A' ' 120' ' ' LYS . 3.9 p -65.9 -17.97 23.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.813 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.2 25.29 37.42 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.445 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -65.26 -38.13 89.34 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.875 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.4 m -70.06 -35.52 74.29 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.2 m -60.45 -43.25 97.04 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.762 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 25' ' ' GLN . 22.8 tp -68.16 -56.42 8.85 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.271 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.63 ' O ' HG12 ' A' ' 27' ' ' VAL . 93.3 m -38.43 -36.65 0.25 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.51 -42.9 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.78 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.637 ' NE2' ' N ' ' A' ' 31' ' ' PHE . 3.0 tp-100 -63.9 -38.32 90.64 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.135 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -76.48 -61.72 1.86 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.101 0.477 . . . . 0.0 111.668 -178.861 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.692 HG21 ' CG ' ' A' ' 43' ' ' PHE . 8.6 p -48.03 -47.9 12.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.672 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.632 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.0 tt0 -84.16 -23.56 30.57 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 75.01 23.4 74.67 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.556 ' NE2' ' O ' ' A' ' 28' ' ' GLU . 1.8 mp0 -148.58 129.99 14.79 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.637 ' N ' ' NE2' ' A' ' 25' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.977 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -174.66 -177.0 1.1 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.465 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.08 124.35 32.59 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.686 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.692 ' CG ' HG21 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -107.15 174.66 5.79 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 120.993 0.425 . . . . 0.0 110.201 179.175 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.28 162.75 34.73 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.16 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -160.04 107.18 1.63 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.309 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.1 mp -106.35 118.58 37.0 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.195 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.651 HD12 ' H ' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -149.38 165.14 3.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.575 -179.721 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.6 m -109.01 127.9 54.49 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.261 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.877 HG11 HG21 ' A' ' 164' ' ' ILE . 6.6 p -127.61 134.08 66.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.387 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.37 3.95 3.52 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.465 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.35 -12.89 63.33 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -91.71 141.23 28.92 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -76.68 144.83 39.15 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.55 0.691 . . . . 0.0 111.114 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.435 ' OH ' ' OE2' ' A' ' 168' ' ' GLU . 9.7 m-85 -135.89 124.21 23.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.203 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.709 ' C ' HD12 ' A' ' 56' ' ' LEU . 2.6 m-70 -118.05 113.37 21.54 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.709 HD12 ' C ' ' A' ' 55' ' ' HIS . 11.2 mp -123.59 146.44 48.15 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.601 0.715 . . . . 0.0 112.128 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.8 ' C ' HD13 ' A' ' 58' ' ' LEU . 0.7 OUTLIER -138.78 127.03 22.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.934 178.464 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.985 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.91 153.1 34.14 Favored 'General case' 0 CA--C 1.499 -1.018 0 C-N-CA 120.251 -0.579 . . . . 0.0 111.886 -178.974 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.53 144.46 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.718 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.96 105.35 9.91 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.344 -1.298 . . . . 0.0 107.961 177.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.479 0 CA-C-O 121.375 0.607 . . . . 0.0 110.445 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 80' ' ' GLY . 41.4 pt . . . . . 0 N--CA 1.435 -1.177 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.07 15.67 1.06 Allowed 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.356 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.51 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -146.21 164.35 28.32 Favored Glycine 0 C--O 1.229 -0.214 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.473 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.11 125.1 8.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.068 -0.566 . . . . 0.0 111.475 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.59 ' O ' HG23 ' A' ' 82' ' ' ILE . 9.8 tt -131.08 104.82 9.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.995 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -96.6 126.17 41.59 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.525 -177.847 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -96.6 130.75 44.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.091 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.609 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 37.2 p90 -128.99 144.5 51.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.444 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.454 ' C ' ' H ' ' A' ' 88' ' ' THR . 4.1 p -87.27 142.83 27.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.211 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.614 HG21 ' N ' ' A' ' 124' ' ' HIS . 22.8 m -71.28 12.69 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.776 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.454 ' H ' ' C ' ' A' ' 86' ' ' SER . 8.6 t -132.86 -20.09 2.25 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 120.892 0.377 . . . . 0.0 111.904 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.533 ' C ' ' N ' ' A' ' 91' ' ' LYS . 33.1 t -90.13 92.63 9.04 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.758 -176.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 tp -61.12 -11.19 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.634 ' O ' HG22 ' A' ' 95' ' ' VAL . 3.3 mttp -78.04 -52.01 9.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 113.351 -1.75 . . . . 0.0 110.327 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 53.5 p -60.58 -33.58 72.93 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.643 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.609 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -74.06 -49.38 24.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.281 -179.013 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.447 ' O ' HG23 ' A' ' 98' ' ' VAL . 40.0 mt-10 -65.23 -42.65 93.2 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.707 -178.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.794 ' O ' HG22 ' A' ' 99' ' ' ILE . 20.1 m -67.42 -38.51 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.652 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.422 ' N ' HG23 ' A' ' 95' ' ' VAL . 2.6 mt -62.25 -38.12 80.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.347 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -69.43 -29.01 66.63 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 94' ' ' GLU . 59.2 t -75.83 -67.03 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.208 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.794 HG22 ' O ' ' A' ' 95' ' ' VAL . 3.1 tt -48.3 -40.12 9.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.615 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.467 ' CE1' ' CD2' ' A' ' 141' ' ' TRP . 12.3 t-80 -58.3 -64.54 0.88 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.484 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -42.64 -60.07 2.98 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 105' ' ' ASP . 14.6 tptp -57.31 -65.22 0.66 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.855 -0.672 . . . . 0.0 110.627 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -36.83 -55.87 0.88 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.237 0.542 . . . . 0.0 109.751 179.519 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.743 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -49.64 -47.75 49.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.73 0.776 . . . . 0.0 109.365 178.753 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.895 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.338 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.476 ' OE1' ' CB ' ' A' ' 173' ' ' ALA . 50.1 mt-30 . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 120.991 0.424 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.473 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -108.04 137.11 19.74 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.474 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.408 ' N ' HG21 ' A' ' 170' ' ' ILE . 44.1 Cg_exo -47.82 117.57 2.52 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.466 1.444 . . . . 0.0 112.313 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 143' ' ' ALA . 2.5 mp -124.78 132.31 71.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.546 ' O ' HD12 ' A' ' 83' ' ' LEU . 4.8 tpt -131.9 117.44 18.48 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.937 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.0 mt -95.75 97.4 9.67 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.0 t -103.91 133.15 48.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 122.327 1.061 . . . . 0.0 110.665 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.413 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -106.18 112.6 3.92 Favored Glycine 0 C--N 1.304 -1.229 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.188 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.497 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.1 t30 -96.98 176.94 5.78 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.898 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.503 ' HZ2' ' C ' ' A' ' 17' ' ' VAL . 8.7 mttp 63.41 58.79 1.31 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.221 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.407 ' H ' ' HB3' ' A' ' 149' ' ' SER . 6.0 tttm -65.03 -12.93 56.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.748 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.451 ' OD2' ' CD1' ' A' ' 123' ' ' LEU . 2.6 p-10 -81.3 -8.43 59.74 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.101 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.598 ' O ' ' N ' ' A' ' 126' ' ' GLU . 11.1 mp -98.52 -23.11 15.66 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.614 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -26.88 -38.59 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.343 1.027 . . . . 0.0 111.284 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.543 ' N ' ' O ' ' A' ' 123' ' ' LEU . 2.0 mmt -46.85 -15.95 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.006 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 123' ' ' LEU . 18.6 mm-40 -92.58 -62.68 1.35 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.406 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.483 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 5.2 tpp85 26.18 65.74 0.07 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.008 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.9 t -49.01 -29.43 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.955 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.2 tp -88.82 156.36 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.877 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.52 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 74.9 p -97.85 123.09 41.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.348 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -37.77 -31.32 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.26 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.6 mp0 -71.66 -64.12 0.99 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.848 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.52 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 67.4 mt-10 -41.1 -40.95 1.63 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.952 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.91 -36.4 65.25 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 132' ' ' GLU . 13.8 tttm -62.39 -54.44 40.29 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.074 -0.563 . . . . 0.0 109.681 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.7 -35.76 71.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.794 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.18 -61.86 1.88 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.89 -38.01 61.25 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.17 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.43 -29.92 68.68 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.263 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.7 -46.67 81.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.989 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.479 ' CZ3' ' CD2' ' A' ' 104' ' ' LEU . 53.0 m95 -89.57 -3.49 58.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.143 0.496 . . . . 0.0 110.148 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 77.07 22.39 1.02 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.723 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.33 167.89 13.14 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.3 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.58 133.9 51.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.338 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.655 ' O ' HD22 ' A' ' 146' ' ' LEU . 6.0 t80 -96.68 122.02 39.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.679 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.794 HD12 HG22 ' A' ' 159' ' ' VAL . 1.2 mm? -134.17 137.91 44.78 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.964 -176.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.483 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 4.1 tt0 -126.24 111.5 14.65 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 27.5 p -137.66 -172.89 3.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.03 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.407 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -137.98 141.48 40.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.221 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.479 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -61.66 -45.61 93.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.354 0.597 . . . . 0.0 109.4 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.445 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 15.7 tttp -65.81 5.22 0.5 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.644 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.479 ' H ' ' C ' ' A' ' 150' ' ' ALA . 43.9 mt-10 -133.85 120.4 20.39 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.836 0.351 . . . . 0.0 110.974 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.558 ' H ' ' ND2' ' A' ' 153' ' ' ASN . 0.0 OUTLIER -77.57 -57.5 3.79 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.071 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 153' ' ' ASN . 9.0 tt0 -36.85 -58.43 0.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.976 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.602 ' O ' HG23 ' A' ' 159' ' ' VAL . 58.8 p -52.06 -45.07 64.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.98 0.419 . . . . 0.0 110.045 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -56.16 -61.37 2.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.493 0.663 . . . . 0.0 109.869 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 59.7 t -40.83 -39.98 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.331 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -65.91 -38.33 88.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.149 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.794 HG22 HD12 ' A' ' 146' ' ' LEU . 21.7 t -67.99 -37.31 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.55 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.75 ' CZ ' HD11 ' A' ' 164' ' ' ILE . 1.2 t80 -57.76 -65.32 0.66 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.338 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.445 ' O ' ' N ' ' A' ' 164' ' ' ILE . 1.1 ttt-85 -46.73 -64.9 0.65 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.117 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.453 ' HA ' HD12 ' A' ' 165' ' ' LEU . 11.3 mmt180 -41.66 -31.21 0.27 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.331 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -68.05 -40.87 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 119.526 -0.869 . . . . 0.0 109.837 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.877 HG21 HG11 ' A' ' 49' ' ' VAL . 49.6 mt -63.92 -38.56 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.71 0.767 . . . . 0.0 109.961 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 168' ' ' GLU . 25.1 mt -57.63 -64.39 0.91 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.018 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -54.56 -25.39 25.79 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -69.53 -27.85 65.51 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 165' ' ' LEU . 3.0 tp10 -69.18 -57.85 4.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.019 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -57.76 -58.86 6.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.791 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.408 HG21 ' N ' ' A' ' 113' ' ' PRO . 1.4 mp -52.86 -34.34 20.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.689 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.492 ' OD2' ' NH2' ' A' ' 7' ' ' ARG . 0.4 OUTLIER -67.39 -40.07 85.65 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.144 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -57.59 -39.6 91.21 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.476 ' CB ' ' OE1' ' A' ' 111' ' ' GLN . . . -69.41 -81.5 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.754 0.312 . . . . 0.0 110.243 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.832 179.923 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.88 0.371 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.19 137.42 34.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.057 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.512 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 5.5 mtpm? -103.48 134.36 46.97 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.487 HD13 ' C ' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -115.93 129.01 73.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.744 -176.467 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.82 133.94 33.59 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.267 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.509 HD11 ' HB2' ' A' ' 58' ' ' LEU . 30.6 mt -97.58 133.87 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 120.695 0.284 . . . . 0.0 111.318 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 12' ' ' LEU . 5.1 tt -130.45 97.67 4.46 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.459 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -141.18 133.41 5.81 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.431 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.475 ' O ' HG12 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -57.9 -173.89 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.075 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -84.89 125.21 32.45 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.195 0.522 . . . . 0.0 111.427 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 75.31 12.1 3.33 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.593 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 14' ' ' TYR . 7.5 p -71.14 -20.86 21.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.535 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.57 24.16 12.74 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.013 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.3 pttm -69.07 -36.49 77.69 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.322 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.1 m -71.86 -26.49 62.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.4 m -68.29 -43.45 77.69 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.163 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.2 tp -77.65 -41.41 38.41 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.897 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.586 ' O ' HG12 ' A' ' 27' ' ' VAL . 16.3 m -52.56 -38.83 60.66 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -78.07 -38.4 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.038 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.466 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -69.51 -33.65 73.15 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.398 -179.497 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -77.98 -61.14 2.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.197 0.522 . . . . 0.0 111.047 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.9 p -46.39 -48.05 6.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.77 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.617 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.2 tt0 -84.18 -24.74 30.0 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 77.97 22.91 67.67 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.252 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -153.02 127.14 9.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 60.1 t80 . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.412 178.623 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 40' ' ' GLU . 3.9 m-20 166.88 -179.29 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.5 0.667 . . . . 0.0 112.504 -178.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.451 HG23 HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -108.98 134.49 51.55 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.632 179.507 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -112.2 170.96 7.8 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.8 156.37 40.07 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HB2' HG23 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -168.06 131.16 1.57 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.668 178.415 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.5 mp -105.97 133.29 50.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.533 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.31 165.4 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.897 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.7 m -133.24 131.16 39.97 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.802 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.738 HG11 HD13 ' A' ' 164' ' ' ILE . 7.6 p -133.89 136.44 53.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.296 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 61.51 2.94 0.73 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.224 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 105.18 -11.29 48.03 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -89.07 118.55 28.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.634 0.254 . . . . 0.0 110.687 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.26 144.23 28.24 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.278 0.561 . . . . 0.0 111.805 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.655 ' CE1' HG12 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -140.63 152.96 45.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.16 178.935 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.627 ' C ' HD12 ' A' ' 56' ' ' LEU . 1.4 m-70 -118.88 116.94 27.53 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.441 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.627 HD12 ' C ' ' A' ' 55' ' ' HIS . 9.9 mp -117.38 139.36 50.96 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.748 0.785 . . . . 0.0 111.193 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -130.08 125.76 35.96 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.097 -1.41 . . . . 0.0 109.195 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.905 HD22 ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -113.7 135.03 54.38 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.322 -178.747 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.451 HG23 HG23 ' A' ' 42' ' ' THR . 0.3 OUTLIER -118.99 139.95 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.866 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -118.83 112.97 20.37 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.626 178.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.3 p . . . . . 0 CA--C 1.512 -0.508 0 CA-C-O 121.316 0.579 . . . . 0.0 111.019 -179.663 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 80' ' ' GLY . 40.2 pt . . . . . 0 N--CA 1.43 -1.444 0 CA-C-O 121.297 0.57 . . . . 0.0 112.373 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -144.53 17.85 1.67 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.757 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.631 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -159.03 166.49 34.58 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.345 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.16 127.39 11.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.553 -0.823 . . . . 0.0 110.7 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.764 ' O ' HG23 ' A' ' 82' ' ' ILE . 12.3 tt -129.18 96.9 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.57 118.58 34.39 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.355 -177.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 84' ' ' VAL . 2.1 t -96.95 111.02 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.273 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.511 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 4.1 p90 -110.66 142.39 42.61 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.416 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.462 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.5 p -88.94 141.17 28.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.429 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.634 HG21 ' N ' ' A' ' 124' ' ' HIS . 19.1 m -77.58 18.05 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.771 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.99 -25.26 1.62 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.51 ' C ' ' N ' ' A' ' 91' ' ' LYS . 20.6 t -94.0 92.37 7.32 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.333 -176.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 90' ' ' ILE . 10.3 tp -59.57 -10.43 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.553 ' O ' HG13 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -78.18 -54.96 5.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.247 179.004 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.1 p -55.13 -27.22 43.8 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.511 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -76.75 -39.58 51.26 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.625 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.456 ' O ' HG23 ' A' ' 98' ' ' VAL . 3.9 mm-40 -68.23 -44.17 76.32 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.22 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 91' ' ' LYS . 2.3 m -69.37 -40.81 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.584 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.428 ' CG1' HD22 ' A' ' 12' ' ' LEU . 18.0 mt -57.09 -51.28 71.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.292 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -72.35 -31.65 65.81 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.853 0.358 . . . . 0.0 111.412 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 94' ' ' GLU . 18.8 t -73.46 -66.36 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.351 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.426 ' O ' ' C ' ' A' ' 100' ' ' HIS . 31.9 mt -48.16 -55.72 2.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.494 ' CE1' ' CE2' ' A' ' 141' ' ' TRP . 25.9 t-80 -41.16 -63.82 0.63 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.64 -52.0 1.9 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 103' ' ' LEU . 24.3 tptt -70.48 -66.66 0.57 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.386 -0.407 . . . . 0.0 111.106 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -36.71 -55.07 0.89 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.969 0.414 . . . . 0.0 109.946 179.718 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.699 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -51.91 -50.7 60.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.495 0.664 . . . . 0.0 109.449 179.157 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.469 ' N ' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.312 -1.027 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.032 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.451 ' HB3' HG23 ' A' ' 170' ' ' ILE . 59.5 mt-30 . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.842 0.353 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.671 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.8 OUTLIER -117.66 152.91 50.36 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.33 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -46.45 111.42 0.36 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 121.717 1.611 . . . . 0.0 112.338 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.479 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.9 mt -121.62 131.82 72.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.1 tpt -128.01 115.78 19.03 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.623 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.9 mt -95.25 97.55 9.96 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.4 133.31 47.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 122.298 1.047 . . . . 0.0 110.996 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.41 110.23 3.41 Favored Glycine 0 C--N 1.304 -1.231 0 CA-C-N 113.459 -1.7 . . . . 0.0 109.018 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.481 ' CG ' ' N ' ' A' ' 120' ' ' LYS . 43.8 t30 -97.23 174.04 6.92 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.818 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.481 ' N ' ' CG ' ' A' ' 119' ' ' ASN . 2.1 mttp 67.11 59.13 0.54 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.845 0.831 . . . . 0.0 109.226 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.37 -37.49 87.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.368 -178.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -59.88 -9.88 3.41 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.899 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.6 mp -93.99 -29.73 15.08 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.634 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.5 OUTLIER -42.03 -22.77 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.805 178.839 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.495 ' N ' ' O ' ' A' ' 123' ' ' LEU . 3.5 mmt -46.65 -23.18 0.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.478 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.3 OUTLIER -103.34 -40.48 6.38 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.218 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.497 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 5.0 tpp85 33.16 83.29 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.199 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.0 m -67.87 -29.5 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.546 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.1 tp -89.42 155.07 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.497 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.447 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 82.0 p -94.7 122.54 37.41 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.838 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -41.35 -33.66 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.404 0.621 . . . . 0.0 109.52 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.5 mp0 -65.07 -64.71 0.8 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.932 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.447 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 65.4 mt-10 -41.26 -43.96 2.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.023 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.16 -32.97 69.0 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 132' ' ' GLU . 20.0 tttm -65.72 -55.26 18.27 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.08 -34.04 65.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.494 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.77 -62.7 1.36 Allowed 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.841 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -55.22 -34.71 64.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.543 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.15 -34.75 75.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.735 0.302 . . . . 0.0 110.55 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.04 -46.29 88.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.906 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.494 ' CE2' ' CE1' ' A' ' 100' ' ' HIS . 56.9 m95 -88.45 -4.51 58.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.977 0.418 . . . . 0.0 110.327 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 73.88 25.1 1.97 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.619 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -90.8 168.34 11.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.42 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.32 133.89 49.34 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.794 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.66 ' O ' HD22 ' A' ' 146' ' ' LEU . 4.6 t80 -96.65 121.37 38.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.182 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.66 HD22 ' O ' ' A' ' 145' ' ' PHE . 1.4 mm? -134.71 137.07 43.19 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.624 -176.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.497 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 5.8 tt0 -124.62 111.01 15.12 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.524 ' OG ' HG21 ' A' ' 159' ' ' VAL . 10.7 p -135.5 -174.96 3.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.994 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.47 132.94 32.08 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.053 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.457 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -56.26 -53.04 61.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.283 0.563 . . . . 0.0 109.732 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -49.4 -12.38 0.06 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.786 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.457 ' H ' ' C ' ' A' ' 150' ' ' ALA . 31.8 mt-10 -122.64 124.17 42.83 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.64 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.468 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 80.1 m-20 -77.71 -53.21 7.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 153' ' ' ASN . 10.7 tt0 -38.81 -57.34 1.23 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.924 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.666 ' O ' HG23 ' A' ' 159' ' ' VAL . 44.2 p -51.97 -44.89 64.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.987 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -55.89 -61.58 2.28 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.566 0.698 . . . . 0.0 109.868 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 61.3 t -41.62 -39.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.518 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -67.86 -36.98 81.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.633 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 155' ' ' THR . 35.5 t -66.61 -36.24 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.803 ' CZ ' HD11 ' A' ' 164' ' ' ILE . 1.3 t80 -62.47 -65.69 0.65 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.691 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -44.09 -53.51 6.32 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.741 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -55.81 -29.45 59.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.914 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -66.64 -35.95 76.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.248 -179.801 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.803 HD11 ' CZ ' ' A' ' 160' ' ' PHE . 42.5 mt -67.54 -38.19 80.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.587 0.708 . . . . 0.0 109.948 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.13 -63.23 1.37 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.748 -178.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -57.59 -31.42 66.15 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.879 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -60.08 -32.3 70.83 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.475 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.49 -55.07 9.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.004 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -55.45 -63.11 1.27 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.091 0.472 . . . . 0.0 110.552 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.671 HG21 ' C ' ' A' ' 112' ' ' ILE . 96.7 mt -51.23 -35.36 15.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.792 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.12 -40.0 86.77 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -57.38 -32.61 64.35 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.85 -79.43 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.727 0.299 . . . . 0.0 110.297 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.153 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.275 -179.889 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 CA-C-O 121.073 0.463 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -139.67 135.42 33.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.939 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.523 ' HB2' HG22 ' A' ' 78' ' ' ILE . 8.3 mttm -106.56 130.05 54.39 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.749 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -103.77 123.04 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-O 121.426 0.631 . . . . 0.0 110.479 -178.586 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.19 134.86 34.95 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.113 -0.992 . . . . 0.0 110.216 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.451 HD11 ' HB2' ' A' ' 58' ' ' LEU . 16.9 mt -96.12 133.71 36.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.502 0.667 . . . . 0.0 111.905 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.548 HD13 HG12 ' A' ' 96' ' ' ILE . 2.0 tt -125.18 97.67 5.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.352 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -139.89 130.56 4.74 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.009 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.425 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -57.99 -155.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.821 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.04 139.36 31.5 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.752 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.7 m 56.8 10.8 0.79 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.986 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.68 -20.84 28.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.459 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.54 22.6 18.42 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 pttm -72.2 -34.44 68.38 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.856 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.462 ' O ' HD13 ' A' ' 24' ' ' ILE . 56.5 m -77.25 -35.19 55.58 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.569 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.06 -36.14 81.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 29.4 tp -76.88 -46.58 24.01 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.471 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.552 ' O ' HG12 ' A' ' 27' ' ' VAL . 71.9 m -45.07 -41.5 7.75 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.92 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.462 HD13 ' O ' ' A' ' 20' ' ' SER . 1.3 mp -77.62 -41.84 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.232 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.495 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.5 OUTLIER -69.43 -32.31 71.2 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.492 -178.781 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.46 ' CG ' ' N ' ' A' ' 27' ' ' VAL . 0.6 OUTLIER -77.92 -63.19 1.45 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.27 0.557 . . . . 0.0 110.805 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.586 HG13 ' N ' ' A' ' 28' ' ' GLU . 11.3 p -44.38 -47.59 2.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.424 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.586 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.5 tt0 -83.14 -24.61 32.49 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 75.12 25.63 68.37 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.288 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 25' ' ' GLN . 0.6 OUTLIER -151.61 126.37 9.62 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 120.886 0.374 . . . . 0.0 111.691 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.1 t80 . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.95 178.48 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.577 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 1.4 pm0 . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 40' ' ' GLU . 1.1 m-80 178.99 -179.78 0.38 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.249 0.547 . . . . 0.0 112.079 -179.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.95 132.91 53.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.072 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -114.45 173.92 6.22 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.167 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.55 155.59 43.74 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -155.4 108.04 2.71 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.604 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 46' ' ' LEU . 8.0 mp -105.36 122.45 45.98 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.725 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 pp -149.55 165.83 3.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.551 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.1 m -114.05 123.81 50.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.567 HG12 ' CD1' ' A' ' 54' ' ' TYR . 7.5 p -119.07 125.39 74.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-N 116.352 -0.386 . . . . 0.0 109.963 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 67.46 15.46 9.85 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.51 -9.95 76.02 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.37 135.71 33.51 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.39 146.99 40.37 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.597 0.713 . . . . 0.0 111.271 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.567 ' CD1' HG12 ' A' ' 49' ' ' VAL . 4.9 m-85 -137.92 123.58 19.82 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.192 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.502 ' NE2' HD23 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -118.16 112.47 20.2 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.4 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.491 HD12 ' C ' ' A' ' 55' ' ' HIS . 8.9 mp -120.92 146.71 46.34 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.585 0.707 . . . . 0.0 112.24 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.805 ' C ' HD13 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -137.56 126.93 24.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.01 178.25 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.974 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.72 154.51 31.57 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.253 -178.246 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.33 140.8 47.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.485 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.31 114.31 19.39 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.02 177.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.512 -0.495 0 CA-C-O 121.587 0.708 . . . . 0.0 111.029 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.523 HG22 ' HB2' ' A' ' 8' ' ' LYS . 43.7 pt . . . . . 0 N--CA 1.432 -1.348 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.39 20.35 0.84 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.137 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -147.95 164.79 28.89 Favored Glycine 0 CA--C 1.517 0.218 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.682 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.2 123.21 7.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.754 -0.723 . . . . 0.0 111.165 178.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.631 ' C ' HD23 ' A' ' 83' ' ' LEU . 9.9 tt -126.85 110.37 22.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.787 ' N ' HD23 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.79 119.1 36.97 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.236 -177.331 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.6 133.07 42.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.075 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.474 ' CD2' ' CE2' ' A' ' 93' ' ' PHE . 8.4 p90 -143.32 144.6 32.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.973 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.583 ' C ' ' H ' ' A' ' 88' ' ' THR . 2.2 t -88.24 143.25 27.15 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.853 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.547 HG21 ' N ' ' A' ' 124' ' ' HIS . 20.2 m -67.18 14.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.972 0.415 . . . . 0.0 110.259 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.583 ' H ' ' C ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -127.78 -18.13 4.35 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.53 -178.675 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.492 ' C ' ' N ' ' A' ' 91' ' ' LYS . 8.6 t -94.95 92.02 6.68 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.447 -175.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.9 tp -62.97 -11.44 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.524 ' O ' HG13 ' A' ' 95' ' ' VAL . 1.0 OUTLIER -78.32 -58.63 3.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 113.712 -1.585 . . . . 0.0 110.576 178.864 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.503 ' O ' HD12 ' A' ' 96' ' ' ILE . 19.0 p -55.38 -31.62 61.94 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.398 0.618 . . . . 0.0 109.539 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.474 ' CE2' ' CD2' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -77.72 -38.1 47.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.195 179.677 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 98' ' ' VAL . 34.9 mt-10 -69.21 -46.79 66.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.477 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 91' ' ' LYS . 2.8 m -67.8 -45.23 84.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.59 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.548 HG12 HD13 ' A' ' 12' ' ' LEU . 33.3 mt -58.41 -46.14 89.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.536 ' HG3' HD11 ' A' ' 137' ' ' LEU . 0.5 OUTLIER -72.24 -37.73 69.06 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.097 0.475 . . . . 0.0 111.06 -179.439 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 94' ' ' GLU . 56.0 t -72.11 -65.3 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.672 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.408 ' O ' ' C ' ' A' ' 100' ' ' HIS . 73.3 mt -42.3 -59.12 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.915 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.441 ' ND1' ' N ' ' A' ' 101' ' ' GLY . 4.3 t-80 -40.98 -64.98 0.47 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.752 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.441 ' N ' ' ND1' ' A' ' 100' ' ' HIS . . . -36.6 -56.71 1.25 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 103' ' ' LEU . 32.8 tptt -69.8 -66.5 0.58 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.472 -0.364 . . . . 0.0 111.611 -179.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.47 ' C ' ' O ' ' A' ' 102' ' ' LYS . 5.8 tp -36.98 -61.83 0.53 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.707 ' C ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -44.5 -50.67 9.38 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.787 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.489 ' N ' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.79 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.448 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.548 ' O ' ' HB2' ' A' ' 174' ' ' ALA . 38.4 mt-30 . . . . . 0 CA--C 1.521 -0.164 0 CA-C-O 120.932 0.396 . . . . 0.0 110.689 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.67 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.8 OUTLIER -118.52 155.84 51.77 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.343 179.242 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -47.04 111.43 0.39 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.813 1.675 . . . . 0.0 112.254 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.476 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.7 mt -121.84 127.3 75.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 6.6 tpt -128.62 117.23 20.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.09 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.7 mt -95.95 97.79 9.9 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.413 ' O ' ' CE1' ' A' ' 85' ' ' TYR . 29.8 t -104.92 128.56 58.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 122.175 0.988 . . . . 0.0 111.319 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.457 ' CA ' ' CE2' ' A' ' 85' ' ' TYR . . . -102.65 114.5 4.91 Favored Glycine 0 C--N 1.307 -1.04 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.508 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 49.1 t30 -97.8 177.16 5.55 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.698 -178.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.508 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 19.4 mttt 61.91 59.17 1.77 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.071 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.444 ' H ' ' HB3' ' A' ' 149' ' ' SER . 29.5 tttm -64.92 -17.99 64.83 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -79.24 0.65 27.74 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.844 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 125' ' ' MET . 9.2 mp -95.88 -25.43 16.01 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.547 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -37.39 -28.19 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.531 178.449 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.521 ' N ' ' O ' ' A' ' 123' ' ' LEU . 9.3 mtt -45.43 -23.58 0.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.471 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -108.98 -38.83 5.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.844 179.397 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.467 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 0.0 OUTLIER 28.68 86.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.173 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.9 m -72.79 -31.65 37.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.451 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.42 151.8 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.779 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.456 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 94.4 p -104.21 126.39 51.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.153 0.501 . . . . 0.0 111.417 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.455 ' CE1' ' CE1' ' A' ' 145' ' ' PHE . 0.8 OUTLIER -39.95 -38.86 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.313 178.738 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -63.21 -64.85 0.79 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.236 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.456 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 59.8 mt-10 -41.08 -46.54 2.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.116 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.42 -33.2 76.72 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 132' ' ' GLU . 21.4 tttm -63.87 -55.42 22.92 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.12 -35.75 69.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.674 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.536 HD11 ' HG3' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -66.79 -62.42 1.46 Allowed 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 121.18 0.514 . . . . 0.0 109.779 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.04 -36.61 50.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.288 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -68.12 -32.52 72.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.755 0.312 . . . . 0.0 110.26 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.89 -46.15 86.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.844 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.451 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 49.7 m95 -88.26 -4.51 58.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.345 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 74.63 27.52 1.31 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.399 0.618 . . . . 0.0 109.411 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -95.46 170.01 9.65 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.57 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.92 133.07 52.79 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.018 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.695 ' O ' HD22 ' A' ' 146' ' ' LEU . 8.3 t80 -97.24 122.33 40.14 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.445 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.825 HD21 ' HE ' ' A' ' 162' ' ' ARG . 1.5 mm? -134.58 136.37 42.92 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.713 -176.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.467 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 5.8 tt0 -123.38 111.95 16.99 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.518 ' OG ' HG21 ' A' ' 159' ' ' VAL . 22.7 p -137.33 -175.74 4.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.752 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.444 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -139.26 136.51 35.01 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.908 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.43 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -57.49 -47.41 81.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.274 0.559 . . . . 0.0 109.827 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -56.08 -8.43 0.46 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.449 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 150' ' ' ALA . 30.4 mt-10 -127.53 124.4 38.16 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.806 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.451 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 5.4 t-20 -77.72 -55.87 4.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.02 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 153' ' ' ASN . 1.6 mt-30 -36.73 -57.74 0.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.103 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.669 ' O ' HG23 ' A' ' 159' ' ' VAL . 58.8 p -52.88 -45.25 67.4 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.085 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.495 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -56.21 -61.67 2.24 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.595 0.712 . . . . 0.0 109.934 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 60.6 t -42.77 -39.18 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.534 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -68.77 -33.79 74.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.788 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 155' ' ' THR . 44.6 t -67.61 -39.38 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.074 0.464 . . . . 0.0 109.815 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.509 ' O ' ' N ' ' A' ' 163' ' ' ILE . 66.5 t80 -63.55 -66.24 0.57 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.779 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.0 ttt85 -43.34 -46.47 6.47 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.667 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.825 ' HE ' HD21 ' A' ' 146' ' ' LEU . 14.9 mmm180 -58.06 -32.64 68.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.16 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.509 ' N ' ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -66.22 -34.8 72.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.26 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.599 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 14.1 mt -63.78 -44.1 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.423 0.63 . . . . 0.0 111.295 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -58.79 -64.67 0.85 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.045 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.462 ' H ' HD23 ' A' ' 165' ' ' LEU . 0.4 OUTLIER -50.52 -23.83 2.77 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.676 -178.88 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -71.77 -31.18 66.35 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.559 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 165' ' ' LEU . 0.5 OUTLIER -70.29 -52.21 24.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.08 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -61.09 -63.56 1.25 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.883 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.67 HG21 ' C ' ' A' ' 112' ' ' ILE . 96.4 mt -50.95 -32.7 12.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.94 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.02 -39.09 86.96 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.484 -0.487 . . . . 0.0 109.908 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -59.48 -35.54 85.78 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.403 ' O ' ' C ' ' A' ' 174' ' ' ALA . . . -68.39 -78.56 0.06 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.025 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 121.223 0.535 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.589 ' NH1' ' HB1' ' A' ' 167' ' ' ALA . 83.4 mtt180 -140.27 135.55 32.39 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.905 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.513 ' HB2' HG22 ' A' ' 78' ' ' ILE . 15.2 mttm -107.3 127.63 53.72 Favored 'General case' 0 C--O 1.212 -0.896 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.768 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.7 OUTLIER -103.02 118.47 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-O 121.691 0.758 . . . . 0.0 110.773 -178.352 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.49 ' HB2' HD13 ' A' ' 78' ' ' ILE . . . -82.73 137.75 34.29 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.691 -0.631 . . . . 0.0 111.848 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.1 mt -92.92 125.82 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.183 0.516 . . . . 0.0 111.92 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tt -123.19 92.33 3.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.896 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -142.03 136.82 7.53 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -178.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.581 ' CD1' HG21 ' A' ' 95' ' ' VAL . 0.5 OUTLIER -53.09 -160.17 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.699 0.762 . . . . 0.0 111.31 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.8 tpp85 -97.11 136.0 38.28 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.701 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.3 m 63.28 11.5 5.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.567 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 p -71.94 -16.84 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.16 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.62 21.35 34.5 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -39.25 81.11 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.359 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.7 m -71.89 -28.65 63.65 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.3 m -63.73 -42.42 97.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.199 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.4 tp -75.53 -28.41 59.08 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.464 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.579 ' O ' HG12 ' A' ' 27' ' ' VAL . 40.0 m -55.94 -49.92 72.18 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.502 HD11 ' CE2' ' A' ' 43' ' ' PHE . 1.4 mp -70.9 -41.04 77.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.075 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.471 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -65.67 -30.24 70.9 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.23 -179.169 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -77.79 -64.02 1.25 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.452 0.644 . . . . 0.0 111.353 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.631 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.1 p -49.65 -47.2 21.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.375 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.631 ' N ' HG13 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -83.66 -24.36 31.38 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.372 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.17 25.99 71.86 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -144.47 125.45 14.42 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.187 0.518 . . . . 0.0 112.297 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.625 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.801 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.553 0 CA-C-O 120.955 0.407 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -160.35 161.7 33.23 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.808 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.5 m -132.52 149.62 52.29 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.266 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.502 ' CE2' HD11 ' A' ' 24' ' ' ILE . 10.9 m-85 -129.63 164.48 23.79 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.55 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -146.72 150.36 35.22 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.148 0.499 . . . . 0.0 111.997 -178.605 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -153.17 119.19 5.42 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.06 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.706 HD21 ' CE1' ' A' ' 55' ' ' HIS . 6.4 mp -107.01 123.86 48.8 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.127 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.823 HD12 ' CE1' ' A' ' 160' ' ' PHE . 0.8 OUTLIER -145.51 165.63 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.221 179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.36 121.85 44.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.224 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 49' ' ' VAL . 8.5 p -114.59 114.66 47.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.92 179.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 49' ' ' VAL . 4.3 t-20 73.72 11.83 4.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.398 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.82 -8.14 63.37 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.577 ' NE2' ' O ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -93.74 135.17 35.31 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.603 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.577 ' O ' ' NE2' ' A' ' 52' ' ' GLN . 2.4 mt-10 -74.35 145.48 43.81 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.577 0.704 . . . . 0.0 111.252 -178.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.697 ' CE2' HG23 ' A' ' 164' ' ' ILE . 4.3 m-85 -136.18 127.07 27.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.183 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.706 ' CE1' HD21 ' A' ' 46' ' ' LEU . 2.2 t-160 -117.63 112.87 21.11 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.505 HD12 ' C ' ' A' ' 55' ' ' HIS . 9.0 mp -118.46 139.12 51.91 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.537 0.684 . . . . 0.0 111.575 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.731 ' C ' HD13 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -132.16 121.0 23.02 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.098 178.915 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.931 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -114.64 155.21 26.98 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.761 -178.214 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.12 145.95 31.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -177.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.407 ' O ' ' OG1' ' A' ' 61' ' ' THR . 0.3 OUTLIER -122.04 117.51 26.53 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 113.504 -1.68 . . . . 0.0 107.898 177.525 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 60' ' ' ASP . 20.3 p . . . . . 0 CA--C 1.497 -1.087 0 O-C-N 123.546 0.528 . . . . 0.0 109.771 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.798 HD12 ' O ' ' A' ' 80' ' ' GLY . 38.3 pt . . . . . 0 N--CA 1.439 -1.024 0 CA-C-O 121.405 0.622 . . . . 0.0 112.664 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.56 19.81 1.04 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.437 178.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.798 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -156.96 168.1 33.89 Favored Glycine 0 CA--C 1.521 0.45 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.187 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -152.15 122.76 7.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.985 -0.608 . . . . 0.0 110.709 177.831 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.641 ' O ' HG23 ' A' ' 82' ' ' ILE . 11.0 tt -125.34 102.3 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.716 0.77 . . . . 0.0 109.312 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.839 ' N ' HD12 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -97.15 125.72 41.84 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.794 -178.56 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -95.51 130.66 43.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.303 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.681 ' CZ ' HG21 ' A' ' 96' ' ' ILE . 49.8 m-85 -110.56 143.75 40.47 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.14 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.499 ' C ' ' H ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -98.21 124.13 42.63 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.534 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.513 HG21 ' N ' ' A' ' 124' ' ' HIS . 14.1 m -72.51 23.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.71 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.499 ' H ' ' C ' ' A' ' 86' ' ' SER . 5.1 t -138.36 -25.57 0.93 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.556 ' C ' ' N ' ' A' ' 91' ' ' LYS . 8.3 t -100.2 95.06 6.55 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.051 -176.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.1 tp -57.86 -11.66 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 175.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' C ' ' A' ' 89' ' ' SER . 18.5 mttp -77.74 -61.51 1.97 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 113.936 -1.483 . . . . 0.0 110.23 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.638 ' O ' HD12 ' A' ' 96' ' ' ILE . 76.5 p -47.17 -29.59 2.4 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.723 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.948 ' CE2' HG21 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -74.07 -51.41 15.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.179 -179.365 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.571 ' O ' HG23 ' A' ' 98' ' ' VAL . 4.0 mm-40 -65.79 -43.96 87.17 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.581 HG21 ' CD1' ' A' ' 14' ' ' TYR . 13.6 m -68.07 -36.5 75.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.12 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.681 HG21 ' CZ ' ' A' ' 85' ' ' TYR . 19.2 mt -63.35 -38.84 83.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -69.68 -25.97 64.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.03 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 94' ' ' GLU . 57.4 t -76.46 -66.47 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.338 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.406 ' H ' HG12 ' A' ' 99' ' ' ILE . 4.5 mm -44.27 -54.36 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.431 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.637 ' ND1' ' CH2' ' A' ' 141' ' ' TRP . 2.0 t-80 -61.45 -64.51 0.92 Allowed 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.805 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.531 ' N ' ' ND1' ' A' ' 100' ' ' HIS . . . -35.39 -57.29 0.91 Allowed Glycine 0 N--CA 1.454 -0.141 0 CA-C-N 116.24 -0.437 . . . . 0.0 112.053 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 103' ' ' LEU . 15.4 tptm -69.69 -65.01 0.77 Allowed 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.359 -0.42 . . . . 0.0 110.736 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.45 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.7 OUTLIER -36.88 -60.87 0.59 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.097 0.475 . . . . 0.0 109.872 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.717 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -46.65 -47.01 20.26 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 178.822 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.83 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.56 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.424 ' HB3' HG23 ' A' ' 170' ' ' ILE . 34.7 mt-30 . . . . . 0 CA--C 1.522 -0.13 0 CA-C-O 120.801 0.334 . . . . 0.0 110.72 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.647 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.8 OUTLIER -118.62 153.67 52.25 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.233 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -48.04 117.06 2.26 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.582 1.521 . . . . 0.0 111.953 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.481 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.4 mp -122.81 126.45 73.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 8.4 tpt -122.31 112.53 18.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.497 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 73.2 mt -96.67 98.86 10.52 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.6 t -108.45 133.67 52.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 122.04 0.924 . . . . 0.0 112.62 -178.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -97.93 114.29 4.96 Favored Glycine 0 C--N 1.315 -0.615 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -98.09 170.08 9.17 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -177.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.452 ' HB3' HD13 ' A' ' 123' ' ' LEU . 25.8 mttt 61.02 57.37 2.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.274 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.2 ttpt -57.73 -29.06 64.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.418 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -67.5 -16.79 64.39 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.295 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.1 mp -82.01 -31.26 31.11 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.513 ' N ' HG21 ' A' ' 87' ' ' VAL . 1.0 OUTLIER -37.74 -24.71 0.01 OUTLIER 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.366 178.874 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.543 ' N ' ' O ' ' A' ' 123' ' ' LEU . 2.7 mmt -48.24 -22.53 0.68 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.44 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -109.0 -37.68 5.76 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.827 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.445 ' NH1' ' OE1' ' A' ' 147' ' ' GLU . 0.2 OUTLIER 27.16 91.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.034 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 38.7 t -70.79 -45.81 71.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.055 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.948 HG21 ' CE2' ' A' ' 93' ' ' PHE . 8.7 tp -91.55 153.54 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.577 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.435 ' OG ' ' OE1' ' A' ' 133' ' ' GLU . 4.1 p -104.51 126.17 51.35 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.3 0.571 . . . . 0.0 111.329 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.638 ' CD1' ' CE1' ' A' ' 145' ' ' PHE . 0.7 OUTLIER -49.41 -43.67 44.71 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.815 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 131' ' ' TYR . 1.2 mp0 -39.07 -63.11 0.56 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.344 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.435 ' OE1' ' OG ' ' A' ' 130' ' ' SER . 11.7 mt-10 -52.24 -37.18 54.48 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 131' ' ' TYR . . . -72.27 -22.23 78.97 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 131' ' ' TYR . 0.3 OUTLIER -75.91 -54.68 6.53 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.478 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -54.49 -37.53 65.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.362 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.6 OUTLIER -69.61 -63.72 1.02 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.8 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -42.41 -32.95 0.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.27 -48.67 67.02 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.867 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -66.96 -27.82 67.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.475 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.637 ' CH2' ' ND1' ' A' ' 100' ' ' HIS . 22.8 m0 -86.67 -10.94 52.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.69 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.23 27.16 16.92 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.428 ' HB2' ' HB ' ' A' ' 114' ' ' ILE . . . -104.15 166.05 10.65 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.24 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -102.62 127.84 49.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.211 0.529 . . . . 0.0 112.115 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.638 ' CE1' ' CD1' ' A' ' 131' ' ' TYR . 11.3 t80 -99.36 118.67 36.52 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.109 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.03 133.12 22.88 Favored 'General case' 0 C--N 1.347 0.491 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.445 ' OE1' ' NH1' ' A' ' 127' ' ' ARG . 3.1 mt-10 -98.47 115.09 27.78 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.875 -0.515 . . . . 0.0 109.838 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.704 ' OG ' HG21 ' A' ' 159' ' ' VAL . 0.5 OUTLIER -140.54 134.88 31.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.705 -179.73 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 152' ' ' GLU . 4.0 p -102.29 142.4 33.57 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 152' ' ' GLU . . . -55.53 -55.28 33.67 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.688 178.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 31.3 tttt -46.84 -15.11 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.998 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 150' ' ' ALA . 60.9 mt-10 -126.0 120.12 29.46 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.973 0.416 . . . . 0.0 110.868 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 9.7 t-20 -77.1 -47.48 20.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 153' ' ' ASN . 5.1 mt-30 -36.92 -58.91 0.74 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.229 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.643 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.2 p -56.49 -42.69 78.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.289 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 153' ' ' ASN . . . -53.78 -60.75 2.92 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.555 0.693 . . . . 0.0 109.938 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 49.2 t -45.84 -44.12 4.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.561 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -53.9 -45.18 71.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.265 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.704 HG21 ' OG ' ' A' ' 148' ' ' SER . 2.2 t -65.59 -49.48 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.423 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.823 ' CE1' HD12 ' A' ' 47' ' ' ILE . 1.3 t80 -45.61 -37.5 5.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.807 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.1 ttt-85 -79.14 -50.27 11.28 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.375 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -34.29 69.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.278 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.637 HG23 ' N ' ' A' ' 164' ' ' ILE . 11.8 tt -67.9 -54.6 21.43 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.944 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.783 HD11 ' CE1' ' A' ' 160' ' ' PHE . 90.8 mt -47.38 -34.6 3.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 119.219 -0.992 . . . . 0.0 109.425 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.66 -64.33 0.95 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.059 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -57.12 -30.64 64.56 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.227 -0.589 . . . . 0.0 109.42 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.589 ' HB1' ' NH1' ' A' ' 7' ' ' ARG . . . -58.96 -32.68 69.85 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.41 -53.14 25.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.383 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 12.6 tttm -59.14 -65.02 0.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.883 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.647 HG21 ' C ' ' A' ' 112' ' ' ILE . 74.6 mt -48.74 -35.04 6.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.678 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -67.21 -37.33 83.43 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.03 -30.89 76.82 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.75 -79.54 0.05 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.191 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.768 179.88 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 121.265 0.555 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.23 136.68 33.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.312 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 22.6 mtmt -107.35 130.02 54.84 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.774 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.1 mm -108.77 121.07 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-O 121.342 0.592 . . . . 0.0 110.277 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.62 135.55 35.03 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.259 -0.9 . . . . 0.0 110.533 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.7 mt -95.54 131.69 41.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.415 0.626 . . . . 0.0 112.09 -178.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 12' ' ' LEU . 5.5 tt -132.34 99.09 4.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.719 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.87 135.57 6.81 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -52.45 -165.42 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.49 0.662 . . . . 0.0 110.791 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -100.33 138.09 37.86 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.487 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.52 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 1.3 m 67.66 20.52 9.56 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.36 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 p -90.08 -21.52 6.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.042 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.44 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 108.33 26.25 5.49 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.463 ' NZ ' ' CB ' ' A' ' 19' ' ' LYS . 1.3 ttmp? -60.76 -49.21 78.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.147 0.499 . . . . 0.0 110.094 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -75.98 -25.45 55.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.254 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 54.3 p -65.62 -44.99 84.8 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.453 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 23' ' ' THR . 20.4 tp -76.33 -58.39 3.31 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 119.784 -0.767 . . . . 0.0 110.975 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.603 ' O ' HG12 ' A' ' 27' ' ' VAL . 90.3 m -39.02 -48.68 1.65 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.961 -0.295 . . . . 0.0 110.705 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.517 HD11 ' CE2' ' A' ' 43' ' ' PHE . 1.3 mp -74.62 -35.31 37.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 123.356 0.41 . . . . 0.0 111.34 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.563 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 1.5 tm0? -69.6 -37.74 77.01 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.964 -178.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.631 ' CZ ' ' CD1' ' A' ' 160' ' ' PHE . 20.0 t80 -77.15 -59.55 2.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.291 0.567 . . . . 0.0 111.342 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 28' ' ' GLU . 9.5 p -48.71 -47.19 15.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.57 -178.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.61 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.0 tt0 -85.13 -24.42 28.02 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.38 35.76 63.29 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -130.34 125.05 33.68 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.371 0.605 . . . . 0.0 111.641 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.718 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.742 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.66 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.443 ' CB ' ' O ' ' A' ' 60' ' ' ASP . 2.0 pt-20 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.783 0.325 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.409 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 1.3 m120 178.72 173.91 0.68 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.215 0.531 . . . . 0.0 111.83 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.91 143.4 36.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.567 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.517 ' CE2' HD11 ' A' ' 24' ' ' ILE . 12.3 m-85 -127.33 165.9 18.84 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.588 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.59 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -143.61 147.16 33.96 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 120.227 -0.589 . . . . 0.0 112.404 -178.453 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.964 ' C ' HD13 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -162.32 114.61 1.68 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.679 178.864 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.049 HD22 ' H ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -115.16 142.39 46.72 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.821 -1.082 . . . . 0.0 111.159 -177.688 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.617 HD11 ' CD2' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -150.77 165.73 2.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.274 179.493 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 m -108.33 124.04 49.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.758 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.616 HG11 HG21 ' A' ' 164' ' ' ILE . 7.1 p -120.94 122.76 68.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.139 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 69.65 12.98 8.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.043 0.449 . . . . 0.0 109.954 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.5 -11.37 70.23 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -89.55 133.25 34.69 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -77.39 147.43 36.05 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.522 0.677 . . . . 0.0 111.172 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -137.66 130.73 30.43 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.011 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.687 ' C ' HD22 ' A' ' 56' ' ' LEU . 1.2 m80 -116.54 117.54 30.17 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.687 HD22 ' C ' ' A' ' 55' ' ' HIS . 3.4 mm? -121.6 140.7 51.91 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.449 0.642 . . . . 0.0 112.019 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.803 ' C ' HD13 ' A' ' 58' ' ' LEU . 0.7 OUTLIER -136.52 124.41 22.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.097 178.696 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.95 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.25 154.95 30.3 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.152 0.501 . . . . 0.0 112.065 -178.717 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.27 145.47 35.28 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-N 115.125 -0.943 . . . . 0.0 113.01 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.443 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -123.34 102.66 8.04 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.009 177.646 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.668 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.036 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.662 HD12 ' O ' ' A' ' 80' ' ' GLY . 22.7 pt . . . . . 0 N--CA 1.438 -1.052 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -145.91 16.43 1.4 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.653 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.662 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -150.63 164.38 29.85 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.582 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.71 123.44 7.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.891 -0.655 . . . . 0.0 110.944 178.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.647 ' O ' HG23 ' A' ' 82' ' ' ILE . 11.7 tt -127.26 104.83 13.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.552 0.691 . . . . 0.0 109.696 178.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.737 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -97.7 120.98 39.06 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.406 -178.684 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 84' ' ' VAL . 1.7 t -97.19 114.14 33.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.675 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.505 ' CZ ' ' CA ' ' A' ' 118' ' ' GLY . 48.7 p90 -115.52 145.08 42.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.608 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.429 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.6 p -86.99 143.16 27.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.452 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.532 HG21 ' N ' ' A' ' 124' ' ' HIS . 10.2 m -80.98 17.67 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 120.998 0.428 . . . . 0.0 110.256 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.4 t -130.26 -19.59 3.12 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.406 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.56 ' C ' ' N ' ' A' ' 91' ' ' LYS . 20.9 t -98.95 93.78 6.2 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.298 -176.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.7 tp -58.7 -11.82 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.56 ' N ' ' C ' ' A' ' 89' ' ' SER . 12.9 mttp -77.97 -54.39 6.35 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.442 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.1 p -53.93 -32.28 53.06 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.038 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.912 ' CE2' HG21 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -73.78 -51.0 17.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.025 -179.469 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.28 -42.62 92.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.876 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 91' ' ' LYS . 17.7 m -65.48 -40.12 87.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.307 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.496 ' CG1' HD22 ' A' ' 12' ' ' LEU . 1.6 mt -63.0 -32.17 55.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.2 tttm -69.85 -26.47 64.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.101 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.4 t -77.24 -67.13 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.957 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.445 HD12 ' N ' ' A' ' 99' ' ' ILE . 1.6 mp -44.26 -38.18 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.245 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.636 ' CD2' ' CZ2' ' A' ' 141' ' ' TRP . 7.3 t60 -66.6 -64.22 0.9 Allowed 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.788 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.556 ' N ' ' CD2' ' A' ' 100' ' ' HIS . . . -35.69 -50.69 1.07 Allowed Glycine 0 C--N 1.329 0.159 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.431 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 17.5 tptm -70.73 -61.15 1.87 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.966 -0.617 . . . . 0.0 110.554 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -42.09 -60.23 1.5 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.462 0.648 . . . . 0.0 109.394 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.735 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -45.98 -44.29 14.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.23 178.51 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.756 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.943 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.466 ' OE1' ' HB1' ' A' ' 173' ' ' ALA . 12.7 mt-30 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.722 0.296 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.663 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.5 OUTLIER -132.67 152.72 80.43 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.264 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -47.84 110.51 0.32 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.949 1.766 . . . . 0.0 112.478 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 3.0 mt -126.51 131.8 70.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 6.2 tpt -129.84 116.97 19.46 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.863 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.9 mt -95.69 98.11 10.23 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.5 t -102.41 126.15 56.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 122.066 0.936 . . . . 0.0 112.144 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.505 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -97.36 115.89 5.37 Favored Glycine 0 C--N 1.31 -0.913 0 N-CA-C 108.067 -2.013 . . . . 0.0 108.067 177.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.494 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 52.6 t30 -96.97 175.89 6.17 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.165 -0.614 . . . . 0.0 112.105 -177.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.52 ' NZ ' ' O ' ' A' ' 16' ' ' SER . 15.6 mttt 58.84 58.2 3.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.632 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.546 ' O ' ' CG ' ' A' ' 124' ' ' HIS . 16.2 ttmt -58.73 -30.8 67.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.362 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -64.83 -27.07 68.63 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.199 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.4 mp -71.52 -29.88 65.28 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.624 ' ND1' ' N ' ' A' ' 125' ' ' MET . 0.6 OUTLIER -35.93 -29.23 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.498 179.207 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.624 ' N ' ' ND1' ' A' ' 124' ' ' HIS . 1.0 OUTLIER -45.11 -24.89 0.28 Allowed 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.709 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.483 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -103.64 -41.02 6.08 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.584 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.573 HH21 ' CB ' ' A' ' 124' ' ' HIS . 32.2 ttm-85 28.16 80.97 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.201 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.4 t -57.72 -53.93 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.055 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.912 HG21 ' CE2' ' A' ' 93' ' ' PHE . 7.5 tp -86.45 153.13 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.76 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.432 ' OG ' ' OE1' ' A' ' 133' ' ' GLU . 1.1 p -87.22 120.77 28.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.365 0.602 . . . . 0.0 111.407 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.621 ' CE1' ' CD1' ' A' ' 145' ' ' PHE . 0.3 OUTLIER -50.18 -47.32 54.57 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.389 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 131' ' ' TYR . 1.6 mp0 -40.28 -60.58 1.05 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.833 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.432 ' OE1' ' OG ' ' A' ' 130' ' ' SER . 26.9 mt-10 -50.61 -38.01 43.39 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.484 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 131' ' ' TYR . . . -69.23 -34.12 74.74 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -67.06 -54.65 19.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.76 -35.93 69.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.39 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.509 ' CD2' ' CE2' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -67.07 -64.32 0.88 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.516 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -45.82 -37.27 5.94 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.7 -40.82 88.64 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER -64.68 -34.15 77.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.231 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.636 ' CZ2' ' CD2' ' A' ' 100' ' ' HIS . 38.5 m0 -87.0 -7.23 58.35 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 70.51 25.32 4.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.988 -178.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -103.97 166.71 10.24 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.644 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.07 133.5 49.75 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.098 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.695 ' O ' HD22 ' A' ' 146' ' ' LEU . 7.5 t80 -97.26 121.04 38.7 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.466 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.695 HD22 ' O ' ' A' ' 145' ' ' PHE . 1.7 mm? -132.2 130.63 41.28 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.69 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.503 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 4.5 mt-10 -110.27 112.34 24.23 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.942 0.401 . . . . 0.0 109.978 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.496 ' OG ' HG21 ' A' ' 159' ' ' VAL . 49.4 p -139.73 179.29 6.67 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.362 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 152' ' ' GLU . 6.0 p -139.17 133.92 32.08 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.501 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -54.91 -40.31 69.71 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -54.03 -42.11 68.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.059 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 149' ' ' SER . 13.3 tt0 -100.7 117.27 34.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.235 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 0.5 OUTLIER -76.43 -42.58 43.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.185 -179.518 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 153' ' ' ASN . 5.3 tt0 -41.1 -47.83 3.25 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.099 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.594 ' O ' HG23 ' A' ' 159' ' ' VAL . 63.2 p -62.83 -44.95 94.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.91 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 153' ' ' ASN . . . -51.2 -64.36 0.84 Allowed 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.62 0.724 . . . . 0.0 109.465 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.0 t -45.12 -35.73 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.837 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -67.85 -41.03 83.58 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.551 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 155' ' ' THR . 19.4 t -62.69 -43.5 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-O 120.937 0.399 . . . . 0.0 110.399 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.631 ' CD1' ' CZ ' ' A' ' 26' ' ' PHE . 1.1 t80 -59.32 -61.23 2.79 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.727 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.53 -48.82 4.0 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.781 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.43 -26.87 68.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.534 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -68.26 -34.08 64.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.046 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.616 HG21 HG11 ' A' ' 49' ' ' VAL . 20.2 mt -71.41 -38.73 69.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.684 0.754 . . . . 0.0 109.787 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.31 -63.38 1.3 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.013 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -53.59 -36.21 61.68 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.462 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -55.95 -32.33 63.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -68.48 -57.69 5.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.671 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.77 -63.16 1.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.619 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.663 HG21 ' C ' ' A' ' 112' ' ' ILE . 68.9 mt -50.37 -34.36 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.914 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.83 -40.31 75.93 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.468 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -58.15 -36.63 83.06 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.466 ' HB1' ' OE1' ' A' ' 111' ' ' GLN . . . -68.71 -65.63 0.68 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.758 0.313 . . . . 0.0 110.383 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.517 179.88 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 120.993 0.425 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.425 HH21 HD21 ' A' ' 56' ' ' LEU . 4.6 mtm180 -140.04 136.63 33.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.702 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.587 ' HB3' HG22 ' A' ' 78' ' ' ILE . 1.9 tttt -102.51 133.43 47.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -110.16 129.49 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.429 -177.325 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.487 ' HB3' ' CE1' ' A' ' 81' ' ' TYR . . . -87.28 133.32 33.7 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 121.627 -0.67 . . . . 0.0 110.144 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.668 HD11 ' HB2' ' A' ' 58' ' ' LEU . 20.2 mt -98.24 133.69 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.15 0.5 . . . . 0.0 112.123 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.568 HD23 ' C ' ' A' ' 12' ' ' LEU . 3.8 tt -126.4 99.43 5.83 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.341 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -140.3 133.21 5.86 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.5 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.68 -179.03 0.16 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.982 0.42 . . . . 0.0 110.003 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -76.33 131.88 39.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.026 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.4 m 63.81 16.28 9.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.721 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 86' ' ' SER . 10.5 p -72.42 -13.15 16.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.393 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.68 23.12 29.17 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.128 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.4 pttm -69.65 -30.34 68.02 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.969 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.8 m -77.5 -34.44 54.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.434 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 61.2 m -65.29 -42.41 93.17 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.635 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.0 tp -77.8 -36.7 50.02 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.3 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.525 ' O ' HG12 ' A' ' 27' ' ' VAL . 97.2 m -55.45 -38.57 69.21 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -73.82 -39.42 52.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.223 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.527 ' OE1' ' N ' ' A' ' 31' ' ' PHE . 5.2 tt0 -70.29 -27.63 64.56 Favored 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.933 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 1.3 t80 -77.46 -60.26 2.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.4 0.619 . . . . 0.0 110.875 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.601 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.9 p -52.71 -45.92 49.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.043 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.601 ' N ' HG13 ' A' ' 27' ' ' VAL . 1.3 tm-20 -84.19 -24.61 30.04 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.474 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 78.77 19.61 72.81 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.748 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.546 ' NE2' ' O ' ' A' ' 31' ' ' PHE . 15.7 tp60 -154.26 134.06 12.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.161 -0.616 . . . . 0.0 112.258 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.546 ' O ' ' NE2' ' A' ' 30' ' ' GLN . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.453 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.474 ' CD ' ' N ' ' A' ' 40' ' ' GLU . 1.8 pm0 . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -170.51 -178.45 2.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.455 0.645 . . . . 0.0 112.348 -178.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.514 HG23 HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -129.93 131.93 46.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.22 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -108.47 171.33 7.48 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.464 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.531 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -145.3 150.95 37.55 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -178.585 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.596 ' C ' HD12 ' A' ' 46' ' ' LEU . 37.8 tptt -154.12 116.44 4.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.84 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.717 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.0 mp -105.85 125.01 50.48 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.203 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.872 HD12 ' CZ ' ' A' ' 160' ' ' PHE . 0.6 OUTLIER -145.76 165.58 10.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.799 0.333 . . . . 0.0 110.585 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.4 m -117.7 123.82 47.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.878 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.813 HG11 HG21 ' A' ' 164' ' ' ILE . 5.8 p -127.15 132.12 70.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.67 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 70.59 7.35 6.18 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.05 -10.39 71.9 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -93.98 139.17 31.25 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -77.21 148.04 36.07 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.59 0.71 . . . . 0.0 111.41 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -139.35 124.47 18.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.215 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.767 ' C ' HD12 ' A' ' 56' ' ' LEU . 1.8 m-70 -117.32 114.15 23.17 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.767 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.2 mp -126.05 150.82 47.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.508 0.67 . . . . 0.0 111.67 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -136.29 133.15 36.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.941 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.917 HD22 ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -114.64 144.28 43.68 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.639 -179.018 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.514 HG23 HG23 ' A' ' 42' ' ' THR . 0.3 OUTLIER -126.02 130.26 72.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.757 0.789 . . . . 0.0 112.89 -178.752 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -123.23 106.4 10.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.349 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 N--CA 1.452 -0.367 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.302 -179.407 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.587 HG22 ' HB3' ' A' ' 8' ' ' LYS . 26.6 pt . . . . . 0 N--CA 1.43 -1.461 0 CA-C-O 121.186 0.517 . . . . 0.0 112.315 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -150.19 28.11 0.75 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.839 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.37 167.39 35.04 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.299 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.487 ' CE1' ' HB3' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -150.75 127.7 11.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.088 -0.556 . . . . 0.0 111.83 179.471 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.744 ' O ' HG23 ' A' ' 82' ' ' ILE . 13.2 tt -132.72 96.44 2.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.478 0.656 . . . . 0.0 109.35 177.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.806 ' N ' HD23 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -98.17 117.66 33.05 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.089 -178.795 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -96.44 117.69 41.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.345 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.448 ' CZ ' ' CA ' ' A' ' 118' ' ' GLY . 35.7 p90 -111.22 144.19 40.77 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.568 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.62 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.3 p -86.95 138.23 31.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.73 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.573 HG21 ' N ' ' A' ' 124' ' ' HIS . 14.0 m -71.94 17.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.611 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.501 ' H ' ' C ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -138.11 -21.07 1.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.747 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.62 ' H ' ' HG ' ' A' ' 86' ' ' SER . 21.3 t -93.18 93.99 8.56 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.141 -176.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 90' ' ' ILE . 10.8 tp -60.57 -8.36 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 176.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.622 ' O ' HG13 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -77.48 -59.55 2.73 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.755 179.181 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.9 p -54.12 -29.39 44.81 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.335 0.588 . . . . 0.0 109.566 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.2 -39.87 47.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.669 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -68.59 -42.98 77.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.263 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 91' ' ' LYS . 2.3 m -67.38 -40.41 84.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.562 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.2 mt -55.05 -43.65 70.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 121.212 -0.195 . . . . 0.0 110.686 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -69.23 -35.03 75.74 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.239 0.543 . . . . 0.0 110.761 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.419 ' O ' ' C ' ' A' ' 99' ' ' ILE . 58.4 t -71.58 -65.63 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.319 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 100' ' ' HIS . 1.4 mp -38.02 -54.38 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.026 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.436 ' N ' HG22 ' A' ' 99' ' ' ILE . 0.9 OUTLIER -46.4 -64.06 0.85 Allowed 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.457 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 100' ' ' HIS . . . -35.14 -58.45 0.8 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.467 ' O ' ' C ' ' A' ' 103' ' ' LEU . 16.5 tptp -69.82 -65.83 0.67 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.355 -0.422 . . . . 0.0 110.992 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.467 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -36.48 -63.02 0.42 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.021 0.438 . . . . 0.0 109.895 179.671 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.7 ' C ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -44.35 -50.83 8.95 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.972 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.481 ' N ' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.76 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.373 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 120.848 0.356 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.482 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -108.57 132.02 21.4 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.569 179.553 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -48.2 123.04 8.32 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.384 1.39 . . . . 0.0 111.901 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.482 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.5 mp -123.91 130.83 73.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 6.7 tpt -128.4 117.27 21.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.793 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 mt -95.83 97.82 9.96 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.1 t -105.5 128.4 59.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 122.136 0.969 . . . . 0.0 111.446 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.448 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -100.25 111.84 4.28 Favored Glycine 0 C--N 1.308 -1.006 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.471 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 53.4 t30 -97.75 173.56 7.05 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.684 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.471 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 5.9 mtpp 61.96 58.38 1.91 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.909 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.534 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 0.5 OUTLIER -60.28 -25.51 65.78 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.568 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -67.53 -9.87 46.5 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.204 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 125' ' ' MET . 11.2 mp -97.2 -25.35 15.32 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.573 ' N ' HG21 ' A' ' 87' ' ' VAL . 2.3 p-80 -36.94 -28.57 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.66 178.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.525 ' N ' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -44.39 -23.14 0.09 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.712 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.477 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -107.66 -40.68 5.24 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.69 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.462 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 22.1 ttm180 24.63 84.33 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.192 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 46.2 t -53.77 -35.35 26.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.308 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.4 tp -88.61 155.92 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.68 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.49 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 89.1 p -100.89 126.68 47.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.682 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -39.54 -33.29 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.796 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.6 mp0 -69.73 -65.3 0.73 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.73 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.49 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 62.4 mt-10 -41.41 -40.12 1.66 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.731 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.69 -37.54 67.25 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 132' ' ' GLU . 4.0 tmtt? -61.15 -55.32 33.71 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.66 -36.34 69.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.77 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.54 -61.78 1.9 Allowed 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.19 -37.36 54.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.109 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.01 -34.83 79.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.597 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.58 -46.4 86.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.891 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.458 ' CZ3' HD22 ' A' ' 104' ' ' LEU . 66.5 m95 -90.58 4.79 50.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.523 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 62.69 31.01 16.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.637 0.732 . . . . 0.0 109.623 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -94.33 167.82 11.29 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.283 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -106.53 132.97 51.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.272 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.703 ' O ' HD22 ' A' ' 146' ' ' LEU . 6.4 t80 -96.89 121.59 38.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.478 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.703 HD22 ' O ' ' A' ' 145' ' ' PHE . 1.6 mm? -134.69 137.36 43.49 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.872 -176.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.462 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 2.4 mt-10 -125.4 111.56 15.27 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.537 ' OG ' HG21 ' A' ' 159' ' ' VAL . 20.8 p -137.43 -176.29 4.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.039 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.0 135.26 34.1 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.063 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.525 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -61.95 -29.47 70.26 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.25 0.548 . . . . 0.0 109.643 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -69.39 0.92 4.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.139 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -141.54 128.51 20.68 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.728 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 156' ' ' ALA . 51.9 t30 -77.52 -54.32 6.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.198 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 153' ' ' ASN . 5.5 mt-30 -36.75 -56.19 0.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.092 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.687 ' O ' HG23 ' A' ' 159' ' ' VAL . 50.5 p -56.14 -42.69 77.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.031 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 153' ' ' ASN . . . -57.7 -61.39 2.55 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.441 0.639 . . . . 0.0 110.196 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 59.7 t -42.55 -40.15 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.582 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -66.74 -36.61 82.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.783 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 155' ' ' THR . 25.7 t -66.14 -41.29 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.007 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.874 ' CZ ' HD11 ' A' ' 164' ' ' ILE . 22.7 t80 -59.66 -65.51 0.66 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.647 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.81 -55.82 2.91 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.789 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -51.83 -31.46 27.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.821 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -66.5 -37.21 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.416 -179.6 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.874 HD11 ' CZ ' ' A' ' 160' ' ' PHE . 15.5 mt -68.97 -31.97 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 121.421 0.629 . . . . 0.0 110.133 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.53 -59.79 4.68 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.719 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 114' ' ' ILE . 6.1 pt-20 -59.24 -30.25 68.12 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.515 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -60.46 -32.24 71.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.442 ' O ' ' OD1' ' A' ' 171' ' ' ASP . 0.0 OUTLIER -71.33 -41.4 69.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.04 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 15.7 tptt -70.19 -58.67 3.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.314 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 170' ' ' ILE . 1.7 mp -55.47 -52.17 49.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.321 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 172' ' ' GLY . 1.6 p-10 -67.58 -26.78 66.44 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.363 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 171' ' ' ASP . . . -60.28 -44.44 97.5 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.38 -67.97 0.46 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.806 0.336 . . . . 0.0 110.497 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.715 -179.795 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 120.974 0.416 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.402 ' NH2' ' OD1' ' A' ' 171' ' ' ASP . 0.0 OUTLIER -139.87 135.97 33.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.457 -179.392 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -104.16 122.39 45.24 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.771 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.7 OUTLIER -104.02 118.54 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-O 121.617 0.722 . . . . 0.0 109.917 -179.068 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.452 ' HB3' ' CE1' ' A' ' 81' ' ' TYR . . . -84.02 134.68 34.62 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 121.191 -0.943 . . . . 0.0 111.339 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.0 mt -95.36 126.88 47.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.705 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.2 tp -127.02 102.0 6.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.499 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -139.21 135.31 7.22 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -53.84 -161.04 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.418 0.628 . . . . 0.0 110.804 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -96.01 130.96 42.87 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.854 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m 67.45 14.6 9.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.748 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.503 ' C ' ' HZ2' ' A' ' 120' ' ' LYS . 7.6 p -76.93 -12.76 14.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.483 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.21 12.35 34.01 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.42 ' NZ ' ' CB ' ' A' ' 19' ' ' LYS . 0.8 OUTLIER -46.82 -48.71 20.77 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.678 0.275 . . . . 0.0 111.122 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.588 ' O ' HD13 ' A' ' 24' ' ' ILE . 1.5 m -76.99 -26.45 53.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.924 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.3 p -68.49 -49.4 59.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.549 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.6 tp -78.15 -30.7 49.37 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.271 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.533 ' O ' HG12 ' A' ' 27' ' ' VAL . 54.1 m -62.59 -47.86 81.95 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.588 HD13 ' O ' ' A' ' 20' ' ' SER . 1.5 mp -68.28 -34.87 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.981 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 150' ' ' ALA . 2.9 tt0 -74.2 -25.39 59.66 Favored 'General case' 0 C--O 1.215 -0.718 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.639 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 1.4 t80 -76.69 -57.97 3.55 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.473 0.654 . . . . 0.0 110.398 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.628 HG13 ' N ' ' A' ' 28' ' ' GLU . 11.5 p -57.17 -49.19 80.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.425 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.628 ' N ' HG13 ' A' ' 27' ' ' VAL . 1.2 tm-20 -80.13 -24.81 40.23 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.463 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 77.75 23.49 66.96 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.822 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.412 ' OE1' ' O ' ' A' ' 31' ' ' PHE . 1.7 pp0? -153.32 138.43 17.34 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 119.345 -0.942 . . . . 0.0 112.72 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.491 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 27.6 t80 . . . . . 0 C--N 1.317 -0.824 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.456 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.419 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 4.2 pt-20 . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 120.599 0.237 . . . . 0.0 110.438 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 1.8 m120 -170.94 179.03 3.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.543 0.687 . . . . 0.0 112.6 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.444 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 0.8 OUTLIER -127.09 145.89 50.57 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.165 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.529 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 7.3 m-85 -133.5 163.75 28.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.991 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.617 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -144.27 149.87 36.99 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.086 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -149.03 112.48 5.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.016 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.607 HD21 ' ND1' ' A' ' 55' ' ' HIS . 6.4 mp -108.02 120.95 43.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.068 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 pp -147.59 165.56 5.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.795 0.331 . . . . 0.0 111.009 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 m -112.46 126.77 55.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.637 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.614 HG23 HH22 ' A' ' 161' ' ' ARG . 7.6 p -124.07 133.83 68.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.809 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 63.5 3.85 1.59 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.114 0.483 . . . . 0.0 109.722 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 103.11 -14.05 55.52 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.459 ' OE1' ' N ' ' A' ' 53' ' ' GLU . 6.5 tp-100 -90.1 141.28 28.84 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.459 ' N ' ' OE1' ' A' ' 52' ' ' GLN . 2.1 mt-10 -76.96 149.89 35.94 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.401 0.619 . . . . 0.0 111.051 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.564 ' CD1' HG12 ' A' ' 49' ' ' VAL . 12.3 m-85 -141.23 124.18 16.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.114 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.671 ' C ' HD12 ' A' ' 56' ' ' LEU . 9.7 t60 -117.69 113.89 22.54 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.671 HD12 ' C ' ' A' ' 55' ' ' HIS . 11.1 mp -120.66 140.81 51.06 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.695 0.76 . . . . 0.0 111.637 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.84 ' C ' HD13 ' A' ' 58' ' ' LEU . 2.6 mt-30 -133.07 123.39 25.68 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.251 -1.341 . . . . 0.0 109.502 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.961 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.89 154.02 31.53 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.04 -178.656 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.92 145.13 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.264 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.66 103.27 10.53 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.708 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 68.8 p . . . . . 0 CA--C 1.51 -0.594 0 CA-C-O 121.769 0.795 . . . . 0.0 110.45 179.717 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 80' ' ' GLY . 31.3 pt . . . . . 0 N--CA 1.438 -1.05 0 CA-C-O 121.586 0.708 . . . . 0.0 112.902 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -152.0 16.76 0.66 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.584 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -157.78 164.07 32.98 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.966 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.452 ' CE1' ' HB3' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -152.29 122.86 7.33 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.672 -0.764 . . . . 0.0 110.589 178.107 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.623 ' O ' HG23 ' A' ' 82' ' ' ILE . 8.8 tt -122.6 98.5 5.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.981 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.37 126.57 42.69 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.174 -178.261 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -95.51 121.03 45.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.845 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.536 ' C ' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -110.06 147.5 33.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.276 -0.874 . . . . 0.0 108.994 179.356 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.688 ' HG ' ' H ' ' A' ' 89' ' ' SER . 0.3 OUTLIER -108.29 144.19 36.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.99 0.424 . . . . 0.0 112.051 -177.615 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.672 HG21 ' N ' ' A' ' 124' ' ' HIS . 14.2 m -81.45 15.86 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.255 179.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.7 -16.1 1.54 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -177.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.688 ' H ' ' HG ' ' A' ' 86' ' ' SER . 28.9 t -112.35 93.5 4.47 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-O 121.378 0.608 . . . . 0.0 110.304 -177.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.408 HD12 ' CG1' ' A' ' 128' ' ' VAL . 4.3 tp -54.84 -13.54 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.787 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.6 OUTLIER -79.1 -45.88 19.15 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.421 178.549 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.1 p -59.05 -46.71 87.56 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.748 ' CZ ' HD13 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -79.14 -32.91 44.55 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 119.0 -1.08 . . . . 0.0 112.215 -178.439 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -66.3 -47.18 74.43 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.908 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 91' ' ' LYS . 34.3 m -65.28 -34.82 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.457 -0.497 . . . . 0.0 109.881 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 mt -60.94 -36.83 74.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.701 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -70.52 -29.26 65.71 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.996 0.427 . . . . 0.0 109.94 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 99' ' ' ILE . 14.0 t -72.23 -66.63 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.4 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.487 HG22 ' N ' ' A' ' 100' ' ' HIS . 1.3 mp -38.55 -60.26 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.612 ' CE1' ' CG ' ' A' ' 141' ' ' TRP . 12.8 t-80 -43.05 -64.9 0.55 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.125 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -36.77 -66.51 0.48 Allowed Glycine 0 CA--C 1.518 0.233 0 CA-C-O 121.521 0.511 . . . . 0.0 112.047 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 103' ' ' LEU . 21.2 tptm -60.92 -61.08 2.84 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.765 -0.717 . . . . 0.0 110.527 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 102' ' ' LYS . 7.4 tp -36.14 -67.24 0.17 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.379 0.609 . . . . 0.0 109.6 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -42.88 -48.62 5.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.57 179.027 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.436 ' N ' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.922 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.456 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.677 ' O ' ' HB2' ' A' ' 174' ' ' ALA . 18.5 mt-30 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.875 0.369 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.6 mt -109.96 134.6 20.64 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.526 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -46.71 109.21 0.19 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.238 1.292 . . . . 0.0 112.295 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.5 mt -123.17 135.75 62.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.543 ' O ' HD12 ' A' ' 83' ' ' LEU . 2.4 tpp -137.65 123.59 20.17 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.394 0.616 . . . . 0.0 110.873 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.499 ' N ' ' SD ' ' A' ' 115' ' ' MET . 5.4 mt -97.88 107.3 19.76 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.623 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.7 t -103.23 127.74 56.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 121.863 0.84 . . . . 0.0 112.181 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.419 ' CA ' ' CE2' ' A' ' 85' ' ' TYR . . . -97.03 103.63 2.92 Favored Glycine 0 C--N 1.311 -0.831 0 N-CA-C 107.816 -2.113 . . . . 0.0 107.816 176.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.468 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.7 t30 -96.8 173.89 7.08 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.049 -177.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.503 ' HZ2' ' C ' ' A' ' 17' ' ' VAL . 7.1 mtpp 63.64 59.29 1.2 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.228 -178.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.432 ' H ' ' HB3' ' A' ' 149' ' ' SER . 0.0 OUTLIER -68.63 0.15 4.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.348 -178.449 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -82.59 -37.32 25.21 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.449 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.813 HD22 ' N ' ' A' ' 123' ' ' LEU . 1.0 OUTLIER -83.87 -18.11 38.58 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.081 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.672 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -39.13 -27.92 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.002 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.504 ' N ' ' O ' ' A' ' 123' ' ' LEU . 9.5 mtt -42.1 -31.27 0.35 Allowed 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.41 ' N ' ' C ' ' A' ' 124' ' ' HIS . 1.3 pt-20 -87.8 -42.41 12.59 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.295 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 124' ' ' HIS . 6.0 tpt85 55.94 72.3 0.5 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.267 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.408 ' CG1' HD12 ' A' ' 90' ' ' ILE . 7.7 t -52.7 -64.35 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.57 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.748 HD13 ' CZ ' ' A' ' 93' ' ' PHE . 10.7 tp -86.89 153.22 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.518 ' HG ' ' HB2' ' A' ' 133' ' ' GLU . 35.8 p -88.24 137.67 32.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.278 0.561 . . . . 0.0 112.343 -178.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -53.5 -33.24 53.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.139 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -69.06 -65.8 0.66 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.194 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.518 ' HB2' ' HG ' ' A' ' 130' ' ' SER . 45.3 mt-10 -42.83 -40.12 2.76 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.63 -35.02 62.67 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 132' ' ' GLU . 3.5 tptm -62.0 -57.29 12.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -55.28 -36.18 65.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.783 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.404 HD21 ' HE1' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -65.45 -61.13 2.28 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.419 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.56 -40.62 62.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.932 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.62 -30.86 71.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.654 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.8 p -63.72 -46.79 83.83 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.965 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.612 ' CG ' ' CE1' ' A' ' 100' ' ' HIS . 34.3 m95 -91.15 -0.58 57.73 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.778 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 3.5 m120 72.5 36.13 1.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.952 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -100.05 163.3 12.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.423 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.538 ' O ' ' SD ' ' A' ' 115' ' ' MET . . . -102.18 128.34 48.72 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.501 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.687 ' O ' HD22 ' A' ' 146' ' ' LEU . 6.2 t80 -98.09 118.43 34.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.755 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.687 HD22 ' O ' ' A' ' 145' ' ' PHE . 2.0 mm? -131.76 126.83 35.41 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -177.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.41 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 1.8 mt-10 -109.12 112.79 25.16 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.13 0.491 . . . . 0.0 110.197 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.516 ' OG ' HG21 ' A' ' 159' ' ' VAL . 4.1 p -136.43 -173.16 3.33 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.647 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.432 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -139.03 141.6 38.26 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.068 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.544 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -65.66 -49.15 69.66 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -49.42 -10.27 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.841 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.477 ' H ' ' C ' ' A' ' 150' ' ' ALA . 23.7 tt0 -129.04 127.27 41.23 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.813 0.339 . . . . 0.0 110.916 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.475 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 52.3 t30 -77.78 -55.43 5.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.116 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 153' ' ' ASN . 10.3 tt0 -37.94 -53.13 1.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.932 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.535 ' O ' HG23 ' A' ' 159' ' ' VAL . 54.9 p -56.74 -41.54 77.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.97 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 153' ' ' ASN . . . -57.38 -62.94 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.624 0.726 . . . . 0.0 109.993 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.1 t -44.95 -37.55 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.443 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -62.29 -42.78 99.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.575 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 155' ' ' THR . 11.9 t -60.06 -45.28 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.696 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.518 ' O ' HG22 ' A' ' 163' ' ' ILE . 53.6 t80 -56.66 -65.38 0.62 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.084 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.614 HH22 HG23 ' A' ' 49' ' ' VAL . 6.1 ttm-85 -41.44 -58.05 2.0 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.178 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.79 -31.65 17.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.755 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.3 OUTLIER -69.18 -34.21 62.16 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.392 -179.758 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.541 HG21 HG21 ' A' ' 49' ' ' VAL . 12.6 mt -63.07 -38.07 81.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.937 0.875 . . . . 0.0 109.102 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -64.72 0.82 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.284 -1.325 . . . . 0.0 111.543 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.71 -33.37 70.11 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.464 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 163' ' ' ILE . . . -58.38 -31.48 67.7 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -67.86 -56.07 10.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.428 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 13.5 tttm -59.03 -63.74 1.19 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.954 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 72.2 mt -47.26 -37.15 4.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.59 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.402 ' OD1' ' NH2' ' A' ' 7' ' ' ARG . 11.6 t70 -69.25 -40.17 78.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.147 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.89 -40.42 57.48 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.37 -77.5 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.329 . . . . 0.0 110.26 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.677 ' HB2' ' O ' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.026 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 121.186 0.517 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.506 ' NH2' ' OD2' ' A' ' 171' ' ' ASP . 12.0 mtt180 -139.94 136.12 33.51 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.784 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.524 ' HB2' HG22 ' A' ' 78' ' ' ILE . 1.5 mttp -105.99 129.49 54.1 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.734 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -101.36 121.28 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-O 121.393 0.616 . . . . 0.0 110.647 -178.435 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.12 135.04 34.96 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.469 -0.77 . . . . 0.0 110.742 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.459 ' O ' HD12 ' A' ' 12' ' ' LEU . 19.9 mt -95.08 128.6 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 CA-C-O 121.759 0.79 . . . . 0.0 111.353 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.546 HD13 ' HE1' ' A' ' 81' ' ' TYR . 1.3 mp -127.26 94.52 4.02 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 113.975 -1.466 . . . . 0.0 110.252 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -140.54 136.01 7.38 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 -179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.494 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.1 OUTLIER -51.69 -161.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.395 0.617 . . . . 0.0 110.823 179.513 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.22 137.46 33.37 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.138 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.5 m 59.78 19.45 8.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.809 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 p -76.05 -21.64 15.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.876 0.369 . . . . 0.0 110.386 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.95 25.39 11.46 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -71.75 -32.09 67.35 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.353 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.433 ' O ' HD13 ' A' ' 24' ' ' ILE . 17.9 m -78.12 -35.83 48.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.777 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.5 p -62.02 -48.3 80.91 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.478 HD12 ' HB3' ' A' ' 25' ' ' GLN . 15.5 tp -63.44 -53.34 53.75 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.656 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.557 ' O ' HG12 ' A' ' 27' ' ' VAL . 50.4 m -38.07 -40.82 0.52 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.433 HD13 ' O ' ' A' ' 20' ' ' SER . 1.3 mp -77.43 -40.8 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.053 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.585 ' OE1' ' N ' ' A' ' 31' ' ' PHE . 3.1 tp-100 -62.65 -41.06 98.84 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.535 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.512 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 0.4 OUTLIER -76.67 -60.7 2.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.169 0.509 . . . . 0.0 111.828 -178.048 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.575 HG13 ' N ' ' A' ' 28' ' ' GLU . 13.2 p -45.51 -44.03 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.037 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.575 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.1 mm-40 -92.01 -23.7 19.45 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.433 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 71.34 26.02 74.26 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -148.99 142.03 24.84 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.585 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.924 177.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 173.93 174.42 0.16 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 119.439 -0.904 . . . . 0.0 113.043 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.14 147.31 32.67 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.291 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -121.58 173.84 7.16 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.428 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.52 161.0 43.0 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -178.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -162.67 110.59 1.31 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.892 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.0 mp -106.9 119.69 40.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.664 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 pp -147.95 166.09 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.663 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.3 m -111.28 126.15 54.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.239 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.724 HG11 HG21 ' A' ' 164' ' ' ILE . 14.9 p -122.06 135.92 60.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.724 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 62.12 3.9 1.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.042 0.449 . . . . 0.0 109.839 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 102.3 -13.31 57.08 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.425 ' OE1' ' N ' ' A' ' 53' ' ' GLU . 7.3 tp-100 -91.49 141.75 28.39 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.425 ' N ' ' OE1' ' A' ' 52' ' ' GLN . 1.8 mt-10 -76.5 146.19 38.65 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.416 0.626 . . . . 0.0 111.229 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.598 ' CD1' HG12 ' A' ' 49' ' ' VAL . 11.7 m-85 -138.71 123.47 18.69 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.142 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.645 ' C ' HD12 ' A' ' 56' ' ' LEU . 1.6 m-70 -117.64 113.92 22.63 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.9 mp -118.72 144.22 46.38 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.617 0.722 . . . . 0.0 112.374 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.781 ' C ' HD13 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -134.1 124.29 25.89 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.09 178.791 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.93 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.65 155.1 30.47 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 120.264 -0.574 . . . . 0.0 112.402 -178.214 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.82 144.82 35.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.408 ' O ' ' OG1' ' A' ' 61' ' ' THR . 0.4 OUTLIER -121.86 124.68 44.7 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.073 178.314 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 60' ' ' ASP . 31.4 p . . . . . 0 CA--C 1.512 -0.506 0 CA-C-O 121.627 0.727 . . . . 0.0 110.381 -179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.524 HG22 ' HB2' ' A' ' 8' ' ' LYS . 31.7 pt . . . . . 0 N--CA 1.427 -1.623 0 CA-C-O 121.286 0.565 . . . . 0.0 112.25 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -153.32 26.81 0.52 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.745 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.435 ' HA3' HD13 ' A' ' 9' ' ' ILE . . . -150.92 165.02 30.13 Favored Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.076 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.546 ' HE1' HD13 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -151.96 124.84 8.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.918 -0.641 . . . . 0.0 111.522 178.077 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.655 ' O ' HG23 ' A' ' 82' ' ' ILE . 12.0 tt -132.89 104.63 7.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.447 0.641 . . . . 0.0 109.693 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.563 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.7 OUTLIER -96.89 124.55 40.9 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.434 -178.52 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -97.86 133.58 39.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.112 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.574 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 26.4 p90 -137.16 145.48 43.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.717 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 89' ' ' SER . 1.0 OUTLIER -87.25 143.88 27.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.697 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.512 HG21 ' N ' ' A' ' 124' ' ' HIS . 17.1 m -71.94 13.42 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.31 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.44 HG22 ' HG ' ' A' ' 86' ' ' SER . 0.6 OUTLIER -135.13 -19.28 1.74 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.911 0.386 . . . . 0.0 111.737 -178.872 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.52 ' C ' ' N ' ' A' ' 91' ' ' LYS . 23.0 t -89.28 92.65 9.25 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.05 -176.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.74 -9.69 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 176.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.78 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -76.86 -53.21 8.19 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.284 178.278 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.422 ' O ' HD12 ' A' ' 96' ' ' ILE . 25.6 p -59.6 -34.21 72.46 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.289 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.574 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -72.06 -56.71 5.15 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.173 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.502 ' O ' HG23 ' A' ' 98' ' ' VAL . 4.6 mm-40 -63.22 -40.51 97.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.031 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 91' ' ' LYS . 17.0 m -68.85 -33.95 61.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.676 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.422 HD12 ' O ' ' A' ' 92' ' ' SER . 2.4 mt -65.17 -40.86 90.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.335 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -70.22 -29.12 65.86 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.043 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 94' ' ' GLU . 54.1 t -74.84 -66.92 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.6 mm -41.76 -66.09 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.532 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.474 ' CE1' HD23 ' A' ' 104' ' ' LEU . 8.6 t-80 -42.24 -64.98 0.51 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.192 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 100' ' ' HIS . . . -35.06 -65.31 0.41 Allowed Glycine 0 CA--C 1.517 0.175 0 CA-C-O 121.337 0.41 . . . . 0.0 112.357 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 14.8 tptm -67.97 -63.53 1.04 Allowed 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.071 -0.565 . . . . 0.0 111.189 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.492 HD13 ' O ' ' A' ' 103' ' ' LEU . 0.5 OUTLIER -36.05 -58.3 0.66 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.047 0.451 . . . . 0.0 110.146 -179.426 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.698 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -51.39 -51.32 55.75 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.872 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.475 ' N ' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.313 -1.019 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.263 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.403 ' HB3' HG23 ' A' ' 170' ' ' ILE . 26.6 mt-30 . . . . . 0 CA--C 1.52 -0.189 0 CA-C-O 120.955 0.407 . . . . 0.0 110.472 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.642 ' C ' HG21 ' A' ' 170' ' ' ILE . 1.1 pt -117.64 150.39 46.75 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.17 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -45.03 121.03 3.28 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.716 1.611 . . . . 0.0 112.014 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.472 ' HB ' ' HB2' ' A' ' 143' ' ' ALA . 1.4 mt -125.0 126.0 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.403 ' CE ' HD23 ' A' ' 146' ' ' LEU . 7.4 tpt -127.15 117.68 22.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.773 -178.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mt -96.19 97.91 9.91 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.0 t -105.07 126.57 60.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 122.249 1.023 . . . . 0.0 111.294 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.43 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -97.83 107.81 3.53 Favored Glycine 0 C--N 1.308 -1.005 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.512 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 52.6 t30 -97.26 176.74 5.8 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.662 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.512 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 41.2 mttt 62.75 60.76 1.25 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.689 0.757 . . . . 0.0 108.977 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.433 ' H ' ' HB3' ' A' ' 149' ' ' SER . 16.1 tttm -67.01 -24.12 65.99 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -73.91 2.47 8.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 118.751 -1.179 . . . . 0.0 111.545 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 126' ' ' GLU . 8.1 mp -94.39 -25.77 16.8 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 176.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.55 ' C ' ' N ' ' A' ' 126' ' ' GLU . 7.6 t60 -27.12 -38.63 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.403 1.065 . . . . 0.0 111.457 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.515 ' N ' ' O ' ' A' ' 123' ' ' LEU . 2.8 mmt -46.98 -16.41 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.851 0.834 . . . . 0.0 108.777 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 123' ' ' LEU . 21.1 mm-40 -98.41 -57.53 2.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.994 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.466 ' CZ ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER 32.81 67.77 0.16 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.458 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.9 m -61.55 -32.1 52.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.828 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.5 tp -88.93 154.97 3.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.474 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.502 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 92.7 p -103.02 129.09 49.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.242 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -42.18 -35.32 0.92 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.564 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.6 mt-10 -66.34 -65.54 0.67 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.052 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.502 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 63.6 mt-10 -41.29 -41.43 1.9 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.925 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.08 -35.91 64.33 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 132' ' ' GLU . 15.4 tttm -62.34 -54.94 33.15 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.066 -0.567 . . . . 0.0 109.601 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.87 69.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.561 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.73 -60.75 2.57 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -54.54 -36.66 64.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.422 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -68.37 -31.77 71.39 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.1 p -63.88 -46.5 84.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.855 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -89.23 -3.53 58.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.935 0.398 . . . . 0.0 110.315 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 76.18 23.35 1.25 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.72 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -90.59 168.13 12.04 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.83 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.41 134.13 50.91 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.045 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.621 ' O ' HD22 ' A' ' 146' ' ' LEU . 5.7 t80 -96.51 122.53 39.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.739 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.747 HD12 HG22 ' A' ' 159' ' ' VAL . 1.1 mm? -134.55 136.95 43.41 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.603 -176.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.466 ' CD ' ' CZ ' ' A' ' 127' ' ' ARG . 5.8 tt0 -123.48 112.23 17.25 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 24.2 p -138.99 -177.16 4.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.052 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.433 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -139.91 130.4 25.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.087 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 152' ' ' GLU . . . -49.24 -64.87 0.68 Allowed 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 150' ' ' ALA . 40.4 tttm -33.88 -30.7 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.217 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 150' ' ' ALA . 34.3 mt-10 -111.71 103.63 11.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.57 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -64.9 -49.4 70.6 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.345 -179.712 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' A' ' 153' ' ' ASN . 15.7 mt-30 -37.27 -53.32 1.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.883 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.693 ' O ' HG23 ' A' ' 159' ' ' VAL . 80.8 p -58.16 -40.45 81.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.726 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 153' ' ' ASN . . . -58.2 -61.85 2.26 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.439 0.638 . . . . 0.0 109.978 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 55.1 t -41.32 -41.67 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.719 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.65 -39.53 93.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.528 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.747 HG22 HD12 ' A' ' 146' ' ' LEU . 29.5 t -63.04 -37.52 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.018 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.718 ' CE2' HD11 ' A' ' 164' ' ' ILE . 52.6 t80 -61.41 -65.18 0.73 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.753 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.45 -53.79 3.29 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.985 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -29.79 65.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.846 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.491 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -67.9 -33.89 64.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.387 -179.551 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.724 HG21 HG11 ' A' ' 49' ' ' VAL . 41.7 mt -69.85 -36.53 69.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 121.594 0.711 . . . . 0.0 109.784 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.28 -65.12 0.74 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.862 -178.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -58.06 -33.51 69.1 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.531 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 163' ' ' ILE . . . -58.17 -31.55 67.37 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -68.44 -57.11 6.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.617 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -54.88 -64.84 0.71 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.844 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.642 HG21 ' C ' ' A' ' 112' ' ' ILE . 96.6 mt -50.57 -34.51 12.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.007 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.506 ' OD2' ' NH2' ' A' ' 7' ' ' ARG . 1.2 t70 -67.26 -40.05 86.19 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -57.91 -31.88 65.39 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.37 -79.14 0.06 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 -0.12 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.86 179.689 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 121.35 0.595 . . . . 0.0 110.54 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.509 ' NH2' ' OD2' ' A' ' 171' ' ' ASP . 0.0 OUTLIER -139.72 135.5 33.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.233 179.836 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.543 ' HB2' HG22 ' A' ' 78' ' ' ILE . 32.6 mttt -109.09 129.23 55.47 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.751 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.9 OUTLIER -102.96 125.06 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-O 121.282 0.563 . . . . 0.0 110.967 -177.824 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.03 133.08 34.68 Favored 'General case' 0 C--O 1.218 -0.566 0 O-C-N 121.463 -0.773 . . . . 0.0 111.303 -178.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.2 mt -95.81 133.97 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 121.795 0.807 . . . . 0.0 112.307 -179.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tp -130.45 102.26 6.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.339 -1.301 . . . . 0.0 110.627 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.67 135.75 6.97 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.4 OUTLIER -53.87 -164.44 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.349 0.595 . . . . 0.0 110.417 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.42 ' NH1' ' OG ' ' A' ' 16' ' ' SER . 9.1 ttt-85 -98.7 134.04 42.17 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.92 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.522 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 1.3 m 67.47 19.85 9.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.572 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 p -87.3 -15.25 9.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.685 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.34 10.53 35.98 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -41.79 -55.53 2.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.015 0.436 . . . . 0.0 110.718 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -69.47 -31.13 69.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.386 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 m -58.08 -44.03 87.35 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.117 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.7 tp -77.63 -48.41 16.91 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.167 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.507 ' O ' HG12 ' A' ' 27' ' ' VAL . 86.9 m -45.68 -54.67 7.45 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.547 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.455 HD11 ' CE2' ' A' ' 43' ' ' PHE . 1.4 mp -59.49 -42.61 88.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.079 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.751 HE21 ' HB2' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -65.09 -33.39 75.91 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.919 -179.301 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.464 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 1.6 t80 -76.83 -62.29 1.69 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.265 0.555 . . . . 0.0 111.858 -178.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.586 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.9 p -48.6 -46.46 15.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.597 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.586 ' N ' HG13 ' A' ' 27' ' ' VAL . 12.4 mt-10 -85.33 -24.1 27.79 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.35 43.73 45.02 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.604 ' C ' HD22 ' A' ' 153' ' ' ASN . 0.0 OUTLIER -136.72 -174.22 3.65 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.566 0.698 . . . . 0.0 110.368 -179.572 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.611 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.494 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.717 178.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.517 -0.313 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -165.6 179.01 6.3 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 119.653 -0.819 . . . . 0.0 113.06 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.51 145.91 51.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.879 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.455 ' CE2' HD11 ' A' ' 24' ' ' ILE . 13.6 m-85 -129.08 166.48 19.18 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.724 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.574 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -146.89 153.28 39.95 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.565 -178.37 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.597 ' C ' HD12 ' A' ' 46' ' ' LEU . 29.4 tptt -156.82 112.03 2.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.455 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.74 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.7 mp -106.48 120.29 41.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.663 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.72 HD12 ' CZ ' ' A' ' 160' ' ' PHE . 0.8 OUTLIER -146.65 165.71 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.622 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 m -111.34 128.46 55.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.359 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.861 HG11 HG21 ' A' ' 164' ' ' ILE . 5.9 p -127.31 135.66 62.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.529 ' CG ' HG22 ' A' ' 49' ' ' VAL . 2.8 m120 63.16 12.83 6.36 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.28 -11.54 69.35 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -90.45 139.16 30.94 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -76.71 145.15 38.87 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.638 0.733 . . . . 0.0 111.32 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.552 ' CE2' HG23 ' A' ' 164' ' ' ILE . 10.3 m-85 -137.08 122.83 19.92 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.995 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.652 ' C ' HD12 ' A' ' 56' ' ' LEU . 66.6 m170 -116.9 113.61 22.7 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.652 HD12 ' C ' ' A' ' 55' ' ' HIS . 11.0 mp -119.57 143.4 47.64 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.657 0.741 . . . . 0.0 112.214 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.731 ' C ' HD13 ' A' ' 58' ' ' LEU . 2.4 mt-30 -135.32 124.86 25.04 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.698 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.916 HD22 ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.83 154.5 30.62 Favored 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 120.034 -0.666 . . . . 0.0 112.218 -178.452 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.17 145.93 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.87 -178.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.73 103.31 8.78 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.049 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.1 p . . . . . 0 N--CA 1.446 -0.634 0 CA-C-O 121.773 0.797 . . . . 0.0 111.562 -179.147 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.543 HG22 ' HB2' ' A' ' 8' ' ' LYS . 29.1 pt . . . . . 0 N--CA 1.438 -1.032 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -151.84 17.86 0.69 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.197 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -146.65 166.57 28.25 Favored Glycine 0 CA--C 1.518 0.232 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.38 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.68 121.69 7.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.951 -0.624 . . . . 0.0 110.763 178.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 82' ' ' ILE . 10.0 tt -123.9 103.31 12.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.97 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -95.9 131.95 41.71 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.456 -0.897 . . . . 0.0 110.447 -178.266 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.483 ' O ' ' CD1' ' A' ' 96' ' ' ILE . 1.2 t -92.34 130.87 40.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.963 -178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -108.04 143.21 37.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.978 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.541 ' OG ' HG22 ' A' ' 88' ' ' THR . 47.8 t -109.88 130.21 55.55 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.889 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.547 HG21 ' N ' ' A' ' 124' ' ' HIS . 14.1 m -81.34 18.35 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.004 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.541 HG22 ' OG ' ' A' ' 86' ' ' SER . 1.4 t -143.54 -3.3 0.92 Allowed 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -177.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.495 ' C ' ' N ' ' A' ' 91' ' ' LYS . 1.0 OUTLIER -134.31 97.94 3.97 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 119.416 -0.914 . . . . 0.0 112.843 -175.566 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.569 HG22 ' HG3' ' A' ' 94' ' ' GLU . 18.1 mm -56.13 -10.9 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 114.155 -1.384 . . . . 0.0 107.859 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.729 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -79.13 -42.03 27.2 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.091 178.686 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.62 -47.49 75.46 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.051 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.742 ' CD2' HD13 ' A' ' 129' ' ' ILE . 0.1 OUTLIER -76.3 -35.39 58.86 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 119.105 -1.038 . . . . 0.0 112.186 -178.034 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.569 ' HG3' HG22 ' A' ' 90' ' ' ILE . 14.0 mm-40 -66.46 -47.95 71.48 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.901 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 91' ' ' LYS . 32.6 m -64.17 -37.49 80.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.023 0.439 . . . . 0.0 110.292 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.483 ' CD1' ' O ' ' A' ' 84' ' ' VAL . 31.8 mt -69.02 -31.28 49.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.887 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.73 -26.42 63.38 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.18 0.514 . . . . 0.0 109.709 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 7.3 t -70.44 -64.98 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.755 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.482 HG23 ' N ' ' A' ' 100' ' ' HIS . 1.8 tt -43.29 -47.95 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.647 178.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.58 ' NE2' ' CD1' ' A' ' 141' ' ' TRP . 15.1 t-80 -44.96 -64.79 0.63 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.852 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -39.43 -57.44 2.24 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 111.931 -0.468 . . . . 0.0 111.931 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 105' ' ' ASP . 13.5 tptp -62.96 -65.77 0.64 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.177 -0.511 . . . . 0.0 111.061 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.476 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -36.52 -56.69 0.8 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.731 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.73 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -46.34 -47.66 18.49 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.635 178.522 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.825 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.317 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.44 ' HB3' HG23 ' A' ' 170' ' ' ILE . 27.3 mt-30 . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.882 0.372 . . . . 0.0 111.086 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.627 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.5 OUTLIER -136.17 154.6 77.45 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.407 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -49.89 110.14 0.35 Allowed 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.772 1.648 . . . . 0.0 112.546 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.485 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.2 mp -121.67 127.84 75.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.574 ' O ' HD12 ' A' ' 83' ' ' LEU . 7.2 tpt -130.68 115.84 17.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.669 -178.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' A' ' 138' ' ' ALA . 28.2 mt -96.71 97.52 9.41 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.8 t -105.64 130.34 57.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.632 0.729 . . . . 0.0 110.977 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -102.02 116.33 5.49 Favored Glycine 0 C--N 1.306 -1.136 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.487 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.7 t30 -97.04 173.92 7.02 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.557 -178.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.522 ' NZ ' ' O ' ' A' ' 16' ' ' SER . 18.0 mttt 60.2 58.25 2.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.545 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 20.5 tttm -63.76 -29.5 70.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.955 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -70.96 -6.8 41.48 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.953 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 125' ' ' MET . 8.6 mp -94.31 -29.85 14.83 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.547 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.9 OUTLIER -38.61 -24.79 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.927 177.914 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.534 ' N ' ' O ' ' A' ' 123' ' ' LEU . 19.1 mtp -44.73 -24.11 0.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.472 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.3 OUTLIER -101.83 -37.63 8.19 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.33 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.425 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 1.2 tpt180 37.08 87.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.794 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.5 m -80.22 -32.36 13.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.15 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.742 HD13 ' CD2' ' A' ' 93' ' ' PHE . 11.1 tp -91.23 154.7 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.21 178.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.434 ' OG ' ' OE1' ' A' ' 133' ' ' GLU . 6.5 p -97.36 134.37 40.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.424 0.631 . . . . 0.0 112.226 -178.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -58.42 -30.63 67.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.095 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mp0 -68.53 -65.66 0.67 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.989 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.434 ' OE1' ' OG ' ' A' ' 130' ' ' SER . 43.5 mt-10 -41.42 -41.26 1.98 Allowed 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.83 -36.33 65.93 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 132' ' ' GLU . 3.5 tttm -60.92 -55.72 29.6 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.56 -33.98 66.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.289 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.61 -62.94 1.23 Allowed 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.832 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 143' ' ' ALA . . . -54.27 -33.67 59.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.655 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.43 -38.15 80.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.703 0.287 . . . . 0.0 110.872 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.41 -47.43 79.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.428 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.58 ' CD1' ' NE2' ' A' ' 100' ' ' HIS . 23.7 m95 -91.64 2.68 56.3 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.352 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 13.4 m120 60.67 35.56 19.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.099 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.507 ' O ' ' HB1' ' A' ' 138' ' ' ALA . . . -92.05 166.71 12.54 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.946 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -103.29 125.5 49.96 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.052 -0.659 . . . . 0.0 112.012 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.418 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 6.7 t80 -98.13 121.22 39.79 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.977 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.31 125.98 15.1 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.418 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.425 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 11.7 tt0 -102.01 110.8 22.86 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.406 ' OG ' HG21 ' A' ' 159' ' ' VAL . 0.1 OUTLIER -123.07 -176.52 3.44 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.245 -178.787 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.85 138.9 37.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.524 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -71.88 -11.22 60.69 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.476 0.655 . . . . 0.0 109.361 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.54 -5.57 59.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.004 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.61 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 51.9 mt-10 -138.97 125.91 21.06 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.474 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.604 HD22 ' C ' ' A' ' 30' ' ' GLN . 65.3 m-20 -75.51 -48.43 22.55 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 153' ' ' ASN . 1.7 mt-30 -36.54 -56.88 0.79 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.998 0.427 . . . . 0.0 110.716 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.719 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.2 p -52.57 -47.8 66.6 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.354 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.751 ' HB2' HE21 ' A' ' 25' ' ' GLN . . . -55.38 -60.35 3.53 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.338 0.589 . . . . 0.0 110.178 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.1 t -41.98 -40.75 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.403 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.3 -32.53 72.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.994 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 155' ' ' THR . 22.0 t -73.78 -36.53 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 121.038 0.447 . . . . 0.0 109.996 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.793 ' CZ ' HD11 ' A' ' 164' ' ' ILE . 25.5 t80 -69.22 -35.63 76.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.038 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.478 HH22 HG23 ' A' ' 49' ' ' VAL . 23.9 ttm-85 -77.4 -45.21 26.6 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.135 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -34.39 74.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.067 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.479 HG23 ' N ' ' A' ' 164' ' ' ILE . 14.0 tt -68.83 -50.46 54.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.365 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.861 HG21 HG11 ' A' ' 49' ' ' VAL . 86.5 mt -50.76 -33.63 12.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 119.064 -1.055 . . . . 0.0 108.885 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.93 -63.61 1.16 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.861 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -57.77 -29.08 64.54 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -60.63 -32.52 71.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.413 ' OE1' ' OH ' ' A' ' 54' ' ' TYR . 1.7 tp10 -68.93 -57.79 5.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.315 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -53.61 -62.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.689 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.627 HG21 ' C ' ' A' ' 112' ' ' ILE . 74.7 mt -51.89 -34.33 16.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.011 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.509 ' OD2' ' NH2' ' A' ' 7' ' ' ARG . 1.9 t70 -69.64 -38.49 77.19 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.679 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -63.21 -35.41 92.04 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.98 -65.48 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.348 . . . . 0.0 110.686 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.691 -179.928 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.177 0.513 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.732 ' NH2' ' HB1' ' A' ' 167' ' ' ALA . 23.2 mtm180 -139.94 136.79 34.2 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.724 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.494 ' HB2' HG22 ' A' ' 78' ' ' ILE . 6.2 mttm -106.25 130.07 54.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.774 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.9 OUTLIER -103.28 123.49 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-O 121.493 0.664 . . . . 0.0 110.49 -178.315 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.53 134.38 34.42 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.304 -0.872 . . . . 0.0 111.325 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.2 mt -95.51 127.66 47.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.38 0.61 . . . . 0.0 111.65 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.617 HD22 HG21 ' A' ' 99' ' ' ILE . 13.0 tp -127.5 99.35 5.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.522 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -142.07 136.09 7.08 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.814 -178.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.1 OUTLIER -49.31 -177.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.217 0.532 . . . . 0.0 110.662 179.002 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -74.46 140.85 44.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.816 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.519 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 9.4 m 53.17 19.63 1.53 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.609 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.2 p -68.64 -17.13 21.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.417 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.429 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 103.82 29.25 5.62 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.7 mtmm -64.61 -62.49 1.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 110.369 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.504 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.9 OUTLIER -55.96 -28.35 56.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.619 -179.149 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 94.6 p -68.2 -50.73 52.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.792 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.1 tp -77.4 -26.45 51.77 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.913 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.622 ' O ' HG12 ' A' ' 27' ' ' VAL . 33.9 m -60.32 -43.33 96.48 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.504 HD13 ' O ' ' A' ' 20' ' ' SER . 1.2 mp -77.89 -42.74 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.729 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.534 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -67.02 -32.13 73.14 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.358 -179.045 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -77.71 -62.59 1.62 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.374 0.607 . . . . 0.0 111.404 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 23' ' ' THR . 14.4 p -48.01 -47.52 12.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.268 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.612 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.2 tm-20 -83.53 -24.6 31.58 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.32 28.74 67.39 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.525 ' CA ' HD21 ' A' ' 153' ' ' ASN . 0.1 OUTLIER -144.94 125.67 14.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.07 0.462 . . . . 0.0 111.861 -178.643 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.516 ' CG ' ' O ' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -72.97 94.11 1.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.346 178.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.642 HG22 ' N ' ' A' ' 33' ' ' ASP . 13.6 p -96.7 167.3 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.892 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.642 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -37.05 -50.85 0.93 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.919 -179.657 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 33' ' ' ASP . 7.0 p 33.21 96.28 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.431 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -150.68 41.87 0.79 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.599 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.427 ' O ' ' O ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -95.09 172.77 5.05 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.083 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 36' ' ' ASP . 44.6 Cg_exo -57.33 -139.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.507 2.138 . . . . 0.0 111.881 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.714 HG23 ' O ' ' A' ' 38' ' ' THR . 10.6 t -130.28 62.89 1.57 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.697 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 tp -82.94 144.81 9.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.282 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.11 148.49 23.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.258 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -178.68 174.05 1.22 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.509 0.671 . . . . 0.0 112.43 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.548 HG23 HG23 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -108.25 137.23 46.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.357 179.61 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -122.09 167.19 13.44 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.714 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -146.41 148.05 31.9 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.38 0.609 . . . . 0.0 112.319 -179.164 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.5 tttp -147.11 112.44 5.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.968 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.498 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.0 mp -106.44 120.28 41.5 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.095 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.812 HD12 ' H ' ' A' ' 47' ' ' ILE . 0.4 OUTLIER -145.47 165.31 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.42 -179.687 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.3 m -115.92 124.96 51.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.489 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.586 ' O ' HG13 ' A' ' 49' ' ' VAL . 13.2 p -119.45 117.63 54.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.734 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.563 ' OD1' HG22 ' A' ' 49' ' ' VAL . 0.8 OUTLIER 69.83 26.06 4.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.025 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.61 -9.41 55.7 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -89.99 132.04 35.57 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.96 145.58 40.25 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.621 0.724 . . . . 0.0 111.352 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.666 ' CE2' HG23 ' A' ' 164' ' ' ILE . 5.5 m-85 -136.53 122.36 19.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.949 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.573 ' C ' HD12 ' A' ' 56' ' ' LEU . 67.3 m170 -117.2 112.7 21.19 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.573 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.4 mp -119.19 142.85 47.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.517 0.675 . . . . 0.0 111.831 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.743 ' C ' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -133.14 121.52 22.71 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.957 178.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.892 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.84 154.42 30.77 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 120.098 -0.641 . . . . 0.0 112.219 -178.286 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.548 HG23 HG23 ' A' ' 42' ' ' THR . 0.3 OUTLIER -128.14 144.87 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.686 -179.503 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.05 107.48 12.68 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.872 -1.513 . . . . 0.0 108.178 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.94 160.03 39.86 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.12 0.486 . . . . 0.0 110.479 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 63' ' ' GLY . . . -144.79 34.37 1.13 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.959 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 62' ' ' ALA . . . -23.52 -77.12 0.01 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 123.862 0.726 . . . . 0.0 112.37 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -123.26 -79.52 0.61 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.378 0.609 . . . . 0.0 110.759 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 67' ' ' TYR . 2.7 t70 -76.64 -178.1 4.57 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.49 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.607 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 20.1 mp0 -45.2 -16.2 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.574 ' CG ' ' O ' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -175.56 -4.81 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.531 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 67' ' ' TYR . 1.8 m 52.49 119.86 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.338 0.59 . . . . 0.0 112.39 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.78 HD12 ' N ' ' A' ' 69' ' ' ILE . 1.6 mp -85.09 -39.52 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.991 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.26 158.49 79.42 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.974 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -41.56 123.24 2.11 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.609 2.206 . . . . 0.0 112.39 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.447 ' O ' ' CB ' ' A' ' 73' ' ' THR . 1.9 tt0 -174.59 50.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.031 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.447 ' CB ' ' O ' ' A' ' 72' ' ' GLN . 0.2 OUTLIER 77.34 -6.67 1.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.392 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.49 ' CD2' ' O ' ' A' ' 67' ' ' TYR . 25.8 m-85 -90.11 8.94 30.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.429 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 76' ' ' ILE . 8.7 p -81.65 28.7 0.4 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.744 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.478 ' HB ' HG23 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -51.87 -170.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.138 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 3.4 p-10 -132.52 49.8 2.29 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.204 0.526 . . . . 0.0 109.816 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.494 HG22 ' HB2' ' A' ' 8' ' ' LYS . 33.5 pt -80.13 -174.14 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.051 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -150.75 17.62 0.79 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.142 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.489 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -146.94 165.92 28.45 Favored Glycine 0 CA--C 1.516 0.143 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.584 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.1 122.4 7.23 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.956 -0.622 . . . . 0.0 110.812 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.614 ' O ' HG23 ' A' ' 82' ' ' ILE . 10.7 tt -125.54 103.38 11.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.803 ' N ' HD23 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -96.28 125.82 41.06 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.737 -178.22 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.476 ' O ' HD11 ' A' ' 96' ' ' ILE . 1.8 t -95.7 119.25 43.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.808 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.481 ' C ' ' CD1' ' A' ' 85' ' ' TYR . 4.1 p90 -109.7 145.41 36.61 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.421 ' OG ' ' N ' ' A' ' 89' ' ' SER . 0.8 OUTLIER -101.85 143.62 31.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.064 0.459 . . . . 0.0 111.752 -178.075 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.597 HG21 ' N ' ' A' ' 124' ' ' HIS . 17.8 m -80.49 20.45 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.23 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.7 t -141.92 -15.94 0.79 Allowed 'General case' 0 C--O 1.232 0.141 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.538 ' C ' ' N ' ' A' ' 91' ' ' LYS . 38.8 t -113.71 94.21 4.74 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -176.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.524 HG22 ' CD ' ' A' ' 94' ' ' GLU . 22.5 mm -52.8 -14.74 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 176.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.775 ' O ' HG22 ' A' ' 95' ' ' VAL . 9.6 mttp -78.22 -46.61 19.95 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.192 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.0 p -61.9 -45.48 93.55 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.575 ' CE2' HD13 ' A' ' 129' ' ' ILE . 0.1 OUTLIER -77.64 -37.27 50.36 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 119.248 -0.981 . . . . 0.0 112.652 -177.831 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.524 ' CD ' HG22 ' A' ' 90' ' ' ILE . 88.5 mt-10 -67.81 -43.89 78.59 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.43 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.775 HG22 ' O ' ' A' ' 91' ' ' LYS . 30.7 m -66.04 -38.16 81.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.85 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.476 HD11 ' O ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -58.92 -39.42 77.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.632 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -69.45 -26.75 64.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.126 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 94' ' ' GLU . 60.9 t -77.29 -66.91 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.785 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.617 HG21 HD22 ' A' ' 12' ' ' LEU . 1.7 mp -41.07 -38.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.028 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -64.4 -64.92 0.76 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.617 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.52 -57.75 1.46 Allowed Glycine 0 CA--C 1.517 0.212 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 105' ' ' ASP . 12.7 tptp -62.9 -64.72 0.83 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.915 -0.643 . . . . 0.0 110.713 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.481 ' CD1' ' OH ' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -36.95 -60.17 0.65 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.734 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.747 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -46.43 -48.07 18.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.471 178.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -60.1 -31.4 70.0 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.419 -179.237 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.447 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 58.2 ttp -73.16 -51.34 18.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.42 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.654 HG23 ' H ' ' A' ' 109' ' ' LYS . 6.7 m -75.48 -24.58 17.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.508 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.03 35.28 0.96 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.654 ' H ' HG23 ' A' ' 107' ' ' VAL . 7.7 ttmt -93.33 -155.15 0.43 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.154 0.502 . . . . 0.0 111.555 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 110' ' ' VAL . 0.0 OUTLIER -96.55 -171.39 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.94 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.413 ' HB3' HG23 ' A' ' 170' ' ' ILE . 61.7 mt-30 -66.79 118.59 10.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.839 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.716 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.8 OUTLIER -115.04 150.35 44.08 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.21 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -48.2 111.7 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.516 1.478 . . . . 0.0 112.32 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.486 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.5 mp -120.99 128.99 76.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 8.7 tpt -129.17 115.45 17.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.76 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mt -96.84 97.77 9.57 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.0 t -102.48 134.06 44.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 122.442 1.115 . . . . 0.0 110.471 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 146' ' ' LEU . . . -101.32 111.73 4.19 Favored Glycine 0 C--N 1.297 -1.595 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.478 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 46.3 t30 -96.95 173.72 7.14 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.415 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.478 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 24.4 mttt 59.57 58.59 2.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.507 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.418 ' H ' ' HB3' ' A' ' 149' ' ' SER . 32.0 tttm -64.41 -35.47 81.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.412 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.444 ' CG ' HN21 ' A' ' 186' ' ' GDP . 6.1 p-10 -60.32 -10.6 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.04 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 125' ' ' MET . 9.1 mp -90.69 -29.93 17.42 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.597 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.7 OUTLIER -40.13 -23.97 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.889 178.499 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.519 ' N ' ' O ' ' A' ' 123' ' ' LEU . 3.6 mmt -45.24 -24.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.44 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -101.36 -37.81 8.31 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.068 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.41 ' NH1' ' OE2' ' A' ' 147' ' ' GLU . 1.9 tpt180 38.91 88.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.082 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.474 HG23 ' N ' ' A' ' 129' ' ' ILE . 17.0 m -78.84 -38.21 20.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.586 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.575 HD13 ' CE2' ' A' ' 93' ' ' PHE . 6.7 tp -90.5 153.52 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.562 ' HG ' ' HB2' ' A' ' 133' ' ' GLU . 18.2 p -94.87 137.16 34.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.274 0.559 . . . . 0.0 112.087 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -54.95 -32.59 61.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.215 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -68.32 -65.83 0.65 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.964 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.562 ' HB2' ' HG ' ' A' ' 130' ' ' SER . 41.0 mt-10 -42.09 -40.93 2.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.622 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.11 -34.29 64.74 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 132' ' ' GLU . 24.1 tttm -64.07 -55.5 21.68 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -55.6 -33.75 64.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.25 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.646 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -65.53 -62.99 1.2 Allowed 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.702 179.429 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -54.69 -34.99 63.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.364 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.56 -30.11 67.84 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.4 p -64.3 -46.8 81.99 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.742 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.646 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 21.9 m95 -88.94 -5.71 57.78 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.089 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.4 ' O ' ' OE2' ' A' ' 166' ' ' GLU . 0.8 OUTLIER 75.91 25.49 1.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.703 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -89.24 169.16 11.69 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.894 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.47 133.81 49.61 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.214 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.633 ' O ' HD22 ' A' ' 146' ' ' LEU . 6.6 t80 -96.83 122.49 39.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.005 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.829 HD12 HG22 ' A' ' 159' ' ' VAL . 1.3 mm? -132.95 139.5 47.34 Favored 'General case' 0 C--O 1.209 -1.054 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.63 -176.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.41 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 5.5 tt0 -129.04 111.28 12.81 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 58.9 p -138.66 -177.15 4.74 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.734 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.418 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -138.4 140.17 39.26 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.086 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -59.68 -43.07 94.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.157 0.503 . . . . 0.0 109.69 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.0 ttpp -65.38 5.64 0.38 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.381 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 150' ' ' ALA . 3.4 tt0 -136.47 120.02 17.08 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.721 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.525 HD21 ' CA ' ' A' ' 30' ' ' GLN . 3.6 m120 -77.57 -56.86 4.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.961 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 153' ' ' ASN . 9.1 tt0 -36.97 -58.23 0.78 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.893 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 159' ' ' VAL . 66.3 p -52.14 -50.16 62.29 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.126 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.534 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -49.75 -60.31 3.01 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.418 0.628 . . . . 0.0 109.717 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.1 t -40.92 -50.35 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.986 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -53.96 -32.6 54.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.661 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.829 HG22 HD12 ' A' ' 146' ' ' LEU . 12.7 t -75.92 -26.74 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.247 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -71.45 -39.92 70.66 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.462 179.321 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.603 ' N ' ' CD1' ' A' ' 160' ' ' PHE . 36.2 ttm-85 -79.48 -47.73 15.12 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.163 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.6 mmm180 -57.75 -37.57 73.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.11 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.628 HG23 ' N ' ' A' ' 164' ' ' ILE . 11.6 tt -69.74 -58.18 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.438 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.666 HG23 ' CE2' ' A' ' 54' ' ' TYR . 91.3 mt -46.2 -35.02 2.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.88 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -64.82 0.82 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.027 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.4 ' OE2' ' O ' ' A' ' 142' ' ' ASN . 2.1 tt0 -54.6 -37.99 66.22 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.732 ' HB1' ' NH2' ' A' ' 7' ' ' ARG . . . -49.56 -35.54 20.82 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -68.06 -52.65 32.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.085 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 3.6 ttpp -54.5 -61.07 2.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.529 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.716 HG21 ' C ' ' A' ' 112' ' ' ILE . 33.7 mm -49.98 -32.98 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.62 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -39.59 89.05 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.102 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -61.9 -34.09 87.63 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.96 -80.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.67 0.271 . . . . 0.0 110.323 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 -0.141 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.817 179.824 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GDP . . . . . 0.519 " H5'" ' HA ' ' A' ' 16' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 121.352 0.596 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.69 135.41 33.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.256 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.548 ' HB2' HG22 ' A' ' 78' ' ' ILE . 8.1 mttm -107.73 127.59 53.82 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.733 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.9 OUTLIER -100.96 122.27 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 121.702 0.763 . . . . 0.0 110.808 -177.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.28 135.24 34.41 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.498 -0.751 . . . . 0.0 110.882 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.4 mt -96.97 131.74 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.554 0.692 . . . . 0.0 112.403 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.91 HD11 HG21 ' A' ' 99' ' ' ILE . 5.0 tt -121.43 101.34 7.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.895 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -139.8 134.4 6.59 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.72 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.442 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -55.34 -158.35 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.368 0.604 . . . . 0.0 110.756 179.339 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.7 tpp85 -96.05 133.57 40.14 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.546 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.502 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 4.1 m 61.57 14.61 6.1 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.288 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.473 ' C ' ' HZ2' ' A' ' 120' ' ' LYS . 4.3 p -70.28 -13.32 17.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.502 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.4 21.65 47.5 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.747 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.4 pttm -68.17 -35.29 77.81 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.055 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.2 m -67.66 -42.21 82.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.545 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.467 ' OG ' ' H8 ' ' A' ' 186' ' ' GDP . 22.6 m -60.42 -47.55 85.62 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.485 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.444 ' O ' ' CB ' ' A' ' 26' ' ' PHE . 45.4 tp -66.95 -26.94 67.08 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.547 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.576 ' O ' HG12 ' A' ' 27' ' ' VAL . 97.2 m -63.06 -51.45 66.62 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.4 mm -65.3 -38.77 83.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.936 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.579 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -77.57 -25.67 50.21 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.541 -178.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.636 ' CZ ' ' CD2' ' A' ' 160' ' ' PHE . 37.1 t80 -77.78 -53.04 7.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.414 0.626 . . . . 0.0 110.614 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.605 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.9 p -59.61 -48.75 86.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.991 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.605 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.6 mt-10 -79.43 -24.41 42.51 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.569 ' O ' ' ND2' ' A' ' 153' ' ' ASN . . . 69.24 36.2 78.75 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -147.14 136.13 22.32 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.205 0.526 . . . . 0.0 111.179 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -39.88 122.09 1.39 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.24 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.647 HG22 ' N ' ' A' ' 33' ' ' ASP . 14.5 p -93.56 166.13 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.785 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.647 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -87.52 10.16 18.65 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.377 -179.172 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.466 ' H ' HG13 ' A' ' 32' ' ' VAL . 12.0 p 42.09 41.26 1.95 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.8 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.51 ' O ' ' CG ' ' A' ' 35' ' ' TYR . 21.5 t80 -158.04 85.91 0.89 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.581 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -162.32 158.85 20.69 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.531 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.59 ' C ' ' H ' ' A' ' 39' ' ' ILE . 94.8 Cg_exo -26.69 84.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.158 0 C-N-CA 124.326 3.35 . . . . 0.0 113.163 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 36' ' ' ASP . 13.2 t -68.65 35.05 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.665 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.59 ' H ' ' C ' ' A' ' 37' ' ' PRO . 1.7 tp -84.33 166.24 2.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.408 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.57 ' HB3' ' HB3' ' A' ' 62' ' ' ALA . 7.2 pt-20 -81.31 132.92 35.36 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.964 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 1.2 m120 -172.85 176.08 3.18 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.576 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.434 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -108.26 152.95 23.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.577 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 25.3 m-85 -132.63 166.37 22.3 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.455 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -147.05 156.3 42.91 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.524 0.678 . . . . 0.0 112.823 -177.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -163.29 117.13 1.6 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.804 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 46' ' ' LEU . 8.2 mp -104.63 129.2 52.8 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.879 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 pp -147.1 160.31 9.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.935 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -114.97 123.28 48.71 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.974 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.26 129.87 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.014 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 63.74 7.26 3.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.019 0.438 . . . . 0.0 109.961 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.83 -11.76 59.17 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -89.15 135.02 33.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -77.13 147.12 36.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.606 0.717 . . . . 0.0 111.525 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -140.38 123.47 16.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.749 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.593 ' C ' HD12 ' A' ' 56' ' ' LEU . 1.2 m-70 -117.33 114.06 23.03 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.593 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.7 mp -118.88 143.88 46.72 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.785 0.802 . . . . 0.0 112.379 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.747 ' C ' HD13 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -135.63 122.15 20.71 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.198 -1.364 . . . . 0.0 109.95 178.794 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.952 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.78 153.53 33.28 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.53 -178.603 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -122.93 144.38 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-N 114.508 -1.224 . . . . 0.0 112.32 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.13 103.43 8.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.107 178.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.472 HG22 ' CE2' ' A' ' 74' ' ' TYR . 1.5 p -70.84 143.54 51.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.385 0.612 . . . . 0.0 110.513 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.57 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . . . -140.66 12.88 2.31 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.644 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -105.21 -63.85 0.65 Allowed Glycine 0 CA--C 1.527 0.784 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.571 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.5 ' OE1' ' NE2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -84.02 -164.63 0.96 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.285 0.564 . . . . 0.0 111.324 -179.321 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.626 ' O ' ' N ' ' A' ' 67' ' ' TYR . 1.8 p30 -76.11 -172.8 2.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.078 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.601 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -21.82 -41.61 0.0 OUTLIER 'General case' 0 C--N 1.344 0.33 0 O-C-N 124.051 0.845 . . . . 0.0 110.778 -179.199 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 65' ' ' ASP . 4.4 t80 -178.86 5.0 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.64 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.55 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 67.0 m 36.67 93.97 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.699 0.285 . . . . 0.0 111.738 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.608 HD11 ' HA ' ' A' ' 103' ' ' LEU . 0.3 OUTLIER -44.21 139.9 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.17 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.445 ' O ' ' CD2' ' A' ' 70' ' ' PHE . 66.1 t80 53.95 64.94 5.92 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.729 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -51.4 163.58 1.03 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.632 2.221 . . . . 0.0 112.215 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.5 ' NE2' ' OE1' ' A' ' 64' ' ' GLN . 8.0 mp0 -91.35 -43.9 9.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.313 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.1 m -131.51 -1.26 3.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.228 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CE2' HG22 ' A' ' 61' ' ' THR . 0.2 OUTLIER -100.88 10.83 40.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.408 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 76' ' ' ILE . 5.4 m -83.58 57.55 4.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.247 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.84 HD12 ' CG2' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -50.53 -169.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.583 -179.57 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -117.29 54.28 0.89 Allowed 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.84 ' CG2' HD12 ' A' ' 76' ' ' ILE . 29.8 pt -78.86 -176.97 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-N 114.479 -1.237 . . . . 0.0 113.238 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -151.19 17.33 0.75 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.04 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -144.17 164.4 27.6 Favored Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.222 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.533 ' OH ' ' CG ' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -152.53 123.93 7.71 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.641 -0.78 . . . . 0.0 111.181 178.458 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.504 ' O ' HG23 ' A' ' 82' ' ' ILE . 7.6 tt -128.71 113.79 30.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.2 mt -97.48 123.93 41.51 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.042 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -98.08 117.82 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.179 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.615 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 42.2 p90 -120.5 145.38 47.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.308 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 88' ' ' THR . 3.3 p -86.03 135.77 33.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.204 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.535 HG21 ' N ' ' A' ' 124' ' ' HIS . 18.0 m -73.69 21.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.459 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.495 ' H ' ' C ' ' A' ' 86' ' ' SER . 0.9 OUTLIER -136.9 -25.6 1.08 Allowed 'General case' 0 CA--C 1.52 -0.212 0 CA-C-O 121.003 0.43 . . . . 0.0 112.063 -178.237 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 91' ' ' LYS . 60.8 p -97.77 100.06 11.42 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.067 -176.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.8 tp -59.37 -8.4 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 176.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.563 ' H ' ' C ' ' A' ' 89' ' ' SER . 21.8 mttp -77.05 -59.31 2.83 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.111 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.432 ' OG ' ' OG ' ' A' ' 89' ' ' SER . 83.1 p -52.22 -33.52 41.53 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.878 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.615 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -73.19 -49.76 26.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.721 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -65.98 -42.35 89.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.214 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 91' ' ' LYS . 19.5 m -66.22 -41.56 89.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.254 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.508 ' N ' HG23 ' A' ' 95' ' ' VAL . 1.4 mt -59.44 -34.51 54.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -71.0 -27.26 63.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.466 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.4 t -77.11 -67.27 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.263 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.91 HG21 HD11 ' A' ' 12' ' ' LEU . 1.4 tp -48.53 -29.53 2.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.684 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.616 ' CG ' ' CH2' ' A' ' 141' ' ' TRP . 35.6 t-80 -67.77 -63.58 1.03 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.235 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -39.58 -47.61 3.0 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 105' ' ' ASP . 37.6 tptt -62.81 -62.72 1.53 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.878 -0.661 . . . . 0.0 109.244 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.608 ' HA ' HD11 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -38.06 -51.09 1.39 Allowed 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.349 0.595 . . . . 0.0 109.498 178.686 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.735 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -52.4 -45.56 65.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.52 179.057 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -61.27 -32.7 72.52 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.035 -179.593 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.529 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 23.7 ttp -77.07 -46.48 23.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.18 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.792 HG23 ' H ' ' A' ' 109' ' ' LYS . 4.8 m -76.86 -11.19 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.623 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.488 ' O ' ' CB ' ' A' ' 109' ' ' LYS . . . 81.32 4.14 90.51 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.543 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.792 ' H ' HG23 ' A' ' 107' ' ' VAL . 5.9 tttp 83.85 94.51 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.137 0.494 . . . . 0.0 111.709 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.5 t -144.34 139.09 24.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.467 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.762 ' O ' ' HB2' ' A' ' 174' ' ' ALA . 2.1 mm100 -73.1 113.66 10.4 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.367 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.67 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.2 OUTLIER -130.61 161.21 62.32 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.585 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -51.83 101.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 120.953 1.102 . . . . 0.0 111.548 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.3 mt -116.22 120.97 66.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.404 ' CE ' HD23 ' A' ' 146' ' ' LEU . 8.5 tpt -121.84 113.73 20.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.033 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 79.8 mt -96.14 97.86 9.88 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.8 t -106.91 135.32 45.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 122.184 0.992 . . . . 0.0 111.696 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.403 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -105.45 116.08 5.1 Favored Glycine 0 C--N 1.308 -0.98 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.476 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 57.9 t30 -97.71 174.88 6.4 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.043 -178.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.476 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 7.2 mttp 62.09 58.19 1.9 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.048 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.44 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 2.9 tttm -58.92 -26.83 64.69 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.669 ' CG ' HN21 ' A' ' 186' ' ' GDP . 3.1 p-10 -64.5 -13.98 54.9 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.97 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 125' ' ' MET . 11.0 mp -89.98 -30.03 18.07 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.61 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.1 OUTLIER -37.53 -25.78 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.132 178.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.61 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 7.2 mtp -49.26 -21.5 0.83 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.448 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -109.99 -38.84 5.22 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.139 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.484 ' HE ' ' HB2' ' A' ' 124' ' ' HIS . 19.6 ttm180 26.68 90.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.106 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.99 -32.98 56.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.437 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.6 tp -88.89 156.37 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.597 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.562 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 88.7 p -103.41 124.98 49.73 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.219 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.511 ' CE1' ' CE1' ' A' ' 145' ' ' PHE . 0.4 OUTLIER -39.23 -39.56 0.63 Allowed 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.064 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mp0 -61.33 -65.75 0.64 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.937 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.562 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 66.6 mt-10 -41.41 -46.18 3.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.076 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.78 -35.05 84.57 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 132' ' ' GLU . 12.1 ttpt -62.04 -55.27 30.81 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.0 -37.82 77.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.307 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.557 ' CD2' ' CE2' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -67.06 -64.78 0.78 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 120.905 0.384 . . . . 0.0 110.017 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -49.71 -32.45 13.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.304 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -67.12 -53.77 27.59 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.911 0.386 . . . . 0.0 110.11 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 88.8 p -62.32 -26.77 68.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.116 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.616 ' CH2' ' CG ' ' A' ' 100' ' ' HIS . 32.6 m0 -88.02 -8.78 55.11 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 65.9 20.61 11.38 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -101.04 166.65 10.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.776 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.01 133.96 48.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.916 -0.583 . . . . 0.0 112.252 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.71 ' O ' HD22 ' A' ' 146' ' ' LEU . 4.5 t80 -97.1 122.92 40.63 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.529 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.913 HD12 HG22 ' A' ' 159' ' ' VAL . 1.2 mm? -135.79 138.89 43.06 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.592 -176.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.48 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 2.3 tt0 -127.77 110.55 12.73 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.1 p -137.86 -176.79 4.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.164 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.71 139.85 38.54 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.857 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.484 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -59.78 -44.38 93.92 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 178.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -62.5 -0.5 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.184 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.484 ' H ' ' C ' ' A' ' 150' ' ' ALA . 1.3 mt-10 -136.42 97.98 3.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.627 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.569 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 39.2 t30 -63.96 -47.71 79.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.969 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 153' ' ' ASN . 0.0 OUTLIER -37.06 -59.13 0.74 Allowed 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.104 0.478 . . . . 0.0 110.485 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.588 ' O ' HG23 ' A' ' 159' ' ' VAL . 74.2 p -52.29 -44.98 65.3 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.847 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.579 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -55.19 -60.31 3.57 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.293 0.568 . . . . 0.0 109.959 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.1 t -41.63 -41.64 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.939 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.32 -39.56 94.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.891 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.913 HG22 HD12 ' A' ' 146' ' ' LEU . 22.4 t -67.39 -31.33 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.371 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.636 ' CD2' ' CZ ' ' A' ' 26' ' ' PHE . 4.8 t80 -62.19 -66.94 0.46 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.67 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 26.3 ttm-85 -48.48 -53.15 19.05 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.849 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.46 -33.98 23.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.95 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.521 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -65.76 -34.07 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.485 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.434 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 10.2 mt -68.06 -40.05 82.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.634 0.731 . . . . 0.0 110.244 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.37 -60.84 2.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.302 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.6 -32.29 65.11 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.546 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -60.0 -32.29 70.72 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -68.32 -55.98 10.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.96 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 18.4 ttpp -59.2 -62.33 1.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.931 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.67 HG21 ' C ' ' A' ' 112' ' ' ILE . 67.1 mt -50.28 -33.14 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.111 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.13 -40.69 90.84 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.141 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.56 -32.71 84.21 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.94 -81.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.419 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.762 ' HB2' ' O ' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.015 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GDP . . . . . 0.669 HN21 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.476 ' HG ' ' CE1' ' A' ' 55' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 121.078 0.466 . . . . 0.0 110.159 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.454 ' NH1' ' HB1' ' A' ' 167' ' ' ALA . 2.1 ptp180 -139.9 136.7 34.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.602 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.546 ' HB2' HG22 ' A' ' 78' ' ' ILE . 4.1 mptt -106.36 133.47 51.0 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.755 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.3 mm -106.06 125.97 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-O 121.345 0.593 . . . . 0.0 110.232 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.445 ' HB2' ' CD1' ' A' ' 78' ' ' ILE . . . -83.74 134.0 34.76 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.124 -0.985 . . . . 0.0 110.631 -178.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 58' ' ' LEU . 17.0 mt -96.9 132.37 41.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.341 0.591 . . . . 0.0 112.121 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.2 tp -132.4 105.92 7.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.569 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -140.26 134.37 6.48 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -54.9 -159.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.371 0.605 . . . . 0.0 110.918 179.624 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -96.18 135.28 38.2 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.864 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.482 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 3.0 m 61.27 19.48 10.16 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.497 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 p -77.8 -19.66 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.852 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.38 23.28 24.67 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.6 pttm -69.32 -34.45 74.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.0 110.263 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.2 m -75.42 -36.16 60.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.086 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.3 p -60.42 -42.16 95.47 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.318 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.6 tp -77.44 -34.14 54.64 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.959 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.596 ' O ' HG12 ' A' ' 27' ' ' VAL . 27.0 m -52.98 -45.48 67.84 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.849 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.47 HD12 ' N ' ' A' ' 24' ' ' ILE . 1.4 mp -74.42 -41.96 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.351 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.618 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -68.45 -28.9 67.45 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.334 -0.547 . . . . 0.0 110.961 -179.433 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.453 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 1.4 t80 -77.93 -64.05 1.25 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.336 0.588 . . . . 0.0 110.957 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.9 p -47.05 -48.41 8.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.727 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.61 ' N ' HG13 ' A' ' 27' ' ' VAL . 0.5 OUTLIER -80.32 -24.95 39.58 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.157 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.431 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 74.09 24.02 74.7 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.154 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -145.32 125.88 14.13 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.657 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -68.05 92.37 0.38 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.224 178.697 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.638 HG22 ' N ' ' A' ' 33' ' ' ASP . 14.7 p -101.33 166.51 2.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.186 0.517 . . . . 0.0 110.581 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.638 ' N ' HG22 ' A' ' 32' ' ' VAL . 1.2 t70 -73.0 26.75 0.06 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.01 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.472 ' H ' HG13 ' A' ' 32' ' ' VAL . 4.2 p -64.62 64.05 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.016 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 33' ' ' ASP . 0.6 OUTLIER -91.04 105.79 18.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.648 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.444 ' O ' ' O ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -137.37 172.37 6.98 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.208 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 36' ' ' ASP . 49.0 Cg_exo -56.68 -137.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.485 2.123 . . . . 0.0 111.763 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 38' ' ' THR . 10.9 t -129.68 60.85 1.57 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.608 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 tp -83.17 149.17 4.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.223 -0.898 . . . . 0.0 111.158 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -87.49 147.33 25.42 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.149 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -172.33 -179.0 2.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.318 0.58 . . . . 0.0 111.837 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.3 m -126.7 143.27 51.29 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.151 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.457 ' CE2' HD11 ' A' ' 24' ' ' ILE . 14.2 m-85 -129.15 165.66 20.85 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.945 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.515 HG23 ' HB2' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -143.03 152.23 41.68 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.322 0.582 . . . . 0.0 112.148 -178.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 tttp -156.47 113.14 3.09 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.868 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.9 mp -105.91 122.21 45.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.899 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.895 HD12 ' H ' ' A' ' 47' ' ' ILE . 0.3 OUTLIER -144.77 165.43 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.672 -179.145 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.6 m -115.23 125.89 53.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.266 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.562 ' O ' HG13 ' A' ' 49' ' ' VAL . 8.0 p -120.61 117.25 52.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.885 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.512 ' CG ' HG22 ' A' ' 49' ' ' VAL . 0.9 OUTLIER 69.88 25.9 4.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 110.118 -179.17 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.38 -10.15 55.8 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -89.34 132.13 35.09 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -75.76 146.17 40.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.535 0.683 . . . . 0.0 111.203 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.559 ' CD1' HG12 ' A' ' 49' ' ' VAL . 5.1 m-85 -137.54 125.72 23.05 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.891 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.517 ' ND1' ' O ' ' A' ' 55' ' ' HIS . 1.3 t-80 -117.47 113.4 21.98 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.497 HD12 ' C ' ' A' ' 55' ' ' HIS . 9.5 mp -118.39 143.17 46.85 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.781 0.8 . . . . 0.0 111.822 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.806 ' C ' HD13 ' A' ' 58' ' ' LEU . 3.2 tt0 -140.44 120.52 13.73 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.047 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.973 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -115.85 154.33 29.89 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.331 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -130.89 144.15 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.267 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.41 102.93 7.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.449 -1.251 . . . . 0.0 108.306 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.14 153.96 45.37 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.38 0.61 . . . . 0.0 110.364 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 64' ' ' GLN . . . -143.17 21.01 1.92 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.319 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -38.84 -25.42 0.04 OUTLIER Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.565 ' CG ' ' H ' ' A' ' 65' ' ' ASP . 0.5 OUTLIER -145.31 -125.3 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.476 0.655 . . . . 0.0 110.888 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.58 ' O ' ' N ' ' A' ' 67' ' ' TYR . 5.9 p30 -76.33 -170.27 1.42 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.816 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.602 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 1.0 OUTLIER -61.63 56.0 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 O-C-N 124.045 0.841 . . . . 0.0 110.223 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.59 ' OH ' HD11 ' A' ' 76' ' ' ILE . 31.9 t80 76.5 71.67 0.07 Allowed 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.574 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 24.1 m -47.22 122.93 4.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.3 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.899 ' H ' HD12 ' A' ' 69' ' ' ILE . 2.6 mp -55.33 -63.68 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.023 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.534 ' O ' ' N ' ' A' ' 72' ' ' GLN . 7.1 m-85 -32.14 97.02 0.1 Allowed Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 114.271 -1.332 . . . . 0.0 110.915 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.19 82.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.071 1.847 . . . . 0.0 112.401 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 70' ' ' PHE . 8.4 tt0 -111.24 -69.9 0.84 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.991 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.7 m -100.54 -20.42 15.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.683 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.573 ' CD1' ' CE1' ' A' ' 67' ' ' TYR . 79.6 m-85 -88.23 49.52 1.81 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.21 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 76' ' ' ILE . 3.7 p -80.71 11.04 4.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.172 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.59 HD11 ' OH ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -49.68 -178.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 120.938 0.399 . . . . 0.0 110.968 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.74 51.43 1.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 8' ' ' LYS . 45.2 pt -78.4 -173.5 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 115.415 -0.812 . . . . 0.0 112.725 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.27 18.25 0.95 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.477 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.425 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -147.55 166.43 28.69 Favored Glycine 0 CA--C 1.519 0.339 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.622 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.54 ' OH ' ' CD2' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -151.9 123.08 7.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.851 -0.675 . . . . 0.0 111.2 178.399 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.621 ' O ' HG23 ' A' ' 82' ' ' ILE . 9.6 tt -128.0 104.81 12.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.505 0.669 . . . . 0.0 109.296 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 1.008 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.53 122.17 40.28 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.144 -178.894 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.405 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.9 OUTLIER -96.47 118.22 42.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.376 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.467 ' CZ ' ' CA ' ' A' ' 118' ' ' GLY . 25.5 p90 -112.12 144.69 41.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.465 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.49 ' C ' ' H ' ' A' ' 88' ' ' THR . 1.5 p -86.94 135.7 33.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.844 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.564 HG21 ' N ' ' A' ' 124' ' ' HIS . 17.6 m -72.35 19.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.991 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.49 ' H ' ' C ' ' A' ' 86' ' ' SER . 5.5 t -136.65 -26.11 1.1 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.061 0.457 . . . . 0.0 112.099 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.545 ' C ' ' N ' ' A' ' 91' ' ' LYS . 18.3 t -93.14 93.74 8.45 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.095 -176.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 tp -60.45 -10.02 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.545 ' N ' ' C ' ' A' ' 89' ' ' SER . 15.6 mttp -75.48 -48.6 21.9 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 113.901 -1.5 . . . . 0.0 109.533 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.1 p -61.44 -30.92 70.88 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.906 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.446 ' CE2' HG21 ' A' ' 129' ' ' ILE . 0.6 OUTLIER -73.24 -51.75 16.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.125 -179.437 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -62.77 -43.78 97.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.701 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 91' ' ' LYS . 14.4 m -66.67 -34.51 70.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.084 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.8 mt -66.48 -36.08 76.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.591 -0.443 . . . . 0.0 109.904 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -70.07 -26.36 63.97 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.273 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.1 t -73.02 -67.03 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.895 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.423 HG23 ' N ' ' A' ' 100' ' ' HIS . 2.5 tt -43.11 -40.37 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.214 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.423 ' N ' HG23 ' A' ' 99' ' ' ILE . 0.9 OUTLIER -58.45 -63.57 1.23 Allowed 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.385 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -38.36 -58.42 1.68 Allowed Glycine 0 CA--C 1.519 0.3 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 105' ' ' ASP . 34.8 tptt -61.71 -62.75 1.58 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.953 -0.623 . . . . 0.0 110.365 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.64 -55.0 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.429 0.633 . . . . 0.0 109.579 179.375 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -49.17 -46.24 45.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.275 178.712 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -60.47 -36.12 77.52 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.726 -179.577 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.518 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 2.0 ttm -59.4 -57.96 10.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.135 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.513 ' C ' ' H ' ' A' ' 109' ' ' LYS . 19.1 m -77.07 -13.31 14.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.584 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.26 -24.83 0.1 OUTLIER Glycine 0 CA--C 1.53 1.028 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.65 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.513 ' H ' ' C ' ' A' ' 107' ' ' VAL . 7.9 tttp -173.9 -134.58 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 117.663 0.731 . . . . 0.0 111.689 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.512 ' H ' ' CG ' ' A' ' 109' ' ' LYS . 5.1 t 52.85 120.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.719 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.458 ' HB3' HG23 ' A' ' 170' ' ' ILE . 23.0 mt-30 -75.14 136.4 41.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.732 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.602 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.4 OUTLIER -138.3 148.2 58.62 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.098 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -48.7 114.59 1.28 Allowed 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 121.94 1.76 . . . . 0.0 112.824 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.513 ' HB ' ' HB2' ' A' ' 143' ' ' ALA . 2.2 mp -124.26 128.65 73.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.542 ' O ' HD12 ' A' ' 83' ' ' LEU . 10.7 tpt -130.36 114.32 15.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.912 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.4 mt -97.65 98.66 10.07 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.3 t -104.98 129.45 57.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.944 0.878 . . . . 0.0 111.461 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.467 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -96.07 117.12 5.6 Favored Glycine 0 C--N 1.311 -0.83 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.445 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 58.7 t30 -97.47 174.14 6.82 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.994 -177.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.516 ' HZ1' " C1'" ' A' ' 186' ' ' GDP . 6.1 mttp 59.91 58.75 2.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.939 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 18.1 tttm -56.27 -26.05 50.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.568 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.655 ' CG ' HN21 ' A' ' 186' ' ' GDP . 3.9 p-10 -72.72 -13.31 61.31 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.084 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.8 mp -91.18 -30.92 16.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.564 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -38.93 -25.04 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.171 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.519 ' N ' ' O ' ' A' ' 123' ' ' LEU . 11.2 mtt -45.65 -23.95 0.3 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.473 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -105.17 -40.46 5.86 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.495 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.488 ' CZ ' ' OE1' ' A' ' 147' ' ' GLU . 2.6 tpp85 27.9 86.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.766 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.1 t -59.41 -32.6 49.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.396 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.446 HG21 ' CE2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -88.29 153.04 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.531 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.501 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 78.3 p -96.89 121.94 39.32 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.304 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.411 ' HB2' HH12 ' A' ' 127' ' ' ARG . 13.8 t80 -37.01 -32.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.249 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.5 mp0 -70.51 -64.84 0.82 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.808 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.501 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 69.6 mt-10 -41.24 -42.52 2.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.724 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.15 -35.68 70.93 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 132' ' ' GLU . 4.2 tttt -61.97 -55.48 29.02 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.92 -35.72 69.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.821 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.644 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -66.27 -63.53 1.06 Allowed 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.85 -35.6 57.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.185 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -68.69 -32.35 72.11 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.173 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 p -63.24 -46.24 87.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.792 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.644 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 30.9 m95 -88.51 -5.12 58.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.982 0.42 . . . . 0.0 110.335 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 141' ' ' TRP . 0.9 OUTLIER 77.41 23.69 0.85 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.384 0.611 . . . . 0.0 109.52 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.29 167.37 13.6 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.869 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.432 ' HB3' ' SD ' ' A' ' 115' ' ' MET . . . -110.97 130.1 55.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.529 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -98.17 120.87 39.33 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.281 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.75 128.73 17.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.488 ' OE1' ' CZ ' ' A' ' 127' ' ' ARG . 6.4 mt-10 -100.28 119.76 38.89 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.043 0.449 . . . . 0.0 110.029 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 63.2 p -137.45 178.1 7.36 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.42 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.3 138.08 38.03 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.974 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -55.73 -49.82 72.01 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.143 0.497 . . . . 0.0 109.748 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.7 tttm -58.84 -3.12 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.284 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 150' ' ' ALA . 6.7 tt0 -127.35 110.92 13.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.421 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.515 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 7.7 t-20 -76.57 -47.21 23.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.684 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -41.3 -57.61 2.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.093 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.644 ' O ' HG23 ' A' ' 159' ' ' VAL . 78.0 p -52.74 -48.42 66.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.975 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.618 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -48.49 -60.56 2.59 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.516 0.674 . . . . 0.0 109.59 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 60.0 t -43.29 -49.58 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.088 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -53.76 -43.1 68.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.553 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 155' ' ' THR . 3.2 t -68.16 -44.12 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.304 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.758 ' CE1' HD11 ' A' ' 164' ' ' ILE . 9.7 t80 -53.72 -40.48 66.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.168 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.3 ttt85 -77.09 -42.12 39.45 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.156 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -60.26 -34.44 73.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.189 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 160' ' ' PHE . 10.3 tt -70.73 -47.16 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 119.281 -0.968 . . . . 0.0 110.79 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.758 HD11 ' CE1' ' A' ' 160' ' ' PHE . 85.5 mt -54.62 -32.07 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.289 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.404 ' HA ' HD13 ' A' ' 165' ' ' LEU . 0.4 OUTLIER -63.21 -64.68 0.84 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.206 -179.419 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -60.01 -29.67 68.64 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.493 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.454 ' HB1' ' NH1' ' A' ' 7' ' ' ARG . . . -61.33 -30.97 70.84 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.417 ' OE2' ' OH ' ' A' ' 54' ' ' TYR . 3.7 tp10 -68.06 -54.34 18.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.177 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -60.9 -61.09 2.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.884 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.602 HG21 ' C ' ' A' ' 112' ' ' ILE . 74.2 mt -50.06 -36.96 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.814 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -70.86 -40.07 72.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.808 0.337 . . . . 0.0 110.605 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -55.16 -41.52 78.81 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.654 -0.979 . . . . 0.0 110.654 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.05 -61.99 1.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.756 0.313 . . . . 0.0 110.621 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.932 -179.832 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GDP . . . . . 0.655 HN21 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 121.212 0.53 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.22 136.05 34.58 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.489 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.543 ' HB2' HG22 ' A' ' 78' ' ' ILE . 1.9 mptt -106.16 132.28 52.41 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.776 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.1 mm -104.45 124.75 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-O 121.333 0.587 . . . . 0.0 110.242 -178.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.475 ' HB2' ' CD1' ' A' ' 78' ' ' ILE . . . -83.83 133.54 34.75 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.084 -1.01 . . . . 0.0 110.931 -177.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 58' ' ' LEU . 14.8 mt -95.56 133.72 35.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.657 0.741 . . . . 0.0 112.33 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.55 HD21 ' HB2' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -134.55 104.91 6.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.877 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -140.98 135.95 7.25 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.467 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -54.09 -158.18 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.769 0.795 . . . . 0.0 111.042 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -95.99 132.75 40.99 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.882 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.56 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 5.8 m 59.14 19.1 7.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.159 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 17' ' ' VAL . 2.5 p -80.48 -10.76 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.801 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.42 7.66 51.23 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.414 ' HE3' ' H ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -40.05 -59.26 1.26 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.118 0.485 . . . . 0.0 110.353 179.565 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -67.75 -26.97 66.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.449 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.596 ' OG ' ' H8 ' ' A' ' 186' ' ' GDP . 8.0 m -64.39 -50.56 67.17 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.017 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.9 tp -75.83 -26.35 57.1 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.42 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.492 ' O ' HG12 ' A' ' 27' ' ' VAL . 55.5 m -58.15 -50.9 71.89 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.4 mp -60.6 -43.73 95.28 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.406 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.541 ' OE1' ' N ' ' A' ' 31' ' ' PHE . 6.4 tt0 -69.69 -25.62 63.96 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.21 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -77.32 -49.94 13.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.246 0.546 . . . . 0.0 110.822 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.591 HG13 ' N ' ' A' ' 28' ' ' GLU . 11.8 p -68.77 -45.1 81.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.139 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.591 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.8 tt0 -81.4 -24.94 36.61 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 77.68 19.25 76.16 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.974 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.539 ' NE2' ' O ' ' A' ' 31' ' ' PHE . 16.8 tp60 -149.0 135.97 19.86 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.301 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.541 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 1.0 OUTLIER -71.76 93.96 1.34 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.567 178.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.636 HG22 ' N ' ' A' ' 33' ' ' ASP . 13.9 p -111.68 166.49 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.094 0.473 . . . . 0.0 110.46 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.636 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -62.68 -14.41 43.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.479 -178.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 33' ' ' ASP . 29.4 p 49.8 173.39 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.399 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -152.81 13.59 0.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.117 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 37' ' ' PRO . 2.2 m-20 -113.88 95.28 37.08 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.664 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 36' ' ' ASP . 66.4 Cg_exo -54.82 -130.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.568 2.179 . . . . 0.0 112.256 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 38' ' ' THR . 12.3 t -109.95 46.25 1.04 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.181 0.515 . . . . 0.0 112.046 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.434 ' CG2' ' OD1' ' A' ' 41' ' ' ASN . 1.5 tp -84.59 165.22 2.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.469 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.98 124.56 28.81 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.434 ' OD1' ' CG2' ' A' ' 39' ' ' ILE . 1.2 m120 -161.97 -178.99 6.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.645 0.736 . . . . 0.0 112.95 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.2 m -137.43 144.3 42.28 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.11 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 12.3 m-85 -127.44 163.65 23.61 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.496 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.528 HG23 ' HB2' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -144.22 150.75 38.47 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.396 0.617 . . . . 0.0 112.661 -178.609 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.0 118.69 2.73 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.771 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.6 mp -105.82 129.3 54.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.654 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.444 HD12 ' HE2' ' A' ' 160' ' ' PHE . 1.0 OUTLIER -147.65 165.83 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.798 -179.095 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.4 m -115.79 126.4 53.97 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.197 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.594 HG12 ' CD1' ' A' ' 54' ' ' TYR . 7.2 p -121.28 118.95 57.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.94 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 71.27 17.36 5.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.12 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.37 -11.58 70.82 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -89.28 133.88 34.28 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.25 144.1 42.74 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.622 0.725 . . . . 0.0 111.163 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.594 ' CD1' HG12 ' A' ' 49' ' ' VAL . 6.6 m-85 -136.47 127.87 28.44 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.664 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 55' ' ' HIS . 1.2 t-80 -117.07 114.39 23.67 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.449 HD12 ' C ' ' A' ' 55' ' ' HIS . 8.4 mp -117.69 143.72 45.92 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 122.078 0.942 . . . . 0.0 112.244 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.772 ' C ' HD13 ' A' ' 58' ' ' LEU . 3.0 tt0 -140.91 121.68 14.38 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 113.702 -1.59 . . . . 0.0 109.725 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.946 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -115.86 154.09 30.33 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.528 0.68 . . . . 0.0 112.347 -178.403 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.02 145.09 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-N 114.532 -1.213 . . . . 0.0 113.172 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -120.88 102.91 8.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.201 178.016 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.64 HG22 ' CE2' ' A' ' 74' ' ' TYR . 72.5 p -70.51 150.85 45.72 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.07 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 63' ' ' GLY . . . -121.31 23.83 10.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.714 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 62' ' ' ALA . . . -51.55 -164.92 0.01 OUTLIER Glycine 0 CA--C 1.529 0.951 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.485 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.22 -64.48 1.16 Allowed 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.391 0.615 . . . . 0.0 111.023 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 66' ' ' GLU . 4.0 t70 -76.26 -178.8 4.7 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.633 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.535 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.6 OUTLIER -45.04 -19.6 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.604 ' CG ' ' O ' ' A' ' 67' ' ' TYR . 11.3 t80 -178.06 4.14 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.959 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.419 ' H ' ' HB3' ' A' ' 65' ' ' ASP . 3.4 m 38.93 81.33 0.03 OUTLIER 'General case' 0 C--O 1.232 0.15 0 O-C-N 122.121 -0.362 . . . . 0.0 111.266 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.562 HD11 ' HA ' ' A' ' 103' ' ' LEU . 0.4 OUTLIER -42.65 140.22 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.337 0.064 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.112 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.4 t80 68.16 63.72 0.65 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.164 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.483 ' C ' ' N ' ' A' ' 73' ' ' THR . 51.0 Cg_exo -47.11 -42.09 26.49 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.7 2.267 . . . . 0.0 112.423 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.3 13.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.077 0.465 . . . . 0.0 109.959 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.483 ' N ' ' C ' ' A' ' 71' ' ' PRO . 87.6 m -135.87 -35.51 0.78 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.193 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.64 ' CE2' HG22 ' A' ' 61' ' ' THR . 0.1 OUTLIER -70.16 -65.74 0.69 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.999 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 t 73.64 49.14 0.14 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.928 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -81.95 172.73 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.48 0.657 . . . . 0.0 111.551 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.49 52.46 1.06 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.052 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.543 HG22 ' HB2' ' A' ' 8' ' ' LYS . 37.6 pt -80.69 -173.08 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.69 16.34 0.88 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.449 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -145.07 166.79 27.45 Favored Glycine 0 CA--C 1.519 0.319 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.317 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.82 122.5 7.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.911 -0.645 . . . . 0.0 111.28 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.698 ' O ' HG23 ' A' ' 82' ' ' ILE . 12.2 tt -127.55 101.04 6.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.562 0.696 . . . . 0.0 109.138 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.968 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -96.86 123.44 40.56 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.376 -178.52 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -96.84 119.67 45.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.97 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.635 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 32.1 p90 -121.64 144.72 48.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.675 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.7 p -87.82 143.28 27.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.735 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.59 HG21 ' N ' ' A' ' 124' ' ' HIS . 15.8 m -80.67 20.32 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.778 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.609 ' HB ' HD23 ' A' ' 123' ' ' LEU . 0.7 OUTLIER -131.05 -27.82 2.01 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.119 0.485 . . . . 0.0 111.936 -178.101 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.543 ' C ' ' N ' ' A' ' 91' ' ' LYS . 44.2 t -97.08 93.94 6.87 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.674 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 tp -58.58 -10.75 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.567 ' O ' HG22 ' A' ' 95' ' ' VAL . 2.6 mtpt -76.07 -50.82 13.7 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.052 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.477 ' O ' ' CG1' ' A' ' 96' ' ' ILE . 59.1 p -60.34 -31.88 70.73 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.01 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -75.56 -46.17 33.55 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.081 -179.337 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -66.02 -44.1 85.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.25 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 91' ' ' LYS . 16.4 m -68.17 -39.8 81.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.621 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.494 ' N ' HG23 ' A' ' 95' ' ' VAL . 1.4 mm -59.18 -42.45 86.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.289 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.49 -27.25 64.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.305 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.0 t -75.55 -66.97 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.166 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.463 HD11 ' OD1' ' A' ' 65' ' ' ASP . 4.6 mm -41.84 -45.49 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.043 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.443 ' ND1' ' C ' ' A' ' 100' ' ' HIS . 9.7 t-80 -56.53 -63.51 1.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.691 -0.403 . . . . 0.0 109.985 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -40.63 -58.57 2.54 Favored Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 103' ' ' LEU . 14.0 tptp -55.8 -66.09 0.48 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.037 -0.582 . . . . 0.0 110.249 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.562 ' HA ' HD11 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -37.98 -59.84 0.8 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.275 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -46.06 -47.72 17.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.577 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -59.91 -30.13 68.83 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.998 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.481 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 3.9 ttm -77.81 -48.53 16.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.723 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.599 HG23 ' H ' ' A' ' 109' ' ' LYS . 6.4 m -75.98 -24.87 16.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.674 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 40.87 37.18 1.29 Allowed Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.599 ' H ' HG23 ' A' ' 107' ' ' VAL . 0.5 OUTLIER -95.36 -158.17 0.63 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.221 0.534 . . . . 0.0 111.63 -178.848 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 110' ' ' VAL . 0.0 OUTLIER -98.47 -170.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.96 -179.595 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -67.34 117.21 9.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.995 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.635 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.7 OUTLIER -119.55 155.74 54.06 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.023 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -47.43 106.01 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.529 1.486 . . . . 0.0 112.335 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.454 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.8 mt -119.8 128.56 75.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.564 ' O ' HD12 ' A' ' 83' ' ' LEU . 10.1 tpt -127.25 116.83 21.18 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.789 -178.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 mt -96.02 97.25 9.45 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.5 t -103.72 133.19 48.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 122.406 1.098 . . . . 0.0 110.371 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.79 113.07 4.11 Favored Glycine 0 C--N 1.299 -1.509 0 CA-C-N 113.265 -1.789 . . . . 0.0 109.032 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.509 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 48.5 t30 -96.88 177.22 5.7 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.279 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.509 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 26.8 mttp 61.96 58.35 1.92 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.016 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -63.48 -31.27 72.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.495 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -63.58 -8.92 11.03 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.003 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.609 HD23 ' HB ' ' A' ' 88' ' ' THR . 8.6 mp -93.67 -27.0 16.8 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.59 ' N ' HG21 ' A' ' 87' ' ' VAL . 1.1 p-80 -39.3 -24.47 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.858 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.518 ' N ' ' O ' ' A' ' 123' ' ' LEU . 2.7 mmt -46.12 -22.27 0.21 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.473 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.3 OUTLIER -106.67 -36.54 6.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.063 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.492 ' NH2' ' CD2' ' A' ' 131' ' ' TYR . 0.1 OUTLIER 33.11 88.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.851 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.6 t -72.05 -38.05 62.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.553 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 tp -89.92 155.63 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.427 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.484 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 62.0 p -103.03 125.44 49.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.949 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.492 ' CD2' ' NH2' ' A' ' 127' ' ' ARG . 0.8 OUTLIER -37.32 -35.91 0.13 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.574 179.13 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.6 mp0 -67.16 -64.75 0.79 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.054 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.484 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 64.6 mt-10 -41.21 -41.52 1.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.979 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.83 -36.3 65.91 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 132' ' ' GLU . 3.6 ttpp -61.69 -55.15 33.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.048 -0.576 . . . . 0.0 109.587 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.69 70.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.865 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.518 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -66.23 -61.66 1.9 Allowed 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.658 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -53.41 -35.78 60.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.34 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -68.85 -29.94 68.37 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.43 -46.65 82.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.715 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.518 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 33.0 m95 -89.35 -4.25 58.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.027 0.442 . . . . 0.0 110.194 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.409 ' O ' ' OE1' ' A' ' 166' ' ' GLU . 0.9 OUTLIER 76.52 22.46 1.22 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.403 -179.084 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -89.29 170.9 10.18 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.595 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.409 ' HB3' ' SD ' ' A' ' 115' ' ' MET . . . -109.65 134.75 51.59 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.428 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.627 ' O ' HD22 ' A' ' 146' ' ' LEU . 7.0 t80 -96.66 122.36 39.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.929 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.782 HD12 HG22 ' A' ' 159' ' ' VAL . 1.2 mm? -133.17 137.7 46.32 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.346 -176.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.456 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 9.1 tt0 -127.38 110.64 13.01 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 36.3 p -136.56 -172.81 3.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.21 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.68 139.57 40.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.716 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.525 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -64.84 -30.97 72.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.287 0.565 . . . . 0.0 109.97 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -79.78 13.65 2.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.029 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -144.19 121.03 11.27 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.745 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 154' ' ' GLN . 41.3 t30 -77.59 -54.51 6.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.408 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 153' ' ' ASN . 7.6 tt0 -37.09 -55.33 0.96 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.823 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 159' ' ' VAL . 60.2 p -57.01 -50.73 71.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.275 0.559 . . . . 0.0 110.158 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -47.68 -59.96 2.9 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.561 0.696 . . . . 0.0 109.574 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.9 t -41.28 -53.35 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.626 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -48.94 -33.1 10.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.733 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.782 HG22 HD12 ' A' ' 146' ' ' LEU . 10.3 t -76.55 -28.54 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.608 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -68.55 -40.71 80.55 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.727 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.507 ' N ' ' CD1' ' A' ' 160' ' ' PHE . 27.6 ttm-85 -79.6 -50.57 10.48 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.196 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -54.53 -36.92 64.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.226 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.627 HG23 ' N ' ' A' ' 164' ' ' ILE . 11.9 tt -69.01 -58.25 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.322 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.627 ' N ' HG23 ' A' ' 163' ' ' ILE . 84.1 mt -46.68 -33.02 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.91 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.25 -64.62 0.87 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.295 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.409 ' OE1' ' O ' ' A' ' 142' ' ' ASN . 3.2 mm-40 -61.21 -26.47 67.75 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.454 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -58.1 -36.8 73.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.419 ' OE2' ' OH ' ' A' ' 54' ' ' TYR . 11.5 mm-40 -69.73 -52.06 28.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.273 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -54.59 -60.22 3.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.515 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.635 HG21 ' C ' ' A' ' 112' ' ' ILE . 71.2 mt -50.0 -35.2 10.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.764 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.17 -39.92 90.13 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -60.4 -32.13 76.37 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.0 -76.59 0.09 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.168 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.061 179.871 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GDP . . . . . 0.596 ' H8 ' ' OG ' ' A' ' 21' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 121.166 0.508 . . . . 0.0 110.369 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.413 ' NH1' ' HB1' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -139.8 135.73 33.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.579 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.426 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 18.3 mttt -107.58 128.33 54.43 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.762 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -101.97 121.66 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-O 121.535 0.684 . . . . 0.0 110.351 -178.469 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.99 135.55 34.4 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 121.426 -0.796 . . . . 0.0 111.062 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.8 mt -95.57 131.39 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.458 0.647 . . . . 0.0 112.226 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.632 HD23 ' C ' ' A' ' 12' ' ' LEU . 6.3 tt -130.58 103.67 6.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.215 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.08 135.32 6.84 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.734 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.478 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -53.72 -160.82 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.366 0.603 . . . . 0.0 110.535 179.168 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.404 ' NE ' ' OG ' ' A' ' 16' ' ' SER . 10.1 ttp180 -96.14 135.94 37.27 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.86 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.404 ' OG ' ' NE ' ' A' ' 15' ' ' ARG . 5.1 m 60.08 19.34 8.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.574 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.477 ' C ' ' HZ2' ' A' ' 120' ' ' LYS . 3.6 p -76.69 -19.75 14.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.737 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.34 21.63 26.67 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.531 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.7 pttm -68.17 -33.97 75.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.928 0.394 . . . . 0.0 110.016 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.7 m -73.16 -38.75 66.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.532 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.8 p -62.16 -40.4 95.86 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.402 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.7 tp -77.75 -25.44 49.17 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.26 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.564 ' O ' HG12 ' A' ' 27' ' ' VAL . 58.4 m -63.67 -38.24 90.39 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.4 mp -74.92 -38.54 43.69 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.214 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.56 ' OE1' ' N ' ' A' ' 31' ' ' PHE . 5.9 tt0 -75.04 -25.48 58.72 Favored 'General case' 0 C--O 1.217 -0.618 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.154 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 23.1 t80 -76.59 -52.82 8.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.29 0.567 . . . . 0.0 110.766 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.593 HG13 ' N ' ' A' ' 28' ' ' GLU . 11.3 p -62.28 -45.96 97.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.906 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.593 ' N ' HG13 ' A' ' 27' ' ' VAL . 1.1 tm-20 -82.22 -24.54 34.81 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.466 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 77.24 18.01 78.79 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.799 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -146.68 134.19 20.89 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.56 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 0.6 OUTLIER -68.57 93.8 0.53 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.47 178.116 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.617 HG22 ' N ' ' A' ' 33' ' ' ASP . 12.3 p -109.07 166.15 4.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.12 0.486 . . . . 0.0 110.586 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.617 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -61.94 -12.17 16.93 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.135 -179.229 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.467 ' H ' HG13 ' A' ' 32' ' ' VAL . 52.7 p 49.1 177.03 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.03 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -150.91 0.33 0.4 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.781 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 37' ' ' PRO . 9.5 m-20 -118.86 87.12 32.43 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.853 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 36' ' ' ASP . 67.7 Cg_exo -54.11 -129.44 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.867 2.378 . . . . 0.0 112.32 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 38' ' ' THR . 10.0 t -78.45 38.63 0.31 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.223 0.535 . . . . 0.0 110.914 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.412 ' H ' ' C ' ' A' ' 37' ' ' PRO . 1.5 tp -84.12 143.83 11.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.013 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.428 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 2.3 pm0 -91.94 144.03 25.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.381 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER 176.44 179.79 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.332 0.587 . . . . 0.0 111.962 -179.31 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.514 HG23 HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -107.69 140.49 40.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.666 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 12.1 m-85 -127.9 163.53 24.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.638 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -143.6 155.8 44.39 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.295 0.569 . . . . 0.0 112.363 -178.52 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.465 ' HD2' HD11 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -160.97 111.68 1.76 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.899 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 46' ' ' LEU . 8.1 mp -105.1 127.1 52.74 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.793 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.81 HD12 ' CZ ' ' A' ' 160' ' ' PHE . 0.9 OUTLIER -148.85 165.6 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.5 179.338 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.2 m -114.66 126.51 54.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.557 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.594 HG21 HG21 ' A' ' 164' ' ' ILE . 7.4 p -123.4 135.04 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.842 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.517 ' CG ' HG22 ' A' ' 49' ' ' VAL . 7.7 m-20 62.6 3.97 1.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.029 0.442 . . . . 0.0 109.829 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 102.69 -13.23 56.52 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -90.29 140.37 29.76 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -77.09 147.23 36.77 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.525 0.679 . . . . 0.0 111.303 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.552 ' CD1' HG12 ' A' ' 49' ' ' VAL . 13.9 m-85 -139.76 123.04 17.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.799 -1.092 . . . . 0.0 109.911 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.626 ' C ' HD12 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -117.48 113.79 22.54 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.626 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.9 mp -118.84 145.9 45.3 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.641 0.734 . . . . 0.0 112.143 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.811 ' C ' HD13 ' A' ' 58' ' ' LEU . 12.4 tt0 -139.18 124.09 18.74 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.053 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.939 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.96 154.99 29.9 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.279 0.561 . . . . 0.0 112.463 -178.248 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.514 HG23 HG23 ' A' ' 42' ' ' THR . 0.3 OUTLIER -133.96 144.41 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.779 -179.495 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.35 104.37 8.14 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.831 177.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.37 166.57 11.53 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.128 0.489 . . . . 0.0 110.511 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 63' ' ' GLY . . . -135.68 29.46 3.21 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.857 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 62' ' ' ALA . . . -30.35 -63.6 0.17 Allowed Glycine 0 CA--C 1.528 0.899 0 O-C-N 123.84 0.712 . . . . 0.0 111.421 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -144.51 -93.16 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.607 0.717 . . . . 0.0 110.208 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 68' ' ' SER . 3.9 p30 -77.0 -172.07 2.21 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.963 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.542 ' O ' ' CB ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -63.77 46.98 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.385 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.542 ' CB ' ' O ' ' A' ' 66' ' ' GLU . 10.9 t80 91.5 69.2 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.103 0 O-C-N 124.003 0.815 . . . . 0.0 109.888 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.564 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.7 OUTLIER -61.03 147.82 42.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.065 -178.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.747 HG22 ' H ' ' A' ' 70' ' ' PHE . 18.1 mm -98.06 -132.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.082 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.747 ' H ' HG22 ' A' ' 69' ' ' ILE . 0.2 OUTLIER 61.67 127.84 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.499 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.484 ' O ' ' N ' ' A' ' 73' ' ' THR . 77.3 Cg_exo -42.25 171.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.004 1.802 . . . . 0.0 112.745 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 65.73 -51.71 0.38 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.764 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.492 HG21 ' HB2' ' A' ' 68' ' ' SER . 13.9 m -40.85 -60.13 1.25 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.586 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.611 ' CD1' HG23 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -134.1 95.24 3.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.417 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.6 p -83.62 51.51 2.03 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.436 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.611 HG23 ' CD1' ' A' ' 74' ' ' TYR . 0.9 OUTLIER -81.99 175.68 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.426 0.631 . . . . 0.0 111.703 -179.818 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 6.3 p-10 -145.54 48.0 1.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.263 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.428 HD12 ' O ' ' A' ' 80' ' ' GLY . 40.6 pt -81.33 -172.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.822 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.24 16.33 0.93 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.144 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.428 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -148.02 166.47 28.91 Favored Glycine 0 CA--C 1.516 0.152 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.73 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.518 ' OH ' ' CD1' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -151.98 123.17 7.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.711 -0.744 . . . . 0.0 111.481 178.193 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.624 ' O ' HG23 ' A' ' 82' ' ' ILE . 10.8 tt -127.07 104.24 12.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.628 0.728 . . . . 0.0 109.064 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.989 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.32 123.29 41.09 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.784 -178.332 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -96.65 118.13 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.468 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.556 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 27.9 p90 -120.28 144.52 47.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.581 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.482 ' HG ' ' H ' ' A' ' 89' ' ' SER . 4.8 p -87.89 142.15 28.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.499 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.562 HG21 ' N ' ' A' ' 124' ' ' HIS . 16.5 m -76.15 18.7 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.245 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.551 ' HB ' HD23 ' A' ' 123' ' ' LEU . 0.7 OUTLIER -133.18 -23.38 1.94 Allowed 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.063 0.459 . . . . 0.0 111.752 -178.342 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.54 ' C ' ' N ' ' A' ' 91' ' ' LYS . 22.7 t -93.71 93.47 8.03 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.96 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 tp -59.69 -11.76 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.648 ' O ' HG22 ' A' ' 95' ' ' VAL . 9.3 mttp -78.07 -51.23 10.62 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.458 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.0 p -56.48 -34.91 67.37 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.374 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.556 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.5 OUTLIER -70.8 -54.85 10.09 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.415 -179.278 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -63.0 -44.41 96.1 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.648 HG22 ' O ' ' A' ' 91' ' ' LYS . 17.7 m -64.79 -34.4 69.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.034 -0.667 . . . . 0.0 110.186 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.441 ' CG1' HD22 ' A' ' 12' ' ' LEU . 1.8 mt -65.2 -35.61 75.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.087 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.0 tttp -69.97 -27.56 64.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.546 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.8 t -76.95 -67.27 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.281 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.6 mp -43.41 -45.31 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.4 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.435 ' CD2' ' N ' ' A' ' 101' ' ' GLY . 24.1 t60 -60.09 -58.36 8.88 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.504 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.435 ' N ' ' CD2' ' A' ' 100' ' ' HIS . . . -37.68 -57.7 1.52 Allowed Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.866 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 105' ' ' ASP . 10.9 tptm -58.68 -66.65 0.46 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.274 -0.463 . . . . 0.0 110.574 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 106' ' ' MET . 0.7 OUTLIER -37.05 -62.25 0.51 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.72 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -42.86 -47.92 5.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.359 178.695 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -62.57 -30.66 71.48 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.258 -179.353 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 103' ' ' LEU . 58.8 ttp -75.86 -47.28 26.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.723 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.657 HG23 ' H ' ' A' ' 109' ' ' LYS . 4.6 m -75.39 -26.62 18.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.482 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 40.61 35.79 0.92 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.657 ' H ' HG23 ' A' ' 107' ' ' VAL . 0.4 OUTLIER -100.09 -157.93 0.64 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.281 0.563 . . . . 0.0 111.806 -178.389 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 110' ' ' VAL . 0.0 OUTLIER -92.05 -167.54 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.158 -179.755 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -66.6 116.43 7.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.896 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.43 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -112.81 150.36 42.67 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.408 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -48.55 107.54 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.707 1.604 . . . . 0.0 112.857 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.458 ' HB ' ' HB2' ' A' ' 143' ' ' ALA . 2.9 mt -120.61 126.5 75.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.48 ' O ' HD12 ' A' ' 83' ' ' LEU . 8.3 tpt -126.47 115.28 19.33 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.237 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.3 mt -96.02 97.82 9.89 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.58 132.56 49.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 122.135 0.969 . . . . 0.0 110.574 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.75 109.47 3.2 Favored Glycine 0 C--N 1.304 -1.239 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.475 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.6 t30 -97.24 175.62 6.21 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.182 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.477 ' HZ2' ' C ' ' A' ' 17' ' ' VAL . 2.9 mttp 66.25 59.54 0.66 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 122.026 0.917 . . . . 0.0 109.291 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.509 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 19.2 tttm -63.77 -37.88 89.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.053 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.637 ' CG ' HN21 ' A' ' 186' ' ' GDP . 5.0 p-10 -60.45 -5.61 1.25 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.783 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.551 HD23 ' HB ' ' A' ' 88' ' ' THR . 8.2 mp -91.95 -26.88 18.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.562 ' N ' HG21 ' A' ' 87' ' ' VAL . 13.2 p-80 -38.97 -24.97 0.01 OUTLIER 'General case' 0 C--N 1.339 0.124 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.719 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.536 ' N ' ' O ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -46.51 -22.89 0.31 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.293 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.479 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -110.38 -37.55 5.48 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.666 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.474 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 0.1 OUTLIER 29.65 91.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.886 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 46.1 t -72.37 -36.75 56.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.193 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.7 tp -89.57 154.74 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.634 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.494 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 99.5 p -101.55 127.24 48.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.742 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -40.63 -34.0 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.988 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -68.51 -65.42 0.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.988 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.494 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 63.6 mt-10 -41.38 -41.61 2.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.933 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.06 -34.7 64.72 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 132' ' ' GLU . 3.2 tttm -63.96 -55.27 23.72 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.28 -35.34 67.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.68 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.48 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -65.54 -62.09 1.72 Allowed 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -53.12 -38.41 62.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.226 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -33.28 75.51 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.736 0.303 . . . . 0.0 110.245 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.8 -46.11 86.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.828 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.48 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 42.2 m95 -89.09 1.04 56.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.695 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 6.5 m120 68.38 32.92 4.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.652 0.739 . . . . 0.0 109.58 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -100.84 169.04 9.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.862 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.14 133.79 51.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.305 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.699 ' O ' HD22 ' A' ' 146' ' ' LEU . 5.2 t80 -96.9 123.39 40.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.814 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.699 HD22 ' O ' ' A' ' 145' ' ' PHE . 1.3 mm? -134.74 137.14 43.2 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.862 -176.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.474 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 6.2 tt0 -126.39 111.17 14.16 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 34.7 p -137.15 -173.85 3.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.134 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.0 136.09 34.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.919 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.517 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -63.79 -26.73 68.76 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.25 4.37 12.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.723 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -138.85 122.6 17.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.11 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 154' ' ' GLN . 65.6 t30 -77.42 -55.48 5.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.614 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 153' ' ' ASN . 10.2 tt0 -36.91 -56.03 0.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.96 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.617 ' O ' HG23 ' A' ' 159' ' ' VAL . 67.6 p -55.59 -46.12 77.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.021 0.439 . . . . 0.0 110.297 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -54.53 -62.08 1.89 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.952 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 61.5 t -43.0 -39.94 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.435 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.77 -33.11 75.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.59 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.691 HG22 HD12 ' A' ' 146' ' ' LEU . 32.4 t -70.72 -35.38 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.954 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.81 ' CZ ' HD12 ' A' ' 47' ' ' ILE . 23.5 t80 -64.32 -65.69 0.64 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.561 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.582 HH22 HG23 ' A' ' 49' ' ' VAL . 9.1 ttm-85 -48.41 -43.33 34.03 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.759 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.574 ' HE ' HD21 ' A' ' 146' ' ' LEU . 11.4 mmm180 -58.51 -33.37 69.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.456 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -66.27 -34.29 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.917 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.78 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 11.1 mt -63.5 -48.18 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.267 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -55.47 -59.93 4.13 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.552 179.609 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.476 ' H ' HD23 ' A' ' 165' ' ' LEU . 4.5 tt0 -51.31 -24.03 4.2 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.78 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -71.34 -31.14 67.03 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.935 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 165' ' ' LEU . 0.4 OUTLIER -70.74 -54.72 10.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.886 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -60.05 -50.23 74.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.068 0.461 . . . . 0.0 110.565 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.466 ' CG1' ' O ' ' A' ' 166' ' ' GLU . 3.1 mm -49.64 -42.98 18.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.966 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -66.29 -39.76 89.57 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.339 -179.579 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.37 -41.94 55.91 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.14 -79.88 0.06 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.754 0.312 . . . . 0.0 110.474 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.022 -179.904 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GDP . . . . . 0.637 HN21 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.171 0.51 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.97 135.64 32.96 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.647 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.518 ' HB2' HG22 ' A' ' 78' ' ' ILE . 17.0 mttt -107.21 128.53 54.5 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.784 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -102.3 122.97 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 121.507 0.67 . . . . 0.0 110.469 -178.511 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.481 ' HB2' ' CD1' ' A' ' 78' ' ' ILE . . . -83.9 134.27 34.69 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.373 -0.83 . . . . 0.0 111.606 -177.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.6 mt -95.44 130.16 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.523 0.678 . . . . 0.0 112.14 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.604 HD23 ' C ' ' A' ' 12' ' ' LEU . 5.1 tt -127.91 102.55 6.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.54 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.12 136.45 7.53 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.485 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -51.94 -161.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.676 0.751 . . . . 0.0 111.321 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -94.14 131.79 39.32 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.666 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.452 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 4.1 m 60.54 20.09 9.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.472 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 p -74.7 -19.59 16.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.606 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.452 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 98.13 20.17 21.56 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.472 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.1 pttm -69.2 -34.81 75.48 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.318 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.9 m -73.45 -30.39 63.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.419 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 65.5 p -67.8 -40.86 83.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.409 ' O ' ' CB ' ' A' ' 26' ' ' PHE . 46.1 tp -77.5 -26.49 51.27 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.759 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.623 ' O ' HG12 ' A' ' 27' ' ' VAL . 57.5 m -62.77 -41.51 99.27 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.59 -41.6 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.606 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.535 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -71.88 -27.29 62.76 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.663 -179.42 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.409 ' CB ' ' O ' ' A' ' 22' ' ' LEU . 52.8 t80 -77.94 -62.05 1.8 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.303 0.573 . . . . 0.0 110.691 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.623 HG12 ' O ' ' A' ' 23' ' ' THR . 11.8 p -48.09 -48.9 12.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.804 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.612 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.4 mt-10 -80.42 -24.3 39.74 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.402 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 72.76 25.47 73.86 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -150.29 126.63 10.73 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.732 0.301 . . . . 0.0 111.338 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.614 ' CD1' ' O ' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -64.96 91.85 0.1 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 122.02 0.915 . . . . 0.0 110.691 178.757 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.593 HG22 ' N ' ' A' ' 33' ' ' ASP . 11.4 p -109.2 166.34 4.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.838 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.593 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -74.36 -41.52 60.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.958 -179.687 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 33' ' ' ASP . 4.2 p 43.5 -170.16 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.961 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -149.9 52.68 0.92 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.453 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 37' ' ' PRO . 9.7 t70 -131.95 81.85 61.31 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.293 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 36' ' ' ASP . 52.1 Cg_exo -57.08 -132.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.869 2.379 . . . . 0.0 111.806 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 38' ' ' THR . 12.4 t -96.25 43.05 1.08 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.167 0.508 . . . . 0.0 111.311 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 tp -84.5 163.64 2.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.901 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -86.5 124.79 33.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.637 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -164.19 -176.69 4.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.236 0.541 . . . . 0.0 111.982 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.411 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 4.0 m -133.14 152.77 51.93 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.13 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 11.9 m-85 -133.17 162.94 30.42 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 111.008 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.61 152.34 43.91 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.537 0.684 . . . . 0.0 112.487 -179.223 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.591 ' C ' HD12 ' A' ' 46' ' ' LEU . 25.8 tttp -157.11 111.01 2.64 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.407 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.718 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.2 mp -105.2 127.28 52.85 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.491 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.484 HD12 ' CE1' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -148.61 165.13 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.708 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.4 m -114.61 126.67 55.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.924 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.701 HG11 HG21 ' A' ' 164' ' ' ILE . 1.5 p -124.95 123.35 65.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.819 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 70.95 19.79 5.56 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.91 -9.77 62.09 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -90.91 134.93 34.08 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.01 145.5 40.19 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.561 0.696 . . . . 0.0 111.058 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.404 ' OH ' ' OE1' ' A' ' 168' ' ' GLU . 9.3 m-85 -139.44 125.14 19.47 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.778 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.605 ' C ' HD22 ' A' ' 56' ' ' LEU . 1.2 m-70 -117.44 113.65 22.36 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.703 ' N ' HD22 ' A' ' 56' ' ' LEU . 2.1 mm? -119.23 140.0 50.95 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 121.509 0.671 . . . . 0.0 111.629 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.828 ' C ' HD13 ' A' ' 58' ' ' LEU . 1.1 mt-30 -136.76 124.98 23.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.777 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.984 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.13 148.86 39.87 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.916 -178.368 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -118.49 141.5 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 114.998 -1.001 . . . . 0.0 113.165 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -114.42 101.65 9.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.333 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.515 ' OG1' ' CZ ' ' A' ' 74' ' ' TYR . 0.9 OUTLIER -149.32 156.74 42.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.473 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 64' ' ' GLN . . . -126.03 7.72 7.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.007 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 62' ' ' ALA . . . 33.78 -94.2 0.01 OUTLIER Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -115.25 -54.33 2.55 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.757 0.789 . . . . 0.0 109.547 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.636 ' O ' ' N ' ' A' ' 67' ' ' TYR . 2.1 p30 -112.16 -172.94 2.14 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.045 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.63 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -28.84 -30.7 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.144 0 O-C-N 123.591 0.557 . . . . 0.0 111.222 -178.899 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.636 ' N ' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -170.36 1.08 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.929 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.2 m 54.48 98.3 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 69' ' ' ILE . 0.4 OUTLIER -69.89 -35.25 63.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-O 121.423 0.63 . . . . 0.0 109.45 178.642 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.89 152.78 59.82 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.723 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -42.44 144.61 1.17 Allowed 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.346 2.031 . . . . 0.0 112.335 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -173.82 -73.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.605 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.9 m -153.73 16.05 0.51 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.205 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.67 ' CE1' HD11 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -113.98 28.99 8.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.356 -179.142 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.5 p -78.95 22.49 0.38 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.229 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.67 HD11 ' CE1' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -56.04 -173.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 111.146 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.69 52.42 1.88 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.378 0.608 . . . . 0.0 109.363 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.518 HG22 ' HB2' ' A' ' 8' ' ' LYS . 35.7 pt -77.44 -172.5 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.723 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.41 14.27 0.98 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.578 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -142.29 165.79 26.59 Favored Glycine 0 N--CA 1.454 -0.114 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.179 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.549 ' OH ' ' CE1' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -151.82 122.41 7.4 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.767 -0.717 . . . . 0.0 111.205 178.27 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.628 ' O ' HG23 ' A' ' 82' ' ' ILE . 11.3 tt -125.28 103.83 12.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.973 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -96.32 126.73 41.73 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.407 -177.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.447 ' O ' HG12 ' A' ' 84' ' ' VAL . 2.0 t -96.07 113.68 31.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.43 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -110.37 146.05 36.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.734 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.558 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.0 OUTLIER -100.55 143.48 30.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.077 0.465 . . . . 0.0 111.881 -177.624 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.575 HG21 ' N ' ' A' ' 124' ' ' HIS . 17.3 m -81.15 21.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.633 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.407 ' HB ' HD23 ' A' ' 123' ' ' LEU . 1.0 OUTLIER -140.55 -17.76 0.88 Allowed 'General case' 0 C--O 1.231 0.097 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.605 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.558 ' H ' ' HG ' ' A' ' 86' ' ' SER . 43.8 t -112.7 93.46 4.44 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 94' ' ' GLU . 30.5 mm -50.84 -15.6 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.793 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.4 OUTLIER -78.31 -49.14 14.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.244 179.287 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.7 p -59.74 -44.6 93.74 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.517 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -79.3 -34.02 42.79 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 119.354 -0.939 . . . . 0.0 112.533 -178.126 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.416 ' HG3' HG22 ' A' ' 90' ' ' ILE . 8.9 mm-40 -69.84 -44.98 68.8 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.15 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 91' ' ' LYS . 28.1 m -64.99 -37.37 80.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.645 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.405 ' N ' HG23 ' A' ' 95' ' ' VAL . 1.3 mt -61.74 -36.03 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -70.1 -25.79 63.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.333 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.5 t -76.1 -67.22 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.5 mp -42.81 -40.68 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.616 ' NE2' ' CD1' ' A' ' 141' ' ' TRP . 25.7 t-80 -60.32 -63.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.673 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.82 -50.6 2.0 Favored Glycine 0 CA--C 1.518 0.267 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 105' ' ' ASP . 12.7 tptm -66.03 -65.79 0.63 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.273 -0.464 . . . . 0.0 110.106 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.36 -58.75 0.81 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.933 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.749 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -47.0 -43.82 19.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.677 178.737 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -62.36 -34.25 76.33 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.374 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.517 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 12.6 ttm -61.57 -55.9 25.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.99 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.471 ' C ' ' H ' ' A' ' 109' ' ' LYS . 18.1 m -77.28 -12.9 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.16 0.505 . . . . 0.0 110.249 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.16 -25.23 0.16 Allowed Glycine 0 CA--C 1.53 1.01 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.949 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.581 ' CG ' ' H ' ' A' ' 110' ' ' VAL . 3.4 tptt -173.92 -128.82 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 117.803 0.802 . . . . 0.0 112.016 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.581 ' H ' ' CG ' ' A' ' 109' ' ' LYS . 6.6 t 52.09 116.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.757 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.563 ' OE1' ' HB1' ' A' ' 173' ' ' ALA . 8.6 mt-30 -77.81 124.76 28.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.891 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.667 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.2 OUTLIER -132.06 155.78 80.92 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.308 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -48.69 107.43 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.689 1.593 . . . . 0.0 112.174 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.6 mt -123.84 129.18 74.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.508 ' O ' HD12 ' A' ' 83' ' ' LEU . 8.7 tpt -128.85 117.42 21.01 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.329 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.1 mt -97.34 97.59 9.26 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.7 t -104.45 134.22 46.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 122.196 0.998 . . . . 0.0 110.958 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -104.88 116.44 5.29 Favored Glycine 0 C--N 1.302 -1.313 0 CA-C-N 113.699 -1.592 . . . . 0.0 109.234 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.487 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 50.1 t30 -98.0 173.87 6.84 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.718 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.487 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 25.5 mttt 61.17 58.67 2.16 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.624 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.527 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -60.2 -35.24 74.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.282 -179.168 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.656 ' CG ' HN21 ' A' ' 186' ' ' GDP . 5.1 p-10 -61.15 -13.63 19.11 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.488 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 125' ' ' MET . 9.8 mp -88.1 -31.37 19.25 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.575 ' N ' HG21 ' A' ' 87' ' ' VAL . 2.5 p-80 -37.67 -26.46 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.976 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.536 ' N ' ' O ' ' A' ' 123' ' ' LEU . 6.9 mmt -43.93 -24.64 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.454 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.3 OUTLIER -103.23 -34.94 8.63 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.815 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.458 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 1.6 tpt180 38.39 92.82 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.23 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.535 HG22 ' C ' ' A' ' 87' ' ' VAL . 19.6 m -85.4 -35.43 9.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.312 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -89.48 130.0 39.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.159 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.408 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 92.4 p -77.1 122.19 24.62 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.946 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -40.56 -38.38 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.322 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -60.98 -64.21 1.03 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.011 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.408 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 64.2 mt-10 -41.11 -49.91 3.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.179 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.33 -25.72 74.56 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 132' ' ' GLU . 13.1 tttm -71.26 -55.98 6.98 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -55.95 -33.01 64.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.296 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.652 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -66.53 -62.97 1.18 Allowed 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.807 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -53.65 -36.89 62.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.312 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -69.56 -30.29 68.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.474 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.526 ' OG ' ' CD2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -63.63 -47.15 82.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.02 -178.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.652 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 8.4 m95 -91.52 -5.27 54.41 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.355 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 141' ' ' TRP . 0.9 OUTLIER 77.45 26.01 0.71 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.779 -179.271 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.45 170.11 11.19 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.218 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.19 133.39 50.03 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.906 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.64 ' O ' HD22 ' A' ' 146' ' ' LEU . 6.5 t80 -97.06 122.96 40.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.767 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.895 HD12 HG22 ' A' ' 159' ' ' VAL . 1.2 mm? -133.12 138.81 46.8 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.939 -176.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.458 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 4.9 tt0 -127.5 110.01 12.31 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.518 ' OG ' HG21 ' A' ' 159' ' ' VAL . 0.1 OUTLIER -136.37 -178.38 5.14 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.676 -178.014 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 152' ' ' GLU . 0.0 OUTLIER -138.77 132.79 31.24 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.39 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.479 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -54.41 -53.07 59.0 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.112 0.482 . . . . 0.0 109.843 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -51.28 -8.74 0.05 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.938 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.479 ' H ' ' C ' ' A' ' 150' ' ' ALA . 18.7 mt-10 -131.4 119.2 21.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.978 0.418 . . . . 0.0 110.657 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.454 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 39.5 t30 -75.35 -48.25 23.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.195 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 153' ' ' ASN . 3.3 mt-30 -36.71 -59.48 0.67 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.023 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.5 p -54.43 -46.64 73.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.169 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.535 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -51.45 -59.4 4.28 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.524 0.678 . . . . 0.0 109.584 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 50.5 t -42.36 -48.43 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.67 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -54.02 -33.07 56.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.525 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.895 HG22 HD12 ' A' ' 146' ' ' LEU . 11.6 t -77.06 -27.67 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.982 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.484 ' CE1' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -68.64 -41.63 79.13 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.5 179.779 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.7 ttm-85 -79.86 -49.98 11.16 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.961 -0.695 . . . . 0.0 110.928 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -53.47 -37.88 63.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.31 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 159' ' ' VAL . 13.0 tt -68.39 -56.7 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.403 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.701 HG21 HG11 ' A' ' 49' ' ' VAL . 84.7 mt -47.9 -33.87 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.975 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.8 -64.42 0.95 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.059 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -58.53 -28.57 65.59 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.532 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -59.56 -33.53 71.53 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.404 ' OE1' ' OH ' ' A' ' 54' ' ' TYR . 33.5 tp10 -68.73 -57.15 6.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.329 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 13.2 tttm -52.49 -56.72 13.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.636 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.667 HG21 ' C ' ' A' ' 112' ' ' ILE . 66.3 mt -52.84 -34.2 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.137 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 172' ' ' GLY . 0.0 OUTLIER -68.9 -40.45 79.14 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.611 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.414 ' N ' ' OD1' ' A' ' 171' ' ' ASP . . . -60.3 -35.83 89.3 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.563 ' HB1' ' OE1' ' A' ' 111' ' ' GLN . . . -68.07 -60.77 2.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.803 0.335 . . . . 0.0 110.494 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.792 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GDP . . . . . 0.656 HN21 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 121.174 0.512 . . . . 0.0 110.445 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.84 136.39 33.95 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.611 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.435 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 4.0 mptt -106.66 121.28 44.03 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.551 HD11 HD12 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -98.95 117.2 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-O 121.824 0.821 . . . . 0.0 110.027 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.82 136.23 34.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.096 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.5 mt -95.27 132.81 38.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.23 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.645 HD23 ' C ' ' A' ' 12' ' ' LEU . 6.3 tt -127.65 104.05 7.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.392 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.39 134.87 6.51 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.691 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.446 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -55.05 -159.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.3 0.571 . . . . 0.0 110.582 179.187 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -92.61 133.28 36.12 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.952 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.52 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 7.7 m 56.58 19.46 4.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.546 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.415 ' H ' HG12 ' A' ' 17' ' ' VAL . 2.8 p -69.85 -27.34 32.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.794 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.448 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 105.1 23.51 7.67 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.418 ' CE ' ' OD2' ' A' ' 60' ' ' ASP . 3.5 pttm -71.18 -33.59 70.13 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.356 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.2 m -75.75 -30.92 59.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.156 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 72.4 p -65.28 -54.15 33.53 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.056 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 23' ' ' THR . 24.7 tp -62.91 -52.06 64.53 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.731 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.49 ' O ' HG12 ' A' ' 27' ' ' VAL . 9.2 m -36.47 -64.12 0.35 Allowed 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 122.976 0.172 . . . . 0.0 110.774 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -57.45 -41.72 79.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.144 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.663 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -66.99 -35.92 81.03 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.263 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.494 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.6 OUTLIER -77.54 -62.81 1.54 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.369 0.604 . . . . 0.0 110.705 -179.636 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.569 HG13 ' N ' ' A' ' 28' ' ' GLU . 9.1 p -44.77 -49.29 2.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.488 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.569 ' N ' HG13 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -79.78 -24.54 41.4 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.081 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 74.96 26.66 66.21 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.784 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 31' ' ' PHE . 10.6 tp60 -147.91 125.89 12.04 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.895 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.528 ' O ' ' NE2' ' A' ' 30' ' ' GLN . 1.2 t80 -66.76 96.37 0.4 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.606 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.624 HG22 ' N ' ' A' ' 33' ' ' ASP . 13.4 p -99.25 166.94 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.18 0.514 . . . . 0.0 110.768 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.624 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -64.18 12.5 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.018 -178.97 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.608 ' H ' HG13 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -39.48 115.12 0.47 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.85 0.357 . . . . 0.0 110.792 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -151.48 85.02 1.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.592 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -133.48 176.63 2.76 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.054 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 36' ' ' ASP . 42.3 Cg_exo -57.31 -138.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.575 2.183 . . . . 0.0 111.371 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.695 HG23 ' O ' ' A' ' 38' ' ' THR . 11.0 t -130.34 61.8 1.59 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.867 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 tp -83.2 147.06 6.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.075 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 2.6 pt-20 -88.11 152.29 22.11 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.045 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 1.4 m120 -177.47 174.48 1.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.235 0.541 . . . . 0.0 112.072 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.31 146.48 32.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.699 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 7.2 m-85 -131.7 164.16 26.55 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.318 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.84 156.67 42.96 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.328 0.585 . . . . 0.0 112.071 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -160.15 111.36 1.93 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.698 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.9 mp -104.81 121.01 42.75 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.943 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.534 ' O ' HD12 ' A' ' 47' ' ' ILE . 1.1 pp -147.72 165.16 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.595 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -111.82 127.97 55.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.99 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.735 HG11 HG21 ' A' ' 164' ' ' ILE . 2.5 p -128.16 124.86 63.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.526 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 49' ' ' VAL . 1.9 t-20 73.23 10.71 5.11 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.19 -11.87 71.04 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -91.21 137.84 32.06 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -76.4 146.06 38.94 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.578 0.704 . . . . 0.0 111.023 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.43 ' OH ' ' OE1' ' A' ' 168' ' ' GLU . 8.2 m-85 -135.87 126.78 27.62 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.459 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.646 ' C ' HD22 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -117.52 113.73 22.43 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.646 HD22 ' C ' ' A' ' 55' ' ' HIS . 2.9 mm? -119.39 138.61 52.97 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 121.356 0.598 . . . . 0.0 111.356 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.453 ' O ' HD12 ' A' ' 58' ' ' LEU . 5.3 mt-30 -126.99 127.3 44.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.087 177.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.546 HD11 ' CG1' ' A' ' 9' ' ' ILE . 3.4 mp -114.43 154.83 27.45 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.098 0.475 . . . . 0.0 112.182 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.12 143.99 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 CA-C-O 122.035 0.921 . . . . 0.0 112.72 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.425 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -125.26 105.14 8.9 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.189 -1.369 . . . . 0.0 107.893 177.64 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.34 153.63 18.82 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.51 -178.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.32 8.91 3.43 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.144 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.72 -55.35 25.8 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -112.02 -139.1 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.386 0.612 . . . . 0.0 110.818 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -74.95 -175.96 2.75 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.927 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.592 ' HG2' HG21 ' A' ' 95' ' ' VAL . 0.9 OUTLIER -33.9 -31.9 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.252 0.549 . . . . 0.0 109.797 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.605 ' CG ' ' O ' ' A' ' 67' ' ' TYR . 2.9 t80 166.8 82.93 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.423 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.52 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 1.4 m -67.71 123.79 21.49 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.977 -178.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.686 HG22 ' H ' ' A' ' 70' ' ' PHE . 6.5 mm -62.08 -131.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.686 ' H ' HG22 ' A' ' 69' ' ' ILE . 40.7 t80 41.42 80.83 0.26 Allowed Pre-proline 0 C--N 1.331 -0.223 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.603 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.462 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 47.1 Cg_exo -52.28 -161.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.674 2.249 . . . . 0.0 112.434 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.462 ' CB ' ' O ' ' A' ' 71' ' ' PRO . 1.1 tt0 81.02 -35.21 0.11 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.269 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.5 m -101.46 -20.67 15.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.255 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -94.66 -28.85 15.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.564 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.6 t 49.32 49.48 19.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.915 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.455 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 0.9 OUTLIER -77.55 -97.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 120.839 0.352 . . . . 0.0 110.906 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 3.0 m-20 87.11 33.57 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.53 HD12 ' O ' ' A' ' 80' ' ' GLY . 37.8 pt -83.95 -169.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 CA-C-N 114.51 -1.223 . . . . 0.0 112.554 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.68 13.73 1.19 Allowed 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.41 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.53 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -148.24 163.29 28.92 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.487 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.55 ' OH ' ' CD2' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -151.45 123.46 8.15 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.787 -0.706 . . . . 0.0 111.094 177.841 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.558 ' O ' HG23 ' A' ' 82' ' ' ILE . 9.5 tt -126.93 106.81 16.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.661 0.743 . . . . 0.0 109.146 178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.715 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -97.32 122.5 40.42 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.459 -178.123 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.405 ' O ' HG12 ' A' ' 84' ' ' VAL . 1.7 t -97.04 114.53 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.456 ' CZ ' ' CA ' ' A' ' 118' ' ' GLY . 26.2 p90 -115.4 144.58 43.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.704 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.477 ' C ' ' H ' ' A' ' 88' ' ' THR . 3.4 p -87.11 141.93 28.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.068 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.63 HG21 ' N ' ' A' ' 124' ' ' HIS . 16.2 m -73.7 18.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.639 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.477 ' H ' ' C ' ' A' ' 86' ' ' SER . 6.4 t -138.91 -22.07 0.96 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.508 ' C ' ' N ' ' A' ' 91' ' ' LYS . 22.9 t -90.83 93.07 9.07 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.201 -176.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.6 tp -59.11 -10.69 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.539 ' O ' HG22 ' A' ' 95' ' ' VAL . 6.9 mttm -77.84 -51.5 10.38 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.18 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 53.5 p -57.68 -31.74 66.65 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.674 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -75.39 -47.66 26.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.89 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.513 ' O ' HG23 ' A' ' 98' ' ' VAL . 6.1 mt-10 -63.35 -43.24 98.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.863 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.592 HG21 ' HG2' ' A' ' 66' ' ' GLU . 31.6 m -67.02 -38.97 82.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.197 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.418 ' N ' HG23 ' A' ' 95' ' ' VAL . 5.2 mt -59.4 -38.47 75.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.1 tttp -73.13 -26.63 61.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.836 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 94' ' ' GLU . 64.0 t -77.37 -67.15 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.985 0.422 . . . . 0.0 110.033 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.515 HD12 ' N ' ' A' ' 100' ' ' HIS . 2.5 pp -45.23 -39.78 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.174 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.62 ' NE2' ' CE2' ' A' ' 141' ' ' TRP . 18.3 t60 -62.56 -61.34 2.5 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.235 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 100' ' ' HIS . . . -35.87 -48.68 1.05 Allowed Glycine 0 C--N 1.33 0.25 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 105' ' ' ASP . 1.9 tppt? -68.8 -66.68 0.54 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.429 -0.385 . . . . 0.0 110.03 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.87 -59.1 0.86 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.13 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.721 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -45.9 -45.39 15.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.487 178.631 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -59.18 -39.02 81.25 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.833 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 5.8 ttm -61.67 -56.65 17.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.816 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' A' ' 109' ' ' LYS . 18.5 m -77.07 -12.55 14.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.035 0.445 . . . . 0.0 110.773 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.04 -25.11 0.06 OUTLIER Glycine 0 CA--C 1.534 1.228 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.891 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.539 ' H ' ' C ' ' A' ' 107' ' ' VAL . 3.9 tttm -174.27 -126.63 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.758 0.779 . . . . 0.0 111.482 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.484 ' H ' ' CG ' ' A' ' 109' ' ' LYS . 6.4 t 52.06 118.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.886 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.513 ' OE1' ' HB1' ' A' ' 173' ' ' ALA . 9.8 mt-30 -77.27 137.52 38.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.97 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.651 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.4 OUTLIER -143.35 151.21 54.22 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.775 179.329 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -48.29 111.82 0.5 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.763 1.642 . . . . 0.0 112.407 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' A' ' 143' ' ' ALA . 2.8 mt -126.86 132.41 70.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.7 tpt -130.85 114.69 15.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.951 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.1 mt -96.74 98.13 9.91 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.2 t -105.03 130.79 55.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 122.153 0.978 . . . . 0.0 111.395 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.456 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -97.83 114.78 5.09 Favored Glycine 0 C--N 1.307 -1.043 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.486 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.9 t30 -97.49 173.99 6.89 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.025 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.486 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 23.2 mttt 60.4 58.87 2.42 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.712 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.3 tttm -60.48 -32.6 71.58 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.643 ' CG ' HN21 ' A' ' 186' ' ' GDP . 3.5 p-10 -60.8 -18.05 53.07 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.956 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 125' ' ' MET . 11.0 mp -85.86 -26.39 25.68 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.63 ' N ' HG21 ' A' ' 87' ' ' VAL . 1.0 OUTLIER -40.27 -24.63 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.854 179.094 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 123' ' ' LEU . 15.1 mtt -46.72 -22.53 0.31 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.462 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -108.28 -42.5 4.59 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.564 -179.654 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.5 ' NE ' ' OE1' ' A' ' 147' ' ' GLU . 22.6 ttm180 26.44 83.61 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.868 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.5 m -62.91 -28.84 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.696 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.4 tp -89.54 155.65 3.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.566 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.445 ' C ' ' N ' ' A' ' 132' ' ' GLU . 57.9 p -97.66 120.51 38.18 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.996 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -39.85 -29.41 0.06 Allowed 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.4 mp0 -70.26 -63.75 1.03 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.895 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.43 ' OE1' ' OG ' ' A' ' 130' ' ' SER . 57.7 mt-10 -41.2 -42.25 2.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.742 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.35 -34.89 63.69 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 132' ' ' GLU . 2.9 tttm -62.04 -55.03 33.26 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.02 -36.66 70.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.75 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.657 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -66.13 -62.87 1.25 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.159 0.504 . . . . 0.0 109.692 179.58 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.45 -35.12 51.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.122 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.03 -30.47 67.76 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.41 -46.86 84.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.757 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.657 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 15.0 m95 -90.5 -5.75 55.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.363 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 141' ' ' TRP . 1.1 t-20 78.73 24.8 0.55 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.008 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.31 167.6 13.4 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.712 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.65 128.83 54.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.975 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 5.9 t80 -97.95 121.38 39.79 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.768 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.08 126.4 14.85 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.5 ' OE1' ' NE ' ' A' ' 127' ' ' ARG . 7.8 mt-10 -99.16 117.26 33.24 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.2 p -137.47 -178.69 5.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.658 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 152' ' ' GLU . 0.1 OUTLIER -138.6 138.77 38.21 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.272 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -57.28 -48.0 80.02 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -55.83 -18.4 8.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.128 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 149' ' ' SER . 38.7 mt-10 -113.53 116.13 29.07 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.942 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.541 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 6.4 t-20 -77.53 -50.34 12.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.78 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 153' ' ' ASN . 5.9 tt0 -39.92 -57.29 1.64 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.428 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.704 ' O ' HG23 ' A' ' 159' ' ' VAL . 80.5 p -51.88 -44.28 63.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.663 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -55.41 -60.46 3.38 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.458 0.647 . . . . 0.0 109.626 178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 57.7 t -41.82 -40.39 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.339 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -67.67 -36.57 80.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.623 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 155' ' ' THR . 22.0 t -70.29 -34.18 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.523 0.678 . . . . 0.0 109.612 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.741 ' CE1' HD11 ' A' ' 164' ' ' ILE . 7.7 t80 -66.13 -51.14 60.73 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.015 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.7 ttt85 -66.74 -36.96 83.7 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.223 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -64.28 -33.61 76.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.875 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.694 HG22 ' O ' ' A' ' 160' ' ' PHE . 15.3 tt -70.85 -39.75 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.167 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.741 HD11 ' CE1' ' A' ' 160' ' ' PHE . 64.6 mt -62.52 -35.59 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.549 0.69 . . . . 0.0 109.231 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.35 -51.8 66.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.522 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -67.89 -26.48 66.02 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.526 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -61.07 -34.67 75.27 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.43 ' OE1' ' OH ' ' A' ' 54' ' ' TYR . 9.9 mm-40 -70.44 -55.98 7.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.647 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -54.81 -62.13 1.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.711 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.651 HG21 ' C ' ' A' ' 112' ' ' ILE . 81.5 mt -52.99 -33.14 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.175 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -69.89 -40.35 75.71 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.752 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -60.71 -36.88 92.59 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.513 ' HB1' ' OE1' ' A' ' 111' ' ' GLN . . . -68.98 -62.81 1.22 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.569 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.722 179.988 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GDP . . . . . 0.643 HN21 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 121.262 0.553 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.465 ' NH1' ' HB1' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -140.05 136.13 33.34 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.984 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.53 ' HB2' HG22 ' A' ' 78' ' ' ILE . 6.5 mttm -109.38 131.36 55.14 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.75 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -104.1 125.4 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 CA-C-O 121.377 0.608 . . . . 0.0 110.674 -178.067 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.07 133.49 34.64 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.352 -0.843 . . . . 0.0 110.792 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.1 mt -96.58 133.21 38.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.645 0.736 . . . . 0.0 112.361 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.602 HD23 ' C ' ' A' ' 12' ' ' LEU . 5.3 tt -125.77 104.01 8.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.114 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -140.16 133.6 6.09 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.64 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.422 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.5 OUTLIER -56.94 -158.51 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.357 0.599 . . . . 0.0 110.605 179.221 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -97.02 131.14 44.13 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.334 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.554 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 1.7 m 64.94 19.0 11.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.568 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 17' ' ' VAL . 4.9 p -80.58 -15.74 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.83 0.348 . . . . 0.0 110.222 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.41 12.24 33.81 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.428 ' NZ ' ' CB ' ' A' ' 19' ' ' LYS . 0.6 OUTLIER -45.22 -52.58 9.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.938 0.399 . . . . 0.0 110.914 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.545 ' O ' HD13 ' A' ' 24' ' ' ILE . 2.1 m -70.69 -26.69 63.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.491 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.576 ' OG ' ' H8 ' ' A' ' 186' ' ' GDP . 60.4 m -68.71 -49.59 57.7 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.989 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 45.9 tp -73.8 -26.32 60.57 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 119.626 -0.829 . . . . 0.0 110.782 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.545 ' O ' HG12 ' A' ' 27' ' ' VAL . 35.1 m -63.38 -41.01 98.77 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.545 HD13 ' O ' ' A' ' 20' ' ' SER . 1.3 mp -78.2 -37.03 21.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.754 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.644 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 0.6 OUTLIER -77.06 -27.48 54.37 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.582 -179.131 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -77.22 -53.41 7.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.432 0.634 . . . . 0.0 110.563 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.573 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.2 p -58.46 -45.58 89.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.08 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.573 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.4 tt0 -82.59 -24.47 33.91 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.72 27.5 70.79 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.52 ' N ' ' NE2' ' A' ' 25' ' ' GLN . 1.7 tp-100 -144.41 135.08 24.82 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.136 0.493 . . . . 0.0 111.637 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -73.07 94.46 1.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.917 179.027 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.626 HG22 ' N ' ' A' ' 33' ' ' ASP . 14.7 p -100.0 166.52 2.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.016 0.436 . . . . 0.0 110.559 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.626 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -41.49 -40.46 1.81 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.6 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.413 ' O ' ' O ' ' A' ' 33' ' ' ASP . 5.0 p 35.29 95.04 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.363 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -152.72 69.83 0.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.85 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.79 174.14 3.25 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.12 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -63.23 -149.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.3 2.0 . . . . 0.0 111.263 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 38' ' ' THR . 13.3 t -130.38 57.59 1.71 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.795 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 tp -83.7 159.28 3.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.414 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.58 138.08 31.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.955 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.29 170.36 4.29 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.351 -0.939 . . . . 0.0 113.34 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.78 143.43 44.02 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.61 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -122.71 169.17 11.34 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.367 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -146.99 147.56 30.82 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 120.008 -0.677 . . . . 0.0 112.605 -178.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.7 tttt -147.1 110.48 4.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.853 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.0 mp -106.4 122.83 47.06 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.254 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.437 HD12 ' CE1' ' A' ' 160' ' ' PHE . 1.2 pt -149.03 165.18 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.624 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 m -114.93 124.44 51.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.044 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.576 HG11 HG21 ' A' ' 164' ' ' ILE . 0.8 OUTLIER -121.95 126.03 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.649 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.12 21.45 10.11 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.14 -8.36 60.93 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.084 -1.207 . . . . 0.0 110.084 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -91.64 134.18 34.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -76.95 145.63 38.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.658 0.742 . . . . 0.0 111.785 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.452 ' CD1' ' CG1' ' A' ' 49' ' ' VAL . 13.5 m-85 -138.76 122.68 17.78 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.023 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.666 ' C ' HD12 ' A' ' 56' ' ' LEU . 67.7 m170 -117.12 113.49 22.35 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.666 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.9 mp -119.7 144.18 47.35 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.589 0.709 . . . . 0.0 112.04 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.756 ' C ' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -134.92 125.26 26.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.919 178.72 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.913 HD22 ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.66 154.19 32.04 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 120.01 -0.676 . . . . 0.0 112.065 -178.59 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.94 144.71 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.68 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.36 104.08 9.74 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.409 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.473 HG22 ' CE2' ' A' ' 74' ' ' TYR . 44.6 p -68.61 139.27 55.51 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.815 0.816 . . . . 0.0 111.152 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -144.1 14.32 1.67 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.299 -1.318 . . . . 0.0 108.461 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -104.38 -18.53 13.0 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.048 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -139.09 -148.65 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.678 0.751 . . . . 0.0 111.74 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.576 ' C ' ' H ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -75.7 -170.4 1.29 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.162 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 67' ' ' TYR . 0.3 OUTLIER -64.25 41.74 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.15 0 O-C-N 123.277 0.361 . . . . 0.0 110.172 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.576 ' H ' ' C ' ' A' ' 65' ' ' ASP . 16.0 t80 96.22 84.15 0.01 OUTLIER 'General case' 0 C--N 1.339 0.132 0 O-C-N 124.109 0.881 . . . . 0.0 108.854 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.564 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 5.6 m -65.77 111.7 3.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.216 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.824 ' H ' HD12 ' A' ' 69' ' ' ILE . 2.1 mp -41.42 150.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.98 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.529 ' O ' ' CD2' ' A' ' 70' ' ' PHE . 61.3 t80 54.9 65.78 4.62 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.872 0.368 . . . . 0.0 110.313 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -47.08 99.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.785 2.323 . . . . 0.0 112.178 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.06 -24.2 23.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.352 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.25 -30.93 10.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.741 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.473 ' CE2' HG22 ' A' ' 61' ' ' THR . 0.1 OUTLIER -85.96 102.24 13.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.891 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.1 m -87.94 52.77 2.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.867 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.434 ' HB ' HG23 ' A' ' 78' ' ' ILE . 0.9 OUTLIER -87.46 172.88 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.497 0.665 . . . . 0.0 112.149 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 4.9 p-10 -145.89 57.04 1.21 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.611 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.53 HG22 ' HB2' ' A' ' 8' ' ' LYS . 29.0 pt -78.72 -175.82 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -177.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.18 16.69 0.74 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.323 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -145.22 167.7 27.31 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.452 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.545 ' OH ' ' CD1' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -152.02 122.9 7.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.853 -0.674 . . . . 0.0 111.318 178.44 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.613 ' O ' HG23 ' A' ' 82' ' ' ILE . 10.5 tt -126.52 105.72 14.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 1.047 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.51 122.47 40.61 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.179 -0.609 . . . . 0.0 111.434 -178.3 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 84' ' ' VAL . 1.6 t -97.04 115.83 37.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.032 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.504 ' OH ' ' CZ ' ' A' ' 145' ' ' PHE . 53.8 p90 -109.76 144.69 37.82 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.494 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.0 OUTLIER -99.79 143.97 29.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.01 0.433 . . . . 0.0 111.47 -178.127 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.661 HG21 ' N ' ' A' ' 124' ' ' HIS . 14.7 m -80.78 22.21 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.34 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.22 -21.1 0.86 Allowed 'General case' 0 C--O 1.232 0.182 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.546 ' C ' ' N ' ' A' ' 91' ' ' LYS . 17.8 t -109.54 92.71 4.16 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.311 0.576 . . . . 0.0 111.694 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.438 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 1.0 OUTLIER -52.42 -15.24 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 176.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.698 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -78.24 -39.33 40.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.177 179.182 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 89' ' ' SER . 79.4 p -69.87 -46.07 66.32 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.495 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -78.6 -32.84 47.72 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 119.473 -0.891 . . . . 0.0 112.489 -177.821 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.486 ' OE1' ' CE1' ' A' ' 93' ' ' PHE . 8.4 mm-40 -69.3 -45.19 70.17 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.277 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 91' ' ' LYS . 27.7 m -66.05 -37.59 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 C-N-CA 120.141 -0.624 . . . . 0.0 109.976 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.583 ' CG1' HD22 ' A' ' 12' ' ' LEU . 2.0 mt -59.25 -40.54 81.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.986 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -70.1 -26.88 64.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.944 0.402 . . . . 0.0 110.411 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.3 t -75.53 -67.03 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.421 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.1 mt -47.37 -35.44 3.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.326 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.603 ' NE2' ' CD1' ' A' ' 141' ' ' TRP . 6.7 t-80 -62.38 -64.85 0.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.167 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -38.4 -57.62 1.79 Allowed Glycine 0 N--CA 1.453 -0.186 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.485 ' O ' ' N ' ' A' ' 105' ' ' ASP . 15.9 tptm -62.7 -65.14 0.73 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.059 -0.571 . . . . 0.0 110.641 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.05 -60.07 0.66 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.121 0.486 . . . . 0.0 109.849 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.758 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -45.85 -46.81 15.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.543 0.687 . . . . 0.0 109.368 178.675 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -61.96 -31.87 72.25 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.258 -179.356 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.524 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 48.8 ttp -69.18 -50.95 42.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.4 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.606 HG23 ' H ' ' A' ' 109' ' ' LYS . 6.9 m -76.47 -24.49 15.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.544 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.15 37.08 1.43 Allowed Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.606 ' H ' HG23 ' A' ' 107' ' ' VAL . 1.0 OUTLIER -95.17 -155.78 0.48 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.163 0.506 . . . . 0.0 111.575 -178.766 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.14 -170.42 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.774 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -65.24 115.82 5.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.896 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.482 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.7 OUTLIER -115.83 156.55 46.35 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.401 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -49.22 109.15 0.24 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.636 1.557 . . . . 0.0 112.599 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.482 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.4 mt -121.66 128.6 75.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.523 ' O ' HD12 ' A' ' 83' ' ' LEU . 7.4 tpt -131.69 112.7 12.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.575 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.9 mt -96.56 97.86 9.75 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.0 t -103.53 130.88 53.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 122.35 1.071 . . . . 0.0 111.364 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.466 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -98.26 106.55 3.3 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 113.593 -1.64 . . . . 0.0 109.082 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.482 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 55.0 t30 -96.78 174.91 6.56 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.527 -178.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.584 ' HZ1' " C1'" ' A' ' 186' ' ' GDP . 7.5 mttp 65.31 59.74 0.8 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.193 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.73 -39.14 90.85 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.682 ' CG ' HN21 ' A' ' 186' ' ' GDP . 5.9 p-10 -61.87 -3.5 1.18 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.047 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 125' ' ' MET . 9.7 mp -99.68 -30.17 12.25 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.661 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -39.93 -28.18 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.59 178.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.453 ' N ' ' O ' ' A' ' 123' ' ' LEU . 0.0 OUTLIER -41.18 -26.74 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.069 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -98.18 -36.18 10.14 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.822 179.495 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.563 HH12 ' CG2' ' A' ' 129' ' ' ILE . 7.0 tpt85 42.55 86.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.709 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.578 HG22 ' C ' ' A' ' 87' ' ' VAL . 30.6 m -80.28 -39.98 19.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.654 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.563 ' CG2' HH12 ' A' ' 127' ' ' ARG . 0.8 OUTLIER -86.68 132.16 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 132' ' ' GLU . 60.8 p -76.75 118.05 18.98 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.389 -0.525 . . . . 0.0 111.026 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -39.06 -29.48 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.28 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.4 mp0 -69.88 -63.07 1.15 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.874 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 132' ' ' GLU . 52.9 mt-10 -41.09 -46.11 2.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.95 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.11 -31.73 72.34 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 132' ' ' GLU . 19.6 tttm -65.43 -56.62 11.47 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -54.94 -33.33 62.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.349 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.11 -62.71 1.34 Allowed 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.892 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -56.95 -31.94 65.49 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.966 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.61 -35.28 72.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.771 0.319 . . . . 0.0 110.534 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -47.11 81.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.288 -178.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.603 ' CD1' ' NE2' ' A' ' 100' ' ' HIS . 18.6 m95 -91.2 -4.12 56.35 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.527 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 72.36 31.78 1.77 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.142 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.34 168.82 12.35 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.255 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -103.63 124.85 49.58 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.347 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.504 ' CZ ' ' OH ' ' A' ' 85' ' ' TYR . 7.3 t80 -97.8 123.19 41.65 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.863 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.52 123.67 12.91 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.471 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 2.8 mt-10 -98.72 114.82 27.5 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 5.0 p -136.33 -173.92 3.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.897 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.03 136.62 35.49 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.105 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.42 -43.63 98.37 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.132 0.491 . . . . 0.0 109.99 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.444 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 33.7 tttm -58.49 -7.03 0.8 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.519 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -126.9 128.4 46.42 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.769 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 154' ' ' GLN . 48.9 t30 -77.37 -56.01 4.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.09 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' A' ' 153' ' ' ASN . 1.7 mt-30 -36.41 -59.02 0.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.135 0.493 . . . . 0.0 110.983 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.586 ' O ' HG23 ' A' ' 159' ' ' VAL . 16.8 p -51.99 -51.34 57.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.649 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -52.31 -58.37 6.87 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.5 0.667 . . . . 0.0 109.713 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 53.7 t -42.21 -51.32 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.129 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -51.27 -36.43 42.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.053 0.454 . . . . 0.0 110.636 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 155' ' ' THR . 11.0 t -73.94 -31.15 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.261 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.529 ' O ' HG22 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -68.77 -46.64 68.25 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.047 0.451 . . . . 0.0 112.119 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.439 ' N ' ' CG ' ' A' ' 160' ' ' PHE . 6.4 ttt180 -73.94 -34.56 64.35 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.751 -0.779 . . . . 0.0 111.152 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -65.65 -34.73 78.9 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.067 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 160' ' ' PHE . 14.1 tt -70.34 -43.16 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.861 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.576 HG21 HG11 ' A' ' 49' ' ' VAL . 85.1 mt -59.58 -35.21 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.544 0.688 . . . . 0.0 109.611 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.421 ' HA ' HD13 ' A' ' 165' ' ' LEU . 0.4 OUTLIER -63.21 -60.31 3.58 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.726 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -58.36 -34.9 71.18 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.465 ' HB1' ' NH1' ' A' ' 7' ' ' ARG . . . -55.98 -32.45 63.93 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 171' ' ' ASP . 6.0 tp10 -66.41 -59.65 3.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.359 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.51 -52.23 64.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.682 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 4.0 mm -50.45 -37.93 15.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.04 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 172' ' ' GLY . 0.0 OUTLIER -67.01 -40.13 87.24 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.028 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 171' ' ' ASP . . . -56.75 -36.41 72.04 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.72 -82.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.743 0.306 . . . . 0.0 110.213 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.838 179.937 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GDP . . . . . 0.682 HN21 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.322 0 CA-C-O 121.202 0.525 . . . . 0.0 110.651 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.606 ' NH1' ' HB1' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -139.71 136.04 33.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.526 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.434 ' HB2' HG22 ' A' ' 78' ' ' ILE . 12.5 mttp -106.0 128.5 53.87 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.752 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.9 OUTLIER -102.82 122.95 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 121.416 0.627 . . . . 0.0 110.563 -178.023 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.439 ' HB3' ' CE1' ' A' ' 81' ' ' TYR . . . -84.56 132.58 34.5 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.172 -0.955 . . . . 0.0 111.156 -178.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.666 ' O ' HD12 ' A' ' 12' ' ' LEU . 11.7 mt -95.46 133.72 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-O 121.916 0.865 . . . . 0.0 112.721 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.687 HD11 ' CG ' ' A' ' 67' ' ' TYR . 2.6 mp -130.33 101.73 5.89 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.866 -1.515 . . . . 0.0 110.359 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.517 ' O ' ' NZ ' ' A' ' 19' ' ' LYS . . . -140.64 134.4 6.42 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.476 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.6 OUTLIER -56.16 -158.2 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.285 0.565 . . . . 0.0 110.736 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -98.93 133.76 42.75 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.485 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.533 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 2.6 m 64.25 19.29 11.72 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.721 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 p -85.91 -16.9 9.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.843 0.354 . . . . 0.0 110.561 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.403 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 102.36 27.92 6.64 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.61 ' HB2' ' HZ2' ' A' ' 19' ' ' LYS . 4.8 ttpm? -61.2 -50.26 73.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.14 0.495 . . . . 0.0 110.435 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.21 -26.38 58.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.436 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 77.6 p -64.29 -43.38 94.94 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.856 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.9 tp -77.74 -39.51 44.13 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.851 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.61 ' O ' HG12 ' A' ' 27' ' ' VAL . 31.4 m -50.2 -43.87 52.83 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.68 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.4 mp -77.42 -41.58 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.635 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.475 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -67.78 -31.79 71.92 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.151 -179.016 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.632 ' CZ ' ' CE1' ' A' ' 160' ' ' PHE . 4.8 t80 -77.61 -64.03 1.24 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.404 0.621 . . . . 0.0 111.192 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.619 HG13 ' N ' ' A' ' 28' ' ' GLU . 13.5 p -45.15 -49.17 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.996 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.619 ' N ' HG13 ' A' ' 27' ' ' VAL . 0.7 OUTLIER -81.49 -25.12 36.26 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.28 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.575 ' O ' ' ND2' ' A' ' 153' ' ' ASN . . . 75.44 28.1 62.28 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.435 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.42 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 5.1 pt20 -146.38 128.05 15.2 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.943 0.878 . . . . 0.0 112.983 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.496 ' CD1' ' C ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -69.66 95.86 0.9 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.083 178.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.637 HG22 ' N ' ' A' ' 33' ' ' ASP . 14.2 p -98.69 166.98 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.483 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.637 ' N ' HG22 ' A' ' 32' ' ' VAL . 1.8 t70 -63.87 16.87 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.109 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.559 ' H ' HG13 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -38.92 119.13 0.84 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.831 0.348 . . . . 0.0 110.898 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -152.7 34.78 0.49 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.586 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -83.44 172.47 9.25 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.434 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 36' ' ' ASP . 46.9 Cg_exo -56.81 -138.25 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.551 2.168 . . . . 0.0 111.902 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 38' ' ' THR . 10.4 t -130.23 62.8 1.56 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.745 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 tp -82.89 144.68 9.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.176 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.418 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -90.0 152.16 21.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.532 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER 177.88 174.34 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.278 0.561 . . . . 0.0 112.278 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.447 HG23 HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -108.04 142.92 37.47 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.426 179.319 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 12.5 m-85 -130.47 165.5 22.5 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.047 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.602 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -142.53 148.02 36.92 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.252 0.549 . . . . 0.0 112.046 -178.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.583 ' C ' HD12 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -151.94 116.1 4.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.978 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.4 mp -105.3 129.69 53.59 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.393 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.3 pt -147.39 160.97 8.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.47 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 m -117.01 123.56 47.19 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.173 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.764 HG11 HG21 ' A' ' 164' ' ' ILE . 1.7 p -118.42 125.48 74.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.984 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.442 ' ND2' HG22 ' A' ' 49' ' ' VAL . 7.8 m-20 61.38 24.94 14.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 0.0 110.239 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.77 -9.52 65.27 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -88.77 130.48 35.35 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -76.96 146.12 37.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.582 0.706 . . . . 0.0 111.302 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.424 ' OH ' ' OE2' ' A' ' 168' ' ' GLU . 9.3 m-85 -138.46 124.92 20.59 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.004 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.656 ' C ' HD12 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -117.28 113.66 22.49 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.656 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.9 mp -119.23 146.58 45.1 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.582 0.706 . . . . 0.0 112.132 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.791 ' C ' HD13 ' A' ' 58' ' ' LEU . 4.9 tt0 -136.35 123.53 21.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.983 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.949 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.12 154.91 30.22 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.541 0.686 . . . . 0.0 112.416 -178.371 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.447 HG23 HG23 ' A' ' 42' ' ' THR . 0.3 OUTLIER -131.85 145.14 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.785 -178.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.16 103.89 8.52 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.019 -1.446 . . . . 0.0 107.92 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.46 152.25 46.67 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.312 0.577 . . . . 0.0 110.775 -178.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 63' ' ' GLY . . . -138.67 30.53 2.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.462 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.463 ' N ' ' OH ' ' A' ' 74' ' ' TYR . . . -30.22 -43.21 0.06 OUTLIER Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -144.1 -100.06 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.455 0.645 . . . . 0.0 109.973 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 68' ' ' SER . 4.3 p30 -76.92 -173.59 2.75 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.56 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.545 ' O ' ' CB ' ' A' ' 67' ' ' TYR . 1.0 OUTLIER -65.69 45.93 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.734 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.687 ' CG ' HD11 ' A' ' 12' ' ' LEU . 21.2 t80 96.69 79.15 0.0 OUTLIER 'General case' 0 C--N 1.343 0.311 0 O-C-N 124.469 1.106 . . . . 0.0 109.784 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.557 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.7 OUTLIER -69.7 124.7 24.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.937 -178.353 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.61 HG22 ' H ' ' A' ' 70' ' ' PHE . 20.7 mm -72.35 -125.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.61 ' H ' HG22 ' A' ' 69' ' ' ILE . 86.7 t80 52.3 86.72 0.15 Allowed Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 120.294 -0.563 . . . . 0.0 109.525 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -41.4 112.45 0.21 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.255 1.97 . . . . 0.0 112.8 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -162.75 -60.82 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.528 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.9 m -144.08 10.15 1.51 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.371 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.463 ' OH ' ' N ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -122.57 -8.9 8.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.472 -179.739 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 76' ' ' ILE . 1.4 p -84.98 63.06 7.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.189 0.519 . . . . 0.0 110.592 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.5 HD12 HG21 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -52.41 -165.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.164 -179.814 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.39 44.36 2.48 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.218 0.533 . . . . 0.0 110.171 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.5 HG21 HD12 ' A' ' 76' ' ' ILE . 33.6 pt -81.51 -173.79 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.38 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -151.11 18.41 0.76 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.115 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -146.69 167.75 28.11 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.15 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.527 ' OH ' ' CE2' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -151.97 123.21 7.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.136 -0.532 . . . . 0.0 111.806 178.156 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.744 ' O ' HG23 ' A' ' 82' ' ' ILE . 12.4 tt -128.06 98.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.797 0.808 . . . . 0.0 109.299 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.787 ' N ' HD23 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -96.32 130.09 43.51 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.639 -178.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.93 132.81 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.885 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.509 ' CE1' ' CD2' ' A' ' 116' ' ' LEU . 2.2 m-85 -108.56 143.5 37.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.886 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.552 ' C ' ' H ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -106.2 121.41 44.13 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.386 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.484 HG11 HH21 ' A' ' 127' ' ' ARG . 12.0 m -73.86 21.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.552 ' H ' ' C ' ' A' ' 86' ' ' SER . 9.7 t -142.72 -7.83 0.85 Allowed 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 114.212 1.189 . . . . 0.0 114.212 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.501 ' N ' ' OG ' ' A' ' 86' ' ' SER . 0.0 OUTLIER -135.46 100.5 4.53 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 122.324 1.059 . . . . 0.0 112.077 -176.311 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.458 HG22 ' CD ' ' A' ' 94' ' ' GLU . 17.1 mm -56.08 -10.63 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 113.915 -1.493 . . . . 0.0 108.754 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.77 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -79.3 -43.99 22.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.466 178.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 55.3 p -62.33 -45.89 91.19 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.151 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.837 ' CD2' HD13 ' A' ' 129' ' ' ILE . 0.1 OUTLIER -76.48 -37.55 56.67 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 118.531 -1.267 . . . . 0.0 111.882 -178.312 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.458 ' CD ' HG22 ' A' ' 90' ' ' ILE . 91.5 mt-10 -69.66 -44.86 69.68 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.902 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 91' ' ' LYS . 23.5 m -63.1 -36.5 76.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.881 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.444 ' N ' HG23 ' A' ' 95' ' ' VAL . 47.8 mt -72.42 -27.14 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.058 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -69.15 -29.17 67.14 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.8 t -76.29 -66.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.481 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.502 HG21 HD21 ' A' ' 12' ' ' LEU . 1.4 mp -39.16 -36.21 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.738 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -66.95 -58.6 4.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.979 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.82 -49.16 1.95 Allowed Glycine 0 CA--C 1.518 0.259 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.804 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 105' ' ' ASP . 23.0 tptt -64.01 -66.31 0.56 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.424 -0.388 . . . . 0.0 110.393 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.7 OUTLIER -39.95 -57.17 1.67 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.627 179.058 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -46.84 -43.84 18.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.53 178.686 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -61.99 -32.89 73.39 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.624 -179.451 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 8.3 ttm -66.89 -53.72 29.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.713 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.545 ' C ' ' H ' ' A' ' 109' ' ' LYS . 15.9 m -77.19 -14.53 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.938 0.399 . . . . 0.0 110.569 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.5 -24.42 0.04 OUTLIER Glycine 0 CA--C 1.532 1.134 0 CA-C-N 115.87 -0.605 . . . . 0.0 113.132 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.545 ' H ' ' C ' ' A' ' 107' ' ' VAL . 24.0 tttt -172.02 -130.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 117.92 0.86 . . . . 0.0 111.601 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.513 ' H ' ' CG ' ' A' ' 109' ' ' LYS . 5.2 t 53.14 119.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.488 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -74.62 124.42 26.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.949 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.484 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -129.93 145.25 56.37 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.713 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -49.5 113.26 0.88 Allowed 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.624 1.55 . . . . 0.0 112.517 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.512 ' HB ' ' HB2' ' A' ' 143' ' ' ALA . 2.4 mp -123.99 132.99 70.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.473 ' SD ' ' HB3' ' A' ' 144' ' ' ALA . 9.4 tpt -133.18 115.3 14.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.011 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.509 ' CD2' ' CE1' ' A' ' 85' ' ' TYR . 4.2 mt -96.83 97.24 9.14 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.0 t -102.11 127.98 55.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.5 0.667 . . . . 0.0 111.753 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -94.73 114.68 4.89 Favored Glycine 0 C--N 1.311 -0.858 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -97.02 171.79 8.26 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.078 -0.649 . . . . 0.0 112.025 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.695 ' HZ1' " H1'" ' A' ' 186' ' ' GDP . 6.3 mtpp 61.73 55.47 2.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.629 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -57.41 -20.66 31.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.674 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.642 ' CG ' HN21 ' A' ' 186' ' ' GDP . 3.4 p-10 -76.64 -20.48 56.65 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.991 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.9 mp -77.96 -31.63 50.96 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.522 ' CE1' ' HG2' ' A' ' 125' ' ' MET . 3.2 p-80 -31.56 -32.56 0.01 OUTLIER 'General case' 0 C--N 1.339 0.141 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.029 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.552 ' N ' ' O ' ' A' ' 123' ' ' LEU . 2.2 mmt -42.02 -27.34 0.12 Allowed 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.487 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -101.17 -37.6 8.48 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.587 179.307 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.484 HH21 HG11 ' A' ' 87' ' ' VAL . 9.8 ttm180 32.01 85.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.449 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.2 m -72.66 -34.77 48.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.167 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.837 HD13 ' CD2' ' A' ' 93' ' ' PHE . 10.7 tp -91.4 153.82 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.691 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.4 ' OG ' ' OE1' ' A' ' 132' ' ' GLU . 3.8 t -95.16 130.19 41.98 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.86 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -50.39 -35.86 30.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.782 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -68.45 -62.21 1.49 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.743 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -40.72 -43.12 1.9 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.722 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.68 -36.1 67.11 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -62.08 -53.53 54.21 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.341 -0.43 . . . . 0.0 109.852 179.574 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -58.39 -38.04 76.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.76 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.649 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -66.43 -60.65 2.56 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.563 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -51.69 -37.16 49.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.984 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.83 -28.9 67.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.71 -47.37 78.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.155 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.649 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 17.1 m95 -91.0 -4.24 56.6 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.313 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 141' ' ' TRP . 0.8 OUTLIER 79.11 26.97 0.42 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.992 -179.434 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.61 168.81 12.24 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.69 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.473 ' HB3' ' SD ' ' A' ' 115' ' ' MET . . . -111.69 127.73 55.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.043 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.406 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 9.9 t80 -98.01 120.81 39.05 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.314 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.53 128.23 17.21 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.338 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.48 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 1.7 mt-10 -100.2 116.74 32.92 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.007 0.432 . . . . 0.0 110.098 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.433 ' OG ' HG21 ' A' ' 159' ' ' VAL . 11.8 p -131.98 -177.97 4.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.596 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.21 131.79 30.82 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.563 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.479 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -56.44 -42.44 78.12 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.123 0.487 . . . . 0.0 110.084 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 38.1 tttt -58.2 -3.7 0.28 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.468 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.479 ' H ' ' C ' ' A' ' 150' ' ' ALA . 1.9 mt-10 -136.37 125.76 24.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.017 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.575 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 66.0 t30 -77.25 -48.95 16.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.831 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 153' ' ' ASN . 1.2 mt-30 -38.5 -59.16 0.94 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.749 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.661 ' O ' HG23 ' A' ' 159' ' ' VAL . 45.7 p -52.5 -49.55 64.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.188 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.475 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -50.63 -60.84 2.62 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.553 0.692 . . . . 0.0 110.285 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 49.0 t -45.76 -42.2 3.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.895 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.15 -41.62 98.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.664 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 155' ' ' THR . 11.5 t -63.38 -46.94 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.66 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.632 ' CE1' ' CZ ' ' A' ' 26' ' ' PHE . 10.4 m-85 -67.79 -22.81 65.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.105 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.428 ' NH1' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -76.24 -42.36 46.09 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.869 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -67.29 -32.35 73.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.132 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 160' ' ' PHE . 7.3 tt -69.14 -47.07 76.64 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.171 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.764 HG21 HG11 ' A' ' 49' ' ' VAL . 95.4 mt -53.5 -37.53 30.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.05 -56.53 19.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.549 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -62.47 -28.73 70.02 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.309 -0.556 . . . . 0.0 109.573 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.606 ' HB1' ' NH1' ' A' ' 7' ' ' ARG . . . -59.23 -33.32 70.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.424 ' OE2' ' OH ' ' A' ' 54' ' ' TYR . 2.3 tp10 -68.83 -50.62 48.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.016 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -60.15 -64.29 1.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.741 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 50.6 mt -49.94 -31.75 7.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.952 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.84 -40.18 79.54 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.368 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -61.71 -35.63 91.5 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.29 -68.96 0.35 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.714 0.292 . . . . 0.0 110.427 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.715 179.927 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GDP . . . . . 0.695 " H1'" ' HZ1' ' A' ' 120' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.308 0.575 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.526 ' NH1' ' HB1' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -139.59 134.96 32.84 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.22 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.52 ' HB2' HG22 ' A' ' 78' ' ' ILE . 35.5 mttt -107.25 126.0 51.86 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.751 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.9 OUTLIER -100.17 122.03 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-O 121.566 0.698 . . . . 0.0 110.914 -177.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.62 134.84 34.78 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.464 -0.773 . . . . 0.0 110.903 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.3 mt -96.64 133.33 38.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.4 0.619 . . . . 0.0 112.382 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.647 HD23 ' C ' ' A' ' 12' ' ' LEU . 5.8 tt -128.61 105.67 8.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.494 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -142.03 134.33 6.11 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -52.99 172.6 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -73.37 131.61 42.07 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.231 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 m 67.1 19.97 10.38 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.698 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.6 p -79.72 -18.44 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.219 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.431 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 101.19 23.7 9.5 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.447 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.4 pttm -70.72 -33.44 70.85 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.423 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.496 ' O ' HD13 ' A' ' 24' ' ' ILE . 39.8 m -77.2 -30.42 54.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.05 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 79.5 p -65.61 -41.91 92.21 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.125 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.0 tp -77.07 -44.05 32.07 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 119.754 -0.779 . . . . 0.0 110.648 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.605 ' O ' HG12 ' A' ' 27' ' ' VAL . 25.3 m -47.93 -42.37 27.13 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.226 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.496 HD13 ' O ' ' A' ' 20' ' ' SER . 1.3 mp -77.15 -41.72 30.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 O-C-N 123.267 0.354 . . . . 0.0 111.272 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.541 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.3 OUTLIER -70.71 -28.69 64.92 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.969 -179.208 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.454 ' O ' ' N ' ' A' ' 29' ' ' GLY . 1.3 t80 -78.05 -63.63 1.35 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.231 0.539 . . . . 0.0 110.692 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.608 HG13 ' N ' ' A' ' 28' ' ' GLU . 13.7 p -45.15 -49.59 2.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.419 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.608 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.5 tt0 -79.06 -24.45 43.55 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.519 ' O ' ' ND2' ' A' ' 153' ' ' ASN . . . 71.5 28.21 69.93 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 114.471 -1.241 . . . . 0.0 110.024 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -149.73 125.8 10.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.49 -178.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.618 ' CD1' ' O ' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -67.45 91.63 0.27 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.318 1.056 . . . . 0.0 110.407 178.643 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.64 HG22 ' N ' ' A' ' 33' ' ' ASP . 14.9 p -98.85 166.44 2.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.006 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.64 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.5 OUTLIER -46.37 -30.01 1.93 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.101 -179.449 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.403 ' H ' HG13 ' A' ' 32' ' ' VAL . 8.2 p 37.74 93.27 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.121 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.41 -38.98 18.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.122 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -37.34 101.01 0.21 Allowed Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.72 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.493 ' O ' ' O ' ' A' ' 36' ' ' ASP . 76.5 Cg_exo -53.72 -128.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.358 2.038 . . . . 0.0 112.164 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 38' ' ' THR . 14.6 t -102.39 46.92 0.91 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.121 0.486 . . . . 0.0 111.137 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 tp -83.69 145.59 8.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.016 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.425 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -90.14 146.36 24.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.436 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 0.7 OUTLIER 177.49 176.68 0.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.185 0.517 . . . . 0.0 111.869 -179.383 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.9 147.47 30.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.873 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 11.6 m-85 -129.77 167.3 18.29 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.239 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.537 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -145.9 151.05 37.24 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.52 -178.668 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.594 ' C ' HD12 ' A' ' 46' ' ' LEU . 5.0 tmtp? -150.91 108.78 3.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.439 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.748 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.4 mp -106.48 121.4 44.2 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.938 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 pp -149.0 165.36 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.785 0.326 . . . . 0.0 110.647 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 m -108.81 127.6 54.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.173 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.631 HG11 HG21 ' A' ' 164' ' ' ILE . 7.6 p -126.39 138.32 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.615 ' OD1' HG22 ' A' ' 49' ' ' VAL . 4.7 m-20 62.06 5.95 1.61 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 97.39 -13.18 64.66 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -91.37 142.21 27.93 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -76.24 145.53 39.66 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.562 0.696 . . . . 0.0 111.073 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.499 ' CD1' HG12 ' A' ' 49' ' ' VAL . 8.0 m-85 -136.34 124.8 23.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.134 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.643 ' C ' HD22 ' A' ' 56' ' ' LEU . 62.3 m170 -116.74 113.98 23.35 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.655 ' N ' HD22 ' A' ' 56' ' ' LEU . 2.7 mm? -118.91 139.75 51.12 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 121.386 0.612 . . . . 0.0 111.34 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.75 ' C ' HD13 ' A' ' 58' ' ' LEU . 1.9 mt-30 -133.36 122.41 23.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.91 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.924 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.19 154.6 30.84 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.345 0.593 . . . . 0.0 112.525 -178.139 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.8 145.29 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-N 114.672 -1.149 . . . . 0.0 113.05 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -123.61 106.5 10.61 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.067 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.67 148.62 49.81 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.614 0.721 . . . . 0.0 111.487 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.481 ' O ' ' N ' ' A' ' 64' ' ' GLN . . . -138.37 15.53 2.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.867 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.433 ' N ' ' OH ' ' A' ' 74' ' ' TYR . . . -38.46 -26.68 0.04 OUTLIER Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.108 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.503 ' CG ' ' H ' ' A' ' 65' ' ' ASP . 1.5 tp60 -145.09 -121.24 0.08 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.554 0.693 . . . . 0.0 110.405 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' A' ' 68' ' ' SER . 0.0 OUTLIER -75.17 -173.82 2.12 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.751 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 67' ' ' TYR . 1.5 mp0 -65.11 47.03 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.257 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.534 ' N ' ' O ' ' A' ' 65' ' ' ASP . 4.0 t80 93.67 80.66 0.0 OUTLIER 'General case' 0 C--O 1.232 0.146 0 O-C-N 124.157 0.911 . . . . 0.0 109.143 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.567 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 12.1 m -68.8 134.43 49.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.611 -178.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.954 ' H ' HD12 ' A' ' 69' ' ' ILE . 2.6 mp -69.07 97.15 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.478 ' O ' ' N ' ' A' ' 72' ' ' GLN . 18.6 t80 -158.03 76.85 3.63 Favored Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.355 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.18 83.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.658 2.239 . . . . 0.0 111.863 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.499 ' NE2' ' OG1' ' A' ' 73' ' ' THR . 1.1 tt0 -169.72 -52.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.684 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.499 ' OG1' ' NE2' ' A' ' 72' ' ' GLN . 1.2 m -135.0 4.09 3.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.64 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.531 ' O ' ' CZ ' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -130.02 5.24 4.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.622 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -155.08 86.17 1.1 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.377 0.608 . . . . 0.0 109.813 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.659 HG22 ' H ' ' A' ' 77' ' ' ASP . 6.9 mm -56.63 -132.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.845 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.659 ' H ' HG22 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -118.34 48.26 1.46 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.384 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.52 HG22 ' HB2' ' A' ' 8' ' ' LYS . 31.5 pt -77.26 -177.65 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 114.572 -1.194 . . . . 0.0 112.838 -177.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.77 19.33 0.7 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.022 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.402 ' HA3' HD13 ' A' ' 9' ' ' ILE . . . -148.02 165.08 28.92 Favored Glycine 0 CA--C 1.517 0.195 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.534 -178.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.531 ' OH ' ' CD1' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -151.82 123.07 7.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.716 -0.742 . . . . 0.0 111.073 177.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.569 ' O ' HG23 ' A' ' 82' ' ' ILE . 9.7 tt -126.19 107.62 17.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.9 0.857 . . . . 0.0 109.029 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.818 ' N ' HD12 ' A' ' 83' ' ' LEU . 3.1 mp -97.27 126.67 42.63 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.979 -178.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -95.26 128.69 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.162 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.707 ' CZ ' HG21 ' A' ' 96' ' ' ILE . 48.6 m-85 -110.69 144.44 39.62 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.172 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.506 ' HG ' ' H ' ' A' ' 89' ' ' SER . 0.9 OUTLIER -98.24 125.99 43.54 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.218 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.487 HG21 ' N ' ' A' ' 124' ' ' HIS . 11.0 m -72.5 22.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.673 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.501 ' H ' ' C ' ' A' ' 86' ' ' SER . 0.8 OUTLIER -138.79 -26.13 0.87 Allowed 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.263 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.535 ' C ' ' N ' ' A' ' 91' ' ' LYS . 4.1 t -98.0 93.98 6.6 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.378 -176.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.477 HD13 ' O ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -58.27 -11.57 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.314 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.535 ' N ' ' C ' ' A' ' 89' ' ' SER . 3.4 mptt -78.28 -57.22 3.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.456 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 69.6 p -49.6 -30.62 9.08 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.591 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.402 ' CE1' ' CD2' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -74.55 -48.29 27.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.838 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.39 -44.22 88.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.595 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 91' ' ' LYS . 4.1 m -64.38 -35.84 75.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.145 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.707 HG21 ' CZ ' ' A' ' 85' ' ' TYR . 44.7 mt -69.12 -29.44 42.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.882 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.03 -27.84 66.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.8 t -74.75 -66.73 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.2 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.474 HD11 ' OD2' ' A' ' 65' ' ' ASP . 1.6 mp -41.39 -48.64 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.514 ' CE1' ' CE2' ' A' ' 141' ' ' TRP . 51.8 t-80 -54.66 -64.84 0.7 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.669 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -38.07 -52.33 2.13 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 105' ' ' ASP . 17.7 tptm -65.87 -63.6 1.05 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.924 -0.638 . . . . 0.0 110.698 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -38.2 -59.24 0.89 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.215 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.736 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -47.05 -45.24 21.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.806 178.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -61.06 -36.07 78.62 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.795 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.517 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 5.2 ttm -60.48 -55.67 30.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.206 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.498 ' C ' ' H ' ' A' ' 109' ' ' LYS . 17.7 m -77.21 -13.8 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.18 0.514 . . . . 0.0 110.243 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 63.67 -24.76 0.09 OUTLIER Glycine 0 CA--C 1.531 1.033 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.999 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.521 ' CG ' ' H ' ' A' ' 110' ' ' VAL . 20.8 tttt -172.85 -135.01 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 117.784 0.792 . . . . 0.0 111.832 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.521 ' H ' ' CG ' ' A' ' 109' ' ' LYS . 5.6 t 52.77 118.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.665 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.538 ' OE1' ' HB1' ' A' ' 173' ' ' ALA . 8.2 mt-30 -76.15 126.97 31.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.022 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.721 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.6 OUTLIER -130.07 153.68 81.12 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.685 179.419 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -48.02 114.69 1.2 Allowed 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.897 1.731 . . . . 0.0 112.572 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.49 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.4 mp -124.28 128.44 73.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.54 ' SD ' ' HB3' ' A' ' 144' ' ' ALA . 12.3 tpt -129.01 114.59 16.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.741 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 138' ' ' ALA . 67.5 mt -97.21 98.91 10.41 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.387 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.83 131.16 57.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.865 0.84 . . . . 0.0 112.396 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -97.96 114.01 4.88 Favored Glycine 0 C--N 1.312 -0.773 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.448 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 57.7 t30 -96.84 172.79 7.65 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.952 -177.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.448 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 19.7 mttt 58.51 58.67 3.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.188 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -14.75 61.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.326 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.656 ' CG ' HN21 ' A' ' 186' ' ' GDP . 3.9 p-10 -79.4 -13.03 59.87 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.633 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.661 ' O ' ' N ' ' A' ' 126' ' ' GLU . 10.9 mp -84.05 -26.57 28.95 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.553 ' C ' ' N ' ' A' ' 126' ' ' GLU . 3.6 t-80 -22.76 -42.34 0.01 OUTLIER 'General case' 0 C--N 1.348 0.503 0 O-C-N 124.544 1.152 . . . . 0.0 111.289 178.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.567 ' N ' ' O ' ' A' ' 123' ' ' LEU . 0.7 OUTLIER -44.77 -19.04 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.416 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.661 ' N ' ' O ' ' A' ' 123' ' ' LEU . 19.8 mm-40 -89.74 -54.49 4.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.011 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.433 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 1.7 tpt85 35.85 71.24 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.269 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.71 -40.13 86.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.292 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 tp -88.44 155.12 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.582 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 132' ' ' GLU . 47.5 p -93.12 118.04 30.76 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.718 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -39.12 -28.66 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.645 0.736 . . . . 0.0 109.373 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.3 mp0 -70.06 -63.27 1.11 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.876 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.4 ' CG ' ' OG ' ' A' ' 130' ' ' SER . 57.1 mt-10 -41.52 -41.73 2.19 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.16 -35.73 64.09 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 132' ' ' GLU . 2.4 tttm -60.72 -55.42 33.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.58 -33.97 66.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.075 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.35 -63.2 1.16 Allowed 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.836 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 143' ' ' ALA . . . -51.67 -35.06 41.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.232 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -35.61 78.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.736 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.58 -47.32 76.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.59 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.558 ' CH2' HD22 ' A' ' 104' ' ' LEU . 25.7 m95 -92.72 2.52 56.69 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.719 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 60.77 39.94 16.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.526 0.679 . . . . 0.0 109.633 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.46 ' O ' ' HB1' ' A' ' 138' ' ' ALA . . . -98.15 168.35 10.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.57 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.54 ' HB3' ' SD ' ' A' ' 115' ' ' MET . . . -105.07 125.46 51.0 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.887 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.437 ' C ' ' CD1' ' A' ' 145' ' ' PHE . 4.0 t80 -98.4 122.03 41.08 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.262 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.01 126.43 15.83 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.433 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 2.7 mt-10 -100.49 114.89 28.86 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.404 ' OG ' HG21 ' A' ' 159' ' ' VAL . 21.0 p -134.77 -178.76 5.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.824 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.93 135.19 34.14 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.28 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -57.44 -46.52 83.5 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.883 0.373 . . . . 0.0 110.365 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -55.21 -6.29 0.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.33 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.481 ' H ' ' C ' ' A' ' 150' ' ' ALA . 2.1 tt0 -131.25 122.63 26.82 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.638 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 48.8 t30 -77.21 -52.02 9.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.167 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 153' ' ' ASN . 2.8 mt-30 -36.77 -58.22 0.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.03 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.678 ' O ' HG23 ' A' ' 159' ' ' VAL . 68.1 p -53.0 -45.1 67.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.127 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.541 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -55.44 -61.48 2.31 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.492 0.663 . . . . 0.0 110.121 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 57.4 t -43.22 -39.67 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.688 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -65.7 -42.81 90.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.199 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 155' ' ' THR . 14.3 t -61.93 -42.41 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.539 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.537 ' O ' HG22 ' A' ' 163' ' ' ILE . 52.3 t80 -59.49 -66.76 0.46 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.216 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 160' ' ' PHE . 19.5 ttm-85 -41.62 -45.29 3.33 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.304 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -62.05 -30.35 70.92 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.754 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.2 OUTLIER -66.41 -32.47 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.457 179.473 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.631 HG21 HG11 ' A' ' 49' ' ' VAL . 7.4 mt -68.39 -42.27 84.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.737 0.779 . . . . 0.0 109.665 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.62 -49.36 78.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.551 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -64.03 -32.56 74.15 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -56.08 -34.41 65.96 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.125 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.39 -55.39 10.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.682 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.62 -62.87 1.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.733 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.721 HG21 ' C ' ' A' ' 112' ' ' ILE . 38.5 mm -53.32 -31.23 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.065 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -69.67 -40.38 76.47 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.633 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.53 -35.31 91.6 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.538 ' HB1' ' OE1' ' A' ' 111' ' ' GLN . . . -67.98 -62.71 1.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.688 0.28 . . . . 0.0 110.429 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.705 179.878 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GDP . . . . . 0.656 HN21 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 121.216 0.531 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.62 136.66 34.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.587 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.534 ' HB2' HG22 ' A' ' 78' ' ' ILE . 11.0 mttm -108.51 127.49 53.97 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.741 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -103.01 123.95 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-O 121.479 0.657 . . . . 0.0 111.13 -178.086 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.43 135.78 34.12 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.422 -0.799 . . . . 0.0 111.254 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.0 mt -95.77 133.84 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.619 HD21 ' O ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -128.24 100.69 5.93 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.349 179.186 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.71 133.73 5.87 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.69 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER -54.62 -167.08 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.034 0.445 . . . . 0.0 110.041 178.822 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.404 ' O ' ' CB ' ' A' ' 16' ' ' SER . 11.5 ttp180 -97.64 128.33 44.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.744 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.514 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 0.7 OUTLIER 76.24 8.79 3.32 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.125 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.469 ' C ' ' NZ ' ' A' ' 120' ' ' LYS . 7.3 p -77.63 -19.32 14.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.942 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.417 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 106.03 31.6 4.08 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.408 ' NZ ' ' CB ' ' A' ' 19' ' ' LYS . 2.6 ttmp? -59.5 -59.1 5.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.005 0.431 . . . . 0.0 110.406 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.07 -26.01 63.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.24 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 89.1 p -63.78 -47.11 82.22 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.714 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 28.4 tp -71.39 -49.94 37.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.473 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.551 ' O ' HG12 ' A' ' 27' ' ' VAL . 48.7 m -43.79 -38.93 3.49 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.311 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.2 -43.68 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.94 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.622 ' NE2' ' N ' ' A' ' 31' ' ' PHE . 1.5 tp-100 -63.46 -40.53 97.37 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.756 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.636 ' CG ' ' CE1' ' A' ' 160' ' ' PHE . 2.2 t80 -74.87 -62.52 1.51 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.209 0.528 . . . . 0.0 111.825 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.576 HG13 ' N ' ' A' ' 28' ' ' GLU . 7.4 p -44.0 -47.52 2.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.722 -178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.576 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.0 tm-20 -83.91 -24.19 30.86 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.467 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 75.11 25.5 68.71 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.075 -1.42 . . . . 0.0 110.348 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.547 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 1.9 tp-100 -152.01 130.1 11.87 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.687 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.622 ' N ' ' NE2' ' A' ' 25' ' ' GLN . 0.7 OUTLIER -67.05 93.82 0.3 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.684 178.461 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.546 HG22 ' N ' ' A' ' 33' ' ' ASP . 12.3 p -105.73 165.85 3.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.098 0.475 . . . . 0.0 110.393 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.546 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -75.66 -32.78 60.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.374 -179.023 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.457 ' H ' HG22 ' A' ' 32' ' ' VAL . 10.0 p 43.0 -168.91 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.855 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.408 ' O ' ' C ' ' A' ' 36' ' ' ASP . 3.6 t80 -149.04 -39.47 0.15 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.21 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 37' ' ' PRO . 4.9 m-20 -36.73 100.11 0.19 Allowed Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.665 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 36' ' ' ASP . 66.4 Cg_exo -54.55 -129.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.319 2.013 . . . . 0.0 112.236 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 38' ' ' THR . 13.8 t -103.17 47.63 0.88 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.227 0.537 . . . . 0.0 111.215 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 tp -83.29 144.68 9.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.444 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.571 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 2.2 pm0 -90.59 145.45 24.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.889 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.571 ' ND2' ' O ' ' A' ' 40' ' ' GLU . 1.0 OUTLIER 177.11 175.33 0.4 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.624 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.81 127.61 53.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.294 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -110.02 174.05 6.04 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.968 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.531 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -143.5 161.7 37.75 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.399 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.595 ' C ' HD12 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -163.18 112.09 1.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.432 179.424 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.699 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.5 mp -105.17 127.93 53.15 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.727 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 pt -147.87 165.31 5.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.569 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.2 m -116.82 123.86 48.12 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.049 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.713 HG11 HG21 ' A' ' 164' ' ' ILE . 2.4 p -119.74 129.99 74.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.631 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.505 ' CG ' HG22 ' A' ' 49' ' ' VAL . 9.2 m-20 61.73 19.71 10.75 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.56 -9.43 71.04 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -90.0 135.6 33.55 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.49 147.28 37.93 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.584 0.706 . . . . 0.0 111.465 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.438 ' CD1' ' CG1' ' A' ' 49' ' ' VAL . 5.8 m-85 -138.3 125.21 21.19 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.042 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.618 ' C ' HD12 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -118.04 113.74 22.09 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.618 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.6 mp -118.62 143.21 46.96 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.629 0.728 . . . . 0.0 112.164 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.806 ' C ' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -133.96 122.6 23.31 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.93 178.834 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.976 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.38 153.52 31.89 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.063 -178.655 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.82 145.48 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-N 114.992 -1.004 . . . . 0.0 112.926 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -124.33 103.24 8.1 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.064 177.627 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.496 ' C ' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -93.06 -70.1 0.72 Allowed 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.374 0.607 . . . . 0.0 110.843 -179.201 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 50.43 9.9 0.05 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.317 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 61' ' ' THR . . . -50.44 -70.48 0.82 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -83.82 -113.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.421 0.629 . . . . 0.0 110.614 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.588 ' OD1' ' N ' ' A' ' 68' ' ' SER . 0.0 OUTLIER -75.35 -173.91 2.22 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.048 179.525 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.619 ' O ' HD21 ' A' ' 12' ' ' LEU . 2.9 mp0 -66.04 44.71 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.628 ' CZ ' ' CZ ' ' A' ' 74' ' ' TYR . 3.4 t80 91.75 73.47 0.0 OUTLIER 'General case' 0 C--N 1.339 0.122 0 O-C-N 124.196 0.935 . . . . 0.0 108.788 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.588 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.9 OUTLIER -72.9 120.51 18.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.964 -178.416 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.768 HG22 ' H ' ' A' ' 70' ' ' PHE . 31.4 mm -61.5 -126.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.768 ' H ' HG22 ' A' ' 69' ' ' ILE . 87.8 t80 49.35 80.64 0.29 Allowed Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 120.379 -0.528 . . . . 0.0 109.683 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -46.54 117.92 2.3 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.53 2.153 . . . . 0.0 112.503 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -171.9 -37.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.612 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.3 m -108.19 -24.0 11.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.618 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.628 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 16.5 m-85 -77.2 -55.19 5.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.078 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 t 74.63 -48.5 0.65 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.35 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.97 173.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.072 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.566 ' O ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -131.2 -15.47 3.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.08 -179.654 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.566 ' O ' ' O ' ' A' ' 77' ' ' ASP . 39.1 pt 33.67 -170.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 177.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -154.85 19.59 0.45 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.776 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.554 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -152.66 165.28 30.97 Favored Glycine 0 C--O 1.227 -0.323 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.873 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.78 122.31 7.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.689 -0.755 . . . . 0.0 110.691 178.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.599 ' O ' HG23 ' A' ' 82' ' ' ILE . 9.6 tt -124.01 102.69 11.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.685 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -97.56 123.22 41.36 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.17 -178.253 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.9 t -95.38 130.54 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.135 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.656 ' CZ ' HG21 ' A' ' 96' ' ' ILE . 69.6 m-85 -111.25 143.94 41.23 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.538 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.583 ' HG ' ' H ' ' A' ' 89' ' ' SER . 0.5 OUTLIER -94.99 121.0 36.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.473 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.52 HG21 ' N ' ' A' ' 124' ' ' HIS . 13.8 m -70.66 21.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.469 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.522 ' H ' ' C ' ' A' ' 86' ' ' SER . 1.1 t -136.27 -23.54 1.28 Allowed 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.583 ' H ' ' HG ' ' A' ' 86' ' ' SER . 8.3 t -100.45 94.1 5.98 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.482 -176.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -56.81 -11.41 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 175.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.555 ' N ' ' C ' ' A' ' 89' ' ' SER . 18.1 mttp -78.11 -56.35 4.55 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.141 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.4 p -49.83 -29.87 8.78 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.692 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.868 ' CE2' HG21 ' A' ' 129' ' ' ILE . 0.3 OUTLIER -75.29 -50.22 16.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.92 -179.305 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -64.68 -42.95 94.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.628 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 91' ' ' LYS . 4.6 m -65.98 -37.62 80.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.469 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.656 HG21 ' CZ ' ' A' ' 85' ' ' TYR . 41.1 mt -68.67 -28.58 40.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.567 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -70.4 -27.48 64.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.835 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 99' ' ' ILE . 17.0 t -74.34 -66.4 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.777 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' A' ' 98' ' ' VAL . 1.6 mp -39.97 -43.01 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.666 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.65 ' CE1' ' CE2' ' A' ' 141' ' ' TRP . 9.1 t60 -57.81 -59.38 5.32 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.616 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -36.39 -49.05 1.25 Allowed Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.716 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 105' ' ' ASP . 22.5 tptt -67.88 -66.03 0.62 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.32 -0.44 . . . . 0.0 110.367 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.48 HD13 ' C ' ' A' ' 103' ' ' LEU . 0.5 OUTLIER -38.0 -59.65 0.82 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.882 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -44.29 -46.96 9.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.821 178.632 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -59.94 -33.39 71.84 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.281 -179.159 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.514 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 21.1 ttm -69.44 -54.98 11.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.07 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.569 ' C ' ' H ' ' A' ' 109' ' ' LYS . 28.9 m -77.25 -15.55 14.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.829 -179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.87 -24.94 0.05 OUTLIER Glycine 0 CA--C 1.533 1.2 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.688 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.569 ' H ' ' C ' ' A' ' 107' ' ' VAL . 1.2 pttt -176.03 -126.69 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.573 0.687 . . . . 0.0 111.004 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 109' ' ' LYS . 5.8 t 52.2 121.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 121.346 0.593 . . . . 0.0 111.889 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -75.17 125.26 28.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.033 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.491 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -136.18 152.72 75.82 Favored Pre-proline 0 C--O 1.223 -0.328 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -48.3 108.18 0.17 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.929 1.753 . . . . 0.0 113.157 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.491 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.3 mt -121.22 127.07 75.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 11.0 tpt -127.99 114.5 17.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.913 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.437 HD12 ' HB2' ' A' ' 138' ' ' ALA . 62.7 mt -96.98 98.33 9.99 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.2 t -105.76 130.08 57.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.846 0.831 . . . . 0.0 112.774 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -97.63 112.51 4.48 Favored Glycine 0 C--N 1.312 -0.761 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.522 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 50.5 t30 -96.86 176.91 5.81 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.939 -0.705 . . . . 0.0 111.792 -177.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.522 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 36.5 mttp 58.61 57.76 3.62 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -59.72 -34.85 73.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.713 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.56 -12.79 10.97 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.171 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.5 mp -92.58 -31.65 15.11 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.52 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.5 OUTLIER -38.68 -25.58 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.226 178.694 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.518 ' N ' ' O ' ' A' ' 123' ' ' LEU . 3.8 mmt -43.33 -26.25 0.18 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.5 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -102.81 -39.68 6.89 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.133 179.062 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.474 HH21 ' HB2' ' A' ' 124' ' ' HIS . 29.1 ttm-85 34.52 72.31 0.09 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.717 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.613 HG23 ' N ' ' A' ' 129' ' ' ILE . 33.9 m -56.04 -48.19 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.545 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.868 HG21 ' CE2' ' A' ' 93' ' ' PHE . 7.8 tp -86.88 152.55 3.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.422 ' OG ' ' OE1' ' A' ' 133' ' ' GLU . 1.9 p -99.13 125.5 44.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.465 0.65 . . . . 0.0 111.78 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.645 ' CD1' ' CE1' ' A' ' 145' ' ' PHE . 0.1 OUTLIER -52.7 -43.32 65.56 Favored 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.406 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 131' ' ' TYR . 1.4 mp0 -39.66 -62.75 0.65 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.95 178.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.422 ' OE1' ' OG ' ' A' ' 130' ' ' SER . 14.9 mt-10 -50.74 -37.42 41.79 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 131' ' ' TYR . . . -70.84 -24.7 76.79 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 131' ' ' TYR . 31.4 tttm -73.68 -55.99 5.57 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -53.97 -35.47 61.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.505 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.608 HD21 ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -68.15 -62.66 1.3 Allowed 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -47.24 -35.37 7.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.775 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.57 -33.37 72.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.154 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -63.95 -47.14 81.62 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.168 -179.246 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.65 ' CE2' ' CE1' ' A' ' 100' ' ' HIS . 29.7 m95 -90.44 -4.0 57.3 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.204 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 72.4 27.66 2.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.493 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -89.2 166.33 13.88 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.125 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -108.18 126.38 52.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.149 0.499 . . . . 0.0 111.47 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.645 ' CE1' ' CD1' ' A' ' 131' ' ' TYR . 11.3 t80 -98.63 122.0 41.3 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.863 -178.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.99 131.28 20.81 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.449 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 11.0 mt-10 -100.39 119.78 38.97 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.491 ' OG ' HG21 ' A' ' 159' ' ' VAL . 0.8 OUTLIER -134.44 -178.95 5.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.736 -179.507 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.04 137.9 39.86 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.968 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.526 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -59.92 -46.13 90.36 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -69.13 11.87 0.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.359 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 150' ' ' ALA . 3.8 tt0 -137.68 117.79 13.48 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.231 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 154' ' ' GLN . 41.0 t30 -77.42 -56.71 4.31 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.43 ' OE1' ' OE2' ' A' ' 152' ' ' GLU . 0.0 OUTLIER -36.47 -59.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.051 0.453 . . . . 0.0 111.229 -179.036 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.621 ' O ' HG23 ' A' ' 159' ' ' VAL . 3.2 p -52.35 -53.81 39.88 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.84 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -47.48 -59.51 3.19 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.598 0.714 . . . . 0.0 110.116 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 47.9 t -48.45 -42.76 12.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.733 -1.122 . . . . 0.0 110.865 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -60.45 -40.95 93.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.533 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 155' ' ' THR . 14.2 t -62.51 -46.27 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.21 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.636 ' CE1' ' CG ' ' A' ' 26' ' ' PHE . 15.2 m-85 -68.66 -24.04 64.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.365 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.8 ttm-85 -77.34 -41.11 41.74 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.01 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.2 mmm-85 -65.66 -33.93 77.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.978 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 164' ' ' ILE . 3.3 tt -68.93 -50.59 52.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.449 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.713 HG21 HG11 ' A' ' 49' ' ' VAL . 94.3 mt -50.99 -35.96 15.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.181 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.23 -60.52 3.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.837 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -60.92 -26.7 67.66 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.704 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -61.64 -33.22 73.57 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.437 ' O ' ' OD2' ' A' ' 171' ' ' ASP . 2.7 tp10 -69.1 -50.13 50.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.417 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -62.37 -51.22 68.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.153 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 24.6 mt -53.59 -42.35 49.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.419 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.437 ' OD2' ' O ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -68.34 -38.58 81.65 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.482 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -54.6 -42.2 76.07 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.87 -73.88 0.15 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.738 0.304 . . . . 0.0 110.607 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.838 -179.727 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GDP . . . . . 0.514 " H5'" ' HA ' ' A' ' 16' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 121.11 0.481 . . . . 0.0 110.453 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.492 ' NH2' ' OD2' ' A' ' 171' ' ' ASP . 0.0 OUTLIER -139.7 134.92 32.62 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.657 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.436 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 5.0 mtmm -106.26 125.51 51.09 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.762 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -101.27 119.98 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 121.573 0.702 . . . . 0.0 110.442 -178.77 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.5 134.89 34.83 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.48 -0.763 . . . . 0.0 111.083 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.477 HD13 ' OG1' ' A' ' 23' ' ' THR . 18.3 mt -95.9 125.65 48.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.294 0.569 . . . . 0.0 111.447 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.492 ' CD2' HD13 ' A' ' 99' ' ' ILE . 13.2 tp -124.49 104.28 8.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.532 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -139.65 135.89 7.49 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.494 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.1 OUTLIER -52.08 -160.97 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.518 0.675 . . . . 0.0 111.144 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.7 ttt-85 -93.52 135.14 35.06 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.407 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.519 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 1.8 m 65.93 6.02 3.79 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.426 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.477 ' C ' ' NZ ' ' A' ' 120' ' ' LYS . 3.9 p -65.9 -17.97 23.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.813 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.2 25.29 37.42 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.445 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -65.26 -38.13 89.34 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.875 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.4 m -70.06 -35.52 74.29 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.544 ' OG ' ' H8 ' ' A' ' 186' ' ' GDP . 69.2 m -60.45 -43.25 97.04 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.762 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 25' ' ' GLN . 22.8 tp -68.16 -56.42 8.85 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.271 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.63 ' O ' HG12 ' A' ' 27' ' ' VAL . 93.3 m -38.43 -36.65 0.25 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.419 HG21 ' O ' ' A' ' 32' ' ' VAL . 1.3 mp -77.51 -42.9 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.78 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.637 ' NE2' ' N ' ' A' ' 31' ' ' PHE . 3.0 tp-100 -63.9 -38.32 90.64 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.135 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -76.48 -61.72 1.86 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.101 0.477 . . . . 0.0 111.668 -178.861 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.692 HG21 ' CG ' ' A' ' 43' ' ' PHE . 8.6 p -48.03 -47.9 12.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.672 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.632 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.0 tt0 -84.16 -23.56 30.57 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 75.01 23.4 74.67 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.556 ' NE2' ' O ' ' A' ' 28' ' ' GLU . 1.8 mp0 -148.58 129.99 14.79 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.637 ' N ' ' NE2' ' A' ' 25' ' ' GLN . 0.8 OUTLIER -61.47 94.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.977 178.512 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.751 HG22 ' H ' ' A' ' 34' ' ' SER . 7.2 p -141.57 165.38 18.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.451 ' O ' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -97.75 -12.94 21.73 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.184 0.516 . . . . 0.0 110.358 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.751 ' H ' HG22 ' A' ' 32' ' ' VAL . 18.5 p 47.09 178.3 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.323 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.19 24.24 1.63 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.116 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.419 ' O ' ' O ' ' A' ' 37' ' ' PRO . 1.4 m-20 -139.36 79.87 24.23 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.324 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.497 ' C ' ' H ' ' A' ' 39' ' ' ILE . 52.0 Cg_exo -56.87 -130.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.94 2.427 . . . . 0.0 111.949 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 38' ' ' THR . 9.2 t -72.79 34.36 0.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.025 0.44 . . . . 0.0 111.239 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.497 ' H ' ' C ' ' A' ' 37' ' ' PRO . 1.5 tp -84.1 148.55 4.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.993 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.566 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 1.8 pm0 -87.37 140.81 29.16 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.723 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -174.66 -177.0 1.1 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.465 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.08 124.35 32.59 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.686 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.692 ' CG ' HG21 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -107.15 174.66 5.79 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 120.993 0.425 . . . . 0.0 110.201 179.175 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.28 162.75 34.73 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.16 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -160.04 107.18 1.63 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.309 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.1 mp -106.35 118.58 37.0 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.195 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.651 HD12 ' H ' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -149.38 165.14 3.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.575 -179.721 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.6 m -109.01 127.9 54.49 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.261 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.877 HG11 HG21 ' A' ' 164' ' ' ILE . 6.6 p -127.61 134.08 66.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.387 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.37 3.95 3.52 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.465 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.35 -12.89 63.33 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -91.71 141.23 28.92 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -76.68 144.83 39.15 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.55 0.691 . . . . 0.0 111.114 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.435 ' OH ' ' OE2' ' A' ' 168' ' ' GLU . 9.7 m-85 -135.89 124.21 23.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.203 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.709 ' C ' HD12 ' A' ' 56' ' ' LEU . 2.6 m-70 -118.05 113.37 21.54 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.709 HD12 ' C ' ' A' ' 55' ' ' HIS . 11.2 mp -123.59 146.44 48.15 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.601 0.715 . . . . 0.0 112.128 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.8 ' C ' HD13 ' A' ' 58' ' ' LEU . 0.7 OUTLIER -138.78 127.03 22.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.934 178.464 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.985 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.91 153.1 34.14 Favored 'General case' 0 CA--C 1.499 -1.018 0 C-N-CA 120.251 -0.579 . . . . 0.0 111.886 -178.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.53 144.46 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.718 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.96 105.35 9.91 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.344 -1.298 . . . . 0.0 107.961 177.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.85 153.02 51.73 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.375 0.607 . . . . 0.0 110.445 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 64' ' ' GLN . . . -141.32 17.65 2.23 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.054 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -40.51 -26.67 0.13 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 62' ' ' ALA . 67.6 mm-40 -140.21 -144.98 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.48 0.657 . . . . 0.0 110.919 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.765 ' O ' ' N ' ' A' ' 67' ' ' TYR . 1.4 p30 -74.68 -170.47 1.06 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.209 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.595 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 1.4 pm0 -44.73 72.38 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 124.342 1.026 . . . . 0.0 110.409 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.765 ' N ' ' O ' ' A' ' 65' ' ' ASP . 15.9 t80 64.47 3.86 2.04 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.682 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.474 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 5.4 m 35.41 100.94 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.174 0.511 . . . . 0.0 112.27 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.69 ' H ' HD12 ' A' ' 69' ' ' ILE . 2.4 mp -41.67 -73.32 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-O 121.496 0.665 . . . . 0.0 110.04 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.482 ' O ' ' O ' ' A' ' 71' ' ' PRO . 0.3 OUTLIER -42.36 167.59 0.06 OUTLIER Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.321 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.492 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 52.9 Cg_exo -52.38 -137.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.968 0 C-N-CA 122.614 2.209 . . . . 0.0 113.0 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.492 ' CB ' ' O ' ' A' ' 71' ' ' PRO . 3.5 tt0 84.89 57.54 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.492 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.463 ' CB ' ' O ' ' A' ' 72' ' ' GLN . 0.2 OUTLIER 79.82 -31.1 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.634 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.4 ' H ' ' C ' ' A' ' 72' ' ' GLN . 30.9 m-85 -78.41 8.43 5.12 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.567 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 76' ' ' ILE . 1.1 p -82.89 29.58 0.46 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.986 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.454 ' HB ' HG23 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -50.44 -174.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.324 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.96 50.76 2.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.464 0.65 . . . . 0.0 109.416 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 80' ' ' GLY . 41.4 pt -79.03 -170.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.985 -178.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.07 15.67 1.06 Allowed 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.356 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.51 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -146.21 164.35 28.32 Favored Glycine 0 C--O 1.229 -0.214 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.473 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.531 ' OH ' ' CD1' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -152.11 125.1 8.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.068 -0.566 . . . . 0.0 111.475 178.146 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.59 ' O ' HG23 ' A' ' 82' ' ' ILE . 9.8 tt -131.08 104.82 9.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.995 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -96.6 126.17 41.59 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.525 -177.847 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -96.6 130.75 44.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.091 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.609 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 37.2 p90 -128.99 144.5 51.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.444 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.454 ' C ' ' H ' ' A' ' 88' ' ' THR . 4.1 p -87.27 142.83 27.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.211 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.614 HG21 ' N ' ' A' ' 124' ' ' HIS . 22.8 m -71.28 12.69 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.776 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.454 ' H ' ' C ' ' A' ' 86' ' ' SER . 8.6 t -132.86 -20.09 2.25 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 120.892 0.377 . . . . 0.0 111.904 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.533 ' C ' ' N ' ' A' ' 91' ' ' LYS . 33.1 t -90.13 92.63 9.04 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.758 -176.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 tp -61.12 -11.19 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.634 ' O ' HG22 ' A' ' 95' ' ' VAL . 3.3 mttp -78.04 -52.01 9.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 113.351 -1.75 . . . . 0.0 110.327 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 53.5 p -60.58 -33.58 72.93 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.643 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.609 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -74.06 -49.38 24.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.281 -179.013 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.447 ' O ' HG23 ' A' ' 98' ' ' VAL . 40.0 mt-10 -65.23 -42.65 93.2 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.707 -178.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.794 ' O ' HG22 ' A' ' 99' ' ' ILE . 20.1 m -67.42 -38.51 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.652 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.422 ' N ' HG23 ' A' ' 95' ' ' VAL . 2.6 mt -62.25 -38.12 80.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.347 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -69.43 -29.01 66.63 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 94' ' ' GLU . 59.2 t -75.83 -67.03 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.208 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.794 HG22 ' O ' ' A' ' 95' ' ' VAL . 3.1 tt -48.3 -40.12 9.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.615 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.467 ' CE1' ' CD2' ' A' ' 141' ' ' TRP . 12.3 t-80 -58.3 -64.54 0.88 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.484 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -42.64 -60.07 2.98 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 105' ' ' ASP . 14.6 tptp -57.31 -65.22 0.66 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.855 -0.672 . . . . 0.0 110.627 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -36.83 -55.87 0.88 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.237 0.542 . . . . 0.0 109.751 179.519 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.743 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -49.64 -47.75 49.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.73 0.776 . . . . 0.0 109.365 178.753 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -61.65 -31.58 71.69 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.338 -179.252 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.506 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 50.7 ttp -67.57 -52.28 40.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.334 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.755 HG23 ' H ' ' A' ' 109' ' ' LYS . 5.1 m -76.87 -22.93 14.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.42 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.32 28.58 0.32 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.755 ' H ' HG23 ' A' ' 107' ' ' VAL . 0.8 OUTLIER -89.41 -153.16 0.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.11 0.481 . . . . 0.0 111.55 -178.816 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.73 -170.56 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.79 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.476 ' OE1' ' CB ' ' A' ' 173' ' ' ALA . 50.1 mt-30 -65.04 117.82 8.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.833 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.473 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -108.04 137.11 19.74 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.474 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.408 ' N ' HG21 ' A' ' 170' ' ' ILE . 44.1 Cg_exo -47.82 117.57 2.52 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.466 1.444 . . . . 0.0 112.313 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 143' ' ' ALA . 2.5 mp -124.78 132.31 71.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.546 ' O ' HD12 ' A' ' 83' ' ' LEU . 4.8 tpt -131.9 117.44 18.48 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.937 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.0 mt -95.75 97.4 9.67 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.0 t -103.91 133.15 48.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 122.327 1.061 . . . . 0.0 110.665 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.413 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -106.18 112.6 3.92 Favored Glycine 0 C--N 1.304 -1.229 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.188 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.497 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.1 t30 -96.98 176.94 5.78 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.898 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.497 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 8.7 mttp 63.41 58.79 1.31 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.221 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.407 ' H ' ' HB3' ' A' ' 149' ' ' SER . 6.0 tttm -65.03 -12.93 56.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.748 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.451 ' OD2' ' CD1' ' A' ' 123' ' ' LEU . 2.6 p-10 -81.3 -8.43 59.74 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.101 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.598 ' O ' ' N ' ' A' ' 126' ' ' GLU . 11.1 mp -98.52 -23.11 15.66 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.614 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -26.88 -38.59 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.343 1.027 . . . . 0.0 111.284 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.543 ' N ' ' O ' ' A' ' 123' ' ' LEU . 2.0 mmt -46.85 -15.95 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.006 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 123' ' ' LEU . 18.6 mm-40 -92.58 -62.68 1.35 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.406 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.483 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 5.2 tpp85 26.18 65.74 0.07 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.008 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.9 t -49.01 -29.43 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.955 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.2 tp -88.82 156.36 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.877 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.52 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 74.9 p -97.85 123.09 41.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.348 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -37.77 -31.32 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.26 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.6 mp0 -71.66 -64.12 0.99 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.848 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.52 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 67.4 mt-10 -41.1 -40.95 1.63 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.952 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.91 -36.4 65.25 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 132' ' ' GLU . 13.8 tttm -62.39 -54.44 40.29 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.074 -0.563 . . . . 0.0 109.681 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.7 -35.76 71.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.794 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.18 -61.86 1.88 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.89 -38.01 61.25 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.17 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.43 -29.92 68.68 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.263 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.7 -46.67 81.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.989 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.479 ' CZ3' ' CD2' ' A' ' 104' ' ' LEU . 53.0 m95 -89.57 -3.49 58.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.143 0.496 . . . . 0.0 110.148 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 77.07 22.39 1.02 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.723 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.33 167.89 13.14 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.3 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.58 133.9 51.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.338 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.655 ' O ' HD22 ' A' ' 146' ' ' LEU . 6.0 t80 -96.68 122.02 39.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.679 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.794 HD12 HG22 ' A' ' 159' ' ' VAL . 1.2 mm? -134.17 137.91 44.78 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.964 -176.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.483 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 4.1 tt0 -126.24 111.5 14.65 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 27.5 p -137.66 -172.89 3.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.03 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.407 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -137.98 141.48 40.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.221 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.505 ' HB3' ' N7 ' ' A' ' 186' ' ' GDP . . . -61.66 -45.61 93.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.354 0.597 . . . . 0.0 109.4 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.445 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 15.7 tttp -65.81 5.22 0.5 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.644 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.479 ' H ' ' C ' ' A' ' 150' ' ' ALA . 43.9 mt-10 -133.85 120.4 20.39 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.836 0.351 . . . . 0.0 110.974 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.558 ' H ' ' ND2' ' A' ' 153' ' ' ASN . 0.0 OUTLIER -77.57 -57.5 3.79 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.071 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 153' ' ' ASN . 9.0 tt0 -36.85 -58.43 0.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.976 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.602 ' O ' HG23 ' A' ' 159' ' ' VAL . 58.8 p -52.06 -45.07 64.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.98 0.419 . . . . 0.0 110.045 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -56.16 -61.37 2.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.493 0.663 . . . . 0.0 109.869 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 59.7 t -40.83 -39.98 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.331 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -65.91 -38.33 88.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.149 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.794 HG22 HD12 ' A' ' 146' ' ' LEU . 21.7 t -67.99 -37.31 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.55 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.75 ' CZ ' HD11 ' A' ' 164' ' ' ILE . 1.2 t80 -57.76 -65.32 0.66 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.338 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.445 ' O ' ' N ' ' A' ' 164' ' ' ILE . 1.1 ttt-85 -46.73 -64.9 0.65 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.117 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.453 ' HA ' HD12 ' A' ' 165' ' ' LEU . 11.3 mmt180 -41.66 -31.21 0.27 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.331 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -68.05 -40.87 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 119.526 -0.869 . . . . 0.0 109.837 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.877 HG21 HG11 ' A' ' 49' ' ' VAL . 49.6 mt -63.92 -38.56 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.71 0.767 . . . . 0.0 109.961 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 168' ' ' GLU . 25.1 mt -57.63 -64.39 0.91 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.018 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -54.56 -25.39 25.79 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -69.53 -27.85 65.51 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 165' ' ' LEU . 3.0 tp10 -69.18 -57.85 4.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.019 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -57.76 -58.86 6.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.791 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.408 HG21 ' N ' ' A' ' 113' ' ' PRO . 1.4 mp -52.86 -34.34 20.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.689 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.492 ' OD2' ' NH2' ' A' ' 7' ' ' ARG . 0.4 OUTLIER -67.39 -40.07 85.65 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.144 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -57.59 -39.6 91.21 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.476 ' CB ' ' OE1' ' A' ' 111' ' ' GLN . . . -69.41 -81.5 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.754 0.312 . . . . 0.0 110.243 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.832 179.923 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GDP . . . . . 0.544 ' H8 ' ' OG ' ' A' ' 21' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.88 0.371 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.19 137.42 34.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.057 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.512 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 5.5 mtpm? -103.48 134.36 46.97 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.487 HD13 ' C ' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -115.93 129.01 73.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.744 -176.467 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.82 133.94 33.59 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.267 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.509 HD11 ' HB2' ' A' ' 58' ' ' LEU . 30.6 mt -97.58 133.87 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 120.695 0.284 . . . . 0.0 111.318 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 12' ' ' LEU . 5.1 tt -130.45 97.67 4.46 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.459 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -141.18 133.41 5.81 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.431 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.475 ' O ' HG12 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -57.9 -173.89 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.075 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -84.89 125.21 32.45 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.195 0.522 . . . . 0.0 111.427 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 75.31 12.1 3.33 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.593 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 14' ' ' TYR . 7.5 p -71.14 -20.86 21.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.535 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.57 24.16 12.74 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.013 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.3 pttm -69.07 -36.49 77.69 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.322 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.1 m -71.86 -26.49 62.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.549 ' OG ' ' H8 ' ' A' ' 186' ' ' GDP . 55.4 m -68.29 -43.45 77.69 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.163 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.2 tp -77.65 -41.41 38.41 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.897 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.586 ' O ' HG12 ' A' ' 27' ' ' VAL . 16.3 m -52.56 -38.83 60.66 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -78.07 -38.4 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.038 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.466 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -69.51 -33.65 73.15 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.398 -179.497 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -77.98 -61.14 2.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.197 0.522 . . . . 0.0 111.047 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.9 p -46.39 -48.05 6.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.77 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.617 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.2 tt0 -84.18 -24.74 30.0 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 77.97 22.91 67.67 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.252 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -153.02 127.14 9.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -59.5 94.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.412 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.566 HG22 ' N ' ' A' ' 33' ' ' ASP . 11.9 p -123.4 166.03 18.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.983 0.42 . . . . 0.0 110.101 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.566 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -78.01 -37.8 46.23 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.211 -179.281 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 33' ' ' ASP . 25.1 p 53.83 148.26 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.857 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -87.29 29.39 0.86 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.63 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -143.41 72.07 17.78 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.795 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 39' ' ' ILE . 46.1 Cg_exo -58.75 -131.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 123.152 2.568 . . . . 0.0 111.64 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.574 HG23 ' O ' ' A' ' 38' ' ' THR . 14.9 t -74.32 46.07 0.25 Allowed 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 121.77 0.795 . . . . 0.0 110.372 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.452 ' H ' ' C ' ' A' ' 37' ' ' PRO . 1.5 tp -82.76 139.75 17.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.094 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.665 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -83.48 130.44 35.02 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.821 -178.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 40' ' ' GLU . 3.9 m-20 166.88 -179.29 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.5 0.667 . . . . 0.0 112.504 -178.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.451 HG23 HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -108.98 134.49 51.55 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.632 179.507 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -112.2 170.96 7.8 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.8 156.37 40.07 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HB2' HG23 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -168.06 131.16 1.57 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.668 178.415 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.5 mp -105.97 133.29 50.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.533 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.31 165.4 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.897 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.7 m -133.24 131.16 39.97 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.802 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.738 HG11 HD13 ' A' ' 164' ' ' ILE . 7.6 p -133.89 136.44 53.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.296 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 61.51 2.94 0.73 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.224 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 105.18 -11.29 48.03 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -89.07 118.55 28.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.634 0.254 . . . . 0.0 110.687 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.26 144.23 28.24 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.278 0.561 . . . . 0.0 111.805 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.655 ' CE1' HG12 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -140.63 152.96 45.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.16 178.935 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.627 ' C ' HD12 ' A' ' 56' ' ' LEU . 1.4 m-70 -118.88 116.94 27.53 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.441 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.627 HD12 ' C ' ' A' ' 55' ' ' HIS . 9.9 mp -117.38 139.36 50.96 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.748 0.785 . . . . 0.0 111.193 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -130.08 125.76 35.96 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.097 -1.41 . . . . 0.0 109.195 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.905 HD22 ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -113.7 135.03 54.38 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.322 -178.747 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.487 ' CG1' ' OH ' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -118.99 139.95 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.866 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -118.83 112.97 20.37 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.626 178.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.436 HG22 ' OD1' ' A' ' 65' ' ' ASP . 45.3 p 41.96 -118.78 0.44 Allowed 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.316 0.579 . . . . 0.0 111.019 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.516 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . . . 59.69 33.99 22.02 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.592 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.36 -158.63 27.94 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.53 ' O ' ' CD1' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -82.01 115.74 21.3 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.021 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 68' ' ' SER . 7.6 p-10 -136.72 -174.17 3.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.038 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.712 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -45.51 -46.78 14.11 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.868 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -43.39 -24.35 0.09 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.305 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 65' ' ' ASP . 81.4 p -156.64 86.26 0.99 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.742 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.531 ' O ' ' CB ' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -51.66 130.36 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.462 179.196 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.554 ' CG ' ' O ' ' A' ' 70' ' ' PHE . 6.6 t80 146.81 76.87 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.837 0 O-C-N 124.097 0.873 . . . . 0.0 109.852 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 45.3 Cg_exo -54.47 -142.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 122.97 2.447 . . . . 0.0 112.958 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.5 ' CB ' ' O ' ' A' ' 71' ' ' PRO . 0.5 OUTLIER 89.67 -8.67 0.39 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.065 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 m -158.67 15.82 0.19 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.827 0.346 . . . . 0.0 110.915 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.53 ' CD1' ' O ' ' A' ' 64' ' ' GLN . 8.3 t80 -110.19 -25.09 10.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.158 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 m 43.61 80.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.82 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.442 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 30.9 pt -70.46 -135.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.507 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 1.9 m-20 83.7 34.8 0.05 OUTLIER 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 80' ' ' GLY . 40.2 pt -83.22 -171.91 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.373 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -144.53 17.85 1.67 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.757 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.631 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -159.03 166.49 34.58 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.345 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.415 ' OH ' ' OE1' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -150.16 127.39 11.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.553 -0.823 . . . . 0.0 110.7 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.764 ' O ' HG23 ' A' ' 82' ' ' ILE . 12.3 tt -129.18 96.9 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.57 118.58 34.39 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.355 -177.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 84' ' ' VAL . 2.1 t -96.95 111.02 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.273 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.511 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 4.1 p90 -110.66 142.39 42.61 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.416 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.462 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.5 p -88.94 141.17 28.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.429 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.634 HG21 ' N ' ' A' ' 124' ' ' HIS . 19.1 m -77.58 18.05 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.771 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.99 -25.26 1.62 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.51 ' C ' ' N ' ' A' ' 91' ' ' LYS . 20.6 t -94.0 92.37 7.32 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.333 -176.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 90' ' ' ILE . 10.3 tp -59.57 -10.43 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.553 ' O ' HG13 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -78.18 -54.96 5.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.247 179.004 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.1 p -55.13 -27.22 43.8 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.511 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -76.75 -39.58 51.26 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.625 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.456 ' O ' HG23 ' A' ' 98' ' ' VAL . 3.9 mm-40 -68.23 -44.17 76.32 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.22 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 91' ' ' LYS . 2.3 m -69.37 -40.81 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.584 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.428 ' CG1' HD22 ' A' ' 12' ' ' LEU . 18.0 mt -57.09 -51.28 71.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.292 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -72.35 -31.65 65.81 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.853 0.358 . . . . 0.0 111.412 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 94' ' ' GLU . 18.8 t -73.46 -66.36 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.351 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.604 HD13 ' O ' ' A' ' 66' ' ' GLU . 31.9 mt -48.16 -55.72 2.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.494 ' CE1' ' CE2' ' A' ' 141' ' ' TRP . 25.9 t-80 -41.16 -63.82 0.63 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.64 -52.0 1.9 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 103' ' ' LEU . 24.3 tptt -70.48 -66.66 0.57 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.386 -0.407 . . . . 0.0 111.106 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -36.71 -55.07 0.89 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.969 0.414 . . . . 0.0 109.946 179.718 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.699 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -51.91 -50.7 60.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.495 0.664 . . . . 0.0 109.449 179.157 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.469 ' N ' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -51.38 -29.67 16.42 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.032 -179.382 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.467 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 17.6 ttp -77.49 -48.67 16.51 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.546 HG23 ' H ' ' A' ' 109' ' ' LYS . 5.9 m -75.44 -25.75 18.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.781 -178.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 40.84 37.34 1.32 Allowed Glycine 0 CA--C 1.531 1.076 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.564 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.546 ' H ' HG23 ' A' ' 107' ' ' VAL . 0.3 OUTLIER -91.25 -157.99 0.53 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 117.224 0.512 . . . . 0.0 111.543 -178.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 174' ' ' ALA . 0.0 OUTLIER -99.19 -177.56 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.762 -179.644 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.451 ' HB3' HG23 ' A' ' 170' ' ' ILE . 59.5 mt-30 -67.49 118.74 11.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.71 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.671 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.8 OUTLIER -117.66 152.91 50.36 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.33 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -46.45 111.42 0.36 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 121.717 1.611 . . . . 0.0 112.338 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.479 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.9 mt -121.62 131.82 72.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.1 tpt -128.01 115.78 19.03 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.623 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.9 mt -95.25 97.55 9.96 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.4 133.31 47.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 122.298 1.047 . . . . 0.0 110.996 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.41 110.23 3.41 Favored Glycine 0 C--N 1.304 -1.231 0 CA-C-N 113.459 -1.7 . . . . 0.0 109.018 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.481 ' CG ' ' N ' ' A' ' 120' ' ' LYS . 43.8 t30 -97.23 174.04 6.92 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.818 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.481 ' N ' ' CG ' ' A' ' 119' ' ' ASN . 2.1 mttp 67.11 59.13 0.54 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.845 0.831 . . . . 0.0 109.226 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.37 -37.49 87.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.368 -178.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.646 ' CG ' HN21 ' A' ' 186' ' ' GDP . 3.6 p-10 -59.88 -9.88 3.41 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.899 -178.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.6 mp -93.99 -29.73 15.08 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.634 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.5 OUTLIER -42.03 -22.77 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.805 178.839 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.495 ' N ' ' O ' ' A' ' 123' ' ' LEU . 3.5 mmt -46.65 -23.18 0.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.478 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.3 OUTLIER -103.34 -40.48 6.38 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.218 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.497 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 5.0 tpp85 33.16 83.29 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.199 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.0 m -67.87 -29.5 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.546 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.1 tp -89.42 155.07 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.497 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.447 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 82.0 p -94.7 122.54 37.41 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.838 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -41.35 -33.66 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.404 0.621 . . . . 0.0 109.52 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.5 mp0 -65.07 -64.71 0.8 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.932 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.447 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 65.4 mt-10 -41.26 -43.96 2.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.023 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.16 -32.97 69.0 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 132' ' ' GLU . 20.0 tttm -65.72 -55.26 18.27 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.08 -34.04 65.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.494 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.77 -62.7 1.36 Allowed 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.841 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -55.22 -34.71 64.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.543 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.15 -34.75 75.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.735 0.302 . . . . 0.0 110.55 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.04 -46.29 88.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.906 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.494 ' CE2' ' CE1' ' A' ' 100' ' ' HIS . 56.9 m95 -88.45 -4.51 58.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.977 0.418 . . . . 0.0 110.327 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 73.88 25.1 1.97 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.619 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -90.8 168.34 11.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.42 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.32 133.89 49.34 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.794 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.66 ' O ' HD22 ' A' ' 146' ' ' LEU . 4.6 t80 -96.65 121.37 38.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.182 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.66 HD22 ' O ' ' A' ' 145' ' ' PHE . 1.4 mm? -134.71 137.07 43.19 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.624 -176.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.497 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 5.8 tt0 -124.62 111.01 15.12 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.524 ' OG ' HG21 ' A' ' 159' ' ' VAL . 10.7 p -135.5 -174.96 3.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.994 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.47 132.94 32.08 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.053 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.457 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -56.26 -53.04 61.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.283 0.563 . . . . 0.0 109.732 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -49.4 -12.38 0.06 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.786 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.457 ' H ' ' C ' ' A' ' 150' ' ' ALA . 31.8 mt-10 -122.64 124.17 42.83 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.64 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.468 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 80.1 m-20 -77.71 -53.21 7.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 153' ' ' ASN . 10.7 tt0 -38.81 -57.34 1.23 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.924 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.666 ' O ' HG23 ' A' ' 159' ' ' VAL . 44.2 p -51.97 -44.89 64.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.987 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -55.89 -61.58 2.28 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.566 0.698 . . . . 0.0 109.868 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 61.3 t -41.62 -39.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.518 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -67.86 -36.98 81.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.633 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 155' ' ' THR . 35.5 t -66.61 -36.24 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.803 ' CZ ' HD11 ' A' ' 164' ' ' ILE . 1.3 t80 -62.47 -65.69 0.65 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.691 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -44.09 -53.51 6.32 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.741 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -55.81 -29.45 59.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.914 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -66.64 -35.95 76.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.248 -179.801 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.803 HD11 ' CZ ' ' A' ' 160' ' ' PHE . 42.5 mt -67.54 -38.19 80.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.587 0.708 . . . . 0.0 109.948 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.13 -63.23 1.37 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.748 -178.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -57.59 -31.42 66.15 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.879 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -60.08 -32.3 70.83 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.475 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.49 -55.07 9.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.004 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -55.45 -63.11 1.27 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.091 0.472 . . . . 0.0 110.552 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.671 HG21 ' C ' ' A' ' 112' ' ' ILE . 96.7 mt -51.23 -35.36 15.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.792 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.12 -40.0 86.77 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -57.38 -32.61 64.35 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.85 -79.43 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.727 0.299 . . . . 0.0 110.297 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.404 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . . . . . . . . 0 C--N 1.332 -0.153 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.275 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GDP . . . . . 0.646 HN21 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 CA-C-O 121.073 0.463 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -139.67 135.42 33.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.939 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.523 ' HB2' HG22 ' A' ' 78' ' ' ILE . 8.3 mttm -106.56 130.05 54.39 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.749 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -103.77 123.04 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-O 121.426 0.631 . . . . 0.0 110.479 -178.586 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.19 134.86 34.95 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.113 -0.992 . . . . 0.0 110.216 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.451 HD11 ' HB2' ' A' ' 58' ' ' LEU . 16.9 mt -96.12 133.71 36.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.502 0.667 . . . . 0.0 111.905 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.548 HD13 HG12 ' A' ' 96' ' ' ILE . 2.0 tt -125.18 97.67 5.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.352 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -139.89 130.56 4.74 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.009 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.425 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -57.99 -155.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.821 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.04 139.36 31.5 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.752 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.7 m 56.8 10.8 0.79 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.986 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.68 -20.84 28.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.459 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.54 22.6 18.42 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 pttm -72.2 -34.44 68.38 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.856 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.462 ' O ' HD13 ' A' ' 24' ' ' ILE . 56.5 m -77.25 -35.19 55.58 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.569 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.06 -36.14 81.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 29.4 tp -76.88 -46.58 24.01 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.471 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.552 ' O ' HG12 ' A' ' 27' ' ' VAL . 71.9 m -45.07 -41.5 7.75 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.92 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.462 HD13 ' O ' ' A' ' 20' ' ' SER . 1.3 mp -77.62 -41.84 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.232 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.495 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.5 OUTLIER -69.43 -32.31 71.2 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.492 -178.781 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.46 ' CG ' ' N ' ' A' ' 27' ' ' VAL . 0.6 OUTLIER -77.92 -63.19 1.45 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.27 0.557 . . . . 0.0 110.805 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.586 HG13 ' N ' ' A' ' 28' ' ' GLU . 11.3 p -44.38 -47.59 2.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.424 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.586 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.5 tt0 -83.14 -24.61 32.49 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 75.12 25.63 68.37 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.288 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 25' ' ' GLN . 0.6 OUTLIER -151.61 126.37 9.62 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 120.886 0.374 . . . . 0.0 111.691 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -63.57 93.71 0.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.95 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.619 HG22 ' N ' ' A' ' 33' ' ' ASP . 12.7 p -107.4 165.87 4.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.26 0.553 . . . . 0.0 110.986 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.619 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -49.87 -13.89 0.12 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.993 -178.536 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.485 ' H ' HG13 ' A' ' 32' ' ' VAL . 17.5 p 42.68 97.98 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.147 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -84.71 12.09 7.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.084 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 37' ' ' PRO . 1.2 m-20 -119.84 86.71 36.52 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.033 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 36' ' ' ASP . 68.5 Cg_exo -54.29 -128.42 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.898 2.398 . . . . 0.0 112.302 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 38' ' ' THR . 13.9 t -91.84 45.44 1.22 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.311 0.577 . . . . 0.0 111.246 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 tp -84.02 142.6 13.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.654 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.577 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 1.4 pm0 -90.77 135.65 33.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.382 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 40' ' ' GLU . 1.1 m-80 178.99 -179.78 0.38 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.249 0.547 . . . . 0.0 112.079 -179.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.95 132.91 53.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.072 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -114.45 173.92 6.22 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.167 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.55 155.59 43.74 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -155.4 108.04 2.71 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.604 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 46' ' ' LEU . 8.0 mp -105.36 122.45 45.98 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.725 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 pp -149.55 165.83 3.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.551 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.1 m -114.05 123.81 50.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.567 HG12 ' CD1' ' A' ' 54' ' ' TYR . 7.5 p -119.07 125.39 74.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-N 116.352 -0.386 . . . . 0.0 109.963 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 67.46 15.46 9.85 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.51 -9.95 76.02 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.37 135.71 33.51 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.39 146.99 40.37 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.597 0.713 . . . . 0.0 111.271 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.567 ' CD1' HG12 ' A' ' 49' ' ' VAL . 4.9 m-85 -137.92 123.58 19.82 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.192 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.502 ' NE2' HD23 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -118.16 112.47 20.2 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.4 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.491 HD12 ' C ' ' A' ' 55' ' ' HIS . 8.9 mp -120.92 146.71 46.34 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.585 0.707 . . . . 0.0 112.24 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.805 ' C ' HD13 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -137.56 126.93 24.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.01 178.25 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.974 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.72 154.51 31.57 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.253 -178.246 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.33 140.8 47.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.485 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.31 114.31 19.39 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.02 177.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.41 ' O ' ' OD2' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -131.53 172.96 11.6 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.587 0.708 . . . . 0.0 111.029 -178.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -143.61 13.04 1.72 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.985 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.413 ' O ' ' OG ' ' A' ' 68' ' ' SER . . . -92.23 -121.11 2.78 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.592 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 10.9 mp0 -82.77 72.18 9.85 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 68' ' ' SER . 35.3 p-10 -138.06 -172.3 3.23 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.091 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.578 ' HB3' HG21 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -50.66 -38.1 44.61 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.547 ' N ' ' OE1' ' A' ' 66' ' ' GLU . 41.4 t80 -48.62 -17.61 0.18 Allowed 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.535 ' N ' ' C ' ' A' ' 66' ' ' GLU . 78.9 p -160.27 84.28 0.71 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.748 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.545 ' O ' ' CD2' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -42.72 127.95 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.585 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 69' ' ' ILE . 0.6 OUTLIER 169.27 81.42 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.829 -179.733 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.92 110.24 0.38 Allowed 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.333 2.022 . . . . 0.0 112.224 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.4 -56.31 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.663 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -105.1 -19.75 13.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.666 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.472 ' C ' ' H ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -87.33 24.38 1.63 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.12 0.486 . . . . 0.0 109.822 179.534 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -77.66 23.42 0.23 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.292 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.472 ' H ' ' C ' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -51.21 -172.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.888 179.729 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.83 49.6 2.21 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.523 HG22 ' HB2' ' A' ' 8' ' ' LYS . 43.7 pt -78.73 -174.88 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.691 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.39 20.35 0.84 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.137 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -147.95 164.79 28.89 Favored Glycine 0 CA--C 1.517 0.218 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.682 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.2 123.21 7.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.754 -0.723 . . . . 0.0 111.165 178.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.631 ' C ' HD23 ' A' ' 83' ' ' LEU . 9.9 tt -126.85 110.37 22.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.787 ' N ' HD23 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.79 119.1 36.97 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.236 -177.331 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.6 133.07 42.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.075 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.474 ' CD2' ' CE2' ' A' ' 93' ' ' PHE . 8.4 p90 -143.32 144.6 32.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.973 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.583 ' C ' ' H ' ' A' ' 88' ' ' THR . 2.2 t -88.24 143.25 27.15 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.853 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.547 HG21 ' N ' ' A' ' 124' ' ' HIS . 20.2 m -67.18 14.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.972 0.415 . . . . 0.0 110.259 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.583 ' H ' ' C ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -127.78 -18.13 4.35 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.53 -178.675 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.492 ' C ' ' N ' ' A' ' 91' ' ' LYS . 8.6 t -94.95 92.02 6.68 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.447 -175.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.9 tp -62.97 -11.44 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.524 ' O ' HG13 ' A' ' 95' ' ' VAL . 1.0 OUTLIER -78.32 -58.63 3.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 113.712 -1.585 . . . . 0.0 110.576 178.864 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.503 ' O ' HD12 ' A' ' 96' ' ' ILE . 19.0 p -55.38 -31.62 61.94 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.398 0.618 . . . . 0.0 109.539 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.474 ' CE2' ' CD2' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -77.72 -38.1 47.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.195 179.677 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 98' ' ' VAL . 34.9 mt-10 -69.21 -46.79 66.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.477 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 91' ' ' LYS . 2.8 m -67.8 -45.23 84.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.59 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.548 HG12 HD13 ' A' ' 12' ' ' LEU . 33.3 mt -58.41 -46.14 89.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.536 ' HG3' HD11 ' A' ' 137' ' ' LEU . 0.5 OUTLIER -72.24 -37.73 69.06 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.097 0.475 . . . . 0.0 111.06 -179.439 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 94' ' ' GLU . 56.0 t -72.11 -65.3 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.672 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.578 HG21 ' HB3' ' A' ' 66' ' ' GLU . 73.3 mt -42.3 -59.12 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.915 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.441 ' ND1' ' N ' ' A' ' 101' ' ' GLY . 4.3 t-80 -40.98 -64.98 0.47 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.752 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.441 ' N ' ' ND1' ' A' ' 100' ' ' HIS . . . -36.6 -56.71 1.25 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 103' ' ' LEU . 32.8 tptt -69.8 -66.5 0.58 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.472 -0.364 . . . . 0.0 111.611 -179.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 106' ' ' MET . 5.8 tp -36.98 -61.83 0.53 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.707 ' C ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -44.5 -50.67 9.38 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.787 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.489 ' N ' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -53.6 -26.65 22.76 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.448 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 103' ' ' LEU . 3.9 tpp -72.96 -53.72 10.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.903 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.471 HG23 ' H ' ' A' ' 109' ' ' LYS . 20.0 m -77.31 -20.87 14.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.384 -0.527 . . . . 0.0 110.837 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 42.07 37.89 2.41 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.593 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.471 ' H ' HG23 ' A' ' 107' ' ' VAL . 2.2 tptp -84.44 -154.65 0.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.178 0.513 . . . . 0.0 111.46 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.62 -173.83 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.993 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.548 ' O ' ' HB2' ' A' ' 174' ' ' ALA . 38.4 mt-30 -67.95 116.97 9.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.689 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.67 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.8 OUTLIER -118.52 155.84 51.77 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.343 179.242 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -47.04 111.43 0.39 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.813 1.675 . . . . 0.0 112.254 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.476 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.7 mt -121.84 127.3 75.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 6.6 tpt -128.62 117.23 20.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.09 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.7 mt -95.95 97.79 9.9 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.413 ' O ' ' CE1' ' A' ' 85' ' ' TYR . 29.8 t -104.92 128.56 58.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 122.175 0.988 . . . . 0.0 111.319 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.457 ' CA ' ' CE2' ' A' ' 85' ' ' TYR . . . -102.65 114.5 4.91 Favored Glycine 0 C--N 1.307 -1.04 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.508 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 49.1 t30 -97.8 177.16 5.55 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.698 -178.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.508 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 19.4 mttt 61.91 59.17 1.77 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.071 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.444 ' H ' ' HB3' ' A' ' 149' ' ' SER . 29.5 tttm -64.92 -17.99 64.83 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.677 ' CG ' HN21 ' A' ' 186' ' ' GDP . 5.5 p-10 -79.24 0.65 27.74 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.844 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 125' ' ' MET . 9.2 mp -95.88 -25.43 16.01 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.547 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -37.39 -28.19 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.531 178.449 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.521 ' N ' ' O ' ' A' ' 123' ' ' LEU . 9.3 mtt -45.43 -23.58 0.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.471 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -108.98 -38.83 5.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.844 179.397 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.467 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 0.0 OUTLIER 28.68 86.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.173 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.9 m -72.79 -31.65 37.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.451 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.42 151.8 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.779 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.456 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 94.4 p -104.21 126.39 51.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.153 0.501 . . . . 0.0 111.417 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.455 ' CE1' ' CE1' ' A' ' 145' ' ' PHE . 0.8 OUTLIER -39.95 -38.86 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.313 178.738 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -63.21 -64.85 0.79 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.236 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.456 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 59.8 mt-10 -41.08 -46.54 2.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.116 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.42 -33.2 76.72 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 132' ' ' GLU . 21.4 tttm -63.87 -55.42 22.92 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.12 -35.75 69.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.674 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.536 HD11 ' HG3' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -66.79 -62.42 1.46 Allowed 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 121.18 0.514 . . . . 0.0 109.779 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.04 -36.61 50.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.288 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -68.12 -32.52 72.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.755 0.312 . . . . 0.0 110.26 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.89 -46.15 86.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.844 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.451 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 49.7 m95 -88.26 -4.51 58.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.345 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 74.63 27.52 1.31 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.399 0.618 . . . . 0.0 109.411 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -95.46 170.01 9.65 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.57 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.92 133.07 52.79 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.018 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.695 ' O ' HD22 ' A' ' 146' ' ' LEU . 8.3 t80 -97.24 122.33 40.14 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.445 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.825 HD21 ' HE ' ' A' ' 162' ' ' ARG . 1.5 mm? -134.58 136.37 42.92 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.713 -176.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.467 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 5.8 tt0 -123.38 111.95 16.99 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.518 ' OG ' HG21 ' A' ' 159' ' ' VAL . 22.7 p -137.33 -175.74 4.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.752 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.444 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -139.26 136.51 35.01 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.908 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.459 ' N ' ' O6 ' ' A' ' 186' ' ' GDP . . . -57.49 -47.41 81.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.274 0.559 . . . . 0.0 109.827 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -56.08 -8.43 0.46 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.449 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 150' ' ' ALA . 30.4 mt-10 -127.53 124.4 38.16 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.806 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.451 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 5.4 t-20 -77.72 -55.87 4.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.02 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 153' ' ' ASN . 1.6 mt-30 -36.73 -57.74 0.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.103 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.669 ' O ' HG23 ' A' ' 159' ' ' VAL . 58.8 p -52.88 -45.25 67.4 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.085 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.495 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -56.21 -61.67 2.24 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.595 0.712 . . . . 0.0 109.934 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 60.6 t -42.77 -39.18 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.534 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -68.77 -33.79 74.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.788 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 155' ' ' THR . 44.6 t -67.61 -39.38 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.074 0.464 . . . . 0.0 109.815 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.509 ' O ' ' N ' ' A' ' 163' ' ' ILE . 66.5 t80 -63.55 -66.24 0.57 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.779 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.0 ttt85 -43.34 -46.47 6.47 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.667 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.825 ' HE ' HD21 ' A' ' 146' ' ' LEU . 14.9 mmm180 -58.06 -32.64 68.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.16 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.509 ' N ' ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -66.22 -34.8 72.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.26 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.599 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 14.1 mt -63.78 -44.1 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.423 0.63 . . . . 0.0 111.295 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -58.79 -64.67 0.85 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.045 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.462 ' H ' HD23 ' A' ' 165' ' ' LEU . 0.4 OUTLIER -50.52 -23.83 2.77 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.676 -178.88 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -71.77 -31.18 66.35 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.559 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 165' ' ' LEU . 0.5 OUTLIER -70.29 -52.21 24.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.08 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -61.09 -63.56 1.25 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.883 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.67 HG21 ' C ' ' A' ' 112' ' ' ILE . 96.4 mt -50.95 -32.7 12.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.94 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.02 -39.09 86.96 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.484 -0.487 . . . . 0.0 109.908 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -59.48 -35.54 85.78 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.403 ' O ' ' C ' ' A' ' 174' ' ' ALA . . . -68.39 -78.56 0.06 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.025 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GDP . . . . . 0.677 HN21 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 121.223 0.535 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.589 ' NH1' ' HB1' ' A' ' 167' ' ' ALA . 83.4 mtt180 -140.27 135.55 32.39 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.905 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.513 ' HB2' HG22 ' A' ' 78' ' ' ILE . 15.2 mttm -107.3 127.63 53.72 Favored 'General case' 0 C--O 1.212 -0.896 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.768 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.7 OUTLIER -103.02 118.47 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-O 121.691 0.758 . . . . 0.0 110.773 -178.352 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.49 ' HB2' HD13 ' A' ' 78' ' ' ILE . . . -82.73 137.75 34.29 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.691 -0.631 . . . . 0.0 111.848 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.1 mt -92.92 125.82 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.183 0.516 . . . . 0.0 111.92 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tt -123.19 92.33 3.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.896 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 66' ' ' GLU . . . -142.03 136.82 7.53 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -178.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.581 ' CD1' HG21 ' A' ' 95' ' ' VAL . 0.5 OUTLIER -53.09 -160.17 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.699 0.762 . . . . 0.0 111.31 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.8 tpp85 -97.11 136.0 38.28 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.701 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.469 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 3.3 m 63.28 11.5 5.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.567 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 p -71.94 -16.84 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.16 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.62 21.35 34.5 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -39.25 81.11 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.359 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.7 m -71.89 -28.65 63.65 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.539 ' OG ' ' H8 ' ' A' ' 186' ' ' GDP . 60.3 m -63.73 -42.42 97.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.199 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.4 tp -75.53 -28.41 59.08 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.464 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.579 ' O ' HG12 ' A' ' 27' ' ' VAL . 40.0 m -55.94 -49.92 72.18 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.502 HD11 ' CE2' ' A' ' 43' ' ' PHE . 1.4 mp -70.9 -41.04 77.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.075 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.471 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -65.67 -30.24 70.9 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.23 -179.169 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -77.79 -64.02 1.25 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.452 0.644 . . . . 0.0 111.353 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.631 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.1 p -49.65 -47.2 21.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.375 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.631 ' N ' HG13 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -83.66 -24.36 31.38 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.372 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.17 25.99 71.86 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -144.47 125.45 14.42 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.187 0.518 . . . . 0.0 112.297 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.625 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -71.65 92.53 1.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.801 179.164 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.62 HG22 ' N ' ' A' ' 33' ' ' ASP . 12.5 p -117.05 165.83 12.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.206 0.527 . . . . 0.0 110.568 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.62 ' N ' HG22 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -87.51 20.51 2.86 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.295 -179.052 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.466 ' H ' HG13 ' A' ' 32' ' ' VAL . 5.0 p -30.03 131.46 0.08 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.798 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.73 100.58 12.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.336 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -166.62 82.95 0.94 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.524 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -58.42 -135.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.753 2.302 . . . . 0.0 112.127 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 38' ' ' THR . 1.6 t -101.24 46.06 0.95 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.986 0.898 . . . . 0.0 111.385 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 tp -82.48 167.1 2.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.228 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.521 ' CB ' ' HB2' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -73.22 116.78 14.16 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.019 -179.289 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -160.35 161.7 33.23 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.808 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.5 m -132.52 149.62 52.29 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.266 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.502 ' CE2' HD11 ' A' ' 24' ' ' ILE . 10.9 m-85 -129.63 164.48 23.79 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.55 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -146.72 150.36 35.22 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.148 0.499 . . . . 0.0 111.997 -178.605 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -153.17 119.19 5.42 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.06 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.706 HD21 ' CE1' ' A' ' 55' ' ' HIS . 6.4 mp -107.01 123.86 48.8 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.127 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.823 HD12 ' CE1' ' A' ' 160' ' ' PHE . 0.8 OUTLIER -145.51 165.63 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.221 179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.36 121.85 44.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.224 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 49' ' ' VAL . 8.5 p -114.59 114.66 47.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.92 179.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 49' ' ' VAL . 4.3 t-20 73.72 11.83 4.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.398 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.82 -8.14 63.37 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.577 ' NE2' ' O ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -93.74 135.17 35.31 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.603 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.577 ' O ' ' NE2' ' A' ' 52' ' ' GLN . 2.4 mt-10 -74.35 145.48 43.81 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.577 0.704 . . . . 0.0 111.252 -178.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.697 ' CE2' HG23 ' A' ' 164' ' ' ILE . 4.3 m-85 -136.18 127.07 27.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.183 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.706 ' CE1' HD21 ' A' ' 46' ' ' LEU . 2.2 t-160 -117.63 112.87 21.11 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.505 HD12 ' C ' ' A' ' 55' ' ' HIS . 9.0 mp -118.46 139.12 51.91 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.537 0.684 . . . . 0.0 111.575 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.731 ' C ' HD13 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -132.16 121.0 23.02 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.098 178.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.931 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -114.64 155.21 26.98 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.761 -178.214 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.12 145.95 31.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -177.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.407 ' O ' ' OG1' ' A' ' 61' ' ' THR . 0.3 OUTLIER -122.04 117.51 26.53 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 113.504 -1.68 . . . . 0.0 107.898 177.525 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.602 ' C ' ' N ' ' A' ' 63' ' ' GLY . 20.3 p 55.88 178.7 0.04 OUTLIER 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 123.546 0.528 . . . . 0.0 109.771 -177.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.521 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . . . 52.85 12.48 0.27 Allowed 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.602 ' N ' ' C ' ' A' ' 61' ' ' THR . . . -150.22 -157.75 7.89 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 113.9 -1.5 . . . . 0.0 111.681 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.627 ' CD ' ' H ' ' A' ' 64' ' ' GLN . 6.8 mp0 -86.23 86.95 7.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.235 0.54 . . . . 0.0 110.73 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.43 ' CG ' ' H ' ' A' ' 67' ' ' TYR . 21.3 p-10 -139.71 -176.67 4.65 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.977 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.525 ' OE1' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -60.36 -9.24 3.29 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.53 ' CD2' ' OH ' ' A' ' 74' ' ' TYR . 32.3 t80 -94.67 12.17 28.65 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.3 p -158.13 152.22 24.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.218 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.9 tt -166.23 -11.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 121.815 0.817 . . . . 0.0 109.386 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.523 ' O ' ' CD2' ' A' ' 70' ' ' PHE . 28.5 t80 -116.59 85.22 16.27 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.477 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.481 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 51.3 Cg_exo -51.66 -163.25 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.551 2.167 . . . . 0.0 112.516 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.481 ' CB ' ' O ' ' A' ' 71' ' ' PRO . 5.7 tt0 81.29 -20.06 0.39 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.288 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 73' ' ' THR . 40.5 m -128.73 -15.41 4.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.65 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.549 ' CD2' ' O ' ' A' ' 63' ' ' GLY . 0.8 OUTLIER -94.93 -22.39 18.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.507 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 55.25 87.32 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.459 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.464 ' HB ' HE21 ' A' ' 64' ' ' GLN . 1.1 pt -92.46 173.6 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 121.022 0.439 . . . . 0.0 111.274 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 170.35 29.13 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.076 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.798 HD12 ' O ' ' A' ' 80' ' ' GLY . 38.3 pt -85.56 -171.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-O 121.405 0.622 . . . . 0.0 112.664 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.56 19.81 1.04 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.437 178.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.798 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -156.96 168.1 33.89 Favored Glycine 0 CA--C 1.521 0.45 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.187 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -152.15 122.76 7.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.985 -0.608 . . . . 0.0 110.709 177.831 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.641 ' O ' HG23 ' A' ' 82' ' ' ILE . 11.0 tt -125.34 102.3 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.716 0.77 . . . . 0.0 109.312 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.839 ' N ' HD12 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -97.15 125.72 41.84 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.794 -178.56 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -95.51 130.66 43.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.303 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.681 ' CZ ' HG21 ' A' ' 96' ' ' ILE . 49.8 m-85 -110.56 143.75 40.47 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.14 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.499 ' C ' ' H ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -98.21 124.13 42.63 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.534 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.513 HG21 ' N ' ' A' ' 124' ' ' HIS . 14.1 m -72.51 23.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.71 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.499 ' H ' ' C ' ' A' ' 86' ' ' SER . 5.1 t -138.36 -25.57 0.93 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.556 ' C ' ' N ' ' A' ' 91' ' ' LYS . 8.3 t -100.2 95.06 6.55 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.051 -176.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.1 tp -57.86 -11.66 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 175.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' C ' ' A' ' 89' ' ' SER . 18.5 mttp -77.74 -61.51 1.97 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 113.936 -1.483 . . . . 0.0 110.23 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.638 ' O ' HD12 ' A' ' 96' ' ' ILE . 76.5 p -47.17 -29.59 2.4 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.723 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.948 ' CE2' HG21 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -74.07 -51.41 15.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.179 -179.365 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.571 ' O ' HG23 ' A' ' 98' ' ' VAL . 4.0 mm-40 -65.79 -43.96 87.17 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.581 HG21 ' CD1' ' A' ' 14' ' ' TYR . 13.6 m -68.07 -36.5 75.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.12 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.681 HG21 ' CZ ' ' A' ' 85' ' ' TYR . 19.2 mt -63.35 -38.84 83.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -69.68 -25.97 64.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.03 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 94' ' ' GLU . 57.4 t -76.46 -66.47 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.338 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.406 ' H ' HG12 ' A' ' 99' ' ' ILE . 4.5 mm -44.27 -54.36 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.431 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.637 ' ND1' ' CH2' ' A' ' 141' ' ' TRP . 2.0 t-80 -61.45 -64.51 0.92 Allowed 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.805 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.531 ' N ' ' ND1' ' A' ' 100' ' ' HIS . . . -35.39 -57.29 0.91 Allowed Glycine 0 N--CA 1.454 -0.141 0 CA-C-N 116.24 -0.437 . . . . 0.0 112.053 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 103' ' ' LEU . 15.4 tptm -69.69 -65.01 0.77 Allowed 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.359 -0.42 . . . . 0.0 110.736 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.45 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.7 OUTLIER -36.88 -60.87 0.59 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.097 0.475 . . . . 0.0 109.872 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.717 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -46.65 -47.01 20.26 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 178.822 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -59.27 -30.68 68.48 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.56 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.477 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 2.1 tpp -65.18 -55.02 20.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.84 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.482 HG23 ' H ' ' A' ' 109' ' ' LYS . 17.2 m -76.59 -23.21 15.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.451 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.45 37.64 1.83 Allowed Glycine 0 CA--C 1.531 1.059 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.607 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.482 ' H ' HG23 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -77.57 -152.88 0.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.156 0.503 . . . . 0.0 111.46 -179.058 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.33 -174.75 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.767 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.424 ' HB3' HG23 ' A' ' 170' ' ' ILE . 34.7 mt-30 -66.96 117.14 8.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.72 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.647 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.8 OUTLIER -118.62 153.67 52.25 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.233 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -48.04 117.06 2.26 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.582 1.521 . . . . 0.0 111.953 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.481 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.4 mp -122.81 126.45 73.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 8.4 tpt -122.31 112.53 18.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.497 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 73.2 mt -96.67 98.86 10.52 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.6 t -108.45 133.67 52.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 122.04 0.924 . . . . 0.0 112.62 -178.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -97.93 114.29 4.96 Favored Glycine 0 C--N 1.315 -0.615 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -98.09 170.08 9.17 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -177.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.452 ' HB3' HD13 ' A' ' 123' ' ' LEU . 25.8 mttt 61.02 57.37 2.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.274 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.2 ttpt -57.73 -29.06 64.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.418 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.645 ' CG ' HN21 ' A' ' 186' ' ' GDP . 4.8 p-10 -67.5 -16.79 64.39 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.295 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.1 mp -82.01 -31.26 31.11 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.513 ' N ' HG21 ' A' ' 87' ' ' VAL . 1.0 OUTLIER -37.74 -24.71 0.01 OUTLIER 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.366 178.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.543 ' N ' ' O ' ' A' ' 123' ' ' LEU . 2.7 mmt -48.24 -22.53 0.68 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.44 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -109.0 -37.68 5.76 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.827 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.445 ' NH1' ' OE1' ' A' ' 147' ' ' GLU . 0.2 OUTLIER 27.16 91.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.034 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 38.7 t -70.79 -45.81 71.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.055 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.948 HG21 ' CE2' ' A' ' 93' ' ' PHE . 8.7 tp -91.55 153.54 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.577 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.435 ' OG ' ' OE1' ' A' ' 133' ' ' GLU . 4.1 p -104.51 126.17 51.35 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.3 0.571 . . . . 0.0 111.329 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.638 ' CD1' ' CE1' ' A' ' 145' ' ' PHE . 0.7 OUTLIER -49.41 -43.67 44.71 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.815 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 131' ' ' TYR . 1.2 mp0 -39.07 -63.11 0.56 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.344 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.435 ' OE1' ' OG ' ' A' ' 130' ' ' SER . 11.7 mt-10 -52.24 -37.18 54.48 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 131' ' ' TYR . . . -72.27 -22.23 78.97 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 131' ' ' TYR . 0.3 OUTLIER -75.91 -54.68 6.53 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.478 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -54.49 -37.53 65.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.362 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.6 OUTLIER -69.61 -63.72 1.02 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.8 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -42.41 -32.95 0.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.27 -48.67 67.02 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.867 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -66.96 -27.82 67.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.475 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.637 ' CH2' ' ND1' ' A' ' 100' ' ' HIS . 22.8 m0 -86.67 -10.94 52.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.69 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.23 27.16 16.92 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.428 ' HB2' ' HB ' ' A' ' 114' ' ' ILE . . . -104.15 166.05 10.65 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.24 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -102.62 127.84 49.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.211 0.529 . . . . 0.0 112.115 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.638 ' CE1' ' CD1' ' A' ' 131' ' ' TYR . 11.3 t80 -99.36 118.67 36.52 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.109 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.03 133.12 22.88 Favored 'General case' 0 C--N 1.347 0.491 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.445 ' OE1' ' NH1' ' A' ' 127' ' ' ARG . 3.1 mt-10 -98.47 115.09 27.78 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.875 -0.515 . . . . 0.0 109.838 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.704 ' OG ' HG21 ' A' ' 159' ' ' VAL . 0.5 OUTLIER -140.54 134.88 31.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.705 -179.73 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 152' ' ' GLU . 4.0 p -102.29 142.4 33.57 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 152' ' ' GLU . . . -55.53 -55.28 33.67 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.688 178.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 31.3 tttt -46.84 -15.11 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.998 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 150' ' ' ALA . 60.9 mt-10 -126.0 120.12 29.46 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.973 0.416 . . . . 0.0 110.868 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 9.7 t-20 -77.1 -47.48 20.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 153' ' ' ASN . 5.1 mt-30 -36.92 -58.91 0.74 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.229 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.643 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.2 p -56.49 -42.69 78.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.289 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 153' ' ' ASN . . . -53.78 -60.75 2.92 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.555 0.693 . . . . 0.0 109.938 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 49.2 t -45.84 -44.12 4.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.561 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -53.9 -45.18 71.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.265 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.704 HG21 ' OG ' ' A' ' 148' ' ' SER . 2.2 t -65.59 -49.48 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.423 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.823 ' CE1' HD12 ' A' ' 47' ' ' ILE . 1.3 t80 -45.61 -37.5 5.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.807 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.1 ttt-85 -79.14 -50.27 11.28 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.375 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -34.29 69.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.278 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.637 HG23 ' N ' ' A' ' 164' ' ' ILE . 11.8 tt -67.9 -54.6 21.43 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.944 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.783 HD11 ' CE1' ' A' ' 160' ' ' PHE . 90.8 mt -47.38 -34.6 3.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 119.219 -0.992 . . . . 0.0 109.425 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.66 -64.33 0.95 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.059 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -57.12 -30.64 64.56 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.227 -0.589 . . . . 0.0 109.42 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.589 ' HB1' ' NH1' ' A' ' 7' ' ' ARG . . . -58.96 -32.68 69.85 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.41 -53.14 25.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.383 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 12.6 tttm -59.14 -65.02 0.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.883 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.647 HG21 ' C ' ' A' ' 112' ' ' ILE . 74.6 mt -48.74 -35.04 6.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.678 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -67.21 -37.33 83.43 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.03 -30.89 76.82 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.75 -79.54 0.05 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.191 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.768 179.88 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GDP . . . . . 0.645 HN21 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 121.265 0.555 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.23 136.68 33.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.312 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 22.6 mtmt -107.35 130.02 54.84 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.774 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.1 mm -108.77 121.07 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-O 121.342 0.592 . . . . 0.0 110.277 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.62 135.55 35.03 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.259 -0.9 . . . . 0.0 110.533 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.7 mt -95.54 131.69 41.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.415 0.626 . . . . 0.0 112.09 -178.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 12' ' ' LEU . 5.5 tt -132.34 99.09 4.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.719 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.87 135.57 6.81 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -52.45 -165.42 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.49 0.662 . . . . 0.0 110.791 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -100.33 138.09 37.86 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.487 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.52 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 1.3 m 67.66 20.52 9.56 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.36 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 p -90.08 -21.52 6.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.042 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.44 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 108.33 26.25 5.49 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.463 ' NZ ' ' CB ' ' A' ' 19' ' ' LYS . 1.3 ttmp? -60.76 -49.21 78.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.147 0.499 . . . . 0.0 110.094 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -75.98 -25.45 55.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.254 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 54.3 p -65.62 -44.99 84.8 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.453 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 23' ' ' THR . 20.4 tp -76.33 -58.39 3.31 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 119.784 -0.767 . . . . 0.0 110.975 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.603 ' O ' HG12 ' A' ' 27' ' ' VAL . 90.3 m -39.02 -48.68 1.65 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.961 -0.295 . . . . 0.0 110.705 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.517 HD11 ' CE2' ' A' ' 43' ' ' PHE . 1.3 mp -74.62 -35.31 37.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 123.356 0.41 . . . . 0.0 111.34 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.563 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 1.5 tm0? -69.6 -37.74 77.01 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.964 -178.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.631 ' CZ ' ' CD1' ' A' ' 160' ' ' PHE . 20.0 t80 -77.15 -59.55 2.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.291 0.567 . . . . 0.0 111.342 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 28' ' ' GLU . 9.5 p -48.71 -47.19 15.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.57 -178.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.61 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.0 tt0 -85.13 -24.42 28.02 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.38 35.76 63.29 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -130.34 125.05 33.68 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.371 0.605 . . . . 0.0 111.641 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.718 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -73.19 94.13 1.93 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.66 -179.633 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.518 HG22 ' N ' ' A' ' 33' ' ' ASP . 7.4 p -118.9 165.42 14.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.326 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.518 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.5 OUTLIER -107.96 18.3 21.4 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.161 -179.2 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 33' ' ' ASP . 32.6 p 50.05 175.23 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.661 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -152.08 -60.82 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.941 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -53.72 167.89 0.45 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.366 -179.636 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 36' ' ' ASP . 52.9 Cg_exo -56.4 -135.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.475 2.117 . . . . 0.0 112.068 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 38' ' ' THR . 8.9 t -129.72 65.81 1.48 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.46 0.648 . . . . 0.0 110.107 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.8 tp -82.46 157.62 3.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.605 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.443 ' CB ' ' O ' ' A' ' 60' ' ' ASP . 2.0 pt-20 -90.61 153.27 20.45 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.34 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.409 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 1.3 m120 178.72 173.91 0.68 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.215 0.531 . . . . 0.0 111.83 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.91 143.4 36.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.567 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.517 ' CE2' HD11 ' A' ' 24' ' ' ILE . 12.3 m-85 -127.33 165.9 18.84 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.588 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.59 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -143.61 147.16 33.96 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 120.227 -0.589 . . . . 0.0 112.404 -178.453 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.964 ' C ' HD13 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -162.32 114.61 1.68 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.679 178.864 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.049 HD22 ' H ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -115.16 142.39 46.72 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.821 -1.082 . . . . 0.0 111.159 -177.688 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.617 HD11 ' CD2' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -150.77 165.73 2.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.274 179.493 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 m -108.33 124.04 49.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.758 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.616 HG11 HG21 ' A' ' 164' ' ' ILE . 7.1 p -120.94 122.76 68.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.139 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 69.65 12.98 8.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.043 0.449 . . . . 0.0 109.954 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.5 -11.37 70.23 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -89.55 133.25 34.69 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -77.39 147.43 36.05 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.522 0.677 . . . . 0.0 111.172 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -137.66 130.73 30.43 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.011 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.687 ' C ' HD22 ' A' ' 56' ' ' LEU . 1.2 m80 -116.54 117.54 30.17 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.687 HD22 ' C ' ' A' ' 55' ' ' HIS . 3.4 mm? -121.6 140.7 51.91 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.449 0.642 . . . . 0.0 112.019 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.803 ' C ' HD13 ' A' ' 58' ' ' LEU . 0.7 OUTLIER -136.52 124.41 22.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.097 178.696 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.95 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.25 154.95 30.3 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.152 0.501 . . . . 0.0 112.065 -178.717 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.27 145.47 35.28 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-N 115.125 -0.943 . . . . 0.0 113.01 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.443 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -123.34 102.66 8.04 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.009 177.646 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.64 161.29 13.74 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.036 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 63' ' ' GLY . . . -132.21 20.75 4.43 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.278 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 62' ' ' ALA . . . -31.94 -72.6 0.07 OUTLIER Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.373 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -144.64 -90.47 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.661 0.743 . . . . 0.0 110.459 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.565 ' OD1' ' N ' ' A' ' 68' ' ' SER . 4.1 p30 -77.37 -173.64 2.96 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.535 -1.212 . . . . 0.0 110.118 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.553 ' O ' ' CB ' ' A' ' 67' ' ' TYR . 3.5 mm-40 -62.89 43.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.918 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.553 ' CB ' ' O ' ' A' ' 66' ' ' GLU . 26.1 t80 97.05 74.85 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 O-C-N 124.368 1.043 . . . . 0.0 109.38 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.565 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 1.7 m -60.6 130.58 47.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.456 -178.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.035 ' H ' HD12 ' A' ' 69' ' ' ILE . 3.2 mp -61.32 -127.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.269 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.765 ' H ' HG22 ' A' ' 69' ' ' ILE . 5.2 m-85 40.24 81.25 0.25 Allowed Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 120.884 -0.327 . . . . 0.0 110.353 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -47.1 -7.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.419 2.08 . . . . 0.0 112.484 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 70' ' ' PHE . 2.9 tt0 -42.03 -68.47 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.827 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.11 -33.9 50.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.692 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.418 ' CE2' ' CE1' ' A' ' 67' ' ' TYR . 0.3 OUTLIER -93.28 103.6 15.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.568 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.5 m -81.37 55.98 2.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.456 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.451 HG23 ' H ' ' A' ' 76' ' ' ILE . 4.1 pt -49.69 163.25 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-O 121.324 0.583 . . . . 0.0 111.747 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 p30 175.52 29.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.953 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.662 HD12 ' O ' ' A' ' 80' ' ' GLY . 22.7 pt -87.45 -167.66 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -145.91 16.43 1.4 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.653 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.662 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -150.63 164.38 29.85 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.582 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.477 ' OH ' ' CD2' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -151.71 123.44 7.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.891 -0.655 . . . . 0.0 110.944 178.268 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.647 ' O ' HG23 ' A' ' 82' ' ' ILE . 11.7 tt -127.26 104.83 13.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.552 0.691 . . . . 0.0 109.696 178.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.737 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -97.7 120.98 39.06 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.406 -178.684 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 84' ' ' VAL . 1.7 t -97.19 114.14 33.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.675 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.505 ' CZ ' ' CA ' ' A' ' 118' ' ' GLY . 48.7 p90 -115.52 145.08 42.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.608 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.429 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.6 p -86.99 143.16 27.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.452 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.532 HG21 ' N ' ' A' ' 124' ' ' HIS . 10.2 m -80.98 17.67 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 120.998 0.428 . . . . 0.0 110.256 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.4 t -130.26 -19.59 3.12 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.406 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.56 ' C ' ' N ' ' A' ' 91' ' ' LYS . 20.9 t -98.95 93.78 6.2 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.298 -176.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.7 tp -58.7 -11.82 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.56 ' N ' ' C ' ' A' ' 89' ' ' SER . 12.9 mttp -77.97 -54.39 6.35 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.442 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.1 p -53.93 -32.28 53.06 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.038 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.912 ' CE2' HG21 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -73.78 -51.0 17.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.025 -179.469 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.28 -42.62 92.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.876 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 91' ' ' LYS . 17.7 m -65.48 -40.12 87.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.307 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.496 ' CG1' HD22 ' A' ' 12' ' ' LEU . 1.6 mt -63.0 -32.17 55.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.2 tttm -69.85 -26.47 64.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.101 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.4 t -77.24 -67.13 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.957 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.445 HD12 ' N ' ' A' ' 99' ' ' ILE . 1.6 mp -44.26 -38.18 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.245 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.636 ' CD2' ' CZ2' ' A' ' 141' ' ' TRP . 7.3 t60 -66.6 -64.22 0.9 Allowed 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.788 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.556 ' N ' ' CD2' ' A' ' 100' ' ' HIS . . . -35.69 -50.69 1.07 Allowed Glycine 0 C--N 1.329 0.159 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.431 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 17.5 tptm -70.73 -61.15 1.87 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.966 -0.617 . . . . 0.0 110.554 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 106' ' ' MET . 0.6 OUTLIER -42.09 -60.23 1.5 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.462 0.648 . . . . 0.0 109.394 179.638 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.735 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -45.98 -44.29 14.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.23 178.51 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -60.52 -32.67 71.69 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.943 179.812 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.495 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 4.6 ttm -58.93 -56.65 19.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.727 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.493 ' C ' ' H ' ' A' ' 109' ' ' LYS . 16.9 m -77.11 -13.55 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.251 0.548 . . . . 0.0 109.865 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.45 -24.99 0.1 OUTLIER Glycine 0 CA--C 1.53 0.989 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.92 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.503 ' CG ' ' H ' ' A' ' 110' ' ' VAL . 7.2 tttp -173.28 -131.88 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 117.705 0.753 . . . . 0.0 111.732 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.503 ' H ' ' CG ' ' A' ' 109' ' ' LYS . 6.7 t 52.34 116.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.61 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.466 ' OE1' ' HB1' ' A' ' 173' ' ' ALA . 12.7 mt-30 -77.63 126.06 30.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.007 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.663 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.5 OUTLIER -132.67 152.72 80.43 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.264 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -47.84 110.51 0.32 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.949 1.766 . . . . 0.0 112.478 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 3.0 mt -126.51 131.8 70.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 6.2 tpt -129.84 116.97 19.46 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.863 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.9 mt -95.69 98.11 10.23 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.5 t -102.41 126.15 56.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 122.066 0.936 . . . . 0.0 112.144 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.505 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -97.36 115.89 5.37 Favored Glycine 0 C--N 1.31 -0.913 0 N-CA-C 108.067 -2.013 . . . . 0.0 108.067 177.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.494 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 52.6 t30 -96.97 175.89 6.17 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.165 -0.614 . . . . 0.0 112.105 -177.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.52 ' NZ ' ' O ' ' A' ' 16' ' ' SER . 15.6 mttt 58.84 58.2 3.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.632 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.546 ' O ' ' CG ' ' A' ' 124' ' ' HIS . 16.2 ttmt -58.73 -30.8 67.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.362 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.631 ' CG ' HN21 ' A' ' 186' ' ' GDP . 5.1 p-10 -64.83 -27.07 68.63 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.199 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.4 mp -71.52 -29.88 65.28 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.624 ' ND1' ' N ' ' A' ' 125' ' ' MET . 0.6 OUTLIER -35.93 -29.23 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.498 179.207 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.624 ' N ' ' ND1' ' A' ' 124' ' ' HIS . 1.0 OUTLIER -45.11 -24.89 0.28 Allowed 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.709 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.483 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -103.64 -41.02 6.08 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.584 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.573 HH21 ' CB ' ' A' ' 124' ' ' HIS . 32.2 ttm-85 28.16 80.97 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.201 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.4 t -57.72 -53.93 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.055 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.912 HG21 ' CE2' ' A' ' 93' ' ' PHE . 7.5 tp -86.45 153.13 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.76 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.432 ' OG ' ' OE1' ' A' ' 133' ' ' GLU . 1.1 p -87.22 120.77 28.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.365 0.602 . . . . 0.0 111.407 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.621 ' CE1' ' CD1' ' A' ' 145' ' ' PHE . 0.3 OUTLIER -50.18 -47.32 54.57 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.389 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 131' ' ' TYR . 1.6 mp0 -40.28 -60.58 1.05 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.833 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.432 ' OE1' ' OG ' ' A' ' 130' ' ' SER . 26.9 mt-10 -50.61 -38.01 43.39 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.484 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 131' ' ' TYR . . . -69.23 -34.12 74.74 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -67.06 -54.65 19.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.76 -35.93 69.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.39 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.509 ' CD2' ' CE2' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -67.07 -64.32 0.88 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.516 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -45.82 -37.27 5.94 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.7 -40.82 88.64 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER -64.68 -34.15 77.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.231 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.636 ' CZ2' ' CD2' ' A' ' 100' ' ' HIS . 38.5 m0 -87.0 -7.23 58.35 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 70.51 25.32 4.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.988 -178.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -103.97 166.71 10.24 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.644 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.07 133.5 49.75 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.098 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.695 ' O ' HD22 ' A' ' 146' ' ' LEU . 7.5 t80 -97.26 121.04 38.7 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.466 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.695 HD22 ' O ' ' A' ' 145' ' ' PHE . 1.7 mm? -132.2 130.63 41.28 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.69 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.503 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 4.5 mt-10 -110.27 112.34 24.23 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.942 0.401 . . . . 0.0 109.978 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.496 ' OG ' HG21 ' A' ' 159' ' ' VAL . 49.4 p -139.73 179.29 6.67 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.362 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 152' ' ' GLU . 6.0 p -139.17 133.92 32.08 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.501 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.426 ' N ' ' O6 ' ' A' ' 186' ' ' GDP . . . -54.91 -40.31 69.71 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -54.03 -42.11 68.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.059 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 149' ' ' SER . 13.3 tt0 -100.7 117.27 34.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.235 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 0.5 OUTLIER -76.43 -42.58 43.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.185 -179.518 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 153' ' ' ASN . 5.3 tt0 -41.1 -47.83 3.25 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.099 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.594 ' O ' HG23 ' A' ' 159' ' ' VAL . 63.2 p -62.83 -44.95 94.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.91 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 153' ' ' ASN . . . -51.2 -64.36 0.84 Allowed 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.62 0.724 . . . . 0.0 109.465 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.0 t -45.12 -35.73 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.837 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -67.85 -41.03 83.58 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.551 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 155' ' ' THR . 19.4 t -62.69 -43.5 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-O 120.937 0.399 . . . . 0.0 110.399 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.631 ' CD1' ' CZ ' ' A' ' 26' ' ' PHE . 1.1 t80 -59.32 -61.23 2.79 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.727 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.53 -48.82 4.0 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.781 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.43 -26.87 68.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.534 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -68.26 -34.08 64.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.046 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.616 HG21 HG11 ' A' ' 49' ' ' VAL . 20.2 mt -71.41 -38.73 69.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.684 0.754 . . . . 0.0 109.787 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.31 -63.38 1.3 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.013 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -53.59 -36.21 61.68 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.462 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -55.95 -32.33 63.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -68.48 -57.69 5.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.671 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.77 -63.16 1.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.619 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.663 HG21 ' C ' ' A' ' 112' ' ' ILE . 68.9 mt -50.37 -34.36 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.914 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.83 -40.31 75.93 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.468 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -58.15 -36.63 83.06 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.466 ' HB1' ' OE1' ' A' ' 111' ' ' GLN . . . -68.71 -65.63 0.68 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.758 0.313 . . . . 0.0 110.383 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.517 179.88 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GDP . . . . . 0.631 HN21 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 120.993 0.425 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.425 HH21 HD21 ' A' ' 56' ' ' LEU . 4.6 mtm180 -140.04 136.63 33.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.702 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.587 ' HB3' HG22 ' A' ' 78' ' ' ILE . 1.9 tttt -102.51 133.43 47.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -110.16 129.49 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.429 -177.325 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.487 ' HB3' ' CE1' ' A' ' 81' ' ' TYR . . . -87.28 133.32 33.7 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 121.627 -0.67 . . . . 0.0 110.144 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.668 HD11 ' HB2' ' A' ' 58' ' ' LEU . 20.2 mt -98.24 133.69 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.15 0.5 . . . . 0.0 112.123 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.568 HD23 ' C ' ' A' ' 12' ' ' LEU . 3.8 tt -126.4 99.43 5.83 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.341 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -140.3 133.21 5.86 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.5 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.68 -179.03 0.16 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.982 0.42 . . . . 0.0 110.003 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -76.33 131.88 39.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.026 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.4 m 63.81 16.28 9.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.721 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 86' ' ' SER . 10.5 p -72.42 -13.15 16.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.393 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.68 23.12 29.17 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.128 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.4 pttm -69.65 -30.34 68.02 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.969 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.8 m -77.5 -34.44 54.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.434 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 61.2 m -65.29 -42.41 93.17 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.635 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.0 tp -77.8 -36.7 50.02 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.3 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.525 ' O ' HG12 ' A' ' 27' ' ' VAL . 97.2 m -55.45 -38.57 69.21 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -73.82 -39.42 52.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.223 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.527 ' OE1' ' N ' ' A' ' 31' ' ' PHE . 5.2 tt0 -70.29 -27.63 64.56 Favored 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.933 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 1.3 t80 -77.46 -60.26 2.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.4 0.619 . . . . 0.0 110.875 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.601 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.9 p -52.71 -45.92 49.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.043 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.601 ' N ' HG13 ' A' ' 27' ' ' VAL . 1.3 tm-20 -84.19 -24.61 30.04 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.474 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 78.77 19.61 72.81 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.748 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.546 ' NE2' ' O ' ' A' ' 31' ' ' PHE . 15.7 tp60 -154.26 134.06 12.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.161 -0.616 . . . . 0.0 112.258 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.546 ' O ' ' NE2' ' A' ' 30' ' ' GLN . 1.0 OUTLIER -65.54 93.81 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.453 178.576 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.611 HG22 ' N ' ' A' ' 33' ' ' ASP . 10.6 p -107.29 166.08 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.212 0.53 . . . . 0.0 110.485 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.611 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -44.66 -14.34 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.944 -178.642 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 32' ' ' VAL . 15.3 p 39.78 86.34 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.208 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -86.99 27.0 1.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.373 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 37' ' ' PRO . 3.8 t70 -115.92 92.02 33.18 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.246 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 36' ' ' ASP . 60.0 Cg_exo -54.5 -131.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.644 2.229 . . . . 0.0 112.407 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 38' ' ' THR . 13.4 t -112.86 50.11 0.9 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.338 0.59 . . . . 0.0 111.696 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 tp -84.26 158.39 3.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.409 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.546 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 1.8 pm0 -85.52 124.22 31.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.819 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -170.51 -178.45 2.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.455 0.645 . . . . 0.0 112.348 -178.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.514 HG23 HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -129.93 131.93 46.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.22 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -108.47 171.33 7.48 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.464 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.531 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -145.3 150.95 37.55 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -178.585 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.596 ' C ' HD12 ' A' ' 46' ' ' LEU . 37.8 tptt -154.12 116.44 4.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.84 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.717 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.0 mp -105.85 125.01 50.48 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.203 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.872 HD12 ' CZ ' ' A' ' 160' ' ' PHE . 0.6 OUTLIER -145.76 165.58 10.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.799 0.333 . . . . 0.0 110.585 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.4 m -117.7 123.82 47.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.878 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.813 HG11 HG21 ' A' ' 164' ' ' ILE . 5.8 p -127.15 132.12 70.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.67 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 70.59 7.35 6.18 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.05 -10.39 71.9 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -93.98 139.17 31.25 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -77.21 148.04 36.07 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.59 0.71 . . . . 0.0 111.41 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -139.35 124.47 18.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.215 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.767 ' C ' HD12 ' A' ' 56' ' ' LEU . 1.8 m-70 -117.32 114.15 23.17 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.767 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.2 mp -126.05 150.82 47.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.508 0.67 . . . . 0.0 111.67 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -136.29 133.15 36.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.941 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.917 HD22 ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -114.64 144.28 43.68 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.639 -179.018 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.514 HG23 HG23 ' A' ' 42' ' ' THR . 0.3 OUTLIER -126.02 130.26 72.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.757 0.789 . . . . 0.0 112.89 -178.752 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -123.23 106.4 10.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.349 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.718 HG21 ' OH ' ' A' ' 74' ' ' TYR . 21.3 p -129.21 -166.86 1.7 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.302 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -148.6 23.69 1.0 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.102 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.431 ' O ' ' OG ' ' A' ' 68' ' ' SER . . . -94.62 -132.6 6.76 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.522 ' CD ' ' H ' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -83.66 66.46 9.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.529 0.68 . . . . 0.0 110.356 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.695 ' O ' ' N ' ' A' ' 68' ' ' SER . 8.5 p-10 -138.57 -177.22 4.76 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.442 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.607 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 1.2 pm0 -37.95 -31.9 0.05 Allowed 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.183 0.516 . . . . 0.0 109.814 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.528 ' CG ' ' O ' ' A' ' 67' ' ' TYR . 2.6 t80 -54.27 -13.85 0.99 Allowed 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.897 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.695 ' N ' ' O ' ' A' ' 65' ' ' ASP . 16.4 p -165.5 -7.49 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.535 ' N ' ' O ' ' A' ' 65' ' ' ASP . 0.4 OUTLIER 45.13 115.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.925 0.869 . . . . 0.0 111.122 -177.766 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' A' ' 69' ' ' ILE . 0.8 OUTLIER -178.17 87.79 0.23 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.358 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.88 131.9 35.69 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.396 2.064 . . . . 0.0 112.559 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -172.89 -72.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.449 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.9 m -141.16 12.24 2.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.82 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.718 ' OH ' HG21 ' A' ' 61' ' ' THR . 0.3 OUTLIER -111.24 4.63 19.33 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.873 -179.526 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -82.28 -15.62 52.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.409 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.499 ' O ' ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER 26.87 -153.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 178.9 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.3 p30 -130.28 51.62 2.09 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.587 HG22 ' HB3' ' A' ' 8' ' ' LYS . 26.6 pt -75.55 173.85 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.315 -178.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -150.19 28.11 0.75 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.839 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.37 167.39 35.04 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.299 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.487 ' CE1' ' HB3' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -150.75 127.7 11.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.088 -0.556 . . . . 0.0 111.83 179.471 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.744 ' O ' HG23 ' A' ' 82' ' ' ILE . 13.2 tt -132.72 96.44 2.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.478 0.656 . . . . 0.0 109.35 177.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.806 ' N ' HD23 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -98.17 117.66 33.05 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.089 -178.795 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -96.44 117.69 41.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.345 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.448 ' CZ ' ' CA ' ' A' ' 118' ' ' GLY . 35.7 p90 -111.22 144.19 40.77 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.568 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.62 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.3 p -86.95 138.23 31.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.73 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.573 HG21 ' N ' ' A' ' 124' ' ' HIS . 14.0 m -71.94 17.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.611 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.501 ' H ' ' C ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -138.11 -21.07 1.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.747 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.62 ' H ' ' HG ' ' A' ' 86' ' ' SER . 21.3 t -93.18 93.99 8.56 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.141 -176.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 90' ' ' ILE . 10.8 tp -60.57 -8.36 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 176.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.622 ' O ' HG13 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -77.48 -59.55 2.73 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.755 179.181 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.9 p -54.12 -29.39 44.81 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.335 0.588 . . . . 0.0 109.566 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.2 -39.87 47.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.669 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -68.59 -42.98 77.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.263 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 91' ' ' LYS . 2.3 m -67.38 -40.41 84.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.562 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.2 mt -55.05 -43.65 70.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 121.212 -0.195 . . . . 0.0 110.686 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -69.23 -35.03 75.74 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.239 0.543 . . . . 0.0 110.761 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.419 ' O ' ' C ' ' A' ' 99' ' ' ILE . 58.4 t -71.58 -65.63 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.319 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 100' ' ' HIS . 1.4 mp -38.02 -54.38 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.026 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.436 ' N ' HG22 ' A' ' 99' ' ' ILE . 0.9 OUTLIER -46.4 -64.06 0.85 Allowed 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.457 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 100' ' ' HIS . . . -35.14 -58.45 0.8 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.467 ' O ' ' C ' ' A' ' 103' ' ' LEU . 16.5 tptp -69.82 -65.83 0.67 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.355 -0.422 . . . . 0.0 110.992 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.503 HD22 HD11 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -36.48 -63.02 0.42 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.021 0.438 . . . . 0.0 109.895 179.671 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.7 ' C ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -44.35 -50.83 8.95 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.481 ' N ' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -52.26 -31.3 31.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.373 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.481 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 3.9 ttm -65.68 -51.44 59.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.378 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.522 ' C ' ' H ' ' A' ' 109' ' ' LYS . 24.2 m -76.6 -13.78 14.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.83 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 63.39 -23.91 0.08 OUTLIER Glycine 0 CA--C 1.532 1.104 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.911 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 107' ' ' VAL . 3.6 tptp -171.77 -142.08 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.67 0.735 . . . . 0.0 111.444 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.505 ' H ' ' CG ' ' A' ' 109' ' ' LYS . 4.7 t 52.96 120.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.51 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -73.96 117.98 16.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.756 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.482 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -108.57 132.02 21.4 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.569 179.553 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -48.2 123.04 8.32 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.384 1.39 . . . . 0.0 111.901 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.482 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.5 mp -123.91 130.83 73.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 6.7 tpt -128.4 117.27 21.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.793 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 mt -95.83 97.82 9.96 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.1 t -105.5 128.4 59.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 122.136 0.969 . . . . 0.0 111.446 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.448 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -100.25 111.84 4.28 Favored Glycine 0 C--N 1.308 -1.006 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.471 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 53.4 t30 -97.75 173.56 7.05 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.684 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.471 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 5.9 mtpp 61.96 58.38 1.91 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.909 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.534 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 0.5 OUTLIER -60.28 -25.51 65.78 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.568 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.641 ' CG ' HN21 ' A' ' 186' ' ' GDP . 4.2 p-10 -67.53 -9.87 46.5 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.204 -179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 125' ' ' MET . 11.2 mp -97.2 -25.35 15.32 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.573 ' N ' HG21 ' A' ' 87' ' ' VAL . 2.3 p-80 -36.94 -28.57 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.66 178.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.525 ' N ' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -44.39 -23.14 0.09 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.712 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.477 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -107.66 -40.68 5.24 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.69 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.462 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 22.1 ttm180 24.63 84.33 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.192 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 46.2 t -53.77 -35.35 26.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.308 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.4 tp -88.61 155.92 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.68 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.49 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 89.1 p -100.89 126.68 47.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.682 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -39.54 -33.29 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.796 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.6 mp0 -69.73 -65.3 0.73 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.73 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.49 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 62.4 mt-10 -41.41 -40.12 1.66 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.731 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.69 -37.54 67.25 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 132' ' ' GLU . 4.0 tmtt? -61.15 -55.32 33.71 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.66 -36.34 69.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.77 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.54 -61.78 1.9 Allowed 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.19 -37.36 54.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.109 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.01 -34.83 79.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.597 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.58 -46.4 86.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.891 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.458 ' CZ3' HD22 ' A' ' 104' ' ' LEU . 66.5 m95 -90.58 4.79 50.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.523 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 62.69 31.01 16.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.637 0.732 . . . . 0.0 109.623 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -94.33 167.82 11.29 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.283 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -106.53 132.97 51.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.272 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.703 ' O ' HD22 ' A' ' 146' ' ' LEU . 6.4 t80 -96.89 121.59 38.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.478 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.703 HD22 ' O ' ' A' ' 145' ' ' PHE . 1.6 mm? -134.69 137.36 43.49 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.872 -176.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.462 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 2.4 mt-10 -125.4 111.56 15.27 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.537 ' OG ' HG21 ' A' ' 159' ' ' VAL . 20.8 p -137.43 -176.29 4.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.039 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.0 135.26 34.1 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.063 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.525 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -61.95 -29.47 70.26 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.25 0.548 . . . . 0.0 109.643 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -69.39 0.92 4.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.139 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -141.54 128.51 20.68 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.728 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.451 ' O ' ' N ' ' A' ' 156' ' ' ALA . 51.9 t30 -77.52 -54.32 6.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.198 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 153' ' ' ASN . 5.5 mt-30 -36.75 -56.19 0.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.092 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.687 ' O ' HG23 ' A' ' 159' ' ' VAL . 50.5 p -56.14 -42.69 77.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.031 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 153' ' ' ASN . . . -57.7 -61.39 2.55 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.441 0.639 . . . . 0.0 110.196 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 59.7 t -42.55 -40.15 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.582 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -66.74 -36.61 82.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.783 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 155' ' ' THR . 25.7 t -66.14 -41.29 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.007 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.874 ' CZ ' HD11 ' A' ' 164' ' ' ILE . 22.7 t80 -59.66 -65.51 0.66 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.647 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.81 -55.82 2.91 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.789 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -51.83 -31.46 27.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.821 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -66.5 -37.21 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.416 -179.6 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.874 HD11 ' CZ ' ' A' ' 160' ' ' PHE . 15.5 mt -68.97 -31.97 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 121.421 0.629 . . . . 0.0 110.133 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.53 -59.79 4.68 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.719 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 114' ' ' ILE . 6.1 pt-20 -59.24 -30.25 68.12 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.515 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -60.46 -32.24 71.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.442 ' O ' ' OD1' ' A' ' 171' ' ' ASP . 0.0 OUTLIER -71.33 -41.4 69.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.04 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 15.7 tptt -70.19 -58.67 3.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.314 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 170' ' ' ILE . 1.7 mp -55.47 -52.17 49.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.321 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 172' ' ' GLY . 1.6 p-10 -67.58 -26.78 66.44 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.363 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 171' ' ' ASP . . . -60.28 -44.44 97.5 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.38 -67.97 0.46 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.806 0.336 . . . . 0.0 110.497 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.715 -179.795 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GDP . . . . . 0.641 HN21 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 120.974 0.416 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.402 ' NH2' ' OD1' ' A' ' 171' ' ' ASP . 0.0 OUTLIER -139.87 135.97 33.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.457 -179.392 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -104.16 122.39 45.24 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.771 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.7 OUTLIER -104.02 118.54 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-O 121.617 0.722 . . . . 0.0 109.917 -179.068 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.452 ' HB3' ' CE1' ' A' ' 81' ' ' TYR . . . -84.02 134.68 34.62 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 121.191 -0.943 . . . . 0.0 111.339 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.0 mt -95.36 126.88 47.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.705 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.2 tp -127.02 102.0 6.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.499 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -139.21 135.31 7.22 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -53.84 -161.04 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.418 0.628 . . . . 0.0 110.804 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -96.01 130.96 42.87 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.854 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.493 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 1.3 m 67.45 14.6 9.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.748 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.48 ' C ' ' NZ ' ' A' ' 120' ' ' LYS . 7.6 p -76.93 -12.76 14.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.483 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.21 12.35 34.01 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.42 ' NZ ' ' CB ' ' A' ' 19' ' ' LYS . 0.8 OUTLIER -46.82 -48.71 20.77 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.678 0.275 . . . . 0.0 111.122 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.588 ' O ' HD13 ' A' ' 24' ' ' ILE . 1.5 m -76.99 -26.45 53.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.924 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.444 ' N ' ' O1A' ' A' ' 186' ' ' GDP . 78.3 p -68.49 -49.4 59.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.549 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.6 tp -78.15 -30.7 49.37 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.271 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.533 ' O ' HG12 ' A' ' 27' ' ' VAL . 54.1 m -62.59 -47.86 81.95 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.588 HD13 ' O ' ' A' ' 20' ' ' SER . 1.5 mp -68.28 -34.87 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.981 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 150' ' ' ALA . 2.9 tt0 -74.2 -25.39 59.66 Favored 'General case' 0 C--O 1.215 -0.718 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.639 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 1.4 t80 -76.69 -57.97 3.55 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.473 0.654 . . . . 0.0 110.398 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.628 HG13 ' N ' ' A' ' 28' ' ' GLU . 11.5 p -57.17 -49.19 80.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.425 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.628 ' N ' HG13 ' A' ' 27' ' ' VAL . 1.2 tm-20 -80.13 -24.81 40.23 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.463 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 77.75 23.49 66.96 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.822 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.412 ' OE1' ' O ' ' A' ' 31' ' ' PHE . 1.7 pp0? -153.32 138.43 17.34 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 119.345 -0.942 . . . . 0.0 112.72 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.491 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 27.6 t80 -58.8 118.21 5.47 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.456 178.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.642 HG22 ' N ' ' A' ' 33' ' ' ASP . 12.4 p -94.04 166.48 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.917 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.642 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -49.16 -26.41 2.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.935 -179.536 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.445 ' H ' HG13 ' A' ' 32' ' ' VAL . 7.8 p 39.7 77.57 0.05 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.174 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -152.4 34.71 0.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.593 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.65 172.92 3.15 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.285 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -63.62 -147.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.247 1.965 . . . . 0.0 111.247 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 38' ' ' THR . 11.7 t -131.02 61.01 1.64 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.164 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.8 tp -82.93 158.5 3.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.255 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.419 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 4.2 pt-20 -86.27 149.36 25.12 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.438 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 1.8 m120 -170.94 179.03 3.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.543 0.687 . . . . 0.0 112.6 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.444 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 0.8 OUTLIER -127.09 145.89 50.57 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.165 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.529 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 7.3 m-85 -133.5 163.75 28.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.991 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.617 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -144.27 149.87 36.99 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.086 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -149.03 112.48 5.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.016 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.607 HD21 ' ND1' ' A' ' 55' ' ' HIS . 6.4 mp -108.02 120.95 43.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.068 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 pp -147.59 165.56 5.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.795 0.331 . . . . 0.0 111.009 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 m -112.46 126.77 55.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.637 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.614 HG23 HH22 ' A' ' 161' ' ' ARG . 7.6 p -124.07 133.83 68.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.809 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 63.5 3.85 1.59 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.114 0.483 . . . . 0.0 109.722 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 103.11 -14.05 55.52 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.459 ' OE1' ' N ' ' A' ' 53' ' ' GLU . 6.5 tp-100 -90.1 141.28 28.84 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.459 ' N ' ' OE1' ' A' ' 52' ' ' GLN . 2.1 mt-10 -76.96 149.89 35.94 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.401 0.619 . . . . 0.0 111.051 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.564 ' CD1' HG12 ' A' ' 49' ' ' VAL . 12.3 m-85 -141.23 124.18 16.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.114 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.671 ' C ' HD12 ' A' ' 56' ' ' LEU . 9.7 t60 -117.69 113.89 22.54 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.671 HD12 ' C ' ' A' ' 55' ' ' HIS . 11.1 mp -120.66 140.81 51.06 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.695 0.76 . . . . 0.0 111.637 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.84 ' C ' HD13 ' A' ' 58' ' ' LEU . 2.6 mt-30 -133.07 123.39 25.68 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.251 -1.341 . . . . 0.0 109.502 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.961 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.89 154.02 31.53 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.04 -178.656 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.92 145.13 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.264 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.66 103.27 10.53 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.708 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.68 HG22 ' CE1' ' A' ' 74' ' ' TYR . 68.8 p -59.46 -99.61 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.769 0.795 . . . . 0.0 110.45 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 61' ' ' THR . . . 70.24 -10.49 0.66 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.186 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 61' ' ' THR . . . -77.0 -10.57 86.19 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -142.49 -148.69 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.168 0.509 . . . . 0.0 110.138 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.619 ' O ' ' N ' ' A' ' 67' ' ' TYR . 2.5 p30 -76.86 -172.84 2.43 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.601 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.621 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -59.77 71.33 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.688 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.619 ' N ' ' O ' ' A' ' 65' ' ' ASP . 62.8 t80 57.94 64.68 1.47 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.937 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.577 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 1.1 m -40.97 134.68 1.91 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.55 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.788 HD12 ' N ' ' A' ' 69' ' ' ILE . 1.9 mp -88.7 83.28 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER 179.62 -54.62 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.862 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -40.72 139.64 1.24 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.186 1.924 . . . . 0.0 112.316 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.57 -40.14 9.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.36 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 m -82.36 -20.22 37.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.365 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.68 ' CE1' HG22 ' A' ' 61' ' ' THR . 0.1 OUTLIER -109.6 35.58 3.28 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.37 0.605 . . . . 0.0 110.458 179.846 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 76' ' ' ILE . 8.7 t -153.98 -18.55 0.13 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.98 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.486 ' O ' ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER 28.83 -155.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 178.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.591 ' O ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -119.36 -24.75 6.27 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.528 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.591 ' O ' ' O ' ' A' ' 77' ' ' ASP . 31.3 pt 29.65 -164.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 O-C-N 124.148 0.905 . . . . 0.0 112.902 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -152.0 16.76 0.66 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.584 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -157.78 164.07 32.98 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.966 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.542 ' OH ' ' CG ' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -152.29 122.86 7.33 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.672 -0.764 . . . . 0.0 110.589 178.107 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.623 ' O ' HG23 ' A' ' 82' ' ' ILE . 8.8 tt -122.6 98.5 5.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.981 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.37 126.57 42.69 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.174 -178.261 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -95.51 121.03 45.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.845 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.536 ' C ' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -110.06 147.5 33.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.276 -0.874 . . . . 0.0 108.994 179.356 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.688 ' HG ' ' H ' ' A' ' 89' ' ' SER . 0.3 OUTLIER -108.29 144.19 36.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.99 0.424 . . . . 0.0 112.051 -177.615 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.672 HG21 ' N ' ' A' ' 124' ' ' HIS . 14.2 m -81.45 15.86 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.255 179.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.7 -16.1 1.54 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -177.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.688 ' H ' ' HG ' ' A' ' 86' ' ' SER . 28.9 t -112.35 93.5 4.47 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-O 121.378 0.608 . . . . 0.0 110.304 -177.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.408 HD12 ' CG1' ' A' ' 128' ' ' VAL . 4.3 tp -54.84 -13.54 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.787 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.6 OUTLIER -79.1 -45.88 19.15 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.421 178.549 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.1 p -59.05 -46.71 87.56 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.748 ' CZ ' HD13 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -79.14 -32.91 44.55 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 119.0 -1.08 . . . . 0.0 112.215 -178.439 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -66.3 -47.18 74.43 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.908 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 91' ' ' LYS . 34.3 m -65.28 -34.82 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.457 -0.497 . . . . 0.0 109.881 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 mt -60.94 -36.83 74.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.701 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -70.52 -29.26 65.71 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.996 0.427 . . . . 0.0 109.94 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 99' ' ' ILE . 14.0 t -72.23 -66.63 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.4 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.487 HG22 ' N ' ' A' ' 100' ' ' HIS . 1.3 mp -38.55 -60.26 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.612 ' CE1' ' CG ' ' A' ' 141' ' ' TRP . 12.8 t-80 -43.05 -64.9 0.55 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.125 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -36.77 -66.51 0.48 Allowed Glycine 0 CA--C 1.518 0.233 0 CA-C-O 121.521 0.511 . . . . 0.0 112.047 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 103' ' ' LEU . 21.2 tptm -60.92 -61.08 2.84 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.765 -0.717 . . . . 0.0 110.527 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 102' ' ' LYS . 7.4 tp -36.14 -67.24 0.17 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.379 0.609 . . . . 0.0 109.6 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -42.88 -48.62 5.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.57 179.027 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.436 ' N ' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -59.39 -31.22 69.05 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.456 -179.179 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 41.7 ttp -69.57 -49.85 50.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.584 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.64 HG23 ' H ' ' A' ' 109' ' ' LYS . 4.4 m -76.99 -25.47 15.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.536 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 40.71 37.22 1.24 Allowed Glycine 0 CA--C 1.53 0.999 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.64 ' H ' HG23 ' A' ' 107' ' ' VAL . 0.1 OUTLIER -104.56 -156.19 0.56 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.262 0.553 . . . . 0.0 111.888 -178.583 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.453 HG23 ' H ' ' A' ' 110' ' ' VAL . 0.1 OUTLIER -82.62 -167.6 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.921 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.677 ' O ' ' HB2' ' A' ' 174' ' ' ALA . 18.5 mt-30 -68.98 119.82 13.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.678 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.6 mt -109.96 134.6 20.64 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.526 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -46.71 109.21 0.19 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.238 1.292 . . . . 0.0 112.295 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.5 mt -123.17 135.75 62.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.543 ' O ' HD12 ' A' ' 83' ' ' LEU . 2.4 tpp -137.65 123.59 20.17 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.394 0.616 . . . . 0.0 110.873 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.499 ' N ' ' SD ' ' A' ' 115' ' ' MET . 5.4 mt -97.88 107.3 19.76 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.623 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.7 t -103.23 127.74 56.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 121.863 0.84 . . . . 0.0 112.181 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.419 ' CA ' ' CE2' ' A' ' 85' ' ' TYR . . . -97.03 103.63 2.92 Favored Glycine 0 C--N 1.311 -0.831 0 N-CA-C 107.816 -2.113 . . . . 0.0 107.816 176.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.468 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.7 t30 -96.8 173.89 7.08 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.049 -177.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.48 ' NZ ' ' C ' ' A' ' 17' ' ' VAL . 7.1 mtpp 63.64 59.29 1.2 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.228 -178.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.432 ' H ' ' HB3' ' A' ' 149' ' ' SER . 0.0 OUTLIER -68.63 0.15 4.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.348 -178.449 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -82.59 -37.32 25.21 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.449 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.813 HD22 ' N ' ' A' ' 123' ' ' LEU . 1.0 OUTLIER -83.87 -18.11 38.58 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.081 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.672 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -39.13 -27.92 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.002 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.504 ' N ' ' O ' ' A' ' 123' ' ' LEU . 9.5 mtt -42.1 -31.27 0.35 Allowed 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.41 ' N ' ' C ' ' A' ' 124' ' ' HIS . 1.3 pt-20 -87.8 -42.41 12.59 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.295 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 124' ' ' HIS . 6.0 tpt85 55.94 72.3 0.5 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.267 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.408 ' CG1' HD12 ' A' ' 90' ' ' ILE . 7.7 t -52.7 -64.35 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.57 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.748 HD13 ' CZ ' ' A' ' 93' ' ' PHE . 10.7 tp -86.89 153.22 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.518 ' HG ' ' HB2' ' A' ' 133' ' ' GLU . 35.8 p -88.24 137.67 32.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.278 0.561 . . . . 0.0 112.343 -178.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -53.5 -33.24 53.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.139 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -69.06 -65.8 0.66 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.194 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.518 ' HB2' ' HG ' ' A' ' 130' ' ' SER . 45.3 mt-10 -42.83 -40.12 2.76 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.63 -35.02 62.67 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 132' ' ' GLU . 3.5 tptm -62.0 -57.29 12.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -55.28 -36.18 65.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.783 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.404 HD21 ' HE1' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -65.45 -61.13 2.28 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.419 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.56 -40.62 62.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.932 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.62 -30.86 71.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.654 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.8 p -63.72 -46.79 83.83 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.965 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.612 ' CG ' ' CE1' ' A' ' 100' ' ' HIS . 34.3 m95 -91.15 -0.58 57.73 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.778 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 3.5 m120 72.5 36.13 1.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.952 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -100.05 163.3 12.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.423 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.538 ' O ' ' SD ' ' A' ' 115' ' ' MET . . . -102.18 128.34 48.72 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.501 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.687 ' O ' HD22 ' A' ' 146' ' ' LEU . 6.2 t80 -98.09 118.43 34.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.755 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.687 HD22 ' O ' ' A' ' 145' ' ' PHE . 2.0 mm? -131.76 126.83 35.41 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -177.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.41 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 1.8 mt-10 -109.12 112.79 25.16 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.13 0.491 . . . . 0.0 110.197 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.516 ' OG ' HG21 ' A' ' 159' ' ' VAL . 4.1 p -136.43 -173.16 3.33 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.647 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.432 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -139.03 141.6 38.26 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.068 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.544 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -65.66 -49.15 69.66 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -49.42 -10.27 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.841 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.477 ' H ' ' C ' ' A' ' 150' ' ' ALA . 23.7 tt0 -129.04 127.27 41.23 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.813 0.339 . . . . 0.0 110.916 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.475 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 52.3 t30 -77.78 -55.43 5.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.116 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 153' ' ' ASN . 10.3 tt0 -37.94 -53.13 1.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.932 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.535 ' O ' HG23 ' A' ' 159' ' ' VAL . 54.9 p -56.74 -41.54 77.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.97 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 153' ' ' ASN . . . -57.38 -62.94 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.624 0.726 . . . . 0.0 109.993 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.1 t -44.95 -37.55 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.443 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -62.29 -42.78 99.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.575 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 155' ' ' THR . 11.9 t -60.06 -45.28 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.696 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.518 ' O ' HG22 ' A' ' 163' ' ' ILE . 53.6 t80 -56.66 -65.38 0.62 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.084 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.614 HH22 HG23 ' A' ' 49' ' ' VAL . 6.1 ttm-85 -41.44 -58.05 2.0 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.178 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.79 -31.65 17.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.755 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.3 OUTLIER -69.18 -34.21 62.16 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.392 -179.758 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.541 HG21 HG21 ' A' ' 49' ' ' VAL . 12.6 mt -63.07 -38.07 81.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.937 0.875 . . . . 0.0 109.102 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -64.72 0.82 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.284 -1.325 . . . . 0.0 111.543 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.71 -33.37 70.11 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.464 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 163' ' ' ILE . . . -58.38 -31.48 67.7 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -67.86 -56.07 10.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.428 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 13.5 tttm -59.03 -63.74 1.19 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.954 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 72.2 mt -47.26 -37.15 4.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.59 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.402 ' OD1' ' NH2' ' A' ' 7' ' ' ARG . 11.6 t70 -69.25 -40.17 78.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.147 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.89 -40.42 57.48 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.37 -77.5 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.329 . . . . 0.0 110.26 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.677 ' HB2' ' O ' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.026 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GDP . . . . . 0.493 " H5'" ' HA ' ' A' ' 16' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 121.186 0.517 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.506 ' NH2' ' OD2' ' A' ' 171' ' ' ASP . 12.0 mtt180 -139.94 136.12 33.51 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.784 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.524 ' HB2' HG22 ' A' ' 78' ' ' ILE . 1.5 mttp -105.99 129.49 54.1 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.734 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -101.36 121.28 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-O 121.393 0.616 . . . . 0.0 110.647 -178.435 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.12 135.04 34.96 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.469 -0.77 . . . . 0.0 110.742 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.459 ' O ' HD12 ' A' ' 12' ' ' LEU . 19.9 mt -95.08 128.6 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 CA-C-O 121.759 0.79 . . . . 0.0 111.353 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.546 HD13 ' HE1' ' A' ' 81' ' ' TYR . 1.3 mp -127.26 94.52 4.02 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 113.975 -1.466 . . . . 0.0 110.252 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -140.54 136.01 7.38 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 -179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.494 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.1 OUTLIER -51.69 -161.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.395 0.617 . . . . 0.0 110.823 179.513 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.22 137.46 33.37 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.138 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.409 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 4.5 m 59.78 19.45 8.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.809 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 p -76.05 -21.64 15.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.876 0.369 . . . . 0.0 110.386 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.95 25.39 11.46 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -71.75 -32.09 67.35 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.353 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.433 ' O ' HD13 ' A' ' 24' ' ' ILE . 17.9 m -78.12 -35.83 48.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.777 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.469 ' OG ' ' N7 ' ' A' ' 186' ' ' GDP . 79.5 p -62.02 -48.3 80.91 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.478 HD12 ' HB3' ' A' ' 25' ' ' GLN . 15.5 tp -63.44 -53.34 53.75 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.656 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.557 ' O ' HG12 ' A' ' 27' ' ' VAL . 50.4 m -38.07 -40.82 0.52 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.433 HD13 ' O ' ' A' ' 20' ' ' SER . 1.3 mp -77.43 -40.8 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.053 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.585 ' OE1' ' N ' ' A' ' 31' ' ' PHE . 3.1 tp-100 -62.65 -41.06 98.84 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.535 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.512 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 0.4 OUTLIER -76.67 -60.7 2.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.169 0.509 . . . . 0.0 111.828 -178.048 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.575 HG13 ' N ' ' A' ' 28' ' ' GLU . 13.2 p -45.51 -44.03 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.037 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.575 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.1 mm-40 -92.01 -23.7 19.45 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.433 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 71.34 26.02 74.26 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -148.99 142.03 24.84 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.585 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 0.6 OUTLIER -78.13 93.65 4.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.924 177.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.621 HG22 ' N ' ' A' ' 33' ' ' ASP . 9.3 p -109.04 166.35 4.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.212 0.529 . . . . 0.0 110.869 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.621 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -50.06 -8.59 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.8 -178.766 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.493 ' H ' HG13 ' A' ' 32' ' ' VAL . 6.4 p 38.53 83.27 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.213 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -86.02 22.71 1.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.519 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 36' ' ' ASP . 10.8 t0 -139.21 76.49 32.17 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.301 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.435 ' C ' ' H ' ' A' ' 39' ' ' ILE . 25.4 Cg_exo -64.1 -138.11 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 123.052 2.501 . . . . 0.0 112.026 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 38' ' ' THR . 14.9 t -74.93 47.41 0.34 Allowed 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.895 0.855 . . . . 0.0 110.513 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.435 ' H ' ' C ' ' A' ' 37' ' ' PRO . 1.5 tp -82.18 143.86 11.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 114.263 -1.335 . . . . 0.0 107.969 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.22 120.32 23.56 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.721 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 173.93 174.42 0.16 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 119.439 -0.904 . . . . 0.0 113.043 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.14 147.31 32.67 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.291 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -121.58 173.84 7.16 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.428 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.52 161.0 43.0 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -178.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -162.67 110.59 1.31 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.892 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.0 mp -106.9 119.69 40.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.664 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 pp -147.95 166.09 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.663 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.3 m -111.28 126.15 54.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.239 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.724 HG11 HG21 ' A' ' 164' ' ' ILE . 14.9 p -122.06 135.92 60.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.724 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 62.12 3.9 1.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.042 0.449 . . . . 0.0 109.839 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 102.3 -13.31 57.08 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.425 ' OE1' ' N ' ' A' ' 53' ' ' GLU . 7.3 tp-100 -91.49 141.75 28.39 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.425 ' N ' ' OE1' ' A' ' 52' ' ' GLN . 1.8 mt-10 -76.5 146.19 38.65 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.416 0.626 . . . . 0.0 111.229 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.598 ' CD1' HG12 ' A' ' 49' ' ' VAL . 11.7 m-85 -138.71 123.47 18.69 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.142 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.645 ' C ' HD12 ' A' ' 56' ' ' LEU . 1.6 m-70 -117.64 113.92 22.63 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.9 mp -118.72 144.22 46.38 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.617 0.722 . . . . 0.0 112.374 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.781 ' C ' HD13 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -134.1 124.29 25.89 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.09 178.791 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.93 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.65 155.1 30.47 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 120.264 -0.574 . . . . 0.0 112.402 -178.214 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.82 144.82 35.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.429 ' C ' ' HG1' ' A' ' 61' ' ' THR . 0.4 OUTLIER -121.86 124.68 44.7 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.073 178.314 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.617 HG22 ' OD2' ' A' ' 65' ' ' ASP . 31.4 p 50.46 -113.2 0.66 Allowed 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.627 0.727 . . . . 0.0 110.381 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 41.36 34.65 0.36 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.727 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.36 -113.9 0.59 Allowed Glycine 0 CA--C 1.523 0.584 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.374 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.557 ' O ' ' CG ' ' A' ' 74' ' ' TYR . 76.1 mm-40 -118.84 126.24 51.37 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.739 0.78 . . . . 0.0 110.286 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.617 ' OD2' HG22 ' A' ' 61' ' ' THR . 23.1 p-10 -139.52 -169.58 2.72 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.961 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.492 ' CD ' ' N ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -50.7 -14.2 0.18 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.482 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.543 ' N ' ' C ' ' A' ' 65' ' ' ASP . 4.8 t80 -67.43 -29.47 68.97 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.222 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 65' ' ' ASP . 7.1 p -138.99 167.73 21.41 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.869 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.671 HD11 ' HB3' ' A' ' 102' ' ' LYS . 9.7 tt -127.89 3.92 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.024 0.44 . . . . 0.0 110.859 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -103.81 103.68 38.38 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.44 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.96 122.78 8.81 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.291 1.994 . . . . 0.0 112.876 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.503 ' O ' ' CB ' ' A' ' 73' ' ' THR . 5.1 mm-40 -145.33 74.36 1.39 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.554 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.503 ' CB ' ' O ' ' A' ' 72' ' ' GLN . 0.6 OUTLIER 86.73 -22.97 0.15 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.336 -179.3 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.557 ' CG ' ' O ' ' A' ' 64' ' ' GLN . 19.3 t80 -63.88 -10.12 19.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.274 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 76' ' ' ILE . 4.0 p -78.21 46.08 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.501 HD12 ' CG2' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -51.78 -163.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.447 -179.377 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 2.9 p-10 -112.08 47.24 1.07 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.524 HG22 ' HB2' ' A' ' 8' ' ' LYS . 31.7 pt -79.98 178.99 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.25 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -153.32 26.81 0.52 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.745 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.435 ' HA3' HD13 ' A' ' 9' ' ' ILE . . . -150.92 165.02 30.13 Favored Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.076 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.546 ' HE1' HD13 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -151.96 124.84 8.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.918 -0.641 . . . . 0.0 111.522 178.077 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.655 ' O ' HG23 ' A' ' 82' ' ' ILE . 12.0 tt -132.89 104.63 7.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.447 0.641 . . . . 0.0 109.693 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.563 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.7 OUTLIER -96.89 124.55 40.9 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.434 -178.52 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -97.86 133.58 39.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.112 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.574 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 26.4 p90 -137.16 145.48 43.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.717 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 89' ' ' SER . 1.0 OUTLIER -87.25 143.88 27.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.697 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.512 HG21 ' N ' ' A' ' 124' ' ' HIS . 17.1 m -71.94 13.42 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.31 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.44 HG22 ' HG ' ' A' ' 86' ' ' SER . 0.6 OUTLIER -135.13 -19.28 1.74 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.911 0.386 . . . . 0.0 111.737 -178.872 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.52 ' C ' ' N ' ' A' ' 91' ' ' LYS . 23.0 t -89.28 92.65 9.25 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.05 -176.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.74 -9.69 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 176.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.78 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -76.86 -53.21 8.19 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.284 178.278 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.422 ' O ' HD12 ' A' ' 96' ' ' ILE . 25.6 p -59.6 -34.21 72.46 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.289 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.574 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -72.06 -56.71 5.15 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.173 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.502 ' O ' HG23 ' A' ' 98' ' ' VAL . 4.6 mm-40 -63.22 -40.51 97.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.031 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 91' ' ' LYS . 17.0 m -68.85 -33.95 61.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.676 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.422 HD12 ' O ' ' A' ' 92' ' ' SER . 2.4 mt -65.17 -40.86 90.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.335 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -70.22 -29.12 65.86 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.043 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 94' ' ' GLU . 54.1 t -74.84 -66.92 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.6 mm -41.76 -66.09 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.532 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.474 ' CE1' HD23 ' A' ' 104' ' ' LEU . 8.6 t-80 -42.24 -64.98 0.51 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.192 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 100' ' ' HIS . . . -35.06 -65.31 0.41 Allowed Glycine 0 CA--C 1.517 0.175 0 CA-C-O 121.337 0.41 . . . . 0.0 112.357 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.671 ' HB3' HD11 ' A' ' 69' ' ' ILE . 14.8 tptm -67.97 -63.53 1.04 Allowed 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.071 -0.565 . . . . 0.0 111.189 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.492 HD13 ' O ' ' A' ' 103' ' ' LEU . 0.5 OUTLIER -36.05 -58.3 0.66 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.047 0.451 . . . . 0.0 110.146 -179.426 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.698 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -51.39 -51.32 55.75 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.872 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.475 ' N ' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -52.09 -29.54 22.03 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.263 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.47 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 4.3 tpp -67.74 -53.63 25.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.711 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.429 HG23 ' H ' ' A' ' 109' ' ' LYS . 17.8 m -77.2 -20.27 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.698 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 42.27 38.16 2.66 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.232 178.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.429 ' H ' HG23 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -81.32 -159.47 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.396 0.598 . . . . 0.0 111.346 -179.379 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.73 -175.01 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.67 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.403 ' HB3' HG23 ' A' ' 170' ' ' ILE . 26.6 mt-30 -66.61 114.4 5.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.472 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.642 ' C ' HG21 ' A' ' 170' ' ' ILE . 1.1 pt -117.64 150.39 46.75 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.17 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -45.03 121.03 3.28 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.716 1.611 . . . . 0.0 112.014 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.472 ' HB ' ' HB2' ' A' ' 143' ' ' ALA . 1.4 mt -125.0 126.0 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.403 ' CE ' HD23 ' A' ' 146' ' ' LEU . 7.4 tpt -127.15 117.68 22.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.773 -178.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mt -96.19 97.91 9.91 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.0 t -105.07 126.57 60.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 122.249 1.023 . . . . 0.0 111.294 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.43 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -97.83 107.81 3.53 Favored Glycine 0 C--N 1.308 -1.005 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.512 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 52.6 t30 -97.26 176.74 5.8 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.662 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.512 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 41.2 mttt 62.75 60.76 1.25 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.689 0.757 . . . . 0.0 108.977 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.433 ' H ' ' HB3' ' A' ' 149' ' ' SER . 16.1 tttm -67.01 -24.12 65.99 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.657 ' CG ' HN21 ' A' ' 186' ' ' GDP . 1.3 p-10 -73.91 2.47 8.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 118.751 -1.179 . . . . 0.0 111.545 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 126' ' ' GLU . 8.1 mp -94.39 -25.77 16.8 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 176.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.55 ' C ' ' N ' ' A' ' 126' ' ' GLU . 7.6 t60 -27.12 -38.63 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.403 1.065 . . . . 0.0 111.457 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.515 ' N ' ' O ' ' A' ' 123' ' ' LEU . 2.8 mmt -46.98 -16.41 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.851 0.834 . . . . 0.0 108.777 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 123' ' ' LEU . 21.1 mm-40 -98.41 -57.53 2.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.994 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.466 ' CZ ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER 32.81 67.77 0.16 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.458 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.9 m -61.55 -32.1 52.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.828 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.5 tp -88.93 154.97 3.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.474 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.502 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 92.7 p -103.02 129.09 49.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.242 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -42.18 -35.32 0.92 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.564 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.6 mt-10 -66.34 -65.54 0.67 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.052 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.502 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 63.6 mt-10 -41.29 -41.43 1.9 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.925 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.08 -35.91 64.33 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 132' ' ' GLU . 15.4 tttm -62.34 -54.94 33.15 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.066 -0.567 . . . . 0.0 109.601 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.87 69.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.561 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.73 -60.75 2.57 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -54.54 -36.66 64.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.422 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -68.37 -31.77 71.39 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.1 p -63.88 -46.5 84.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.855 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -89.23 -3.53 58.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.935 0.398 . . . . 0.0 110.315 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 76.18 23.35 1.25 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.72 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -90.59 168.13 12.04 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.83 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.41 134.13 50.91 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.045 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.621 ' O ' HD22 ' A' ' 146' ' ' LEU . 5.7 t80 -96.51 122.53 39.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.739 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.747 HD12 HG22 ' A' ' 159' ' ' VAL . 1.1 mm? -134.55 136.95 43.41 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.603 -176.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.466 ' CD ' ' CZ ' ' A' ' 127' ' ' ARG . 5.8 tt0 -123.48 112.23 17.25 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 24.2 p -138.99 -177.16 4.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.052 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.433 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -139.91 130.4 25.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.087 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 152' ' ' GLU . . . -49.24 -64.87 0.68 Allowed 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 150' ' ' ALA . 40.4 tttm -33.88 -30.7 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.217 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 150' ' ' ALA . 34.3 mt-10 -111.71 103.63 11.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.57 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -64.9 -49.4 70.6 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.345 -179.712 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' A' ' 153' ' ' ASN . 15.7 mt-30 -37.27 -53.32 1.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.883 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.693 ' O ' HG23 ' A' ' 159' ' ' VAL . 80.8 p -58.16 -40.45 81.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.726 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 153' ' ' ASN . . . -58.2 -61.85 2.26 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.439 0.638 . . . . 0.0 109.978 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 55.1 t -41.32 -41.67 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.719 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.65 -39.53 93.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.528 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.747 HG22 HD12 ' A' ' 146' ' ' LEU . 29.5 t -63.04 -37.52 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.018 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.718 ' CE2' HD11 ' A' ' 164' ' ' ILE . 52.6 t80 -61.41 -65.18 0.73 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.753 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.45 -53.79 3.29 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.985 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -29.79 65.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.846 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.491 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -67.9 -33.89 64.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.387 -179.551 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.724 HG21 HG11 ' A' ' 49' ' ' VAL . 41.7 mt -69.85 -36.53 69.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 121.594 0.711 . . . . 0.0 109.784 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.28 -65.12 0.74 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.862 -178.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -58.06 -33.51 69.1 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.531 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 163' ' ' ILE . . . -58.17 -31.55 67.37 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -68.44 -57.11 6.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.617 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -54.88 -64.84 0.71 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.844 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.642 HG21 ' C ' ' A' ' 112' ' ' ILE . 96.6 mt -50.57 -34.51 12.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.007 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.506 ' OD2' ' NH2' ' A' ' 7' ' ' ARG . 1.2 t70 -67.26 -40.05 86.19 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -57.91 -31.88 65.39 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.37 -79.14 0.06 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 -0.12 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.86 179.689 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GDP . . . . . 0.657 HN21 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 121.35 0.595 . . . . 0.0 110.54 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.509 ' NH2' ' OD2' ' A' ' 171' ' ' ASP . 0.0 OUTLIER -139.72 135.5 33.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.233 179.836 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.543 ' HB2' HG22 ' A' ' 78' ' ' ILE . 32.6 mttt -109.09 129.23 55.47 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.751 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.9 OUTLIER -102.96 125.06 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-O 121.282 0.563 . . . . 0.0 110.967 -177.824 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.03 133.08 34.68 Favored 'General case' 0 C--O 1.218 -0.566 0 O-C-N 121.463 -0.773 . . . . 0.0 111.303 -178.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.2 mt -95.81 133.97 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 121.795 0.807 . . . . 0.0 112.307 -179.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.584 HD11 ' HB3' ' A' ' 67' ' ' TYR . 1.1 tp -130.45 102.26 6.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.339 -1.301 . . . . 0.0 110.627 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.67 135.75 6.97 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.4 OUTLIER -53.87 -164.44 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.349 0.595 . . . . 0.0 110.417 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.42 ' NH1' ' OG ' ' A' ' 16' ' ' SER . 9.1 ttt-85 -98.7 134.04 42.17 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.92 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.577 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 1.3 m 67.47 19.85 9.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.572 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 p -87.3 -15.25 9.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.685 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.34 10.53 35.98 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -41.79 -55.53 2.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.015 0.436 . . . . 0.0 110.718 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -69.47 -31.13 69.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.386 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.569 ' OG ' ' H8 ' ' A' ' 186' ' ' GDP . 1.6 m -58.08 -44.03 87.35 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.117 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.7 tp -77.63 -48.41 16.91 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.167 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.507 ' O ' HG12 ' A' ' 27' ' ' VAL . 86.9 m -45.68 -54.67 7.45 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.547 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.455 HD11 ' CE2' ' A' ' 43' ' ' PHE . 1.4 mp -59.49 -42.61 88.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.079 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.751 HE21 ' HB2' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -65.09 -33.39 75.91 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.919 -179.301 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.464 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 1.6 t80 -76.83 -62.29 1.69 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.265 0.555 . . . . 0.0 111.858 -178.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.586 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.9 p -48.6 -46.46 15.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.597 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.586 ' N ' HG13 ' A' ' 27' ' ' VAL . 12.4 mt-10 -85.33 -24.1 27.79 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.35 43.73 45.02 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.604 ' C ' HD22 ' A' ' 153' ' ' ASN . 0.0 OUTLIER -136.72 -174.22 3.65 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.566 0.698 . . . . 0.0 110.368 -179.572 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.611 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -135.39 89.49 2.51 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.717 178.515 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.563 HG22 ' N ' ' A' ' 33' ' ' ASP . 10.5 p -107.98 166.13 4.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.633 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.563 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.5 OUTLIER -66.26 -28.92 69.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.611 -179.096 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.539 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 3.9 p 34.94 51.4 0.52 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.085 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -88.6 64.43 7.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.868 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.75 176.68 1.51 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.731 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -65.42 -153.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.12 1.88 . . . . 0.0 111.169 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.741 HG23 ' O ' ' A' ' 38' ' ' THR . 11.3 t -131.69 64.9 1.58 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.923 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 tp -82.58 161.95 3.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.267 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -85.05 136.24 33.66 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.717 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -165.6 179.01 6.3 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 119.653 -0.819 . . . . 0.0 113.06 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.51 145.91 51.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.879 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.455 ' CE2' HD11 ' A' ' 24' ' ' ILE . 13.6 m-85 -129.08 166.48 19.18 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.724 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.574 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -146.89 153.28 39.95 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.565 -178.37 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.597 ' C ' HD12 ' A' ' 46' ' ' LEU . 29.4 tptt -156.82 112.03 2.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.455 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.74 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.7 mp -106.48 120.29 41.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.663 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.72 HD12 ' CZ ' ' A' ' 160' ' ' PHE . 0.8 OUTLIER -146.65 165.71 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.622 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 m -111.34 128.46 55.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.359 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.861 HG11 HG21 ' A' ' 164' ' ' ILE . 5.9 p -127.31 135.66 62.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.529 ' CG ' HG22 ' A' ' 49' ' ' VAL . 2.8 m120 63.16 12.83 6.36 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.28 -11.54 69.35 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -90.45 139.16 30.94 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -76.71 145.15 38.87 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.638 0.733 . . . . 0.0 111.32 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.552 ' CE2' HG23 ' A' ' 164' ' ' ILE . 10.3 m-85 -137.08 122.83 19.92 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.995 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.652 ' C ' HD12 ' A' ' 56' ' ' LEU . 66.6 m170 -116.9 113.61 22.7 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.652 HD12 ' C ' ' A' ' 55' ' ' HIS . 11.0 mp -119.57 143.4 47.64 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.657 0.741 . . . . 0.0 112.214 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.731 ' C ' HD13 ' A' ' 58' ' ' LEU . 2.4 mt-30 -135.32 124.86 25.04 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.698 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.916 HD22 ' N ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.83 154.5 30.62 Favored 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 120.034 -0.666 . . . . 0.0 112.218 -178.452 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.17 145.93 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.87 -178.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.73 103.31 8.78 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.049 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.536 HG22 ' CE2' ' A' ' 74' ' ' TYR . 51.1 p -68.98 137.49 53.77 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.773 0.797 . . . . 0.0 111.562 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . . . -144.71 13.85 1.53 Allowed 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.188 -1.369 . . . . 0.0 108.639 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.85 -2.4 30.35 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.523 ' N ' ' OE1' ' A' ' 64' ' ' GLN . 13.2 mp0 -142.14 -153.0 0.44 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.543 0.687 . . . . 0.0 111.107 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 67' ' ' TYR . 2.3 t70 -74.46 -177.38 3.08 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.507 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.546 ' N ' ' CG ' ' A' ' 65' ' ' ASP . 3.8 mp0 -43.39 -18.47 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.66 ' CD1' HD12 ' A' ' 99' ' ' ILE . 17.2 p90 -172.01 -22.73 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.751 -178.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.58 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 1.4 m 41.36 93.02 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.536 0.208 . . . . 0.0 111.439 -178.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.798 HD13 ' H ' ' A' ' 70' ' ' PHE . 0.5 OUTLIER -56.94 156.53 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.355 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.798 ' H ' HD13 ' A' ' 69' ' ' ILE . 29.0 t80 58.82 65.89 2.67 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.89 0.376 . . . . 0.0 110.383 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -46.6 109.9 0.24 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.729 2.286 . . . . 0.0 111.988 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -97.7 -6.81 32.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.623 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.41 -26.83 2.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.569 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.536 ' CE2' HG22 ' A' ' 61' ' ' THR . 0.1 OUTLIER -83.64 101.6 11.62 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.515 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.0 m -86.93 51.9 2.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.8 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.414 ' HB ' HG23 ' A' ' 78' ' ' ILE . 0.9 OUTLIER -86.15 172.36 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 121.562 0.696 . . . . 0.0 112.056 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 5.1 p-10 -147.56 57.53 1.12 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.565 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.543 HG22 ' HB2' ' A' ' 8' ' ' LYS . 29.1 pt -79.01 -176.56 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -177.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -151.84 17.86 0.69 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.197 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -146.65 166.57 28.25 Favored Glycine 0 CA--C 1.518 0.232 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.38 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.68 121.69 7.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.951 -0.624 . . . . 0.0 110.763 178.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 82' ' ' ILE . 10.0 tt -123.9 103.31 12.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.97 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -95.9 131.95 41.71 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.456 -0.897 . . . . 0.0 110.447 -178.266 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.483 ' O ' ' CD1' ' A' ' 96' ' ' ILE . 1.2 t -92.34 130.87 40.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.963 -178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -108.04 143.21 37.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.978 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.541 ' OG ' HG22 ' A' ' 88' ' ' THR . 47.8 t -109.88 130.21 55.55 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.889 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.547 HG21 ' N ' ' A' ' 124' ' ' HIS . 14.1 m -81.34 18.35 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.004 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.541 HG22 ' OG ' ' A' ' 86' ' ' SER . 1.4 t -143.54 -3.3 0.92 Allowed 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -177.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.495 ' C ' ' N ' ' A' ' 91' ' ' LYS . 1.0 OUTLIER -134.31 97.94 3.97 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 119.416 -0.914 . . . . 0.0 112.843 -175.566 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.569 HG22 ' HG3' ' A' ' 94' ' ' GLU . 18.1 mm -56.13 -10.9 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 114.155 -1.384 . . . . 0.0 107.859 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.729 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -79.13 -42.03 27.2 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.091 178.686 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.62 -47.49 75.46 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.051 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.742 ' CD2' HD13 ' A' ' 129' ' ' ILE . 0.1 OUTLIER -76.3 -35.39 58.86 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 119.105 -1.038 . . . . 0.0 112.186 -178.034 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.569 ' HG3' HG22 ' A' ' 90' ' ' ILE . 14.0 mm-40 -66.46 -47.95 71.48 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.901 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 91' ' ' LYS . 32.6 m -64.17 -37.49 80.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.023 0.439 . . . . 0.0 110.292 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.483 ' CD1' ' O ' ' A' ' 84' ' ' VAL . 31.8 mt -69.02 -31.28 49.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.887 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.73 -26.42 63.38 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.18 0.514 . . . . 0.0 109.709 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 7.3 t -70.44 -64.98 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.755 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.66 HD12 ' CD1' ' A' ' 67' ' ' TYR . 1.8 tt -43.29 -47.95 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.647 178.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.58 ' NE2' ' CD1' ' A' ' 141' ' ' TRP . 15.1 t-80 -44.96 -64.79 0.63 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.852 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -39.43 -57.44 2.24 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 111.931 -0.468 . . . . 0.0 111.931 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 105' ' ' ASP . 13.5 tptp -62.96 -65.77 0.64 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.177 -0.511 . . . . 0.0 111.061 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.727 HD22 HD11 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -36.52 -56.69 0.8 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.731 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.73 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -46.34 -47.66 18.49 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.635 178.522 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -56.83 -33.76 67.07 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.317 -179.0 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.529 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 2.4 tpp -67.99 -55.74 11.56 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.869 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.562 ' C ' ' H ' ' A' ' 109' ' ' LYS . 16.5 m -77.03 -12.82 14.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.016 -178.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.29 -24.87 0.04 OUTLIER Glycine 0 CA--C 1.534 1.227 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.853 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.57 ' CG ' ' H ' ' A' ' 110' ' ' VAL . 1.4 tptt -173.45 -128.73 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.856 0.828 . . . . 0.0 111.533 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.57 ' H ' ' CG ' ' A' ' 109' ' ' LYS . 7.8 t 51.1 118.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.909 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.44 ' HB3' HG23 ' A' ' 170' ' ' ILE . 27.3 mt-30 -76.14 131.6 39.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.086 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.627 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.5 OUTLIER -136.17 154.6 77.45 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.407 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -49.89 110.14 0.35 Allowed 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.772 1.648 . . . . 0.0 112.546 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.485 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.2 mp -121.67 127.84 75.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.574 ' O ' HD12 ' A' ' 83' ' ' LEU . 7.2 tpt -130.68 115.84 17.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.669 -178.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' A' ' 138' ' ' ALA . 28.2 mt -96.71 97.52 9.41 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.8 t -105.64 130.34 57.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.632 0.729 . . . . 0.0 110.977 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -102.02 116.33 5.49 Favored Glycine 0 C--N 1.306 -1.136 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.487 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.7 t30 -97.04 173.92 7.02 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.557 -178.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.522 ' NZ ' ' O ' ' A' ' 16' ' ' SER . 18.0 mttt 60.2 58.25 2.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.545 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 20.5 tttm -63.76 -29.5 70.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.955 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -70.96 -6.8 41.48 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.953 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 125' ' ' MET . 8.6 mp -94.31 -29.85 14.83 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.547 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.9 OUTLIER -38.61 -24.79 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.927 177.914 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.534 ' N ' ' O ' ' A' ' 123' ' ' LEU . 19.1 mtp -44.73 -24.11 0.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.472 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.3 OUTLIER -101.83 -37.63 8.19 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.33 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.425 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 1.2 tpt180 37.08 87.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.794 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.5 m -80.22 -32.36 13.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.15 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.742 HD13 ' CD2' ' A' ' 93' ' ' PHE . 11.1 tp -91.23 154.7 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.21 178.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.434 ' OG ' ' OE1' ' A' ' 133' ' ' GLU . 6.5 p -97.36 134.37 40.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.424 0.631 . . . . 0.0 112.226 -178.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -58.42 -30.63 67.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.095 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mp0 -68.53 -65.66 0.67 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.989 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.434 ' OE1' ' OG ' ' A' ' 130' ' ' SER . 43.5 mt-10 -41.42 -41.26 1.98 Allowed 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.83 -36.33 65.93 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 132' ' ' GLU . 3.5 tttm -60.92 -55.72 29.6 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.56 -33.98 66.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.289 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.61 -62.94 1.23 Allowed 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.832 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 143' ' ' ALA . . . -54.27 -33.67 59.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.655 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.43 -38.15 80.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.703 0.287 . . . . 0.0 110.872 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.41 -47.43 79.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.428 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.58 ' CD1' ' NE2' ' A' ' 100' ' ' HIS . 23.7 m95 -91.64 2.68 56.3 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.352 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 13.4 m120 60.67 35.56 19.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.099 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.507 ' O ' ' HB1' ' A' ' 138' ' ' ALA . . . -92.05 166.71 12.54 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.946 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -103.29 125.5 49.96 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.052 -0.659 . . . . 0.0 112.012 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.418 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 6.7 t80 -98.13 121.22 39.79 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.977 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.31 125.98 15.1 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.418 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.425 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 11.7 tt0 -102.01 110.8 22.86 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.406 ' OG ' HG21 ' A' ' 159' ' ' VAL . 0.1 OUTLIER -123.07 -176.52 3.44 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.245 -178.787 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.85 138.9 37.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.524 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -71.88 -11.22 60.69 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.476 0.655 . . . . 0.0 109.361 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.54 -5.57 59.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.004 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.61 ' O ' ' NE2' ' A' ' 25' ' ' GLN . 51.9 mt-10 -138.97 125.91 21.06 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.474 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.604 HD22 ' C ' ' A' ' 30' ' ' GLN . 65.3 m-20 -75.51 -48.43 22.55 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 153' ' ' ASN . 1.7 mt-30 -36.54 -56.88 0.79 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.998 0.427 . . . . 0.0 110.716 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.719 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.2 p -52.57 -47.8 66.6 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.354 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.751 ' HB2' HE21 ' A' ' 25' ' ' GLN . . . -55.38 -60.35 3.53 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.338 0.589 . . . . 0.0 110.178 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.1 t -41.98 -40.75 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.403 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.3 -32.53 72.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.994 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 155' ' ' THR . 22.0 t -73.78 -36.53 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 121.038 0.447 . . . . 0.0 109.996 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.793 ' CZ ' HD11 ' A' ' 164' ' ' ILE . 25.5 t80 -69.22 -35.63 76.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.038 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.478 HH22 HG23 ' A' ' 49' ' ' VAL . 23.9 ttm-85 -77.4 -45.21 26.6 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.135 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -34.39 74.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.067 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.479 HG23 ' N ' ' A' ' 164' ' ' ILE . 14.0 tt -68.83 -50.46 54.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.365 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.861 HG21 HG11 ' A' ' 49' ' ' VAL . 86.5 mt -50.76 -33.63 12.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 119.064 -1.055 . . . . 0.0 108.885 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.93 -63.61 1.16 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.861 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -57.77 -29.08 64.54 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -60.63 -32.52 71.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.413 ' OE1' ' OH ' ' A' ' 54' ' ' TYR . 1.7 tp10 -68.93 -57.79 5.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.315 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -53.61 -62.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.689 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.627 HG21 ' C ' ' A' ' 112' ' ' ILE . 74.7 mt -51.89 -34.33 16.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.011 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.509 ' OD2' ' NH2' ' A' ' 7' ' ' ARG . 1.9 t70 -69.64 -38.49 77.19 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.679 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -63.21 -35.41 92.04 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.98 -65.48 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.348 . . . . 0.0 110.686 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.691 -179.928 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GDP . . . . . 0.577 " H5'" ' HA ' ' A' ' 16' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.177 0.513 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.732 ' NH2' ' HB1' ' A' ' 167' ' ' ALA . 23.2 mtm180 -139.94 136.79 34.2 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.724 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.642 ' HZ1' HE22 ' A' ' 57' ' ' GLN . 6.2 mttm -106.25 130.07 54.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.774 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.9 OUTLIER -103.28 123.49 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-O 121.493 0.664 . . . . 0.0 110.49 -178.315 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.53 134.38 34.42 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.304 -0.872 . . . . 0.0 111.325 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.2 mt -95.51 127.66 47.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.38 0.61 . . . . 0.0 111.65 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.617 HD22 HG21 ' A' ' 99' ' ' ILE . 13.0 tp -127.5 99.35 5.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.522 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -142.07 136.09 7.08 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.814 -178.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.1 OUTLIER -49.31 -177.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.217 0.532 . . . . 0.0 110.662 179.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -74.46 140.85 44.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.816 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.4 m 53.17 19.63 1.53 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.609 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.2 p -68.64 -17.13 21.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.417 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.429 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 103.82 29.25 5.62 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.403 ' HG3' ' HZ3' ' A' ' 19' ' ' LYS . 6.7 mtmm -64.61 -62.49 1.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 110.369 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.504 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.9 OUTLIER -55.96 -28.35 56.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.619 -179.149 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 94.6 p -68.2 -50.73 52.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.792 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.1 tp -77.4 -26.45 51.77 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.913 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.622 ' O ' HG12 ' A' ' 27' ' ' VAL . 33.9 m -60.32 -43.33 96.48 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.504 HD13 ' O ' ' A' ' 20' ' ' SER . 1.2 mp -77.89 -42.74 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.729 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.534 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -67.02 -32.13 73.14 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.358 -179.045 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -77.71 -62.59 1.62 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.374 0.607 . . . . 0.0 111.404 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 23' ' ' THR . 14.4 p -48.01 -47.52 12.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.268 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.612 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.2 tm-20 -83.53 -24.6 31.58 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.32 28.74 67.39 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.525 ' CA ' HD21 ' A' ' 153' ' ' ASN . 0.1 OUTLIER -144.94 125.67 14.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.07 0.462 . . . . 0.0 111.861 -178.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.516 ' O ' ' CG ' ' A' ' 31' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.346 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -178.68 174.05 1.22 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.509 0.671 . . . . 0.0 112.43 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.548 HG23 HG23 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -108.25 137.23 46.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.357 179.61 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -122.09 167.19 13.44 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.714 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -146.41 148.05 31.9 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.38 0.609 . . . . 0.0 112.319 -179.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.5 tttp -147.11 112.44 5.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.968 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.498 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.0 mp -106.44 120.28 41.5 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.095 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.812 ' H ' HD12 ' A' ' 47' ' ' ILE . 0.4 OUTLIER -145.47 165.31 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.42 -179.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.3 m -115.92 124.96 51.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.489 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.586 ' O ' HG13 ' A' ' 49' ' ' VAL . 13.2 p -119.45 117.63 54.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.734 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.563 ' OD1' HG22 ' A' ' 49' ' ' VAL . 0.8 OUTLIER 69.83 26.06 4.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.025 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.61 -9.41 55.7 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -89.99 132.04 35.57 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.96 145.58 40.25 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.621 0.724 . . . . 0.0 111.352 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.666 ' CE2' HG23 ' A' ' 164' ' ' ILE . 5.5 m-85 -136.53 122.36 19.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.949 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.573 ' C ' HD12 ' A' ' 56' ' ' LEU . 67.3 m170 -117.2 112.7 21.19 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.573 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.4 mp -119.19 142.85 47.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.517 0.675 . . . . 0.0 111.831 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.743 ' C ' HD13 ' A' ' 58' ' ' LEU . 2.4 mt-30 -133.14 121.52 22.71 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.957 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.892 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.84 154.42 30.77 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 120.098 -0.641 . . . . 0.0 112.219 -178.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.548 HG23 HG23 ' A' ' 42' ' ' THR . 0.3 OUTLIER -128.14 144.87 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.686 -179.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.05 107.48 12.68 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.872 -1.513 . . . . 0.0 108.178 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 121.12 0.486 . . . . 0.0 110.479 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.494 HG22 ' HB2' ' A' ' 8' ' ' LYS . 33.5 pt . . . . . 0 N--CA 1.436 -1.159 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -150.75 17.62 0.79 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.142 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.489 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -146.94 165.92 28.45 Favored Glycine 0 CA--C 1.516 0.143 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.584 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.1 122.4 7.23 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.956 -0.622 . . . . 0.0 110.812 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.614 HG23 ' O ' ' A' ' 82' ' ' ILE . 10.7 tt -125.54 103.38 11.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.803 HD23 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -96.28 125.82 41.06 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.737 -178.22 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.476 ' O ' HD11 ' A' ' 96' ' ' ILE . 1.8 t -95.7 119.25 43.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.808 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.481 ' C ' ' CD1' ' A' ' 85' ' ' TYR . 4.1 p90 -109.7 145.41 36.61 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.421 ' OG ' ' N ' ' A' ' 89' ' ' SER . 0.8 OUTLIER -101.85 143.62 31.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.064 0.459 . . . . 0.0 111.752 -178.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.597 HG21 ' N ' ' A' ' 124' ' ' HIS . 17.8 m -80.49 20.45 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.23 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.7 t -141.92 -15.94 0.79 Allowed 'General case' 0 C--O 1.232 0.141 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.538 ' C ' ' N ' ' A' ' 91' ' ' LYS . 38.8 t -113.71 94.21 4.74 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -176.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.524 HG22 ' CD ' ' A' ' 94' ' ' GLU . 22.5 mm -52.8 -14.74 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 176.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.775 ' O ' HG22 ' A' ' 95' ' ' VAL . 9.6 mttp -78.22 -46.61 19.95 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.192 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.0 p -61.9 -45.48 93.55 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.575 ' CE2' HD13 ' A' ' 129' ' ' ILE . 0.1 OUTLIER -77.64 -37.27 50.36 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 119.248 -0.981 . . . . 0.0 112.652 -177.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.524 ' CD ' HG22 ' A' ' 90' ' ' ILE . 88.5 mt-10 -67.81 -43.89 78.59 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.43 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.775 HG22 ' O ' ' A' ' 91' ' ' LYS . 30.7 m -66.04 -38.16 81.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.85 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.476 HD11 ' O ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -58.92 -39.42 77.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -69.45 -26.75 64.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.126 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 94' ' ' GLU . 60.9 t -77.29 -66.91 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.785 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.617 HG21 HD22 ' A' ' 12' ' ' LEU . 1.7 mp -41.07 -38.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.028 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.518 ' CE1' ' CD1' ' A' ' 141' ' ' TRP . 7.1 t-160 -64.4 -64.92 0.76 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.617 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.52 -57.75 1.46 Allowed Glycine 0 CA--C 1.517 0.212 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 105' ' ' ASP . 12.7 tptp -62.9 -64.72 0.83 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.915 -0.643 . . . . 0.0 110.713 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -36.95 -60.17 0.65 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.747 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -46.43 -48.07 18.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.471 178.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.92 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.419 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.413 ' HB3' HG23 ' A' ' 170' ' ' ILE . 61.7 mt-30 . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.925 0.393 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.716 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.8 OUTLIER -115.04 150.35 44.08 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.21 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -48.2 111.7 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.516 1.478 . . . . 0.0 112.32 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.486 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.5 mp -120.99 128.99 76.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 8.7 tpt -129.17 115.45 17.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.76 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mt -96.84 97.77 9.57 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.0 t -102.48 134.06 44.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 122.442 1.115 . . . . 0.0 110.471 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 146' ' ' LEU . . . -101.32 111.73 4.19 Favored Glycine 0 C--N 1.297 -1.595 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.478 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 46.3 t30 -96.95 173.72 7.14 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.415 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.478 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 24.4 mttt 59.57 58.59 2.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.507 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.418 ' H ' ' HB3' ' A' ' 149' ' ' SER . 32.0 tttm -64.41 -35.47 81.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.412 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.32 -10.6 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.04 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 125' ' ' MET . 9.1 mp -90.69 -29.93 17.42 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.598 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.1 OUTLIER -40.13 -23.97 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.889 178.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.598 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 3.6 mmt -45.24 -24.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.44 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -101.36 -37.81 8.31 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.068 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.41 ' NH1' ' OE2' ' A' ' 147' ' ' GLU . 1.9 tpt180 38.91 88.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.082 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.474 HG23 ' N ' ' A' ' 129' ' ' ILE . 17.0 m -78.84 -38.21 20.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.586 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.575 HD13 ' CE2' ' A' ' 93' ' ' PHE . 6.7 tp -90.5 153.52 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.562 ' HG ' ' HB2' ' A' ' 133' ' ' GLU . 18.2 p -94.87 137.16 34.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.274 0.559 . . . . 0.0 112.087 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -54.95 -32.59 61.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.215 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -68.32 -65.83 0.65 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.964 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.562 ' HB2' ' HG ' ' A' ' 130' ' ' SER . 41.0 mt-10 -42.09 -40.93 2.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.622 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.11 -34.29 64.74 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 132' ' ' GLU . 24.1 tttm -64.07 -55.5 21.68 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -55.6 -33.75 64.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.25 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.646 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -65.53 -62.99 1.2 Allowed 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.702 179.429 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -54.69 -34.99 63.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.364 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.56 -30.11 67.84 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.4 p -64.3 -46.8 81.99 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.742 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.646 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 21.9 m95 -88.94 -5.71 57.78 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.089 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.4 ' O ' ' OE2' ' A' ' 166' ' ' GLU . 0.8 OUTLIER 75.91 25.49 1.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -89.24 169.16 11.69 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.894 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.47 133.81 49.61 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.214 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.633 ' O ' HD22 ' A' ' 146' ' ' LEU . 6.6 t80 -96.83 122.49 39.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.005 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.829 HD12 HG22 ' A' ' 159' ' ' VAL . 1.3 mm? -132.95 139.5 47.34 Favored 'General case' 0 C--O 1.209 -1.054 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.63 -176.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.41 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 5.5 tt0 -129.04 111.28 12.81 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 58.9 p -138.66 -177.15 4.74 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.734 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.418 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -138.4 140.17 39.26 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.086 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -59.68 -43.07 94.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.157 0.503 . . . . 0.0 109.69 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.0 ttpp -65.38 5.64 0.38 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.381 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 150' ' ' ALA . 3.4 tt0 -136.47 120.02 17.08 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.721 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.525 HD21 ' CA ' ' A' ' 30' ' ' GLN . 3.6 m120 -77.57 -56.86 4.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.961 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 153' ' ' ASN . 9.1 tt0 -36.97 -58.23 0.78 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.893 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 159' ' ' VAL . 66.3 p -52.14 -50.16 62.29 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.126 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.534 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -49.75 -60.31 3.01 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.418 0.628 . . . . 0.0 109.717 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.1 t -40.92 -50.35 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.986 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -53.96 -32.6 54.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.661 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.829 HG22 HD12 ' A' ' 146' ' ' LEU . 12.7 t -75.92 -26.74 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.247 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -71.45 -39.92 70.66 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.462 179.321 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.603 ' N ' ' CD1' ' A' ' 160' ' ' PHE . 36.2 ttm-85 -79.48 -47.73 15.12 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.163 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.6 mmm180 -57.75 -37.57 73.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.11 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.628 HG23 ' N ' ' A' ' 164' ' ' ILE . 11.6 tt -69.74 -58.18 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.438 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.666 HG23 ' CE2' ' A' ' 54' ' ' TYR . 91.3 mt -46.2 -35.02 2.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.88 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -64.82 0.82 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.027 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.4 ' OE2' ' O ' ' A' ' 142' ' ' ASN . 2.1 tt0 -54.6 -37.99 66.22 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.732 ' HB1' ' NH2' ' A' ' 7' ' ' ARG . . . -49.56 -35.54 20.82 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -68.06 -52.65 32.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.085 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 3.6 ttpp -54.5 -61.07 2.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.529 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.716 HG21 ' C ' ' A' ' 112' ' ' ILE . 33.7 mm -49.98 -32.98 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.62 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -39.59 89.05 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.102 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -61.9 -34.09 87.63 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.96 -80.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.67 0.271 . . . . 0.0 110.323 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 -0.141 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.817 179.824 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 121.352 0.596 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.69 135.41 33.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.256 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.605 ' NZ ' ' NE2' ' A' ' 57' ' ' GLN . 8.1 mttm -107.73 127.59 53.82 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.733 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.9 OUTLIER -100.96 122.27 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 121.702 0.763 . . . . 0.0 110.808 -177.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.28 135.24 34.41 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.498 -0.751 . . . . 0.0 110.882 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.4 mt -96.97 131.74 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.554 0.692 . . . . 0.0 112.403 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.91 HD11 HG21 ' A' ' 99' ' ' ILE . 5.0 tt -121.43 101.34 7.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.895 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -139.8 134.4 6.59 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.72 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.442 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -55.34 -158.35 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.368 0.604 . . . . 0.0 110.756 179.339 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.7 tpp85 -96.05 133.57 40.14 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.546 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.1 m 61.57 14.61 6.1 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.288 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.473 ' C ' ' HZ2' ' A' ' 120' ' ' LYS . 4.3 p -70.28 -13.32 17.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.502 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.4 21.65 47.5 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.747 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.4 pttm -68.17 -35.29 77.81 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.055 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.2 m -67.66 -42.21 82.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.545 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 m -60.42 -47.55 85.62 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.485 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.444 ' O ' ' CB ' ' A' ' 26' ' ' PHE . 45.4 tp -66.95 -26.94 67.08 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.547 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.576 ' O ' HG12 ' A' ' 27' ' ' VAL . 97.2 m -63.06 -51.45 66.62 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.4 mm -65.3 -38.77 83.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.936 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.579 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -77.57 -25.67 50.21 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.541 -178.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.636 ' CZ ' ' CD2' ' A' ' 160' ' ' PHE . 37.1 t80 -77.78 -53.04 7.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.414 0.626 . . . . 0.0 110.614 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.605 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.9 p -59.61 -48.75 86.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.991 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.605 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.6 mt-10 -79.43 -24.41 42.51 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.416 ' O ' ' OD1' ' A' ' 153' ' ' ASN . . . 69.24 36.2 78.75 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -147.14 136.13 22.32 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.205 0.526 . . . . 0.0 111.179 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.24 179.29 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.42 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 7.2 pt-20 . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 1.2 m120 -172.85 176.08 3.18 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.576 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.434 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -108.26 152.95 23.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.577 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.45 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 25.3 m-85 -132.63 166.37 22.3 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.455 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -147.05 156.3 42.91 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.524 0.678 . . . . 0.0 112.823 -177.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -163.29 117.13 1.6 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.804 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 46' ' ' LEU . 8.2 mp -104.63 129.2 52.8 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.879 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 pp -147.1 160.31 9.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.935 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -114.97 123.28 48.71 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.974 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.26 129.87 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.014 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 63.74 7.26 3.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.019 0.438 . . . . 0.0 109.961 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.83 -11.76 59.17 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -89.15 135.02 33.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -77.13 147.12 36.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.606 0.717 . . . . 0.0 111.525 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -140.38 123.47 16.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.749 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.593 ' C ' HD12 ' A' ' 56' ' ' LEU . 1.2 m-70 -117.33 114.06 23.03 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.593 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.7 mp -118.88 143.88 46.72 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.785 0.802 . . . . 0.0 112.379 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.747 ' C ' HD13 ' A' ' 58' ' ' LEU . 2.9 mt-30 -135.63 122.15 20.71 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.198 -1.364 . . . . 0.0 109.95 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.952 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.78 153.53 33.28 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.53 -178.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -122.93 144.38 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-N 114.508 -1.224 . . . . 0.0 112.32 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.13 103.43 8.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.107 178.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 121.385 0.612 . . . . 0.0 110.513 -179.902 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.548 HG22 ' HB2' ' A' ' 8' ' ' LYS . 29.8 pt . . . . . 0 N--CA 1.429 -1.475 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -151.19 17.33 0.75 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.04 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -144.17 164.4 27.6 Favored Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.222 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.53 123.93 7.71 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.641 -0.78 . . . . 0.0 111.181 178.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 82' ' ' ILE . 7.6 tt -128.71 113.79 30.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.2 mt -97.48 123.93 41.51 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.042 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -98.08 117.82 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.179 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.615 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 42.2 p90 -120.5 145.38 47.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.308 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 88' ' ' THR . 3.3 p -86.03 135.77 33.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.204 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.535 HG21 ' N ' ' A' ' 124' ' ' HIS . 18.0 m -73.69 21.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.459 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.495 ' H ' ' C ' ' A' ' 86' ' ' SER . 0.9 OUTLIER -136.9 -25.6 1.08 Allowed 'General case' 0 CA--C 1.52 -0.212 0 CA-C-O 121.003 0.43 . . . . 0.0 112.063 -178.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 91' ' ' LYS . 60.8 p -97.77 100.06 11.42 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.067 -176.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.8 tp -59.37 -8.4 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 176.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.563 ' H ' ' C ' ' A' ' 89' ' ' SER . 21.8 mttp -77.05 -59.31 2.83 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.111 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.432 ' OG ' ' OG ' ' A' ' 89' ' ' SER . 83.1 p -52.22 -33.52 41.53 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.878 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.615 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -73.19 -49.76 26.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.721 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -65.98 -42.35 89.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.214 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 91' ' ' LYS . 19.5 m -66.22 -41.56 89.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.254 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.508 ' N ' HG23 ' A' ' 95' ' ' VAL . 1.4 mt -59.44 -34.51 54.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -71.0 -27.26 63.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.466 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.4 t -77.11 -67.27 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.263 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.91 HG21 HD11 ' A' ' 12' ' ' LEU . 1.4 tp -48.53 -29.53 2.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.684 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.616 ' CG ' ' CH2' ' A' ' 141' ' ' TRP . 35.6 t-80 -67.77 -63.58 1.03 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.235 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -39.58 -47.61 3.0 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 105' ' ' ASP . 37.6 tptt -62.81 -62.72 1.53 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.878 -0.661 . . . . 0.0 109.244 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -38.06 -51.09 1.39 Allowed 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.349 0.595 . . . . 0.0 109.498 178.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.735 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -52.4 -45.56 65.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.52 179.057 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.313 -0.983 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.035 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.762 ' O ' ' HB2' ' A' ' 174' ' ' ALA . 2.1 mm100 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 121.083 0.468 . . . . 0.0 111.367 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.67 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.2 OUTLIER -130.61 161.21 62.32 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -51.83 101.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 120.953 1.102 . . . . 0.0 111.548 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.3 mt -116.22 120.97 66.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.404 ' CE ' HD23 ' A' ' 146' ' ' LEU . 8.5 tpt -121.84 113.73 20.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.033 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 79.8 mt -96.14 97.86 9.88 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.8 t -106.91 135.32 45.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 122.184 0.992 . . . . 0.0 111.696 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.403 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -105.45 116.08 5.1 Favored Glycine 0 C--N 1.308 -0.98 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.476 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 57.9 t30 -97.71 174.88 6.4 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.043 -178.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.476 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 7.2 mttp 62.09 58.19 1.9 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.048 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.44 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 2.9 tttm -58.92 -26.83 64.69 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -64.5 -13.98 54.9 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.97 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 125' ' ' MET . 11.0 mp -89.98 -30.03 18.07 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.61 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.1 OUTLIER -37.53 -25.78 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.132 178.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.61 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 7.2 mtp -49.26 -21.5 0.83 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.448 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -109.99 -38.84 5.22 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.139 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.484 ' HE ' ' HB2' ' A' ' 124' ' ' HIS . 19.6 ttm180 26.68 90.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.106 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.99 -32.98 56.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.437 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.6 tp -88.89 156.37 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.597 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.562 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 88.7 p -103.41 124.98 49.73 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.219 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.511 ' CE1' ' CE1' ' A' ' 145' ' ' PHE . 0.4 OUTLIER -39.23 -39.56 0.63 Allowed 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.064 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mp0 -61.33 -65.75 0.64 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.937 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.562 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 66.6 mt-10 -41.41 -46.18 3.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.076 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.78 -35.05 84.57 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 132' ' ' GLU . 12.1 ttpt -62.04 -55.27 30.81 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.0 -37.82 77.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.307 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.557 ' CD2' ' CE2' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -67.06 -64.78 0.78 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 120.905 0.384 . . . . 0.0 110.017 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -49.71 -32.45 13.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.304 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -67.12 -53.77 27.59 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.911 0.386 . . . . 0.0 110.11 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 88.8 p -62.32 -26.77 68.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.116 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.616 ' CH2' ' CG ' ' A' ' 100' ' ' HIS . 32.6 m0 -88.02 -8.78 55.11 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 65.9 20.61 11.38 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -101.04 166.65 10.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.776 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.01 133.96 48.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.916 -0.583 . . . . 0.0 112.252 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.71 ' O ' HD22 ' A' ' 146' ' ' LEU . 4.5 t80 -97.1 122.92 40.63 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.529 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.913 HD12 HG22 ' A' ' 159' ' ' VAL . 1.2 mm? -135.79 138.89 43.06 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.592 -176.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.48 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 2.3 tt0 -127.77 110.55 12.73 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.1 p -137.86 -176.79 4.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.164 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.71 139.85 38.54 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.857 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.484 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -59.78 -44.38 93.92 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 178.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -62.5 -0.5 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.184 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.484 ' H ' ' C ' ' A' ' 150' ' ' ALA . 1.3 mt-10 -136.42 97.98 3.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.627 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.528 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 11.2 t-20 -63.96 -47.71 79.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.969 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 153' ' ' ASN . 0.0 OUTLIER -37.06 -59.13 0.74 Allowed 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.104 0.478 . . . . 0.0 110.485 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.588 ' O ' HG23 ' A' ' 159' ' ' VAL . 74.2 p -52.29 -44.98 65.3 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.847 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.579 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -55.19 -60.31 3.57 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.293 0.568 . . . . 0.0 109.959 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.1 t -41.63 -41.64 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.939 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.32 -39.56 94.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.891 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.913 HG22 HD12 ' A' ' 146' ' ' LEU . 22.4 t -67.39 -31.33 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.371 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.636 ' CD2' ' CZ ' ' A' ' 26' ' ' PHE . 4.8 t80 -62.19 -66.94 0.46 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.67 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 26.3 ttm-85 -48.48 -53.15 19.05 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.849 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.46 -33.98 23.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.95 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.521 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -65.76 -34.07 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.485 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.434 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 10.2 mt -68.06 -40.05 82.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.634 0.731 . . . . 0.0 110.244 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.37 -60.84 2.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.302 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.6 -32.29 65.11 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.546 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -60.0 -32.29 70.72 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -68.32 -55.98 10.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.96 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 18.4 ttpp -59.2 -62.33 1.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.931 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.67 HG21 ' C ' ' A' ' 112' ' ' ILE . 67.1 mt -50.28 -33.14 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.111 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.13 -40.69 90.84 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.141 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.56 -32.71 84.21 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.94 -81.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.419 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.762 ' HB2' ' O ' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.015 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.476 ' HG ' ' CE1' ' A' ' 55' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 121.078 0.466 . . . . 0.0 110.159 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.454 ' NH1' ' HB1' ' A' ' 167' ' ' ALA . 2.1 ptp180 -139.9 136.7 34.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.602 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.546 ' HB2' HG22 ' A' ' 78' ' ' ILE . 4.1 mptt -106.36 133.47 51.0 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.755 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.3 mm -106.06 125.97 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-O 121.345 0.593 . . . . 0.0 110.232 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.445 ' HB2' ' CD1' ' A' ' 78' ' ' ILE . . . -83.74 134.0 34.76 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.124 -0.985 . . . . 0.0 110.631 -178.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 58' ' ' LEU . 17.0 mt -96.9 132.37 41.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.341 0.591 . . . . 0.0 112.121 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.2 tp -132.4 105.92 7.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.569 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -140.26 134.37 6.48 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -54.9 -159.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.371 0.605 . . . . 0.0 110.918 179.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -96.18 135.28 38.2 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.864 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.0 m 61.27 19.48 10.16 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.497 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 p -77.8 -19.66 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.852 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.38 23.28 24.67 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.6 pttm -69.32 -34.45 74.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.0 110.263 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.2 m -75.42 -36.16 60.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.086 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.3 p -60.42 -42.16 95.47 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.318 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.6 tp -77.44 -34.14 54.64 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.959 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.596 ' O ' HG12 ' A' ' 27' ' ' VAL . 27.0 m -52.98 -45.48 67.84 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.849 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 24' ' ' ILE . 1.4 mp -74.42 -41.96 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.351 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.618 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -68.45 -28.9 67.45 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.334 -0.547 . . . . 0.0 110.961 -179.433 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.453 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 1.4 t80 -77.93 -64.05 1.25 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.336 0.588 . . . . 0.0 110.957 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.9 p -47.05 -48.41 8.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.727 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.61 ' N ' HG13 ' A' ' 27' ' ' VAL . 0.5 OUTLIER -80.32 -24.95 39.58 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.431 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 74.09 24.02 74.7 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.154 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.32 125.88 14.13 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.657 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.239 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.224 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 . . . . . 0 N--CA 1.45 -0.447 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -172.33 -179.0 2.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.318 0.58 . . . . 0.0 111.837 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.3 m -126.7 143.27 51.29 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.151 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.457 ' CE2' HD11 ' A' ' 24' ' ' ILE . 14.2 m-85 -129.15 165.66 20.85 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.945 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.515 HG23 ' HB2' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -143.03 152.23 41.68 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.322 0.582 . . . . 0.0 112.148 -178.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 tttp -156.47 113.14 3.09 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.868 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.9 mp -105.91 122.21 45.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.899 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.895 ' H ' HD12 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -144.77 165.43 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.672 -179.145 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.6 m -115.23 125.89 53.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.266 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.562 ' O ' HG13 ' A' ' 49' ' ' VAL . 8.0 p -120.61 117.25 52.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.885 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.512 ' CG ' HG22 ' A' ' 49' ' ' VAL . 0.9 OUTLIER 69.88 25.9 4.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 110.118 -179.17 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.38 -10.15 55.8 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -89.34 132.13 35.09 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -75.76 146.17 40.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.535 0.683 . . . . 0.0 111.203 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.559 ' CD1' HG12 ' A' ' 49' ' ' VAL . 5.1 m-85 -137.54 125.72 23.05 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.891 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.517 ' O ' ' ND1' ' A' ' 55' ' ' HIS . 1.3 t-80 -117.47 113.4 21.98 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.497 HD12 ' C ' ' A' ' 55' ' ' HIS . 9.5 mp -118.39 143.17 46.85 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.781 0.8 . . . . 0.0 111.822 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.806 ' C ' HD13 ' A' ' 58' ' ' LEU . 3.2 tt0 -140.44 120.52 13.73 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.047 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.973 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -115.85 154.33 29.89 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.331 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -130.89 144.15 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.267 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.41 102.93 7.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.449 -1.251 . . . . 0.0 108.306 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 121.38 0.61 . . . . 0.0 110.364 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 8' ' ' LYS . 45.2 pt . . . . . 0 N--CA 1.434 -1.265 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.27 18.25 0.95 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.477 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.425 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -147.55 166.43 28.69 Favored Glycine 0 CA--C 1.519 0.339 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.622 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.9 123.08 7.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.851 -0.675 . . . . 0.0 111.2 178.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.621 HG23 ' O ' ' A' ' 82' ' ' ILE . 9.6 tt -128.0 104.81 12.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.505 0.669 . . . . 0.0 109.296 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 1.008 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.53 122.17 40.28 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.144 -178.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.405 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.9 OUTLIER -96.47 118.22 42.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.376 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.467 ' CZ ' ' CA ' ' A' ' 118' ' ' GLY . 25.5 p90 -112.12 144.69 41.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.465 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.49 ' C ' ' H ' ' A' ' 88' ' ' THR . 1.5 p -86.94 135.7 33.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.844 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.564 HG21 ' N ' ' A' ' 124' ' ' HIS . 17.6 m -72.35 19.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.991 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.49 ' H ' ' C ' ' A' ' 86' ' ' SER . 5.5 t -136.65 -26.11 1.1 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.061 0.457 . . . . 0.0 112.099 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.545 ' C ' ' N ' ' A' ' 91' ' ' LYS . 18.3 t -93.14 93.74 8.45 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.095 -176.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 tp -60.45 -10.02 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.545 ' N ' ' C ' ' A' ' 89' ' ' SER . 15.6 mttp -75.48 -48.6 21.9 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 113.901 -1.5 . . . . 0.0 109.533 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.1 p -61.44 -30.92 70.88 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.906 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.446 ' CE2' HG21 ' A' ' 129' ' ' ILE . 0.6 OUTLIER -73.24 -51.75 16.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.125 -179.437 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -62.77 -43.78 97.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.701 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 91' ' ' LYS . 14.4 m -66.67 -34.51 70.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.084 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.8 mt -66.48 -36.08 76.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.591 -0.443 . . . . 0.0 109.904 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -70.07 -26.36 63.97 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.273 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.1 t -73.02 -67.03 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.895 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.423 HG23 ' N ' ' A' ' 100' ' ' HIS . 2.5 tt -43.11 -40.37 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.214 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.614 ' CE1' ' CD1' ' A' ' 141' ' ' TRP . 1.1 t-160 -58.45 -63.57 1.23 Allowed 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.385 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -38.36 -58.42 1.68 Allowed Glycine 0 CA--C 1.519 0.3 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 105' ' ' ASP . 34.8 tptt -61.71 -62.75 1.58 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.953 -0.623 . . . . 0.0 110.365 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.64 -55.0 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.429 0.633 . . . . 0.0 109.579 179.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.728 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -49.17 -46.24 45.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.275 178.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.874 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.726 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.458 ' HB3' HG23 ' A' ' 170' ' ' ILE . 23.0 mt-30 . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.592 0.234 . . . . 0.0 110.732 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.602 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.4 OUTLIER -138.3 148.2 58.62 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.098 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -48.7 114.59 1.28 Allowed 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 121.94 1.76 . . . . 0.0 112.824 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.513 ' HB ' ' HB2' ' A' ' 143' ' ' ALA . 2.2 mp -124.26 128.65 73.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.542 ' O ' HD12 ' A' ' 83' ' ' LEU . 10.7 tpt -130.36 114.32 15.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.912 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.4 mt -97.65 98.66 10.07 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.3 t -104.98 129.45 57.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.944 0.878 . . . . 0.0 111.461 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.467 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -96.07 117.12 5.6 Favored Glycine 0 C--N 1.311 -0.83 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.445 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 58.7 t30 -97.47 174.14 6.82 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.994 -177.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.445 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 6.1 mttp 59.91 58.75 2.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.939 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.46 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 18.1 tttm -56.27 -26.05 50.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.568 -178.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.405 ' OD2' ' CD1' ' A' ' 123' ' ' LEU . 3.9 p-10 -72.72 -13.31 61.31 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.084 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.8 mp -91.18 -30.92 16.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.606 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.1 OUTLIER -38.93 -25.04 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.171 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.606 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 11.2 mtt -45.65 -23.95 0.3 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.473 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -105.17 -40.46 5.86 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.495 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.488 ' CZ ' ' OE1' ' A' ' 147' ' ' GLU . 2.6 tpp85 27.9 86.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.766 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.1 t -59.41 -32.6 49.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.396 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.446 HG21 ' CE2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -88.29 153.04 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.531 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.501 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 78.3 p -96.89 121.94 39.32 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.304 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.411 ' HB2' HH12 ' A' ' 127' ' ' ARG . 13.8 t80 -37.01 -32.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.249 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.5 mp0 -70.51 -64.84 0.82 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.808 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.501 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 69.6 mt-10 -41.24 -42.52 2.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.724 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.15 -35.68 70.93 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 132' ' ' GLU . 4.2 tttt -61.97 -55.48 29.02 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.92 -35.72 69.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.821 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.644 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -66.27 -63.53 1.06 Allowed 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.85 -35.6 57.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.185 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -68.69 -32.35 72.11 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.173 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 p -63.24 -46.24 87.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.792 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.644 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 30.9 m95 -88.51 -5.12 58.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.982 0.42 . . . . 0.0 110.335 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 141' ' ' TRP . 0.9 OUTLIER 77.41 23.69 0.85 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.384 0.611 . . . . 0.0 109.52 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.29 167.37 13.6 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.869 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.432 ' HB3' ' SD ' ' A' ' 115' ' ' MET . . . -110.97 130.1 55.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.529 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -98.17 120.87 39.33 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.281 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.75 128.73 17.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.488 ' OE1' ' CZ ' ' A' ' 127' ' ' ARG . 6.4 mt-10 -100.28 119.76 38.89 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.043 0.449 . . . . 0.0 110.029 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 63.2 p -137.45 178.1 7.36 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.42 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.3 138.08 38.03 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.974 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -55.73 -49.82 72.01 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.143 0.497 . . . . 0.0 109.748 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.7 tttm -58.84 -3.12 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.284 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 150' ' ' ALA . 6.7 tt0 -127.35 110.92 13.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.421 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.515 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 7.7 t-20 -76.57 -47.21 23.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.684 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -41.3 -57.61 2.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.093 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.644 ' O ' HG23 ' A' ' 159' ' ' VAL . 78.0 p -52.74 -48.42 66.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.975 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.618 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -48.49 -60.56 2.59 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.516 0.674 . . . . 0.0 109.59 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 60.0 t -43.29 -49.58 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.088 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -53.76 -43.1 68.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.553 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 155' ' ' THR . 3.2 t -68.16 -44.12 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.304 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.758 ' CE1' HD11 ' A' ' 164' ' ' ILE . 9.7 t80 -53.72 -40.48 66.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.168 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.3 ttt85 -77.09 -42.12 39.45 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.156 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -60.26 -34.44 73.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.189 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 160' ' ' PHE . 10.3 tt -70.73 -47.16 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 119.281 -0.968 . . . . 0.0 110.79 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.758 HD11 ' CE1' ' A' ' 160' ' ' PHE . 85.5 mt -54.62 -32.07 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.289 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.404 ' HA ' HD13 ' A' ' 165' ' ' LEU . 0.4 OUTLIER -63.21 -64.68 0.84 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.206 -179.419 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -60.01 -29.67 68.64 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.493 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.454 ' HB1' ' NH1' ' A' ' 7' ' ' ARG . . . -61.33 -30.97 70.84 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.417 ' OE2' ' OH ' ' A' ' 54' ' ' TYR . 3.7 tp10 -68.06 -54.34 18.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.177 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -60.9 -61.09 2.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.884 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.602 HG21 ' C ' ' A' ' 112' ' ' ILE . 74.2 mt -50.06 -36.96 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.814 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -70.86 -40.07 72.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.808 0.337 . . . . 0.0 110.605 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -55.16 -41.52 78.81 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.654 -0.979 . . . . 0.0 110.654 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.05 -61.99 1.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.756 0.313 . . . . 0.0 110.621 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.932 -179.832 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 121.212 0.53 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.22 136.05 34.58 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.489 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.543 ' HB2' HG22 ' A' ' 78' ' ' ILE . 1.9 mptt -106.16 132.28 52.41 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.776 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.1 mm -104.45 124.75 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-O 121.333 0.587 . . . . 0.0 110.242 -178.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.475 ' HB2' ' CD1' ' A' ' 78' ' ' ILE . . . -83.83 133.54 34.75 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.084 -1.01 . . . . 0.0 110.931 -177.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 58' ' ' LEU . 14.8 mt -95.56 133.72 35.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.657 0.741 . . . . 0.0 112.33 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.55 104.91 6.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.877 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -140.98 135.95 7.25 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.467 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -54.09 -158.18 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.769 0.795 . . . . 0.0 111.042 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -95.99 132.75 40.99 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.882 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.8 m 59.14 19.1 7.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.159 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.537 ' O ' HG22 ' A' ' 17' ' ' VAL . 2.5 p -80.48 -10.76 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.801 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.42 7.66 51.23 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.414 ' HE3' ' H ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -40.05 -59.26 1.26 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.118 0.485 . . . . 0.0 110.353 179.565 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -67.75 -26.97 66.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.449 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.0 m -64.39 -50.56 67.17 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.017 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.9 tp -75.83 -26.35 57.1 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.42 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.492 ' O ' HG12 ' A' ' 27' ' ' VAL . 55.5 m -58.15 -50.9 71.89 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.4 mp -60.6 -43.73 95.28 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.406 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.541 ' OE1' ' N ' ' A' ' 31' ' ' PHE . 6.4 tt0 -69.69 -25.62 63.96 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.21 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -77.32 -49.94 13.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.246 0.546 . . . . 0.0 110.822 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.591 HG13 ' N ' ' A' ' 28' ' ' GLU . 11.8 p -68.77 -45.1 81.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.139 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.591 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.8 tt0 -81.4 -24.94 36.61 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.466 ' O ' ' ND2' ' A' ' 153' ' ' ASN . . . 77.68 19.25 76.16 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.974 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.539 ' NE2' ' O ' ' A' ' 31' ' ' PHE . 16.8 tp60 -149.0 135.97 19.86 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.301 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.541 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 1.0 OUTLIER . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.567 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -161.97 -178.99 6.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.645 0.736 . . . . 0.0 112.95 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.2 m -137.43 144.3 42.28 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.11 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 12.3 m-85 -127.44 163.65 23.61 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.496 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.528 HG23 ' HB2' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -144.22 150.75 38.47 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.396 0.617 . . . . 0.0 112.661 -178.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.0 118.69 2.73 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.771 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.6 mp -105.82 129.3 54.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.654 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.444 HD12 ' HE2' ' A' ' 160' ' ' PHE . 1.0 OUTLIER -147.65 165.83 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.798 -179.095 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.4 m -115.79 126.4 53.97 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.197 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.594 HG12 ' CD1' ' A' ' 54' ' ' TYR . 7.2 p -121.28 118.95 57.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.94 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 71.27 17.36 5.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.12 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.37 -11.58 70.82 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -89.28 133.88 34.28 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.25 144.1 42.74 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.622 0.725 . . . . 0.0 111.163 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.594 ' CD1' HG12 ' A' ' 49' ' ' VAL . 6.6 m-85 -136.47 127.87 28.44 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.664 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.525 ' O ' ' ND1' ' A' ' 55' ' ' HIS . 1.2 t-80 -117.07 114.39 23.67 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.449 HD12 ' C ' ' A' ' 55' ' ' HIS . 8.4 mp -117.69 143.72 45.92 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 122.078 0.942 . . . . 0.0 112.244 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.772 ' C ' HD13 ' A' ' 58' ' ' LEU . 3.0 tt0 -140.91 121.68 14.38 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 113.702 -1.59 . . . . 0.0 109.725 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.946 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -115.86 154.09 30.33 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.528 0.68 . . . . 0.0 112.347 -178.403 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.02 145.09 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-N 114.532 -1.213 . . . . 0.0 113.172 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.88 102.91 8.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.201 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.5 p . . . . . 0 N--CA 1.446 -0.661 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.07 -179.547 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.543 HG22 ' HB2' ' A' ' 8' ' ' LYS . 37.6 pt . . . . . 0 N--CA 1.438 -1.044 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.69 16.34 0.88 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.449 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -145.07 166.79 27.45 Favored Glycine 0 CA--C 1.519 0.319 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.317 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.82 122.5 7.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.911 -0.645 . . . . 0.0 111.28 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.698 HG23 ' O ' ' A' ' 82' ' ' ILE . 12.2 tt -127.55 101.04 6.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.562 0.696 . . . . 0.0 109.138 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.968 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -96.86 123.44 40.56 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.376 -178.52 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -96.84 119.67 45.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.97 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.635 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 32.1 p90 -121.64 144.72 48.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.675 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.7 p -87.82 143.28 27.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.735 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.59 HG21 ' N ' ' A' ' 124' ' ' HIS . 15.8 m -80.67 20.32 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.778 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.609 ' HB ' HD23 ' A' ' 123' ' ' LEU . 0.7 OUTLIER -131.05 -27.82 2.01 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.119 0.485 . . . . 0.0 111.936 -178.101 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.543 ' C ' ' N ' ' A' ' 91' ' ' LYS . 44.2 t -97.08 93.94 6.87 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.674 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 tp -58.58 -10.75 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.567 ' O ' HG22 ' A' ' 95' ' ' VAL . 2.6 mtpt -76.07 -50.82 13.7 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.052 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.477 ' O ' ' CG1' ' A' ' 96' ' ' ILE . 59.1 p -60.34 -31.88 70.73 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.01 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -75.56 -46.17 33.55 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.081 -179.337 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -66.02 -44.1 85.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.25 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 91' ' ' LYS . 16.4 m -68.17 -39.8 81.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.621 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.494 ' N ' HG23 ' A' ' 95' ' ' VAL . 1.4 mm -59.18 -42.45 86.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.289 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.49 -27.25 64.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.305 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.0 t -75.55 -66.97 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.166 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.6 mm -41.84 -45.49 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.043 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.443 ' ND1' ' C ' ' A' ' 100' ' ' HIS . 9.7 t-80 -56.53 -63.51 1.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.691 -0.403 . . . . 0.0 109.985 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -40.63 -58.57 2.54 Favored Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 103' ' ' LEU . 14.0 tptp -55.8 -66.09 0.48 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.037 -0.582 . . . . 0.0 110.249 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.45 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.98 -59.84 0.8 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.275 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.728 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -46.06 -47.72 17.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.577 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.439 ' N ' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.313 -0.988 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.998 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 . . . . . 0 CA--C 1.52 -0.174 0 CA-C-O 120.941 0.401 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.635 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.7 OUTLIER -119.55 155.74 54.06 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.023 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -47.43 106.01 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.529 1.486 . . . . 0.0 112.335 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.454 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.8 mt -119.8 128.56 75.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.564 ' O ' HD12 ' A' ' 83' ' ' LEU . 10.1 tpt -127.25 116.83 21.18 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.789 -178.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 mt -96.02 97.25 9.45 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.5 t -103.72 133.19 48.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 122.406 1.098 . . . . 0.0 110.371 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.79 113.07 4.11 Favored Glycine 0 C--N 1.299 -1.509 0 CA-C-N 113.265 -1.789 . . . . 0.0 109.032 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.509 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 48.5 t30 -96.88 177.22 5.7 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.279 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.509 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 26.8 mttp 61.96 58.35 1.92 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.016 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.46 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 15.7 tttm -63.48 -31.27 72.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.495 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -63.58 -8.92 11.03 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.003 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.609 HD23 ' HB ' ' A' ' 88' ' ' THR . 8.6 mp -93.67 -27.0 16.8 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.59 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -39.3 -24.47 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.858 178.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.59 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 2.7 mmt -46.12 -22.27 0.21 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.473 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.3 OUTLIER -106.67 -36.54 6.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.063 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.492 ' NH2' ' CD2' ' A' ' 131' ' ' TYR . 0.1 OUTLIER 33.11 88.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.851 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.6 t -72.05 -38.05 62.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.553 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 tp -89.92 155.63 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.427 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.484 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 62.0 p -103.03 125.44 49.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.949 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.492 ' CD2' ' NH2' ' A' ' 127' ' ' ARG . 0.8 OUTLIER -37.32 -35.91 0.13 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.574 179.13 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.6 mp0 -67.16 -64.75 0.79 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.054 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.484 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 64.6 mt-10 -41.21 -41.52 1.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.979 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.83 -36.3 65.91 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 132' ' ' GLU . 3.6 ttpp -61.69 -55.15 33.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.048 -0.576 . . . . 0.0 109.587 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.69 70.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.865 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.518 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -66.23 -61.66 1.9 Allowed 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.658 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -53.41 -35.78 60.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.34 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -68.85 -29.94 68.37 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.43 -46.65 82.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.715 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.518 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 33.0 m95 -89.35 -4.25 58.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.027 0.442 . . . . 0.0 110.194 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.409 ' O ' ' OE1' ' A' ' 166' ' ' GLU . 0.9 OUTLIER 76.52 22.46 1.22 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.403 -179.084 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -89.29 170.9 10.18 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.595 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.409 ' HB3' ' SD ' ' A' ' 115' ' ' MET . . . -109.65 134.75 51.59 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.428 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.627 ' O ' HD22 ' A' ' 146' ' ' LEU . 7.0 t80 -96.66 122.36 39.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.929 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.782 HD12 HG22 ' A' ' 159' ' ' VAL . 1.2 mm? -133.17 137.7 46.32 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.346 -176.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.456 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 9.1 tt0 -127.38 110.64 13.01 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 36.3 p -136.56 -172.81 3.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.21 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.68 139.57 40.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.716 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.525 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -64.84 -30.97 72.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.287 0.565 . . . . 0.0 109.97 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -79.78 13.65 2.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.029 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -144.19 121.03 11.27 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.745 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 9.5 t-20 -77.59 -54.51 6.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.408 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 153' ' ' ASN . 7.6 tt0 -37.09 -55.33 0.96 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.823 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 159' ' ' VAL . 60.2 p -57.01 -50.73 71.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.275 0.559 . . . . 0.0 110.158 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -47.68 -59.96 2.9 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.561 0.696 . . . . 0.0 109.574 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.9 t -41.28 -53.35 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.626 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -48.94 -33.1 10.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.733 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.782 HG22 HD12 ' A' ' 146' ' ' LEU . 10.3 t -76.55 -28.54 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.608 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -68.55 -40.71 80.55 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.727 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.507 ' N ' ' CD1' ' A' ' 160' ' ' PHE . 27.6 ttm-85 -79.6 -50.57 10.48 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.196 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -54.53 -36.92 64.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.226 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.627 HG23 ' N ' ' A' ' 164' ' ' ILE . 11.9 tt -69.01 -58.25 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.322 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.627 ' N ' HG23 ' A' ' 163' ' ' ILE . 84.1 mt -46.68 -33.02 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.91 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.25 -64.62 0.87 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.295 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.409 ' OE1' ' O ' ' A' ' 142' ' ' ASN . 3.2 mm-40 -61.21 -26.47 67.75 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.454 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -58.1 -36.8 73.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.419 ' OE2' ' OH ' ' A' ' 54' ' ' TYR . 11.5 mm-40 -69.73 -52.06 28.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.273 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -54.59 -60.22 3.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.515 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.635 HG21 ' C ' ' A' ' 112' ' ' ILE . 71.2 mt -50.0 -35.2 10.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.764 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.17 -39.92 90.13 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -60.4 -32.13 76.37 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.0 -76.59 0.09 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.168 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.061 179.871 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 121.166 0.508 . . . . 0.0 110.369 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.413 ' NH1' ' HB1' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -139.8 135.73 33.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.579 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.426 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 18.3 mttt -107.58 128.33 54.43 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.762 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -101.97 121.66 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-O 121.535 0.684 . . . . 0.0 110.351 -178.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.99 135.55 34.4 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 121.426 -0.796 . . . . 0.0 111.062 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.8 mt -95.57 131.39 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.458 0.647 . . . . 0.0 112.226 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.632 ' C ' HD23 ' A' ' 12' ' ' LEU . 6.3 tt -130.58 103.67 6.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.215 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.08 135.32 6.84 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.734 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.478 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -53.72 -160.82 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.366 0.603 . . . . 0.0 110.535 179.168 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.404 ' NE ' ' OG ' ' A' ' 16' ' ' SER . 10.1 ttp180 -96.14 135.94 37.27 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.86 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.404 ' OG ' ' NE ' ' A' ' 15' ' ' ARG . 5.1 m 60.08 19.34 8.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.574 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.477 ' C ' ' HZ2' ' A' ' 120' ' ' LYS . 3.6 p -76.69 -19.75 14.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.737 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.34 21.63 26.67 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.531 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.7 pttm -68.17 -33.97 75.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.928 0.394 . . . . 0.0 110.016 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.7 m -73.16 -38.75 66.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.532 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.8 p -62.16 -40.4 95.86 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.402 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.7 tp -77.75 -25.44 49.17 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.26 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.564 ' O ' HG12 ' A' ' 27' ' ' VAL . 58.4 m -63.67 -38.24 90.39 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.4 mp -74.92 -38.54 43.69 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.214 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.56 ' OE1' ' N ' ' A' ' 31' ' ' PHE . 5.9 tt0 -75.04 -25.48 58.72 Favored 'General case' 0 C--O 1.217 -0.618 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.154 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 23.1 t80 -76.59 -52.82 8.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.29 0.567 . . . . 0.0 110.766 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.593 HG13 ' N ' ' A' ' 28' ' ' GLU . 11.3 p -62.28 -45.96 97.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.906 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.593 ' N ' HG13 ' A' ' 27' ' ' VAL . 1.1 tm-20 -82.22 -24.54 34.81 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.466 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 77.24 18.01 78.79 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.799 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -146.68 134.19 20.89 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.56 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.47 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.428 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 2.3 pm0 . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.682 0.277 . . . . 0.0 110.381 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER 176.44 179.79 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.332 0.587 . . . . 0.0 111.962 -179.31 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.514 HG23 HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -107.69 140.49 40.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.666 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.418 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 12.1 m-85 -127.9 163.53 24.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.638 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -143.6 155.8 44.39 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.295 0.569 . . . . 0.0 112.363 -178.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.465 ' HD2' HD11 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -160.97 111.68 1.76 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.899 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 46' ' ' LEU . 8.1 mp -105.1 127.1 52.74 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.793 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.81 HD12 ' CZ ' ' A' ' 160' ' ' PHE . 0.9 OUTLIER -148.85 165.6 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.5 179.338 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.2 m -114.66 126.51 54.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.557 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.594 HG21 HG21 ' A' ' 164' ' ' ILE . 7.4 p -123.4 135.04 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.842 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.517 ' CG ' HG22 ' A' ' 49' ' ' VAL . 2.8 m120 62.6 3.97 1.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.029 0.442 . . . . 0.0 109.829 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 102.69 -13.23 56.52 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.458 ' NE2' ' H ' ' A' ' 53' ' ' GLU . 43.9 tp60 -90.29 140.37 29.76 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.458 ' H ' ' NE2' ' A' ' 52' ' ' GLN . 3.4 mt-10 -77.09 147.23 36.77 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.525 0.679 . . . . 0.0 111.303 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.552 ' CD1' HG12 ' A' ' 49' ' ' VAL . 13.9 m-85 -139.76 123.04 17.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.799 -1.092 . . . . 0.0 109.911 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.626 ' C ' HD12 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -117.48 113.79 22.54 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.626 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.9 mp -118.84 145.9 45.3 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.641 0.734 . . . . 0.0 112.143 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.811 ' C ' HD13 ' A' ' 58' ' ' LEU . 12.4 tt0 -139.18 124.09 18.74 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.053 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.939 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.96 154.99 29.9 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.279 0.561 . . . . 0.0 112.463 -178.248 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.514 HG23 HG23 ' A' ' 42' ' ' THR . 0.3 OUTLIER -133.96 144.41 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.779 -179.495 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.35 104.37 8.14 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.831 177.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.47 0 CA-C-O 121.128 0.489 . . . . 0.0 110.511 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.428 HD12 ' O ' ' A' ' 80' ' ' GLY . 40.6 pt . . . . . 0 N--CA 1.439 -1.008 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.24 16.33 0.93 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.144 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.428 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -148.02 166.47 28.91 Favored Glycine 0 CA--C 1.516 0.152 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.73 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.98 123.17 7.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.711 -0.744 . . . . 0.0 111.481 178.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.624 HG23 ' O ' ' A' ' 82' ' ' ILE . 10.8 tt -127.07 104.24 12.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.628 0.728 . . . . 0.0 109.064 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.989 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.32 123.29 41.09 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.784 -178.332 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -96.65 118.13 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.468 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.556 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 27.9 p90 -120.28 144.52 47.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.581 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.482 ' HG ' ' H ' ' A' ' 89' ' ' SER . 4.8 p -87.89 142.15 28.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.499 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.562 HG21 ' N ' ' A' ' 124' ' ' HIS . 16.5 m -76.15 18.7 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.245 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.551 ' HB ' HD23 ' A' ' 123' ' ' LEU . 0.7 OUTLIER -133.18 -23.38 1.94 Allowed 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.063 0.459 . . . . 0.0 111.752 -178.342 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.54 ' C ' ' N ' ' A' ' 91' ' ' LYS . 22.7 t -93.71 93.47 8.03 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.96 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 tp -59.69 -11.76 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.648 ' O ' HG22 ' A' ' 95' ' ' VAL . 9.3 mttp -78.07 -51.23 10.62 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.458 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.0 p -56.48 -34.91 67.37 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.374 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.556 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.5 OUTLIER -70.8 -54.85 10.09 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.415 -179.278 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -63.0 -44.41 96.1 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.648 HG22 ' O ' ' A' ' 91' ' ' LYS . 17.7 m -64.79 -34.4 69.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.034 -0.667 . . . . 0.0 110.186 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.441 ' CG1' HD22 ' A' ' 12' ' ' LEU . 1.8 mt -65.2 -35.61 75.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.087 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.0 tttp -69.97 -27.56 64.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.546 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.8 t -76.95 -67.27 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.281 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.6 mp -43.41 -45.31 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.4 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.402 ' CE1' ' CE2' ' A' ' 141' ' ' TRP . 6.6 t-80 -60.09 -58.36 8.88 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.504 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.68 -57.7 1.52 Allowed Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.866 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 105' ' ' ASP . 10.9 tptm -58.68 -66.65 0.46 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.274 -0.463 . . . . 0.0 110.574 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.7 OUTLIER -37.05 -62.25 0.51 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.72 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -42.86 -47.92 5.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.359 178.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.79 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.258 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 120.848 0.356 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.43 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -112.81 150.36 42.67 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.408 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -48.55 107.54 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.707 1.604 . . . . 0.0 112.857 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.458 ' HB ' ' HB2' ' A' ' 143' ' ' ALA . 2.9 mt -120.61 126.5 75.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.48 ' O ' HD12 ' A' ' 83' ' ' LEU . 8.3 tpt -126.47 115.28 19.33 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.237 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.3 mt -96.02 97.82 9.89 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.58 132.56 49.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 122.135 0.969 . . . . 0.0 110.574 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.75 109.47 3.2 Favored Glycine 0 C--N 1.304 -1.239 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.475 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.6 t30 -97.24 175.62 6.21 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.182 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.477 ' HZ2' ' C ' ' A' ' 17' ' ' VAL . 2.9 mttp 66.25 59.54 0.66 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 122.026 0.917 . . . . 0.0 109.291 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.509 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 19.2 tttm -63.77 -37.88 89.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.053 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -60.45 -5.61 1.25 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.783 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.551 HD23 ' HB ' ' A' ' 88' ' ' THR . 8.2 mp -91.95 -26.88 18.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.562 ' N ' HG21 ' A' ' 87' ' ' VAL . 13.2 p-80 -38.97 -24.97 0.01 OUTLIER 'General case' 0 C--N 1.339 0.124 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.719 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.536 ' N ' ' O ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -46.51 -22.89 0.31 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.293 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.479 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -110.38 -37.55 5.48 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.666 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.474 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 0.1 OUTLIER 29.65 91.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.886 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 46.1 t -72.37 -36.75 56.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.193 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.7 tp -89.57 154.74 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.634 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.494 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 99.5 p -101.55 127.24 48.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.742 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -40.63 -34.0 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.988 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -68.51 -65.42 0.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.988 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.494 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 63.6 mt-10 -41.38 -41.61 2.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.933 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.06 -34.7 64.72 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 132' ' ' GLU . 3.2 tttm -63.96 -55.27 23.72 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.28 -35.34 67.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.68 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.48 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -65.54 -62.09 1.72 Allowed 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -53.12 -38.41 62.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.226 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -33.28 75.51 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.736 0.303 . . . . 0.0 110.245 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.8 -46.11 86.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.828 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.48 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 42.2 m95 -89.09 1.04 56.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.695 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 6.5 m120 68.38 32.92 4.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.652 0.739 . . . . 0.0 109.58 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -100.84 169.04 9.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.862 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.14 133.79 51.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.305 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.699 ' O ' HD22 ' A' ' 146' ' ' LEU . 5.2 t80 -96.9 123.39 40.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.814 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.699 HD22 ' O ' ' A' ' 145' ' ' PHE . 1.3 mm? -134.74 137.14 43.2 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.862 -176.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.474 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 6.2 tt0 -126.39 111.17 14.16 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 34.7 p -137.15 -173.85 3.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.134 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.0 136.09 34.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.919 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.517 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -63.79 -26.73 68.76 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.25 4.37 12.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.723 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -138.85 122.6 17.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.11 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 154' ' ' GLN . 4.8 t-20 -77.42 -55.48 5.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.614 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 153' ' ' ASN . 10.2 tt0 -36.91 -56.03 0.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.96 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.617 ' O ' HG23 ' A' ' 159' ' ' VAL . 67.6 p -55.59 -46.12 77.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.021 0.439 . . . . 0.0 110.297 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -54.53 -62.08 1.89 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.952 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 61.5 t -43.0 -39.94 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.435 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.77 -33.11 75.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.59 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.691 HG22 HD12 ' A' ' 146' ' ' LEU . 32.4 t -70.72 -35.38 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.954 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.81 ' CZ ' HD12 ' A' ' 47' ' ' ILE . 23.5 t80 -64.32 -65.69 0.64 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.561 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.582 HH22 HG23 ' A' ' 49' ' ' VAL . 9.1 ttm-85 -48.41 -43.33 34.03 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.759 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.574 ' HE ' HD21 ' A' ' 146' ' ' LEU . 11.4 mmm180 -58.51 -33.37 69.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.456 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -66.27 -34.29 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.917 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.78 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 11.1 mt -63.5 -48.18 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.267 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -55.47 -59.93 4.13 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.552 179.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.476 ' H ' HD23 ' A' ' 165' ' ' LEU . 4.5 tt0 -51.31 -24.03 4.2 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.78 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -71.34 -31.14 67.03 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.935 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 165' ' ' LEU . 0.4 OUTLIER -70.74 -54.72 10.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.886 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -60.05 -50.23 74.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.068 0.461 . . . . 0.0 110.565 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.466 ' CG1' ' O ' ' A' ' 166' ' ' GLU . 3.1 mm -49.64 -42.98 18.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.966 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -66.29 -39.76 89.57 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.339 -179.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.37 -41.94 55.91 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.14 -79.88 0.06 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.754 0.312 . . . . 0.0 110.474 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.022 -179.904 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.171 0.51 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.97 135.64 32.96 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.647 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.518 ' HB2' HG22 ' A' ' 78' ' ' ILE . 17.0 mttt -107.21 128.53 54.5 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.784 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -102.3 122.97 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 121.507 0.67 . . . . 0.0 110.469 -178.511 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.481 ' HB2' ' CD1' ' A' ' 78' ' ' ILE . . . -83.9 134.27 34.69 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.373 -0.83 . . . . 0.0 111.606 -177.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.6 mt -95.44 130.16 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.523 0.678 . . . . 0.0 112.14 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.604 ' C ' HD23 ' A' ' 12' ' ' LEU . 5.1 tt -127.91 102.55 6.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.54 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.12 136.45 7.53 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.485 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -51.94 -161.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.676 0.751 . . . . 0.0 111.321 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -94.14 131.79 39.32 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.666 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.452 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 4.1 m 60.54 20.09 9.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.472 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 p -74.7 -19.59 16.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.606 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.413 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 98.13 20.17 21.56 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.472 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.1 pttm -69.2 -34.81 75.48 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.318 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.9 m -73.45 -30.39 63.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.419 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 65.5 p -67.8 -40.86 83.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.409 ' O ' ' CB ' ' A' ' 26' ' ' PHE . 46.1 tp -77.5 -26.49 51.27 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.759 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.623 ' O ' HG12 ' A' ' 27' ' ' VAL . 57.5 m -62.77 -41.51 99.27 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.59 -41.6 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.606 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.535 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -71.88 -27.29 62.76 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.663 -179.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.409 ' CB ' ' O ' ' A' ' 22' ' ' LEU . 52.8 t80 -77.94 -62.05 1.8 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.303 0.573 . . . . 0.0 110.691 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.623 HG12 ' O ' ' A' ' 23' ' ' THR . 11.8 p -48.09 -48.9 12.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.804 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.612 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.4 mt-10 -80.42 -24.3 39.74 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.451 ' O ' ' ND2' ' A' ' 153' ' ' ASN . . . 72.76 25.47 73.86 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -150.29 126.63 10.73 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.732 0.301 . . . . 0.0 111.338 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.614 ' O ' ' CD1' ' A' ' 31' ' ' PHE . 0.1 OUTLIER . . . . . 0 CA--C 1.536 0.424 0 CA-C-O 122.02 0.915 . . . . 0.0 110.691 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -164.19 -176.69 4.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.236 0.541 . . . . 0.0 111.982 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.411 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 4.0 m -133.14 152.77 51.93 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.13 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.455 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 11.9 m-85 -133.17 162.94 30.42 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 111.008 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.61 152.34 43.91 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.537 0.684 . . . . 0.0 112.487 -179.223 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.591 ' C ' HD12 ' A' ' 46' ' ' LEU . 25.8 tttp -157.11 111.01 2.64 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.407 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.718 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.2 mp -105.2 127.28 52.85 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.491 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.484 HD12 ' CE1' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -148.61 165.13 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.708 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.4 m -114.61 126.67 55.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.924 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.701 HG11 HG21 ' A' ' 164' ' ' ILE . 1.5 p -124.95 123.35 65.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.819 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 70.95 19.79 5.56 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.91 -9.77 62.09 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -90.91 134.93 34.08 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.01 145.5 40.19 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.561 0.696 . . . . 0.0 111.058 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.404 ' OH ' ' OE1' ' A' ' 168' ' ' GLU . 9.3 m-85 -139.44 125.14 19.47 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.778 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.605 ' C ' HD22 ' A' ' 56' ' ' LEU . 1.2 m-70 -117.44 113.65 22.36 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.703 HD22 ' N ' ' A' ' 56' ' ' LEU . 2.1 mm? -119.23 140.0 50.95 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 121.509 0.671 . . . . 0.0 111.629 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.828 ' C ' HD13 ' A' ' 58' ' ' LEU . 1.1 mt-30 -136.76 124.98 23.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.777 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.984 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.13 148.86 39.87 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.916 -178.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -118.49 141.5 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 114.998 -1.001 . . . . 0.0 113.165 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -114.42 101.65 9.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.333 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.473 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.518 HG22 ' HB2' ' A' ' 8' ' ' LYS . 35.7 pt . . . . . 0 N--CA 1.437 -1.124 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.41 14.27 0.98 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.578 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -142.29 165.79 26.59 Favored Glycine 0 N--CA 1.454 -0.114 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.179 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.407 ' CD1' ' HB3' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -151.82 122.41 7.4 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.767 -0.717 . . . . 0.0 111.205 178.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.628 HG23 ' O ' ' A' ' 82' ' ' ILE . 11.3 tt -125.28 103.83 12.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.973 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -96.32 126.73 41.73 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.407 -177.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.447 ' O ' HG12 ' A' ' 84' ' ' VAL . 2.0 t -96.07 113.68 31.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.43 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -110.37 146.05 36.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.734 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.558 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.0 OUTLIER -100.55 143.48 30.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.077 0.465 . . . . 0.0 111.881 -177.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.575 HG21 ' N ' ' A' ' 124' ' ' HIS . 17.3 m -81.15 21.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.633 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.407 ' HB ' HD23 ' A' ' 123' ' ' LEU . 1.0 OUTLIER -140.55 -17.76 0.88 Allowed 'General case' 0 C--O 1.231 0.097 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.558 ' H ' ' HG ' ' A' ' 86' ' ' SER . 43.8 t -112.7 93.46 4.44 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 94' ' ' GLU . 30.5 mm -50.84 -15.6 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.793 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.4 OUTLIER -78.31 -49.14 14.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.244 179.287 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.7 p -59.74 -44.6 93.74 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.517 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -79.3 -34.02 42.79 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 119.354 -0.939 . . . . 0.0 112.533 -178.126 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.416 ' HG3' HG22 ' A' ' 90' ' ' ILE . 8.9 mm-40 -69.84 -44.98 68.8 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.15 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 91' ' ' LYS . 28.1 m -64.99 -37.37 80.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.645 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.405 ' N ' HG23 ' A' ' 95' ' ' VAL . 1.3 mt -61.74 -36.03 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -70.1 -25.79 63.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.333 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.5 t -76.1 -67.22 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.5 mp -42.81 -40.68 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.616 ' NE2' ' CD1' ' A' ' 141' ' ' TRP . 25.7 t-80 -60.32 -63.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.673 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.82 -50.6 2.0 Favored Glycine 0 CA--C 1.518 0.267 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 105' ' ' ASP . 12.7 tptm -66.03 -65.79 0.63 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.273 -0.464 . . . . 0.0 110.106 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.36 -58.75 0.81 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.749 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -47.0 -43.82 19.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.677 178.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.838 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.374 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.563 ' OE1' ' HB1' ' A' ' 173' ' ' ALA . 8.6 mt-30 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.657 0.265 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.667 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.2 OUTLIER -132.06 155.78 80.92 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.308 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -48.69 107.43 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.689 1.593 . . . . 0.0 112.174 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.6 mt -123.84 129.18 74.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.508 ' O ' HD12 ' A' ' 83' ' ' LEU . 8.7 tpt -128.85 117.42 21.01 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.329 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.1 mt -97.34 97.59 9.26 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.7 t -104.45 134.22 46.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 122.196 0.998 . . . . 0.0 110.958 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -104.88 116.44 5.29 Favored Glycine 0 C--N 1.302 -1.313 0 CA-C-N 113.699 -1.592 . . . . 0.0 109.234 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.487 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 50.1 t30 -98.0 173.87 6.84 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.718 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.487 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 25.5 mttt 61.17 58.67 2.16 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.624 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.527 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -60.2 -35.24 74.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.282 -179.168 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -61.15 -13.63 19.11 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.488 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 125' ' ' MET . 9.8 mp -88.1 -31.37 19.25 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.575 ' N ' HG21 ' A' ' 87' ' ' VAL . 2.5 p-80 -37.67 -26.46 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.976 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.536 ' N ' ' O ' ' A' ' 123' ' ' LEU . 6.9 mmt -43.93 -24.64 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.454 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.3 OUTLIER -103.23 -34.94 8.63 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.815 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.458 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 1.6 tpt180 38.39 92.82 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.23 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.535 HG22 ' C ' ' A' ' 87' ' ' VAL . 19.6 m -85.4 -35.43 9.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.312 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -89.48 130.0 39.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.159 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.408 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 92.4 p -77.1 122.19 24.62 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.946 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -40.56 -38.38 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.322 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -60.98 -64.21 1.03 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.011 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.408 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 64.2 mt-10 -41.11 -49.91 3.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.179 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.33 -25.72 74.56 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 132' ' ' GLU . 13.1 tttm -71.26 -55.98 6.98 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -55.95 -33.01 64.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.296 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.652 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -66.53 -62.97 1.18 Allowed 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.807 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -53.65 -36.89 62.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.312 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -69.56 -30.29 68.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.474 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.526 ' OG ' ' CD2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -63.63 -47.15 82.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.02 -178.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.652 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 8.4 m95 -91.52 -5.27 54.41 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.355 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 141' ' ' TRP . 0.9 OUTLIER 77.45 26.01 0.71 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.779 -179.271 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.45 170.11 11.19 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.218 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.19 133.39 50.03 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.906 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.64 ' O ' HD22 ' A' ' 146' ' ' LEU . 6.5 t80 -97.06 122.96 40.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.767 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.895 HD12 HG22 ' A' ' 159' ' ' VAL . 1.2 mm? -133.12 138.81 46.8 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.939 -176.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.458 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 4.9 tt0 -127.5 110.01 12.31 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.518 ' OG ' HG21 ' A' ' 159' ' ' VAL . 0.1 OUTLIER -136.37 -178.38 5.14 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.676 -178.014 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 152' ' ' GLU . 0.0 OUTLIER -138.77 132.79 31.24 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.39 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.479 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -54.41 -53.07 59.0 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.112 0.482 . . . . 0.0 109.843 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -51.28 -8.74 0.05 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.938 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.479 ' H ' ' C ' ' A' ' 150' ' ' ALA . 18.7 mt-10 -131.4 119.2 21.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.978 0.418 . . . . 0.0 110.657 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.454 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 10.2 t-20 -75.35 -48.25 23.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.195 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 153' ' ' ASN . 0.5 OUTLIER -36.71 -59.48 0.67 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.023 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.5 p -54.43 -46.64 73.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.169 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.535 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -51.45 -59.4 4.28 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.524 0.678 . . . . 0.0 109.584 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 50.5 t -42.36 -48.43 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.67 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -54.02 -33.07 56.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.525 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.895 HG22 HD12 ' A' ' 146' ' ' LEU . 11.6 t -77.06 -27.67 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.982 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.484 ' CE1' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -68.64 -41.63 79.13 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.5 179.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.7 ttm-85 -79.86 -49.98 11.16 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.961 -0.695 . . . . 0.0 110.928 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -53.47 -37.88 63.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.31 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 159' ' ' VAL . 13.0 tt -68.39 -56.7 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.403 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.701 HG21 HG11 ' A' ' 49' ' ' VAL . 84.7 mt -47.9 -33.87 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.975 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.8 -64.42 0.95 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.059 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -58.53 -28.57 65.59 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.532 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -59.56 -33.53 71.53 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.404 ' OE1' ' OH ' ' A' ' 54' ' ' TYR . 33.5 tp10 -68.73 -57.15 6.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.329 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 13.2 tttm -52.49 -56.72 13.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.636 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.667 HG21 ' C ' ' A' ' 112' ' ' ILE . 66.3 mt -52.84 -34.2 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.137 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 172' ' ' GLY . 0.0 OUTLIER -68.9 -40.45 79.14 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.611 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.414 ' N ' ' OD1' ' A' ' 171' ' ' ASP . . . -60.3 -35.83 89.3 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.563 ' HB1' ' OE1' ' A' ' 111' ' ' GLN . . . -68.07 -60.77 2.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.803 0.335 . . . . 0.0 110.494 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.792 179.964 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 121.174 0.512 . . . . 0.0 110.445 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.84 136.39 33.95 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.611 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.435 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 4.0 mptt -106.66 121.28 44.03 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.551 HD11 HD12 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -98.95 117.2 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-O 121.824 0.821 . . . . 0.0 110.027 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.82 136.23 34.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.096 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.5 mt -95.27 132.81 38.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.23 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.645 ' C ' HD23 ' A' ' 12' ' ' LEU . 6.3 tt -127.65 104.05 7.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.392 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.39 134.87 6.51 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.691 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.446 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -55.05 -159.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.3 0.571 . . . . 0.0 110.582 179.187 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -92.61 133.28 36.12 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.952 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.454 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 7.7 m 56.58 19.46 4.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.546 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.415 ' H ' HG12 ' A' ' 17' ' ' VAL . 2.8 p -69.85 -27.34 32.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.794 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.409 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 105.1 23.51 7.67 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.418 ' CE ' ' OD2' ' A' ' 60' ' ' ASP . 3.5 pttm -71.18 -33.59 70.13 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.356 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.2 m -75.75 -30.92 59.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.156 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 72.4 p -65.28 -54.15 33.53 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.056 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 23' ' ' THR . 24.7 tp -62.91 -52.06 64.53 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.731 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.49 ' O ' HG12 ' A' ' 27' ' ' VAL . 9.2 m -36.47 -64.12 0.35 Allowed 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 122.976 0.172 . . . . 0.0 110.774 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -57.45 -41.72 79.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.144 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.663 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -66.99 -35.92 81.03 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.263 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.494 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.6 OUTLIER -77.54 -62.81 1.54 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.369 0.604 . . . . 0.0 110.705 -179.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.569 HG13 ' N ' ' A' ' 28' ' ' GLU . 9.1 p -44.77 -49.29 2.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.488 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.569 ' N ' HG13 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -79.78 -24.54 41.4 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.081 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 74.96 26.66 66.21 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.784 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 31' ' ' PHE . 10.6 tp60 -147.91 125.89 12.04 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.895 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.528 ' O ' ' NE2' ' A' ' 30' ' ' GLN . 1.2 t80 . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.606 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 2.6 pt-20 . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 1.4 m120 -177.47 174.48 1.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.235 0.541 . . . . 0.0 112.072 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.31 146.48 32.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.699 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.458 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 7.2 m-85 -131.7 164.16 26.55 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.318 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.84 156.67 42.96 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.328 0.585 . . . . 0.0 112.071 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -160.15 111.36 1.93 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.698 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.9 mp -104.81 121.01 42.75 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.943 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.534 ' O ' HD12 ' A' ' 47' ' ' ILE . 1.1 pp -147.72 165.16 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.595 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -111.82 127.97 55.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.99 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.735 HG11 HG21 ' A' ' 164' ' ' ILE . 2.5 p -128.16 124.86 63.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.526 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 49' ' ' VAL . 1.9 t-20 73.23 10.71 5.11 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.19 -11.87 71.04 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -91.21 137.84 32.06 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -76.4 146.06 38.94 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.578 0.704 . . . . 0.0 111.023 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.43 ' OH ' ' OE1' ' A' ' 168' ' ' GLU . 8.2 m-85 -135.87 126.78 27.62 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.459 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.646 ' C ' HD22 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -117.52 113.73 22.43 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.646 HD22 ' C ' ' A' ' 55' ' ' HIS . 2.9 mm? -119.39 138.61 52.97 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 121.356 0.598 . . . . 0.0 111.356 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.453 ' O ' HD12 ' A' ' 58' ' ' LEU . 5.3 mt-30 -126.99 127.3 44.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.087 177.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.546 HD11 ' CG1' ' A' ' 9' ' ' ILE . 3.4 mp -114.43 154.83 27.45 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.098 0.475 . . . . 0.0 112.182 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.12 143.99 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 CA-C-O 122.035 0.921 . . . . 0.0 112.72 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.425 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -125.26 105.14 8.9 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.189 -1.369 . . . . 0.0 107.893 177.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.443 -0.819 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.51 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.53 HD12 ' O ' ' A' ' 80' ' ' GLY . 37.8 pt . . . . . 0 N--CA 1.433 -1.293 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.68 13.73 1.19 Allowed 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.41 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.53 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -148.24 163.29 28.92 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.487 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.45 123.46 8.15 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.787 -0.706 . . . . 0.0 111.094 177.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 82' ' ' ILE . 9.5 tt -126.93 106.81 16.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.661 0.743 . . . . 0.0 109.146 178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.715 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -97.32 122.5 40.42 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.459 -178.123 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.405 ' O ' HG12 ' A' ' 84' ' ' VAL . 1.7 t -97.04 114.53 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.456 ' CZ ' ' CA ' ' A' ' 118' ' ' GLY . 26.2 p90 -115.4 144.58 43.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.704 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.477 ' C ' ' H ' ' A' ' 88' ' ' THR . 3.4 p -87.11 141.93 28.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.068 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.63 HG21 ' N ' ' A' ' 124' ' ' HIS . 16.2 m -73.7 18.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.639 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.477 ' H ' ' C ' ' A' ' 86' ' ' SER . 6.4 t -138.91 -22.07 0.96 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.508 ' C ' ' N ' ' A' ' 91' ' ' LYS . 22.9 t -90.83 93.07 9.07 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.201 -176.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.6 tp -59.11 -10.69 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.539 ' O ' HG22 ' A' ' 95' ' ' VAL . 6.9 mttm -77.84 -51.5 10.38 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.18 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 53.5 p -57.68 -31.74 66.65 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.674 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -75.39 -47.66 26.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.89 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.513 ' O ' HG23 ' A' ' 98' ' ' VAL . 6.1 mt-10 -63.35 -43.24 98.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.863 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 91' ' ' LYS . 31.6 m -67.02 -38.97 82.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.197 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.418 ' N ' HG23 ' A' ' 95' ' ' VAL . 5.2 mt -59.4 -38.47 75.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.1 tttp -73.13 -26.63 61.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.836 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 94' ' ' GLU . 64.0 t -77.37 -67.15 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.985 0.422 . . . . 0.0 110.033 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.515 HD12 ' N ' ' A' ' 100' ' ' HIS . 2.5 pp -45.23 -39.78 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.174 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.62 ' NE2' ' CE2' ' A' ' 141' ' ' TRP . 18.3 t60 -62.56 -61.34 2.5 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.235 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 100' ' ' HIS . . . -35.87 -48.68 1.05 Allowed Glycine 0 C--N 1.33 0.25 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 105' ' ' ASP . 1.9 tppt? -68.8 -66.68 0.54 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.429 -0.385 . . . . 0.0 110.03 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.87 -59.1 0.86 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.13 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.721 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -45.9 -45.39 15.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.487 178.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.706 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.833 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.513 ' OE1' ' HB1' ' A' ' 173' ' ' ALA . 9.8 mt-30 . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.79 0.328 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.651 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.4 OUTLIER -143.35 151.21 54.22 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.775 179.329 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -48.29 111.82 0.5 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.763 1.642 . . . . 0.0 112.407 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' A' ' 143' ' ' ALA . 2.8 mt -126.86 132.41 70.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.7 tpt -130.85 114.69 15.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.951 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.1 mt -96.74 98.13 9.91 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.2 t -105.03 130.79 55.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 122.153 0.978 . . . . 0.0 111.395 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.456 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -97.83 114.78 5.09 Favored Glycine 0 C--N 1.307 -1.043 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.486 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.9 t30 -97.49 173.99 6.89 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.025 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.486 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 23.2 mttt 60.4 58.87 2.42 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.712 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.498 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 17.3 tttm -60.48 -32.6 71.58 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -60.8 -18.05 53.07 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.956 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 125' ' ' MET . 11.0 mp -85.86 -26.39 25.68 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.63 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -40.27 -24.63 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.854 179.094 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.6 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 15.1 mtt -46.72 -22.53 0.31 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.462 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -108.28 -42.5 4.59 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.564 -179.654 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.5 ' NE ' ' OE1' ' A' ' 147' ' ' GLU . 22.6 ttm180 26.44 83.61 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.868 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.5 m -62.91 -28.84 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.696 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.4 tp -89.54 155.65 3.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.566 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.445 ' C ' ' N ' ' A' ' 132' ' ' GLU . 57.9 p -97.66 120.51 38.18 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.996 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -39.85 -29.41 0.06 Allowed 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.4 mp0 -70.26 -63.75 1.03 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.895 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.43 ' OE1' ' OG ' ' A' ' 130' ' ' SER . 57.7 mt-10 -41.2 -42.25 2.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.742 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.35 -34.89 63.69 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 132' ' ' GLU . 2.9 tttm -62.04 -55.03 33.26 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.02 -36.66 70.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.75 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.657 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -66.13 -62.87 1.25 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.159 0.504 . . . . 0.0 109.692 179.58 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.45 -35.12 51.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.122 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.03 -30.47 67.76 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.41 -46.86 84.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.757 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.657 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 15.0 m95 -90.5 -5.75 55.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.363 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 141' ' ' TRP . 1.1 t-20 78.73 24.8 0.55 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.008 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.31 167.6 13.4 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.712 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.65 128.83 54.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.975 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 5.9 t80 -97.95 121.38 39.79 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.768 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.08 126.4 14.85 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.5 ' OE1' ' NE ' ' A' ' 127' ' ' ARG . 7.8 mt-10 -99.16 117.26 33.24 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.2 p -137.47 -178.69 5.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.658 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 152' ' ' GLU . 0.1 OUTLIER -138.6 138.77 38.21 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.272 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -57.28 -48.0 80.02 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -55.83 -18.4 8.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.128 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 149' ' ' SER . 38.7 mt-10 -113.53 116.13 29.07 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.942 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.541 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 6.4 t-20 -77.53 -50.34 12.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.78 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 153' ' ' ASN . 5.9 tt0 -39.92 -57.29 1.64 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.428 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.704 ' O ' HG23 ' A' ' 159' ' ' VAL . 80.5 p -51.88 -44.28 63.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.663 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -55.41 -60.46 3.38 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.458 0.647 . . . . 0.0 109.626 178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 57.7 t -41.82 -40.39 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.339 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -67.67 -36.57 80.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.623 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 155' ' ' THR . 22.0 t -70.29 -34.18 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.523 0.678 . . . . 0.0 109.612 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.741 ' CE1' HD11 ' A' ' 164' ' ' ILE . 7.7 t80 -66.13 -51.14 60.73 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.015 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.7 ttt85 -66.74 -36.96 83.7 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.223 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -64.28 -33.61 76.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.875 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.694 HG22 ' O ' ' A' ' 160' ' ' PHE . 15.3 tt -70.85 -39.75 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.167 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.741 HD11 ' CE1' ' A' ' 160' ' ' PHE . 64.6 mt -62.52 -35.59 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.549 0.69 . . . . 0.0 109.231 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.35 -51.8 66.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.522 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -67.89 -26.48 66.02 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.526 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -61.07 -34.67 75.27 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.43 ' OE1' ' OH ' ' A' ' 54' ' ' TYR . 9.9 mm-40 -70.44 -55.98 7.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.647 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -54.81 -62.13 1.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.711 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.651 HG21 ' C ' ' A' ' 112' ' ' ILE . 81.5 mt -52.99 -33.14 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.175 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -69.89 -40.35 75.71 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.752 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -60.71 -36.88 92.59 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.513 ' HB1' ' OE1' ' A' ' 111' ' ' GLN . . . -68.98 -62.81 1.22 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.569 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.722 179.988 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 121.262 0.553 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.465 ' NH1' ' HB1' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -140.05 136.13 33.34 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.984 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.53 ' HB2' HG22 ' A' ' 78' ' ' ILE . 6.5 mttm -109.38 131.36 55.14 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.75 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -104.1 125.4 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 CA-C-O 121.377 0.608 . . . . 0.0 110.674 -178.067 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.07 133.49 34.64 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.352 -0.843 . . . . 0.0 110.792 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.1 mt -96.58 133.21 38.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.645 0.736 . . . . 0.0 112.361 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.602 ' C ' HD23 ' A' ' 12' ' ' LEU . 5.3 tt -125.77 104.01 8.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.114 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -140.16 133.6 6.09 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.64 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.422 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.5 OUTLIER -56.94 -158.51 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.357 0.599 . . . . 0.0 110.605 179.221 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -97.02 131.14 44.13 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.334 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 m 64.94 19.0 11.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.568 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.42 ' O ' HG22 ' A' ' 17' ' ' VAL . 4.9 p -80.58 -15.74 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.83 0.348 . . . . 0.0 110.222 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.41 12.24 33.81 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.428 ' CB ' ' NZ ' ' A' ' 19' ' ' LYS . 0.6 OUTLIER -45.22 -52.58 9.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.938 0.399 . . . . 0.0 110.914 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.545 ' O ' HD13 ' A' ' 24' ' ' ILE . 2.1 m -70.69 -26.69 63.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.491 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.4 m -68.71 -49.59 57.7 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.989 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 45.9 tp -73.8 -26.32 60.57 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 119.626 -0.829 . . . . 0.0 110.782 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.545 ' O ' HG12 ' A' ' 27' ' ' VAL . 35.1 m -63.38 -41.01 98.77 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.545 HD13 ' O ' ' A' ' 20' ' ' SER . 1.3 mp -78.2 -37.03 21.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.754 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.64 ' NE2' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -77.06 -27.48 54.37 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.582 -179.131 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -77.22 -53.41 7.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.432 0.634 . . . . 0.0 110.563 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.573 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.2 p -58.46 -45.58 89.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.08 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.573 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.4 tt0 -82.59 -24.47 33.91 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.515 ' O ' ' ND2' ' A' ' 153' ' ' ASN . . . 71.72 27.5 70.79 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.488 ' CD ' ' N ' ' A' ' 31' ' ' PHE . 1.7 tp-100 -144.41 135.08 24.82 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.136 0.493 . . . . 0.0 111.637 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.64 ' N ' ' NE2' ' A' ' 25' ' ' GLN . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.917 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.29 170.36 4.29 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.351 -0.939 . . . . 0.0 113.34 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.78 143.43 44.02 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.61 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -122.71 169.17 11.34 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.367 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -146.99 147.56 30.82 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 120.008 -0.677 . . . . 0.0 112.605 -178.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.7 tttt -147.1 110.48 4.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.853 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.0 mp -106.4 122.83 47.06 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.254 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.437 HD12 ' CE1' ' A' ' 160' ' ' PHE . 1.2 pt -149.03 165.18 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.624 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 m -114.93 124.44 51.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.044 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.576 HG11 HG21 ' A' ' 164' ' ' ILE . 0.8 OUTLIER -121.95 126.03 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.649 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.12 21.45 10.11 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.14 -8.36 60.93 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.084 -1.207 . . . . 0.0 110.084 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -91.64 134.18 34.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -76.95 145.63 38.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.658 0.742 . . . . 0.0 111.785 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.452 ' CD1' ' CG1' ' A' ' 49' ' ' VAL . 13.5 m-85 -138.76 122.68 17.78 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.023 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.666 ' C ' HD12 ' A' ' 56' ' ' LEU . 67.7 m170 -117.12 113.49 22.35 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.666 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.9 mp -119.7 144.18 47.35 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.589 0.709 . . . . 0.0 112.04 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.756 ' C ' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -134.92 125.26 26.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.919 178.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.913 ' N ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.66 154.19 32.04 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 120.01 -0.676 . . . . 0.0 112.065 -178.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.94 144.71 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.68 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.36 104.08 9.74 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.409 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 44.6 p . . . . . 0 N--CA 1.444 -0.737 0 CA-C-O 121.815 0.816 . . . . 0.0 111.152 -179.526 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.53 HG22 ' HB2' ' A' ' 8' ' ' LYS . 29.0 pt . . . . . 0 N--CA 1.439 -0.993 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.18 16.69 0.74 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.323 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -145.22 167.7 27.31 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.452 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.02 122.9 7.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.853 -0.674 . . . . 0.0 111.318 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.613 HG23 ' O ' ' A' ' 82' ' ' ILE . 10.5 tt -126.52 105.72 14.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 1.047 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.51 122.47 40.61 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.179 -0.609 . . . . 0.0 111.434 -178.3 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 84' ' ' VAL . 1.6 t -97.04 115.83 37.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.032 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.504 ' OH ' ' CZ ' ' A' ' 145' ' ' PHE . 53.8 p90 -109.76 144.69 37.82 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.494 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.0 OUTLIER -99.79 143.97 29.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.01 0.433 . . . . 0.0 111.47 -178.127 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.661 HG21 ' N ' ' A' ' 124' ' ' HIS . 14.7 m -80.78 22.21 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.34 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.22 -21.1 0.86 Allowed 'General case' 0 C--O 1.232 0.182 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.546 ' C ' ' N ' ' A' ' 91' ' ' LYS . 17.8 t -109.54 92.71 4.16 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.311 0.576 . . . . 0.0 111.694 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.438 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 1.0 OUTLIER -52.42 -15.24 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 176.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.698 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -78.24 -39.33 40.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.177 179.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 89' ' ' SER . 79.4 p -69.87 -46.07 66.32 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.495 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -78.6 -32.84 47.72 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 119.473 -0.891 . . . . 0.0 112.489 -177.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.486 ' OE1' ' CE1' ' A' ' 93' ' ' PHE . 8.4 mm-40 -69.3 -45.19 70.17 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.277 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 91' ' ' LYS . 27.7 m -66.05 -37.59 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 C-N-CA 120.141 -0.624 . . . . 0.0 109.976 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.583 ' CG1' HD22 ' A' ' 12' ' ' LEU . 2.0 mt -59.25 -40.54 81.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.986 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -70.1 -26.88 64.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.944 0.402 . . . . 0.0 110.411 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.3 t -75.53 -67.03 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.421 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.1 mt -47.37 -35.44 3.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.326 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.603 ' NE2' ' CD1' ' A' ' 141' ' ' TRP . 6.7 t-80 -62.38 -64.85 0.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.167 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -38.4 -57.62 1.79 Allowed Glycine 0 N--CA 1.453 -0.186 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.485 ' O ' ' N ' ' A' ' 105' ' ' ASP . 15.9 tptm -62.7 -65.14 0.73 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.059 -0.571 . . . . 0.0 110.641 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.05 -60.07 0.66 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.121 0.486 . . . . 0.0 109.849 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.758 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -45.85 -46.81 15.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.543 0.687 . . . . 0.0 109.368 178.675 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.941 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.258 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 121.011 0.434 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.482 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.7 OUTLIER -115.83 156.55 46.35 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.401 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -49.22 109.15 0.24 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.636 1.557 . . . . 0.0 112.599 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.482 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.4 mt -121.66 128.6 75.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.523 ' O ' HD12 ' A' ' 83' ' ' LEU . 7.4 tpt -131.69 112.7 12.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.575 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.9 mt -96.56 97.86 9.75 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.0 t -103.53 130.88 53.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 122.35 1.071 . . . . 0.0 111.364 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.466 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -98.26 106.55 3.3 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 113.593 -1.64 . . . . 0.0 109.082 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.482 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 55.0 t30 -96.78 174.91 6.56 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.527 -178.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.482 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 7.5 mttp 65.31 59.74 0.8 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.193 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.73 -39.14 90.85 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -61.87 -3.5 1.18 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.047 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 125' ' ' MET . 9.7 mp -99.68 -30.17 12.25 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.661 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -39.93 -28.18 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.59 178.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.453 ' N ' ' O ' ' A' ' 123' ' ' LEU . 0.0 OUTLIER -41.18 -26.74 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -98.18 -36.18 10.14 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.822 179.495 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.563 HH12 ' CG2' ' A' ' 129' ' ' ILE . 7.0 tpt85 42.55 86.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.709 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.578 HG22 ' C ' ' A' ' 87' ' ' VAL . 30.6 m -80.28 -39.98 19.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.654 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.563 ' CG2' HH12 ' A' ' 127' ' ' ARG . 0.8 OUTLIER -86.68 132.16 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 132' ' ' GLU . 60.8 p -76.75 118.05 18.98 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.389 -0.525 . . . . 0.0 111.026 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -39.06 -29.48 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.28 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.4 mp0 -69.88 -63.07 1.15 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.874 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 132' ' ' GLU . 52.9 mt-10 -41.09 -46.11 2.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.95 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.11 -31.73 72.34 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 132' ' ' GLU . 19.6 tttm -65.43 -56.62 11.47 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -54.94 -33.33 62.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.349 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.11 -62.71 1.34 Allowed 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.892 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -56.95 -31.94 65.49 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.966 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.61 -35.28 72.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.771 0.319 . . . . 0.0 110.534 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -47.11 81.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.288 -178.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.603 ' CD1' ' NE2' ' A' ' 100' ' ' HIS . 18.6 m95 -91.2 -4.12 56.35 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.527 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 72.36 31.78 1.77 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.142 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.34 168.82 12.35 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.255 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -103.63 124.85 49.58 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.347 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.504 ' CZ ' ' OH ' ' A' ' 85' ' ' TYR . 7.3 t80 -97.8 123.19 41.65 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.863 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.52 123.67 12.91 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.471 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 2.8 mt-10 -98.72 114.82 27.5 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 5.0 p -136.33 -173.92 3.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.897 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.03 136.62 35.49 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.105 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.42 -43.63 98.37 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.132 0.491 . . . . 0.0 109.99 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.444 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 33.7 tttm -58.49 -7.03 0.8 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.519 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -126.9 128.4 46.42 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.769 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 2.5 t-20 -77.37 -56.01 4.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.09 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' A' ' 153' ' ' ASN . 0.0 OUTLIER -36.41 -59.02 0.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.135 0.493 . . . . 0.0 110.983 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.586 ' O ' HG23 ' A' ' 159' ' ' VAL . 16.8 p -51.99 -51.34 57.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.649 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -52.31 -58.37 6.87 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.5 0.667 . . . . 0.0 109.713 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 53.7 t -42.21 -51.32 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.129 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -51.27 -36.43 42.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.053 0.454 . . . . 0.0 110.636 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 155' ' ' THR . 11.0 t -73.94 -31.15 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.261 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.529 ' O ' HG22 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -68.77 -46.64 68.25 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.047 0.451 . . . . 0.0 112.119 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.439 ' N ' ' CG ' ' A' ' 160' ' ' PHE . 6.4 ttt180 -73.94 -34.56 64.35 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.751 -0.779 . . . . 0.0 111.152 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -65.65 -34.73 78.9 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.067 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 160' ' ' PHE . 14.1 tt -70.34 -43.16 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.861 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.576 HG21 HG11 ' A' ' 49' ' ' VAL . 85.1 mt -59.58 -35.21 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.544 0.688 . . . . 0.0 109.611 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.421 ' HA ' HD13 ' A' ' 165' ' ' LEU . 0.4 OUTLIER -63.21 -60.31 3.58 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.726 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -58.36 -34.9 71.18 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.465 ' HB1' ' NH1' ' A' ' 7' ' ' ARG . . . -55.98 -32.45 63.93 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 171' ' ' ASP . 6.0 tp10 -66.41 -59.65 3.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.359 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.51 -52.23 64.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.682 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 4.0 mm -50.45 -37.93 15.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.04 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 172' ' ' GLY . 0.0 OUTLIER -67.01 -40.13 87.24 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.028 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 171' ' ' ASP . . . -56.75 -36.41 72.04 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.72 -82.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.743 0.306 . . . . 0.0 110.213 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.838 179.937 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.322 0 CA-C-O 121.202 0.525 . . . . 0.0 110.651 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.606 ' NH1' ' HB1' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -139.71 136.04 33.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.526 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.434 ' HB2' HG22 ' A' ' 78' ' ' ILE . 12.5 mttp -106.0 128.5 53.87 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.752 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.9 OUTLIER -102.82 122.95 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 121.416 0.627 . . . . 0.0 110.563 -178.023 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.439 ' HB3' ' CE1' ' A' ' 81' ' ' TYR . . . -84.56 132.58 34.5 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.172 -0.955 . . . . 0.0 111.156 -178.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.666 ' O ' HD12 ' A' ' 12' ' ' LEU . 11.7 mt -95.46 133.72 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-O 121.916 0.865 . . . . 0.0 112.721 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.666 HD12 ' O ' ' A' ' 11' ' ' ILE . 2.6 mp -130.33 101.73 5.89 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.866 -1.515 . . . . 0.0 110.359 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.517 ' O ' ' NZ ' ' A' ' 19' ' ' LYS . . . -140.64 134.4 6.42 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.476 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.6 OUTLIER -56.16 -158.2 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.285 0.565 . . . . 0.0 110.736 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -98.93 133.76 42.75 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.485 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.6 m 64.25 19.29 11.72 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.721 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 p -85.91 -16.9 9.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.843 0.354 . . . . 0.0 110.561 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.36 27.92 6.64 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.61 ' HB2' ' HZ2' ' A' ' 19' ' ' LYS . 4.8 ttpm? -61.2 -50.26 73.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.14 0.495 . . . . 0.0 110.435 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.21 -26.38 58.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.436 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.6 p -64.29 -43.38 94.94 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.856 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.9 tp -77.74 -39.51 44.13 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.851 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.61 ' O ' HG12 ' A' ' 27' ' ' VAL . 31.4 m -50.2 -43.87 52.83 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.68 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.4 mp -77.42 -41.58 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.635 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.475 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -67.78 -31.79 71.92 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.151 -179.016 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.632 ' CZ ' ' CE1' ' A' ' 160' ' ' PHE . 4.8 t80 -77.61 -64.03 1.24 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.404 0.621 . . . . 0.0 111.192 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.619 HG13 ' N ' ' A' ' 28' ' ' GLU . 13.5 p -45.15 -49.17 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.996 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.619 ' N ' HG13 ' A' ' 27' ' ' VAL . 0.7 OUTLIER -81.49 -25.12 36.26 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.28 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 153' ' ' ASN . . . 75.44 28.1 62.28 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.435 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.42 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 5.2 pt20 -146.38 128.05 15.2 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.943 0.878 . . . . 0.0 112.983 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.496 ' C ' ' CD1' ' A' ' 31' ' ' PHE . 0.7 OUTLIER . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.083 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.418 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 120.547 0.213 . . . . 0.0 110.532 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER 177.88 174.34 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.278 0.561 . . . . 0.0 112.278 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.447 HG23 HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -108.04 142.92 37.47 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.426 179.319 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.432 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 12.5 m-85 -130.47 165.5 22.5 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.047 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.602 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -142.53 148.02 36.92 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.252 0.549 . . . . 0.0 112.046 -178.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.583 ' C ' HD12 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -151.94 116.1 4.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.978 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.4 mp -105.3 129.69 53.59 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.393 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.3 pt -147.39 160.97 8.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.47 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 m -117.01 123.56 47.19 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.173 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.764 HG11 HG21 ' A' ' 164' ' ' ILE . 1.7 p -118.42 125.48 74.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.984 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.408 ' CG ' HG22 ' A' ' 49' ' ' VAL . 2.7 m120 61.38 24.94 14.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 0.0 110.239 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.77 -9.52 65.27 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -88.77 130.48 35.35 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -76.96 146.12 37.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.582 0.706 . . . . 0.0 111.302 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.424 ' OH ' ' OE2' ' A' ' 168' ' ' GLU . 9.3 m-85 -138.46 124.92 20.59 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.004 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.656 ' C ' HD12 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -117.28 113.66 22.49 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.656 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.9 mp -119.23 146.58 45.1 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.582 0.706 . . . . 0.0 112.132 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.791 ' C ' HD13 ' A' ' 58' ' ' LEU . 4.9 tt0 -136.35 123.53 21.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.983 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.949 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.12 154.91 30.22 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.541 0.686 . . . . 0.0 112.416 -178.371 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.447 HG23 HG23 ' A' ' 42' ' ' THR . 0.3 OUTLIER -131.85 145.14 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.785 -178.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.16 103.89 8.52 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.019 -1.446 . . . . 0.0 107.92 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.516 -0.343 0 CA-C-O 121.312 0.577 . . . . 0.0 110.775 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.434 HG22 ' HB2' ' A' ' 8' ' ' LYS . 33.6 pt . . . . . 0 N--CA 1.433 -1.299 0 CA-C-O 121.319 0.581 . . . . 0.0 112.38 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -151.11 18.41 0.76 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.115 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -146.69 167.75 28.11 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.15 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.439 ' CE1' ' HB3' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -151.97 123.21 7.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.136 -0.532 . . . . 0.0 111.806 178.156 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.744 HG23 ' O ' ' A' ' 82' ' ' ILE . 12.4 tt -128.06 98.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.797 0.808 . . . . 0.0 109.299 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.787 HD23 ' N ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -96.32 130.09 43.51 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.639 -178.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.93 132.81 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.885 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.509 ' CE1' ' CD2' ' A' ' 116' ' ' LEU . 2.2 m-85 -108.56 143.5 37.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.886 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.552 ' C ' ' H ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -106.2 121.41 44.13 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.386 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.484 HG11 HH21 ' A' ' 127' ' ' ARG . 12.0 m -73.86 21.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.552 ' H ' ' C ' ' A' ' 86' ' ' SER . 9.7 t -142.72 -7.83 0.85 Allowed 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 114.212 1.189 . . . . 0.0 114.212 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.501 ' N ' ' OG ' ' A' ' 86' ' ' SER . 0.0 OUTLIER -135.46 100.5 4.53 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 122.324 1.059 . . . . 0.0 112.077 -176.311 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.458 HG22 ' CD ' ' A' ' 94' ' ' GLU . 17.1 mm -56.08 -10.63 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 113.915 -1.493 . . . . 0.0 108.754 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.77 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -79.3 -43.99 22.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.466 178.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 55.3 p -62.33 -45.89 91.19 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.151 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.837 ' CD2' HD13 ' A' ' 129' ' ' ILE . 0.1 OUTLIER -76.48 -37.55 56.67 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 118.531 -1.267 . . . . 0.0 111.882 -178.312 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.458 ' CD ' HG22 ' A' ' 90' ' ' ILE . 91.5 mt-10 -69.66 -44.86 69.68 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.902 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 91' ' ' LYS . 23.5 m -63.1 -36.5 76.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.881 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.444 ' N ' HG23 ' A' ' 95' ' ' VAL . 47.8 mt -72.42 -27.14 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.058 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -69.15 -29.17 67.14 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.8 t -76.29 -66.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.481 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.502 HG21 HD21 ' A' ' 12' ' ' LEU . 1.4 mp -39.16 -36.21 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.738 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.452 ' CE1' ' CE2' ' A' ' 141' ' ' TRP . 53.2 t-80 -66.95 -58.6 4.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.979 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.82 -49.16 1.95 Allowed Glycine 0 CA--C 1.518 0.259 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.804 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 105' ' ' ASP . 23.0 tptt -64.01 -66.31 0.56 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.424 -0.388 . . . . 0.0 110.393 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.7 OUTLIER -39.95 -57.17 1.67 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.627 179.058 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.769 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -46.84 -43.84 18.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.53 178.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.802 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.624 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.74 0.305 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.484 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -129.93 145.25 56.37 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.713 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -49.5 113.26 0.88 Allowed 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.624 1.55 . . . . 0.0 112.517 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.512 ' HB ' ' HB2' ' A' ' 143' ' ' ALA . 2.4 mp -123.99 132.99 70.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.473 ' SD ' ' HB3' ' A' ' 144' ' ' ALA . 9.4 tpt -133.18 115.3 14.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.011 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.509 ' CD2' ' CE1' ' A' ' 85' ' ' TYR . 4.2 mt -96.83 97.24 9.14 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.0 t -102.11 127.98 55.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.5 0.667 . . . . 0.0 111.753 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -94.73 114.68 4.89 Favored Glycine 0 C--N 1.311 -0.858 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -97.02 171.79 8.26 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.078 -0.649 . . . . 0.0 112.025 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 6.3 mtpp 61.73 55.47 2.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.629 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.556 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 8.8 tttm -57.41 -20.66 31.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.674 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -76.64 -20.48 56.65 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.991 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.9 mp -77.96 -31.63 50.96 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.621 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.3 OUTLIER -31.56 -32.56 0.01 OUTLIER 'General case' 0 C--N 1.339 0.141 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.029 178.196 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.621 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 2.2 mmt -42.02 -27.34 0.12 Allowed 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.487 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -101.17 -37.6 8.48 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.587 179.307 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.484 HH21 HG11 ' A' ' 87' ' ' VAL . 9.8 ttm180 32.01 85.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.449 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.2 m -72.66 -34.77 48.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.167 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.837 HD13 ' CD2' ' A' ' 93' ' ' PHE . 10.7 tp -91.4 153.82 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.691 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.4 ' OG ' ' OE1' ' A' ' 132' ' ' GLU . 3.8 t -95.16 130.19 41.98 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.86 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -50.39 -35.86 30.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.782 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -68.45 -62.21 1.49 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.743 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -40.72 -43.12 1.9 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.722 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.68 -36.1 67.11 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -62.08 -53.53 54.21 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.341 -0.43 . . . . 0.0 109.852 179.574 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -58.39 -38.04 76.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.76 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.649 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -66.43 -60.65 2.56 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.563 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -51.69 -37.16 49.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.984 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.83 -28.9 67.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.71 -47.37 78.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.155 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.649 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 17.1 m95 -91.0 -4.24 56.6 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.313 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 141' ' ' TRP . 0.8 OUTLIER 79.11 26.97 0.42 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.992 -179.434 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.61 168.81 12.24 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.69 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.473 ' HB3' ' SD ' ' A' ' 115' ' ' MET . . . -111.69 127.73 55.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.043 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.406 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 9.9 t80 -98.01 120.81 39.05 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.314 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.53 128.23 17.21 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.338 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.48 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 1.7 mt-10 -100.2 116.74 32.92 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.007 0.432 . . . . 0.0 110.098 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.433 ' OG ' HG21 ' A' ' 159' ' ' VAL . 11.8 p -131.98 -177.97 4.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.596 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.21 131.79 30.82 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.563 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.479 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -56.44 -42.44 78.12 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.123 0.487 . . . . 0.0 110.084 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 38.1 tttt -58.2 -3.7 0.28 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.468 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.479 ' H ' ' C ' ' A' ' 150' ' ' ALA . 1.9 mt-10 -136.37 125.76 24.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.017 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 29' ' ' GLY . 5.3 t-20 -77.25 -48.95 16.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.831 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 153' ' ' ASN . 0.0 OUTLIER -38.5 -59.16 0.94 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.749 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.661 ' O ' HG23 ' A' ' 159' ' ' VAL . 45.7 p -52.5 -49.55 64.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.188 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.475 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -50.63 -60.84 2.62 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.553 0.692 . . . . 0.0 110.285 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 49.0 t -45.76 -42.2 3.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.895 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.15 -41.62 98.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.664 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 155' ' ' THR . 11.5 t -63.38 -46.94 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.66 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.632 ' CE1' ' CZ ' ' A' ' 26' ' ' PHE . 10.4 m-85 -67.79 -22.81 65.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.105 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.428 ' NH1' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -76.24 -42.36 46.09 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.869 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -67.29 -32.35 73.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.132 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 160' ' ' PHE . 7.3 tt -69.14 -47.07 76.64 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.171 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.764 HG21 HG11 ' A' ' 49' ' ' VAL . 95.4 mt -53.5 -37.53 30.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.05 -56.53 19.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.549 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -62.47 -28.73 70.02 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.309 -0.556 . . . . 0.0 109.573 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.606 ' HB1' ' NH1' ' A' ' 7' ' ' ARG . . . -59.23 -33.32 70.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.424 ' OE2' ' OH ' ' A' ' 54' ' ' TYR . 2.3 tp10 -68.83 -50.62 48.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.016 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -60.15 -64.29 1.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.741 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 50.6 mt -49.94 -31.75 7.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.952 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.84 -40.18 79.54 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.368 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -61.71 -35.63 91.5 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.29 -68.96 0.35 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.714 0.292 . . . . 0.0 110.427 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.715 179.927 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.308 0.575 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.526 ' NH1' ' HB1' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -139.59 134.96 32.84 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.22 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.52 ' HB2' HG22 ' A' ' 78' ' ' ILE . 35.5 mttt -107.25 126.0 51.86 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.751 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.9 OUTLIER -100.17 122.03 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-O 121.566 0.698 . . . . 0.0 110.914 -177.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.62 134.84 34.78 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.464 -0.773 . . . . 0.0 110.903 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.3 mt -96.64 133.33 38.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.4 0.619 . . . . 0.0 112.382 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.647 ' C ' HD23 ' A' ' 12' ' ' LEU . 5.8 tt -128.61 105.67 8.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.494 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -142.03 134.33 6.11 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -52.99 172.6 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -73.37 131.61 42.07 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.231 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 m 67.1 19.97 10.38 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.698 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.6 p -79.72 -18.44 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.219 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.401 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 101.19 23.7 9.5 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.447 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.4 pttm -70.72 -33.44 70.85 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.423 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.496 ' O ' HD13 ' A' ' 24' ' ' ILE . 39.8 m -77.2 -30.42 54.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.05 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 79.5 p -65.61 -41.91 92.21 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.125 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.0 tp -77.07 -44.05 32.07 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 119.754 -0.779 . . . . 0.0 110.648 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.605 ' O ' HG12 ' A' ' 27' ' ' VAL . 25.3 m -47.93 -42.37 27.13 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.226 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.496 HD13 ' O ' ' A' ' 20' ' ' SER . 1.3 mp -77.15 -41.72 30.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 O-C-N 123.267 0.354 . . . . 0.0 111.272 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.541 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.3 OUTLIER -70.71 -28.69 64.92 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.969 -179.208 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.454 ' O ' ' N ' ' A' ' 29' ' ' GLY . 1.3 t80 -78.05 -63.63 1.35 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.231 0.539 . . . . 0.0 110.692 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.608 HG13 ' N ' ' A' ' 28' ' ' GLU . 13.7 p -45.15 -49.59 2.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.419 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.608 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.5 tt0 -79.06 -24.45 43.55 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 71.5 28.21 69.93 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 114.471 -1.241 . . . . 0.0 110.024 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -149.73 125.8 10.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.49 -178.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.618 ' O ' ' CD1' ' A' ' 31' ' ' PHE . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.357 0 CA-C-O 122.318 1.056 . . . . 0.0 110.407 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.425 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.358 0 CA-C-O 120.683 0.278 . . . . 0.0 110.436 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 0.7 OUTLIER 177.49 176.68 0.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.185 0.517 . . . . 0.0 111.869 -179.383 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.9 147.47 30.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.873 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.442 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 11.6 m-85 -129.77 167.3 18.29 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.239 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.537 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -145.9 151.05 37.24 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.52 -178.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.594 ' C ' HD12 ' A' ' 46' ' ' LEU . 5.0 tmtp? -150.91 108.78 3.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.439 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.748 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.4 mp -106.48 121.4 44.2 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.938 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 pp -149.0 165.36 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.785 0.326 . . . . 0.0 110.647 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 m -108.81 127.6 54.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.173 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.631 HG11 HG21 ' A' ' 164' ' ' ILE . 7.6 p -126.39 138.32 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.615 ' OD1' HG22 ' A' ' 49' ' ' VAL . 4.7 m-20 62.06 5.95 1.61 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 97.39 -13.18 64.66 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -91.37 142.21 27.93 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -76.24 145.53 39.66 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.562 0.696 . . . . 0.0 111.073 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.499 ' CD1' HG12 ' A' ' 49' ' ' VAL . 8.0 m-85 -136.34 124.8 23.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.134 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.643 ' C ' HD22 ' A' ' 56' ' ' LEU . 62.3 m170 -116.74 113.98 23.35 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.655 HD22 ' N ' ' A' ' 56' ' ' LEU . 2.7 mm? -118.91 139.75 51.12 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 121.386 0.612 . . . . 0.0 111.34 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.75 ' C ' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -133.36 122.41 23.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.91 178.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.924 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.19 154.6 30.84 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.345 0.593 . . . . 0.0 112.525 -178.139 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.8 145.29 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-N 114.672 -1.149 . . . . 0.0 113.05 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -123.61 106.5 10.61 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.067 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.516 -0.341 0 CA-C-O 121.614 0.721 . . . . 0.0 111.487 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.52 HG22 ' HB2' ' A' ' 8' ' ' LYS . 31.5 pt . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.77 19.33 0.7 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.022 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.402 ' HA3' HD13 ' A' ' 9' ' ' ILE . . . -148.02 165.08 28.92 Favored Glycine 0 CA--C 1.517 0.195 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.534 -178.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.82 123.07 7.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.716 -0.742 . . . . 0.0 111.073 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.569 HG23 ' O ' ' A' ' 82' ' ' ILE . 9.7 tt -126.19 107.62 17.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.9 0.857 . . . . 0.0 109.029 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.818 ' N ' HD12 ' A' ' 83' ' ' LEU . 3.1 mp -97.27 126.67 42.63 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.979 -178.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -95.26 128.69 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.162 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.707 ' CZ ' HG21 ' A' ' 96' ' ' ILE . 48.6 m-85 -110.69 144.44 39.62 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.172 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.506 ' HG ' ' H ' ' A' ' 89' ' ' SER . 0.9 OUTLIER -98.24 125.99 43.54 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.487 HG21 ' N ' ' A' ' 124' ' ' HIS . 11.0 m -72.5 22.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.673 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.501 ' H ' ' C ' ' A' ' 86' ' ' SER . 0.8 OUTLIER -138.79 -26.13 0.87 Allowed 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.535 ' C ' ' N ' ' A' ' 91' ' ' LYS . 4.1 t -98.0 93.98 6.6 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.378 -176.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.477 ' O ' HD13 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -58.27 -11.57 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.314 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.535 ' N ' ' C ' ' A' ' 89' ' ' SER . 3.4 mptt -78.28 -57.22 3.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.456 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 69.6 p -49.6 -30.62 9.08 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.591 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.402 ' CE1' ' CD2' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -74.55 -48.29 27.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.838 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.39 -44.22 88.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.595 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 91' ' ' LYS . 4.1 m -64.38 -35.84 75.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.145 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.707 HG21 ' CZ ' ' A' ' 85' ' ' TYR . 44.7 mt -69.12 -29.44 42.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.882 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.03 -27.84 66.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.8 t -74.75 -66.73 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.2 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.6 mp -41.39 -48.64 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.514 ' CE1' ' CE2' ' A' ' 141' ' ' TRP . 51.8 t-80 -54.66 -64.84 0.7 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.669 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -38.07 -52.33 2.13 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 105' ' ' ASP . 17.7 tptm -65.87 -63.6 1.05 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.924 -0.638 . . . . 0.0 110.698 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -38.2 -59.24 0.89 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.215 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.736 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -47.05 -45.24 21.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.806 178.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.878 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.795 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.538 ' OE1' ' HB1' ' A' ' 173' ' ' ALA . 8.2 mt-30 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.711 0.291 . . . . 0.0 111.022 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.721 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.6 OUTLIER -130.07 153.68 81.12 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.685 179.419 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -48.02 114.69 1.2 Allowed 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.897 1.731 . . . . 0.0 112.572 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.49 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.4 mp -124.28 128.44 73.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.54 ' SD ' ' HB3' ' A' ' 144' ' ' ALA . 12.3 tpt -129.01 114.59 16.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.741 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 138' ' ' ALA . 67.5 mt -97.21 98.91 10.41 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.387 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.83 131.16 57.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.865 0.84 . . . . 0.0 112.396 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -97.96 114.01 4.88 Favored Glycine 0 C--N 1.312 -0.773 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.448 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 57.7 t30 -96.84 172.79 7.65 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.952 -177.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.448 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 19.7 mttt 58.51 58.67 3.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.188 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -14.75 61.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.326 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -79.4 -13.03 59.87 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.633 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.661 ' O ' ' N ' ' A' ' 126' ' ' GLU . 10.9 mp -84.05 -26.57 28.95 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.553 ' O ' ' N ' ' A' ' 126' ' ' GLU . 10.3 t60 -22.76 -42.34 0.01 OUTLIER 'General case' 0 C--N 1.348 0.503 0 O-C-N 124.544 1.152 . . . . 0.0 111.289 178.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.567 ' N ' ' O ' ' A' ' 123' ' ' LEU . 0.7 OUTLIER -44.77 -19.04 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.661 ' N ' ' O ' ' A' ' 123' ' ' LEU . 19.8 mm-40 -89.74 -54.49 4.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.011 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.433 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 1.7 tpt85 35.85 71.24 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.269 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.71 -40.13 86.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.292 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 tp -88.44 155.12 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.582 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 132' ' ' GLU . 47.5 p -93.12 118.04 30.76 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.718 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -39.12 -28.66 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.645 0.736 . . . . 0.0 109.373 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.3 mp0 -70.06 -63.27 1.11 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.876 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.4 ' CG ' ' OG ' ' A' ' 130' ' ' SER . 57.1 mt-10 -41.52 -41.73 2.19 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.16 -35.73 64.09 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 132' ' ' GLU . 2.4 tttm -60.72 -55.42 33.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.58 -33.97 66.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.075 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.35 -63.2 1.16 Allowed 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.836 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 143' ' ' ALA . . . -51.67 -35.06 41.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.232 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -35.61 78.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.736 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.58 -47.32 76.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.59 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.558 ' CH2' HD22 ' A' ' 104' ' ' LEU . 25.7 m95 -92.72 2.52 56.69 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.719 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 60.77 39.94 16.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.526 0.679 . . . . 0.0 109.633 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.46 ' O ' ' HB1' ' A' ' 138' ' ' ALA . . . -98.15 168.35 10.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.57 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.54 ' HB3' ' SD ' ' A' ' 115' ' ' MET . . . -105.07 125.46 51.0 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.887 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.437 ' C ' ' CD1' ' A' ' 145' ' ' PHE . 4.0 t80 -98.4 122.03 41.08 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.262 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.01 126.43 15.83 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.433 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 2.7 mt-10 -100.49 114.89 28.86 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.404 ' OG ' HG21 ' A' ' 159' ' ' VAL . 21.0 p -134.77 -178.76 5.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.824 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.93 135.19 34.14 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.28 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -57.44 -46.52 83.5 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.883 0.373 . . . . 0.0 110.365 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -55.21 -6.29 0.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.33 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.481 ' H ' ' C ' ' A' ' 150' ' ' ALA . 2.1 tt0 -131.25 122.63 26.82 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.638 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 10.4 t-20 -77.21 -52.02 9.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.167 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 153' ' ' ASN . 0.2 OUTLIER -36.77 -58.22 0.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.03 -179.632 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.678 ' O ' HG23 ' A' ' 159' ' ' VAL . 68.1 p -53.0 -45.1 67.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.127 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.541 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -55.44 -61.48 2.31 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.492 0.663 . . . . 0.0 110.121 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 57.4 t -43.22 -39.67 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.688 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -65.7 -42.81 90.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.199 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 155' ' ' THR . 14.3 t -61.93 -42.41 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.539 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.537 ' O ' HG22 ' A' ' 163' ' ' ILE . 52.3 t80 -59.49 -66.76 0.46 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.216 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 160' ' ' PHE . 19.5 ttm-85 -41.62 -45.29 3.33 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.304 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -62.05 -30.35 70.92 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.754 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.2 OUTLIER -66.41 -32.47 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.457 179.473 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.631 HG21 HG11 ' A' ' 49' ' ' VAL . 7.4 mt -68.39 -42.27 84.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.737 0.779 . . . . 0.0 109.665 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.62 -49.36 78.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.551 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -64.03 -32.56 74.15 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -56.08 -34.41 65.96 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.125 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.39 -55.39 10.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.682 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.62 -62.87 1.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.733 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.721 HG21 ' C ' ' A' ' 112' ' ' ILE . 38.5 mm -53.32 -31.23 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.065 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -69.67 -40.38 76.47 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.633 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.53 -35.31 91.6 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.538 ' HB1' ' OE1' ' A' ' 111' ' ' GLN . . . -67.98 -62.71 1.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.688 0.28 . . . . 0.0 110.429 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.705 179.878 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 121.216 0.531 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.62 136.66 34.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.587 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.534 ' HB2' HG22 ' A' ' 78' ' ' ILE . 11.0 mttm -108.51 127.49 53.97 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.741 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -103.01 123.95 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-O 121.479 0.657 . . . . 0.0 111.13 -178.086 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.43 135.78 34.12 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.422 -0.799 . . . . 0.0 111.254 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.0 mt -95.77 133.84 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.24 100.69 5.93 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.349 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.71 133.73 5.87 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.69 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER -54.62 -167.08 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.034 0.445 . . . . 0.0 110.041 178.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.404 ' O ' ' CB ' ' A' ' 16' ' ' SER . 11.5 ttp180 -97.64 128.33 44.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.744 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER 76.24 8.79 3.32 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.125 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.488 ' C ' ' HZ2' ' A' ' 120' ' ' LYS . 7.3 p -77.63 -19.32 14.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.942 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.417 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 106.03 31.6 4.08 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.408 ' NZ ' ' CB ' ' A' ' 19' ' ' LYS . 2.6 ttmp? -59.5 -59.1 5.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.005 0.431 . . . . 0.0 110.406 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.07 -26.01 63.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.24 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 89.1 p -63.78 -47.11 82.22 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.714 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 28.4 tp -71.39 -49.94 37.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.473 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.551 ' O ' HG12 ' A' ' 27' ' ' VAL . 48.7 m -43.79 -38.93 3.49 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.311 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.2 -43.68 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.94 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.622 ' NE2' ' N ' ' A' ' 31' ' ' PHE . 1.5 tp-100 -63.46 -40.53 97.37 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.756 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.636 ' CG ' ' CE1' ' A' ' 160' ' ' PHE . 2.2 t80 -74.87 -62.52 1.51 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.209 0.528 . . . . 0.0 111.825 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.576 HG13 ' N ' ' A' ' 28' ' ' GLU . 7.4 p -44.0 -47.52 2.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.722 -178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.576 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.0 tm-20 -83.91 -24.19 30.86 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.526 ' O ' ' ND2' ' A' ' 153' ' ' ASN . . . 75.11 25.5 68.71 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.075 -1.42 . . . . 0.0 110.348 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.547 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 1.9 tp-100 -152.01 130.1 11.87 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.687 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.622 ' N ' ' NE2' ' A' ' 25' ' ' GLN . 0.7 OUTLIER . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.684 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.421 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 2.2 pm0 . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 120.802 0.334 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 0.7 OUTLIER 177.11 175.33 0.4 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.624 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.81 127.61 53.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.294 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -110.02 174.05 6.04 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.968 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.531 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -143.5 161.7 37.75 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.399 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.595 ' C ' HD12 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -163.18 112.09 1.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.432 179.424 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.699 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.5 mp -105.17 127.93 53.15 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.727 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 pt -147.87 165.31 5.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.569 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.2 m -116.82 123.86 48.12 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.049 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.713 HG11 HG21 ' A' ' 164' ' ' ILE . 2.4 p -119.74 129.99 74.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.631 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.505 ' CG ' HG22 ' A' ' 49' ' ' VAL . 3.0 m120 61.73 19.71 10.75 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.56 -9.43 71.04 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -90.0 135.6 33.55 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.49 147.28 37.93 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.584 0.706 . . . . 0.0 111.465 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.438 ' CD1' ' CG1' ' A' ' 49' ' ' VAL . 5.8 m-85 -138.3 125.21 21.19 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.042 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.618 ' C ' HD12 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -118.04 113.74 22.09 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.618 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.6 mp -118.62 143.21 46.96 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.629 0.728 . . . . 0.0 112.164 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.806 ' C ' HD13 ' A' ' 58' ' ' LEU . 1.2 mt-30 -133.96 122.6 23.31 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.93 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.976 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.38 153.52 31.89 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.063 -178.655 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.82 145.48 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-N 114.992 -1.004 . . . . 0.0 112.926 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -124.33 103.24 8.1 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.064 177.627 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.513 -0.458 0 CA-C-O 121.374 0.607 . . . . 0.0 110.843 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.554 HD12 ' O ' ' A' ' 80' ' ' GLY . 39.1 pt . . . . . 0 N--CA 1.439 -1.015 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -154.85 19.59 0.45 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.776 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.554 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -152.66 165.28 30.97 Favored Glycine 0 C--O 1.227 -0.323 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.873 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.78 122.31 7.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.689 -0.755 . . . . 0.0 110.691 178.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.599 HG23 ' O ' ' A' ' 82' ' ' ILE . 9.6 tt -124.01 102.69 11.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.685 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -97.56 123.22 41.36 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.17 -178.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.9 t -95.38 130.54 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.135 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.656 ' CZ ' HG21 ' A' ' 96' ' ' ILE . 69.6 m-85 -111.25 143.94 41.23 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.538 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.583 ' HG ' ' H ' ' A' ' 89' ' ' SER . 0.5 OUTLIER -94.99 121.0 36.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.473 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.52 HG21 ' N ' ' A' ' 124' ' ' HIS . 13.8 m -70.66 21.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.469 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.522 ' H ' ' C ' ' A' ' 86' ' ' SER . 1.1 t -136.27 -23.54 1.28 Allowed 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.583 ' H ' ' HG ' ' A' ' 86' ' ' SER . 8.3 t -100.45 94.1 5.98 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.482 -176.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.485 ' O ' HD13 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -56.81 -11.41 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 175.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.555 ' N ' ' C ' ' A' ' 89' ' ' SER . 18.1 mttp -78.11 -56.35 4.55 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.141 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.4 p -49.83 -29.87 8.78 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.692 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.868 ' CE2' HG21 ' A' ' 129' ' ' ILE . 0.3 OUTLIER -75.29 -50.22 16.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.92 -179.305 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -64.68 -42.95 94.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.628 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 91' ' ' LYS . 4.6 m -65.98 -37.62 80.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.469 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.656 HG21 ' CZ ' ' A' ' 85' ' ' TYR . 41.1 mt -68.67 -28.58 40.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.567 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -70.4 -27.48 64.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.835 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 99' ' ' ILE . 17.0 t -74.34 -66.4 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.777 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' A' ' 98' ' ' VAL . 1.6 mp -39.97 -43.01 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.666 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.65 ' CE1' ' CE2' ' A' ' 141' ' ' TRP . 9.1 t60 -57.81 -59.38 5.32 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.616 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -36.39 -49.05 1.25 Allowed Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.716 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 105' ' ' ASP . 22.5 tptt -67.88 -66.03 0.62 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.32 -0.44 . . . . 0.0 110.367 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.48 HD13 ' C ' ' A' ' 103' ' ' LEU . 0.5 OUTLIER -38.0 -59.65 0.82 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.718 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -44.29 -46.96 9.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.821 178.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.792 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.281 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.697 0.284 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.491 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -136.18 152.72 75.82 Favored Pre-proline 0 C--O 1.223 -0.328 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -48.3 108.18 0.17 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.929 1.753 . . . . 0.0 113.157 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.491 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.3 mt -121.22 127.07 75.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 11.0 tpt -127.99 114.5 17.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.913 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.437 HD12 ' HB2' ' A' ' 138' ' ' ALA . 62.7 mt -96.98 98.33 9.99 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.2 t -105.76 130.08 57.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.846 0.831 . . . . 0.0 112.774 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -97.63 112.51 4.48 Favored Glycine 0 C--N 1.312 -0.761 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.522 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 50.5 t30 -96.86 176.91 5.81 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.939 -0.705 . . . . 0.0 111.792 -177.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.522 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 36.5 mttp 58.61 57.76 3.62 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -59.72 -34.85 73.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.713 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.56 -12.79 10.97 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.171 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.5 mp -92.58 -31.65 15.11 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.603 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -38.68 -25.58 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.226 178.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.603 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 3.8 mmt -43.33 -26.25 0.18 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.5 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -102.81 -39.68 6.89 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.133 179.062 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.474 HH21 ' HB2' ' A' ' 124' ' ' HIS . 29.1 ttm-85 34.52 72.31 0.09 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.717 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.613 HG23 ' N ' ' A' ' 129' ' ' ILE . 33.9 m -56.04 -48.19 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.545 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.868 HG21 ' CE2' ' A' ' 93' ' ' PHE . 7.8 tp -86.88 152.55 3.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.422 ' OG ' ' OE1' ' A' ' 133' ' ' GLU . 1.9 p -99.13 125.5 44.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.465 0.65 . . . . 0.0 111.78 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.645 ' CD1' ' CE1' ' A' ' 145' ' ' PHE . 0.1 OUTLIER -52.7 -43.32 65.56 Favored 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.406 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 131' ' ' TYR . 1.4 mp0 -39.66 -62.75 0.65 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.95 178.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.422 ' OE1' ' OG ' ' A' ' 130' ' ' SER . 14.9 mt-10 -50.74 -37.42 41.79 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 131' ' ' TYR . . . -70.84 -24.7 76.79 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 131' ' ' TYR . 31.4 tttm -73.68 -55.99 5.57 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -53.97 -35.47 61.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.505 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.608 HD21 ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -68.15 -62.66 1.3 Allowed 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -47.24 -35.37 7.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.775 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.57 -33.37 72.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.154 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -63.95 -47.14 81.62 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.168 -179.246 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.65 ' CE2' ' CE1' ' A' ' 100' ' ' HIS . 29.7 m95 -90.44 -4.0 57.3 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.204 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 72.4 27.66 2.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.493 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -89.2 166.33 13.88 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.125 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -108.18 126.38 52.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.149 0.499 . . . . 0.0 111.47 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.645 ' CE1' ' CD1' ' A' ' 131' ' ' TYR . 11.3 t80 -98.63 122.0 41.3 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.863 -178.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.99 131.28 20.81 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.449 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 11.0 mt-10 -100.39 119.78 38.97 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.491 ' OG ' HG21 ' A' ' 159' ' ' VAL . 0.8 OUTLIER -134.44 -178.95 5.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.736 -179.507 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.04 137.9 39.86 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.968 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.526 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -59.92 -46.13 90.36 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -69.13 11.87 0.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.359 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 150' ' ' ALA . 3.8 tt0 -137.68 117.79 13.48 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.231 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 10.1 t-20 -77.42 -56.71 4.31 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.43 ' OE1' ' OE2' ' A' ' 152' ' ' GLU . 0.0 OUTLIER -36.47 -59.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.051 0.453 . . . . 0.0 111.229 -179.036 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.621 ' O ' HG23 ' A' ' 159' ' ' VAL . 3.2 p -52.35 -53.81 39.88 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.84 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -47.48 -59.51 3.19 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.598 0.714 . . . . 0.0 110.116 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 47.9 t -48.45 -42.76 12.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.733 -1.122 . . . . 0.0 110.865 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -60.45 -40.95 93.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.533 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 155' ' ' THR . 14.2 t -62.51 -46.27 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.21 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.636 ' CE1' ' CG ' ' A' ' 26' ' ' PHE . 15.2 m-85 -68.66 -24.04 64.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.365 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.8 ttm-85 -77.34 -41.11 41.74 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.01 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.2 mmm-85 -65.66 -33.93 77.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.978 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 164' ' ' ILE . 3.3 tt -68.93 -50.59 52.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.449 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.713 HG21 HG11 ' A' ' 49' ' ' VAL . 94.3 mt -50.99 -35.96 15.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.181 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.23 -60.52 3.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.837 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -60.92 -26.7 67.66 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.704 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -61.64 -33.22 73.57 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.437 ' O ' ' OD2' ' A' ' 171' ' ' ASP . 2.7 tp10 -69.1 -50.13 50.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.417 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -62.37 -51.22 68.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.153 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 24.6 mt -53.59 -42.35 49.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.419 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.437 ' OD2' ' O ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -68.34 -38.58 81.65 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.482 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -54.6 -42.2 76.07 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.87 -73.88 0.15 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.738 0.304 . . . . 0.0 110.607 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.838 -179.727 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 121.11 0.481 . . . . 0.0 110.453 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.492 ' NH2' ' OD2' ' A' ' 171' ' ' ASP . 0.0 OUTLIER -139.7 134.92 32.62 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.657 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.436 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 5.0 mtmm -106.26 125.51 51.09 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.762 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -101.27 119.98 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 121.573 0.702 . . . . 0.0 110.442 -178.77 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.5 134.89 34.83 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.48 -0.763 . . . . 0.0 111.083 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.477 HD13 ' OG1' ' A' ' 23' ' ' THR . 18.3 mt -95.9 125.65 48.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.294 0.569 . . . . 0.0 111.447 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.492 ' CD2' HD13 ' A' ' 99' ' ' ILE . 13.2 tp -124.49 104.28 8.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.532 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -139.65 135.89 7.49 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.494 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.1 OUTLIER -52.08 -160.97 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.518 0.675 . . . . 0.0 111.144 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.7 ttt-85 -93.52 135.14 35.06 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.407 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m 65.93 6.02 3.79 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.426 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.503 ' C ' ' HZ2' ' A' ' 120' ' ' LYS . 3.9 p -65.9 -17.97 23.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.813 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.2 25.29 37.42 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.445 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -65.26 -38.13 89.34 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.875 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.4 m -70.06 -35.52 74.29 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.2 m -60.45 -43.25 97.04 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.762 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 25' ' ' GLN . 22.8 tp -68.16 -56.42 8.85 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.271 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.63 ' O ' HG12 ' A' ' 27' ' ' VAL . 93.3 m -38.43 -36.65 0.25 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.51 -42.9 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.78 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.753 HE22 ' ND2' ' A' ' 153' ' ' ASN . 3.0 tp-100 -63.9 -38.32 90.64 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.135 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -76.48 -61.72 1.86 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.101 0.477 . . . . 0.0 111.668 -178.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.692 HG21 ' CG ' ' A' ' 43' ' ' PHE . 8.6 p -48.03 -47.9 12.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.672 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.632 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.0 tt0 -84.16 -23.56 30.57 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 75.01 23.4 74.67 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.532 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 11.7 mp0 -148.58 129.99 14.79 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.637 ' N ' ' NE2' ' A' ' 25' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.977 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -174.66 -177.0 1.1 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.465 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.08 124.35 32.59 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.686 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.692 ' CG ' HG21 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -107.15 174.66 5.79 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 120.993 0.425 . . . . 0.0 110.201 179.175 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.28 162.75 34.73 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.16 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -160.04 107.18 1.63 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.309 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.1 mp -106.35 118.58 37.0 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.195 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.651 ' H ' HD12 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -149.38 165.14 3.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.575 -179.721 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.6 m -109.01 127.9 54.49 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.261 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.877 HG11 HG21 ' A' ' 164' ' ' ILE . 6.6 p -127.61 134.08 66.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.387 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.37 3.95 3.52 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.465 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.35 -12.89 63.33 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -91.71 141.23 28.92 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -76.68 144.83 39.15 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.55 0.691 . . . . 0.0 111.114 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.435 ' OH ' ' OE2' ' A' ' 168' ' ' GLU . 9.7 m-85 -135.89 124.21 23.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.203 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.709 ' C ' HD12 ' A' ' 56' ' ' LEU . 2.6 m-70 -118.05 113.37 21.54 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.709 HD12 ' C ' ' A' ' 55' ' ' HIS . 11.2 mp -123.59 146.44 48.15 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.601 0.715 . . . . 0.0 112.128 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.8 ' C ' HD13 ' A' ' 58' ' ' LEU . 0.7 OUTLIER -138.78 127.03 22.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.934 178.464 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.985 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.91 153.1 34.14 Favored 'General case' 0 CA--C 1.499 -1.018 0 C-N-CA 120.251 -0.579 . . . . 0.0 111.886 -178.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.53 144.46 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.718 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.96 105.35 9.91 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.344 -1.298 . . . . 0.0 107.961 177.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.479 0 CA-C-O 121.375 0.607 . . . . 0.0 110.445 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 80' ' ' GLY . 41.4 pt . . . . . 0 N--CA 1.435 -1.177 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.07 15.67 1.06 Allowed 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.356 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.51 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -146.21 164.35 28.32 Favored Glycine 0 C--O 1.229 -0.214 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.473 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.11 125.1 8.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.068 -0.566 . . . . 0.0 111.475 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 82' ' ' ILE . 9.8 tt -131.08 104.82 9.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.995 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -96.6 126.17 41.59 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.525 -177.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -96.6 130.75 44.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.091 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.609 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 37.2 p90 -128.99 144.5 51.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.444 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.454 ' C ' ' H ' ' A' ' 88' ' ' THR . 4.1 p -87.27 142.83 27.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.211 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.614 HG21 ' N ' ' A' ' 124' ' ' HIS . 22.8 m -71.28 12.69 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.776 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.454 ' H ' ' C ' ' A' ' 86' ' ' SER . 8.6 t -132.86 -20.09 2.25 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 120.892 0.377 . . . . 0.0 111.904 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.533 ' C ' ' N ' ' A' ' 91' ' ' LYS . 33.1 t -90.13 92.63 9.04 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.758 -176.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 tp -61.12 -11.19 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.634 ' O ' HG22 ' A' ' 95' ' ' VAL . 3.3 mttp -78.04 -52.01 9.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 113.351 -1.75 . . . . 0.0 110.327 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 53.5 p -60.58 -33.58 72.93 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.643 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.609 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -74.06 -49.38 24.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.281 -179.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.447 ' O ' HG23 ' A' ' 98' ' ' VAL . 40.0 mt-10 -65.23 -42.65 93.2 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.707 -178.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.794 ' O ' HG22 ' A' ' 99' ' ' ILE . 20.1 m -67.42 -38.51 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.652 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.422 ' N ' HG23 ' A' ' 95' ' ' VAL . 2.6 mt -62.25 -38.12 80.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.347 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -69.43 -29.01 66.63 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 94' ' ' GLU . 59.2 t -75.83 -67.03 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.208 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.794 HG22 ' O ' ' A' ' 95' ' ' VAL . 3.1 tt -48.3 -40.12 9.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.615 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.467 ' CE1' ' CD2' ' A' ' 141' ' ' TRP . 12.3 t-80 -58.3 -64.54 0.88 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.484 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -42.64 -60.07 2.98 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 105' ' ' ASP . 14.6 tptp -57.31 -65.22 0.66 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.855 -0.672 . . . . 0.0 110.627 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -36.83 -55.87 0.88 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.237 0.542 . . . . 0.0 109.751 179.519 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.743 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -49.64 -47.75 49.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.73 0.776 . . . . 0.0 109.365 178.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.895 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.338 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.476 ' OE1' ' CB ' ' A' ' 173' ' ' ALA . 50.1 mt-30 . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 120.991 0.424 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.473 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -108.04 137.11 19.74 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.474 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.408 ' N ' HG21 ' A' ' 170' ' ' ILE . 44.1 Cg_exo -47.82 117.57 2.52 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.466 1.444 . . . . 0.0 112.313 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 143' ' ' ALA . 2.5 mp -124.78 132.31 71.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.546 ' O ' HD12 ' A' ' 83' ' ' LEU . 4.8 tpt -131.9 117.44 18.48 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.937 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.0 mt -95.75 97.4 9.67 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.0 t -103.91 133.15 48.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 122.327 1.061 . . . . 0.0 110.665 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.413 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -106.18 112.6 3.92 Favored Glycine 0 C--N 1.304 -1.229 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.188 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.497 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.1 t30 -96.98 176.94 5.78 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.898 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.503 ' HZ2' ' C ' ' A' ' 17' ' ' VAL . 8.7 mttp 63.41 58.79 1.31 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.221 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.407 ' H ' ' HB3' ' A' ' 149' ' ' SER . 6.0 tttm -65.03 -12.93 56.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.748 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.451 ' OD2' ' CD1' ' A' ' 123' ' ' LEU . 2.6 p-10 -81.3 -8.43 59.74 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.101 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.598 ' O ' ' N ' ' A' ' 126' ' ' GLU . 11.1 mp -98.52 -23.11 15.66 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.614 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -26.88 -38.59 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.343 1.027 . . . . 0.0 111.284 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.543 ' N ' ' O ' ' A' ' 123' ' ' LEU . 2.0 mmt -46.85 -15.95 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.006 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 123' ' ' LEU . 18.6 mm-40 -92.58 -62.68 1.35 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.406 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.561 HH21 ' CD2' ' A' ' 124' ' ' HIS . 5.2 tpp85 26.18 65.74 0.07 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.008 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.9 t -49.01 -29.43 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.955 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.2 tp -88.82 156.36 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.877 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.52 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 74.9 p -97.85 123.09 41.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.348 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -37.77 -31.32 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.26 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.6 mp0 -71.66 -64.12 0.99 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.848 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.52 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 67.4 mt-10 -41.1 -40.95 1.63 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.952 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.91 -36.4 65.25 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 132' ' ' GLU . 13.8 tttm -62.39 -54.44 40.29 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.074 -0.563 . . . . 0.0 109.681 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.7 -35.76 71.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.794 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.18 -61.86 1.88 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.89 -38.01 61.25 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.17 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.43 -29.92 68.68 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.263 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.7 -46.67 81.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.989 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.479 ' CZ3' ' CD2' ' A' ' 104' ' ' LEU . 53.0 m95 -89.57 -3.49 58.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.143 0.496 . . . . 0.0 110.148 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 77.07 22.39 1.02 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.723 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.33 167.89 13.14 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.3 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.58 133.9 51.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.338 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.655 ' O ' HD22 ' A' ' 146' ' ' LEU . 6.0 t80 -96.68 122.02 39.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.679 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.794 HD12 HG22 ' A' ' 159' ' ' VAL . 1.2 mm? -134.17 137.91 44.78 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.964 -176.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.483 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 4.1 tt0 -126.24 111.5 14.65 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 27.5 p -137.66 -172.89 3.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.03 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.407 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -137.98 141.48 40.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.221 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.479 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -61.66 -45.61 93.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.354 0.597 . . . . 0.0 109.4 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.445 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 15.7 tttp -65.81 5.22 0.5 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.644 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.479 ' H ' ' C ' ' A' ' 150' ' ' ALA . 43.9 mt-10 -133.85 120.4 20.39 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.836 0.351 . . . . 0.0 110.974 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.753 ' ND2' HE22 ' A' ' 25' ' ' GLN . 0.0 OUTLIER -77.57 -57.5 3.79 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.071 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 153' ' ' ASN . 9.0 tt0 -36.85 -58.43 0.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.976 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.602 ' O ' HG23 ' A' ' 159' ' ' VAL . 58.8 p -52.06 -45.07 64.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.98 0.419 . . . . 0.0 110.045 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -56.16 -61.37 2.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.493 0.663 . . . . 0.0 109.869 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 59.7 t -40.83 -39.98 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.331 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -65.91 -38.33 88.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.149 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.794 HG22 HD12 ' A' ' 146' ' ' LEU . 21.7 t -67.99 -37.31 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.55 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.75 ' CZ ' HD11 ' A' ' 164' ' ' ILE . 1.2 t80 -57.76 -65.32 0.66 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.338 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.445 ' O ' ' N ' ' A' ' 164' ' ' ILE . 1.1 ttt-85 -46.73 -64.9 0.65 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.117 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.453 ' HA ' HD12 ' A' ' 165' ' ' LEU . 11.3 mmt180 -41.66 -31.21 0.27 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.331 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -68.05 -40.87 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 119.526 -0.869 . . . . 0.0 109.837 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.877 HG21 HG11 ' A' ' 49' ' ' VAL . 49.6 mt -63.92 -38.56 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.71 0.767 . . . . 0.0 109.961 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 168' ' ' GLU . 25.1 mt -57.63 -64.39 0.91 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.018 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -54.56 -25.39 25.79 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -69.53 -27.85 65.51 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 165' ' ' LEU . 3.0 tp10 -69.18 -57.85 4.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.019 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -57.76 -58.86 6.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.791 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.408 HG21 ' N ' ' A' ' 113' ' ' PRO . 1.4 mp -52.86 -34.34 20.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.689 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.492 ' OD2' ' NH2' ' A' ' 7' ' ' ARG . 0.4 OUTLIER -67.39 -40.07 85.65 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.144 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -57.59 -39.6 91.21 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.476 ' CB ' ' OE1' ' A' ' 111' ' ' GLN . . . -69.41 -81.5 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.754 0.312 . . . . 0.0 110.243 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.832 179.923 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.88 0.371 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.19 137.42 34.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.057 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.512 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 5.5 mtpm? -103.48 134.36 46.97 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.487 HD13 ' C ' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -115.93 129.01 73.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.744 -176.467 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.82 133.94 33.59 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.267 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.509 HD11 ' HB2' ' A' ' 58' ' ' LEU . 30.6 mt -97.58 133.87 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 120.695 0.284 . . . . 0.0 111.318 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.565 ' C ' HD23 ' A' ' 12' ' ' LEU . 5.1 tt -130.45 97.67 4.46 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.459 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -141.18 133.41 5.81 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.431 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.475 ' O ' HG12 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -57.9 -173.89 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.075 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -84.89 125.21 32.45 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.195 0.522 . . . . 0.0 111.427 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 75.31 12.1 3.33 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.593 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 14' ' ' TYR . 7.5 p -71.14 -20.86 21.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.535 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.57 24.16 12.74 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.013 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.3 pttm -69.07 -36.49 77.69 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.322 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.1 m -71.86 -26.49 62.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.4 m -68.29 -43.45 77.69 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.163 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.2 tp -77.65 -41.41 38.41 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.897 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.586 ' O ' HG12 ' A' ' 27' ' ' VAL . 16.3 m -52.56 -38.83 60.66 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -78.07 -38.4 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.038 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.554 ' CG ' ' ND2' ' A' ' 153' ' ' ASN . 0.1 OUTLIER -69.51 -33.65 73.15 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.398 -179.497 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -77.98 -61.14 2.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.197 0.522 . . . . 0.0 111.047 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.9 p -46.39 -48.05 6.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.77 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.617 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.2 tt0 -84.18 -24.74 30.0 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 77.97 22.91 67.67 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.252 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -153.02 127.14 9.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.797 ' H ' HD21 ' A' ' 153' ' ' ASN . 60.1 t80 . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.412 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 40' ' ' GLU . 3.9 m-20 166.88 -179.29 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.5 0.667 . . . . 0.0 112.504 -178.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.451 HG23 HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -108.98 134.49 51.55 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.632 179.507 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -112.2 170.96 7.8 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.8 156.37 40.07 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HB2' HG23 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -168.06 131.16 1.57 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.668 178.415 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.5 mp -105.97 133.29 50.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.533 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.31 165.4 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.897 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.7 m -133.24 131.16 39.97 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.802 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.738 HG11 HD13 ' A' ' 164' ' ' ILE . 7.6 p -133.89 136.44 53.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.296 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 61.51 2.94 0.73 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.224 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 105.18 -11.29 48.03 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -89.07 118.55 28.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.634 0.254 . . . . 0.0 110.687 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.26 144.23 28.24 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.278 0.561 . . . . 0.0 111.805 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.655 ' CE1' HG12 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -140.63 152.96 45.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.16 178.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.627 ' C ' HD12 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -118.88 116.94 27.53 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.441 179.011 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.627 HD12 ' C ' ' A' ' 55' ' ' HIS . 9.9 mp -117.38 139.36 50.96 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.748 0.785 . . . . 0.0 111.193 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -130.08 125.76 35.96 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.097 -1.41 . . . . 0.0 109.195 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.905 ' N ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -113.7 135.03 54.38 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.322 -178.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.451 HG23 HG23 ' A' ' 42' ' ' THR . 0.3 OUTLIER -118.99 139.95 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -118.83 112.97 20.37 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.626 178.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.3 p . . . . . 0 CA--C 1.512 -0.508 0 CA-C-O 121.316 0.579 . . . . 0.0 111.019 -179.663 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 80' ' ' GLY . 40.2 pt . . . . . 0 N--CA 1.43 -1.444 0 CA-C-O 121.297 0.57 . . . . 0.0 112.373 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -144.53 17.85 1.67 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.757 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.631 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -159.03 166.49 34.58 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.345 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.16 127.39 11.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.553 -0.823 . . . . 0.0 110.7 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.764 HG23 ' O ' ' A' ' 82' ' ' ILE . 12.3 tt -129.18 96.9 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.57 118.58 34.39 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.355 -177.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 84' ' ' VAL . 2.1 t -96.95 111.02 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.273 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.511 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 4.1 p90 -110.66 142.39 42.61 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.416 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.462 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.5 p -88.94 141.17 28.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.429 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.634 HG21 ' N ' ' A' ' 124' ' ' HIS . 19.1 m -77.58 18.05 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.771 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.99 -25.26 1.62 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.51 ' C ' ' N ' ' A' ' 91' ' ' LYS . 20.6 t -94.0 92.37 7.32 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.333 -176.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 90' ' ' ILE . 10.3 tp -59.57 -10.43 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.553 ' O ' HG13 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -78.18 -54.96 5.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.247 179.004 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.1 p -55.13 -27.22 43.8 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.511 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -76.75 -39.58 51.26 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.625 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.456 ' O ' HG23 ' A' ' 98' ' ' VAL . 3.9 mm-40 -68.23 -44.17 76.32 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.22 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 91' ' ' LYS . 2.3 m -69.37 -40.81 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.584 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.428 ' CG1' HD22 ' A' ' 12' ' ' LEU . 18.0 mt -57.09 -51.28 71.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.292 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -72.35 -31.65 65.81 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.853 0.358 . . . . 0.0 111.412 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 94' ' ' GLU . 18.8 t -73.46 -66.36 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.351 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.426 ' O ' ' C ' ' A' ' 100' ' ' HIS . 31.9 mt -48.16 -55.72 2.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.494 ' CE1' ' CE2' ' A' ' 141' ' ' TRP . 25.9 t-80 -41.16 -63.82 0.63 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.64 -52.0 1.9 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 103' ' ' LEU . 24.3 tptt -70.48 -66.66 0.57 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.386 -0.407 . . . . 0.0 111.106 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -36.71 -55.07 0.89 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.969 0.414 . . . . 0.0 109.946 179.718 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.699 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -51.91 -50.7 60.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.495 0.664 . . . . 0.0 109.449 179.157 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.469 ' N ' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.312 -1.027 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.032 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.451 ' HB3' HG23 ' A' ' 170' ' ' ILE . 59.5 mt-30 . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.842 0.353 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.671 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.8 OUTLIER -117.66 152.91 50.36 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.33 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -46.45 111.42 0.36 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 121.717 1.611 . . . . 0.0 112.338 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.479 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.9 mt -121.62 131.82 72.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.1 tpt -128.01 115.78 19.03 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.623 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.9 mt -95.25 97.55 9.96 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.4 133.31 47.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 122.298 1.047 . . . . 0.0 110.996 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.41 110.23 3.41 Favored Glycine 0 C--N 1.304 -1.231 0 CA-C-N 113.459 -1.7 . . . . 0.0 109.018 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.481 ' CG ' ' N ' ' A' ' 120' ' ' LYS . 43.8 t30 -97.23 174.04 6.92 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.818 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.481 ' N ' ' CG ' ' A' ' 119' ' ' ASN . 2.1 mttp 67.11 59.13 0.54 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.845 0.831 . . . . 0.0 109.226 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.37 -37.49 87.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.368 -178.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -59.88 -9.88 3.41 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.899 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.6 mp -93.99 -29.73 15.08 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.634 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -42.03 -22.77 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.805 178.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.568 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 3.5 mmt -46.65 -23.18 0.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.478 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.3 OUTLIER -103.34 -40.48 6.38 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.218 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.497 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 5.0 tpp85 33.16 83.29 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.199 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.0 m -67.87 -29.5 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.546 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.1 tp -89.42 155.07 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.497 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.447 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 82.0 p -94.7 122.54 37.41 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.838 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -41.35 -33.66 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.404 0.621 . . . . 0.0 109.52 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.5 mp0 -65.07 -64.71 0.8 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.932 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.447 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 65.4 mt-10 -41.26 -43.96 2.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.023 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.16 -32.97 69.0 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 132' ' ' GLU . 20.0 tttm -65.72 -55.26 18.27 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.08 -34.04 65.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.494 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.77 -62.7 1.36 Allowed 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.841 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -55.22 -34.71 64.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.543 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.15 -34.75 75.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.735 0.302 . . . . 0.0 110.55 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.04 -46.29 88.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.906 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.494 ' CE2' ' CE1' ' A' ' 100' ' ' HIS . 56.9 m95 -88.45 -4.51 58.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.977 0.418 . . . . 0.0 110.327 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 73.88 25.1 1.97 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.619 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -90.8 168.34 11.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.42 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.32 133.89 49.34 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.794 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.66 ' O ' HD22 ' A' ' 146' ' ' LEU . 4.6 t80 -96.65 121.37 38.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.182 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.66 HD22 ' O ' ' A' ' 145' ' ' PHE . 1.4 mm? -134.71 137.07 43.19 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.624 -176.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.497 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 5.8 tt0 -124.62 111.01 15.12 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.524 ' OG ' HG21 ' A' ' 159' ' ' VAL . 10.7 p -135.5 -174.96 3.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.994 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.47 132.94 32.08 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.053 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.457 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -56.26 -53.04 61.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.283 0.563 . . . . 0.0 109.732 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -49.4 -12.38 0.06 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.786 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.457 ' H ' ' C ' ' A' ' 150' ' ' ALA . 31.8 mt-10 -122.64 124.17 42.83 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.64 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.797 HD21 ' H ' ' A' ' 31' ' ' PHE . 29.1 m120 -77.71 -53.21 7.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 153' ' ' ASN . 10.7 tt0 -38.81 -57.34 1.23 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.924 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.666 ' O ' HG23 ' A' ' 159' ' ' VAL . 44.2 p -51.97 -44.89 64.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.987 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -55.89 -61.58 2.28 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.566 0.698 . . . . 0.0 109.868 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 61.3 t -41.62 -39.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.518 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -67.86 -36.98 81.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.633 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 155' ' ' THR . 35.5 t -66.61 -36.24 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.803 ' CZ ' HD11 ' A' ' 164' ' ' ILE . 1.3 t80 -62.47 -65.69 0.65 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.691 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -44.09 -53.51 6.32 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.741 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -55.81 -29.45 59.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.914 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -66.64 -35.95 76.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.248 -179.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.803 HD11 ' CZ ' ' A' ' 160' ' ' PHE . 42.5 mt -67.54 -38.19 80.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.587 0.708 . . . . 0.0 109.948 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.13 -63.23 1.37 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.748 -178.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -57.59 -31.42 66.15 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.879 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -60.08 -32.3 70.83 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.475 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.49 -55.07 9.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.004 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -55.45 -63.11 1.27 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.091 0.472 . . . . 0.0 110.552 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.671 HG21 ' C ' ' A' ' 112' ' ' ILE . 96.7 mt -51.23 -35.36 15.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.792 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.12 -40.0 86.77 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -57.38 -32.61 64.35 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.85 -79.43 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.727 0.299 . . . . 0.0 110.297 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.153 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.275 -179.889 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 CA-C-O 121.073 0.463 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -139.67 135.42 33.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.939 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.523 ' HB2' HG22 ' A' ' 78' ' ' ILE . 8.3 mttm -106.56 130.05 54.39 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.749 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -103.77 123.04 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-O 121.426 0.631 . . . . 0.0 110.479 -178.586 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.19 134.86 34.95 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.113 -0.992 . . . . 0.0 110.216 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.451 HD11 ' HB2' ' A' ' 58' ' ' LEU . 16.9 mt -96.12 133.71 36.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.502 0.667 . . . . 0.0 111.905 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.548 HD13 HG12 ' A' ' 96' ' ' ILE . 2.0 tt -125.18 97.67 5.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.352 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -139.89 130.56 4.74 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.009 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.425 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -57.99 -155.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.04 139.36 31.5 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.752 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.7 m 56.8 10.8 0.79 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.986 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.68 -20.84 28.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.459 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.54 22.6 18.42 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 pttm -72.2 -34.44 68.38 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.856 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.462 ' O ' HD13 ' A' ' 24' ' ' ILE . 56.5 m -77.25 -35.19 55.58 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.569 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.06 -36.14 81.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 29.4 tp -76.88 -46.58 24.01 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.471 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.552 ' O ' HG12 ' A' ' 27' ' ' VAL . 71.9 m -45.07 -41.5 7.75 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.92 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.462 HD13 ' O ' ' A' ' 20' ' ' SER . 1.3 mp -77.62 -41.84 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.232 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.495 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.5 OUTLIER -69.43 -32.31 71.2 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.492 -178.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.46 ' CG ' ' N ' ' A' ' 27' ' ' VAL . 0.6 OUTLIER -77.92 -63.19 1.45 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.27 0.557 . . . . 0.0 110.805 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.586 HG13 ' N ' ' A' ' 28' ' ' GLU . 11.3 p -44.38 -47.59 2.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.424 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.586 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.5 tt0 -83.14 -24.61 32.49 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 75.12 25.63 68.37 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.288 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 25' ' ' GLN . 0.6 OUTLIER -151.61 126.37 9.62 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 120.886 0.374 . . . . 0.0 111.691 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.1 t80 . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.95 178.48 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.426 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 1.4 pm0 . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 0.7 OUTLIER 178.99 -179.78 0.38 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.249 0.547 . . . . 0.0 112.079 -179.15 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.95 132.91 53.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.072 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -114.45 173.92 6.22 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.167 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.55 155.59 43.74 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -155.4 108.04 2.71 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.604 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 46' ' ' LEU . 8.0 mp -105.36 122.45 45.98 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.725 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 pp -149.55 165.83 3.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.551 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.1 m -114.05 123.81 50.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.567 HG12 ' CD1' ' A' ' 54' ' ' TYR . 7.5 p -119.07 125.39 74.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-N 116.352 -0.386 . . . . 0.0 109.963 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 67.46 15.46 9.85 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.51 -9.95 76.02 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.37 135.71 33.51 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.39 146.99 40.37 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.597 0.713 . . . . 0.0 111.271 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.567 ' CD1' HG12 ' A' ' 49' ' ' VAL . 4.9 m-85 -137.92 123.58 19.82 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.192 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.502 ' NE2' HD23 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -118.16 112.47 20.2 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.491 HD12 ' C ' ' A' ' 55' ' ' HIS . 8.9 mp -120.92 146.71 46.34 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.585 0.707 . . . . 0.0 112.24 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.805 ' C ' HD13 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -137.56 126.93 24.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.01 178.25 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.974 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.72 154.51 31.57 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.253 -178.246 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.33 140.8 47.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.485 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.31 114.31 19.39 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.02 177.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.512 -0.495 0 CA-C-O 121.587 0.708 . . . . 0.0 111.029 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.523 HG22 ' HB2' ' A' ' 8' ' ' LYS . 43.7 pt . . . . . 0 N--CA 1.432 -1.348 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.39 20.35 0.84 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.137 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -147.95 164.79 28.89 Favored Glycine 0 CA--C 1.517 0.218 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.682 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.2 123.21 7.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.754 -0.723 . . . . 0.0 111.165 178.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.631 ' C ' HD23 ' A' ' 83' ' ' LEU . 9.9 tt -126.85 110.37 22.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.787 HD23 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.79 119.1 36.97 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.236 -177.331 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.6 133.07 42.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.075 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.474 ' CD2' ' CE2' ' A' ' 93' ' ' PHE . 8.4 p90 -143.32 144.6 32.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.973 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.583 ' C ' ' H ' ' A' ' 88' ' ' THR . 2.2 t -88.24 143.25 27.15 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.853 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.547 HG21 ' N ' ' A' ' 124' ' ' HIS . 20.2 m -67.18 14.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.972 0.415 . . . . 0.0 110.259 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.583 ' H ' ' C ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -127.78 -18.13 4.35 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.53 -178.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.492 ' C ' ' N ' ' A' ' 91' ' ' LYS . 8.6 t -94.95 92.02 6.68 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.447 -175.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.9 tp -62.97 -11.44 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.524 ' O ' HG13 ' A' ' 95' ' ' VAL . 1.0 OUTLIER -78.32 -58.63 3.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 113.712 -1.585 . . . . 0.0 110.576 178.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.503 ' O ' HD12 ' A' ' 96' ' ' ILE . 19.0 p -55.38 -31.62 61.94 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.398 0.618 . . . . 0.0 109.539 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.474 ' CE2' ' CD2' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -77.72 -38.1 47.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.195 179.677 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 98' ' ' VAL . 34.9 mt-10 -69.21 -46.79 66.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.477 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 91' ' ' LYS . 2.8 m -67.8 -45.23 84.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.59 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.548 HG12 HD13 ' A' ' 12' ' ' LEU . 33.3 mt -58.41 -46.14 89.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.536 ' HG3' HD11 ' A' ' 137' ' ' LEU . 0.5 OUTLIER -72.24 -37.73 69.06 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.097 0.475 . . . . 0.0 111.06 -179.439 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 94' ' ' GLU . 56.0 t -72.11 -65.3 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.672 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.408 ' O ' ' C ' ' A' ' 100' ' ' HIS . 73.3 mt -42.3 -59.12 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.915 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.441 ' ND1' ' N ' ' A' ' 101' ' ' GLY . 4.3 t-80 -40.98 -64.98 0.47 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.752 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.441 ' N ' ' ND1' ' A' ' 100' ' ' HIS . . . -36.6 -56.71 1.25 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 103' ' ' LEU . 32.8 tptt -69.8 -66.5 0.58 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.472 -0.364 . . . . 0.0 111.611 -179.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.47 ' C ' ' O ' ' A' ' 102' ' ' LYS . 5.8 tp -36.98 -61.83 0.53 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.707 ' C ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -44.5 -50.67 9.38 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.489 ' N ' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.79 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.448 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.548 ' O ' ' HB2' ' A' ' 174' ' ' ALA . 38.4 mt-30 . . . . . 0 CA--C 1.521 -0.164 0 CA-C-O 120.932 0.396 . . . . 0.0 110.689 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.67 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.8 OUTLIER -118.52 155.84 51.77 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.343 179.242 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -47.04 111.43 0.39 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.813 1.675 . . . . 0.0 112.254 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.476 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.7 mt -121.84 127.3 75.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 6.6 tpt -128.62 117.23 20.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.09 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.7 mt -95.95 97.79 9.9 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.413 ' O ' ' CE1' ' A' ' 85' ' ' TYR . 29.8 t -104.92 128.56 58.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 122.175 0.988 . . . . 0.0 111.319 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.457 ' CA ' ' CE2' ' A' ' 85' ' ' TYR . . . -102.65 114.5 4.91 Favored Glycine 0 C--N 1.307 -1.04 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.508 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 49.1 t30 -97.8 177.16 5.55 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.698 -178.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.508 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 19.4 mttt 61.91 59.17 1.77 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.071 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.444 ' H ' ' HB3' ' A' ' 149' ' ' SER . 29.5 tttm -64.92 -17.99 64.83 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -79.24 0.65 27.74 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.844 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 125' ' ' MET . 9.2 mp -95.88 -25.43 16.01 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.547 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -37.39 -28.19 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.531 178.449 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.521 ' N ' ' O ' ' A' ' 123' ' ' LEU . 9.3 mtt -45.43 -23.58 0.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.471 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -108.98 -38.83 5.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.844 179.397 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.467 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 0.0 OUTLIER 28.68 86.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.173 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.9 m -72.79 -31.65 37.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.451 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.42 151.8 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.779 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.456 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 94.4 p -104.21 126.39 51.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.153 0.501 . . . . 0.0 111.417 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.455 ' CE1' ' CE1' ' A' ' 145' ' ' PHE . 0.8 OUTLIER -39.95 -38.86 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.313 178.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -63.21 -64.85 0.79 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.236 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.456 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 59.8 mt-10 -41.08 -46.54 2.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.116 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.42 -33.2 76.72 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 132' ' ' GLU . 21.4 tttm -63.87 -55.42 22.92 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.12 -35.75 69.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.674 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.536 HD11 ' HG3' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -66.79 -62.42 1.46 Allowed 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 121.18 0.514 . . . . 0.0 109.779 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.04 -36.61 50.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.288 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -68.12 -32.52 72.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.755 0.312 . . . . 0.0 110.26 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.89 -46.15 86.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.844 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.451 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 49.7 m95 -88.26 -4.51 58.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.345 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 74.63 27.52 1.31 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.399 0.618 . . . . 0.0 109.411 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -95.46 170.01 9.65 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.57 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.92 133.07 52.79 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.018 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.695 ' O ' HD22 ' A' ' 146' ' ' LEU . 8.3 t80 -97.24 122.33 40.14 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.445 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.825 HD21 ' HE ' ' A' ' 162' ' ' ARG . 1.5 mm? -134.58 136.37 42.92 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.713 -176.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.467 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 5.8 tt0 -123.38 111.95 16.99 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.518 ' OG ' HG21 ' A' ' 159' ' ' VAL . 22.7 p -137.33 -175.74 4.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.752 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.444 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -139.26 136.51 35.01 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.908 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.43 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -57.49 -47.41 81.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.274 0.559 . . . . 0.0 109.827 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -56.08 -8.43 0.46 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.449 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 150' ' ' ALA . 30.4 mt-10 -127.53 124.4 38.16 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.806 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.451 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 5.4 t-20 -77.72 -55.87 4.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.02 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 153' ' ' ASN . 1.6 mt-30 -36.73 -57.74 0.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.103 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.669 ' O ' HG23 ' A' ' 159' ' ' VAL . 58.8 p -52.88 -45.25 67.4 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.085 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.495 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -56.21 -61.67 2.24 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.595 0.712 . . . . 0.0 109.934 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 60.6 t -42.77 -39.18 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.534 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -68.77 -33.79 74.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.788 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 155' ' ' THR . 44.6 t -67.61 -39.38 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.074 0.464 . . . . 0.0 109.815 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.509 ' O ' ' N ' ' A' ' 163' ' ' ILE . 66.5 t80 -63.55 -66.24 0.57 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.779 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.0 ttt85 -43.34 -46.47 6.47 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.667 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.825 ' HE ' HD21 ' A' ' 146' ' ' LEU . 14.9 mmm180 -58.06 -32.64 68.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.16 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.509 ' N ' ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -66.22 -34.8 72.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.26 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.599 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 14.1 mt -63.78 -44.1 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.423 0.63 . . . . 0.0 111.295 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -58.79 -64.67 0.85 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.045 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.462 ' H ' HD23 ' A' ' 165' ' ' LEU . 0.4 OUTLIER -50.52 -23.83 2.77 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.676 -178.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -71.77 -31.18 66.35 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.559 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 165' ' ' LEU . 0.5 OUTLIER -70.29 -52.21 24.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.08 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -61.09 -63.56 1.25 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.883 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.67 HG21 ' C ' ' A' ' 112' ' ' ILE . 96.4 mt -50.95 -32.7 12.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.94 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.02 -39.09 86.96 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.484 -0.487 . . . . 0.0 109.908 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -59.48 -35.54 85.78 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.403 ' O ' ' C ' ' A' ' 174' ' ' ALA . . . -68.39 -78.56 0.06 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.025 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 121.223 0.535 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.589 ' NH1' ' HB1' ' A' ' 167' ' ' ALA . 83.4 mtt180 -140.27 135.55 32.39 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.905 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.513 ' HB2' HG22 ' A' ' 78' ' ' ILE . 15.2 mttm -107.3 127.63 53.72 Favored 'General case' 0 C--O 1.212 -0.896 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.768 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.7 OUTLIER -103.02 118.47 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-O 121.691 0.758 . . . . 0.0 110.773 -178.352 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.49 ' HB2' HD13 ' A' ' 78' ' ' ILE . . . -82.73 137.75 34.29 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.691 -0.631 . . . . 0.0 111.848 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.1 mt -92.92 125.82 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.183 0.516 . . . . 0.0 111.92 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tt -123.19 92.33 3.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.896 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -142.03 136.82 7.53 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -178.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.581 ' CD1' HG21 ' A' ' 95' ' ' VAL . 0.5 OUTLIER -53.09 -160.17 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.699 0.762 . . . . 0.0 111.31 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.8 tpp85 -97.11 136.0 38.28 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.701 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.3 m 63.28 11.5 5.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.567 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 p -71.94 -16.84 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.16 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.62 21.35 34.5 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -39.25 81.11 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.359 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.7 m -71.89 -28.65 63.65 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.3 m -63.73 -42.42 97.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.199 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.4 tp -75.53 -28.41 59.08 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.464 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.579 ' O ' HG12 ' A' ' 27' ' ' VAL . 40.0 m -55.94 -49.92 72.18 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.502 HD11 ' CE2' ' A' ' 43' ' ' PHE . 1.4 mp -70.9 -41.04 77.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.075 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.471 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -65.67 -30.24 70.9 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.23 -179.169 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -77.79 -64.02 1.25 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.452 0.644 . . . . 0.0 111.353 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.631 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.1 p -49.65 -47.2 21.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.375 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.631 ' N ' HG13 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -83.66 -24.36 31.38 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.372 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.17 25.99 71.86 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -144.47 125.45 14.42 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.187 0.518 . . . . 0.0 112.297 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.625 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.801 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.553 0 CA-C-O 120.955 0.407 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -160.35 161.7 33.23 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.808 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.5 m -132.52 149.62 52.29 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.266 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.502 ' CE2' HD11 ' A' ' 24' ' ' ILE . 10.9 m-85 -129.63 164.48 23.79 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.55 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -146.72 150.36 35.22 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.148 0.499 . . . . 0.0 111.997 -178.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -153.17 119.19 5.42 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.06 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.706 HD21 ' CE1' ' A' ' 55' ' ' HIS . 6.4 mp -107.01 123.86 48.8 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.127 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.823 HD12 ' CE1' ' A' ' 160' ' ' PHE . 0.8 OUTLIER -145.51 165.63 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.221 179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.36 121.85 44.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.224 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 49' ' ' VAL . 8.5 p -114.59 114.66 47.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.92 179.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 49' ' ' VAL . 4.3 t-20 73.72 11.83 4.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.398 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.82 -8.14 63.37 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.684 ' NE2' ' H ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -93.74 135.17 35.31 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.603 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.684 ' H ' ' NE2' ' A' ' 52' ' ' GLN . 2.4 mt-10 -74.35 145.48 43.81 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.577 0.704 . . . . 0.0 111.252 -178.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.697 ' CE2' HG23 ' A' ' 164' ' ' ILE . 4.3 m-85 -136.18 127.07 27.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.183 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.706 ' CE1' HD21 ' A' ' 46' ' ' LEU . 2.2 t-160 -117.63 112.87 21.11 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.505 HD12 ' C ' ' A' ' 55' ' ' HIS . 9.0 mp -118.46 139.12 51.91 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.537 0.684 . . . . 0.0 111.575 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.731 ' C ' HD13 ' A' ' 58' ' ' LEU . 1.9 mt-30 -132.16 121.0 23.02 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.098 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.931 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -114.64 155.21 26.98 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.761 -178.214 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.12 145.95 31.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -177.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.407 ' O ' ' OG1' ' A' ' 61' ' ' THR . 0.3 OUTLIER -122.04 117.51 26.53 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 113.504 -1.68 . . . . 0.0 107.898 177.525 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 60' ' ' ASP . 20.3 p . . . . . 0 CA--C 1.497 -1.087 0 O-C-N 123.546 0.528 . . . . 0.0 109.771 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.798 HD12 ' O ' ' A' ' 80' ' ' GLY . 38.3 pt . . . . . 0 N--CA 1.439 -1.024 0 CA-C-O 121.405 0.622 . . . . 0.0 112.664 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.56 19.81 1.04 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.437 178.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.798 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -156.96 168.1 33.89 Favored Glycine 0 CA--C 1.521 0.45 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.187 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -152.15 122.76 7.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.985 -0.608 . . . . 0.0 110.709 177.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.641 HG23 ' O ' ' A' ' 82' ' ' ILE . 11.0 tt -125.34 102.3 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.716 0.77 . . . . 0.0 109.312 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.839 ' N ' HD12 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -97.15 125.72 41.84 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.794 -178.56 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -95.51 130.66 43.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.303 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.681 ' CZ ' HG21 ' A' ' 96' ' ' ILE . 49.8 m-85 -110.56 143.75 40.47 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.14 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.499 ' C ' ' H ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -98.21 124.13 42.63 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.513 HG21 ' N ' ' A' ' 124' ' ' HIS . 14.1 m -72.51 23.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.71 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.499 ' H ' ' C ' ' A' ' 86' ' ' SER . 5.1 t -138.36 -25.57 0.93 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.556 ' C ' ' N ' ' A' ' 91' ' ' LYS . 8.3 t -100.2 95.06 6.55 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.051 -176.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.1 tp -57.86 -11.66 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 175.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' C ' ' A' ' 89' ' ' SER . 18.5 mttp -77.74 -61.51 1.97 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 113.936 -1.483 . . . . 0.0 110.23 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.638 ' O ' HD12 ' A' ' 96' ' ' ILE . 76.5 p -47.17 -29.59 2.4 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.723 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.948 ' CE2' HG21 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -74.07 -51.41 15.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.179 -179.365 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.571 ' O ' HG23 ' A' ' 98' ' ' VAL . 4.0 mm-40 -65.79 -43.96 87.17 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.581 HG21 ' CD1' ' A' ' 14' ' ' TYR . 13.6 m -68.07 -36.5 75.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.12 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.681 HG21 ' CZ ' ' A' ' 85' ' ' TYR . 19.2 mt -63.35 -38.84 83.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -69.68 -25.97 64.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.03 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 94' ' ' GLU . 57.4 t -76.46 -66.47 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.338 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.406 ' H ' HG12 ' A' ' 99' ' ' ILE . 4.5 mm -44.27 -54.36 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.431 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.637 ' ND1' ' CH2' ' A' ' 141' ' ' TRP . 2.0 t-80 -61.45 -64.51 0.92 Allowed 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.805 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.531 ' N ' ' ND1' ' A' ' 100' ' ' HIS . . . -35.39 -57.29 0.91 Allowed Glycine 0 N--CA 1.454 -0.141 0 CA-C-N 116.24 -0.437 . . . . 0.0 112.053 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 103' ' ' LEU . 15.4 tptm -69.69 -65.01 0.77 Allowed 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.359 -0.42 . . . . 0.0 110.736 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.45 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.7 OUTLIER -36.88 -60.87 0.59 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.097 0.475 . . . . 0.0 109.872 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.717 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -46.65 -47.01 20.26 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 178.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.83 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.56 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.424 ' HB3' HG23 ' A' ' 170' ' ' ILE . 34.7 mt-30 . . . . . 0 CA--C 1.522 -0.13 0 CA-C-O 120.801 0.334 . . . . 0.0 110.72 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.647 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.8 OUTLIER -118.62 153.67 52.25 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.233 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -48.04 117.06 2.26 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.582 1.521 . . . . 0.0 111.953 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.481 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.4 mp -122.81 126.45 73.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 8.4 tpt -122.31 112.53 18.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.497 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 73.2 mt -96.67 98.86 10.52 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.6 t -108.45 133.67 52.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 122.04 0.924 . . . . 0.0 112.62 -178.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -97.93 114.29 4.96 Favored Glycine 0 C--N 1.315 -0.615 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -98.09 170.08 9.17 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -177.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.452 ' HB3' HD13 ' A' ' 123' ' ' LEU . 25.8 mttt 61.02 57.37 2.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.274 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.526 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 9.2 ttpt -57.73 -29.06 64.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.418 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -67.5 -16.79 64.39 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.295 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.1 mp -82.01 -31.26 31.11 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.603 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.1 OUTLIER -37.74 -24.71 0.01 OUTLIER 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.366 178.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.603 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 2.7 mmt -48.24 -22.53 0.68 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.44 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -109.0 -37.68 5.76 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.827 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.445 ' NH1' ' OE1' ' A' ' 147' ' ' GLU . 0.2 OUTLIER 27.16 91.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.034 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 38.7 t -70.79 -45.81 71.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.055 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.948 HG21 ' CE2' ' A' ' 93' ' ' PHE . 8.7 tp -91.55 153.54 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.577 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.435 ' OG ' ' OE1' ' A' ' 133' ' ' GLU . 4.1 p -104.51 126.17 51.35 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.3 0.571 . . . . 0.0 111.329 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.638 ' CD1' ' CE1' ' A' ' 145' ' ' PHE . 0.7 OUTLIER -49.41 -43.67 44.71 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 131' ' ' TYR . 1.2 mp0 -39.07 -63.11 0.56 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.344 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.435 ' OE1' ' OG ' ' A' ' 130' ' ' SER . 11.7 mt-10 -52.24 -37.18 54.48 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 131' ' ' TYR . . . -72.27 -22.23 78.97 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 131' ' ' TYR . 0.3 OUTLIER -75.91 -54.68 6.53 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.478 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -54.49 -37.53 65.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.362 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.6 OUTLIER -69.61 -63.72 1.02 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -42.41 -32.95 0.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.27 -48.67 67.02 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.867 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -66.96 -27.82 67.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.475 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.637 ' CH2' ' ND1' ' A' ' 100' ' ' HIS . 22.8 m0 -86.67 -10.94 52.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.69 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.23 27.16 16.92 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.428 ' HB2' ' HB ' ' A' ' 114' ' ' ILE . . . -104.15 166.05 10.65 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.24 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -102.62 127.84 49.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.211 0.529 . . . . 0.0 112.115 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.638 ' CE1' ' CD1' ' A' ' 131' ' ' TYR . 11.3 t80 -99.36 118.67 36.52 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.109 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.03 133.12 22.88 Favored 'General case' 0 C--N 1.347 0.491 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.445 ' OE1' ' NH1' ' A' ' 127' ' ' ARG . 3.1 mt-10 -98.47 115.09 27.78 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.875 -0.515 . . . . 0.0 109.838 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.704 ' OG ' HG21 ' A' ' 159' ' ' VAL . 0.5 OUTLIER -140.54 134.88 31.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.705 -179.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 152' ' ' GLU . 4.0 p -102.29 142.4 33.57 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 152' ' ' GLU . . . -55.53 -55.28 33.67 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.688 178.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 31.3 tttt -46.84 -15.11 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.998 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 150' ' ' ALA . 60.9 mt-10 -126.0 120.12 29.46 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.973 0.416 . . . . 0.0 110.868 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 9.7 t-20 -77.1 -47.48 20.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 153' ' ' ASN . 1.4 mt-30 -36.92 -58.91 0.74 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.229 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.643 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.2 p -56.49 -42.69 78.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.289 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 153' ' ' ASN . . . -53.78 -60.75 2.92 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.555 0.693 . . . . 0.0 109.938 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 49.2 t -45.84 -44.12 4.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.561 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -53.9 -45.18 71.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.265 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.704 HG21 ' OG ' ' A' ' 148' ' ' SER . 2.2 t -65.59 -49.48 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.423 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.823 ' CE1' HD12 ' A' ' 47' ' ' ILE . 1.3 t80 -45.61 -37.5 5.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.807 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.1 ttt-85 -79.14 -50.27 11.28 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.375 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -34.29 69.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.278 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.637 HG23 ' N ' ' A' ' 164' ' ' ILE . 11.8 tt -67.9 -54.6 21.43 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.944 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.783 HD11 ' CE1' ' A' ' 160' ' ' PHE . 90.8 mt -47.38 -34.6 3.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 119.219 -0.992 . . . . 0.0 109.425 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.66 -64.33 0.95 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.059 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -57.12 -30.64 64.56 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.227 -0.589 . . . . 0.0 109.42 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.589 ' HB1' ' NH1' ' A' ' 7' ' ' ARG . . . -58.96 -32.68 69.85 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.41 -53.14 25.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.383 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 12.6 tttm -59.14 -65.02 0.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.883 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.647 HG21 ' C ' ' A' ' 112' ' ' ILE . 74.6 mt -48.74 -35.04 6.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.678 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -67.21 -37.33 83.43 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.03 -30.89 76.82 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.75 -79.54 0.05 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.191 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.768 179.88 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 121.265 0.555 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.23 136.68 33.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.312 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 22.6 mtmt -107.35 130.02 54.84 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.774 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.1 mm -108.77 121.07 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-O 121.342 0.592 . . . . 0.0 110.277 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.62 135.55 35.03 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.259 -0.9 . . . . 0.0 110.533 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.7 mt -95.54 131.69 41.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.415 0.626 . . . . 0.0 112.09 -178.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.613 ' C ' HD23 ' A' ' 12' ' ' LEU . 5.5 tt -132.34 99.09 4.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.719 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.87 135.57 6.81 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -52.45 -165.42 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.49 0.662 . . . . 0.0 110.791 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -100.33 138.09 37.86 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.487 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.52 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 1.3 m 67.66 20.52 9.56 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.36 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 p -90.08 -21.52 6.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.042 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.44 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 108.33 26.25 5.49 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.463 ' CB ' ' NZ ' ' A' ' 19' ' ' LYS . 1.3 ttmp? -60.76 -49.21 78.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.147 0.499 . . . . 0.0 110.094 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -75.98 -25.45 55.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.254 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 54.3 p -65.62 -44.99 84.8 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.453 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 23' ' ' THR . 20.4 tp -76.33 -58.39 3.31 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 119.784 -0.767 . . . . 0.0 110.975 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.603 ' O ' HG12 ' A' ' 27' ' ' VAL . 90.3 m -39.02 -48.68 1.65 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.961 -0.295 . . . . 0.0 110.705 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.517 HD11 ' CE2' ' A' ' 43' ' ' PHE . 1.3 mp -74.62 -35.31 37.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 123.356 0.41 . . . . 0.0 111.34 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.432 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.8 OUTLIER -69.6 -37.74 77.01 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.964 -178.589 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.631 ' CZ ' ' CD1' ' A' ' 160' ' ' PHE . 20.0 t80 -77.15 -59.55 2.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.291 0.567 . . . . 0.0 111.342 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 28' ' ' GLU . 9.5 p -48.71 -47.19 15.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.57 -178.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.61 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.0 tt0 -85.13 -24.42 28.02 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.38 35.76 63.29 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -130.34 125.05 33.68 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.371 0.605 . . . . 0.0 111.641 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.718 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.742 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.66 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.443 ' CB ' ' O ' ' A' ' 60' ' ' ASP . 2.0 pt-20 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.783 0.325 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.409 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 1.3 m120 178.72 173.91 0.68 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.215 0.531 . . . . 0.0 111.83 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.91 143.4 36.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.567 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.517 ' CE2' HD11 ' A' ' 24' ' ' ILE . 12.3 m-85 -127.33 165.9 18.84 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.588 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.59 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -143.61 147.16 33.96 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 120.227 -0.589 . . . . 0.0 112.404 -178.453 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.964 ' C ' HD13 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -162.32 114.61 1.68 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.679 178.864 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.049 HD22 ' H ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -115.16 142.39 46.72 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.821 -1.082 . . . . 0.0 111.159 -177.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.617 HD11 ' CD2' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -150.77 165.73 2.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.274 179.493 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 m -108.33 124.04 49.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.758 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.616 HG11 HG21 ' A' ' 164' ' ' ILE . 7.1 p -120.94 122.76 68.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.139 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 69.65 12.98 8.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.043 0.449 . . . . 0.0 109.954 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.5 -11.37 70.23 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -89.55 133.25 34.69 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -77.39 147.43 36.05 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.522 0.677 . . . . 0.0 111.172 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -137.66 130.73 30.43 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.011 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.687 ' C ' HD22 ' A' ' 56' ' ' LEU . 1.2 m80 -116.54 117.54 30.17 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.687 HD22 ' C ' ' A' ' 55' ' ' HIS . 3.4 mm? -121.6 140.7 51.91 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.449 0.642 . . . . 0.0 112.019 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.803 ' C ' HD13 ' A' ' 58' ' ' LEU . 0.7 OUTLIER -136.52 124.41 22.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.097 178.696 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.95 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.25 154.95 30.3 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.152 0.501 . . . . 0.0 112.065 -178.717 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.27 145.47 35.28 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-N 115.125 -0.943 . . . . 0.0 113.01 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.443 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -123.34 102.66 8.04 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.009 177.646 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.668 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.036 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.662 HD12 ' O ' ' A' ' 80' ' ' GLY . 22.7 pt . . . . . 0 N--CA 1.438 -1.052 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -145.91 16.43 1.4 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.653 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.662 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -150.63 164.38 29.85 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.582 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.71 123.44 7.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.891 -0.655 . . . . 0.0 110.944 178.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.647 HG23 ' O ' ' A' ' 82' ' ' ILE . 11.7 tt -127.26 104.83 13.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.552 0.691 . . . . 0.0 109.696 178.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.737 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -97.7 120.98 39.06 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.406 -178.684 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 84' ' ' VAL . 1.7 t -97.19 114.14 33.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.675 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.505 ' CZ ' ' CA ' ' A' ' 118' ' ' GLY . 48.7 p90 -115.52 145.08 42.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.608 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.429 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.6 p -86.99 143.16 27.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.452 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.532 HG21 ' N ' ' A' ' 124' ' ' HIS . 10.2 m -80.98 17.67 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 120.998 0.428 . . . . 0.0 110.256 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.4 t -130.26 -19.59 3.12 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.406 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.56 ' C ' ' N ' ' A' ' 91' ' ' LYS . 20.9 t -98.95 93.78 6.2 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.298 -176.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.7 tp -58.7 -11.82 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.56 ' N ' ' C ' ' A' ' 89' ' ' SER . 12.9 mttp -77.97 -54.39 6.35 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.442 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.1 p -53.93 -32.28 53.06 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.038 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.912 ' CE2' HG21 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -73.78 -51.0 17.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.025 -179.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.28 -42.62 92.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.876 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 91' ' ' LYS . 17.7 m -65.48 -40.12 87.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.307 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.496 ' CG1' HD22 ' A' ' 12' ' ' LEU . 1.6 mt -63.0 -32.17 55.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.2 tttm -69.85 -26.47 64.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.101 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.4 t -77.24 -67.13 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.957 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 99' ' ' ILE . 1.6 mp -44.26 -38.18 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.245 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.636 ' CD2' ' CZ2' ' A' ' 141' ' ' TRP . 7.3 t60 -66.6 -64.22 0.9 Allowed 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.788 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.556 ' N ' ' CD2' ' A' ' 100' ' ' HIS . . . -35.69 -50.69 1.07 Allowed Glycine 0 C--N 1.329 0.159 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.431 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 17.5 tptm -70.73 -61.15 1.87 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.966 -0.617 . . . . 0.0 110.554 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -42.09 -60.23 1.5 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.462 0.648 . . . . 0.0 109.394 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.735 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -45.98 -44.29 14.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.23 178.51 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.756 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.943 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.466 ' OE1' ' HB1' ' A' ' 173' ' ' ALA . 12.7 mt-30 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.722 0.296 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.663 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.5 OUTLIER -132.67 152.72 80.43 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.264 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -47.84 110.51 0.32 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.949 1.766 . . . . 0.0 112.478 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 3.0 mt -126.51 131.8 70.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 6.2 tpt -129.84 116.97 19.46 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.863 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.9 mt -95.69 98.11 10.23 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.5 t -102.41 126.15 56.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 122.066 0.936 . . . . 0.0 112.144 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.505 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -97.36 115.89 5.37 Favored Glycine 0 C--N 1.31 -0.913 0 N-CA-C 108.067 -2.013 . . . . 0.0 108.067 177.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.494 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 52.6 t30 -96.97 175.89 6.17 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.165 -0.614 . . . . 0.0 112.105 -177.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.52 ' NZ ' ' O ' ' A' ' 16' ' ' SER . 15.6 mttt 58.84 58.2 3.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.632 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.546 ' O ' ' CG ' ' A' ' 124' ' ' HIS . 16.2 ttmt -58.73 -30.8 67.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.362 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -64.83 -27.07 68.63 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.199 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.4 mp -71.52 -29.88 65.28 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.624 ' ND1' ' N ' ' A' ' 125' ' ' MET . 0.6 OUTLIER -35.93 -29.23 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.498 179.207 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.624 ' N ' ' ND1' ' A' ' 124' ' ' HIS . 1.0 OUTLIER -45.11 -24.89 0.28 Allowed 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.709 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.483 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -103.64 -41.02 6.08 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.584 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.573 HH21 ' CB ' ' A' ' 124' ' ' HIS . 32.2 ttm-85 28.16 80.97 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.201 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.4 t -57.72 -53.93 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.055 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.912 HG21 ' CE2' ' A' ' 93' ' ' PHE . 7.5 tp -86.45 153.13 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.76 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.432 ' OG ' ' OE1' ' A' ' 133' ' ' GLU . 1.1 p -87.22 120.77 28.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.365 0.602 . . . . 0.0 111.407 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.621 ' CE1' ' CD1' ' A' ' 145' ' ' PHE . 0.3 OUTLIER -50.18 -47.32 54.57 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.389 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 131' ' ' TYR . 1.6 mp0 -40.28 -60.58 1.05 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.833 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.432 ' OE1' ' OG ' ' A' ' 130' ' ' SER . 26.9 mt-10 -50.61 -38.01 43.39 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.484 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 131' ' ' TYR . . . -69.23 -34.12 74.74 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -67.06 -54.65 19.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.76 -35.93 69.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.39 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.509 ' CD2' ' CE2' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -67.07 -64.32 0.88 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.516 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -45.82 -37.27 5.94 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.7 -40.82 88.64 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER -64.68 -34.15 77.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.231 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.636 ' CZ2' ' CD2' ' A' ' 100' ' ' HIS . 38.5 m0 -87.0 -7.23 58.35 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 70.51 25.32 4.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.988 -178.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -103.97 166.71 10.24 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.644 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.07 133.5 49.75 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.098 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.695 ' O ' HD22 ' A' ' 146' ' ' LEU . 7.5 t80 -97.26 121.04 38.7 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.466 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.695 HD22 ' O ' ' A' ' 145' ' ' PHE . 1.7 mm? -132.2 130.63 41.28 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.69 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.503 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 4.5 mt-10 -110.27 112.34 24.23 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.942 0.401 . . . . 0.0 109.978 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.496 ' OG ' HG21 ' A' ' 159' ' ' VAL . 49.4 p -139.73 179.29 6.67 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.362 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 152' ' ' GLU . 6.0 p -139.17 133.92 32.08 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.501 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -54.91 -40.31 69.71 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -54.03 -42.11 68.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.059 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 149' ' ' SER . 13.3 tt0 -100.7 117.27 34.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.235 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 0.7 OUTLIER -76.43 -42.58 43.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.185 -179.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 153' ' ' ASN . 5.3 tt0 -41.1 -47.83 3.25 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.099 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.594 ' O ' HG23 ' A' ' 159' ' ' VAL . 63.2 p -62.83 -44.95 94.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.91 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.432 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -51.2 -64.36 0.84 Allowed 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.62 0.724 . . . . 0.0 109.465 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.0 t -45.12 -35.73 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.837 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -67.85 -41.03 83.58 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.551 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 155' ' ' THR . 19.4 t -62.69 -43.5 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-O 120.937 0.399 . . . . 0.0 110.399 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.631 ' CD1' ' CZ ' ' A' ' 26' ' ' PHE . 1.1 t80 -59.32 -61.23 2.79 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.727 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.53 -48.82 4.0 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.781 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.43 -26.87 68.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.534 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -68.26 -34.08 64.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.046 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.616 HG21 HG11 ' A' ' 49' ' ' VAL . 20.2 mt -71.41 -38.73 69.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.684 0.754 . . . . 0.0 109.787 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.31 -63.38 1.3 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.013 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -53.59 -36.21 61.68 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.462 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -55.95 -32.33 63.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -68.48 -57.69 5.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.671 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.77 -63.16 1.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.619 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.663 HG21 ' C ' ' A' ' 112' ' ' ILE . 68.9 mt -50.37 -34.36 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.914 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.83 -40.31 75.93 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.468 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -58.15 -36.63 83.06 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.466 ' HB1' ' OE1' ' A' ' 111' ' ' GLN . . . -68.71 -65.63 0.68 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.758 0.313 . . . . 0.0 110.383 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.517 179.88 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 120.993 0.425 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.425 HH21 HD21 ' A' ' 56' ' ' LEU . 4.6 mtm180 -140.04 136.63 33.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.702 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.587 ' HB3' HG22 ' A' ' 78' ' ' ILE . 1.9 tttt -102.51 133.43 47.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -110.16 129.49 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.429 -177.325 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.487 ' HB3' ' CE1' ' A' ' 81' ' ' TYR . . . -87.28 133.32 33.7 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 121.627 -0.67 . . . . 0.0 110.144 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.668 HD11 ' HB2' ' A' ' 58' ' ' LEU . 20.2 mt -98.24 133.69 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.15 0.5 . . . . 0.0 112.123 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.568 ' C ' HD23 ' A' ' 12' ' ' LEU . 3.8 tt -126.4 99.43 5.83 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.341 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -140.3 133.21 5.86 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.5 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.68 -179.03 0.16 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.982 0.42 . . . . 0.0 110.003 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -76.33 131.88 39.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.026 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.4 m 63.81 16.28 9.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.721 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 86' ' ' SER . 10.5 p -72.42 -13.15 16.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.393 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.68 23.12 29.17 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.128 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.4 pttm -69.65 -30.34 68.02 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.969 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.8 m -77.5 -34.44 54.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.434 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 61.2 m -65.29 -42.41 93.17 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.635 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.0 tp -77.8 -36.7 50.02 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.3 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.525 ' O ' HG12 ' A' ' 27' ' ' VAL . 97.2 m -55.45 -38.57 69.21 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -73.82 -39.42 52.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.223 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.61 ' CG ' HD22 ' A' ' 153' ' ' ASN . 5.2 tt0 -70.29 -27.63 64.56 Favored 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.933 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 1.3 t80 -77.46 -60.26 2.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.4 0.619 . . . . 0.0 110.875 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.601 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.9 p -52.71 -45.92 49.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.043 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.601 ' N ' HG13 ' A' ' 27' ' ' VAL . 1.3 tm-20 -84.19 -24.61 30.04 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.474 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 78.77 19.61 72.81 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.748 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.546 ' NE2' ' O ' ' A' ' 31' ' ' PHE . 15.7 tp60 -154.26 134.06 12.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.161 -0.616 . . . . 0.0 112.258 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.546 ' O ' ' NE2' ' A' ' 30' ' ' GLN . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.453 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 40' ' ' GLU . 1.8 pm0 . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -170.51 -178.45 2.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.455 0.645 . . . . 0.0 112.348 -178.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.514 HG23 HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -129.93 131.93 46.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.22 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -108.47 171.33 7.48 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.464 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.531 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -145.3 150.95 37.55 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -178.585 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.596 ' C ' HD12 ' A' ' 46' ' ' LEU . 37.8 tptt -154.12 116.44 4.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.84 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.717 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.0 mp -105.85 125.01 50.48 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.203 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.872 HD12 ' CZ ' ' A' ' 160' ' ' PHE . 0.6 OUTLIER -145.76 165.58 10.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.799 0.333 . . . . 0.0 110.585 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.4 m -117.7 123.82 47.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.878 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.813 HG11 HG21 ' A' ' 164' ' ' ILE . 5.8 p -127.15 132.12 70.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.67 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 70.59 7.35 6.18 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.05 -10.39 71.9 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -93.98 139.17 31.25 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -77.21 148.04 36.07 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.59 0.71 . . . . 0.0 111.41 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -139.35 124.47 18.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.215 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.767 ' C ' HD12 ' A' ' 56' ' ' LEU . 1.8 m-70 -117.32 114.15 23.17 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.767 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.2 mp -126.05 150.82 47.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.508 0.67 . . . . 0.0 111.67 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.29 133.15 36.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.941 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.917 ' N ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -114.64 144.28 43.68 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.639 -179.018 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.514 HG23 HG23 ' A' ' 42' ' ' THR . 0.3 OUTLIER -126.02 130.26 72.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.757 0.789 . . . . 0.0 112.89 -178.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -123.23 106.4 10.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.349 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 N--CA 1.452 -0.367 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.302 -179.407 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.587 HG22 ' HB3' ' A' ' 8' ' ' LYS . 26.6 pt . . . . . 0 N--CA 1.43 -1.461 0 CA-C-O 121.186 0.517 . . . . 0.0 112.315 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -150.19 28.11 0.75 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.839 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.37 167.39 35.04 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.299 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.487 ' CE1' ' HB3' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -150.75 127.7 11.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.088 -0.556 . . . . 0.0 111.83 179.471 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.744 HG23 ' O ' ' A' ' 82' ' ' ILE . 13.2 tt -132.72 96.44 2.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.478 0.656 . . . . 0.0 109.35 177.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.806 HD23 ' N ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -98.17 117.66 33.05 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.089 -178.795 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -96.44 117.69 41.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.345 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.448 ' CZ ' ' CA ' ' A' ' 118' ' ' GLY . 35.7 p90 -111.22 144.19 40.77 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.568 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.62 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.3 p -86.95 138.23 31.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.73 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.573 HG21 ' N ' ' A' ' 124' ' ' HIS . 14.0 m -71.94 17.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.611 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.501 ' H ' ' C ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -138.11 -21.07 1.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.62 ' H ' ' HG ' ' A' ' 86' ' ' SER . 21.3 t -93.18 93.99 8.56 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.141 -176.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 90' ' ' ILE . 10.8 tp -60.57 -8.36 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 176.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.622 ' O ' HG13 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -77.48 -59.55 2.73 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.755 179.181 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.9 p -54.12 -29.39 44.81 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.335 0.588 . . . . 0.0 109.566 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.2 -39.87 47.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.669 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -68.59 -42.98 77.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.263 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 91' ' ' LYS . 2.3 m -67.38 -40.41 84.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.562 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.2 mt -55.05 -43.65 70.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 121.212 -0.195 . . . . 0.0 110.686 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -69.23 -35.03 75.74 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.239 0.543 . . . . 0.0 110.761 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.419 ' O ' ' C ' ' A' ' 99' ' ' ILE . 58.4 t -71.58 -65.63 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.319 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 100' ' ' HIS . 1.4 mp -38.02 -54.38 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.026 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.483 ' CE1' ' CG ' ' A' ' 141' ' ' TRP . 1.1 t-160 -46.4 -64.06 0.85 Allowed 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.457 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 100' ' ' HIS . . . -35.14 -58.45 0.8 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.467 ' O ' ' C ' ' A' ' 103' ' ' LEU . 16.5 tptp -69.82 -65.83 0.67 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.355 -0.422 . . . . 0.0 110.992 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.467 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -36.48 -63.02 0.42 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.021 0.438 . . . . 0.0 109.895 179.671 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.7 ' C ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -44.35 -50.83 8.95 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.481 ' N ' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.76 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.373 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 120.848 0.356 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.482 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -108.57 132.02 21.4 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.569 179.553 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -48.2 123.04 8.32 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.384 1.39 . . . . 0.0 111.901 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.482 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.5 mp -123.91 130.83 73.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 6.7 tpt -128.4 117.27 21.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.793 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 mt -95.83 97.82 9.96 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.1 t -105.5 128.4 59.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 122.136 0.969 . . . . 0.0 111.446 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.448 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -100.25 111.84 4.28 Favored Glycine 0 C--N 1.308 -1.006 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.471 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 53.4 t30 -97.75 173.56 7.05 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.684 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.471 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 5.9 mtpp 61.96 58.38 1.91 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.909 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.534 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 0.5 OUTLIER -60.28 -25.51 65.78 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.568 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -67.53 -9.87 46.5 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.204 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 125' ' ' MET . 11.2 mp -97.2 -25.35 15.32 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.573 ' N ' HG21 ' A' ' 87' ' ' VAL . 2.3 p-80 -36.94 -28.57 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.66 178.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.525 ' N ' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -44.39 -23.14 0.09 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.477 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -107.66 -40.68 5.24 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.69 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.462 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 22.1 ttm180 24.63 84.33 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.192 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 46.2 t -53.77 -35.35 26.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.308 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.4 tp -88.61 155.92 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.68 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.49 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 89.1 p -100.89 126.68 47.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.682 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -39.54 -33.29 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.796 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.6 mp0 -69.73 -65.3 0.73 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.73 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.49 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 62.4 mt-10 -41.41 -40.12 1.66 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.731 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.69 -37.54 67.25 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 132' ' ' GLU . 4.0 tmtt? -61.15 -55.32 33.71 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.66 -36.34 69.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.77 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.54 -61.78 1.9 Allowed 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.19 -37.36 54.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.109 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.01 -34.83 79.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.597 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.58 -46.4 86.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.891 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.483 ' CG ' ' CE1' ' A' ' 100' ' ' HIS . 66.5 m95 -90.58 4.79 50.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.523 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 62.69 31.01 16.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.637 0.732 . . . . 0.0 109.623 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -94.33 167.82 11.29 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.283 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -106.53 132.97 51.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.272 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.703 ' O ' HD22 ' A' ' 146' ' ' LEU . 6.4 t80 -96.89 121.59 38.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.478 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.703 HD22 ' O ' ' A' ' 145' ' ' PHE . 1.6 mm? -134.69 137.36 43.49 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.872 -176.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.462 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 2.4 mt-10 -125.4 111.56 15.27 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.537 ' OG ' HG21 ' A' ' 159' ' ' VAL . 20.8 p -137.43 -176.29 4.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.039 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.0 135.26 34.1 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.063 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.525 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -61.95 -29.47 70.26 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.25 0.548 . . . . 0.0 109.643 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -69.39 0.92 4.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.139 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -141.54 128.51 20.68 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.728 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.61 HD22 ' CG ' ' A' ' 25' ' ' GLN . 6.1 t-20 -77.52 -54.32 6.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.198 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 153' ' ' ASN . 1.1 mt-30 -36.75 -56.19 0.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.092 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.687 ' O ' HG23 ' A' ' 159' ' ' VAL . 50.5 p -56.14 -42.69 77.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.031 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 153' ' ' ASN . . . -57.7 -61.39 2.55 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.441 0.639 . . . . 0.0 110.196 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 59.7 t -42.55 -40.15 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.582 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -66.74 -36.61 82.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.783 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 155' ' ' THR . 25.7 t -66.14 -41.29 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.007 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.874 ' CZ ' HD11 ' A' ' 164' ' ' ILE . 22.7 t80 -59.66 -65.51 0.66 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.647 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.81 -55.82 2.91 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.789 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -51.83 -31.46 27.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.821 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -66.5 -37.21 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.416 -179.6 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.874 HD11 ' CZ ' ' A' ' 160' ' ' PHE . 15.5 mt -68.97 -31.97 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 121.421 0.629 . . . . 0.0 110.133 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.53 -59.79 4.68 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.719 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 114' ' ' ILE . 6.1 pt-20 -59.24 -30.25 68.12 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.515 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -60.46 -32.24 71.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.442 ' O ' ' OD1' ' A' ' 171' ' ' ASP . 0.0 OUTLIER -71.33 -41.4 69.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.04 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 15.7 tptt -70.19 -58.67 3.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.314 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 170' ' ' ILE . 1.7 mp -55.47 -52.17 49.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.321 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 172' ' ' GLY . 1.6 p-10 -67.58 -26.78 66.44 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.363 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 171' ' ' ASP . . . -60.28 -44.44 97.5 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.38 -67.97 0.46 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.806 0.336 . . . . 0.0 110.497 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.715 -179.795 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 120.974 0.416 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.402 ' NH2' ' OD1' ' A' ' 171' ' ' ASP . 0.0 OUTLIER -139.87 135.97 33.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.457 -179.392 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -104.16 122.39 45.24 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.771 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.7 OUTLIER -104.02 118.54 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-O 121.617 0.722 . . . . 0.0 109.917 -179.068 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.452 ' HB3' ' CE1' ' A' ' 81' ' ' TYR . . . -84.02 134.68 34.62 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 121.191 -0.943 . . . . 0.0 111.339 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.0 mt -95.36 126.88 47.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.705 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.2 tp -127.02 102.0 6.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.499 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -139.21 135.31 7.22 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -53.84 -161.04 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.418 0.628 . . . . 0.0 110.804 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -96.01 130.96 42.87 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.854 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m 67.45 14.6 9.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.748 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.503 ' C ' ' HZ2' ' A' ' 120' ' ' LYS . 7.6 p -76.93 -12.76 14.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.483 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.21 12.35 34.01 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.42 ' CB ' ' NZ ' ' A' ' 19' ' ' LYS . 0.8 OUTLIER -46.82 -48.71 20.77 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.678 0.275 . . . . 0.0 111.122 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.588 ' O ' HD13 ' A' ' 24' ' ' ILE . 1.5 m -76.99 -26.45 53.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.924 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.3 p -68.49 -49.4 59.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.549 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.6 tp -78.15 -30.7 49.37 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.271 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.533 ' O ' HG12 ' A' ' 27' ' ' VAL . 54.1 m -62.59 -47.86 81.95 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.588 HD13 ' O ' ' A' ' 20' ' ' SER . 1.5 mp -68.28 -34.87 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.981 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 150' ' ' ALA . 2.9 tt0 -74.2 -25.39 59.66 Favored 'General case' 0 C--O 1.215 -0.718 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.639 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 1.4 t80 -76.69 -57.97 3.55 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.473 0.654 . . . . 0.0 110.398 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.628 HG13 ' N ' ' A' ' 28' ' ' GLU . 11.5 p -57.17 -49.19 80.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.425 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.628 ' N ' HG13 ' A' ' 27' ' ' VAL . 1.2 tm-20 -80.13 -24.81 40.23 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.463 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 77.75 23.49 66.96 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.822 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.412 ' OE1' ' O ' ' A' ' 31' ' ' PHE . 1.7 pp0? -153.32 138.43 17.34 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 119.345 -0.942 . . . . 0.0 112.72 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.491 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 27.6 t80 . . . . . 0 C--N 1.317 -0.824 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.456 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.419 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 4.2 pt-20 . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 120.599 0.237 . . . . 0.0 110.438 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 1.8 m120 -170.94 179.03 3.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.543 0.687 . . . . 0.0 112.6 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.444 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 0.8 OUTLIER -127.09 145.89 50.57 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.165 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.529 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 7.3 m-85 -133.5 163.75 28.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.991 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.617 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -144.27 149.87 36.99 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.086 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -149.03 112.48 5.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.016 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.607 HD21 ' ND1' ' A' ' 55' ' ' HIS . 6.4 mp -108.02 120.95 43.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.068 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 pp -147.59 165.56 5.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.795 0.331 . . . . 0.0 111.009 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 m -112.46 126.77 55.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.637 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.614 HG23 HH22 ' A' ' 161' ' ' ARG . 7.6 p -124.07 133.83 68.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.809 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 63.5 3.85 1.59 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.114 0.483 . . . . 0.0 109.722 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 103.11 -14.05 55.52 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.64 ' NE2' ' H ' ' A' ' 53' ' ' GLU . 35.3 tp60 -90.1 141.28 28.84 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.64 ' H ' ' NE2' ' A' ' 52' ' ' GLN . 2.1 mt-10 -76.96 149.89 35.94 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.401 0.619 . . . . 0.0 111.051 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.564 ' CD1' HG12 ' A' ' 49' ' ' VAL . 12.3 m-85 -141.23 124.18 16.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.114 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.671 ' C ' HD12 ' A' ' 56' ' ' LEU . 9.7 t60 -117.69 113.89 22.54 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.671 HD12 ' C ' ' A' ' 55' ' ' HIS . 11.1 mp -120.66 140.81 51.06 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.695 0.76 . . . . 0.0 111.637 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.84 ' C ' HD13 ' A' ' 58' ' ' LEU . 2.6 mt-30 -133.07 123.39 25.68 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.251 -1.341 . . . . 0.0 109.502 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.961 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.89 154.02 31.53 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.04 -178.656 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.92 145.13 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.264 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.66 103.27 10.53 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.708 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 68.8 p . . . . . 0 CA--C 1.51 -0.594 0 CA-C-O 121.769 0.795 . . . . 0.0 110.45 179.717 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 80' ' ' GLY . 31.3 pt . . . . . 0 N--CA 1.438 -1.05 0 CA-C-O 121.586 0.708 . . . . 0.0 112.902 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -152.0 16.76 0.66 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.584 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -157.78 164.07 32.98 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.966 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.452 ' CE1' ' HB3' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -152.29 122.86 7.33 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.672 -0.764 . . . . 0.0 110.589 178.107 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.623 HG23 ' O ' ' A' ' 82' ' ' ILE . 8.8 tt -122.6 98.5 5.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.981 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.37 126.57 42.69 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.174 -178.261 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -95.51 121.03 45.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.845 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.536 ' C ' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -110.06 147.5 33.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.276 -0.874 . . . . 0.0 108.994 179.356 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.688 ' HG ' ' H ' ' A' ' 89' ' ' SER . 0.3 OUTLIER -108.29 144.19 36.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.99 0.424 . . . . 0.0 112.051 -177.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.672 HG21 ' N ' ' A' ' 124' ' ' HIS . 14.2 m -81.45 15.86 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.255 179.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.7 -16.1 1.54 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -177.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.688 ' H ' ' HG ' ' A' ' 86' ' ' SER . 28.9 t -112.35 93.5 4.47 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-O 121.378 0.608 . . . . 0.0 110.304 -177.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.408 HD12 ' CG1' ' A' ' 128' ' ' VAL . 4.3 tp -54.84 -13.54 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.787 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.6 OUTLIER -79.1 -45.88 19.15 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.421 178.549 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.1 p -59.05 -46.71 87.56 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.748 ' CZ ' HD13 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -79.14 -32.91 44.55 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 119.0 -1.08 . . . . 0.0 112.215 -178.439 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -66.3 -47.18 74.43 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.908 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 91' ' ' LYS . 34.3 m -65.28 -34.82 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.457 -0.497 . . . . 0.0 109.881 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 mt -60.94 -36.83 74.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.701 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -70.52 -29.26 65.71 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.996 0.427 . . . . 0.0 109.94 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 99' ' ' ILE . 14.0 t -72.23 -66.63 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.4 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.487 HG22 ' N ' ' A' ' 100' ' ' HIS . 1.3 mp -38.55 -60.26 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.612 ' CE1' ' CG ' ' A' ' 141' ' ' TRP . 12.8 t-80 -43.05 -64.9 0.55 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.125 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -36.77 -66.51 0.48 Allowed Glycine 0 CA--C 1.518 0.233 0 CA-C-O 121.521 0.511 . . . . 0.0 112.047 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 103' ' ' LEU . 21.2 tptm -60.92 -61.08 2.84 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.765 -0.717 . . . . 0.0 110.527 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 102' ' ' LYS . 7.4 tp -36.14 -67.24 0.17 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.379 0.609 . . . . 0.0 109.6 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.727 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -42.88 -48.62 5.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.57 179.027 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.436 ' N ' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.922 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.456 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.677 ' O ' ' HB2' ' A' ' 174' ' ' ALA . 18.5 mt-30 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.875 0.369 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.6 mt -109.96 134.6 20.64 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.526 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -46.71 109.21 0.19 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.238 1.292 . . . . 0.0 112.295 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.5 mt -123.17 135.75 62.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.543 ' O ' HD12 ' A' ' 83' ' ' LEU . 2.4 tpp -137.65 123.59 20.17 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.394 0.616 . . . . 0.0 110.873 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.499 ' N ' ' SD ' ' A' ' 115' ' ' MET . 5.4 mt -97.88 107.3 19.76 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.623 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.7 t -103.23 127.74 56.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 121.863 0.84 . . . . 0.0 112.181 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.419 ' CA ' ' CE2' ' A' ' 85' ' ' TYR . . . -97.03 103.63 2.92 Favored Glycine 0 C--N 1.311 -0.831 0 N-CA-C 107.816 -2.113 . . . . 0.0 107.816 176.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.468 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.7 t30 -96.8 173.89 7.08 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.049 -177.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.503 ' HZ2' ' C ' ' A' ' 17' ' ' VAL . 7.1 mtpp 63.64 59.29 1.2 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.228 -178.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.432 ' H ' ' HB3' ' A' ' 149' ' ' SER . 0.0 OUTLIER -68.63 0.15 4.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.348 -178.449 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -82.59 -37.32 25.21 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.449 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.813 HD22 ' N ' ' A' ' 123' ' ' LEU . 1.0 OUTLIER -83.87 -18.11 38.58 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.081 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.672 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -39.13 -27.92 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.002 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.504 ' N ' ' O ' ' A' ' 123' ' ' LEU . 9.5 mtt -42.1 -31.27 0.35 Allowed 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.41 ' N ' ' C ' ' A' ' 124' ' ' HIS . 1.3 pt-20 -87.8 -42.41 12.59 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.295 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 124' ' ' HIS . 6.0 tpt85 55.94 72.3 0.5 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.267 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.408 ' CG1' HD12 ' A' ' 90' ' ' ILE . 7.7 t -52.7 -64.35 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.57 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.748 HD13 ' CZ ' ' A' ' 93' ' ' PHE . 10.7 tp -86.89 153.22 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.518 ' HG ' ' HB2' ' A' ' 133' ' ' GLU . 35.8 p -88.24 137.67 32.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.278 0.561 . . . . 0.0 112.343 -178.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -53.5 -33.24 53.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.139 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -69.06 -65.8 0.66 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.194 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.518 ' HB2' ' HG ' ' A' ' 130' ' ' SER . 45.3 mt-10 -42.83 -40.12 2.76 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.63 -35.02 62.67 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 132' ' ' GLU . 3.5 tptm -62.0 -57.29 12.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -55.28 -36.18 65.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.783 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.404 HD21 ' HE1' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -65.45 -61.13 2.28 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.419 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.56 -40.62 62.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.932 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.62 -30.86 71.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.654 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.8 p -63.72 -46.79 83.83 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.965 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.612 ' CG ' ' CE1' ' A' ' 100' ' ' HIS . 34.3 m95 -91.15 -0.58 57.73 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.778 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 3.5 m120 72.5 36.13 1.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.952 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -100.05 163.3 12.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.423 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.538 ' O ' ' SD ' ' A' ' 115' ' ' MET . . . -102.18 128.34 48.72 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.501 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.687 ' O ' HD22 ' A' ' 146' ' ' LEU . 6.2 t80 -98.09 118.43 34.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.755 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.687 HD22 ' O ' ' A' ' 145' ' ' PHE . 2.0 mm? -131.76 126.83 35.41 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -177.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.41 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 1.8 mt-10 -109.12 112.79 25.16 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.13 0.491 . . . . 0.0 110.197 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.516 ' OG ' HG21 ' A' ' 159' ' ' VAL . 4.1 p -136.43 -173.16 3.33 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.647 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.432 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -139.03 141.6 38.26 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.068 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.544 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -65.66 -49.15 69.66 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -49.42 -10.27 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.841 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.477 ' H ' ' C ' ' A' ' 150' ' ' ALA . 23.7 tt0 -129.04 127.27 41.23 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.813 0.339 . . . . 0.0 110.916 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.487 HD22 ' CG ' ' A' ' 25' ' ' GLN . 4.0 t-20 -77.78 -55.43 5.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.116 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 153' ' ' ASN . 10.3 tt0 -37.94 -53.13 1.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.932 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.535 ' O ' HG23 ' A' ' 159' ' ' VAL . 54.9 p -56.74 -41.54 77.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.97 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 153' ' ' ASN . . . -57.38 -62.94 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.624 0.726 . . . . 0.0 109.993 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.1 t -44.95 -37.55 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.443 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -62.29 -42.78 99.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.575 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 155' ' ' THR . 11.9 t -60.06 -45.28 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.696 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.518 ' O ' HG22 ' A' ' 163' ' ' ILE . 53.6 t80 -56.66 -65.38 0.62 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.084 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.614 HH22 HG23 ' A' ' 49' ' ' VAL . 6.1 ttm-85 -41.44 -58.05 2.0 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.178 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.79 -31.65 17.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.755 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.3 OUTLIER -69.18 -34.21 62.16 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.392 -179.758 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.541 HG21 HG21 ' A' ' 49' ' ' VAL . 12.6 mt -63.07 -38.07 81.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.937 0.875 . . . . 0.0 109.102 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -64.72 0.82 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.284 -1.325 . . . . 0.0 111.543 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.71 -33.37 70.11 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.464 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 163' ' ' ILE . . . -58.38 -31.48 67.7 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -67.86 -56.07 10.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.428 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 13.5 tttm -59.03 -63.74 1.19 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.954 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 72.2 mt -47.26 -37.15 4.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.59 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.402 ' OD1' ' NH2' ' A' ' 7' ' ' ARG . 11.6 t70 -69.25 -40.17 78.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.147 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.89 -40.42 57.48 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.37 -77.5 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.329 . . . . 0.0 110.26 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.677 ' HB2' ' O ' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.026 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 121.186 0.517 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.506 ' NH2' ' OD2' ' A' ' 171' ' ' ASP . 12.0 mtt180 -139.94 136.12 33.51 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.784 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.524 ' HB2' HG22 ' A' ' 78' ' ' ILE . 1.5 mttp -105.99 129.49 54.1 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.734 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -101.36 121.28 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-O 121.393 0.616 . . . . 0.0 110.647 -178.435 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.12 135.04 34.96 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.469 -0.77 . . . . 0.0 110.742 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.459 ' O ' HD12 ' A' ' 12' ' ' LEU . 19.9 mt -95.08 128.6 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 CA-C-O 121.759 0.79 . . . . 0.0 111.353 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.546 HD13 ' HE1' ' A' ' 81' ' ' TYR . 1.3 mp -127.26 94.52 4.02 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 113.975 -1.466 . . . . 0.0 110.252 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -140.54 136.01 7.38 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 -179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.494 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.1 OUTLIER -51.69 -161.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.395 0.617 . . . . 0.0 110.823 179.513 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.22 137.46 33.37 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.138 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.5 m 59.78 19.45 8.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.809 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 p -76.05 -21.64 15.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.876 0.369 . . . . 0.0 110.386 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.95 25.39 11.46 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -71.75 -32.09 67.35 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.353 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.433 ' O ' HD13 ' A' ' 24' ' ' ILE . 17.9 m -78.12 -35.83 48.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.777 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.5 p -62.02 -48.3 80.91 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.478 HD12 ' HB3' ' A' ' 25' ' ' GLN . 15.5 tp -63.44 -53.34 53.75 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.656 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.557 ' O ' HG12 ' A' ' 27' ' ' VAL . 50.4 m -38.07 -40.82 0.52 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.433 HD13 ' O ' ' A' ' 20' ' ' SER . 1.3 mp -77.43 -40.8 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.053 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.585 ' OE1' ' N ' ' A' ' 31' ' ' PHE . 3.1 tp-100 -62.65 -41.06 98.84 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.535 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.512 ' C ' ' CD1' ' A' ' 26' ' ' PHE . 0.4 OUTLIER -76.67 -60.7 2.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.169 0.509 . . . . 0.0 111.828 -178.048 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.575 HG13 ' N ' ' A' ' 28' ' ' GLU . 13.2 p -45.51 -44.03 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.037 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.575 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.1 mm-40 -92.01 -23.7 19.45 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.433 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 71.34 26.02 74.26 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -148.99 142.03 24.84 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.585 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.924 177.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 173.93 174.42 0.16 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 119.439 -0.904 . . . . 0.0 113.043 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.14 147.31 32.67 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.291 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -121.58 173.84 7.16 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.428 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.52 161.0 43.0 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -178.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -162.67 110.59 1.31 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.892 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.0 mp -106.9 119.69 40.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.664 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 pp -147.95 166.09 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.663 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.3 m -111.28 126.15 54.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.239 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.724 HG11 HG21 ' A' ' 164' ' ' ILE . 14.9 p -122.06 135.92 60.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.724 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 62.12 3.9 1.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.042 0.449 . . . . 0.0 109.839 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 102.3 -13.31 57.08 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.671 ' NE2' ' H ' ' A' ' 53' ' ' GLU . 39.5 tp60 -91.49 141.75 28.39 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.671 ' H ' ' NE2' ' A' ' 52' ' ' GLN . 1.8 mt-10 -76.5 146.19 38.65 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.416 0.626 . . . . 0.0 111.229 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.598 ' CD1' HG12 ' A' ' 49' ' ' VAL . 11.7 m-85 -138.71 123.47 18.69 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.142 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.645 ' C ' HD12 ' A' ' 56' ' ' LEU . 1.6 m-70 -117.64 113.92 22.63 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.9 mp -118.72 144.22 46.38 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.617 0.722 . . . . 0.0 112.374 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.781 ' C ' HD13 ' A' ' 58' ' ' LEU . 3.3 mt-30 -134.1 124.29 25.89 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.09 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.93 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.65 155.1 30.47 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 120.264 -0.574 . . . . 0.0 112.402 -178.214 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.82 144.82 35.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.408 ' O ' ' OG1' ' A' ' 61' ' ' THR . 0.4 OUTLIER -121.86 124.68 44.7 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.073 178.314 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 60' ' ' ASP . 31.4 p . . . . . 0 CA--C 1.512 -0.506 0 CA-C-O 121.627 0.727 . . . . 0.0 110.381 -179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.524 HG22 ' HB2' ' A' ' 8' ' ' LYS . 31.7 pt . . . . . 0 N--CA 1.427 -1.623 0 CA-C-O 121.286 0.565 . . . . 0.0 112.25 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -153.32 26.81 0.52 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.745 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.435 ' HA3' HD13 ' A' ' 9' ' ' ILE . . . -150.92 165.02 30.13 Favored Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.076 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.546 ' HE1' HD13 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -151.96 124.84 8.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.918 -0.641 . . . . 0.0 111.522 178.077 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.655 HG23 ' O ' ' A' ' 82' ' ' ILE . 12.0 tt -132.89 104.63 7.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.447 0.641 . . . . 0.0 109.693 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.563 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.7 OUTLIER -96.89 124.55 40.9 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.434 -178.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -97.86 133.58 39.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.112 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.574 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 26.4 p90 -137.16 145.48 43.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.717 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 89' ' ' SER . 1.0 OUTLIER -87.25 143.88 27.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.697 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.512 HG21 ' N ' ' A' ' 124' ' ' HIS . 17.1 m -71.94 13.42 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.31 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.44 HG22 ' HG ' ' A' ' 86' ' ' SER . 0.6 OUTLIER -135.13 -19.28 1.74 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.911 0.386 . . . . 0.0 111.737 -178.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.52 ' C ' ' N ' ' A' ' 91' ' ' LYS . 23.0 t -89.28 92.65 9.25 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.05 -176.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.74 -9.69 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 176.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.78 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -76.86 -53.21 8.19 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.284 178.278 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.422 ' O ' HD12 ' A' ' 96' ' ' ILE . 25.6 p -59.6 -34.21 72.46 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.289 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.574 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -72.06 -56.71 5.15 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.173 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.502 ' O ' HG23 ' A' ' 98' ' ' VAL . 4.6 mm-40 -63.22 -40.51 97.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.031 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 91' ' ' LYS . 17.0 m -68.85 -33.95 61.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.676 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.422 HD12 ' O ' ' A' ' 92' ' ' SER . 2.4 mt -65.17 -40.86 90.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.335 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -70.22 -29.12 65.86 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.043 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 94' ' ' GLU . 54.1 t -74.84 -66.92 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.6 mm -41.76 -66.09 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.532 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.474 ' CE1' HD23 ' A' ' 104' ' ' LEU . 8.6 t-80 -42.24 -64.98 0.51 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.192 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 100' ' ' HIS . . . -35.06 -65.31 0.41 Allowed Glycine 0 CA--C 1.517 0.175 0 CA-C-O 121.337 0.41 . . . . 0.0 112.357 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 14.8 tptm -67.97 -63.53 1.04 Allowed 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.071 -0.565 . . . . 0.0 111.189 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.492 ' O ' HD13 ' A' ' 103' ' ' LEU . 0.5 OUTLIER -36.05 -58.3 0.66 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.047 0.451 . . . . 0.0 110.146 -179.426 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.698 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -51.39 -51.32 55.75 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.475 ' N ' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.313 -1.019 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.263 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.403 ' HB3' HG23 ' A' ' 170' ' ' ILE . 26.6 mt-30 . . . . . 0 CA--C 1.52 -0.189 0 CA-C-O 120.955 0.407 . . . . 0.0 110.472 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.642 ' C ' HG21 ' A' ' 170' ' ' ILE . 1.1 pt -117.64 150.39 46.75 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.17 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -45.03 121.03 3.28 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.716 1.611 . . . . 0.0 112.014 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.472 ' HB ' ' HB2' ' A' ' 143' ' ' ALA . 1.4 mt -125.0 126.0 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.403 ' CE ' HD23 ' A' ' 146' ' ' LEU . 7.4 tpt -127.15 117.68 22.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.773 -178.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mt -96.19 97.91 9.91 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.0 t -105.07 126.57 60.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 122.249 1.023 . . . . 0.0 111.294 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.43 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -97.83 107.81 3.53 Favored Glycine 0 C--N 1.308 -1.005 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.512 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 52.6 t30 -97.26 176.74 5.8 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.662 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.512 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 41.2 mttt 62.75 60.76 1.25 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.689 0.757 . . . . 0.0 108.977 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.433 ' H ' ' HB3' ' A' ' 149' ' ' SER . 16.1 tttm -67.01 -24.12 65.99 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -73.91 2.47 8.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 118.751 -1.179 . . . . 0.0 111.545 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 126' ' ' GLU . 8.1 mp -94.39 -25.77 16.8 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 176.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.55 ' C ' ' N ' ' A' ' 126' ' ' GLU . 7.6 t60 -27.12 -38.63 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.403 1.065 . . . . 0.0 111.457 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.515 ' N ' ' O ' ' A' ' 123' ' ' LEU . 2.8 mmt -46.98 -16.41 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.851 0.834 . . . . 0.0 108.777 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 123' ' ' LEU . 21.1 mm-40 -98.41 -57.53 2.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.994 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.466 ' CZ ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER 32.81 67.77 0.16 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.458 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.9 m -61.55 -32.1 52.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.828 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.5 tp -88.93 154.97 3.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.474 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.502 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 92.7 p -103.02 129.09 49.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.242 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -42.18 -35.32 0.92 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.564 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.6 mt-10 -66.34 -65.54 0.67 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.052 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.502 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 63.6 mt-10 -41.29 -41.43 1.9 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.925 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.08 -35.91 64.33 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 132' ' ' GLU . 15.4 tttm -62.34 -54.94 33.15 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.066 -0.567 . . . . 0.0 109.601 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.87 69.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.561 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.73 -60.75 2.57 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -54.54 -36.66 64.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.422 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -68.37 -31.77 71.39 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.1 p -63.88 -46.5 84.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.855 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -89.23 -3.53 58.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.935 0.398 . . . . 0.0 110.315 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 76.18 23.35 1.25 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.72 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -90.59 168.13 12.04 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.83 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.41 134.13 50.91 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.045 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.621 ' O ' HD22 ' A' ' 146' ' ' LEU . 5.7 t80 -96.51 122.53 39.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.739 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.747 HD12 HG22 ' A' ' 159' ' ' VAL . 1.1 mm? -134.55 136.95 43.41 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.603 -176.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.466 ' CD ' ' CZ ' ' A' ' 127' ' ' ARG . 5.8 tt0 -123.48 112.23 17.25 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 24.2 p -138.99 -177.16 4.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.052 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.433 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -139.91 130.4 25.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.087 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 152' ' ' GLU . . . -49.24 -64.87 0.68 Allowed 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 150' ' ' ALA . 40.4 tttm -33.88 -30.7 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.217 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 150' ' ' ALA . 34.3 mt-10 -111.71 103.63 11.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.57 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -64.9 -49.4 70.6 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.345 -179.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' A' ' 153' ' ' ASN . 4.1 mt-30 -37.27 -53.32 1.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.883 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.693 ' O ' HG23 ' A' ' 159' ' ' VAL . 80.8 p -58.16 -40.45 81.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.726 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 153' ' ' ASN . . . -58.2 -61.85 2.26 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.439 0.638 . . . . 0.0 109.978 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 55.1 t -41.32 -41.67 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.719 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.65 -39.53 93.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.528 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.747 HG22 HD12 ' A' ' 146' ' ' LEU . 29.5 t -63.04 -37.52 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.018 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.718 ' CE2' HD11 ' A' ' 164' ' ' ILE . 52.6 t80 -61.41 -65.18 0.73 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.753 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.45 -53.79 3.29 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.985 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -29.79 65.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.846 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.491 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -67.9 -33.89 64.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.387 -179.551 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.724 HG21 HG11 ' A' ' 49' ' ' VAL . 41.7 mt -69.85 -36.53 69.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 121.594 0.711 . . . . 0.0 109.784 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.28 -65.12 0.74 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.862 -178.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -58.06 -33.51 69.1 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.531 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 163' ' ' ILE . . . -58.17 -31.55 67.37 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -68.44 -57.11 6.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.617 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -54.88 -64.84 0.71 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.844 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.642 HG21 ' C ' ' A' ' 112' ' ' ILE . 96.6 mt -50.57 -34.51 12.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.007 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.506 ' OD2' ' NH2' ' A' ' 7' ' ' ARG . 1.2 t70 -67.26 -40.05 86.19 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -57.91 -31.88 65.39 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.37 -79.14 0.06 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 -0.12 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.86 179.689 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 121.35 0.595 . . . . 0.0 110.54 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.509 ' NH2' ' OD2' ' A' ' 171' ' ' ASP . 0.0 OUTLIER -139.72 135.5 33.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.233 179.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.543 ' HB2' HG22 ' A' ' 78' ' ' ILE . 32.6 mttt -109.09 129.23 55.47 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.751 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.9 OUTLIER -102.96 125.06 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-O 121.282 0.563 . . . . 0.0 110.967 -177.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.03 133.08 34.68 Favored 'General case' 0 C--O 1.218 -0.566 0 O-C-N 121.463 -0.773 . . . . 0.0 111.303 -178.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.2 mt -95.81 133.97 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 121.795 0.807 . . . . 0.0 112.307 -179.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tp -130.45 102.26 6.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.339 -1.301 . . . . 0.0 110.627 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.67 135.75 6.97 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.4 OUTLIER -53.87 -164.44 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.349 0.595 . . . . 0.0 110.417 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.42 ' NH1' ' OG ' ' A' ' 16' ' ' SER . 9.1 ttt-85 -98.7 134.04 42.17 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.92 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.522 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 1.3 m 67.47 19.85 9.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.572 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 p -87.3 -15.25 9.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.685 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.34 10.53 35.98 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -41.79 -55.53 2.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.015 0.436 . . . . 0.0 110.718 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -69.47 -31.13 69.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.386 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 m -58.08 -44.03 87.35 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.117 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.7 tp -77.63 -48.41 16.91 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.167 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.507 ' O ' HG12 ' A' ' 27' ' ' VAL . 86.9 m -45.68 -54.67 7.45 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.547 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.455 HD11 ' CE2' ' A' ' 43' ' ' PHE . 1.4 mp -59.49 -42.61 88.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.079 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.622 ' NE2' ' ND2' ' A' ' 153' ' ' ASN . 0.0 OUTLIER -65.09 -33.39 75.91 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.919 -179.301 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.464 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 1.6 t80 -76.83 -62.29 1.69 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.265 0.555 . . . . 0.0 111.858 -178.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.586 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.9 p -48.6 -46.46 15.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.597 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.586 ' N ' HG13 ' A' ' 27' ' ' VAL . 12.4 mt-10 -85.33 -24.1 27.79 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.35 43.73 45.02 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.72 -174.22 3.65 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.566 0.698 . . . . 0.0 110.368 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.611 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.494 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.717 178.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.517 -0.313 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -165.6 179.01 6.3 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 119.653 -0.819 . . . . 0.0 113.06 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.51 145.91 51.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.879 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.455 ' CE2' HD11 ' A' ' 24' ' ' ILE . 13.6 m-85 -129.08 166.48 19.18 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.724 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.574 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -146.89 153.28 39.95 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.565 -178.37 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.597 ' C ' HD12 ' A' ' 46' ' ' LEU . 29.4 tptt -156.82 112.03 2.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.455 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.74 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.7 mp -106.48 120.29 41.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.663 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.72 HD12 ' CZ ' ' A' ' 160' ' ' PHE . 0.8 OUTLIER -146.65 165.71 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.622 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 m -111.34 128.46 55.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.359 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.861 HG11 HG21 ' A' ' 164' ' ' ILE . 5.9 p -127.31 135.66 62.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.529 ' CG ' HG22 ' A' ' 49' ' ' VAL . 2.8 m120 63.16 12.83 6.36 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.28 -11.54 69.35 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -90.45 139.16 30.94 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -76.71 145.15 38.87 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.638 0.733 . . . . 0.0 111.32 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.552 ' CE2' HG23 ' A' ' 164' ' ' ILE . 10.3 m-85 -137.08 122.83 19.92 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.995 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.652 ' C ' HD12 ' A' ' 56' ' ' LEU . 66.6 m170 -116.9 113.61 22.7 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.652 HD12 ' C ' ' A' ' 55' ' ' HIS . 11.0 mp -119.57 143.4 47.64 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.657 0.741 . . . . 0.0 112.214 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.731 ' C ' HD13 ' A' ' 58' ' ' LEU . 2.4 mt-30 -135.32 124.86 25.04 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.698 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.916 ' N ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.83 154.5 30.62 Favored 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 120.034 -0.666 . . . . 0.0 112.218 -178.452 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.17 145.93 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.87 -178.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.73 103.31 8.78 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.049 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.1 p . . . . . 0 N--CA 1.446 -0.634 0 CA-C-O 121.773 0.797 . . . . 0.0 111.562 -179.147 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.543 HG22 ' HB2' ' A' ' 8' ' ' LYS . 29.1 pt . . . . . 0 N--CA 1.438 -1.032 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -151.84 17.86 0.69 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.197 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -146.65 166.57 28.25 Favored Glycine 0 CA--C 1.518 0.232 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.38 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.68 121.69 7.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.951 -0.624 . . . . 0.0 110.763 178.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 82' ' ' ILE . 10.0 tt -123.9 103.31 12.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.97 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -95.9 131.95 41.71 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.456 -0.897 . . . . 0.0 110.447 -178.266 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.483 ' O ' ' CD1' ' A' ' 96' ' ' ILE . 1.2 t -92.34 130.87 40.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.963 -178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -108.04 143.21 37.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.978 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.541 ' OG ' HG22 ' A' ' 88' ' ' THR . 47.8 t -109.88 130.21 55.55 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.889 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.547 HG21 ' N ' ' A' ' 124' ' ' HIS . 14.1 m -81.34 18.35 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.004 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.541 HG22 ' OG ' ' A' ' 86' ' ' SER . 1.4 t -143.54 -3.3 0.92 Allowed 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -177.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.495 ' C ' ' N ' ' A' ' 91' ' ' LYS . 1.0 OUTLIER -134.31 97.94 3.97 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 119.416 -0.914 . . . . 0.0 112.843 -175.566 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.569 HG22 ' HG3' ' A' ' 94' ' ' GLU . 18.1 mm -56.13 -10.9 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 114.155 -1.384 . . . . 0.0 107.859 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.729 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -79.13 -42.03 27.2 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.091 178.686 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.62 -47.49 75.46 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.051 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.742 ' CD2' HD13 ' A' ' 129' ' ' ILE . 0.1 OUTLIER -76.3 -35.39 58.86 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 119.105 -1.038 . . . . 0.0 112.186 -178.034 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.569 ' HG3' HG22 ' A' ' 90' ' ' ILE . 14.0 mm-40 -66.46 -47.95 71.48 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.901 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 91' ' ' LYS . 32.6 m -64.17 -37.49 80.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.023 0.439 . . . . 0.0 110.292 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.483 ' CD1' ' O ' ' A' ' 84' ' ' VAL . 31.8 mt -69.02 -31.28 49.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.887 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.73 -26.42 63.38 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.18 0.514 . . . . 0.0 109.709 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 7.3 t -70.44 -64.98 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.755 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.482 HG23 ' N ' ' A' ' 100' ' ' HIS . 1.8 tt -43.29 -47.95 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.647 178.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.58 ' NE2' ' CD1' ' A' ' 141' ' ' TRP . 15.1 t-80 -44.96 -64.79 0.63 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.852 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -39.43 -57.44 2.24 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 111.931 -0.468 . . . . 0.0 111.931 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 105' ' ' ASP . 13.5 tptp -62.96 -65.77 0.64 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.177 -0.511 . . . . 0.0 111.061 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.476 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -36.52 -56.69 0.8 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.731 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.73 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -46.34 -47.66 18.49 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.635 178.522 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.825 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.317 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.44 ' HB3' HG23 ' A' ' 170' ' ' ILE . 27.3 mt-30 . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.882 0.372 . . . . 0.0 111.086 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.627 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.5 OUTLIER -136.17 154.6 77.45 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.407 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -49.89 110.14 0.35 Allowed 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.772 1.648 . . . . 0.0 112.546 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.485 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.2 mp -121.67 127.84 75.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.574 ' O ' HD12 ' A' ' 83' ' ' LEU . 7.2 tpt -130.68 115.84 17.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.669 -178.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' A' ' 138' ' ' ALA . 28.2 mt -96.71 97.52 9.41 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.8 t -105.64 130.34 57.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.632 0.729 . . . . 0.0 110.977 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -102.02 116.33 5.49 Favored Glycine 0 C--N 1.306 -1.136 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.487 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.7 t30 -97.04 173.92 7.02 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.557 -178.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.522 ' NZ ' ' O ' ' A' ' 16' ' ' SER . 18.0 mttt 60.2 58.25 2.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.545 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.46 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 20.5 tttm -63.76 -29.5 70.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.955 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -70.96 -6.8 41.48 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.953 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 125' ' ' MET . 8.6 mp -94.31 -29.85 14.83 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.609 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.1 OUTLIER -38.61 -24.79 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.927 177.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.609 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 19.1 mtp -44.73 -24.11 0.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.472 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.3 OUTLIER -101.83 -37.63 8.19 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.33 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.425 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 1.2 tpt180 37.08 87.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.794 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.5 m -80.22 -32.36 13.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.15 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.742 HD13 ' CD2' ' A' ' 93' ' ' PHE . 11.1 tp -91.23 154.7 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.21 178.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.434 ' OG ' ' OE1' ' A' ' 133' ' ' GLU . 6.5 p -97.36 134.37 40.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.424 0.631 . . . . 0.0 112.226 -178.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -58.42 -30.63 67.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.095 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mp0 -68.53 -65.66 0.67 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.989 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.434 ' OE1' ' OG ' ' A' ' 130' ' ' SER . 43.5 mt-10 -41.42 -41.26 1.98 Allowed 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.83 -36.33 65.93 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 132' ' ' GLU . 3.5 tttm -60.92 -55.72 29.6 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.56 -33.98 66.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.289 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.61 -62.94 1.23 Allowed 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.832 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 143' ' ' ALA . . . -54.27 -33.67 59.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.655 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.43 -38.15 80.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.703 0.287 . . . . 0.0 110.872 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.41 -47.43 79.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.428 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.58 ' CD1' ' NE2' ' A' ' 100' ' ' HIS . 23.7 m95 -91.64 2.68 56.3 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.352 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 13.4 m120 60.67 35.56 19.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.099 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.507 ' O ' ' HB1' ' A' ' 138' ' ' ALA . . . -92.05 166.71 12.54 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.946 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -103.29 125.5 49.96 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.052 -0.659 . . . . 0.0 112.012 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.418 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 6.7 t80 -98.13 121.22 39.79 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.977 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.31 125.98 15.1 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.418 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.425 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 11.7 tt0 -102.01 110.8 22.86 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.406 ' OG ' HG21 ' A' ' 159' ' ' VAL . 0.1 OUTLIER -123.07 -176.52 3.44 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.245 -178.787 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.85 138.9 37.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.524 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.537 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -71.88 -11.22 60.69 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.476 0.655 . . . . 0.0 109.361 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.54 -5.57 59.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.004 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.46 ' O ' ' OE1' ' A' ' 25' ' ' GLN . 51.9 mt-10 -138.97 125.91 21.06 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.474 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.622 ' ND2' ' NE2' ' A' ' 25' ' ' GLN . 4.2 m120 -75.51 -48.43 22.55 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 153' ' ' ASN . 0.0 OUTLIER -36.54 -56.88 0.79 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.998 0.427 . . . . 0.0 110.716 -179.166 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.719 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.2 p -52.57 -47.8 66.6 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.354 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -55.38 -60.35 3.53 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.338 0.589 . . . . 0.0 110.178 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.1 t -41.98 -40.75 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.403 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.3 -32.53 72.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.994 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 155' ' ' THR . 22.0 t -73.78 -36.53 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 121.038 0.447 . . . . 0.0 109.996 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.793 ' CZ ' HD11 ' A' ' 164' ' ' ILE . 25.5 t80 -69.22 -35.63 76.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.038 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.478 HH22 HG23 ' A' ' 49' ' ' VAL . 23.9 ttm-85 -77.4 -45.21 26.6 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.135 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -34.39 74.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.067 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.479 HG23 ' N ' ' A' ' 164' ' ' ILE . 14.0 tt -68.83 -50.46 54.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.365 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.861 HG21 HG11 ' A' ' 49' ' ' VAL . 86.5 mt -50.76 -33.63 12.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 119.064 -1.055 . . . . 0.0 108.885 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.93 -63.61 1.16 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.861 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -57.77 -29.08 64.54 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -60.63 -32.52 71.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.413 ' OE1' ' OH ' ' A' ' 54' ' ' TYR . 1.7 tp10 -68.93 -57.79 5.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.315 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -53.61 -62.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.689 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.627 HG21 ' C ' ' A' ' 112' ' ' ILE . 74.7 mt -51.89 -34.33 16.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.011 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.509 ' OD2' ' NH2' ' A' ' 7' ' ' ARG . 1.9 t70 -69.64 -38.49 77.19 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.679 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -63.21 -35.41 92.04 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.98 -65.48 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.348 . . . . 0.0 110.686 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.691 -179.928 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.177 0.513 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.732 ' NH2' ' HB1' ' A' ' 167' ' ' ALA . 23.2 mtm180 -139.94 136.79 34.2 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.724 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.642 ' HZ1' HE22 ' A' ' 57' ' ' GLN . 6.2 mttm -106.25 130.07 54.17 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.774 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.9 OUTLIER -103.28 123.49 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-O 121.493 0.664 . . . . 0.0 110.49 -178.315 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.53 134.38 34.42 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.304 -0.872 . . . . 0.0 111.325 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.2 mt -95.51 127.66 47.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.38 0.61 . . . . 0.0 111.65 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.617 HD22 HG21 ' A' ' 99' ' ' ILE . 13.0 tp -127.5 99.35 5.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.522 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -142.07 136.09 7.08 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.814 -178.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.1 OUTLIER -49.31 -177.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.217 0.532 . . . . 0.0 110.662 179.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -74.46 140.85 44.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.816 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.519 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 9.4 m 53.17 19.63 1.53 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.609 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.2 p -68.64 -17.13 21.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.417 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.429 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 103.82 29.25 5.62 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.7 mtmm -64.61 -62.49 1.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 110.369 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.504 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.9 OUTLIER -55.96 -28.35 56.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.619 -179.149 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 94.6 p -68.2 -50.73 52.32 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.792 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.1 tp -77.4 -26.45 51.77 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.913 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.622 ' O ' HG12 ' A' ' 27' ' ' VAL . 33.9 m -60.32 -43.33 96.48 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.504 HD13 ' O ' ' A' ' 20' ' ' SER . 1.2 mp -77.89 -42.74 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.729 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.534 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -67.02 -32.13 73.14 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.358 -179.045 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -77.71 -62.59 1.62 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.374 0.607 . . . . 0.0 111.404 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 23' ' ' THR . 14.4 p -48.01 -47.52 12.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.268 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.612 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.2 tm-20 -83.53 -24.6 31.58 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.32 28.74 67.39 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.525 ' CA ' HD21 ' A' ' 153' ' ' ASN . 0.1 OUTLIER -144.94 125.67 14.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.07 0.462 . . . . 0.0 111.861 -178.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.516 ' O ' ' CG ' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -72.97 94.11 1.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.346 178.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.642 HG22 ' N ' ' A' ' 33' ' ' ASP . 13.6 p -96.7 167.3 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.892 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.642 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -37.05 -50.85 0.93 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.919 -179.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 33' ' ' ASP . 7.0 p 33.21 96.28 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.431 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -150.68 41.87 0.79 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.599 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.427 ' O ' ' O ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -95.09 172.77 5.05 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.083 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 36' ' ' ASP . 44.6 Cg_exo -57.33 -139.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.507 2.138 . . . . 0.0 111.881 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.714 HG23 ' O ' ' A' ' 38' ' ' THR . 10.6 t -130.28 62.89 1.57 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.697 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 tp -82.94 144.81 9.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.282 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.11 148.49 23.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.258 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -178.68 174.05 1.22 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.509 0.671 . . . . 0.0 112.43 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.548 HG23 HG23 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -108.25 137.23 46.58 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.357 179.61 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -122.09 167.19 13.44 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.714 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -146.41 148.05 31.9 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 121.38 0.609 . . . . 0.0 112.319 -179.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.5 tttp -147.11 112.44 5.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.968 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.498 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.0 mp -106.44 120.28 41.5 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.095 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.812 ' H ' HD12 ' A' ' 47' ' ' ILE . 0.4 OUTLIER -145.47 165.31 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.42 -179.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.3 m -115.92 124.96 51.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.489 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.586 ' O ' HG13 ' A' ' 49' ' ' VAL . 13.2 p -119.45 117.63 54.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.734 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.563 ' OD1' HG22 ' A' ' 49' ' ' VAL . 0.8 OUTLIER 69.83 26.06 4.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.025 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.61 -9.41 55.7 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -89.99 132.04 35.57 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.96 145.58 40.25 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.621 0.724 . . . . 0.0 111.352 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.666 ' CE2' HG23 ' A' ' 164' ' ' ILE . 5.5 m-85 -136.53 122.36 19.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.949 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.573 ' C ' HD12 ' A' ' 56' ' ' LEU . 67.3 m170 -117.2 112.7 21.19 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.573 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.4 mp -119.19 142.85 47.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.517 0.675 . . . . 0.0 111.831 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.743 ' C ' HD13 ' A' ' 58' ' ' LEU . 2.4 mt-30 -133.14 121.52 22.71 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.957 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.892 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.84 154.42 30.77 Favored 'General case' 0 CA--C 1.503 -0.847 0 C-N-CA 120.098 -0.641 . . . . 0.0 112.219 -178.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.548 HG23 HG23 ' A' ' 42' ' ' THR . 0.3 OUTLIER -128.14 144.87 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.686 -179.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.05 107.48 12.68 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.872 -1.513 . . . . 0.0 108.178 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.94 160.03 39.86 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.12 0.486 . . . . 0.0 110.479 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 63' ' ' GLY . . . -144.79 34.37 1.13 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.959 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 62' ' ' ALA . . . -23.52 -77.12 0.01 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 123.862 0.726 . . . . 0.0 112.37 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -123.26 -79.52 0.61 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.378 0.609 . . . . 0.0 110.759 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 67' ' ' TYR . 2.7 t70 -76.64 -178.1 4.57 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.49 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.607 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 20.1 mp0 -45.2 -16.2 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.574 ' CG ' ' O ' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -175.56 -4.81 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.531 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 67' ' ' TYR . 1.8 m 52.49 119.86 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.338 0.59 . . . . 0.0 112.39 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.78 ' N ' HD12 ' A' ' 69' ' ' ILE . 1.6 mp -85.09 -39.52 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.991 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.26 158.49 79.42 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.974 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -41.56 123.24 2.11 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.609 2.206 . . . . 0.0 112.39 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.447 ' O ' ' CB ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -174.59 50.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.031 179.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.447 ' CB ' ' O ' ' A' ' 72' ' ' GLN . 0.2 OUTLIER 77.34 -6.67 1.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.392 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.49 ' CD2' ' O ' ' A' ' 67' ' ' TYR . 25.8 m-85 -90.11 8.94 30.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.429 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 76' ' ' ILE . 8.7 p -81.65 28.7 0.4 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.744 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.478 ' HB ' HG23 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -51.87 -170.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.138 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 3.4 p-10 -132.52 49.8 2.29 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.204 0.526 . . . . 0.0 109.816 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.494 HG22 ' HB2' ' A' ' 8' ' ' LYS . 33.5 pt -80.13 -174.14 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.051 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -150.75 17.62 0.79 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.142 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.489 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -146.94 165.92 28.45 Favored Glycine 0 CA--C 1.516 0.143 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.584 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.1 122.4 7.23 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.956 -0.622 . . . . 0.0 110.812 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.614 HG23 ' O ' ' A' ' 82' ' ' ILE . 10.7 tt -125.54 103.38 11.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.803 HD23 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -96.28 125.82 41.06 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.737 -178.22 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.476 ' O ' HD11 ' A' ' 96' ' ' ILE . 1.8 t -95.7 119.25 43.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.808 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.481 ' C ' ' CD1' ' A' ' 85' ' ' TYR . 4.1 p90 -109.7 145.41 36.61 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.421 ' OG ' ' N ' ' A' ' 89' ' ' SER . 0.8 OUTLIER -101.85 143.62 31.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.064 0.459 . . . . 0.0 111.752 -178.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.597 HG21 ' N ' ' A' ' 124' ' ' HIS . 17.8 m -80.49 20.45 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.23 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.7 t -141.92 -15.94 0.79 Allowed 'General case' 0 C--O 1.232 0.141 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.538 ' C ' ' N ' ' A' ' 91' ' ' LYS . 38.8 t -113.71 94.21 4.74 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -176.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.524 HG22 ' CD ' ' A' ' 94' ' ' GLU . 22.5 mm -52.8 -14.74 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 176.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.775 ' O ' HG22 ' A' ' 95' ' ' VAL . 9.6 mttp -78.22 -46.61 19.95 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.192 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.0 p -61.9 -45.48 93.55 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.575 ' CE2' HD13 ' A' ' 129' ' ' ILE . 0.1 OUTLIER -77.64 -37.27 50.36 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 119.248 -0.981 . . . . 0.0 112.652 -177.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.524 ' CD ' HG22 ' A' ' 90' ' ' ILE . 88.5 mt-10 -67.81 -43.89 78.59 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.43 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.775 HG22 ' O ' ' A' ' 91' ' ' LYS . 30.7 m -66.04 -38.16 81.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.85 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.476 HD11 ' O ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -58.92 -39.42 77.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -69.45 -26.75 64.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.126 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 94' ' ' GLU . 60.9 t -77.29 -66.91 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.785 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.617 HG21 HD22 ' A' ' 12' ' ' LEU . 1.7 mp -41.07 -38.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.028 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.518 ' CE1' ' CD1' ' A' ' 141' ' ' TRP . 7.1 t-160 -64.4 -64.92 0.76 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.617 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.52 -57.75 1.46 Allowed Glycine 0 CA--C 1.517 0.212 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 105' ' ' ASP . 12.7 tptp -62.9 -64.72 0.83 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.915 -0.643 . . . . 0.0 110.713 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.481 ' CD1' ' OH ' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -36.95 -60.17 0.65 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.747 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -46.43 -48.07 18.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.471 178.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -60.1 -31.4 70.0 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.419 -179.237 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.447 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 58.2 ttp -73.16 -51.34 18.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.42 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.654 HG23 ' H ' ' A' ' 109' ' ' LYS . 6.7 m -75.48 -24.58 17.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.508 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.03 35.28 0.96 Allowed Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.654 ' H ' HG23 ' A' ' 107' ' ' VAL . 7.7 ttmt -93.33 -155.15 0.43 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.154 0.502 . . . . 0.0 111.555 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 110' ' ' VAL . 0.0 OUTLIER -96.55 -171.39 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.94 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.413 ' HB3' HG23 ' A' ' 170' ' ' ILE . 61.7 mt-30 -66.79 118.59 10.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.839 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.716 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.8 OUTLIER -115.04 150.35 44.08 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.21 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -48.2 111.7 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.516 1.478 . . . . 0.0 112.32 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.486 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.5 mp -120.99 128.99 76.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 8.7 tpt -129.17 115.45 17.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.76 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mt -96.84 97.77 9.57 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.0 t -102.48 134.06 44.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 122.442 1.115 . . . . 0.0 110.471 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 146' ' ' LEU . . . -101.32 111.73 4.19 Favored Glycine 0 C--N 1.297 -1.595 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.478 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 46.3 t30 -96.95 173.72 7.14 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.415 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.478 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 24.4 mttt 59.57 58.59 2.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.507 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.418 ' H ' ' HB3' ' A' ' 149' ' ' SER . 32.0 tttm -64.41 -35.47 81.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.412 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.444 ' CG ' HN21 ' A' ' 186' ' ' GDP . 6.1 p-10 -60.32 -10.6 4.91 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.04 -178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 125' ' ' MET . 9.1 mp -90.69 -29.93 17.42 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.598 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.1 OUTLIER -40.13 -23.97 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.889 178.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.598 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 3.6 mmt -45.24 -24.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.44 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -101.36 -37.81 8.31 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.068 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.41 ' NH1' ' OE2' ' A' ' 147' ' ' GLU . 1.9 tpt180 38.91 88.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.082 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.474 HG23 ' N ' ' A' ' 129' ' ' ILE . 17.0 m -78.84 -38.21 20.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.586 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.575 HD13 ' CE2' ' A' ' 93' ' ' PHE . 6.7 tp -90.5 153.52 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.562 ' HG ' ' HB2' ' A' ' 133' ' ' GLU . 18.2 p -94.87 137.16 34.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.274 0.559 . . . . 0.0 112.087 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -54.95 -32.59 61.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.215 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -68.32 -65.83 0.65 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.964 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.562 ' HB2' ' HG ' ' A' ' 130' ' ' SER . 41.0 mt-10 -42.09 -40.93 2.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.622 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.11 -34.29 64.74 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 132' ' ' GLU . 24.1 tttm -64.07 -55.5 21.68 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -55.6 -33.75 64.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.25 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.646 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -65.53 -62.99 1.2 Allowed 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.702 179.429 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -54.69 -34.99 63.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.364 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.56 -30.11 67.84 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.4 p -64.3 -46.8 81.99 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.742 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.646 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 21.9 m95 -88.94 -5.71 57.78 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.089 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.4 ' O ' ' OE2' ' A' ' 166' ' ' GLU . 0.8 OUTLIER 75.91 25.49 1.11 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -89.24 169.16 11.69 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.894 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.47 133.81 49.61 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.214 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.633 ' O ' HD22 ' A' ' 146' ' ' LEU . 6.6 t80 -96.83 122.49 39.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.005 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.829 HD12 HG22 ' A' ' 159' ' ' VAL . 1.3 mm? -132.95 139.5 47.34 Favored 'General case' 0 C--O 1.209 -1.054 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.63 -176.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.41 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 5.5 tt0 -129.04 111.28 12.81 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 58.9 p -138.66 -177.15 4.74 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.734 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.418 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -138.4 140.17 39.26 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.086 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -59.68 -43.07 94.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.157 0.503 . . . . 0.0 109.69 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.0 ttpp -65.38 5.64 0.38 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.381 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 150' ' ' ALA . 3.4 tt0 -136.47 120.02 17.08 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.721 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.525 HD21 ' CA ' ' A' ' 30' ' ' GLN . 3.6 m120 -77.57 -56.86 4.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.961 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 153' ' ' ASN . 9.1 tt0 -36.97 -58.23 0.78 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.893 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 159' ' ' VAL . 66.3 p -52.14 -50.16 62.29 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.126 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.534 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -49.75 -60.31 3.01 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.418 0.628 . . . . 0.0 109.717 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.1 t -40.92 -50.35 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.986 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -53.96 -32.6 54.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.661 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.829 HG22 HD12 ' A' ' 146' ' ' LEU . 12.7 t -75.92 -26.74 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.247 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -71.45 -39.92 70.66 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.462 179.321 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.603 ' N ' ' CD1' ' A' ' 160' ' ' PHE . 36.2 ttm-85 -79.48 -47.73 15.12 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.163 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.6 mmm180 -57.75 -37.57 73.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.11 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.628 HG23 ' N ' ' A' ' 164' ' ' ILE . 11.6 tt -69.74 -58.18 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.438 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.666 HG23 ' CE2' ' A' ' 54' ' ' TYR . 91.3 mt -46.2 -35.02 2.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.88 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -64.82 0.82 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.027 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.4 ' OE2' ' O ' ' A' ' 142' ' ' ASN . 2.1 tt0 -54.6 -37.99 66.22 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.732 ' HB1' ' NH2' ' A' ' 7' ' ' ARG . . . -49.56 -35.54 20.82 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -68.06 -52.65 32.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.085 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 3.6 ttpp -54.5 -61.07 2.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.529 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.716 HG21 ' C ' ' A' ' 112' ' ' ILE . 33.7 mm -49.98 -32.98 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.62 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -39.59 89.05 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.102 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -61.9 -34.09 87.63 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.96 -80.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.67 0.271 . . . . 0.0 110.323 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 -0.141 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.817 179.824 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GDP . . . . . 0.519 " H5'" ' HA ' ' A' ' 16' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 121.352 0.596 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.69 135.41 33.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.256 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.605 ' NZ ' ' NE2' ' A' ' 57' ' ' GLN . 8.1 mttm -107.73 127.59 53.82 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.733 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.9 OUTLIER -100.96 122.27 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 121.702 0.763 . . . . 0.0 110.808 -177.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.28 135.24 34.41 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.498 -0.751 . . . . 0.0 110.882 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.4 mt -96.97 131.74 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.554 0.692 . . . . 0.0 112.403 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.91 HD11 HG21 ' A' ' 99' ' ' ILE . 5.0 tt -121.43 101.34 7.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.895 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -139.8 134.4 6.59 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.72 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.442 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -55.34 -158.35 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.368 0.604 . . . . 0.0 110.756 179.339 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.7 tpp85 -96.05 133.57 40.14 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.546 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.502 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 4.1 m 61.57 14.61 6.1 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.288 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.473 ' C ' ' HZ2' ' A' ' 120' ' ' LYS . 4.3 p -70.28 -13.32 17.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.502 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.4 21.65 47.5 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.747 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.4 pttm -68.17 -35.29 77.81 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.055 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.2 m -67.66 -42.21 82.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.545 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.467 ' OG ' ' H8 ' ' A' ' 186' ' ' GDP . 22.6 m -60.42 -47.55 85.62 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.485 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.444 ' O ' ' CB ' ' A' ' 26' ' ' PHE . 45.4 tp -66.95 -26.94 67.08 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.547 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.576 ' O ' HG12 ' A' ' 27' ' ' VAL . 97.2 m -63.06 -51.45 66.62 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.4 mm -65.3 -38.77 83.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.936 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.579 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -77.57 -25.67 50.21 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.541 -178.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.636 ' CZ ' ' CD2' ' A' ' 160' ' ' PHE . 37.1 t80 -77.78 -53.04 7.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.414 0.626 . . . . 0.0 110.614 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.605 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.9 p -59.61 -48.75 86.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.991 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.605 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.6 mt-10 -79.43 -24.41 42.51 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.416 ' O ' ' OD1' ' A' ' 153' ' ' ASN . . . 69.24 36.2 78.75 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -147.14 136.13 22.32 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.205 0.526 . . . . 0.0 111.179 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -39.88 122.09 1.39 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.24 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.647 HG22 ' N ' ' A' ' 33' ' ' ASP . 14.5 p -93.56 166.13 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.785 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.647 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -87.52 10.16 18.65 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.377 -179.172 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.466 ' H ' HG13 ' A' ' 32' ' ' VAL . 12.0 p 42.09 41.26 1.95 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.8 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.51 ' O ' ' CG ' ' A' ' 35' ' ' TYR . 21.5 t80 -158.04 85.91 0.89 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.581 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -162.32 158.85 20.69 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.531 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.59 ' C ' ' H ' ' A' ' 39' ' ' ILE . 94.8 Cg_exo -26.69 84.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.158 0 C-N-CA 124.326 3.35 . . . . 0.0 113.163 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 36' ' ' ASP . 13.2 t -68.65 35.05 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.665 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.59 ' H ' ' C ' ' A' ' 37' ' ' PRO . 1.7 tp -84.33 166.24 2.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.408 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.57 ' HB3' ' HB3' ' A' ' 62' ' ' ALA . 7.2 pt-20 -81.31 132.92 35.36 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.964 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 1.2 m120 -172.85 176.08 3.18 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.576 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.434 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -108.26 152.95 23.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.577 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.45 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 25.3 m-85 -132.63 166.37 22.3 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.455 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -147.05 156.3 42.91 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.524 0.678 . . . . 0.0 112.823 -177.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -163.29 117.13 1.6 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.804 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 46' ' ' LEU . 8.2 mp -104.63 129.2 52.8 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.879 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 pp -147.1 160.31 9.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.935 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -114.97 123.28 48.71 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.974 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.26 129.87 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.014 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 63.74 7.26 3.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.019 0.438 . . . . 0.0 109.961 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.83 -11.76 59.17 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -89.15 135.02 33.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -77.13 147.12 36.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.606 0.717 . . . . 0.0 111.525 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -140.38 123.47 16.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.749 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.593 ' C ' HD12 ' A' ' 56' ' ' LEU . 1.2 m-70 -117.33 114.06 23.03 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.593 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.7 mp -118.88 143.88 46.72 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.785 0.802 . . . . 0.0 112.379 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.747 ' C ' HD13 ' A' ' 58' ' ' LEU . 2.9 mt-30 -135.63 122.15 20.71 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.198 -1.364 . . . . 0.0 109.95 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.952 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.78 153.53 33.28 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.53 -178.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -122.93 144.38 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-N 114.508 -1.224 . . . . 0.0 112.32 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.13 103.43 8.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.107 178.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.472 HG22 ' CE2' ' A' ' 74' ' ' TYR . 1.5 p -70.84 143.54 51.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.385 0.612 . . . . 0.0 110.513 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.57 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . . . -140.66 12.88 2.31 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.644 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -105.21 -63.85 0.65 Allowed Glycine 0 CA--C 1.527 0.784 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.571 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.5 ' OE1' ' NE2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -84.02 -164.63 0.96 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.285 0.564 . . . . 0.0 111.324 -179.321 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.626 ' O ' ' N ' ' A' ' 67' ' ' TYR . 1.8 p30 -76.11 -172.8 2.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.078 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.601 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -21.82 -41.61 0.0 OUTLIER 'General case' 0 C--N 1.344 0.33 0 O-C-N 124.051 0.845 . . . . 0.0 110.778 -179.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 65' ' ' ASP . 4.4 t80 -178.86 5.0 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.64 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.55 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 67.0 m 36.67 93.97 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.699 0.285 . . . . 0.0 111.738 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.608 HD11 ' HA ' ' A' ' 103' ' ' LEU . 0.3 OUTLIER -44.21 139.9 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.17 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.445 ' CD2' ' O ' ' A' ' 70' ' ' PHE . 66.1 t80 53.95 64.94 5.92 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.729 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -51.4 163.58 1.03 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.632 2.221 . . . . 0.0 112.215 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.5 ' NE2' ' OE1' ' A' ' 64' ' ' GLN . 8.0 mp0 -91.35 -43.9 9.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.313 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.1 m -131.51 -1.26 3.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.228 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CE2' HG22 ' A' ' 61' ' ' THR . 0.2 OUTLIER -100.88 10.83 40.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.408 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 76' ' ' ILE . 5.4 m -83.58 57.55 4.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.247 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.84 HD12 ' CG2' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -50.53 -169.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.583 -179.57 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -117.29 54.28 0.89 Allowed 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.84 ' CG2' HD12 ' A' ' 76' ' ' ILE . 29.8 pt -78.86 -176.97 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-N 114.479 -1.237 . . . . 0.0 113.238 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -151.19 17.33 0.75 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.04 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -144.17 164.4 27.6 Favored Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.222 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.533 ' OH ' ' CG ' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -152.53 123.93 7.71 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.641 -0.78 . . . . 0.0 111.181 178.458 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 82' ' ' ILE . 7.6 tt -128.71 113.79 30.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.2 mt -97.48 123.93 41.51 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.042 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -98.08 117.82 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.179 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.615 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 42.2 p90 -120.5 145.38 47.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.308 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 88' ' ' THR . 3.3 p -86.03 135.77 33.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.204 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.535 HG21 ' N ' ' A' ' 124' ' ' HIS . 18.0 m -73.69 21.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.459 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.495 ' H ' ' C ' ' A' ' 86' ' ' SER . 0.9 OUTLIER -136.9 -25.6 1.08 Allowed 'General case' 0 CA--C 1.52 -0.212 0 CA-C-O 121.003 0.43 . . . . 0.0 112.063 -178.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 91' ' ' LYS . 60.8 p -97.77 100.06 11.42 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.067 -176.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.8 tp -59.37 -8.4 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 176.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.563 ' H ' ' C ' ' A' ' 89' ' ' SER . 21.8 mttp -77.05 -59.31 2.83 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.111 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.432 ' OG ' ' OG ' ' A' ' 89' ' ' SER . 83.1 p -52.22 -33.52 41.53 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.878 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.615 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -73.19 -49.76 26.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.721 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -65.98 -42.35 89.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.214 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 91' ' ' LYS . 19.5 m -66.22 -41.56 89.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.254 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.508 ' N ' HG23 ' A' ' 95' ' ' VAL . 1.4 mt -59.44 -34.51 54.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -71.0 -27.26 63.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.466 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.4 t -77.11 -67.27 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.263 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.91 HG21 HD11 ' A' ' 12' ' ' LEU . 1.4 tp -48.53 -29.53 2.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.684 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.616 ' CG ' ' CH2' ' A' ' 141' ' ' TRP . 35.6 t-80 -67.77 -63.58 1.03 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.235 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -39.58 -47.61 3.0 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 105' ' ' ASP . 37.6 tptt -62.81 -62.72 1.53 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.878 -0.661 . . . . 0.0 109.244 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.608 ' HA ' HD11 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -38.06 -51.09 1.39 Allowed 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.349 0.595 . . . . 0.0 109.498 178.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.735 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -52.4 -45.56 65.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.52 179.057 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -61.27 -32.7 72.52 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.035 -179.593 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.529 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 23.7 ttp -77.07 -46.48 23.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.18 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.792 HG23 ' H ' ' A' ' 109' ' ' LYS . 4.8 m -76.86 -11.19 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.623 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.488 ' O ' ' CB ' ' A' ' 109' ' ' LYS . . . 81.32 4.14 90.51 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.543 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.792 ' H ' HG23 ' A' ' 107' ' ' VAL . 5.9 tttp 83.85 94.51 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.137 0.494 . . . . 0.0 111.709 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.5 t -144.34 139.09 24.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.467 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.762 ' O ' ' HB2' ' A' ' 174' ' ' ALA . 2.1 mm100 -73.1 113.66 10.4 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.367 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.67 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.2 OUTLIER -130.61 161.21 62.32 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -51.83 101.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 120.953 1.102 . . . . 0.0 111.548 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.3 mt -116.22 120.97 66.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.404 ' CE ' HD23 ' A' ' 146' ' ' LEU . 8.5 tpt -121.84 113.73 20.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.033 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 79.8 mt -96.14 97.86 9.88 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.8 t -106.91 135.32 45.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 122.184 0.992 . . . . 0.0 111.696 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.403 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -105.45 116.08 5.1 Favored Glycine 0 C--N 1.308 -0.98 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.476 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 57.9 t30 -97.71 174.88 6.4 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.043 -178.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.476 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 7.2 mttp 62.09 58.19 1.9 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.048 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.44 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 2.9 tttm -58.92 -26.83 64.69 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.669 ' CG ' HN21 ' A' ' 186' ' ' GDP . 3.1 p-10 -64.5 -13.98 54.9 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.97 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 125' ' ' MET . 11.0 mp -89.98 -30.03 18.07 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.61 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.1 OUTLIER -37.53 -25.78 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.132 178.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.61 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 7.2 mtp -49.26 -21.5 0.83 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.448 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -109.99 -38.84 5.22 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.139 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.484 ' HE ' ' HB2' ' A' ' 124' ' ' HIS . 19.6 ttm180 26.68 90.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.106 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.99 -32.98 56.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.437 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.6 tp -88.89 156.37 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.597 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.562 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 88.7 p -103.41 124.98 49.73 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.219 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.511 ' CE1' ' CE1' ' A' ' 145' ' ' PHE . 0.4 OUTLIER -39.23 -39.56 0.63 Allowed 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.064 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mp0 -61.33 -65.75 0.64 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.937 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.562 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 66.6 mt-10 -41.41 -46.18 3.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.076 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.78 -35.05 84.57 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 132' ' ' GLU . 12.1 ttpt -62.04 -55.27 30.81 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.0 -37.82 77.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.307 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.557 ' CD2' ' CE2' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -67.06 -64.78 0.78 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 120.905 0.384 . . . . 0.0 110.017 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -49.71 -32.45 13.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.304 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -67.12 -53.77 27.59 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.911 0.386 . . . . 0.0 110.11 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 88.8 p -62.32 -26.77 68.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.116 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.616 ' CH2' ' CG ' ' A' ' 100' ' ' HIS . 32.6 m0 -88.02 -8.78 55.11 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 65.9 20.61 11.38 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -101.04 166.65 10.7 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.776 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.01 133.96 48.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.916 -0.583 . . . . 0.0 112.252 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.71 ' O ' HD22 ' A' ' 146' ' ' LEU . 4.5 t80 -97.1 122.92 40.63 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.529 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.913 HD12 HG22 ' A' ' 159' ' ' VAL . 1.2 mm? -135.79 138.89 43.06 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.592 -176.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.48 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 2.3 tt0 -127.77 110.55 12.73 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.1 p -137.86 -176.79 4.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.164 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.71 139.85 38.54 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.857 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.484 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -59.78 -44.38 93.92 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 178.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -62.5 -0.5 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.184 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.484 ' H ' ' C ' ' A' ' 150' ' ' ALA . 1.3 mt-10 -136.42 97.98 3.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.627 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.528 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 11.2 t-20 -63.96 -47.71 79.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.969 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 153' ' ' ASN . 0.0 OUTLIER -37.06 -59.13 0.74 Allowed 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.104 0.478 . . . . 0.0 110.485 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.588 ' O ' HG23 ' A' ' 159' ' ' VAL . 74.2 p -52.29 -44.98 65.3 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.847 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.579 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -55.19 -60.31 3.57 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.293 0.568 . . . . 0.0 109.959 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.1 t -41.63 -41.64 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.939 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.32 -39.56 94.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.891 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.913 HG22 HD12 ' A' ' 146' ' ' LEU . 22.4 t -67.39 -31.33 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.371 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.636 ' CD2' ' CZ ' ' A' ' 26' ' ' PHE . 4.8 t80 -62.19 -66.94 0.46 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.67 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 26.3 ttm-85 -48.48 -53.15 19.05 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.849 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.46 -33.98 23.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.95 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.521 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -65.76 -34.07 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.485 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.434 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 10.2 mt -68.06 -40.05 82.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.634 0.731 . . . . 0.0 110.244 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.37 -60.84 2.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.302 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.6 -32.29 65.11 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.546 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -60.0 -32.29 70.72 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -68.32 -55.98 10.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.96 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 18.4 ttpp -59.2 -62.33 1.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.931 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.67 HG21 ' C ' ' A' ' 112' ' ' ILE . 67.1 mt -50.28 -33.14 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.111 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.13 -40.69 90.84 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.141 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.56 -32.71 84.21 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.94 -81.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.419 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.762 ' HB2' ' O ' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.015 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GDP . . . . . 0.669 HN21 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.476 ' HG ' ' CE1' ' A' ' 55' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 121.078 0.466 . . . . 0.0 110.159 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.454 ' NH1' ' HB1' ' A' ' 167' ' ' ALA . 2.1 ptp180 -139.9 136.7 34.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.602 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.546 ' HB2' HG22 ' A' ' 78' ' ' ILE . 4.1 mptt -106.36 133.47 51.0 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.755 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.3 mm -106.06 125.97 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-O 121.345 0.593 . . . . 0.0 110.232 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.445 ' HB2' ' CD1' ' A' ' 78' ' ' ILE . . . -83.74 134.0 34.76 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.124 -0.985 . . . . 0.0 110.631 -178.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 58' ' ' LEU . 17.0 mt -96.9 132.37 41.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.341 0.591 . . . . 0.0 112.121 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.2 tp -132.4 105.92 7.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.569 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -140.26 134.37 6.48 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -54.9 -159.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.371 0.605 . . . . 0.0 110.918 179.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -96.18 135.28 38.2 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.864 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.482 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 3.0 m 61.27 19.48 10.16 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.497 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 p -77.8 -19.66 13.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.852 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.38 23.28 24.67 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.6 pttm -69.32 -34.45 74.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.0 110.263 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.2 m -75.42 -36.16 60.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.086 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.3 p -60.42 -42.16 95.47 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.318 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.6 tp -77.44 -34.14 54.64 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.959 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.596 ' O ' HG12 ' A' ' 27' ' ' VAL . 27.0 m -52.98 -45.48 67.84 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.849 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 24' ' ' ILE . 1.4 mp -74.42 -41.96 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.351 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.618 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -68.45 -28.9 67.45 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.334 -0.547 . . . . 0.0 110.961 -179.433 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.453 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 1.4 t80 -77.93 -64.05 1.25 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.336 0.588 . . . . 0.0 110.957 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.9 p -47.05 -48.41 8.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.727 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.61 ' N ' HG13 ' A' ' 27' ' ' VAL . 0.5 OUTLIER -80.32 -24.95 39.58 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.431 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 74.09 24.02 74.7 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.154 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -145.32 125.88 14.13 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.657 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -68.05 92.37 0.38 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.224 178.697 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.638 HG22 ' N ' ' A' ' 33' ' ' ASP . 14.7 p -101.33 166.51 2.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.186 0.517 . . . . 0.0 110.581 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.638 ' N ' HG22 ' A' ' 32' ' ' VAL . 1.2 t70 -73.0 26.75 0.06 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.01 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.472 ' H ' HG13 ' A' ' 32' ' ' VAL . 4.2 p -64.62 64.05 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.016 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.515 ' N ' ' O ' ' A' ' 33' ' ' ASP . 0.6 OUTLIER -91.04 105.79 18.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.648 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.444 ' O ' ' O ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -137.37 172.37 6.98 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.208 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 36' ' ' ASP . 49.0 Cg_exo -56.68 -137.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.485 2.123 . . . . 0.0 111.763 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 38' ' ' THR . 10.9 t -129.68 60.85 1.57 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.608 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 tp -83.17 149.17 4.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.223 -0.898 . . . . 0.0 111.158 -179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -87.49 147.33 25.42 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.149 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -172.33 -179.0 2.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.318 0.58 . . . . 0.0 111.837 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.3 m -126.7 143.27 51.29 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.151 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.457 ' CE2' HD11 ' A' ' 24' ' ' ILE . 14.2 m-85 -129.15 165.66 20.85 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.945 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.515 HG23 ' HB2' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -143.03 152.23 41.68 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.322 0.582 . . . . 0.0 112.148 -178.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 tttp -156.47 113.14 3.09 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.868 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.9 mp -105.91 122.21 45.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.899 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.895 ' H ' HD12 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -144.77 165.43 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.672 -179.145 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.6 m -115.23 125.89 53.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.266 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.562 ' O ' HG13 ' A' ' 49' ' ' VAL . 8.0 p -120.61 117.25 52.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.885 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.512 ' CG ' HG22 ' A' ' 49' ' ' VAL . 0.9 OUTLIER 69.88 25.9 4.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 110.118 -179.17 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.38 -10.15 55.8 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -89.34 132.13 35.09 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -75.76 146.17 40.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.535 0.683 . . . . 0.0 111.203 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.559 ' CD1' HG12 ' A' ' 49' ' ' VAL . 5.1 m-85 -137.54 125.72 23.05 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.891 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.517 ' O ' ' ND1' ' A' ' 55' ' ' HIS . 1.3 t-80 -117.47 113.4 21.98 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.497 HD12 ' C ' ' A' ' 55' ' ' HIS . 9.5 mp -118.39 143.17 46.85 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 121.781 0.8 . . . . 0.0 111.822 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.806 ' C ' HD13 ' A' ' 58' ' ' LEU . 3.2 tt0 -140.44 120.52 13.73 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.047 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.973 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -115.85 154.33 29.89 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.331 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -130.89 144.15 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.267 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.41 102.93 7.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.449 -1.251 . . . . 0.0 108.306 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.14 153.96 45.37 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.38 0.61 . . . . 0.0 110.364 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 64' ' ' GLN . . . -143.17 21.01 1.92 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.319 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -38.84 -25.42 0.04 OUTLIER Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.565 ' CG ' ' H ' ' A' ' 65' ' ' ASP . 0.5 OUTLIER -145.31 -125.3 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.476 0.655 . . . . 0.0 110.888 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.58 ' O ' ' N ' ' A' ' 67' ' ' TYR . 5.9 p30 -76.33 -170.27 1.42 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.816 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.602 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 1.0 OUTLIER -61.63 56.0 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 O-C-N 124.045 0.841 . . . . 0.0 110.223 179.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.59 ' OH ' HD11 ' A' ' 76' ' ' ILE . 31.9 t80 76.5 71.67 0.07 Allowed 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.574 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 24.1 m -47.22 122.93 4.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.3 -177.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.899 ' H ' HD12 ' A' ' 69' ' ' ILE . 2.6 mp -55.33 -63.68 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.023 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.534 ' O ' ' N ' ' A' ' 72' ' ' GLN . 7.1 m-85 -32.14 97.02 0.1 Allowed Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 114.271 -1.332 . . . . 0.0 110.915 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.19 82.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.071 1.847 . . . . 0.0 112.401 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -111.24 -69.9 0.84 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.991 179.584 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.45 ' OG1' ' NE2' ' A' ' 72' ' ' GLN . 3.7 m -100.54 -20.42 15.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.683 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.573 ' CD1' ' CE1' ' A' ' 67' ' ' TYR . 79.6 m-85 -88.23 49.52 1.81 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.21 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 76' ' ' ILE . 3.7 p -80.71 11.04 4.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.172 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.59 HD11 ' OH ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -49.68 -178.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 120.938 0.399 . . . . 0.0 110.968 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.74 51.43 1.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 8' ' ' LYS . 45.2 pt -78.4 -173.5 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 115.415 -0.812 . . . . 0.0 112.725 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.27 18.25 0.95 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.477 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.425 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -147.55 166.43 28.69 Favored Glycine 0 CA--C 1.519 0.339 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.622 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.54 ' OH ' ' CD2' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -151.9 123.08 7.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.851 -0.675 . . . . 0.0 111.2 178.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.621 HG23 ' O ' ' A' ' 82' ' ' ILE . 9.6 tt -128.0 104.81 12.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.505 0.669 . . . . 0.0 109.296 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 1.008 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.53 122.17 40.28 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.144 -178.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.405 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.9 OUTLIER -96.47 118.22 42.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.376 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.467 ' CZ ' ' CA ' ' A' ' 118' ' ' GLY . 25.5 p90 -112.12 144.69 41.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.465 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.49 ' C ' ' H ' ' A' ' 88' ' ' THR . 1.5 p -86.94 135.7 33.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.844 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.564 HG21 ' N ' ' A' ' 124' ' ' HIS . 17.6 m -72.35 19.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.991 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.49 ' H ' ' C ' ' A' ' 86' ' ' SER . 5.5 t -136.65 -26.11 1.1 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.061 0.457 . . . . 0.0 112.099 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.545 ' C ' ' N ' ' A' ' 91' ' ' LYS . 18.3 t -93.14 93.74 8.45 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.095 -176.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 tp -60.45 -10.02 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.545 ' N ' ' C ' ' A' ' 89' ' ' SER . 15.6 mttp -75.48 -48.6 21.9 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 113.901 -1.5 . . . . 0.0 109.533 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.1 p -61.44 -30.92 70.88 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.906 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.446 ' CE2' HG21 ' A' ' 129' ' ' ILE . 0.6 OUTLIER -73.24 -51.75 16.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.125 -179.437 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -62.77 -43.78 97.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.701 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 91' ' ' LYS . 14.4 m -66.67 -34.51 70.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.084 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.8 mt -66.48 -36.08 76.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.591 -0.443 . . . . 0.0 109.904 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -70.07 -26.36 63.97 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.273 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 13.1 t -73.02 -67.03 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.895 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.423 HG23 ' N ' ' A' ' 100' ' ' HIS . 2.5 tt -43.11 -40.37 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.214 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.614 ' CE1' ' CD1' ' A' ' 141' ' ' TRP . 1.1 t-160 -58.45 -63.57 1.23 Allowed 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.385 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -38.36 -58.42 1.68 Allowed Glycine 0 CA--C 1.519 0.3 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 105' ' ' ASP . 34.8 tptt -61.71 -62.75 1.58 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.953 -0.623 . . . . 0.0 110.365 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.64 -55.0 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.429 0.633 . . . . 0.0 109.579 179.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.728 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -49.17 -46.24 45.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.275 178.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -60.47 -36.12 77.52 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.726 -179.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.518 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 2.0 ttm -59.4 -57.96 10.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.135 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.513 ' C ' ' H ' ' A' ' 109' ' ' LYS . 19.1 m -77.07 -13.31 14.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.584 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.26 -24.83 0.1 OUTLIER Glycine 0 CA--C 1.53 1.028 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.65 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.513 ' H ' ' C ' ' A' ' 107' ' ' VAL . 7.9 tttp -173.9 -134.58 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 117.663 0.731 . . . . 0.0 111.689 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.512 ' H ' ' CG ' ' A' ' 109' ' ' LYS . 5.1 t 52.85 120.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.719 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.458 ' HB3' HG23 ' A' ' 170' ' ' ILE . 23.0 mt-30 -75.14 136.4 41.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.732 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.602 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.4 OUTLIER -138.3 148.2 58.62 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.098 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -48.7 114.59 1.28 Allowed 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 121.94 1.76 . . . . 0.0 112.824 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.513 ' HB ' ' HB2' ' A' ' 143' ' ' ALA . 2.2 mp -124.26 128.65 73.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.542 ' O ' HD12 ' A' ' 83' ' ' LEU . 10.7 tpt -130.36 114.32 15.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.912 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.4 mt -97.65 98.66 10.07 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.3 t -104.98 129.45 57.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.944 0.878 . . . . 0.0 111.461 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.467 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -96.07 117.12 5.6 Favored Glycine 0 C--N 1.311 -0.83 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.445 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 58.7 t30 -97.47 174.14 6.82 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.994 -177.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.516 ' HZ1' " C1'" ' A' ' 186' ' ' GDP . 6.1 mttp 59.91 58.75 2.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.939 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.46 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 18.1 tttm -56.27 -26.05 50.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.568 -178.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.655 ' CG ' HN21 ' A' ' 186' ' ' GDP . 3.9 p-10 -72.72 -13.31 61.31 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.084 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.8 mp -91.18 -30.92 16.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.606 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.1 OUTLIER -38.93 -25.04 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.171 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.606 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 11.2 mtt -45.65 -23.95 0.3 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.473 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -105.17 -40.46 5.86 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.495 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.488 ' CZ ' ' OE1' ' A' ' 147' ' ' GLU . 2.6 tpp85 27.9 86.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.766 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.1 t -59.41 -32.6 49.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.396 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.446 HG21 ' CE2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -88.29 153.04 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.531 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.501 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 78.3 p -96.89 121.94 39.32 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.304 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.411 ' HB2' HH12 ' A' ' 127' ' ' ARG . 13.8 t80 -37.01 -32.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.249 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.5 mp0 -70.51 -64.84 0.82 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.808 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.501 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 69.6 mt-10 -41.24 -42.52 2.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.724 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.15 -35.68 70.93 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 132' ' ' GLU . 4.2 tttt -61.97 -55.48 29.02 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.92 -35.72 69.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.821 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.644 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -66.27 -63.53 1.06 Allowed 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.85 -35.6 57.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.185 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -68.69 -32.35 72.11 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.173 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 p -63.24 -46.24 87.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.792 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.644 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 30.9 m95 -88.51 -5.12 58.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.982 0.42 . . . . 0.0 110.335 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 141' ' ' TRP . 0.9 OUTLIER 77.41 23.69 0.85 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.384 0.611 . . . . 0.0 109.52 -179.312 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.29 167.37 13.6 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.869 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.432 ' HB3' ' SD ' ' A' ' 115' ' ' MET . . . -110.97 130.1 55.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.529 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -98.17 120.87 39.33 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.281 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.75 128.73 17.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.488 ' OE1' ' CZ ' ' A' ' 127' ' ' ARG . 6.4 mt-10 -100.28 119.76 38.89 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.043 0.449 . . . . 0.0 110.029 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 63.2 p -137.45 178.1 7.36 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.42 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.3 138.08 38.03 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.974 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -55.73 -49.82 72.01 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.143 0.497 . . . . 0.0 109.748 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.7 tttm -58.84 -3.12 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.284 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 150' ' ' ALA . 6.7 tt0 -127.35 110.92 13.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.421 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.515 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 7.7 t-20 -76.57 -47.21 23.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.684 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -41.3 -57.61 2.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.093 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.644 ' O ' HG23 ' A' ' 159' ' ' VAL . 78.0 p -52.74 -48.42 66.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.975 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.618 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -48.49 -60.56 2.59 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.516 0.674 . . . . 0.0 109.59 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 60.0 t -43.29 -49.58 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.088 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -53.76 -43.1 68.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.553 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 155' ' ' THR . 3.2 t -68.16 -44.12 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.304 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.758 ' CE1' HD11 ' A' ' 164' ' ' ILE . 9.7 t80 -53.72 -40.48 66.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.168 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.3 ttt85 -77.09 -42.12 39.45 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.156 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -60.26 -34.44 73.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.189 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 160' ' ' PHE . 10.3 tt -70.73 -47.16 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 119.281 -0.968 . . . . 0.0 110.79 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.758 HD11 ' CE1' ' A' ' 160' ' ' PHE . 85.5 mt -54.62 -32.07 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.289 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.404 ' HA ' HD13 ' A' ' 165' ' ' LEU . 0.4 OUTLIER -63.21 -64.68 0.84 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.206 -179.419 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -60.01 -29.67 68.64 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.493 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.454 ' HB1' ' NH1' ' A' ' 7' ' ' ARG . . . -61.33 -30.97 70.84 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.417 ' OE2' ' OH ' ' A' ' 54' ' ' TYR . 3.7 tp10 -68.06 -54.34 18.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.177 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -60.9 -61.09 2.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.884 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.602 HG21 ' C ' ' A' ' 112' ' ' ILE . 74.2 mt -50.06 -36.96 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.814 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -70.86 -40.07 72.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.808 0.337 . . . . 0.0 110.605 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -55.16 -41.52 78.81 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.654 -0.979 . . . . 0.0 110.654 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.05 -61.99 1.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.756 0.313 . . . . 0.0 110.621 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.932 -179.832 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GDP . . . . . 0.655 HN21 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 121.212 0.53 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.22 136.05 34.58 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.489 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.543 ' HB2' HG22 ' A' ' 78' ' ' ILE . 1.9 mptt -106.16 132.28 52.41 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.776 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.1 mm -104.45 124.75 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-O 121.333 0.587 . . . . 0.0 110.242 -178.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.475 ' HB2' ' CD1' ' A' ' 78' ' ' ILE . . . -83.83 133.54 34.75 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 121.084 -1.01 . . . . 0.0 110.931 -177.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 58' ' ' LEU . 14.8 mt -95.56 133.72 35.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.657 0.741 . . . . 0.0 112.33 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.55 HD21 ' HB2' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -134.55 104.91 6.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.877 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -140.98 135.95 7.25 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 -178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.467 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -54.09 -158.18 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.769 0.795 . . . . 0.0 111.042 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -95.99 132.75 40.99 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.882 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.56 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 5.8 m 59.14 19.1 7.06 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.159 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.537 ' O ' HG22 ' A' ' 17' ' ' VAL . 2.5 p -80.48 -10.76 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.801 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.42 7.66 51.23 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.414 ' HE3' ' H ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -40.05 -59.26 1.26 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.118 0.485 . . . . 0.0 110.353 179.565 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -67.75 -26.97 66.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.449 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.596 ' OG ' ' H8 ' ' A' ' 186' ' ' GDP . 8.0 m -64.39 -50.56 67.17 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.017 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.9 tp -75.83 -26.35 57.1 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.42 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.492 ' O ' HG12 ' A' ' 27' ' ' VAL . 55.5 m -58.15 -50.9 71.89 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.4 mp -60.6 -43.73 95.28 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.406 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.541 ' OE1' ' N ' ' A' ' 31' ' ' PHE . 6.4 tt0 -69.69 -25.62 63.96 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.21 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -77.32 -49.94 13.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.246 0.546 . . . . 0.0 110.822 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.591 HG13 ' N ' ' A' ' 28' ' ' GLU . 11.8 p -68.77 -45.1 81.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.139 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.591 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.8 tt0 -81.4 -24.94 36.61 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.466 ' O ' ' ND2' ' A' ' 153' ' ' ASN . . . 77.68 19.25 76.16 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.974 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.539 ' NE2' ' O ' ' A' ' 31' ' ' PHE . 16.8 tp60 -149.0 135.97 19.86 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.301 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.541 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 1.0 OUTLIER -71.76 93.96 1.34 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.567 178.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.636 HG22 ' N ' ' A' ' 33' ' ' ASP . 13.9 p -111.68 166.49 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.094 0.473 . . . . 0.0 110.46 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.636 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -62.68 -14.41 43.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.479 -178.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 33' ' ' ASP . 29.4 p 49.8 173.39 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.399 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -152.81 13.59 0.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.117 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 37' ' ' PRO . 2.2 m-20 -113.88 95.28 37.08 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.664 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 36' ' ' ASP . 66.4 Cg_exo -54.82 -130.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.568 2.179 . . . . 0.0 112.256 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 38' ' ' THR . 12.3 t -109.95 46.25 1.04 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.181 0.515 . . . . 0.0 112.046 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.434 ' CG2' ' OD1' ' A' ' 41' ' ' ASN . 1.5 tp -84.59 165.22 2.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.469 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.98 124.56 28.81 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.434 ' OD1' ' CG2' ' A' ' 39' ' ' ILE . 1.2 m120 -161.97 -178.99 6.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.645 0.736 . . . . 0.0 112.95 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.2 m -137.43 144.3 42.28 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.11 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 12.3 m-85 -127.44 163.65 23.61 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.496 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.528 HG23 ' HB2' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -144.22 150.75 38.47 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.396 0.617 . . . . 0.0 112.661 -178.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.0 118.69 2.73 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.771 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.6 mp -105.82 129.3 54.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.654 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.444 HD12 ' HE2' ' A' ' 160' ' ' PHE . 1.0 OUTLIER -147.65 165.83 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.798 -179.095 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.4 m -115.79 126.4 53.97 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.197 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.594 HG12 ' CD1' ' A' ' 54' ' ' TYR . 7.2 p -121.28 118.95 57.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.94 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 71.27 17.36 5.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.12 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.37 -11.58 70.82 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -89.28 133.88 34.28 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.25 144.1 42.74 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.622 0.725 . . . . 0.0 111.163 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.594 ' CD1' HG12 ' A' ' 49' ' ' VAL . 6.6 m-85 -136.47 127.87 28.44 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.664 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.525 ' O ' ' ND1' ' A' ' 55' ' ' HIS . 1.2 t-80 -117.07 114.39 23.67 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.449 HD12 ' C ' ' A' ' 55' ' ' HIS . 8.4 mp -117.69 143.72 45.92 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 122.078 0.942 . . . . 0.0 112.244 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.772 ' C ' HD13 ' A' ' 58' ' ' LEU . 3.0 tt0 -140.91 121.68 14.38 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 113.702 -1.59 . . . . 0.0 109.725 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.946 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -115.86 154.09 30.33 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.528 0.68 . . . . 0.0 112.347 -178.403 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.02 145.09 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-N 114.532 -1.213 . . . . 0.0 113.172 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.422 ' OD2' ' O ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -120.88 102.91 8.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.201 178.016 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.64 HG22 ' CE2' ' A' ' 74' ' ' TYR . 72.5 p -70.51 150.85 45.72 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.07 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 63' ' ' GLY . . . -121.31 23.83 10.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.714 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 62' ' ' ALA . . . -51.55 -164.92 0.01 OUTLIER Glycine 0 CA--C 1.529 0.951 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.485 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.42 ' NE2' ' O ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -83.22 -64.48 1.16 Allowed 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.391 0.615 . . . . 0.0 111.023 -179.618 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 66' ' ' GLU . 4.0 t70 -76.26 -178.8 4.7 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.633 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.535 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.6 OUTLIER -45.04 -19.6 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.604 ' CG ' ' O ' ' A' ' 67' ' ' TYR . 11.3 t80 -178.06 4.14 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.959 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.419 ' H ' ' HB3' ' A' ' 65' ' ' ASP . 3.4 m 38.93 81.33 0.03 OUTLIER 'General case' 0 C--O 1.232 0.15 0 O-C-N 122.121 -0.362 . . . . 0.0 111.266 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.562 HD11 ' HA ' ' A' ' 103' ' ' LEU . 0.4 OUTLIER -42.65 140.22 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.337 0.064 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.112 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 13.4 t80 68.16 63.72 0.65 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.164 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.483 ' C ' ' N ' ' A' ' 73' ' ' THR . 51.0 Cg_exo -47.11 -42.09 26.49 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.7 2.267 . . . . 0.0 112.423 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.3 13.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.077 0.465 . . . . 0.0 109.959 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.483 ' N ' ' C ' ' A' ' 71' ' ' PRO . 87.6 m -135.87 -35.51 0.78 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.193 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.64 ' CE2' HG22 ' A' ' 61' ' ' THR . 0.1 OUTLIER -70.16 -65.74 0.69 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.999 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 t 73.64 49.14 0.14 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.928 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -81.95 172.73 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.48 0.657 . . . . 0.0 111.551 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.49 52.46 1.06 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.052 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.543 HG22 ' HB2' ' A' ' 8' ' ' LYS . 37.6 pt -80.69 -173.08 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.69 16.34 0.88 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.449 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -145.07 166.79 27.45 Favored Glycine 0 CA--C 1.519 0.319 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.317 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.82 122.5 7.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.911 -0.645 . . . . 0.0 111.28 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.698 HG23 ' O ' ' A' ' 82' ' ' ILE . 12.2 tt -127.55 101.04 6.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.562 0.696 . . . . 0.0 109.138 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.968 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -96.86 123.44 40.56 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.376 -178.52 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -96.84 119.67 45.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.97 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.635 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 32.1 p90 -121.64 144.72 48.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.675 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.7 p -87.82 143.28 27.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.735 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.59 HG21 ' N ' ' A' ' 124' ' ' HIS . 15.8 m -80.67 20.32 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.778 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.609 ' HB ' HD23 ' A' ' 123' ' ' LEU . 0.7 OUTLIER -131.05 -27.82 2.01 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.119 0.485 . . . . 0.0 111.936 -178.101 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.543 ' C ' ' N ' ' A' ' 91' ' ' LYS . 44.2 t -97.08 93.94 6.87 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.674 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 tp -58.58 -10.75 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.567 ' O ' HG22 ' A' ' 95' ' ' VAL . 2.6 mtpt -76.07 -50.82 13.7 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.052 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.477 ' O ' ' CG1' ' A' ' 96' ' ' ILE . 59.1 p -60.34 -31.88 70.73 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.01 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -75.56 -46.17 33.55 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.081 -179.337 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -66.02 -44.1 85.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.25 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 91' ' ' LYS . 16.4 m -68.17 -39.8 81.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.621 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.494 ' N ' HG23 ' A' ' 95' ' ' VAL . 1.4 mm -59.18 -42.45 86.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.289 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.49 -27.25 64.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.305 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.0 t -75.55 -66.97 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.166 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.463 HD11 ' OD1' ' A' ' 65' ' ' ASP . 4.6 mm -41.84 -45.49 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.043 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.443 ' ND1' ' C ' ' A' ' 100' ' ' HIS . 9.7 t-80 -56.53 -63.51 1.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.691 -0.403 . . . . 0.0 109.985 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -40.63 -58.57 2.54 Favored Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 103' ' ' LEU . 14.0 tptp -55.8 -66.09 0.48 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.037 -0.582 . . . . 0.0 110.249 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.562 ' HA ' HD11 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -37.98 -59.84 0.8 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.275 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.728 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -46.06 -47.72 17.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.577 178.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -59.91 -30.13 68.83 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.998 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.481 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 3.9 ttm -77.81 -48.53 16.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.723 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.599 HG23 ' H ' ' A' ' 109' ' ' LYS . 6.4 m -75.98 -24.87 16.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.674 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 40.87 37.18 1.29 Allowed Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.599 ' H ' HG23 ' A' ' 107' ' ' VAL . 0.5 OUTLIER -95.36 -158.17 0.63 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.221 0.534 . . . . 0.0 111.63 -178.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 110' ' ' VAL . 0.0 OUTLIER -98.47 -170.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.96 -179.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -67.34 117.21 9.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.995 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.635 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.7 OUTLIER -119.55 155.74 54.06 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.023 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -47.43 106.01 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.529 1.486 . . . . 0.0 112.335 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.454 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.8 mt -119.8 128.56 75.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.564 ' O ' HD12 ' A' ' 83' ' ' LEU . 10.1 tpt -127.25 116.83 21.18 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.789 -178.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 mt -96.02 97.25 9.45 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.5 t -103.72 133.19 48.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 122.406 1.098 . . . . 0.0 110.371 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.79 113.07 4.11 Favored Glycine 0 C--N 1.299 -1.509 0 CA-C-N 113.265 -1.789 . . . . 0.0 109.032 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.509 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 48.5 t30 -96.88 177.22 5.7 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.279 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.509 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 26.8 mttp 61.96 58.35 1.92 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.016 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.46 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 15.7 tttm -63.48 -31.27 72.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.495 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -63.58 -8.92 11.03 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.003 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.609 HD23 ' HB ' ' A' ' 88' ' ' THR . 8.6 mp -93.67 -27.0 16.8 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.59 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -39.3 -24.47 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.858 178.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.59 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 2.7 mmt -46.12 -22.27 0.21 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.473 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.3 OUTLIER -106.67 -36.54 6.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.063 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.492 ' NH2' ' CD2' ' A' ' 131' ' ' TYR . 0.1 OUTLIER 33.11 88.81 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.851 -179.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.6 t -72.05 -38.05 62.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.553 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 tp -89.92 155.63 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.427 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.484 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 62.0 p -103.03 125.44 49.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.949 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.492 ' CD2' ' NH2' ' A' ' 127' ' ' ARG . 0.8 OUTLIER -37.32 -35.91 0.13 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.574 179.13 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.6 mp0 -67.16 -64.75 0.79 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.054 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.484 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 64.6 mt-10 -41.21 -41.52 1.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.979 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.83 -36.3 65.91 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 132' ' ' GLU . 3.6 ttpp -61.69 -55.15 33.52 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.048 -0.576 . . . . 0.0 109.587 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.69 70.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.865 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.518 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -66.23 -61.66 1.9 Allowed 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.658 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -53.41 -35.78 60.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.34 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -68.85 -29.94 68.37 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.43 -46.65 82.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.715 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.518 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 33.0 m95 -89.35 -4.25 58.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.027 0.442 . . . . 0.0 110.194 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.409 ' O ' ' OE1' ' A' ' 166' ' ' GLU . 0.9 OUTLIER 76.52 22.46 1.22 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.403 -179.084 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -89.29 170.9 10.18 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.595 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.409 ' HB3' ' SD ' ' A' ' 115' ' ' MET . . . -109.65 134.75 51.59 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.428 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.627 ' O ' HD22 ' A' ' 146' ' ' LEU . 7.0 t80 -96.66 122.36 39.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.929 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.782 HD12 HG22 ' A' ' 159' ' ' VAL . 1.2 mm? -133.17 137.7 46.32 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.346 -176.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.456 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 9.1 tt0 -127.38 110.64 13.01 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 36.3 p -136.56 -172.81 3.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.21 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.68 139.57 40.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.716 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.525 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -64.84 -30.97 72.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.287 0.565 . . . . 0.0 109.97 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -79.78 13.65 2.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.029 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -144.19 121.03 11.27 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.745 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 9.5 t-20 -77.59 -54.51 6.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.408 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 153' ' ' ASN . 7.6 tt0 -37.09 -55.33 0.96 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.823 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 159' ' ' VAL . 60.2 p -57.01 -50.73 71.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.275 0.559 . . . . 0.0 110.158 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -47.68 -59.96 2.9 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.561 0.696 . . . . 0.0 109.574 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.9 t -41.28 -53.35 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.626 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -48.94 -33.1 10.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.733 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.782 HG22 HD12 ' A' ' 146' ' ' LEU . 10.3 t -76.55 -28.54 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.608 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -68.55 -40.71 80.55 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.727 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.507 ' N ' ' CD1' ' A' ' 160' ' ' PHE . 27.6 ttm-85 -79.6 -50.57 10.48 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.196 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -54.53 -36.92 64.78 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.226 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.627 HG23 ' N ' ' A' ' 164' ' ' ILE . 11.9 tt -69.01 -58.25 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.322 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.627 ' N ' HG23 ' A' ' 163' ' ' ILE . 84.1 mt -46.68 -33.02 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.91 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.25 -64.62 0.87 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.295 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.409 ' OE1' ' O ' ' A' ' 142' ' ' ASN . 3.2 mm-40 -61.21 -26.47 67.75 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.454 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -58.1 -36.8 73.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.419 ' OE2' ' OH ' ' A' ' 54' ' ' TYR . 11.5 mm-40 -69.73 -52.06 28.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.273 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -54.59 -60.22 3.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.515 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.635 HG21 ' C ' ' A' ' 112' ' ' ILE . 71.2 mt -50.0 -35.2 10.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.764 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.17 -39.92 90.13 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -60.4 -32.13 76.37 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.0 -76.59 0.09 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.168 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.061 179.871 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GDP . . . . . 0.596 ' H8 ' ' OG ' ' A' ' 21' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 121.166 0.508 . . . . 0.0 110.369 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.413 ' NH1' ' HB1' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -139.8 135.73 33.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.579 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.426 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 18.3 mttt -107.58 128.33 54.43 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.762 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -101.97 121.66 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-O 121.535 0.684 . . . . 0.0 110.351 -178.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.99 135.55 34.4 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 121.426 -0.796 . . . . 0.0 111.062 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.8 mt -95.57 131.39 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.458 0.647 . . . . 0.0 112.226 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.632 ' C ' HD23 ' A' ' 12' ' ' LEU . 6.3 tt -130.58 103.67 6.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.215 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.08 135.32 6.84 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.734 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.478 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -53.72 -160.82 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.366 0.603 . . . . 0.0 110.535 179.168 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.404 ' NE ' ' OG ' ' A' ' 16' ' ' SER . 10.1 ttp180 -96.14 135.94 37.27 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.86 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.404 ' OG ' ' NE ' ' A' ' 15' ' ' ARG . 5.1 m 60.08 19.34 8.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.574 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.477 ' C ' ' HZ2' ' A' ' 120' ' ' LYS . 3.6 p -76.69 -19.75 14.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.737 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.34 21.63 26.67 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.531 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.7 pttm -68.17 -33.97 75.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.928 0.394 . . . . 0.0 110.016 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.7 m -73.16 -38.75 66.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.532 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.8 p -62.16 -40.4 95.86 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.402 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.7 tp -77.75 -25.44 49.17 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.26 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.564 ' O ' HG12 ' A' ' 27' ' ' VAL . 58.4 m -63.67 -38.24 90.39 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.4 mp -74.92 -38.54 43.69 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.214 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.56 ' OE1' ' N ' ' A' ' 31' ' ' PHE . 5.9 tt0 -75.04 -25.48 58.72 Favored 'General case' 0 C--O 1.217 -0.618 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.154 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 23.1 t80 -76.59 -52.82 8.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.29 0.567 . . . . 0.0 110.766 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.593 HG13 ' N ' ' A' ' 28' ' ' GLU . 11.3 p -62.28 -45.96 97.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.906 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.593 ' N ' HG13 ' A' ' 27' ' ' VAL . 1.1 tm-20 -82.22 -24.54 34.81 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.466 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 77.24 18.01 78.79 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.799 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -146.68 134.19 20.89 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.56 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 0.6 OUTLIER -68.57 93.8 0.53 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.47 178.116 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.617 HG22 ' N ' ' A' ' 33' ' ' ASP . 12.3 p -109.07 166.15 4.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.12 0.486 . . . . 0.0 110.586 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.617 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -61.94 -12.17 16.93 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.135 -179.229 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.467 ' H ' HG13 ' A' ' 32' ' ' VAL . 52.7 p 49.1 177.03 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.03 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -150.91 0.33 0.4 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.781 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 37' ' ' PRO . 9.5 m-20 -118.86 87.12 32.43 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.853 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 36' ' ' ASP . 67.7 Cg_exo -54.11 -129.44 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.867 2.378 . . . . 0.0 112.32 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 38' ' ' THR . 10.0 t -78.45 38.63 0.31 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.223 0.535 . . . . 0.0 110.914 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.412 ' H ' ' C ' ' A' ' 37' ' ' PRO . 1.5 tp -84.12 143.83 11.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.013 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.428 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 2.3 pm0 -91.94 144.03 25.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.381 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER 176.44 179.79 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.332 0.587 . . . . 0.0 111.962 -179.31 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.514 HG23 HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -107.69 140.49 40.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.666 179.51 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.418 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 12.1 m-85 -127.9 163.53 24.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.638 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -143.6 155.8 44.39 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.295 0.569 . . . . 0.0 112.363 -178.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.465 ' HD2' HD11 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -160.97 111.68 1.76 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.899 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 46' ' ' LEU . 8.1 mp -105.1 127.1 52.74 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.793 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.81 HD12 ' CZ ' ' A' ' 160' ' ' PHE . 0.9 OUTLIER -148.85 165.6 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.5 179.338 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.2 m -114.66 126.51 54.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.557 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.594 HG21 HG21 ' A' ' 164' ' ' ILE . 7.4 p -123.4 135.04 64.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.842 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.517 ' CG ' HG22 ' A' ' 49' ' ' VAL . 2.8 m120 62.6 3.97 1.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.029 0.442 . . . . 0.0 109.829 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 102.69 -13.23 56.52 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.458 ' NE2' ' H ' ' A' ' 53' ' ' GLU . 43.9 tp60 -90.29 140.37 29.76 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.458 ' H ' ' NE2' ' A' ' 52' ' ' GLN . 3.4 mt-10 -77.09 147.23 36.77 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.525 0.679 . . . . 0.0 111.303 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.552 ' CD1' HG12 ' A' ' 49' ' ' VAL . 13.9 m-85 -139.76 123.04 17.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.799 -1.092 . . . . 0.0 109.911 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.626 ' C ' HD12 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -117.48 113.79 22.54 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.626 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.9 mp -118.84 145.9 45.3 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.641 0.734 . . . . 0.0 112.143 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.811 ' C ' HD13 ' A' ' 58' ' ' LEU . 12.4 tt0 -139.18 124.09 18.74 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.053 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.939 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.96 154.99 29.9 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.279 0.561 . . . . 0.0 112.463 -178.248 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.514 HG23 HG23 ' A' ' 42' ' ' THR . 0.3 OUTLIER -133.96 144.41 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.779 -179.495 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.35 104.37 8.14 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.831 177.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.37 166.57 11.53 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.128 0.489 . . . . 0.0 110.511 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 63' ' ' GLY . . . -135.68 29.46 3.21 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.857 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 62' ' ' ALA . . . -30.35 -63.6 0.17 Allowed Glycine 0 CA--C 1.528 0.899 0 O-C-N 123.84 0.712 . . . . 0.0 111.421 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -144.51 -93.16 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.607 0.717 . . . . 0.0 110.208 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 68' ' ' SER . 3.9 p30 -77.0 -172.07 2.21 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.963 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.542 ' O ' ' CB ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -63.77 46.98 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.385 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.542 ' CB ' ' O ' ' A' ' 66' ' ' GLU . 10.9 t80 91.5 69.2 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.103 0 O-C-N 124.003 0.815 . . . . 0.0 109.888 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.564 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.7 OUTLIER -61.03 147.82 42.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.065 -178.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.747 HG22 ' H ' ' A' ' 70' ' ' PHE . 18.1 mm -98.06 -132.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.082 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.747 ' H ' HG22 ' A' ' 69' ' ' ILE . 0.2 OUTLIER 61.67 127.84 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.484 ' O ' ' N ' ' A' ' 73' ' ' THR . 77.3 Cg_exo -42.25 171.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.004 1.802 . . . . 0.0 112.745 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 65.73 -51.71 0.38 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.764 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.492 HG21 ' HB2' ' A' ' 68' ' ' SER . 13.9 m -40.85 -60.13 1.25 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.586 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.611 ' CD1' HG23 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -134.1 95.24 3.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.417 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.6 p -83.62 51.51 2.03 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.436 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.611 HG23 ' CD1' ' A' ' 74' ' ' TYR . 0.9 OUTLIER -81.99 175.68 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.426 0.631 . . . . 0.0 111.703 -179.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 6.3 p-10 -145.54 48.0 1.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.263 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.428 HD12 ' O ' ' A' ' 80' ' ' GLY . 40.6 pt -81.33 -172.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.822 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.24 16.33 0.93 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.144 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.428 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -148.02 166.47 28.91 Favored Glycine 0 CA--C 1.516 0.152 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.73 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.518 ' OH ' ' CD1' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -151.98 123.17 7.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.711 -0.744 . . . . 0.0 111.481 178.193 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.624 HG23 ' O ' ' A' ' 82' ' ' ILE . 10.8 tt -127.07 104.24 12.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.628 0.728 . . . . 0.0 109.064 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.989 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.32 123.29 41.09 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.784 -178.332 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -96.65 118.13 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.468 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.556 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 27.9 p90 -120.28 144.52 47.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.581 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.482 ' HG ' ' H ' ' A' ' 89' ' ' SER . 4.8 p -87.89 142.15 28.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.499 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.562 HG21 ' N ' ' A' ' 124' ' ' HIS . 16.5 m -76.15 18.7 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.245 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.551 ' HB ' HD23 ' A' ' 123' ' ' LEU . 0.7 OUTLIER -133.18 -23.38 1.94 Allowed 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.063 0.459 . . . . 0.0 111.752 -178.342 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.54 ' C ' ' N ' ' A' ' 91' ' ' LYS . 22.7 t -93.71 93.47 8.03 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.96 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 tp -59.69 -11.76 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.648 ' O ' HG22 ' A' ' 95' ' ' VAL . 9.3 mttp -78.07 -51.23 10.62 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.458 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.0 p -56.48 -34.91 67.37 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.374 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.556 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.5 OUTLIER -70.8 -54.85 10.09 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.415 -179.278 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -63.0 -44.41 96.1 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.648 HG22 ' O ' ' A' ' 91' ' ' LYS . 17.7 m -64.79 -34.4 69.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.034 -0.667 . . . . 0.0 110.186 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.441 ' CG1' HD22 ' A' ' 12' ' ' LEU . 1.8 mt -65.2 -35.61 75.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.087 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.0 tttp -69.97 -27.56 64.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.546 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.8 t -76.95 -67.27 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.281 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.6 mp -43.41 -45.31 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.4 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.402 ' CE1' ' CE2' ' A' ' 141' ' ' TRP . 6.6 t-80 -60.09 -58.36 8.88 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.504 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.68 -57.7 1.52 Allowed Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.866 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 105' ' ' ASP . 10.9 tptm -58.68 -66.65 0.46 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.274 -0.463 . . . . 0.0 110.574 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 106' ' ' MET . 0.7 OUTLIER -37.05 -62.25 0.51 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.72 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -42.86 -47.92 5.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.359 178.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -62.57 -30.66 71.48 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.258 -179.353 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 103' ' ' LEU . 58.8 ttp -75.86 -47.28 26.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.723 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.657 HG23 ' H ' ' A' ' 109' ' ' LYS . 4.6 m -75.39 -26.62 18.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.482 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 40.61 35.79 0.92 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.657 ' H ' HG23 ' A' ' 107' ' ' VAL . 0.4 OUTLIER -100.09 -157.93 0.64 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.281 0.563 . . . . 0.0 111.806 -178.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 110' ' ' VAL . 0.0 OUTLIER -92.05 -167.54 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.158 -179.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -66.6 116.43 7.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.896 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.43 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -112.81 150.36 42.67 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.408 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -48.55 107.54 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.707 1.604 . . . . 0.0 112.857 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.458 ' HB ' ' HB2' ' A' ' 143' ' ' ALA . 2.9 mt -120.61 126.5 75.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.48 ' O ' HD12 ' A' ' 83' ' ' LEU . 8.3 tpt -126.47 115.28 19.33 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.237 -178.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.3 mt -96.02 97.82 9.89 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.58 132.56 49.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 122.135 0.969 . . . . 0.0 110.574 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.75 109.47 3.2 Favored Glycine 0 C--N 1.304 -1.239 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.475 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.6 t30 -97.24 175.62 6.21 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.182 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.477 ' HZ2' ' C ' ' A' ' 17' ' ' VAL . 2.9 mttp 66.25 59.54 0.66 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 122.026 0.917 . . . . 0.0 109.291 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.509 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 19.2 tttm -63.77 -37.88 89.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.053 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.637 ' CG ' HN21 ' A' ' 186' ' ' GDP . 5.0 p-10 -60.45 -5.61 1.25 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.783 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.551 HD23 ' HB ' ' A' ' 88' ' ' THR . 8.2 mp -91.95 -26.88 18.21 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.562 ' N ' HG21 ' A' ' 87' ' ' VAL . 13.2 p-80 -38.97 -24.97 0.01 OUTLIER 'General case' 0 C--N 1.339 0.124 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.719 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.536 ' N ' ' O ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -46.51 -22.89 0.31 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.293 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.479 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -110.38 -37.55 5.48 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.666 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.474 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 0.1 OUTLIER 29.65 91.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.886 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 46.1 t -72.37 -36.75 56.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.193 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.7 tp -89.57 154.74 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.634 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.494 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 99.5 p -101.55 127.24 48.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.742 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -40.63 -34.0 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.988 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -68.51 -65.42 0.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.988 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.494 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 63.6 mt-10 -41.38 -41.61 2.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.933 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.06 -34.7 64.72 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 132' ' ' GLU . 3.2 tttm -63.96 -55.27 23.72 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.28 -35.34 67.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.68 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.48 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -65.54 -62.09 1.72 Allowed 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -53.12 -38.41 62.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.226 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -33.28 75.51 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.736 0.303 . . . . 0.0 110.245 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.8 -46.11 86.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.828 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.48 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 42.2 m95 -89.09 1.04 56.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.695 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 6.5 m120 68.38 32.92 4.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.652 0.739 . . . . 0.0 109.58 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -100.84 169.04 9.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.862 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.14 133.79 51.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.305 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.699 ' O ' HD22 ' A' ' 146' ' ' LEU . 5.2 t80 -96.9 123.39 40.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.814 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.699 HD22 ' O ' ' A' ' 145' ' ' PHE . 1.3 mm? -134.74 137.14 43.2 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.862 -176.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.474 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 6.2 tt0 -126.39 111.17 14.16 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 34.7 p -137.15 -173.85 3.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.134 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.0 136.09 34.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.919 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.517 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -63.79 -26.73 68.76 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.25 4.37 12.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.723 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -138.85 122.6 17.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.11 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 154' ' ' GLN . 4.8 t-20 -77.42 -55.48 5.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.614 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 153' ' ' ASN . 10.2 tt0 -36.91 -56.03 0.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.96 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.617 ' O ' HG23 ' A' ' 159' ' ' VAL . 67.6 p -55.59 -46.12 77.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.021 0.439 . . . . 0.0 110.297 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -54.53 -62.08 1.89 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.952 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 61.5 t -43.0 -39.94 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.435 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.77 -33.11 75.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.59 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.691 HG22 HD12 ' A' ' 146' ' ' LEU . 32.4 t -70.72 -35.38 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.954 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.81 ' CZ ' HD12 ' A' ' 47' ' ' ILE . 23.5 t80 -64.32 -65.69 0.64 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.561 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.582 HH22 HG23 ' A' ' 49' ' ' VAL . 9.1 ttm-85 -48.41 -43.33 34.03 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.759 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.574 ' HE ' HD21 ' A' ' 146' ' ' LEU . 11.4 mmm180 -58.51 -33.37 69.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.456 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -66.27 -34.29 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.917 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.78 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 11.1 mt -63.5 -48.18 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.267 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -55.47 -59.93 4.13 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.552 179.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.476 ' H ' HD23 ' A' ' 165' ' ' LEU . 4.5 tt0 -51.31 -24.03 4.2 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.78 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -71.34 -31.14 67.03 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.935 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 165' ' ' LEU . 0.4 OUTLIER -70.74 -54.72 10.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.886 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -60.05 -50.23 74.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.068 0.461 . . . . 0.0 110.565 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.466 ' CG1' ' O ' ' A' ' 166' ' ' GLU . 3.1 mm -49.64 -42.98 18.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.966 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -66.29 -39.76 89.57 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.339 -179.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.37 -41.94 55.91 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.14 -79.88 0.06 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.754 0.312 . . . . 0.0 110.474 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.022 -179.904 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GDP . . . . . 0.637 HN21 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.171 0.51 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.97 135.64 32.96 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.647 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.518 ' HB2' HG22 ' A' ' 78' ' ' ILE . 17.0 mttt -107.21 128.53 54.5 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.784 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -102.3 122.97 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 121.507 0.67 . . . . 0.0 110.469 -178.511 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.481 ' HB2' ' CD1' ' A' ' 78' ' ' ILE . . . -83.9 134.27 34.69 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.373 -0.83 . . . . 0.0 111.606 -177.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.6 mt -95.44 130.16 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.523 0.678 . . . . 0.0 112.14 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.604 ' C ' HD23 ' A' ' 12' ' ' LEU . 5.1 tt -127.91 102.55 6.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.54 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.12 136.45 7.53 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.485 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -51.94 -161.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.676 0.751 . . . . 0.0 111.321 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -94.14 131.79 39.32 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.666 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.452 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 4.1 m 60.54 20.09 9.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.472 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 p -74.7 -19.59 16.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.606 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.452 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 98.13 20.17 21.56 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.472 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.1 pttm -69.2 -34.81 75.48 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.318 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.9 m -73.45 -30.39 63.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.419 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 65.5 p -67.8 -40.86 83.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.409 ' O ' ' CB ' ' A' ' 26' ' ' PHE . 46.1 tp -77.5 -26.49 51.27 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.759 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.623 ' O ' HG12 ' A' ' 27' ' ' VAL . 57.5 m -62.77 -41.51 99.27 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.59 -41.6 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.606 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.535 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -71.88 -27.29 62.76 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.663 -179.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.409 ' CB ' ' O ' ' A' ' 22' ' ' LEU . 52.8 t80 -77.94 -62.05 1.8 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.303 0.573 . . . . 0.0 110.691 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.623 HG12 ' O ' ' A' ' 23' ' ' THR . 11.8 p -48.09 -48.9 12.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.804 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.612 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.4 mt-10 -80.42 -24.3 39.74 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.451 ' O ' ' ND2' ' A' ' 153' ' ' ASN . . . 72.76 25.47 73.86 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -150.29 126.63 10.73 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.732 0.301 . . . . 0.0 111.338 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.614 ' O ' ' CD1' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -64.96 91.85 0.1 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 122.02 0.915 . . . . 0.0 110.691 178.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.593 HG22 ' N ' ' A' ' 33' ' ' ASP . 11.4 p -109.2 166.34 4.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.838 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.593 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -74.36 -41.52 60.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.958 -179.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 33' ' ' ASP . 4.2 p 43.5 -170.16 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.961 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -149.9 52.68 0.92 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.453 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 37' ' ' PRO . 9.7 t70 -131.95 81.85 61.31 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.293 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 36' ' ' ASP . 52.1 Cg_exo -57.08 -132.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.869 2.379 . . . . 0.0 111.806 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 38' ' ' THR . 12.4 t -96.25 43.05 1.08 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.167 0.508 . . . . 0.0 111.311 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.544 ' CG2' ' ND2' ' A' ' 41' ' ' ASN . 1.5 tp -84.5 163.64 2.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.901 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -86.5 124.79 33.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.637 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.544 ' ND2' ' CG2' ' A' ' 39' ' ' ILE . 31.7 m-20 -164.19 -176.69 4.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.236 0.541 . . . . 0.0 111.982 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.411 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 4.0 m -133.14 152.77 51.93 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.13 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.455 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 11.9 m-85 -133.17 162.94 30.42 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.895 0.379 . . . . 0.0 111.008 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -141.61 152.34 43.91 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.537 0.684 . . . . 0.0 112.487 -179.223 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.591 ' C ' HD12 ' A' ' 46' ' ' LEU . 25.8 tttp -157.11 111.01 2.64 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.407 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.718 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.2 mp -105.2 127.28 52.85 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.491 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.484 HD12 ' CE1' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -148.61 165.13 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.708 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.4 m -114.61 126.67 55.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.924 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.701 HG11 HG21 ' A' ' 164' ' ' ILE . 1.5 p -124.95 123.35 65.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.819 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 70.95 19.79 5.56 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.91 -9.77 62.09 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -90.91 134.93 34.08 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.01 145.5 40.19 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.561 0.696 . . . . 0.0 111.058 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.404 ' OH ' ' OE1' ' A' ' 168' ' ' GLU . 9.3 m-85 -139.44 125.14 19.47 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.778 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.605 ' C ' HD22 ' A' ' 56' ' ' LEU . 1.2 m-70 -117.44 113.65 22.36 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.703 HD22 ' N ' ' A' ' 56' ' ' LEU . 2.1 mm? -119.23 140.0 50.95 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 121.509 0.671 . . . . 0.0 111.629 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.828 ' C ' HD13 ' A' ' 58' ' ' LEU . 1.1 mt-30 -136.76 124.98 23.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.777 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.984 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.13 148.86 39.87 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.916 -178.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -118.49 141.5 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 114.998 -1.001 . . . . 0.0 113.165 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -114.42 101.65 9.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.333 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.515 ' OG1' ' CZ ' ' A' ' 74' ' ' TYR . 0.9 OUTLIER -149.32 156.74 42.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.473 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 64' ' ' GLN . . . -126.03 7.72 7.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.007 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 62' ' ' ALA . . . 33.78 -94.2 0.01 OUTLIER Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -115.25 -54.33 2.55 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.757 0.789 . . . . 0.0 109.547 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.636 ' O ' ' N ' ' A' ' 67' ' ' TYR . 2.1 p30 -112.16 -172.94 2.14 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.045 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.63 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -28.84 -30.7 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.144 0 O-C-N 123.591 0.557 . . . . 0.0 111.222 -178.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.636 ' N ' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -170.36 1.08 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.929 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.2 m 54.48 98.3 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 69' ' ' ILE . 0.4 OUTLIER -69.89 -35.25 63.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-O 121.423 0.63 . . . . 0.0 109.45 178.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.89 152.78 59.82 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.723 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -42.44 144.61 1.17 Allowed 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.346 2.031 . . . . 0.0 112.335 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -173.82 -73.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.605 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.9 m -153.73 16.05 0.51 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.205 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.67 ' CE1' HD11 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -113.98 28.99 8.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.356 -179.142 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.5 p -78.95 22.49 0.38 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.229 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.67 HD11 ' CE1' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -56.04 -173.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 111.146 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.69 52.42 1.88 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.378 0.608 . . . . 0.0 109.363 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.518 HG22 ' HB2' ' A' ' 8' ' ' LYS . 35.7 pt -77.44 -172.5 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.723 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.41 14.27 0.98 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.578 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -142.29 165.79 26.59 Favored Glycine 0 N--CA 1.454 -0.114 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.179 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.549 ' OH ' ' CE1' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -151.82 122.41 7.4 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.767 -0.717 . . . . 0.0 111.205 178.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.628 HG23 ' O ' ' A' ' 82' ' ' ILE . 11.3 tt -125.28 103.83 12.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.973 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -96.32 126.73 41.73 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.407 -177.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.447 ' O ' HG12 ' A' ' 84' ' ' VAL . 2.0 t -96.07 113.68 31.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.43 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -110.37 146.05 36.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.734 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.558 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.0 OUTLIER -100.55 143.48 30.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.077 0.465 . . . . 0.0 111.881 -177.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.575 HG21 ' N ' ' A' ' 124' ' ' HIS . 17.3 m -81.15 21.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.633 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.407 ' HB ' HD23 ' A' ' 123' ' ' LEU . 1.0 OUTLIER -140.55 -17.76 0.88 Allowed 'General case' 0 C--O 1.231 0.097 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.558 ' H ' ' HG ' ' A' ' 86' ' ' SER . 43.8 t -112.7 93.46 4.44 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 94' ' ' GLU . 30.5 mm -50.84 -15.6 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.793 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.4 OUTLIER -78.31 -49.14 14.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.244 179.287 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.7 p -59.74 -44.6 93.74 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.517 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -79.3 -34.02 42.79 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 119.354 -0.939 . . . . 0.0 112.533 -178.126 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.416 ' HG3' HG22 ' A' ' 90' ' ' ILE . 8.9 mm-40 -69.84 -44.98 68.8 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.15 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 91' ' ' LYS . 28.1 m -64.99 -37.37 80.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.248 -0.581 . . . . 0.0 109.645 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.405 ' N ' HG23 ' A' ' 95' ' ' VAL . 1.3 mt -61.74 -36.03 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -70.1 -25.79 63.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.333 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.5 t -76.1 -67.22 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.5 mp -42.81 -40.68 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.616 ' NE2' ' CD1' ' A' ' 141' ' ' TRP . 25.7 t-80 -60.32 -63.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.673 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.82 -50.6 2.0 Favored Glycine 0 CA--C 1.518 0.267 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 105' ' ' ASP . 12.7 tptm -66.03 -65.79 0.63 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.273 -0.464 . . . . 0.0 110.106 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.36 -58.75 0.81 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.749 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -47.0 -43.82 19.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.677 178.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -62.36 -34.25 76.33 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.374 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.517 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 12.6 ttm -61.57 -55.9 25.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.99 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.471 ' C ' ' H ' ' A' ' 109' ' ' LYS . 18.1 m -77.28 -12.9 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.16 0.505 . . . . 0.0 110.249 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.16 -25.23 0.16 Allowed Glycine 0 CA--C 1.53 1.01 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.949 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.581 ' CG ' ' H ' ' A' ' 110' ' ' VAL . 3.4 tptt -173.92 -128.82 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 117.803 0.802 . . . . 0.0 112.016 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.581 ' H ' ' CG ' ' A' ' 109' ' ' LYS . 6.6 t 52.09 116.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.757 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.563 ' OE1' ' HB1' ' A' ' 173' ' ' ALA . 8.6 mt-30 -77.81 124.76 28.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.891 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.667 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.2 OUTLIER -132.06 155.78 80.92 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.308 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -48.69 107.43 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.689 1.593 . . . . 0.0 112.174 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.6 mt -123.84 129.18 74.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.508 ' O ' HD12 ' A' ' 83' ' ' LEU . 8.7 tpt -128.85 117.42 21.01 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.329 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.1 mt -97.34 97.59 9.26 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.7 t -104.45 134.22 46.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 122.196 0.998 . . . . 0.0 110.958 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -104.88 116.44 5.29 Favored Glycine 0 C--N 1.302 -1.313 0 CA-C-N 113.699 -1.592 . . . . 0.0 109.234 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.487 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 50.1 t30 -98.0 173.87 6.84 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.718 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.487 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 25.5 mttt 61.17 58.67 2.16 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.624 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.527 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -60.2 -35.24 74.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.282 -179.168 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.656 ' CG ' HN21 ' A' ' 186' ' ' GDP . 5.1 p-10 -61.15 -13.63 19.11 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.488 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 125' ' ' MET . 9.8 mp -88.1 -31.37 19.25 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.575 ' N ' HG21 ' A' ' 87' ' ' VAL . 2.5 p-80 -37.67 -26.46 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.976 178.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.536 ' N ' ' O ' ' A' ' 123' ' ' LEU . 6.9 mmt -43.93 -24.64 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.454 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.3 OUTLIER -103.23 -34.94 8.63 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.815 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.458 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 1.6 tpt180 38.39 92.82 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.23 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.535 HG22 ' C ' ' A' ' 87' ' ' VAL . 19.6 m -85.4 -35.43 9.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.312 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -89.48 130.0 39.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.159 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.408 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 92.4 p -77.1 122.19 24.62 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.946 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -40.56 -38.38 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.322 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -60.98 -64.21 1.03 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.011 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.408 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 64.2 mt-10 -41.11 -49.91 3.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.179 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.33 -25.72 74.56 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 132' ' ' GLU . 13.1 tttm -71.26 -55.98 6.98 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -55.95 -33.01 64.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.296 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.652 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -66.53 -62.97 1.18 Allowed 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.807 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -53.65 -36.89 62.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.312 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -69.56 -30.29 68.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.474 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.526 ' OG ' ' CD2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -63.63 -47.15 82.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.02 -178.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.652 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 8.4 m95 -91.52 -5.27 54.41 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.355 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 141' ' ' TRP . 0.9 OUTLIER 77.45 26.01 0.71 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.779 -179.271 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.45 170.11 11.19 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.218 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.19 133.39 50.03 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.906 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.64 ' O ' HD22 ' A' ' 146' ' ' LEU . 6.5 t80 -97.06 122.96 40.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.767 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.895 HD12 HG22 ' A' ' 159' ' ' VAL . 1.2 mm? -133.12 138.81 46.8 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.939 -176.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.458 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 4.9 tt0 -127.5 110.01 12.31 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.518 ' OG ' HG21 ' A' ' 159' ' ' VAL . 0.1 OUTLIER -136.37 -178.38 5.14 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.676 -178.014 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 152' ' ' GLU . 0.0 OUTLIER -138.77 132.79 31.24 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.39 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.479 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -54.41 -53.07 59.0 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.112 0.482 . . . . 0.0 109.843 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 30.4 tttm -51.28 -8.74 0.05 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.938 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.479 ' H ' ' C ' ' A' ' 150' ' ' ALA . 18.7 mt-10 -131.4 119.2 21.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.978 0.418 . . . . 0.0 110.657 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.454 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 10.2 t-20 -75.35 -48.25 23.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.195 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 153' ' ' ASN . 0.5 OUTLIER -36.71 -59.48 0.67 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.023 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.5 p -54.43 -46.64 73.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.169 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.535 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -51.45 -59.4 4.28 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.524 0.678 . . . . 0.0 109.584 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 50.5 t -42.36 -48.43 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.67 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -54.02 -33.07 56.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.525 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.895 HG22 HD12 ' A' ' 146' ' ' LEU . 11.6 t -77.06 -27.67 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.982 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.484 ' CE1' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -68.64 -41.63 79.13 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.5 179.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.7 ttm-85 -79.86 -49.98 11.16 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.961 -0.695 . . . . 0.0 110.928 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -53.47 -37.88 63.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.31 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 159' ' ' VAL . 13.0 tt -68.39 -56.7 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.403 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.701 HG21 HG11 ' A' ' 49' ' ' VAL . 84.7 mt -47.9 -33.87 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.975 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.8 -64.42 0.95 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.059 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -58.53 -28.57 65.59 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.532 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -59.56 -33.53 71.53 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.404 ' OE1' ' OH ' ' A' ' 54' ' ' TYR . 33.5 tp10 -68.73 -57.15 6.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.329 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 13.2 tttm -52.49 -56.72 13.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.636 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.667 HG21 ' C ' ' A' ' 112' ' ' ILE . 66.3 mt -52.84 -34.2 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.137 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 172' ' ' GLY . 0.0 OUTLIER -68.9 -40.45 79.14 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.611 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.414 ' N ' ' OD1' ' A' ' 171' ' ' ASP . . . -60.3 -35.83 89.3 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.563 ' HB1' ' OE1' ' A' ' 111' ' ' GLN . . . -68.07 -60.77 2.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.803 0.335 . . . . 0.0 110.494 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.792 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GDP . . . . . 0.656 HN21 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 121.174 0.512 . . . . 0.0 110.445 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.84 136.39 33.95 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.611 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.435 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 4.0 mptt -106.66 121.28 44.03 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.551 HD11 HD12 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -98.95 117.2 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-O 121.824 0.821 . . . . 0.0 110.027 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.82 136.23 34.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.096 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.5 mt -95.27 132.81 38.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.23 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.645 ' C ' HD23 ' A' ' 12' ' ' LEU . 6.3 tt -127.65 104.05 7.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.392 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.39 134.87 6.51 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.691 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.446 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -55.05 -159.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.3 0.571 . . . . 0.0 110.582 179.187 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -92.61 133.28 36.12 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.952 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.52 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 7.7 m 56.58 19.46 4.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.546 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.415 ' H ' HG12 ' A' ' 17' ' ' VAL . 2.8 p -69.85 -27.34 32.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.794 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.448 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 105.1 23.51 7.67 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.418 ' CE ' ' OD2' ' A' ' 60' ' ' ASP . 3.5 pttm -71.18 -33.59 70.13 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.356 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.2 m -75.75 -30.92 59.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.156 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 72.4 p -65.28 -54.15 33.53 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.056 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 23' ' ' THR . 24.7 tp -62.91 -52.06 64.53 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.731 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.49 ' O ' HG12 ' A' ' 27' ' ' VAL . 9.2 m -36.47 -64.12 0.35 Allowed 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 122.976 0.172 . . . . 0.0 110.774 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -57.45 -41.72 79.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.144 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.663 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -66.99 -35.92 81.03 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.263 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.494 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.6 OUTLIER -77.54 -62.81 1.54 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.369 0.604 . . . . 0.0 110.705 -179.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.569 HG13 ' N ' ' A' ' 28' ' ' GLU . 9.1 p -44.77 -49.29 2.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.488 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.569 ' N ' HG13 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -79.78 -24.54 41.4 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.081 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 74.96 26.66 66.21 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.784 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 31' ' ' PHE . 10.6 tp60 -147.91 125.89 12.04 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.895 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.528 ' O ' ' NE2' ' A' ' 30' ' ' GLN . 1.2 t80 -66.76 96.37 0.4 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.606 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.624 HG22 ' N ' ' A' ' 33' ' ' ASP . 13.4 p -99.25 166.94 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.18 0.514 . . . . 0.0 110.768 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.624 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -64.18 12.5 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.018 -178.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.608 ' H ' HG13 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -39.48 115.12 0.47 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.85 0.357 . . . . 0.0 110.792 -179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -151.48 85.02 1.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.592 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -133.48 176.63 2.76 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.054 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 36' ' ' ASP . 42.3 Cg_exo -57.31 -138.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.575 2.183 . . . . 0.0 111.371 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.695 HG23 ' O ' ' A' ' 38' ' ' THR . 11.0 t -130.34 61.8 1.59 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.867 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 tp -83.2 147.06 6.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.075 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.431 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 2.6 pt-20 -88.11 152.29 22.11 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.045 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 1.4 m120 -177.47 174.48 1.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.235 0.541 . . . . 0.0 112.072 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.31 146.48 32.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.699 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.458 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 7.2 m-85 -131.7 164.16 26.55 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.318 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.84 156.67 42.96 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.328 0.585 . . . . 0.0 112.071 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -160.15 111.36 1.93 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.698 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.9 mp -104.81 121.01 42.75 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.943 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.534 ' O ' HD12 ' A' ' 47' ' ' ILE . 1.1 pp -147.72 165.16 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.595 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.0 m -111.82 127.97 55.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.99 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.735 HG11 HG21 ' A' ' 164' ' ' ILE . 2.5 p -128.16 124.86 63.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.526 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 49' ' ' VAL . 1.9 t-20 73.23 10.71 5.11 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.19 -11.87 71.04 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -91.21 137.84 32.06 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -76.4 146.06 38.94 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.578 0.704 . . . . 0.0 111.023 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.43 ' OH ' ' OE1' ' A' ' 168' ' ' GLU . 8.2 m-85 -135.87 126.78 27.62 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.459 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.646 ' C ' HD22 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -117.52 113.73 22.43 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.646 HD22 ' C ' ' A' ' 55' ' ' HIS . 2.9 mm? -119.39 138.61 52.97 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 121.356 0.598 . . . . 0.0 111.356 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.453 ' O ' HD12 ' A' ' 58' ' ' LEU . 5.3 mt-30 -126.99 127.3 44.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.087 177.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.546 HD11 ' CG1' ' A' ' 9' ' ' ILE . 3.4 mp -114.43 154.83 27.45 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.098 0.475 . . . . 0.0 112.182 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.12 143.99 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 CA-C-O 122.035 0.921 . . . . 0.0 112.72 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.425 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -125.26 105.14 8.9 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.189 -1.369 . . . . 0.0 107.893 177.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.34 153.63 18.82 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.51 -178.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.32 8.91 3.43 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.144 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.72 -55.35 25.8 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -112.02 -139.1 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.386 0.612 . . . . 0.0 110.818 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -74.95 -175.96 2.75 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.927 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.592 ' HG2' HG21 ' A' ' 95' ' ' VAL . 0.9 OUTLIER -33.9 -31.9 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.252 0.549 . . . . 0.0 109.797 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.605 ' CG ' ' O ' ' A' ' 67' ' ' TYR . 2.9 t80 166.8 82.93 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.423 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.52 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 1.4 m -67.71 123.79 21.49 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.977 -178.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.686 HG22 ' H ' ' A' ' 70' ' ' PHE . 6.5 mm -62.08 -131.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.686 ' H ' HG22 ' A' ' 69' ' ' ILE . 40.7 t80 41.42 80.83 0.26 Allowed Pre-proline 0 C--N 1.331 -0.223 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.603 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.462 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 47.1 Cg_exo -52.28 -161.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.674 2.249 . . . . 0.0 112.434 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.462 ' CB ' ' O ' ' A' ' 71' ' ' PRO . 1.1 tt0 81.02 -35.21 0.11 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.269 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.5 m -101.46 -20.67 15.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.255 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -94.66 -28.85 15.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.564 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.6 t 49.32 49.48 19.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.915 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.455 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 0.9 OUTLIER -77.55 -97.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 120.839 0.352 . . . . 0.0 110.906 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 3.0 m-20 87.11 33.57 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.53 HD12 ' O ' ' A' ' 80' ' ' GLY . 37.8 pt -83.95 -169.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 CA-C-N 114.51 -1.223 . . . . 0.0 112.554 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.68 13.73 1.19 Allowed 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.41 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.53 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -148.24 163.29 28.92 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.487 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.55 ' OH ' ' CD2' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -151.45 123.46 8.15 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.787 -0.706 . . . . 0.0 111.094 177.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 82' ' ' ILE . 9.5 tt -126.93 106.81 16.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.661 0.743 . . . . 0.0 109.146 178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.715 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -97.32 122.5 40.42 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.459 -178.123 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.405 ' O ' HG12 ' A' ' 84' ' ' VAL . 1.7 t -97.04 114.53 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.456 ' CZ ' ' CA ' ' A' ' 118' ' ' GLY . 26.2 p90 -115.4 144.58 43.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.704 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.477 ' C ' ' H ' ' A' ' 88' ' ' THR . 3.4 p -87.11 141.93 28.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.068 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.63 HG21 ' N ' ' A' ' 124' ' ' HIS . 16.2 m -73.7 18.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.639 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.477 ' H ' ' C ' ' A' ' 86' ' ' SER . 6.4 t -138.91 -22.07 0.96 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.508 ' C ' ' N ' ' A' ' 91' ' ' LYS . 22.9 t -90.83 93.07 9.07 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.201 -176.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.6 tp -59.11 -10.69 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.539 ' O ' HG22 ' A' ' 95' ' ' VAL . 6.9 mttm -77.84 -51.5 10.38 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.18 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 53.5 p -57.68 -31.74 66.65 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.674 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -75.39 -47.66 26.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.89 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.513 ' O ' HG23 ' A' ' 98' ' ' VAL . 6.1 mt-10 -63.35 -43.24 98.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.863 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.592 HG21 ' HG2' ' A' ' 66' ' ' GLU . 31.6 m -67.02 -38.97 82.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.197 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.418 ' N ' HG23 ' A' ' 95' ' ' VAL . 5.2 mt -59.4 -38.47 75.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.1 tttp -73.13 -26.63 61.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.836 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 94' ' ' GLU . 64.0 t -77.37 -67.15 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.985 0.422 . . . . 0.0 110.033 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.515 HD12 ' N ' ' A' ' 100' ' ' HIS . 2.5 pp -45.23 -39.78 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.174 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.62 ' NE2' ' CE2' ' A' ' 141' ' ' TRP . 18.3 t60 -62.56 -61.34 2.5 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.235 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 100' ' ' HIS . . . -35.87 -48.68 1.05 Allowed Glycine 0 C--N 1.33 0.25 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 105' ' ' ASP . 1.9 tppt? -68.8 -66.68 0.54 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.429 -0.385 . . . . 0.0 110.03 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.87 -59.1 0.86 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.13 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.721 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -45.9 -45.39 15.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.487 178.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -59.18 -39.02 81.25 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.833 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 5.8 ttm -61.67 -56.65 17.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.816 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' A' ' 109' ' ' LYS . 18.5 m -77.07 -12.55 14.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.035 0.445 . . . . 0.0 110.773 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.04 -25.11 0.06 OUTLIER Glycine 0 CA--C 1.534 1.228 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.891 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.539 ' H ' ' C ' ' A' ' 107' ' ' VAL . 3.9 tttm -174.27 -126.63 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.758 0.779 . . . . 0.0 111.482 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.484 ' H ' ' CG ' ' A' ' 109' ' ' LYS . 6.4 t 52.06 118.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.886 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.513 ' OE1' ' HB1' ' A' ' 173' ' ' ALA . 9.8 mt-30 -77.27 137.52 38.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.97 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.651 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.4 OUTLIER -143.35 151.21 54.22 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.775 179.329 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -48.29 111.82 0.5 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 121.763 1.642 . . . . 0.0 112.407 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' A' ' 143' ' ' ALA . 2.8 mt -126.86 132.41 70.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.7 tpt -130.85 114.69 15.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.951 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.1 mt -96.74 98.13 9.91 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.2 t -105.03 130.79 55.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 122.153 0.978 . . . . 0.0 111.395 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.456 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -97.83 114.78 5.09 Favored Glycine 0 C--N 1.307 -1.043 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.486 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.9 t30 -97.49 173.99 6.89 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.025 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.486 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 23.2 mttt 60.4 58.87 2.42 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.712 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.498 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 17.3 tttm -60.48 -32.6 71.58 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.643 ' CG ' HN21 ' A' ' 186' ' ' GDP . 3.5 p-10 -60.8 -18.05 53.07 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.956 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 125' ' ' MET . 11.0 mp -85.86 -26.39 25.68 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.63 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -40.27 -24.63 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.854 179.094 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.6 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 15.1 mtt -46.72 -22.53 0.31 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.462 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -108.28 -42.5 4.59 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.564 -179.654 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.5 ' NE ' ' OE1' ' A' ' 147' ' ' GLU . 22.6 ttm180 26.44 83.61 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.868 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.5 m -62.91 -28.84 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.696 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.4 tp -89.54 155.65 3.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.566 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.445 ' C ' ' N ' ' A' ' 132' ' ' GLU . 57.9 p -97.66 120.51 38.18 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.996 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -39.85 -29.41 0.06 Allowed 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.4 mp0 -70.26 -63.75 1.03 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.895 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.43 ' OE1' ' OG ' ' A' ' 130' ' ' SER . 57.7 mt-10 -41.2 -42.25 2.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.742 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.35 -34.89 63.69 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 132' ' ' GLU . 2.9 tttm -62.04 -55.03 33.26 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.02 -36.66 70.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.75 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.657 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -66.13 -62.87 1.25 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.159 0.504 . . . . 0.0 109.692 179.58 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.45 -35.12 51.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.122 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.03 -30.47 67.76 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.41 -46.86 84.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.757 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.657 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 15.0 m95 -90.5 -5.75 55.64 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.363 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 141' ' ' TRP . 1.1 t-20 78.73 24.8 0.55 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.008 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.31 167.6 13.4 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.712 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.65 128.83 54.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.975 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 5.9 t80 -97.95 121.38 39.79 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.768 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.08 126.4 14.85 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.5 ' OE1' ' NE ' ' A' ' 127' ' ' ARG . 7.8 mt-10 -99.16 117.26 33.24 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.2 p -137.47 -178.69 5.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.658 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 152' ' ' GLU . 0.1 OUTLIER -138.6 138.77 38.21 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.272 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -57.28 -48.0 80.02 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -55.83 -18.4 8.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.128 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 149' ' ' SER . 38.7 mt-10 -113.53 116.13 29.07 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.942 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.541 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 6.4 t-20 -77.53 -50.34 12.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.78 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 153' ' ' ASN . 5.9 tt0 -39.92 -57.29 1.64 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.428 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.704 ' O ' HG23 ' A' ' 159' ' ' VAL . 80.5 p -51.88 -44.28 63.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.663 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -55.41 -60.46 3.38 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.458 0.647 . . . . 0.0 109.626 178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 57.7 t -41.82 -40.39 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.339 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -67.67 -36.57 80.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.623 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 155' ' ' THR . 22.0 t -70.29 -34.18 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.523 0.678 . . . . 0.0 109.612 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.741 ' CE1' HD11 ' A' ' 164' ' ' ILE . 7.7 t80 -66.13 -51.14 60.73 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.015 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.7 ttt85 -66.74 -36.96 83.7 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.223 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -64.28 -33.61 76.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.875 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.694 HG22 ' O ' ' A' ' 160' ' ' PHE . 15.3 tt -70.85 -39.75 75.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.167 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.741 HD11 ' CE1' ' A' ' 160' ' ' PHE . 64.6 mt -62.52 -35.59 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.549 0.69 . . . . 0.0 109.231 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.35 -51.8 66.18 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.522 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -67.89 -26.48 66.02 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.526 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -61.07 -34.67 75.27 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.43 ' OE1' ' OH ' ' A' ' 54' ' ' TYR . 9.9 mm-40 -70.44 -55.98 7.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.647 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -54.81 -62.13 1.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.711 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.651 HG21 ' C ' ' A' ' 112' ' ' ILE . 81.5 mt -52.99 -33.14 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.175 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -69.89 -40.35 75.71 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.752 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -60.71 -36.88 92.59 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.513 ' HB1' ' OE1' ' A' ' 111' ' ' GLN . . . -68.98 -62.81 1.22 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.569 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.722 179.988 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GDP . . . . . 0.643 HN21 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 121.262 0.553 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.465 ' NH1' ' HB1' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -140.05 136.13 33.34 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.984 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.53 ' HB2' HG22 ' A' ' 78' ' ' ILE . 6.5 mttm -109.38 131.36 55.14 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.75 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -104.1 125.4 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 CA-C-O 121.377 0.608 . . . . 0.0 110.674 -178.067 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.07 133.49 34.64 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.352 -0.843 . . . . 0.0 110.792 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.1 mt -96.58 133.21 38.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.645 0.736 . . . . 0.0 112.361 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.602 ' C ' HD23 ' A' ' 12' ' ' LEU . 5.3 tt -125.77 104.01 8.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.114 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -140.16 133.6 6.09 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.64 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.422 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.5 OUTLIER -56.94 -158.51 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.357 0.599 . . . . 0.0 110.605 179.221 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -97.02 131.14 44.13 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.334 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.554 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 1.7 m 64.94 19.0 11.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.568 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.42 ' O ' HG22 ' A' ' 17' ' ' VAL . 4.9 p -80.58 -15.74 12.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.83 0.348 . . . . 0.0 110.222 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.41 12.24 33.81 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.428 ' CB ' ' NZ ' ' A' ' 19' ' ' LYS . 0.6 OUTLIER -45.22 -52.58 9.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.938 0.399 . . . . 0.0 110.914 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.545 ' O ' HD13 ' A' ' 24' ' ' ILE . 2.1 m -70.69 -26.69 63.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.491 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.576 ' OG ' ' H8 ' ' A' ' 186' ' ' GDP . 60.4 m -68.71 -49.59 57.7 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.989 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 45.9 tp -73.8 -26.32 60.57 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 119.626 -0.829 . . . . 0.0 110.782 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.545 ' O ' HG12 ' A' ' 27' ' ' VAL . 35.1 m -63.38 -41.01 98.77 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.545 HD13 ' O ' ' A' ' 20' ' ' SER . 1.3 mp -78.2 -37.03 21.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.754 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.64 ' NE2' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -77.06 -27.48 54.37 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.582 -179.131 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -77.22 -53.41 7.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.432 0.634 . . . . 0.0 110.563 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.573 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.2 p -58.46 -45.58 89.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.08 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.573 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.4 tt0 -82.59 -24.47 33.91 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.515 ' O ' ' ND2' ' A' ' 153' ' ' ASN . . . 71.72 27.5 70.79 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.488 ' CD ' ' N ' ' A' ' 31' ' ' PHE . 1.7 tp-100 -144.41 135.08 24.82 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.136 0.493 . . . . 0.0 111.637 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.64 ' N ' ' NE2' ' A' ' 25' ' ' GLN . 0.7 OUTLIER -73.07 94.46 1.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.917 179.027 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.626 HG22 ' N ' ' A' ' 33' ' ' ASP . 14.7 p -100.0 166.52 2.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.016 0.436 . . . . 0.0 110.559 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.626 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -41.49 -40.46 1.81 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.6 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.413 ' O ' ' O ' ' A' ' 33' ' ' ASP . 5.0 p 35.29 95.04 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.363 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -152.72 69.83 0.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.85 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.79 174.14 3.25 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.12 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -63.23 -149.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.3 2.0 . . . . 0.0 111.263 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 38' ' ' THR . 13.3 t -130.38 57.59 1.71 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.795 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 tp -83.7 159.28 3.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.414 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.58 138.08 31.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.955 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.29 170.36 4.29 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.351 -0.939 . . . . 0.0 113.34 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.78 143.43 44.02 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.61 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -122.71 169.17 11.34 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.367 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -146.99 147.56 30.82 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 120.008 -0.677 . . . . 0.0 112.605 -178.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.7 tttt -147.1 110.48 4.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.853 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.0 mp -106.4 122.83 47.06 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.254 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.437 HD12 ' CE1' ' A' ' 160' ' ' PHE . 1.2 pt -149.03 165.18 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.624 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 m -114.93 124.44 51.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.044 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.576 HG11 HG21 ' A' ' 164' ' ' ILE . 0.8 OUTLIER -121.95 126.03 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.649 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.12 21.45 10.11 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.14 -8.36 60.93 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.084 -1.207 . . . . 0.0 110.084 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -91.64 134.18 34.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -76.95 145.63 38.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.658 0.742 . . . . 0.0 111.785 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.452 ' CD1' ' CG1' ' A' ' 49' ' ' VAL . 13.5 m-85 -138.76 122.68 17.78 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.023 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.666 ' C ' HD12 ' A' ' 56' ' ' LEU . 67.7 m170 -117.12 113.49 22.35 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.666 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.9 mp -119.7 144.18 47.35 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.589 0.709 . . . . 0.0 112.04 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.756 ' C ' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -134.92 125.26 26.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.919 178.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.913 ' N ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.66 154.19 32.04 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 120.01 -0.676 . . . . 0.0 112.065 -178.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.94 144.71 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.68 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.36 104.08 9.74 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.409 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.473 HG22 ' CE2' ' A' ' 74' ' ' TYR . 44.6 p -68.61 139.27 55.51 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.815 0.816 . . . . 0.0 111.152 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -144.1 14.32 1.67 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.299 -1.318 . . . . 0.0 108.461 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -104.38 -18.53 13.0 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.048 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -139.09 -148.65 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.678 0.751 . . . . 0.0 111.74 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.576 ' C ' ' H ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -75.7 -170.4 1.29 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.162 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 67' ' ' TYR . 0.3 OUTLIER -64.25 41.74 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.15 0 O-C-N 123.277 0.361 . . . . 0.0 110.172 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.576 ' H ' ' C ' ' A' ' 65' ' ' ASP . 16.0 t80 96.22 84.15 0.01 OUTLIER 'General case' 0 C--N 1.339 0.132 0 O-C-N 124.109 0.881 . . . . 0.0 108.854 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.564 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 5.6 m -65.77 111.7 3.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.216 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.824 ' H ' HD12 ' A' ' 69' ' ' ILE . 2.1 mp -41.42 150.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.98 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.529 ' CD2' ' O ' ' A' ' 70' ' ' PHE . 61.3 t80 54.9 65.78 4.62 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.872 0.368 . . . . 0.0 110.313 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -47.08 99.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.785 2.323 . . . . 0.0 112.178 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.06 -24.2 23.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.352 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.25 -30.93 10.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.741 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.473 ' CE2' HG22 ' A' ' 61' ' ' THR . 0.1 OUTLIER -85.96 102.24 13.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.891 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.1 m -87.94 52.77 2.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.867 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.434 ' HB ' HG23 ' A' ' 78' ' ' ILE . 0.9 OUTLIER -87.46 172.88 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.497 0.665 . . . . 0.0 112.149 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 4.9 p-10 -145.89 57.04 1.21 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.611 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.53 HG22 ' HB2' ' A' ' 8' ' ' LYS . 29.0 pt -78.72 -175.82 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -177.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.18 16.69 0.74 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.323 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -145.22 167.7 27.31 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.452 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.545 ' OH ' ' CD1' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -152.02 122.9 7.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.853 -0.674 . . . . 0.0 111.318 178.44 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.613 HG23 ' O ' ' A' ' 82' ' ' ILE . 10.5 tt -126.52 105.72 14.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 1.047 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.51 122.47 40.61 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.179 -0.609 . . . . 0.0 111.434 -178.3 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 84' ' ' VAL . 1.6 t -97.04 115.83 37.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.032 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.504 ' OH ' ' CZ ' ' A' ' 145' ' ' PHE . 53.8 p90 -109.76 144.69 37.82 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.494 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.0 OUTLIER -99.79 143.97 29.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.01 0.433 . . . . 0.0 111.47 -178.127 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.661 HG21 ' N ' ' A' ' 124' ' ' HIS . 14.7 m -80.78 22.21 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.34 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.22 -21.1 0.86 Allowed 'General case' 0 C--O 1.232 0.182 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.546 ' C ' ' N ' ' A' ' 91' ' ' LYS . 17.8 t -109.54 92.71 4.16 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.311 0.576 . . . . 0.0 111.694 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.438 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 1.0 OUTLIER -52.42 -15.24 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 176.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.698 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -78.24 -39.33 40.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.177 179.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 89' ' ' SER . 79.4 p -69.87 -46.07 66.32 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.495 ' C ' ' CD1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -78.6 -32.84 47.72 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 119.473 -0.891 . . . . 0.0 112.489 -177.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.486 ' OE1' ' CE1' ' A' ' 93' ' ' PHE . 8.4 mm-40 -69.3 -45.19 70.17 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.277 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 91' ' ' LYS . 27.7 m -66.05 -37.59 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 C-N-CA 120.141 -0.624 . . . . 0.0 109.976 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.583 ' CG1' HD22 ' A' ' 12' ' ' LEU . 2.0 mt -59.25 -40.54 81.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.986 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -70.1 -26.88 64.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.944 0.402 . . . . 0.0 110.411 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.3 t -75.53 -67.03 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.421 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.1 mt -47.37 -35.44 3.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.326 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.603 ' NE2' ' CD1' ' A' ' 141' ' ' TRP . 6.7 t-80 -62.38 -64.85 0.8 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.167 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -38.4 -57.62 1.79 Allowed Glycine 0 N--CA 1.453 -0.186 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.485 ' O ' ' N ' ' A' ' 105' ' ' ASP . 15.9 tptm -62.7 -65.14 0.73 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.059 -0.571 . . . . 0.0 110.641 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -37.05 -60.07 0.66 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.121 0.486 . . . . 0.0 109.849 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.758 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -45.85 -46.81 15.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.543 0.687 . . . . 0.0 109.368 178.675 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -61.96 -31.87 72.25 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.258 -179.356 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.524 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 48.8 ttp -69.18 -50.95 42.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.4 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.606 HG23 ' H ' ' A' ' 109' ' ' LYS . 6.9 m -76.47 -24.49 15.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.544 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.15 37.08 1.43 Allowed Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.606 ' H ' HG23 ' A' ' 107' ' ' VAL . 1.0 OUTLIER -95.17 -155.78 0.48 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.163 0.506 . . . . 0.0 111.575 -178.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.14 -170.42 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.774 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -65.24 115.82 5.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.896 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.482 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.7 OUTLIER -115.83 156.55 46.35 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.401 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -49.22 109.15 0.24 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.636 1.557 . . . . 0.0 112.599 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.482 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.4 mt -121.66 128.6 75.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.523 ' O ' HD12 ' A' ' 83' ' ' LEU . 7.4 tpt -131.69 112.7 12.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.575 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.9 mt -96.56 97.86 9.75 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.0 t -103.53 130.88 53.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 122.35 1.071 . . . . 0.0 111.364 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.466 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -98.26 106.55 3.3 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 113.593 -1.64 . . . . 0.0 109.082 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.482 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 55.0 t30 -96.78 174.91 6.56 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.527 -178.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.584 ' HZ1' " C1'" ' A' ' 186' ' ' GDP . 7.5 mttp 65.31 59.74 0.8 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.193 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.73 -39.14 90.85 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.682 ' CG ' HN21 ' A' ' 186' ' ' GDP . 5.9 p-10 -61.87 -3.5 1.18 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.047 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 125' ' ' MET . 9.7 mp -99.68 -30.17 12.25 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.661 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -39.93 -28.18 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.59 178.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.453 ' N ' ' O ' ' A' ' 123' ' ' LEU . 0.0 OUTLIER -41.18 -26.74 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -98.18 -36.18 10.14 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.822 179.495 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.563 HH12 ' CG2' ' A' ' 129' ' ' ILE . 7.0 tpt85 42.55 86.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.709 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.578 HG22 ' C ' ' A' ' 87' ' ' VAL . 30.6 m -80.28 -39.98 19.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.654 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.563 ' CG2' HH12 ' A' ' 127' ' ' ARG . 0.8 OUTLIER -86.68 132.16 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 132' ' ' GLU . 60.8 p -76.75 118.05 18.98 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.389 -0.525 . . . . 0.0 111.026 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -39.06 -29.48 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.28 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.4 mp0 -69.88 -63.07 1.15 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.874 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 132' ' ' GLU . 52.9 mt-10 -41.09 -46.11 2.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.95 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.11 -31.73 72.34 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 132' ' ' GLU . 19.6 tttm -65.43 -56.62 11.47 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -54.94 -33.33 62.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.349 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.11 -62.71 1.34 Allowed 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.892 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -56.95 -31.94 65.49 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.966 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.61 -35.28 72.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.771 0.319 . . . . 0.0 110.534 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.2 -47.11 81.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.288 -178.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.603 ' CD1' ' NE2' ' A' ' 100' ' ' HIS . 18.6 m95 -91.2 -4.12 56.35 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.527 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 72.36 31.78 1.77 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.142 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.34 168.82 12.35 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.255 179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -103.63 124.85 49.58 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.347 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.504 ' CZ ' ' OH ' ' A' ' 85' ' ' TYR . 7.3 t80 -97.8 123.19 41.65 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.863 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.52 123.67 12.91 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.471 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 2.8 mt-10 -98.72 114.82 27.5 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 5.0 p -136.33 -173.92 3.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.897 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.03 136.62 35.49 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.105 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.42 -43.63 98.37 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.132 0.491 . . . . 0.0 109.99 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.444 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 33.7 tttm -58.49 -7.03 0.8 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.519 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -126.9 128.4 46.42 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.769 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 2.5 t-20 -77.37 -56.01 4.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.09 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' A' ' 153' ' ' ASN . 0.0 OUTLIER -36.41 -59.02 0.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.135 0.493 . . . . 0.0 110.983 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.586 ' O ' HG23 ' A' ' 159' ' ' VAL . 16.8 p -51.99 -51.34 57.9 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.649 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -52.31 -58.37 6.87 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.5 0.667 . . . . 0.0 109.713 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 53.7 t -42.21 -51.32 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.129 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -51.27 -36.43 42.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.053 0.454 . . . . 0.0 110.636 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 155' ' ' THR . 11.0 t -73.94 -31.15 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.261 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.529 ' O ' HG22 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -68.77 -46.64 68.25 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.047 0.451 . . . . 0.0 112.119 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.439 ' N ' ' CG ' ' A' ' 160' ' ' PHE . 6.4 ttt180 -73.94 -34.56 64.35 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.751 -0.779 . . . . 0.0 111.152 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -65.65 -34.73 78.9 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.067 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 160' ' ' PHE . 14.1 tt -70.34 -43.16 78.59 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.861 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.576 HG21 HG11 ' A' ' 49' ' ' VAL . 85.1 mt -59.58 -35.21 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.544 0.688 . . . . 0.0 109.611 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.421 ' HA ' HD13 ' A' ' 165' ' ' LEU . 0.4 OUTLIER -63.21 -60.31 3.58 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.726 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -58.36 -34.9 71.18 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.465 ' HB1' ' NH1' ' A' ' 7' ' ' ARG . . . -55.98 -32.45 63.93 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.424 ' O ' ' OD1' ' A' ' 171' ' ' ASP . 6.0 tp10 -66.41 -59.65 3.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.359 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.51 -52.23 64.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.682 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 4.0 mm -50.45 -37.93 15.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.04 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 172' ' ' GLY . 0.0 OUTLIER -67.01 -40.13 87.24 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.028 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 171' ' ' ASP . . . -56.75 -36.41 72.04 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.72 -82.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.743 0.306 . . . . 0.0 110.213 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.838 179.937 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GDP . . . . . 0.682 HN21 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.322 0 CA-C-O 121.202 0.525 . . . . 0.0 110.651 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.606 ' NH1' ' HB1' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -139.71 136.04 33.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.526 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.434 ' HB2' HG22 ' A' ' 78' ' ' ILE . 12.5 mttp -106.0 128.5 53.87 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.752 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.9 OUTLIER -102.82 122.95 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 121.416 0.627 . . . . 0.0 110.563 -178.023 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.439 ' HB3' ' CE1' ' A' ' 81' ' ' TYR . . . -84.56 132.58 34.5 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.172 -0.955 . . . . 0.0 111.156 -178.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.666 ' O ' HD12 ' A' ' 12' ' ' LEU . 11.7 mt -95.46 133.72 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-O 121.916 0.865 . . . . 0.0 112.721 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.687 HD11 ' CG ' ' A' ' 67' ' ' TYR . 2.6 mp -130.33 101.73 5.89 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.866 -1.515 . . . . 0.0 110.359 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.517 ' O ' ' NZ ' ' A' ' 19' ' ' LYS . . . -140.64 134.4 6.42 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.476 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.6 OUTLIER -56.16 -158.2 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.285 0.565 . . . . 0.0 110.736 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -98.93 133.76 42.75 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.485 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.533 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 2.6 m 64.25 19.29 11.72 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.721 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 p -85.91 -16.9 9.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.843 0.354 . . . . 0.0 110.561 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.403 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 102.36 27.92 6.64 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.61 ' HB2' ' HZ2' ' A' ' 19' ' ' LYS . 4.8 ttpm? -61.2 -50.26 73.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.14 0.495 . . . . 0.0 110.435 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.21 -26.38 58.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.436 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 77.6 p -64.29 -43.38 94.94 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.856 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.9 tp -77.74 -39.51 44.13 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.851 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.61 ' O ' HG12 ' A' ' 27' ' ' VAL . 31.4 m -50.2 -43.87 52.83 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.68 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.4 mp -77.42 -41.58 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.635 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.475 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -67.78 -31.79 71.92 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.151 -179.016 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.632 ' CZ ' ' CE1' ' A' ' 160' ' ' PHE . 4.8 t80 -77.61 -64.03 1.24 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.404 0.621 . . . . 0.0 111.192 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.619 HG13 ' N ' ' A' ' 28' ' ' GLU . 13.5 p -45.15 -49.17 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.996 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.619 ' N ' HG13 ' A' ' 27' ' ' VAL . 0.7 OUTLIER -81.49 -25.12 36.26 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.28 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.425 ' O ' ' OD1' ' A' ' 153' ' ' ASN . . . 75.44 28.1 62.28 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.435 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.42 ' O ' ' CG ' ' A' ' 30' ' ' GLN . 5.2 pt20 -146.38 128.05 15.2 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.943 0.878 . . . . 0.0 112.983 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.496 ' C ' ' CD1' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -69.66 95.86 0.9 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.083 178.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.637 HG22 ' N ' ' A' ' 33' ' ' ASP . 14.2 p -98.69 166.98 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.483 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.637 ' N ' HG22 ' A' ' 32' ' ' VAL . 1.8 t70 -63.87 16.87 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.109 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.559 ' H ' HG13 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -38.92 119.13 0.84 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.831 0.348 . . . . 0.0 110.898 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -152.7 34.78 0.49 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.586 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -83.44 172.47 9.25 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.434 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 36' ' ' ASP . 46.9 Cg_exo -56.81 -138.25 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.551 2.168 . . . . 0.0 111.902 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 38' ' ' THR . 10.4 t -130.23 62.8 1.56 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.745 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 tp -82.89 144.68 9.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.176 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.418 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -90.0 152.16 21.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.532 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER 177.88 174.34 0.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.278 0.561 . . . . 0.0 112.278 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.447 HG23 HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -108.04 142.92 37.47 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.426 179.319 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.432 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 12.5 m-85 -130.47 165.5 22.5 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.047 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.602 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -142.53 148.02 36.92 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.252 0.549 . . . . 0.0 112.046 -178.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.583 ' C ' HD12 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -151.94 116.1 4.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.978 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.4 mp -105.3 129.69 53.59 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.393 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.3 pt -147.39 160.97 8.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.47 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 m -117.01 123.56 47.19 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.173 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.764 HG11 HG21 ' A' ' 164' ' ' ILE . 1.7 p -118.42 125.48 74.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.984 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.408 ' CG ' HG22 ' A' ' 49' ' ' VAL . 2.7 m120 61.38 24.94 14.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 0.0 110.239 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.77 -9.52 65.27 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -88.77 130.48 35.35 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -76.96 146.12 37.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.582 0.706 . . . . 0.0 111.302 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.424 ' OH ' ' OE2' ' A' ' 168' ' ' GLU . 9.3 m-85 -138.46 124.92 20.59 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.004 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.656 ' C ' HD12 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -117.28 113.66 22.49 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.656 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.9 mp -119.23 146.58 45.1 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.582 0.706 . . . . 0.0 112.132 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.791 ' C ' HD13 ' A' ' 58' ' ' LEU . 4.9 tt0 -136.35 123.53 21.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.983 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.949 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.12 154.91 30.22 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.541 0.686 . . . . 0.0 112.416 -178.371 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.447 HG23 HG23 ' A' ' 42' ' ' THR . 0.3 OUTLIER -131.85 145.14 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.785 -178.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.16 103.89 8.52 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.019 -1.446 . . . . 0.0 107.92 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.46 152.25 46.67 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.312 0.577 . . . . 0.0 110.775 -178.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 63' ' ' GLY . . . -138.67 30.53 2.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.462 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.463 ' N ' ' OH ' ' A' ' 74' ' ' TYR . . . -30.22 -43.21 0.06 OUTLIER Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -144.1 -100.06 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.455 0.645 . . . . 0.0 109.973 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 68' ' ' SER . 4.3 p30 -76.92 -173.59 2.75 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.56 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.545 ' O ' ' CB ' ' A' ' 67' ' ' TYR . 1.0 OUTLIER -65.69 45.93 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.687 ' CG ' HD11 ' A' ' 12' ' ' LEU . 21.2 t80 96.69 79.15 0.0 OUTLIER 'General case' 0 C--N 1.343 0.311 0 O-C-N 124.469 1.106 . . . . 0.0 109.784 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.557 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.7 OUTLIER -69.7 124.7 24.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.937 -178.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.61 HG22 ' H ' ' A' ' 70' ' ' PHE . 20.7 mm -72.35 -125.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.61 ' H ' HG22 ' A' ' 69' ' ' ILE . 86.7 t80 52.3 86.72 0.15 Allowed Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 120.294 -0.563 . . . . 0.0 109.525 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -41.4 112.45 0.21 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.255 1.97 . . . . 0.0 112.8 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.429 ' NE2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -162.75 -60.82 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.528 179.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.429 ' OG1' ' NE2' ' A' ' 72' ' ' GLN . 1.9 m -144.08 10.15 1.51 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.371 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.463 ' OH ' ' N ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -122.57 -8.9 8.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.472 -179.739 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 76' ' ' ILE . 1.4 p -84.98 63.06 7.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.189 0.519 . . . . 0.0 110.592 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.5 HD12 HG21 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -52.41 -165.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.164 -179.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.39 44.36 2.48 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.218 0.533 . . . . 0.0 110.171 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.5 HG21 HD12 ' A' ' 76' ' ' ILE . 33.6 pt -81.51 -173.79 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.38 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -151.11 18.41 0.76 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.115 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -146.69 167.75 28.11 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.15 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.527 ' OH ' ' CE2' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -151.97 123.21 7.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.136 -0.532 . . . . 0.0 111.806 178.156 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.744 HG23 ' O ' ' A' ' 82' ' ' ILE . 12.4 tt -128.06 98.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.797 0.808 . . . . 0.0 109.299 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.787 HD23 ' N ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -96.32 130.09 43.51 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.639 -178.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.93 132.81 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.885 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.509 ' CE1' ' CD2' ' A' ' 116' ' ' LEU . 2.2 m-85 -108.56 143.5 37.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.886 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.552 ' C ' ' H ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -106.2 121.41 44.13 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.386 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.484 HG11 HH21 ' A' ' 127' ' ' ARG . 12.0 m -73.86 21.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.552 ' H ' ' C ' ' A' ' 86' ' ' SER . 9.7 t -142.72 -7.83 0.85 Allowed 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 114.212 1.189 . . . . 0.0 114.212 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.501 ' N ' ' OG ' ' A' ' 86' ' ' SER . 0.0 OUTLIER -135.46 100.5 4.53 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-O 122.324 1.059 . . . . 0.0 112.077 -176.311 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.458 HG22 ' CD ' ' A' ' 94' ' ' GLU . 17.1 mm -56.08 -10.63 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 113.915 -1.493 . . . . 0.0 108.754 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.77 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -79.3 -43.99 22.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.466 178.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 55.3 p -62.33 -45.89 91.19 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.151 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.837 ' CD2' HD13 ' A' ' 129' ' ' ILE . 0.1 OUTLIER -76.48 -37.55 56.67 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 118.531 -1.267 . . . . 0.0 111.882 -178.312 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.458 ' CD ' HG22 ' A' ' 90' ' ' ILE . 91.5 mt-10 -69.66 -44.86 69.68 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.902 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 91' ' ' LYS . 23.5 m -63.1 -36.5 76.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.881 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.444 ' N ' HG23 ' A' ' 95' ' ' VAL . 47.8 mt -72.42 -27.14 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.058 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -69.15 -29.17 67.14 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.8 t -76.29 -66.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.481 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.502 HG21 HD21 ' A' ' 12' ' ' LEU . 1.4 mp -39.16 -36.21 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.738 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.452 ' CE1' ' CE2' ' A' ' 141' ' ' TRP . 53.2 t-80 -66.95 -58.6 4.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.979 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.82 -49.16 1.95 Allowed Glycine 0 CA--C 1.518 0.259 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.804 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 105' ' ' ASP . 23.0 tptt -64.01 -66.31 0.56 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.424 -0.388 . . . . 0.0 110.393 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.7 OUTLIER -39.95 -57.17 1.67 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.627 179.058 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.769 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -46.84 -43.84 18.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.53 178.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -61.99 -32.89 73.39 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.624 -179.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 8.3 ttm -66.89 -53.72 29.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.713 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.545 ' C ' ' H ' ' A' ' 109' ' ' LYS . 15.9 m -77.19 -14.53 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.938 0.399 . . . . 0.0 110.569 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.5 -24.42 0.04 OUTLIER Glycine 0 CA--C 1.532 1.134 0 CA-C-N 115.87 -0.605 . . . . 0.0 113.132 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.545 ' H ' ' C ' ' A' ' 107' ' ' VAL . 24.0 tttt -172.02 -130.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 117.92 0.86 . . . . 0.0 111.601 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.513 ' H ' ' CG ' ' A' ' 109' ' ' LYS . 5.2 t 53.14 119.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.488 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -74.62 124.42 26.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.949 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.484 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -129.93 145.25 56.37 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.713 179.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -49.5 113.26 0.88 Allowed 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.624 1.55 . . . . 0.0 112.517 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.512 ' HB ' ' HB2' ' A' ' 143' ' ' ALA . 2.4 mp -123.99 132.99 70.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.473 ' SD ' ' HB3' ' A' ' 144' ' ' ALA . 9.4 tpt -133.18 115.3 14.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.011 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.509 ' CD2' ' CE1' ' A' ' 85' ' ' TYR . 4.2 mt -96.83 97.24 9.14 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.0 t -102.11 127.98 55.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.5 0.667 . . . . 0.0 111.753 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -94.73 114.68 4.89 Favored Glycine 0 C--N 1.311 -0.858 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -97.02 171.79 8.26 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.078 -0.649 . . . . 0.0 112.025 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.695 ' HZ1' " H1'" ' A' ' 186' ' ' GDP . 6.3 mtpp 61.73 55.47 2.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.629 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.556 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 8.8 tttm -57.41 -20.66 31.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.674 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.642 ' CG ' HN21 ' A' ' 186' ' ' GDP . 3.4 p-10 -76.64 -20.48 56.65 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.991 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.9 mp -77.96 -31.63 50.96 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.621 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.3 OUTLIER -31.56 -32.56 0.01 OUTLIER 'General case' 0 C--N 1.339 0.141 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.029 178.196 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.621 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 2.2 mmt -42.02 -27.34 0.12 Allowed 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.487 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -101.17 -37.6 8.48 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.587 179.307 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.484 HH21 HG11 ' A' ' 87' ' ' VAL . 9.8 ttm180 32.01 85.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.449 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.2 m -72.66 -34.77 48.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.167 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.837 HD13 ' CD2' ' A' ' 93' ' ' PHE . 10.7 tp -91.4 153.82 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.691 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.4 ' OG ' ' OE1' ' A' ' 132' ' ' GLU . 3.8 t -95.16 130.19 41.98 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.86 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -50.39 -35.86 30.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.782 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -68.45 -62.21 1.49 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.743 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -40.72 -43.12 1.9 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.722 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.68 -36.1 67.11 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -62.08 -53.53 54.21 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.341 -0.43 . . . . 0.0 109.852 179.574 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -58.39 -38.04 76.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.76 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.649 ' CD2' ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -66.43 -60.65 2.56 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.563 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -51.69 -37.16 49.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.984 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.83 -28.9 67.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.71 -47.37 78.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.155 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.649 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 17.1 m95 -91.0 -4.24 56.6 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.313 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 141' ' ' TRP . 0.8 OUTLIER 79.11 26.97 0.42 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.992 -179.434 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.61 168.81 12.24 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.69 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.473 ' HB3' ' SD ' ' A' ' 115' ' ' MET . . . -111.69 127.73 55.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.043 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.406 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 9.9 t80 -98.01 120.81 39.05 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.314 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.53 128.23 17.21 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.338 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.48 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 1.7 mt-10 -100.2 116.74 32.92 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.007 0.432 . . . . 0.0 110.098 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.433 ' OG ' HG21 ' A' ' 159' ' ' VAL . 11.8 p -131.98 -177.97 4.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.596 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.21 131.79 30.82 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.563 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.479 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -56.44 -42.44 78.12 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.123 0.487 . . . . 0.0 110.084 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 38.1 tttt -58.2 -3.7 0.28 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.468 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.479 ' H ' ' C ' ' A' ' 150' ' ' ALA . 1.9 mt-10 -136.37 125.76 24.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.017 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 29' ' ' GLY . 5.3 t-20 -77.25 -48.95 16.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.831 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 153' ' ' ASN . 0.0 OUTLIER -38.5 -59.16 0.94 Allowed 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.749 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.661 ' O ' HG23 ' A' ' 159' ' ' VAL . 45.7 p -52.5 -49.55 64.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.188 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.475 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -50.63 -60.84 2.62 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.553 0.692 . . . . 0.0 110.285 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 49.0 t -45.76 -42.2 3.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.895 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.15 -41.62 98.46 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.664 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 155' ' ' THR . 11.5 t -63.38 -46.94 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.66 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.632 ' CE1' ' CZ ' ' A' ' 26' ' ' PHE . 10.4 m-85 -67.79 -22.81 65.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.105 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.428 ' NH1' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -76.24 -42.36 46.09 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.869 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -67.29 -32.35 73.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.132 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 160' ' ' PHE . 7.3 tt -69.14 -47.07 76.64 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.171 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.764 HG21 HG11 ' A' ' 49' ' ' VAL . 95.4 mt -53.5 -37.53 30.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.05 -56.53 19.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.549 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -62.47 -28.73 70.02 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.309 -0.556 . . . . 0.0 109.573 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.606 ' HB1' ' NH1' ' A' ' 7' ' ' ARG . . . -59.23 -33.32 70.85 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.424 ' OE2' ' OH ' ' A' ' 54' ' ' TYR . 2.3 tp10 -68.83 -50.62 48.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.016 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -60.15 -64.29 1.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.741 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 50.6 mt -49.94 -31.75 7.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.952 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.84 -40.18 79.54 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.368 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -61.71 -35.63 91.5 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.29 -68.96 0.35 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.714 0.292 . . . . 0.0 110.427 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.715 179.927 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GDP . . . . . 0.695 " H1'" ' HZ1' ' A' ' 120' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.308 0.575 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.526 ' NH1' ' HB1' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -139.59 134.96 32.84 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.22 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.52 ' HB2' HG22 ' A' ' 78' ' ' ILE . 35.5 mttt -107.25 126.0 51.86 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.751 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.9 OUTLIER -100.17 122.03 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-O 121.566 0.698 . . . . 0.0 110.914 -177.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.62 134.84 34.78 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.464 -0.773 . . . . 0.0 110.903 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.3 mt -96.64 133.33 38.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.4 0.619 . . . . 0.0 112.382 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.647 ' C ' HD23 ' A' ' 12' ' ' LEU . 5.8 tt -128.61 105.67 8.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.494 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -142.03 134.33 6.11 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -52.99 172.6 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -73.37 131.61 42.07 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.231 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 m 67.1 19.97 10.38 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.698 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.6 p -79.72 -18.44 12.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.219 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.431 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 101.19 23.7 9.5 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.447 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.4 pttm -70.72 -33.44 70.85 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.423 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.496 ' O ' HD13 ' A' ' 24' ' ' ILE . 39.8 m -77.2 -30.42 54.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.05 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 79.5 p -65.61 -41.91 92.21 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.125 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.0 tp -77.07 -44.05 32.07 Favored 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 119.754 -0.779 . . . . 0.0 110.648 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.605 ' O ' HG12 ' A' ' 27' ' ' VAL . 25.3 m -47.93 -42.37 27.13 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.226 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.496 HD13 ' O ' ' A' ' 20' ' ' SER . 1.3 mp -77.15 -41.72 30.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 O-C-N 123.267 0.354 . . . . 0.0 111.272 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.541 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.3 OUTLIER -70.71 -28.69 64.92 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.969 -179.208 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.454 ' O ' ' N ' ' A' ' 29' ' ' GLY . 1.3 t80 -78.05 -63.63 1.35 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.231 0.539 . . . . 0.0 110.692 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.608 HG13 ' N ' ' A' ' 28' ' ' GLU . 13.7 p -45.15 -49.59 2.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.419 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.608 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.5 tt0 -79.06 -24.45 43.55 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 71.5 28.21 69.93 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 114.471 -1.241 . . . . 0.0 110.024 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 25' ' ' GLN . 0.2 OUTLIER -149.73 125.8 10.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.49 -178.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.618 ' O ' ' CD1' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -67.45 91.63 0.27 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.318 1.056 . . . . 0.0 110.407 178.643 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.64 HG22 ' N ' ' A' ' 33' ' ' ASP . 14.9 p -98.85 166.44 2.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.006 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.64 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.5 OUTLIER -46.37 -30.01 1.93 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.101 -179.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.403 ' H ' HG13 ' A' ' 32' ' ' VAL . 8.2 p 37.74 93.27 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.121 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.41 -38.98 18.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.122 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -37.34 101.01 0.21 Allowed Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.72 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.493 ' O ' ' O ' ' A' ' 36' ' ' ASP . 76.5 Cg_exo -53.72 -128.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.358 2.038 . . . . 0.0 112.164 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 38' ' ' THR . 14.6 t -102.39 46.92 0.91 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.121 0.486 . . . . 0.0 111.137 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 tp -83.69 145.59 8.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.016 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.425 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -90.14 146.36 24.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.436 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 0.7 OUTLIER 177.49 176.68 0.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.185 0.517 . . . . 0.0 111.869 -179.383 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.9 147.47 30.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.873 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.442 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 11.6 m-85 -129.77 167.3 18.29 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.239 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.537 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -145.9 151.05 37.24 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.52 -178.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.594 ' C ' HD12 ' A' ' 46' ' ' LEU . 5.0 tmtp? -150.91 108.78 3.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.439 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.748 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.4 mp -106.48 121.4 44.2 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.938 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 pp -149.0 165.36 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.785 0.326 . . . . 0.0 110.647 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 m -108.81 127.6 54.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.173 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.631 HG11 HG21 ' A' ' 164' ' ' ILE . 7.6 p -126.39 138.32 55.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.615 ' OD1' HG22 ' A' ' 49' ' ' VAL . 4.7 m-20 62.06 5.95 1.61 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 97.39 -13.18 64.66 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -91.37 142.21 27.93 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -76.24 145.53 39.66 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.562 0.696 . . . . 0.0 111.073 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.499 ' CD1' HG12 ' A' ' 49' ' ' VAL . 8.0 m-85 -136.34 124.8 23.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.134 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.643 ' C ' HD22 ' A' ' 56' ' ' LEU . 62.3 m170 -116.74 113.98 23.35 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.655 HD22 ' N ' ' A' ' 56' ' ' LEU . 2.7 mm? -118.91 139.75 51.12 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 121.386 0.612 . . . . 0.0 111.34 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.75 ' C ' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -133.36 122.41 23.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.91 178.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.924 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.19 154.6 30.84 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.345 0.593 . . . . 0.0 112.525 -178.139 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.8 145.29 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-N 114.672 -1.149 . . . . 0.0 113.05 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -123.61 106.5 10.61 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.067 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.67 148.62 49.81 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.614 0.721 . . . . 0.0 111.487 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.481 ' O ' ' N ' ' A' ' 64' ' ' GLN . . . -138.37 15.53 2.78 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.867 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.433 ' N ' ' OH ' ' A' ' 74' ' ' TYR . . . -38.46 -26.68 0.04 OUTLIER Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.108 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.503 ' CG ' ' H ' ' A' ' 65' ' ' ASP . 1.5 tp60 -145.09 -121.24 0.08 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.554 0.693 . . . . 0.0 110.405 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' A' ' 68' ' ' SER . 0.0 OUTLIER -75.17 -173.82 2.12 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.751 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 67' ' ' TYR . 1.5 mp0 -65.11 47.03 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.257 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.534 ' N ' ' O ' ' A' ' 65' ' ' ASP . 4.0 t80 93.67 80.66 0.0 OUTLIER 'General case' 0 C--O 1.232 0.146 0 O-C-N 124.157 0.911 . . . . 0.0 109.143 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.567 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 12.1 m -68.8 134.43 49.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.611 -178.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.954 ' H ' HD12 ' A' ' 69' ' ' ILE . 2.6 mp -69.07 97.15 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.478 ' O ' ' N ' ' A' ' 72' ' ' GLN . 18.6 t80 -158.03 76.85 3.63 Favored Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.355 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.18 83.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.658 2.239 . . . . 0.0 111.863 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.499 ' NE2' ' OG1' ' A' ' 73' ' ' THR . 1.1 tt0 -169.72 -52.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.684 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.499 ' OG1' ' NE2' ' A' ' 72' ' ' GLN . 1.2 m -135.0 4.09 3.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.64 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.531 ' O ' ' CZ ' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -130.02 5.24 4.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.622 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -155.08 86.17 1.1 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.377 0.608 . . . . 0.0 109.813 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.659 HG22 ' H ' ' A' ' 77' ' ' ASP . 6.9 mm -56.63 -132.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.845 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.659 ' H ' HG22 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -118.34 48.26 1.46 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.384 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.52 HG22 ' HB2' ' A' ' 8' ' ' LYS . 31.5 pt -77.26 -177.65 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 114.572 -1.194 . . . . 0.0 112.838 -177.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.77 19.33 0.7 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.022 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.402 ' HA3' HD13 ' A' ' 9' ' ' ILE . . . -148.02 165.08 28.92 Favored Glycine 0 CA--C 1.517 0.195 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.534 -178.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.531 ' OH ' ' CD1' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -151.82 123.07 7.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.716 -0.742 . . . . 0.0 111.073 177.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.569 HG23 ' O ' ' A' ' 82' ' ' ILE . 9.7 tt -126.19 107.62 17.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.9 0.857 . . . . 0.0 109.029 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.818 ' N ' HD12 ' A' ' 83' ' ' LEU . 3.1 mp -97.27 126.67 42.63 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.979 -178.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -95.26 128.69 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.162 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.707 ' CZ ' HG21 ' A' ' 96' ' ' ILE . 48.6 m-85 -110.69 144.44 39.62 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.172 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.506 ' HG ' ' H ' ' A' ' 89' ' ' SER . 0.9 OUTLIER -98.24 125.99 43.54 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.487 HG21 ' N ' ' A' ' 124' ' ' HIS . 11.0 m -72.5 22.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.673 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.501 ' H ' ' C ' ' A' ' 86' ' ' SER . 0.8 OUTLIER -138.79 -26.13 0.87 Allowed 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.535 ' C ' ' N ' ' A' ' 91' ' ' LYS . 4.1 t -98.0 93.98 6.6 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.378 -176.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.477 ' O ' HD13 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -58.27 -11.57 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.314 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.535 ' N ' ' C ' ' A' ' 89' ' ' SER . 3.4 mptt -78.28 -57.22 3.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.456 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 69.6 p -49.6 -30.62 9.08 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.591 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.402 ' CE1' ' CD2' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -74.55 -48.29 27.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.838 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.39 -44.22 88.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.595 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 91' ' ' LYS . 4.1 m -64.38 -35.84 75.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.145 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.707 HG21 ' CZ ' ' A' ' 85' ' ' TYR . 44.7 mt -69.12 -29.44 42.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.882 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.03 -27.84 66.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.8 t -74.75 -66.73 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.2 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.474 HD11 ' OD2' ' A' ' 65' ' ' ASP . 1.6 mp -41.39 -48.64 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.514 ' CE1' ' CE2' ' A' ' 141' ' ' TRP . 51.8 t-80 -54.66 -64.84 0.7 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.669 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -38.07 -52.33 2.13 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 105' ' ' ASP . 17.7 tptm -65.87 -63.6 1.05 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.924 -0.638 . . . . 0.0 110.698 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -38.2 -59.24 0.89 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.215 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.736 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -47.05 -45.24 21.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.806 178.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -61.06 -36.07 78.62 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.795 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.517 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 5.2 ttm -60.48 -55.67 30.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.206 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.498 ' C ' ' H ' ' A' ' 109' ' ' LYS . 17.7 m -77.21 -13.8 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.18 0.514 . . . . 0.0 110.243 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 63.67 -24.76 0.09 OUTLIER Glycine 0 CA--C 1.531 1.033 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.999 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.521 ' CG ' ' H ' ' A' ' 110' ' ' VAL . 20.8 tttt -172.85 -135.01 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 117.784 0.792 . . . . 0.0 111.832 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.521 ' H ' ' CG ' ' A' ' 109' ' ' LYS . 5.6 t 52.77 118.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.665 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.538 ' OE1' ' HB1' ' A' ' 173' ' ' ALA . 8.2 mt-30 -76.15 126.97 31.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.022 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.721 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.6 OUTLIER -130.07 153.68 81.12 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.685 179.419 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -48.02 114.69 1.2 Allowed 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.897 1.731 . . . . 0.0 112.572 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.49 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.4 mp -124.28 128.44 73.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.54 ' SD ' ' HB3' ' A' ' 144' ' ' ALA . 12.3 tpt -129.01 114.59 16.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.741 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 138' ' ' ALA . 67.5 mt -97.21 98.91 10.41 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.387 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.83 131.16 57.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.865 0.84 . . . . 0.0 112.396 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -97.96 114.01 4.88 Favored Glycine 0 C--N 1.312 -0.773 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.448 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 57.7 t30 -96.84 172.79 7.65 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.952 -177.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.448 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 19.7 mttt 58.51 58.67 3.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.188 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -14.75 61.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.326 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.656 ' CG ' HN21 ' A' ' 186' ' ' GDP . 3.9 p-10 -79.4 -13.03 59.87 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.633 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.661 ' O ' ' N ' ' A' ' 126' ' ' GLU . 10.9 mp -84.05 -26.57 28.95 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.553 ' O ' ' N ' ' A' ' 126' ' ' GLU . 10.3 t60 -22.76 -42.34 0.01 OUTLIER 'General case' 0 C--N 1.348 0.503 0 O-C-N 124.544 1.152 . . . . 0.0 111.289 178.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.567 ' N ' ' O ' ' A' ' 123' ' ' LEU . 0.7 OUTLIER -44.77 -19.04 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.661 ' N ' ' O ' ' A' ' 123' ' ' LEU . 19.8 mm-40 -89.74 -54.49 4.04 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.011 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.433 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 1.7 tpt85 35.85 71.24 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.269 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.71 -40.13 86.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.292 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 tp -88.44 155.12 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.582 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 132' ' ' GLU . 47.5 p -93.12 118.04 30.76 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.718 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -39.12 -28.66 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.645 0.736 . . . . 0.0 109.373 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.3 mp0 -70.06 -63.27 1.11 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.876 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.4 ' CG ' ' OG ' ' A' ' 130' ' ' SER . 57.1 mt-10 -41.52 -41.73 2.19 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.16 -35.73 64.09 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' A' ' 132' ' ' GLU . 2.4 tttm -60.72 -55.42 33.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.58 -33.97 66.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.075 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.35 -63.2 1.16 Allowed 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.836 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 143' ' ' ALA . . . -51.67 -35.06 41.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.232 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -35.61 78.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.736 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.58 -47.32 76.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.59 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.558 ' CH2' HD22 ' A' ' 104' ' ' LEU . 25.7 m95 -92.72 2.52 56.69 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.719 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 60.77 39.94 16.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.526 0.679 . . . . 0.0 109.633 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.46 ' O ' ' HB1' ' A' ' 138' ' ' ALA . . . -98.15 168.35 10.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.57 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.54 ' HB3' ' SD ' ' A' ' 115' ' ' MET . . . -105.07 125.46 51.0 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.887 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.437 ' C ' ' CD1' ' A' ' 145' ' ' PHE . 4.0 t80 -98.4 122.03 41.08 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.262 -178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.01 126.43 15.83 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.433 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 2.7 mt-10 -100.49 114.89 28.86 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.404 ' OG ' HG21 ' A' ' 159' ' ' VAL . 21.0 p -134.77 -178.76 5.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.824 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.93 135.19 34.14 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.28 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.481 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -57.44 -46.52 83.5 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.883 0.373 . . . . 0.0 110.365 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -55.21 -6.29 0.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.33 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.481 ' H ' ' C ' ' A' ' 150' ' ' ALA . 2.1 tt0 -131.25 122.63 26.82 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.638 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.471 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 10.4 t-20 -77.21 -52.02 9.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.167 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 153' ' ' ASN . 0.2 OUTLIER -36.77 -58.22 0.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.03 -179.632 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.678 ' O ' HG23 ' A' ' 159' ' ' VAL . 68.1 p -53.0 -45.1 67.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.127 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.541 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -55.44 -61.48 2.31 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.492 0.663 . . . . 0.0 110.121 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 57.4 t -43.22 -39.67 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.688 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -65.7 -42.81 90.71 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.199 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 155' ' ' THR . 14.3 t -61.93 -42.41 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.539 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.537 ' O ' HG22 ' A' ' 163' ' ' ILE . 52.3 t80 -59.49 -66.76 0.46 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.216 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 160' ' ' PHE . 19.5 ttm-85 -41.62 -45.29 3.33 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.304 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -62.05 -30.35 70.92 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.754 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.2 OUTLIER -66.41 -32.47 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.457 179.473 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.631 HG21 HG11 ' A' ' 49' ' ' VAL . 7.4 mt -68.39 -42.27 84.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.737 0.779 . . . . 0.0 109.665 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.62 -49.36 78.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.551 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -64.03 -32.56 74.15 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -56.08 -34.41 65.96 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.125 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.39 -55.39 10.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.682 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.62 -62.87 1.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.733 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.721 HG21 ' C ' ' A' ' 112' ' ' ILE . 38.5 mm -53.32 -31.23 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.065 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -69.67 -40.38 76.47 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.633 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.53 -35.31 91.6 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.538 ' HB1' ' OE1' ' A' ' 111' ' ' GLN . . . -67.98 -62.71 1.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.688 0.28 . . . . 0.0 110.429 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.705 179.878 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GDP . . . . . 0.656 HN21 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 121.216 0.531 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.62 136.66 34.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.587 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.534 ' HB2' HG22 ' A' ' 78' ' ' ILE . 11.0 mttm -108.51 127.49 53.97 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.741 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -103.01 123.95 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-O 121.479 0.657 . . . . 0.0 111.13 -178.086 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.43 135.78 34.12 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.422 -0.799 . . . . 0.0 111.254 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.0 mt -95.77 133.84 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.619 HD21 ' O ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -128.24 100.69 5.93 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.349 179.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.71 133.73 5.87 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.69 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER -54.62 -167.08 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.034 0.445 . . . . 0.0 110.041 178.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.404 ' O ' ' CB ' ' A' ' 16' ' ' SER . 11.5 ttp180 -97.64 128.33 44.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.744 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.514 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 0.7 OUTLIER 76.24 8.79 3.32 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.125 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.469 ' C ' ' NZ ' ' A' ' 120' ' ' LYS . 7.3 p -77.63 -19.32 14.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.942 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.417 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 106.03 31.6 4.08 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.408 ' NZ ' ' CB ' ' A' ' 19' ' ' LYS . 2.6 ttmp? -59.5 -59.1 5.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.005 0.431 . . . . 0.0 110.406 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.07 -26.01 63.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.24 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 89.1 p -63.78 -47.11 82.22 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.714 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 28.4 tp -71.39 -49.94 37.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.473 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.551 ' O ' HG12 ' A' ' 27' ' ' VAL . 48.7 m -43.79 -38.93 3.49 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.311 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.2 -43.68 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.94 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.622 ' NE2' ' N ' ' A' ' 31' ' ' PHE . 1.5 tp-100 -63.46 -40.53 97.37 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.756 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.636 ' CG ' ' CE1' ' A' ' 160' ' ' PHE . 2.2 t80 -74.87 -62.52 1.51 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.209 0.528 . . . . 0.0 111.825 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.576 HG13 ' N ' ' A' ' 28' ' ' GLU . 7.4 p -44.0 -47.52 2.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.722 -178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.576 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.0 tm-20 -83.91 -24.19 30.86 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.526 ' O ' ' ND2' ' A' ' 153' ' ' ASN . . . 75.11 25.5 68.71 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.075 -1.42 . . . . 0.0 110.348 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.547 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 1.9 tp-100 -152.01 130.1 11.87 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.687 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.622 ' N ' ' NE2' ' A' ' 25' ' ' GLN . 0.7 OUTLIER -67.05 93.82 0.3 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.684 178.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.546 HG22 ' N ' ' A' ' 33' ' ' ASP . 12.3 p -105.73 165.85 3.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.098 0.475 . . . . 0.0 110.393 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.546 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -75.66 -32.78 60.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.374 -179.023 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.457 ' H ' HG22 ' A' ' 32' ' ' VAL . 10.0 p 43.0 -168.91 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.855 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.408 ' O ' ' C ' ' A' ' 36' ' ' ASP . 3.6 t80 -149.04 -39.47 0.15 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.21 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 37' ' ' PRO . 4.9 m-20 -36.73 100.11 0.19 Allowed Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.665 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 36' ' ' ASP . 66.4 Cg_exo -54.55 -129.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.319 2.013 . . . . 0.0 112.236 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 38' ' ' THR . 13.8 t -103.17 47.63 0.88 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.227 0.537 . . . . 0.0 111.215 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 tp -83.29 144.68 9.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.444 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.482 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 2.2 pm0 -90.59 145.45 24.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.889 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 0.7 OUTLIER 177.11 175.33 0.4 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.624 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.81 127.61 53.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.294 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -110.02 174.05 6.04 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.968 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.531 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -143.5 161.7 37.75 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.399 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.595 ' C ' HD12 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -163.18 112.09 1.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.432 179.424 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.699 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.5 mp -105.17 127.93 53.15 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.727 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.5 pt -147.87 165.31 5.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.569 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.2 m -116.82 123.86 48.12 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.049 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.713 HG11 HG21 ' A' ' 164' ' ' ILE . 2.4 p -119.74 129.99 74.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.631 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.505 ' CG ' HG22 ' A' ' 49' ' ' VAL . 3.0 m120 61.73 19.71 10.75 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.56 -9.43 71.04 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -90.0 135.6 33.55 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.49 147.28 37.93 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.584 0.706 . . . . 0.0 111.465 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.438 ' CD1' ' CG1' ' A' ' 49' ' ' VAL . 5.8 m-85 -138.3 125.21 21.19 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.042 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.618 ' C ' HD12 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -118.04 113.74 22.09 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.618 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.6 mp -118.62 143.21 46.96 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.629 0.728 . . . . 0.0 112.164 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.806 ' C ' HD13 ' A' ' 58' ' ' LEU . 1.2 mt-30 -133.96 122.6 23.31 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.93 178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.976 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.38 153.52 31.89 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.063 -178.655 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.82 145.48 34.32 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-N 114.992 -1.004 . . . . 0.0 112.926 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -124.33 103.24 8.1 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.064 177.627 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.496 ' C ' ' H ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -93.06 -70.1 0.72 Allowed 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.374 0.607 . . . . 0.0 110.843 -179.201 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 50.43 9.9 0.05 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.317 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 61' ' ' THR . . . -50.44 -70.48 0.82 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -83.82 -113.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.421 0.629 . . . . 0.0 110.614 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.588 ' OD1' ' N ' ' A' ' 68' ' ' SER . 0.0 OUTLIER -75.35 -173.91 2.22 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.048 179.525 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.619 ' O ' HD21 ' A' ' 12' ' ' LEU . 2.9 mp0 -66.04 44.71 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.628 ' CZ ' ' CZ ' ' A' ' 74' ' ' TYR . 3.4 t80 91.75 73.47 0.0 OUTLIER 'General case' 0 C--N 1.339 0.122 0 O-C-N 124.196 0.935 . . . . 0.0 108.788 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.588 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.9 OUTLIER -72.9 120.51 18.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.964 -178.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.768 HG22 ' H ' ' A' ' 70' ' ' PHE . 31.4 mm -61.5 -126.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.768 ' H ' HG22 ' A' ' 69' ' ' ILE . 87.8 t80 49.35 80.64 0.29 Allowed Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 120.379 -0.528 . . . . 0.0 109.683 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -46.54 117.92 2.3 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.53 2.153 . . . . 0.0 112.503 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -171.9 -37.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.612 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.3 m -108.19 -24.0 11.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.618 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.628 ' CZ ' ' CZ ' ' A' ' 67' ' ' TYR . 16.5 m-85 -77.2 -55.19 5.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.078 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.1 t 74.63 -48.5 0.65 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.35 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.97 173.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.072 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.566 ' O ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -131.2 -15.47 3.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.08 -179.654 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.566 ' O ' ' O ' ' A' ' 77' ' ' ASP . 39.1 pt 33.67 -170.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 177.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -154.85 19.59 0.45 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.776 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.554 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -152.66 165.28 30.97 Favored Glycine 0 C--O 1.227 -0.323 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.873 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.78 122.31 7.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.689 -0.755 . . . . 0.0 110.691 178.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.599 HG23 ' O ' ' A' ' 82' ' ' ILE . 9.6 tt -124.01 102.69 11.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.685 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -97.56 123.22 41.36 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.17 -178.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.9 t -95.38 130.54 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.135 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.656 ' CZ ' HG21 ' A' ' 96' ' ' ILE . 69.6 m-85 -111.25 143.94 41.23 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.538 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.583 ' HG ' ' H ' ' A' ' 89' ' ' SER . 0.5 OUTLIER -94.99 121.0 36.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.473 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.52 HG21 ' N ' ' A' ' 124' ' ' HIS . 13.8 m -70.66 21.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.469 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.522 ' H ' ' C ' ' A' ' 86' ' ' SER . 1.1 t -136.27 -23.54 1.28 Allowed 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.583 ' H ' ' HG ' ' A' ' 86' ' ' SER . 8.3 t -100.45 94.1 5.98 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.482 -176.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.485 ' O ' HD13 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -56.81 -11.41 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 175.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.555 ' N ' ' C ' ' A' ' 89' ' ' SER . 18.1 mttp -78.11 -56.35 4.55 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.141 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.4 p -49.83 -29.87 8.78 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.692 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.868 ' CE2' HG21 ' A' ' 129' ' ' ILE . 0.3 OUTLIER -75.29 -50.22 16.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.92 -179.305 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -64.68 -42.95 94.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.628 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 91' ' ' LYS . 4.6 m -65.98 -37.62 80.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.469 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.656 HG21 ' CZ ' ' A' ' 85' ' ' TYR . 41.1 mt -68.67 -28.58 40.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.567 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -70.4 -27.48 64.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.835 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 99' ' ' ILE . 17.0 t -74.34 -66.4 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.777 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' A' ' 98' ' ' VAL . 1.6 mp -39.97 -43.01 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.666 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.65 ' CE1' ' CE2' ' A' ' 141' ' ' TRP . 9.1 t60 -57.81 -59.38 5.32 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.616 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -36.39 -49.05 1.25 Allowed Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.716 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 105' ' ' ASP . 22.5 tptt -67.88 -66.03 0.62 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.32 -0.44 . . . . 0.0 110.367 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.48 HD13 ' C ' ' A' ' 103' ' ' LEU . 0.5 OUTLIER -38.0 -59.65 0.82 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.718 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -44.29 -46.96 9.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.821 178.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -59.94 -33.39 71.84 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.281 -179.159 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.514 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 21.1 ttm -69.44 -54.98 11.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.07 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.569 ' C ' ' H ' ' A' ' 109' ' ' LYS . 28.9 m -77.25 -15.55 14.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.829 -179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.87 -24.94 0.05 OUTLIER Glycine 0 CA--C 1.533 1.2 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.688 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.569 ' H ' ' C ' ' A' ' 107' ' ' VAL . 1.2 pttt -176.03 -126.69 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.573 0.687 . . . . 0.0 111.004 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 109' ' ' LYS . 5.8 t 52.2 121.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 121.346 0.593 . . . . 0.0 111.889 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -75.17 125.26 28.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.033 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.491 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -136.18 152.72 75.82 Favored Pre-proline 0 C--O 1.223 -0.328 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -48.3 108.18 0.17 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.929 1.753 . . . . 0.0 113.157 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.491 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.3 mt -121.22 127.07 75.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 11.0 tpt -127.99 114.5 17.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.913 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.437 HD12 ' HB2' ' A' ' 138' ' ' ALA . 62.7 mt -96.98 98.33 9.99 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.2 t -105.76 130.08 57.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.846 0.831 . . . . 0.0 112.774 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -97.63 112.51 4.48 Favored Glycine 0 C--N 1.312 -0.761 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.522 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 50.5 t30 -96.86 176.91 5.81 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 119.939 -0.705 . . . . 0.0 111.792 -177.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.522 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 36.5 mttp 58.61 57.76 3.62 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -59.72 -34.85 73.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.713 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.56 -12.79 10.97 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.171 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.5 mp -92.58 -31.65 15.11 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.603 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -38.68 -25.58 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.226 178.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.603 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 3.8 mmt -43.33 -26.25 0.18 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.5 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -102.81 -39.68 6.89 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.133 179.062 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.474 HH21 ' HB2' ' A' ' 124' ' ' HIS . 29.1 ttm-85 34.52 72.31 0.09 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.717 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.613 HG23 ' N ' ' A' ' 129' ' ' ILE . 33.9 m -56.04 -48.19 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.545 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.868 HG21 ' CE2' ' A' ' 93' ' ' PHE . 7.8 tp -86.88 152.55 3.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.422 ' OG ' ' OE1' ' A' ' 133' ' ' GLU . 1.9 p -99.13 125.5 44.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.465 0.65 . . . . 0.0 111.78 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.645 ' CD1' ' CE1' ' A' ' 145' ' ' PHE . 0.1 OUTLIER -52.7 -43.32 65.56 Favored 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.406 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 131' ' ' TYR . 1.4 mp0 -39.66 -62.75 0.65 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.95 178.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.422 ' OE1' ' OG ' ' A' ' 130' ' ' SER . 14.9 mt-10 -50.74 -37.42 41.79 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 131' ' ' TYR . . . -70.84 -24.7 76.79 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 131' ' ' TYR . 31.4 tttm -73.68 -55.99 5.57 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -53.97 -35.47 61.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.505 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.608 HD21 ' HE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -68.15 -62.66 1.3 Allowed 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -47.24 -35.37 7.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.775 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.57 -33.37 72.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.154 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -63.95 -47.14 81.62 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.168 -179.246 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.65 ' CE2' ' CE1' ' A' ' 100' ' ' HIS . 29.7 m95 -90.44 -4.0 57.3 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.204 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 72.4 27.66 2.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.493 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -89.2 166.33 13.88 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.125 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -108.18 126.38 52.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.149 0.499 . . . . 0.0 111.47 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.645 ' CE1' ' CD1' ' A' ' 131' ' ' TYR . 11.3 t80 -98.63 122.0 41.3 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.863 -178.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.99 131.28 20.81 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.449 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 11.0 mt-10 -100.39 119.78 38.97 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.491 ' OG ' HG21 ' A' ' 159' ' ' VAL . 0.8 OUTLIER -134.44 -178.95 5.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.736 -179.507 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.04 137.9 39.86 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.968 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.526 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -59.92 -46.13 90.36 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -69.13 11.87 0.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.359 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 150' ' ' ALA . 3.8 tt0 -137.68 117.79 13.48 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.231 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 10.1 t-20 -77.42 -56.71 4.31 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.43 ' OE1' ' OE2' ' A' ' 152' ' ' GLU . 0.0 OUTLIER -36.47 -59.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.051 0.453 . . . . 0.0 111.229 -179.036 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.621 ' O ' HG23 ' A' ' 159' ' ' VAL . 3.2 p -52.35 -53.81 39.88 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.84 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -47.48 -59.51 3.19 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.598 0.714 . . . . 0.0 110.116 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 47.9 t -48.45 -42.76 12.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.733 -1.122 . . . . 0.0 110.865 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -60.45 -40.95 93.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.533 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 155' ' ' THR . 14.2 t -62.51 -46.27 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.21 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.636 ' CE1' ' CG ' ' A' ' 26' ' ' PHE . 15.2 m-85 -68.66 -24.04 64.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.365 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.8 ttm-85 -77.34 -41.11 41.74 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.01 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.2 mmm-85 -65.66 -33.93 77.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.978 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 164' ' ' ILE . 3.3 tt -68.93 -50.59 52.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.449 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.713 HG21 HG11 ' A' ' 49' ' ' VAL . 94.3 mt -50.99 -35.96 15.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.181 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.23 -60.52 3.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.837 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -60.92 -26.7 67.66 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.704 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -61.64 -33.22 73.57 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.437 ' O ' ' OD2' ' A' ' 171' ' ' ASP . 2.7 tp10 -69.1 -50.13 50.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.417 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -62.37 -51.22 68.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.153 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 24.6 mt -53.59 -42.35 49.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.419 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.437 ' OD2' ' O ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -68.34 -38.58 81.65 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.482 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -54.6 -42.2 76.07 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.87 -73.88 0.15 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.738 0.304 . . . . 0.0 110.607 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.838 -179.727 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GDP . . . . . 0.514 " H5'" ' HA ' ' A' ' 16' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 121.11 0.481 . . . . 0.0 110.453 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.492 ' NH2' ' OD2' ' A' ' 171' ' ' ASP . 0.0 OUTLIER -139.7 134.92 32.62 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.657 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.436 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 5.0 mtmm -106.26 125.51 51.09 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.762 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -101.27 119.98 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 121.573 0.702 . . . . 0.0 110.442 -178.77 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.5 134.89 34.83 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.48 -0.763 . . . . 0.0 111.083 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.477 HD13 ' OG1' ' A' ' 23' ' ' THR . 18.3 mt -95.9 125.65 48.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.294 0.569 . . . . 0.0 111.447 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.492 ' CD2' HD13 ' A' ' 99' ' ' ILE . 13.2 tp -124.49 104.28 8.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.532 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -139.65 135.89 7.49 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.494 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.1 OUTLIER -52.08 -160.97 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.518 0.675 . . . . 0.0 111.144 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.7 ttt-85 -93.52 135.14 35.06 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.407 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.519 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 1.8 m 65.93 6.02 3.79 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.426 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.477 ' C ' ' NZ ' ' A' ' 120' ' ' LYS . 3.9 p -65.9 -17.97 23.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.813 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.2 25.29 37.42 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.445 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -65.26 -38.13 89.34 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.875 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.4 m -70.06 -35.52 74.29 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.544 ' OG ' ' H8 ' ' A' ' 186' ' ' GDP . 69.2 m -60.45 -43.25 97.04 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.762 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 25' ' ' GLN . 22.8 tp -68.16 -56.42 8.85 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.271 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.63 ' O ' HG12 ' A' ' 27' ' ' VAL . 93.3 m -38.43 -36.65 0.25 Allowed 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.419 HG21 ' O ' ' A' ' 32' ' ' VAL . 1.3 mp -77.51 -42.9 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.78 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.753 HE22 ' ND2' ' A' ' 153' ' ' ASN . 3.0 tp-100 -63.9 -38.32 90.64 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.135 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -76.48 -61.72 1.86 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.101 0.477 . . . . 0.0 111.668 -178.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.692 HG21 ' CG ' ' A' ' 43' ' ' PHE . 8.6 p -48.03 -47.9 12.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.672 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.632 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.0 tt0 -84.16 -23.56 30.57 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 75.01 23.4 74.67 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.532 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 11.7 mp0 -148.58 129.99 14.79 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.637 ' N ' ' NE2' ' A' ' 25' ' ' GLN . 0.8 OUTLIER -61.47 94.59 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.977 178.512 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.751 HG22 ' H ' ' A' ' 34' ' ' SER . 7.2 p -141.57 165.38 18.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.451 ' O ' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -97.75 -12.94 21.73 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.184 0.516 . . . . 0.0 110.358 -179.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.751 ' H ' HG22 ' A' ' 32' ' ' VAL . 18.5 p 47.09 178.3 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.323 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.19 24.24 1.63 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.116 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.419 ' O ' ' O ' ' A' ' 37' ' ' PRO . 1.4 m-20 -139.36 79.87 24.23 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.324 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.497 ' C ' ' H ' ' A' ' 39' ' ' ILE . 52.0 Cg_exo -56.87 -130.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.94 2.427 . . . . 0.0 111.949 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 38' ' ' THR . 9.2 t -72.79 34.36 0.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.025 0.44 . . . . 0.0 111.239 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.497 ' H ' ' C ' ' A' ' 37' ' ' PRO . 1.5 tp -84.1 148.55 4.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.993 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.566 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 1.8 pm0 -87.37 140.81 29.16 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.723 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -174.66 -177.0 1.1 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.465 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.08 124.35 32.59 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.686 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.692 ' CG ' HG21 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -107.15 174.66 5.79 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 120.993 0.425 . . . . 0.0 110.201 179.175 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.28 162.75 34.73 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.16 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -160.04 107.18 1.63 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.309 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.1 mp -106.35 118.58 37.0 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.195 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.651 ' H ' HD12 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -149.38 165.14 3.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.575 -179.721 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.6 m -109.01 127.9 54.49 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.261 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.877 HG11 HG21 ' A' ' 164' ' ' ILE . 6.6 p -127.61 134.08 66.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.387 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.37 3.95 3.52 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.465 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.35 -12.89 63.33 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -91.71 141.23 28.92 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -76.68 144.83 39.15 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.55 0.691 . . . . 0.0 111.114 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.435 ' OH ' ' OE2' ' A' ' 168' ' ' GLU . 9.7 m-85 -135.89 124.21 23.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.203 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.709 ' C ' HD12 ' A' ' 56' ' ' LEU . 2.6 m-70 -118.05 113.37 21.54 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.709 HD12 ' C ' ' A' ' 55' ' ' HIS . 11.2 mp -123.59 146.44 48.15 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.601 0.715 . . . . 0.0 112.128 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.8 ' C ' HD13 ' A' ' 58' ' ' LEU . 0.7 OUTLIER -138.78 127.03 22.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.934 178.464 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.985 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.91 153.1 34.14 Favored 'General case' 0 CA--C 1.499 -1.018 0 C-N-CA 120.251 -0.579 . . . . 0.0 111.886 -178.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.53 144.46 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.718 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.96 105.35 9.91 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.344 -1.298 . . . . 0.0 107.961 177.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.85 153.02 51.73 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.375 0.607 . . . . 0.0 110.445 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 64' ' ' GLN . . . -141.32 17.65 2.23 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.054 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -40.51 -26.67 0.13 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 62' ' ' ALA . 10.7 mm100 -140.21 -144.98 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.48 0.657 . . . . 0.0 110.919 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.765 ' O ' ' N ' ' A' ' 67' ' ' TYR . 1.4 p30 -74.68 -170.47 1.06 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.209 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.595 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 1.4 pm0 -44.73 72.38 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 124.342 1.026 . . . . 0.0 110.409 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.765 ' N ' ' O ' ' A' ' 65' ' ' ASP . 15.9 t80 64.47 3.86 2.04 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.682 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.474 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 5.4 m 35.41 100.94 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.174 0.511 . . . . 0.0 112.27 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.69 ' H ' HD12 ' A' ' 69' ' ' ILE . 2.4 mp -41.67 -73.32 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-O 121.496 0.665 . . . . 0.0 110.04 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.482 ' O ' ' O ' ' A' ' 71' ' ' PRO . 0.3 OUTLIER -42.36 167.59 0.06 OUTLIER Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.321 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.492 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 52.9 Cg_exo -52.38 -137.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.968 0 C-N-CA 122.614 2.209 . . . . 0.0 113.0 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.492 ' CB ' ' O ' ' A' ' 71' ' ' PRO . 3.5 tt0 84.89 57.54 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.492 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.463 ' CB ' ' O ' ' A' ' 72' ' ' GLN . 0.2 OUTLIER 79.82 -31.1 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.634 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.4 ' H ' ' C ' ' A' ' 72' ' ' GLN . 30.9 m-85 -78.41 8.43 5.12 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.567 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 76' ' ' ILE . 1.1 p -82.89 29.58 0.46 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.986 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.454 ' HB ' HG23 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -50.44 -174.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.324 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.96 50.76 2.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.464 0.65 . . . . 0.0 109.416 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 80' ' ' GLY . 41.4 pt -79.03 -170.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.985 -178.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.07 15.67 1.06 Allowed 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.356 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.51 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -146.21 164.35 28.32 Favored Glycine 0 C--O 1.229 -0.214 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.473 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.531 ' OH ' ' CD1' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -152.11 125.1 8.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.068 -0.566 . . . . 0.0 111.475 178.146 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 82' ' ' ILE . 9.8 tt -131.08 104.82 9.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.995 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -96.6 126.17 41.59 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.525 -177.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -96.6 130.75 44.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.091 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.609 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 37.2 p90 -128.99 144.5 51.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.444 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.454 ' C ' ' H ' ' A' ' 88' ' ' THR . 4.1 p -87.27 142.83 27.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.211 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.614 HG21 ' N ' ' A' ' 124' ' ' HIS . 22.8 m -71.28 12.69 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.776 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.454 ' H ' ' C ' ' A' ' 86' ' ' SER . 8.6 t -132.86 -20.09 2.25 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 120.892 0.377 . . . . 0.0 111.904 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.533 ' C ' ' N ' ' A' ' 91' ' ' LYS . 33.1 t -90.13 92.63 9.04 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.758 -176.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 tp -61.12 -11.19 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.634 ' O ' HG22 ' A' ' 95' ' ' VAL . 3.3 mttp -78.04 -52.01 9.43 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 113.351 -1.75 . . . . 0.0 110.327 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 53.5 p -60.58 -33.58 72.93 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.643 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.609 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -74.06 -49.38 24.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.281 -179.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.447 ' O ' HG23 ' A' ' 98' ' ' VAL . 40.0 mt-10 -65.23 -42.65 93.2 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.707 -178.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.794 ' O ' HG22 ' A' ' 99' ' ' ILE . 20.1 m -67.42 -38.51 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.652 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.422 ' N ' HG23 ' A' ' 95' ' ' VAL . 2.6 mt -62.25 -38.12 80.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.347 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -69.43 -29.01 66.63 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 94' ' ' GLU . 59.2 t -75.83 -67.03 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.208 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.794 HG22 ' O ' ' A' ' 95' ' ' VAL . 3.1 tt -48.3 -40.12 9.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.615 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.467 ' CE1' ' CD2' ' A' ' 141' ' ' TRP . 12.3 t-80 -58.3 -64.54 0.88 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.484 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -42.64 -60.07 2.98 Favored Glycine 0 CA--C 1.519 0.286 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 105' ' ' ASP . 14.6 tptp -57.31 -65.22 0.66 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.855 -0.672 . . . . 0.0 110.627 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -36.83 -55.87 0.88 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.237 0.542 . . . . 0.0 109.751 179.519 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.743 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -49.64 -47.75 49.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.73 0.776 . . . . 0.0 109.365 178.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -61.65 -31.58 71.69 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.338 -179.252 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.506 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 50.7 ttp -67.57 -52.28 40.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.334 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.755 HG23 ' H ' ' A' ' 109' ' ' LYS . 5.1 m -76.87 -22.93 14.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.42 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.32 28.58 0.32 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.755 ' H ' HG23 ' A' ' 107' ' ' VAL . 0.8 OUTLIER -89.41 -153.16 0.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.11 0.481 . . . . 0.0 111.55 -178.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.73 -170.56 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.79 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.476 ' OE1' ' CB ' ' A' ' 173' ' ' ALA . 50.1 mt-30 -65.04 117.82 8.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.833 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.473 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -108.04 137.11 19.74 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.474 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.408 ' N ' HG21 ' A' ' 170' ' ' ILE . 44.1 Cg_exo -47.82 117.57 2.52 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.466 1.444 . . . . 0.0 112.313 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 143' ' ' ALA . 2.5 mp -124.78 132.31 71.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.546 ' O ' HD12 ' A' ' 83' ' ' LEU . 4.8 tpt -131.9 117.44 18.48 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.937 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.0 mt -95.75 97.4 9.67 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.0 t -103.91 133.15 48.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 122.327 1.061 . . . . 0.0 110.665 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.413 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -106.18 112.6 3.92 Favored Glycine 0 C--N 1.304 -1.229 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.188 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.497 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.1 t30 -96.98 176.94 5.78 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.898 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.497 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 8.7 mttp 63.41 58.79 1.31 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.221 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.407 ' H ' ' HB3' ' A' ' 149' ' ' SER . 6.0 tttm -65.03 -12.93 56.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.748 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.451 ' OD2' ' CD1' ' A' ' 123' ' ' LEU . 2.6 p-10 -81.3 -8.43 59.74 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.101 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.598 ' O ' ' N ' ' A' ' 126' ' ' GLU . 11.1 mp -98.52 -23.11 15.66 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.614 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -26.88 -38.59 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.343 1.027 . . . . 0.0 111.284 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.543 ' N ' ' O ' ' A' ' 123' ' ' LEU . 2.0 mmt -46.85 -15.95 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.006 178.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 123' ' ' LEU . 18.6 mm-40 -92.58 -62.68 1.35 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.406 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.561 HH21 ' CD2' ' A' ' 124' ' ' HIS . 5.2 tpp85 26.18 65.74 0.07 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.008 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.9 t -49.01 -29.43 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.955 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.2 tp -88.82 156.36 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.877 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.52 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 74.9 p -97.85 123.09 41.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.348 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -37.77 -31.32 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.26 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.6 mp0 -71.66 -64.12 0.99 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.848 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.52 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 67.4 mt-10 -41.1 -40.95 1.63 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.952 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.91 -36.4 65.25 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 132' ' ' GLU . 13.8 tttm -62.39 -54.44 40.29 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.074 -0.563 . . . . 0.0 109.681 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.7 -35.76 71.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.794 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.18 -61.86 1.88 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.89 -38.01 61.25 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.17 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.43 -29.92 68.68 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.263 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.7 -46.67 81.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.989 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.479 ' CZ3' ' CD2' ' A' ' 104' ' ' LEU . 53.0 m95 -89.57 -3.49 58.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.143 0.496 . . . . 0.0 110.148 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 77.07 22.39 1.02 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.723 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -88.33 167.89 13.14 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.3 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.58 133.9 51.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.338 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.655 ' O ' HD22 ' A' ' 146' ' ' LEU . 6.0 t80 -96.68 122.02 39.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.679 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.794 HD12 HG22 ' A' ' 159' ' ' VAL . 1.2 mm? -134.17 137.91 44.78 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.964 -176.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.483 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 4.1 tt0 -126.24 111.5 14.65 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 27.5 p -137.66 -172.89 3.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.03 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.407 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -137.98 141.48 40.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.221 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.505 ' HB3' ' N7 ' ' A' ' 186' ' ' GDP . . . -61.66 -45.61 93.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.354 0.597 . . . . 0.0 109.4 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.445 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 15.7 tttp -65.81 5.22 0.5 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.644 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.479 ' H ' ' C ' ' A' ' 150' ' ' ALA . 43.9 mt-10 -133.85 120.4 20.39 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.836 0.351 . . . . 0.0 110.974 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.753 ' ND2' HE22 ' A' ' 25' ' ' GLN . 0.0 OUTLIER -77.57 -57.5 3.79 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.071 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 153' ' ' ASN . 9.0 tt0 -36.85 -58.43 0.76 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.976 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.602 ' O ' HG23 ' A' ' 159' ' ' VAL . 58.8 p -52.06 -45.07 64.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.98 0.419 . . . . 0.0 110.045 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -56.16 -61.37 2.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.493 0.663 . . . . 0.0 109.869 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 59.7 t -40.83 -39.98 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.331 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -65.91 -38.33 88.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.149 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.794 HG22 HD12 ' A' ' 146' ' ' LEU . 21.7 t -67.99 -37.31 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.55 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.75 ' CZ ' HD11 ' A' ' 164' ' ' ILE . 1.2 t80 -57.76 -65.32 0.66 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.338 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.445 ' O ' ' N ' ' A' ' 164' ' ' ILE . 1.1 ttt-85 -46.73 -64.9 0.65 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.117 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.453 ' HA ' HD12 ' A' ' 165' ' ' LEU . 11.3 mmt180 -41.66 -31.21 0.27 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.331 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -68.05 -40.87 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 119.526 -0.869 . . . . 0.0 109.837 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.877 HG21 HG11 ' A' ' 49' ' ' VAL . 49.6 mt -63.92 -38.56 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.71 0.767 . . . . 0.0 109.961 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 168' ' ' GLU . 25.1 mt -57.63 -64.39 0.91 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.018 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -54.56 -25.39 25.79 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -69.53 -27.85 65.51 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 165' ' ' LEU . 3.0 tp10 -69.18 -57.85 4.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.019 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -57.76 -58.86 6.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.791 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.408 HG21 ' N ' ' A' ' 113' ' ' PRO . 1.4 mp -52.86 -34.34 20.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.689 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.492 ' OD2' ' NH2' ' A' ' 7' ' ' ARG . 0.4 OUTLIER -67.39 -40.07 85.65 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.144 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -57.59 -39.6 91.21 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.476 ' CB ' ' OE1' ' A' ' 111' ' ' GLN . . . -69.41 -81.5 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.754 0.312 . . . . 0.0 110.243 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.832 179.923 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GDP . . . . . 0.544 ' H8 ' ' OG ' ' A' ' 21' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.88 0.371 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.19 137.42 34.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.057 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.512 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 5.5 mtpm? -103.48 134.36 46.97 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.487 HD13 ' C ' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -115.93 129.01 73.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.744 -176.467 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.82 133.94 33.59 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.267 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.509 HD11 ' HB2' ' A' ' 58' ' ' LEU . 30.6 mt -97.58 133.87 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 120.695 0.284 . . . . 0.0 111.318 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.565 ' C ' HD23 ' A' ' 12' ' ' LEU . 5.1 tt -130.45 97.67 4.46 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.459 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -141.18 133.41 5.81 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.431 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.475 ' O ' HG12 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -57.9 -173.89 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.075 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -84.89 125.21 32.45 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.195 0.522 . . . . 0.0 111.427 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 75.31 12.1 3.33 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.593 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 14' ' ' TYR . 7.5 p -71.14 -20.86 21.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.535 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.57 24.16 12.74 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.013 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.3 pttm -69.07 -36.49 77.69 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.322 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.1 m -71.86 -26.49 62.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.549 ' OG ' ' H8 ' ' A' ' 186' ' ' GDP . 55.4 m -68.29 -43.45 77.69 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.163 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.2 tp -77.65 -41.41 38.41 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.897 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.586 ' O ' HG12 ' A' ' 27' ' ' VAL . 16.3 m -52.56 -38.83 60.66 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -78.07 -38.4 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.038 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.554 ' CG ' ' ND2' ' A' ' 153' ' ' ASN . 0.1 OUTLIER -69.51 -33.65 73.15 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.398 -179.497 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -77.98 -61.14 2.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.197 0.522 . . . . 0.0 111.047 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.9 p -46.39 -48.05 6.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.77 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.617 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.2 tt0 -84.18 -24.74 30.0 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 77.97 22.91 67.67 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.252 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -153.02 127.14 9.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.797 ' H ' HD21 ' A' ' 153' ' ' ASN . 60.1 t80 -59.5 94.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.412 178.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.566 HG22 ' N ' ' A' ' 33' ' ' ASP . 11.9 p -123.4 166.03 18.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.983 0.42 . . . . 0.0 110.101 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.566 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -78.01 -37.8 46.23 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.211 -179.281 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 33' ' ' ASP . 25.1 p 53.83 148.26 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.857 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -87.29 29.39 0.86 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.63 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -143.41 72.07 17.78 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.795 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 39' ' ' ILE . 46.1 Cg_exo -58.75 -131.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 123.152 2.568 . . . . 0.0 111.64 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.574 HG23 ' O ' ' A' ' 38' ' ' THR . 14.9 t -74.32 46.07 0.25 Allowed 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 121.77 0.795 . . . . 0.0 110.372 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.452 ' H ' ' C ' ' A' ' 37' ' ' PRO . 1.5 tp -82.76 139.75 17.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.094 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.665 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -83.48 130.44 35.02 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.821 -178.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 40' ' ' GLU . 3.9 m-20 166.88 -179.29 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.5 0.667 . . . . 0.0 112.504 -178.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.451 HG23 HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -108.98 134.49 51.55 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.632 179.507 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -112.2 170.96 7.8 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.8 156.37 40.07 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HB2' HG23 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -168.06 131.16 1.57 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.668 178.415 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.5 mp -105.97 133.29 50.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.533 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.31 165.4 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.897 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.7 m -133.24 131.16 39.97 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.802 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.738 HG11 HD13 ' A' ' 164' ' ' ILE . 7.6 p -133.89 136.44 53.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.296 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 61.51 2.94 0.73 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.224 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 105.18 -11.29 48.03 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -89.07 118.55 28.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.634 0.254 . . . . 0.0 110.687 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -85.26 144.23 28.24 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.278 0.561 . . . . 0.0 111.805 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.655 ' CE1' HG12 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -140.63 152.96 45.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.16 178.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.627 ' C ' HD12 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -118.88 116.94 27.53 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.441 179.011 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.627 HD12 ' C ' ' A' ' 55' ' ' HIS . 9.9 mp -117.38 139.36 50.96 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.748 0.785 . . . . 0.0 111.193 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -130.08 125.76 35.96 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.097 -1.41 . . . . 0.0 109.195 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.905 ' N ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -113.7 135.03 54.38 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.322 -178.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.487 ' CG1' ' OH ' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -118.99 139.95 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -118.83 112.97 20.37 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.626 178.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.436 HG22 ' OD1' ' A' ' 65' ' ' ASP . 45.3 p 41.96 -118.78 0.44 Allowed 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.316 0.579 . . . . 0.0 111.019 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.516 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . . . 59.69 33.99 22.02 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.592 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.36 -158.63 27.94 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.53 ' O ' ' CD1' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -82.01 115.74 21.3 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.021 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 68' ' ' SER . 7.6 p-10 -136.72 -174.17 3.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.038 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.712 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -45.51 -46.78 14.11 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -43.39 -24.35 0.09 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.305 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 65' ' ' ASP . 81.4 p -156.64 86.26 0.99 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.742 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.531 ' O ' ' CB ' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -51.66 130.36 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.462 179.196 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.554 ' O ' ' CG ' ' A' ' 70' ' ' PHE . 6.6 t80 146.81 76.87 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.837 0 O-C-N 124.097 0.873 . . . . 0.0 109.852 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 45.3 Cg_exo -54.47 -142.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 122.97 2.447 . . . . 0.0 112.958 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.5 ' CB ' ' O ' ' A' ' 71' ' ' PRO . 0.5 OUTLIER 89.67 -8.67 0.39 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.065 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 m -158.67 15.82 0.19 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.827 0.346 . . . . 0.0 110.915 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.53 ' CD1' ' O ' ' A' ' 64' ' ' GLN . 8.3 t80 -110.19 -25.09 10.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.158 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 m 43.61 80.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.82 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.442 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 30.9 pt -70.46 -135.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.507 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 1.9 m-20 83.7 34.8 0.05 OUTLIER 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 80' ' ' GLY . 40.2 pt -83.22 -171.91 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.373 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -144.53 17.85 1.67 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.757 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.631 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -159.03 166.49 34.58 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.345 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.415 ' OH ' ' OE1' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -150.16 127.39 11.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.553 -0.823 . . . . 0.0 110.7 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.764 HG23 ' O ' ' A' ' 82' ' ' ILE . 12.3 tt -129.18 96.9 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.57 118.58 34.39 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.355 -177.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 84' ' ' VAL . 2.1 t -96.95 111.02 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.273 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.511 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 4.1 p90 -110.66 142.39 42.61 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.416 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.462 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.5 p -88.94 141.17 28.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.429 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.634 HG21 ' N ' ' A' ' 124' ' ' HIS . 19.1 m -77.58 18.05 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.771 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.99 -25.26 1.62 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.51 ' C ' ' N ' ' A' ' 91' ' ' LYS . 20.6 t -94.0 92.37 7.32 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.333 -176.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 90' ' ' ILE . 10.3 tp -59.57 -10.43 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.553 ' O ' HG13 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -78.18 -54.96 5.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.247 179.004 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.1 p -55.13 -27.22 43.8 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.511 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -76.75 -39.58 51.26 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.625 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.456 ' O ' HG23 ' A' ' 98' ' ' VAL . 3.9 mm-40 -68.23 -44.17 76.32 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.22 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 91' ' ' LYS . 2.3 m -69.37 -40.81 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.584 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.428 ' CG1' HD22 ' A' ' 12' ' ' LEU . 18.0 mt -57.09 -51.28 71.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.292 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -72.35 -31.65 65.81 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.853 0.358 . . . . 0.0 111.412 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 94' ' ' GLU . 18.8 t -73.46 -66.36 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.351 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.604 HD13 ' O ' ' A' ' 66' ' ' GLU . 31.9 mt -48.16 -55.72 2.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.494 ' CE1' ' CE2' ' A' ' 141' ' ' TRP . 25.9 t-80 -41.16 -63.82 0.63 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -37.64 -52.0 1.9 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 103' ' ' LEU . 24.3 tptt -70.48 -66.66 0.57 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.386 -0.407 . . . . 0.0 111.106 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -36.71 -55.07 0.89 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.969 0.414 . . . . 0.0 109.946 179.718 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.699 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -51.91 -50.7 60.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.495 0.664 . . . . 0.0 109.449 179.157 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.469 ' N ' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -51.38 -29.67 16.42 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.032 -179.382 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.467 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 17.6 ttp -77.49 -48.67 16.51 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.546 HG23 ' H ' ' A' ' 109' ' ' LYS . 5.9 m -75.44 -25.75 18.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.781 -178.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 40.84 37.34 1.32 Allowed Glycine 0 CA--C 1.531 1.076 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.564 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.546 ' H ' HG23 ' A' ' 107' ' ' VAL . 0.3 OUTLIER -91.25 -157.99 0.53 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 117.224 0.512 . . . . 0.0 111.543 -178.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 174' ' ' ALA . 0.0 OUTLIER -99.19 -177.56 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.762 -179.644 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.451 ' HB3' HG23 ' A' ' 170' ' ' ILE . 59.5 mt-30 -67.49 118.74 11.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.71 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.671 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.8 OUTLIER -117.66 152.91 50.36 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.33 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -46.45 111.42 0.36 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 121.717 1.611 . . . . 0.0 112.338 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.479 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.9 mt -121.62 131.82 72.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 7.1 tpt -128.01 115.78 19.03 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.623 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.9 mt -95.25 97.55 9.96 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.4 133.31 47.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 122.298 1.047 . . . . 0.0 110.996 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.41 110.23 3.41 Favored Glycine 0 C--N 1.304 -1.231 0 CA-C-N 113.459 -1.7 . . . . 0.0 109.018 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.481 ' CG ' ' N ' ' A' ' 120' ' ' LYS . 43.8 t30 -97.23 174.04 6.92 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.818 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.481 ' N ' ' CG ' ' A' ' 119' ' ' ASN . 2.1 mttp 67.11 59.13 0.54 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.845 0.831 . . . . 0.0 109.226 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.37 -37.49 87.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.368 -178.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.646 ' CG ' HN21 ' A' ' 186' ' ' GDP . 3.6 p-10 -59.88 -9.88 3.41 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.899 -178.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.6 mp -93.99 -29.73 15.08 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.634 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -42.03 -22.77 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.805 178.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.568 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 3.5 mmt -46.65 -23.18 0.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.478 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.3 OUTLIER -103.34 -40.48 6.38 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.218 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.497 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 5.0 tpp85 33.16 83.29 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.199 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.0 m -67.87 -29.5 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.546 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.1 tp -89.42 155.07 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.497 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.447 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 82.0 p -94.7 122.54 37.41 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.838 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -41.35 -33.66 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.404 0.621 . . . . 0.0 109.52 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.5 mp0 -65.07 -64.71 0.8 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.932 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.447 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 65.4 mt-10 -41.26 -43.96 2.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.023 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.16 -32.97 69.0 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 132' ' ' GLU . 20.0 tttm -65.72 -55.26 18.27 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.08 -34.04 65.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.494 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.77 -62.7 1.36 Allowed 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.841 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -55.22 -34.71 64.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.543 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.15 -34.75 75.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.735 0.302 . . . . 0.0 110.55 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.04 -46.29 88.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.906 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.494 ' CE2' ' CE1' ' A' ' 100' ' ' HIS . 56.9 m95 -88.45 -4.51 58.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.977 0.418 . . . . 0.0 110.327 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 73.88 25.1 1.97 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.619 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -90.8 168.34 11.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.42 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.32 133.89 49.34 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.794 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.66 ' O ' HD22 ' A' ' 146' ' ' LEU . 4.6 t80 -96.65 121.37 38.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.182 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.66 HD22 ' O ' ' A' ' 145' ' ' PHE . 1.4 mm? -134.71 137.07 43.19 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.624 -176.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.497 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 5.8 tt0 -124.62 111.01 15.12 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.524 ' OG ' HG21 ' A' ' 159' ' ' VAL . 10.7 p -135.5 -174.96 3.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.994 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.47 132.94 32.08 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.053 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.457 ' C ' ' H ' ' A' ' 152' ' ' GLU . . . -56.26 -53.04 61.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.283 0.563 . . . . 0.0 109.732 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -49.4 -12.38 0.06 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.786 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.457 ' H ' ' C ' ' A' ' 150' ' ' ALA . 31.8 mt-10 -122.64 124.17 42.83 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.64 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.797 HD21 ' H ' ' A' ' 31' ' ' PHE . 29.1 m120 -77.71 -53.21 7.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 153' ' ' ASN . 10.7 tt0 -38.81 -57.34 1.23 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.924 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.666 ' O ' HG23 ' A' ' 159' ' ' VAL . 44.2 p -51.97 -44.89 64.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.987 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -55.89 -61.58 2.28 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.566 0.698 . . . . 0.0 109.868 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 61.3 t -41.62 -39.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.518 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -67.86 -36.98 81.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.633 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 155' ' ' THR . 35.5 t -66.61 -36.24 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.803 ' CZ ' HD11 ' A' ' 164' ' ' ILE . 1.3 t80 -62.47 -65.69 0.65 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.691 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -44.09 -53.51 6.32 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.741 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -55.81 -29.45 59.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.914 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -66.64 -35.95 76.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.248 -179.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.803 HD11 ' CZ ' ' A' ' 160' ' ' PHE . 42.5 mt -67.54 -38.19 80.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.587 0.708 . . . . 0.0 109.948 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.13 -63.23 1.37 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.748 -178.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -57.59 -31.42 66.15 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.879 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -60.08 -32.3 70.83 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.475 178.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.49 -55.07 9.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.004 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -55.45 -63.11 1.27 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.091 0.472 . . . . 0.0 110.552 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.671 HG21 ' C ' ' A' ' 112' ' ' ILE . 96.7 mt -51.23 -35.36 15.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.792 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.12 -40.0 86.77 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -57.38 -32.61 64.35 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.85 -79.43 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.727 0.299 . . . . 0.0 110.297 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.404 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . . . . . . . . 0 C--N 1.332 -0.153 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.275 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GDP . . . . . 0.646 HN21 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 CA-C-O 121.073 0.463 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -139.67 135.42 33.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.939 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.523 ' HB2' HG22 ' A' ' 78' ' ' ILE . 8.3 mttm -106.56 130.05 54.39 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.749 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -103.77 123.04 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-O 121.426 0.631 . . . . 0.0 110.479 -178.586 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.19 134.86 34.95 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.113 -0.992 . . . . 0.0 110.216 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.451 HD11 ' HB2' ' A' ' 58' ' ' LEU . 16.9 mt -96.12 133.71 36.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.502 0.667 . . . . 0.0 111.905 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.548 HD13 HG12 ' A' ' 96' ' ' ILE . 2.0 tt -125.18 97.67 5.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.352 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -139.89 130.56 4.74 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.009 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.425 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -57.99 -155.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.04 139.36 31.5 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.752 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.7 m 56.8 10.8 0.79 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.986 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.68 -20.84 28.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.459 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.54 22.6 18.42 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.3 pttm -72.2 -34.44 68.38 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.856 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.462 ' O ' HD13 ' A' ' 24' ' ' ILE . 56.5 m -77.25 -35.19 55.58 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.569 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.06 -36.14 81.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 29.4 tp -76.88 -46.58 24.01 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.471 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.552 ' O ' HG12 ' A' ' 27' ' ' VAL . 71.9 m -45.07 -41.5 7.75 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.92 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.462 HD13 ' O ' ' A' ' 20' ' ' SER . 1.3 mp -77.62 -41.84 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.232 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.495 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.5 OUTLIER -69.43 -32.31 71.2 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.492 -178.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.46 ' CG ' ' N ' ' A' ' 27' ' ' VAL . 0.6 OUTLIER -77.92 -63.19 1.45 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.27 0.557 . . . . 0.0 110.805 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.586 HG13 ' N ' ' A' ' 28' ' ' GLU . 11.3 p -44.38 -47.59 2.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.424 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.586 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.5 tt0 -83.14 -24.61 32.49 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . 75.12 25.63 68.37 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.288 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 25' ' ' GLN . 0.6 OUTLIER -151.61 126.37 9.62 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 120.886 0.374 . . . . 0.0 111.691 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -63.57 93.71 0.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.95 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.619 HG22 ' N ' ' A' ' 33' ' ' ASP . 12.7 p -107.4 165.87 4.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.26 0.553 . . . . 0.0 110.986 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.619 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -49.87 -13.89 0.12 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.993 -178.536 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.485 ' H ' HG13 ' A' ' 32' ' ' VAL . 17.5 p 42.68 97.98 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.147 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -84.71 12.09 7.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.084 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 37' ' ' PRO . 1.2 m-20 -119.84 86.71 36.52 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.033 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 36' ' ' ASP . 68.5 Cg_exo -54.29 -128.42 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.898 2.398 . . . . 0.0 112.302 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 38' ' ' THR . 13.9 t -91.84 45.44 1.22 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.311 0.577 . . . . 0.0 111.246 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 tp -84.02 142.6 13.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.654 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.426 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 1.4 pm0 -90.77 135.65 33.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.382 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 0.7 OUTLIER 178.99 -179.78 0.38 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.249 0.547 . . . . 0.0 112.079 -179.15 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.95 132.91 53.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.072 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -114.45 173.92 6.22 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.167 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.55 155.59 43.74 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -155.4 108.04 2.71 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.604 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 46' ' ' LEU . 8.0 mp -105.36 122.45 45.98 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.725 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 pp -149.55 165.83 3.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.551 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.1 m -114.05 123.81 50.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.567 HG12 ' CD1' ' A' ' 54' ' ' TYR . 7.5 p -119.07 125.39 74.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-N 116.352 -0.386 . . . . 0.0 109.963 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 67.46 15.46 9.85 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.51 -9.95 76.02 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.37 135.71 33.51 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.39 146.99 40.37 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.597 0.713 . . . . 0.0 111.271 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.567 ' CD1' HG12 ' A' ' 49' ' ' VAL . 4.9 m-85 -137.92 123.58 19.82 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.192 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.502 ' NE2' HD23 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -118.16 112.47 20.2 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.491 HD12 ' C ' ' A' ' 55' ' ' HIS . 8.9 mp -120.92 146.71 46.34 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.585 0.707 . . . . 0.0 112.24 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.805 ' C ' HD13 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -137.56 126.93 24.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.01 178.25 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.974 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.72 154.51 31.57 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.253 -178.246 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.33 140.8 47.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.485 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.31 114.31 19.39 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.02 177.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.41 ' O ' ' OD2' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -131.53 172.96 11.6 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.587 0.708 . . . . 0.0 111.029 -178.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -143.61 13.04 1.72 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.985 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.413 ' O ' ' OG ' ' A' ' 68' ' ' SER . . . -92.23 -121.11 2.78 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.592 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 10.9 mp0 -82.77 72.18 9.85 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 68' ' ' SER . 35.3 p-10 -138.06 -172.3 3.23 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.091 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.578 ' HB3' HG21 ' A' ' 99' ' ' ILE . 0.0 OUTLIER -50.66 -38.1 44.61 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.547 ' N ' ' OE1' ' A' ' 66' ' ' GLU . 41.4 t80 -48.62 -17.61 0.18 Allowed 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.535 ' N ' ' C ' ' A' ' 66' ' ' GLU . 78.9 p -160.27 84.28 0.71 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.748 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.545 ' O ' ' CD2' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -42.72 127.95 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.585 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 69' ' ' ILE . 0.6 OUTLIER 169.27 81.42 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.829 -179.733 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.92 110.24 0.38 Allowed 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.333 2.022 . . . . 0.0 112.224 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.4 -56.31 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.663 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -105.1 -19.75 13.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.666 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.472 ' C ' ' H ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -87.33 24.38 1.63 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.12 0.486 . . . . 0.0 109.822 179.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -77.66 23.42 0.23 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.292 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.472 ' H ' ' C ' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -51.21 -172.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.888 179.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.83 49.6 2.21 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.523 HG22 ' HB2' ' A' ' 8' ' ' LYS . 43.7 pt -78.73 -174.88 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.691 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.39 20.35 0.84 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.137 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -147.95 164.79 28.89 Favored Glycine 0 CA--C 1.517 0.218 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.682 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.2 123.21 7.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.754 -0.723 . . . . 0.0 111.165 178.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.631 ' C ' HD23 ' A' ' 83' ' ' LEU . 9.9 tt -126.85 110.37 22.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.787 HD23 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -98.79 119.1 36.97 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.236 -177.331 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.6 133.07 42.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.075 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.474 ' CD2' ' CE2' ' A' ' 93' ' ' PHE . 8.4 p90 -143.32 144.6 32.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.973 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.583 ' C ' ' H ' ' A' ' 88' ' ' THR . 2.2 t -88.24 143.25 27.15 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.853 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.547 HG21 ' N ' ' A' ' 124' ' ' HIS . 20.2 m -67.18 14.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.972 0.415 . . . . 0.0 110.259 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.583 ' H ' ' C ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -127.78 -18.13 4.35 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.53 -178.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.492 ' C ' ' N ' ' A' ' 91' ' ' LYS . 8.6 t -94.95 92.02 6.68 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.447 -175.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.9 tp -62.97 -11.44 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 175.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.524 ' O ' HG13 ' A' ' 95' ' ' VAL . 1.0 OUTLIER -78.32 -58.63 3.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 113.712 -1.585 . . . . 0.0 110.576 178.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.503 ' O ' HD12 ' A' ' 96' ' ' ILE . 19.0 p -55.38 -31.62 61.94 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.398 0.618 . . . . 0.0 109.539 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.474 ' CE2' ' CD2' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -77.72 -38.1 47.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.195 179.677 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 98' ' ' VAL . 34.9 mt-10 -69.21 -46.79 66.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.477 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 91' ' ' LYS . 2.8 m -67.8 -45.23 84.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.59 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.548 HG12 HD13 ' A' ' 12' ' ' LEU . 33.3 mt -58.41 -46.14 89.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.536 ' HG3' HD11 ' A' ' 137' ' ' LEU . 0.5 OUTLIER -72.24 -37.73 69.06 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.097 0.475 . . . . 0.0 111.06 -179.439 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 94' ' ' GLU . 56.0 t -72.11 -65.3 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.672 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.578 HG21 ' HB3' ' A' ' 66' ' ' GLU . 73.3 mt -42.3 -59.12 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.915 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.441 ' ND1' ' N ' ' A' ' 101' ' ' GLY . 4.3 t-80 -40.98 -64.98 0.47 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.752 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.441 ' N ' ' ND1' ' A' ' 100' ' ' HIS . . . -36.6 -56.71 1.25 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.47 ' O ' ' C ' ' A' ' 103' ' ' LEU . 32.8 tptt -69.8 -66.5 0.58 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.472 -0.364 . . . . 0.0 111.611 -179.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 106' ' ' MET . 5.8 tp -36.98 -61.83 0.53 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.707 ' C ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -44.5 -50.67 9.38 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.489 ' N ' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -53.6 -26.65 22.76 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.448 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 103' ' ' LEU . 3.9 tpp -72.96 -53.72 10.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.903 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.471 HG23 ' H ' ' A' ' 109' ' ' LYS . 20.0 m -77.31 -20.87 14.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.384 -0.527 . . . . 0.0 110.837 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 42.07 37.89 2.41 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.593 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.471 ' H ' HG23 ' A' ' 107' ' ' VAL . 2.2 tptp -84.44 -154.65 0.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.178 0.513 . . . . 0.0 111.46 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.62 -173.83 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.993 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.548 ' O ' ' HB2' ' A' ' 174' ' ' ALA . 38.4 mt-30 -67.95 116.97 9.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.689 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.67 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.8 OUTLIER -118.52 155.84 51.77 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.343 179.242 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -47.04 111.43 0.39 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.813 1.675 . . . . 0.0 112.254 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.476 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.7 mt -121.84 127.3 75.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 6.6 tpt -128.62 117.23 20.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.09 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.7 mt -95.95 97.79 9.9 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.413 ' O ' ' CE1' ' A' ' 85' ' ' TYR . 29.8 t -104.92 128.56 58.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 122.175 0.988 . . . . 0.0 111.319 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.457 ' CA ' ' CE2' ' A' ' 85' ' ' TYR . . . -102.65 114.5 4.91 Favored Glycine 0 C--N 1.307 -1.04 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.508 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 49.1 t30 -97.8 177.16 5.55 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.698 -178.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.508 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 19.4 mttt 61.91 59.17 1.77 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.071 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.444 ' H ' ' HB3' ' A' ' 149' ' ' SER . 29.5 tttm -64.92 -17.99 64.83 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.213 0.819 . . . . 0.0 113.213 -178.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.677 ' CG ' HN21 ' A' ' 186' ' ' GDP . 5.5 p-10 -79.24 0.65 27.74 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.844 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 125' ' ' MET . 9.2 mp -95.88 -25.43 16.01 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.547 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -37.39 -28.19 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.531 178.449 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.521 ' N ' ' O ' ' A' ' 123' ' ' LEU . 9.3 mtt -45.43 -23.58 0.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.471 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -108.98 -38.83 5.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.844 179.397 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.467 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 0.0 OUTLIER 28.68 86.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.173 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.9 m -72.79 -31.65 37.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.451 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.42 151.8 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.779 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.456 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 94.4 p -104.21 126.39 51.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.153 0.501 . . . . 0.0 111.417 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.455 ' CE1' ' CE1' ' A' ' 145' ' ' PHE . 0.8 OUTLIER -39.95 -38.86 0.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.313 178.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -63.21 -64.85 0.79 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.236 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.456 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 59.8 mt-10 -41.08 -46.54 2.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.116 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.42 -33.2 76.72 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 132' ' ' GLU . 21.4 tttm -63.87 -55.42 22.92 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.12 -35.75 69.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.674 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.536 HD11 ' HG3' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -66.79 -62.42 1.46 Allowed 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 121.18 0.514 . . . . 0.0 109.779 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.04 -36.61 50.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.288 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -68.12 -32.52 72.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.755 0.312 . . . . 0.0 110.26 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.89 -46.15 86.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.844 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.451 ' HE1' ' CD2' ' A' ' 137' ' ' LEU . 49.7 m95 -88.26 -4.51 58.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.345 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 74.63 27.52 1.31 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.399 0.618 . . . . 0.0 109.411 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -95.46 170.01 9.65 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.57 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.92 133.07 52.79 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.018 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.695 ' O ' HD22 ' A' ' 146' ' ' LEU . 8.3 t80 -97.24 122.33 40.14 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.445 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.825 HD21 ' HE ' ' A' ' 162' ' ' ARG . 1.5 mm? -134.58 136.37 42.92 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.713 -176.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.467 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 5.8 tt0 -123.38 111.95 16.99 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.518 ' OG ' HG21 ' A' ' 159' ' ' VAL . 22.7 p -137.33 -175.74 4.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.752 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.444 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -139.26 136.51 35.01 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.908 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.459 ' N ' ' O6 ' ' A' ' 186' ' ' GDP . . . -57.49 -47.41 81.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.274 0.559 . . . . 0.0 109.827 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -56.08 -8.43 0.46 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.449 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 150' ' ' ALA . 30.4 mt-10 -127.53 124.4 38.16 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.806 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.451 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 5.4 t-20 -77.72 -55.87 4.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.02 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 153' ' ' ASN . 1.6 mt-30 -36.73 -57.74 0.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.103 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.669 ' O ' HG23 ' A' ' 159' ' ' VAL . 58.8 p -52.88 -45.25 67.4 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.085 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.495 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -56.21 -61.67 2.24 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.595 0.712 . . . . 0.0 109.934 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 60.6 t -42.77 -39.18 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.534 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -68.77 -33.79 74.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.788 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 155' ' ' THR . 44.6 t -67.61 -39.38 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 121.074 0.464 . . . . 0.0 109.815 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.509 ' O ' ' N ' ' A' ' 163' ' ' ILE . 66.5 t80 -63.55 -66.24 0.57 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.779 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.0 ttt85 -43.34 -46.47 6.47 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.667 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.825 ' HE ' HD21 ' A' ' 146' ' ' LEU . 14.9 mmm180 -58.06 -32.64 68.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.16 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.509 ' N ' ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -66.22 -34.8 72.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.26 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.599 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 14.1 mt -63.78 -44.1 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.423 0.63 . . . . 0.0 111.295 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -58.79 -64.67 0.85 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.045 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.462 ' H ' HD23 ' A' ' 165' ' ' LEU . 0.4 OUTLIER -50.52 -23.83 2.77 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.676 -178.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -71.77 -31.18 66.35 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.559 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 165' ' ' LEU . 0.5 OUTLIER -70.29 -52.21 24.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.08 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -61.09 -63.56 1.25 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.883 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.67 HG21 ' C ' ' A' ' 112' ' ' ILE . 96.4 mt -50.95 -32.7 12.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.94 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.02 -39.09 86.96 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.484 -0.487 . . . . 0.0 109.908 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -59.48 -35.54 85.78 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.403 ' O ' ' C ' ' A' ' 174' ' ' ALA . . . -68.39 -78.56 0.06 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.025 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GDP . . . . . 0.677 HN21 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 121.223 0.535 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.589 ' NH1' ' HB1' ' A' ' 167' ' ' ALA . 83.4 mtt180 -140.27 135.55 32.39 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.905 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.513 ' HB2' HG22 ' A' ' 78' ' ' ILE . 15.2 mttm -107.3 127.63 53.72 Favored 'General case' 0 C--O 1.212 -0.896 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.768 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.7 OUTLIER -103.02 118.47 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-O 121.691 0.758 . . . . 0.0 110.773 -178.352 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.49 ' HB2' HD13 ' A' ' 78' ' ' ILE . . . -82.73 137.75 34.29 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.691 -0.631 . . . . 0.0 111.848 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.1 mt -92.92 125.82 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.183 0.516 . . . . 0.0 111.92 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tt -123.19 92.33 3.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.896 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.525 ' N ' ' OE1' ' A' ' 66' ' ' GLU . . . -142.03 136.82 7.53 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -178.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.581 ' CD1' HG21 ' A' ' 95' ' ' VAL . 0.5 OUTLIER -53.09 -160.17 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.699 0.762 . . . . 0.0 111.31 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.8 tpp85 -97.11 136.0 38.28 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.701 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.469 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 3.3 m 63.28 11.5 5.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.567 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 p -71.94 -16.84 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.16 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.62 21.35 34.5 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -39.25 81.11 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.359 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.7 m -71.89 -28.65 63.65 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.539 ' OG ' ' H8 ' ' A' ' 186' ' ' GDP . 60.3 m -63.73 -42.42 97.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.199 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.4 tp -75.53 -28.41 59.08 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.464 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.579 ' O ' HG12 ' A' ' 27' ' ' VAL . 40.0 m -55.94 -49.92 72.18 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.502 HD11 ' CE2' ' A' ' 43' ' ' PHE . 1.4 mp -70.9 -41.04 77.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.075 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.471 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.1 OUTLIER -65.67 -30.24 70.9 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.23 -179.169 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -77.79 -64.02 1.25 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.452 0.644 . . . . 0.0 111.353 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.631 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.1 p -49.65 -47.2 21.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.375 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.631 ' N ' HG13 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -83.66 -24.36 31.38 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.372 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.17 25.99 71.86 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -144.47 125.45 14.42 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.187 0.518 . . . . 0.0 112.297 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.625 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -71.65 92.53 1.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.801 179.164 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.62 HG22 ' N ' ' A' ' 33' ' ' ASP . 12.5 p -117.05 165.83 12.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.206 0.527 . . . . 0.0 110.568 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.62 ' N ' HG22 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -87.51 20.51 2.86 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.295 -179.052 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.466 ' H ' HG13 ' A' ' 32' ' ' VAL . 5.0 p -30.03 131.46 0.08 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.798 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.73 100.58 12.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.336 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -166.62 82.95 0.94 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.524 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -58.42 -135.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.753 2.302 . . . . 0.0 112.127 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 38' ' ' THR . 1.6 t -101.24 46.06 0.95 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.986 0.898 . . . . 0.0 111.385 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.405 HG22 HD22 ' A' ' 41' ' ' ASN . 1.6 tp -82.48 167.1 2.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.228 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.521 ' CB ' ' HB2' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -73.22 116.78 14.16 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.019 -179.289 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.405 HD22 HG22 ' A' ' 39' ' ' ILE . 13.7 m-20 -160.35 161.7 33.23 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.808 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.5 m -132.52 149.62 52.29 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.266 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.502 ' CE2' HD11 ' A' ' 24' ' ' ILE . 10.9 m-85 -129.63 164.48 23.79 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.55 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -146.72 150.36 35.22 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.148 0.499 . . . . 0.0 111.997 -178.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -153.17 119.19 5.42 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.06 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.706 HD21 ' CE1' ' A' ' 55' ' ' HIS . 6.4 mp -107.01 123.86 48.8 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.127 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.823 HD12 ' CE1' ' A' ' 160' ' ' PHE . 0.8 OUTLIER -145.51 165.63 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.221 179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.36 121.85 44.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.224 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 49' ' ' VAL . 8.5 p -114.59 114.66 47.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.92 179.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 49' ' ' VAL . 4.3 t-20 73.72 11.83 4.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.398 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.82 -8.14 63.37 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.684 ' NE2' ' H ' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -93.74 135.17 35.31 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.603 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.684 ' H ' ' NE2' ' A' ' 52' ' ' GLN . 2.4 mt-10 -74.35 145.48 43.81 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.577 0.704 . . . . 0.0 111.252 -178.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.697 ' CE2' HG23 ' A' ' 164' ' ' ILE . 4.3 m-85 -136.18 127.07 27.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.183 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.706 ' CE1' HD21 ' A' ' 46' ' ' LEU . 2.2 t-160 -117.63 112.87 21.11 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.505 HD12 ' C ' ' A' ' 55' ' ' HIS . 9.0 mp -118.46 139.12 51.91 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.537 0.684 . . . . 0.0 111.575 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.731 ' C ' HD13 ' A' ' 58' ' ' LEU . 1.9 mt-30 -132.16 121.0 23.02 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.098 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.931 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -114.64 155.21 26.98 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.761 -178.214 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.12 145.95 31.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -177.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.407 ' O ' ' OG1' ' A' ' 61' ' ' THR . 0.3 OUTLIER -122.04 117.51 26.53 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 113.504 -1.68 . . . . 0.0 107.898 177.525 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.602 ' C ' ' N ' ' A' ' 63' ' ' GLY . 20.3 p 55.88 178.7 0.04 OUTLIER 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 123.546 0.528 . . . . 0.0 109.771 -177.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.521 ' HB2' ' CB ' ' A' ' 40' ' ' GLU . . . 52.85 12.48 0.27 Allowed 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.602 ' N ' ' C ' ' A' ' 61' ' ' THR . . . -150.22 -157.75 7.89 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 113.9 -1.5 . . . . 0.0 111.681 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.627 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 6.8 mp0 -86.23 86.95 7.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.235 0.54 . . . . 0.0 110.73 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.43 ' CG ' ' H ' ' A' ' 67' ' ' TYR . 21.3 p-10 -139.71 -176.67 4.65 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.977 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.525 ' OE1' ' N ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -60.36 -9.24 3.29 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.53 ' CD2' ' OH ' ' A' ' 74' ' ' TYR . 32.3 t80 -94.67 12.17 28.65 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.3 p -158.13 152.22 24.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.218 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.9 tt -166.23 -11.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 121.815 0.817 . . . . 0.0 109.386 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 70' ' ' PHE . 28.5 t80 -116.59 85.22 16.27 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.477 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.481 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 51.3 Cg_exo -51.66 -163.25 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.551 2.167 . . . . 0.0 112.516 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.481 ' CB ' ' O ' ' A' ' 71' ' ' PRO . 1.8 tt0 81.29 -20.06 0.39 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.288 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 73' ' ' THR . 40.5 m -128.73 -15.41 4.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.65 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.549 ' CD2' ' O ' ' A' ' 63' ' ' GLY . 0.8 OUTLIER -94.93 -22.39 18.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.507 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 55.25 87.32 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.459 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.464 ' HB ' HE21 ' A' ' 64' ' ' GLN . 1.1 pt -92.46 173.6 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 121.022 0.439 . . . . 0.0 111.274 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 170.35 29.13 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.076 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.798 HD12 ' O ' ' A' ' 80' ' ' GLY . 38.3 pt -85.56 -171.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-O 121.405 0.622 . . . . 0.0 112.664 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.56 19.81 1.04 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.437 178.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.798 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -156.96 168.1 33.89 Favored Glycine 0 CA--C 1.521 0.45 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.187 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -152.15 122.76 7.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.985 -0.608 . . . . 0.0 110.709 177.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.641 HG23 ' O ' ' A' ' 82' ' ' ILE . 11.0 tt -125.34 102.3 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.716 0.77 . . . . 0.0 109.312 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.839 ' N ' HD12 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -97.15 125.72 41.84 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.224 -0.59 . . . . 0.0 110.794 -178.56 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -95.51 130.66 43.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.303 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.681 ' CZ ' HG21 ' A' ' 96' ' ' ILE . 49.8 m-85 -110.56 143.75 40.47 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.14 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.499 ' C ' ' H ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -98.21 124.13 42.63 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.513 HG21 ' N ' ' A' ' 124' ' ' HIS . 14.1 m -72.51 23.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.71 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.499 ' H ' ' C ' ' A' ' 86' ' ' SER . 5.1 t -138.36 -25.57 0.93 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.556 ' C ' ' N ' ' A' ' 91' ' ' LYS . 8.3 t -100.2 95.06 6.55 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.051 -176.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.1 tp -57.86 -11.66 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 175.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.556 ' N ' ' C ' ' A' ' 89' ' ' SER . 18.5 mttp -77.74 -61.51 1.97 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 113.936 -1.483 . . . . 0.0 110.23 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.638 ' O ' HD12 ' A' ' 96' ' ' ILE . 76.5 p -47.17 -29.59 2.4 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.723 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.948 ' CE2' HG21 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -74.07 -51.41 15.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.179 -179.365 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.571 ' O ' HG23 ' A' ' 98' ' ' VAL . 4.0 mm-40 -65.79 -43.96 87.17 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.581 HG21 ' CD1' ' A' ' 14' ' ' TYR . 13.6 m -68.07 -36.5 75.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.12 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.681 HG21 ' CZ ' ' A' ' 85' ' ' TYR . 19.2 mt -63.35 -38.84 83.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -69.68 -25.97 64.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.03 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 94' ' ' GLU . 57.4 t -76.46 -66.47 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.338 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.406 ' H ' HG12 ' A' ' 99' ' ' ILE . 4.5 mm -44.27 -54.36 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.431 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.637 ' ND1' ' CH2' ' A' ' 141' ' ' TRP . 2.0 t-80 -61.45 -64.51 0.92 Allowed 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.805 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.531 ' N ' ' ND1' ' A' ' 100' ' ' HIS . . . -35.39 -57.29 0.91 Allowed Glycine 0 N--CA 1.454 -0.141 0 CA-C-N 116.24 -0.437 . . . . 0.0 112.053 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 103' ' ' LEU . 15.4 tptm -69.69 -65.01 0.77 Allowed 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.359 -0.42 . . . . 0.0 110.736 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.45 ' C ' ' O ' ' A' ' 102' ' ' LYS . 0.7 OUTLIER -36.88 -60.87 0.59 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.097 0.475 . . . . 0.0 109.872 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.717 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -46.65 -47.01 20.26 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 178.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -59.27 -30.68 68.48 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.56 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.477 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 2.1 tpp -65.18 -55.02 20.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.84 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.482 HG23 ' H ' ' A' ' 109' ' ' LYS . 17.2 m -76.59 -23.21 15.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.451 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.45 37.64 1.83 Allowed Glycine 0 CA--C 1.531 1.059 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.607 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.482 ' H ' HG23 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -77.57 -152.88 0.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.156 0.503 . . . . 0.0 111.46 -179.058 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.33 -174.75 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.767 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.424 ' HB3' HG23 ' A' ' 170' ' ' ILE . 34.7 mt-30 -66.96 117.14 8.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.72 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.647 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.8 OUTLIER -118.62 153.67 52.25 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.233 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -48.04 117.06 2.26 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.582 1.521 . . . . 0.0 111.953 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.481 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.4 mp -122.81 126.45 73.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 8.4 tpt -122.31 112.53 18.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.497 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 73.2 mt -96.67 98.86 10.52 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.6 t -108.45 133.67 52.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 122.04 0.924 . . . . 0.0 112.62 -178.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -97.93 114.29 4.96 Favored Glycine 0 C--N 1.315 -0.615 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -98.09 170.08 9.17 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -177.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.452 ' HB3' HD13 ' A' ' 123' ' ' LEU . 25.8 mttt 61.02 57.37 2.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.274 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.526 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 9.2 ttpt -57.73 -29.06 64.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.418 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.645 ' CG ' HN21 ' A' ' 186' ' ' GDP . 4.8 p-10 -67.5 -16.79 64.39 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.295 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.1 mp -82.01 -31.26 31.11 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.603 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.1 OUTLIER -37.74 -24.71 0.01 OUTLIER 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.366 178.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.603 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 2.7 mmt -48.24 -22.53 0.68 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.44 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -109.0 -37.68 5.76 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.827 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.445 ' NH1' ' OE1' ' A' ' 147' ' ' GLU . 0.2 OUTLIER 27.16 91.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.034 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 38.7 t -70.79 -45.81 71.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.055 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.948 HG21 ' CE2' ' A' ' 93' ' ' PHE . 8.7 tp -91.55 153.54 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.577 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.435 ' OG ' ' OE1' ' A' ' 133' ' ' GLU . 4.1 p -104.51 126.17 51.35 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.3 0.571 . . . . 0.0 111.329 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.638 ' CD1' ' CE1' ' A' ' 145' ' ' PHE . 0.7 OUTLIER -49.41 -43.67 44.71 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 131' ' ' TYR . 1.2 mp0 -39.07 -63.11 0.56 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.344 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.435 ' OE1' ' OG ' ' A' ' 130' ' ' SER . 11.7 mt-10 -52.24 -37.18 54.48 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 131' ' ' TYR . . . -72.27 -22.23 78.97 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 131' ' ' TYR . 0.3 OUTLIER -75.91 -54.68 6.53 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.478 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -54.49 -37.53 65.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.362 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 140' ' ' SER . 0.6 OUTLIER -69.61 -63.72 1.02 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -42.41 -32.95 0.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.27 -48.67 67.02 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.867 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -66.96 -27.82 67.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.475 179.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.637 ' CH2' ' ND1' ' A' ' 100' ' ' HIS . 22.8 m0 -86.67 -10.94 52.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.69 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.23 27.16 16.92 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.428 ' HB2' ' HB ' ' A' ' 114' ' ' ILE . . . -104.15 166.05 10.65 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.24 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -102.62 127.84 49.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.211 0.529 . . . . 0.0 112.115 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.638 ' CE1' ' CD1' ' A' ' 131' ' ' TYR . 11.3 t80 -99.36 118.67 36.52 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.109 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.03 133.12 22.88 Favored 'General case' 0 C--N 1.347 0.491 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.445 ' OE1' ' NH1' ' A' ' 127' ' ' ARG . 3.1 mt-10 -98.47 115.09 27.78 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.875 -0.515 . . . . 0.0 109.838 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.704 ' OG ' HG21 ' A' ' 159' ' ' VAL . 0.5 OUTLIER -140.54 134.88 31.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.705 -179.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 152' ' ' GLU . 4.0 p -102.29 142.4 33.57 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 152' ' ' GLU . . . -55.53 -55.28 33.67 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.688 178.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 31.3 tttt -46.84 -15.11 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.998 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 150' ' ' ALA . 60.9 mt-10 -126.0 120.12 29.46 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.973 0.416 . . . . 0.0 110.868 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 9.7 t-20 -77.1 -47.48 20.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 153' ' ' ASN . 1.4 mt-30 -36.92 -58.91 0.74 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.229 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.643 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.2 p -56.49 -42.69 78.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.289 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 153' ' ' ASN . . . -53.78 -60.75 2.92 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.555 0.693 . . . . 0.0 109.938 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 49.2 t -45.84 -44.12 4.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.561 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -53.9 -45.18 71.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.265 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.704 HG21 ' OG ' ' A' ' 148' ' ' SER . 2.2 t -65.59 -49.48 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.423 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.823 ' CE1' HD12 ' A' ' 47' ' ' ILE . 1.3 t80 -45.61 -37.5 5.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.807 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.1 ttt-85 -79.14 -50.27 11.28 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.375 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.6 -34.29 69.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.278 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.637 HG23 ' N ' ' A' ' 164' ' ' ILE . 11.8 tt -67.9 -54.6 21.43 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.944 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.783 HD11 ' CE1' ' A' ' 160' ' ' PHE . 90.8 mt -47.38 -34.6 3.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 119.219 -0.992 . . . . 0.0 109.425 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.66 -64.33 0.95 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.059 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -57.12 -30.64 64.56 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.227 -0.589 . . . . 0.0 109.42 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.589 ' HB1' ' NH1' ' A' ' 7' ' ' ARG . . . -58.96 -32.68 69.85 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -68.41 -53.14 25.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.383 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 12.6 tttm -59.14 -65.02 0.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.883 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.647 HG21 ' C ' ' A' ' 112' ' ' ILE . 74.6 mt -48.74 -35.04 6.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.678 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -67.21 -37.33 83.43 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -62.03 -30.89 76.82 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.75 -79.54 0.05 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.191 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.768 179.88 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GDP . . . . . 0.645 HN21 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 121.265 0.555 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.23 136.68 33.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.312 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 22.6 mtmt -107.35 130.02 54.84 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.774 ' HB ' HD12 ' A' ' 58' ' ' LEU . 1.1 mm -108.77 121.07 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-O 121.342 0.592 . . . . 0.0 110.277 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.62 135.55 35.03 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.259 -0.9 . . . . 0.0 110.533 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.7 mt -95.54 131.69 41.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.415 0.626 . . . . 0.0 112.09 -178.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.613 ' C ' HD23 ' A' ' 12' ' ' LEU . 5.5 tt -132.34 99.09 4.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.719 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.87 135.57 6.81 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -52.45 -165.42 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.49 0.662 . . . . 0.0 110.791 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -100.33 138.09 37.86 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.487 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.52 ' O ' ' NZ ' ' A' ' 120' ' ' LYS . 1.3 m 67.66 20.52 9.56 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.36 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 p -90.08 -21.52 6.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.042 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.44 ' O ' ' OG ' ' A' ' 21' ' ' SER . . . 108.33 26.25 5.49 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.463 ' CB ' ' NZ ' ' A' ' 19' ' ' LYS . 1.3 ttmp? -60.76 -49.21 78.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.147 0.499 . . . . 0.0 110.094 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -75.98 -25.45 55.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.254 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 18' ' ' GLY . 54.3 p -65.62 -44.99 84.8 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.453 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 23' ' ' THR . 20.4 tp -76.33 -58.39 3.31 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 119.784 -0.767 . . . . 0.0 110.975 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.603 ' O ' HG12 ' A' ' 27' ' ' VAL . 90.3 m -39.02 -48.68 1.65 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.961 -0.295 . . . . 0.0 110.705 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.517 HD11 ' CE2' ' A' ' 43' ' ' PHE . 1.3 mp -74.62 -35.31 37.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 123.356 0.41 . . . . 0.0 111.34 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.432 HE22 ' HB2' ' A' ' 156' ' ' ALA . 0.8 OUTLIER -69.6 -37.74 77.01 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.964 -178.589 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.631 ' CZ ' ' CD1' ' A' ' 160' ' ' PHE . 20.0 t80 -77.15 -59.55 2.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.291 0.567 . . . . 0.0 111.342 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 28' ' ' GLU . 9.5 p -48.71 -47.19 15.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.57 -178.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.61 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.0 tt0 -85.13 -24.42 28.02 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.38 35.76 63.29 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -130.34 125.05 33.68 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.371 0.605 . . . . 0.0 111.641 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.718 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -73.19 94.13 1.93 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.66 -179.633 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.518 HG22 ' N ' ' A' ' 33' ' ' ASP . 7.4 p -118.9 165.42 14.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.326 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.518 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.5 OUTLIER -107.96 18.3 21.4 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.161 -179.2 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 33' ' ' ASP . 32.6 p 50.05 175.23 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.661 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -152.08 -60.82 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.941 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -53.72 167.89 0.45 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.366 -179.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' A' ' 36' ' ' ASP . 52.9 Cg_exo -56.4 -135.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.475 2.117 . . . . 0.0 112.068 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 38' ' ' THR . 8.9 t -129.72 65.81 1.48 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.46 0.648 . . . . 0.0 110.107 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.8 tp -82.46 157.62 3.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.605 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.443 ' CB ' ' O ' ' A' ' 60' ' ' ASP . 2.0 pt-20 -90.61 153.27 20.45 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.34 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.409 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 1.3 m120 178.72 173.91 0.68 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.215 0.531 . . . . 0.0 111.83 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.91 143.4 36.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.567 179.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.517 ' CE2' HD11 ' A' ' 24' ' ' ILE . 12.3 m-85 -127.33 165.9 18.84 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.588 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.59 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -143.61 147.16 33.96 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 120.227 -0.589 . . . . 0.0 112.404 -178.453 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.964 ' C ' HD13 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -162.32 114.61 1.68 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.679 178.864 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.049 HD22 ' H ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -115.16 142.39 46.72 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.821 -1.082 . . . . 0.0 111.159 -177.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.617 HD11 ' CD2' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -150.77 165.73 2.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.274 179.493 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 m -108.33 124.04 49.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.758 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.616 HG11 HG21 ' A' ' 164' ' ' ILE . 7.1 p -120.94 122.76 68.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.139 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 69.65 12.98 8.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.043 0.449 . . . . 0.0 109.954 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.5 -11.37 70.23 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -89.55 133.25 34.69 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -77.39 147.43 36.05 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.522 0.677 . . . . 0.0 111.172 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -137.66 130.73 30.43 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.011 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.687 ' C ' HD22 ' A' ' 56' ' ' LEU . 1.2 m80 -116.54 117.54 30.17 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.687 HD22 ' C ' ' A' ' 55' ' ' HIS . 3.4 mm? -121.6 140.7 51.91 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.449 0.642 . . . . 0.0 112.019 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.803 ' C ' HD13 ' A' ' 58' ' ' LEU . 0.7 OUTLIER -136.52 124.41 22.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.097 178.696 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.95 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.25 154.95 30.3 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.152 0.501 . . . . 0.0 112.065 -178.717 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.27 145.47 35.28 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-N 115.125 -0.943 . . . . 0.0 113.01 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.443 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -123.34 102.66 8.04 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.009 177.646 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.64 161.29 13.74 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.036 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 63' ' ' GLY . . . -132.21 20.75 4.43 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.278 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 62' ' ' ALA . . . -31.94 -72.6 0.07 OUTLIER Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.373 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -144.64 -90.47 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.661 0.743 . . . . 0.0 110.459 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.565 ' OD1' ' N ' ' A' ' 68' ' ' SER . 4.1 p30 -77.37 -173.64 2.96 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.535 -1.212 . . . . 0.0 110.118 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.553 ' O ' ' CB ' ' A' ' 67' ' ' TYR . 3.5 mm-40 -62.89 43.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.918 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.553 ' CB ' ' O ' ' A' ' 66' ' ' GLU . 26.1 t80 97.05 74.85 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 O-C-N 124.368 1.043 . . . . 0.0 109.38 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.565 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 1.7 m -60.6 130.58 47.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.456 -178.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.035 ' H ' HD12 ' A' ' 69' ' ' ILE . 3.2 mp -61.32 -127.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.269 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.765 ' H ' HG22 ' A' ' 69' ' ' ILE . 5.2 m-85 40.24 81.25 0.25 Allowed Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 120.884 -0.327 . . . . 0.0 110.353 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -47.1 -7.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.419 2.08 . . . . 0.0 112.484 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -42.03 -68.47 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.827 -180.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.456 ' N ' HE21 ' A' ' 72' ' ' GLN . 0.0 OUTLIER -78.11 -33.9 50.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.692 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.418 ' CE2' ' CE1' ' A' ' 67' ' ' TYR . 0.3 OUTLIER -93.28 103.6 15.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.568 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.5 m -81.37 55.98 2.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.456 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.451 HG23 ' H ' ' A' ' 76' ' ' ILE . 4.1 pt -49.69 163.25 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-O 121.324 0.583 . . . . 0.0 111.747 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 p30 175.52 29.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.953 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.662 HD12 ' O ' ' A' ' 80' ' ' GLY . 22.7 pt -87.45 -167.66 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -145.91 16.43 1.4 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.653 178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.662 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -150.63 164.38 29.85 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.582 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.477 ' OH ' ' CD2' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -151.71 123.44 7.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.891 -0.655 . . . . 0.0 110.944 178.268 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.647 HG23 ' O ' ' A' ' 82' ' ' ILE . 11.7 tt -127.26 104.83 13.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.552 0.691 . . . . 0.0 109.696 178.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.737 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -97.7 120.98 39.06 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.406 -178.684 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 84' ' ' VAL . 1.7 t -97.19 114.14 33.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.675 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.505 ' CZ ' ' CA ' ' A' ' 118' ' ' GLY . 48.7 p90 -115.52 145.08 42.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.608 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.429 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.6 p -86.99 143.16 27.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.452 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.532 HG21 ' N ' ' A' ' 124' ' ' HIS . 10.2 m -80.98 17.67 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 120.998 0.428 . . . . 0.0 110.256 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.4 t -130.26 -19.59 3.12 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.406 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.56 ' C ' ' N ' ' A' ' 91' ' ' LYS . 20.9 t -98.95 93.78 6.2 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.298 -176.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.7 tp -58.7 -11.82 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.56 ' N ' ' C ' ' A' ' 89' ' ' SER . 12.9 mttp -77.97 -54.39 6.35 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.442 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.1 p -53.93 -32.28 53.06 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.038 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.912 ' CE2' HG21 ' A' ' 129' ' ' ILE . 0.2 OUTLIER -73.78 -51.0 17.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.025 -179.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.28 -42.62 92.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.876 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 91' ' ' LYS . 17.7 m -65.48 -40.12 87.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.307 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.496 ' CG1' HD22 ' A' ' 12' ' ' LEU . 1.6 mt -63.0 -32.17 55.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.2 tttm -69.85 -26.47 64.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.101 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.4 t -77.24 -67.13 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.957 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 99' ' ' ILE . 1.6 mp -44.26 -38.18 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.245 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.636 ' CD2' ' CZ2' ' A' ' 141' ' ' TRP . 7.3 t60 -66.6 -64.22 0.9 Allowed 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.788 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.556 ' N ' ' CD2' ' A' ' 100' ' ' HIS . . . -35.69 -50.69 1.07 Allowed Glycine 0 C--N 1.329 0.159 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.431 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 17.5 tptm -70.73 -61.15 1.87 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.966 -0.617 . . . . 0.0 110.554 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 106' ' ' MET . 0.6 OUTLIER -42.09 -60.23 1.5 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.462 0.648 . . . . 0.0 109.394 179.638 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.735 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -45.98 -44.29 14.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.23 178.51 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -60.52 -32.67 71.69 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.943 179.812 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.495 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 4.6 ttm -58.93 -56.65 19.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.727 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.493 ' C ' ' H ' ' A' ' 109' ' ' LYS . 16.9 m -77.11 -13.55 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.251 0.548 . . . . 0.0 109.865 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.45 -24.99 0.1 OUTLIER Glycine 0 CA--C 1.53 0.989 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.92 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.503 ' CG ' ' H ' ' A' ' 110' ' ' VAL . 7.2 tttp -173.28 -131.88 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 117.705 0.753 . . . . 0.0 111.732 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.503 ' H ' ' CG ' ' A' ' 109' ' ' LYS . 6.7 t 52.34 116.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.61 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.466 ' OE1' ' HB1' ' A' ' 173' ' ' ALA . 12.7 mt-30 -77.63 126.06 30.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.007 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.663 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.5 OUTLIER -132.67 152.72 80.43 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.264 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -47.84 110.51 0.32 Allowed 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.949 1.766 . . . . 0.0 112.478 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 3.0 mt -126.51 131.8 70.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 6.2 tpt -129.84 116.97 19.46 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.863 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.9 mt -95.69 98.11 10.23 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.5 t -102.41 126.15 56.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 122.066 0.936 . . . . 0.0 112.144 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.505 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -97.36 115.89 5.37 Favored Glycine 0 C--N 1.31 -0.913 0 N-CA-C 108.067 -2.013 . . . . 0.0 108.067 177.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.494 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 52.6 t30 -96.97 175.89 6.17 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.165 -0.614 . . . . 0.0 112.105 -177.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.52 ' NZ ' ' O ' ' A' ' 16' ' ' SER . 15.6 mttt 58.84 58.2 3.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.632 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.546 ' O ' ' CG ' ' A' ' 124' ' ' HIS . 16.2 ttmt -58.73 -30.8 67.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.362 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.631 ' CG ' HN21 ' A' ' 186' ' ' GDP . 5.1 p-10 -64.83 -27.07 68.63 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.199 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 125' ' ' MET . 10.4 mp -71.52 -29.88 65.28 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.624 ' ND1' ' N ' ' A' ' 125' ' ' MET . 0.6 OUTLIER -35.93 -29.23 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.498 179.207 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.624 ' N ' ' ND1' ' A' ' 124' ' ' HIS . 1.0 OUTLIER -45.11 -24.89 0.28 Allowed 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.709 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.483 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.4 OUTLIER -103.64 -41.02 6.08 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.584 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.573 HH21 ' CB ' ' A' ' 124' ' ' HIS . 32.2 ttm-85 28.16 80.97 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.201 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.4 t -57.72 -53.93 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.055 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.912 HG21 ' CE2' ' A' ' 93' ' ' PHE . 7.5 tp -86.45 153.13 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.76 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.432 ' OG ' ' OE1' ' A' ' 133' ' ' GLU . 1.1 p -87.22 120.77 28.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.365 0.602 . . . . 0.0 111.407 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.621 ' CE1' ' CD1' ' A' ' 145' ' ' PHE . 0.3 OUTLIER -50.18 -47.32 54.57 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.389 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 131' ' ' TYR . 1.6 mp0 -40.28 -60.58 1.05 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.833 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.432 ' OE1' ' OG ' ' A' ' 130' ' ' SER . 26.9 mt-10 -50.61 -38.01 43.39 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.484 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 131' ' ' TYR . . . -69.23 -34.12 74.74 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -67.06 -54.65 19.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.76 -35.93 69.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.39 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.509 ' CD2' ' CE2' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -67.07 -64.32 0.88 Allowed 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.516 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -45.82 -37.27 5.94 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.7 -40.82 88.64 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER -64.68 -34.15 77.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.231 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.636 ' CZ2' ' CD2' ' A' ' 100' ' ' HIS . 38.5 m0 -87.0 -7.23 58.35 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 70.51 25.32 4.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.988 -178.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -103.97 166.71 10.24 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.644 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.07 133.5 49.75 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.098 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.695 ' O ' HD22 ' A' ' 146' ' ' LEU . 7.5 t80 -97.26 121.04 38.7 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.466 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.695 HD22 ' O ' ' A' ' 145' ' ' PHE . 1.7 mm? -132.2 130.63 41.28 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.69 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.503 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 4.5 mt-10 -110.27 112.34 24.23 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.942 0.401 . . . . 0.0 109.978 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.496 ' OG ' HG21 ' A' ' 159' ' ' VAL . 49.4 p -139.73 179.29 6.67 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.362 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 152' ' ' GLU . 6.0 p -139.17 133.92 32.08 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.501 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.426 ' N ' ' O6 ' ' A' ' 186' ' ' GDP . . . -54.91 -40.31 69.71 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -54.03 -42.11 68.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.059 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 149' ' ' SER . 13.3 tt0 -100.7 117.27 34.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.235 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 0.7 OUTLIER -76.43 -42.58 43.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.185 -179.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 153' ' ' ASN . 5.3 tt0 -41.1 -47.83 3.25 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.099 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.594 ' O ' HG23 ' A' ' 159' ' ' VAL . 63.2 p -62.83 -44.95 94.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.91 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.432 ' HB2' HE22 ' A' ' 25' ' ' GLN . . . -51.2 -64.36 0.84 Allowed 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.62 0.724 . . . . 0.0 109.465 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.0 t -45.12 -35.73 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.837 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -67.85 -41.03 83.58 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.551 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 155' ' ' THR . 19.4 t -62.69 -43.5 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-O 120.937 0.399 . . . . 0.0 110.399 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.631 ' CD1' ' CZ ' ' A' ' 26' ' ' PHE . 1.1 t80 -59.32 -61.23 2.79 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.727 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.53 -48.82 4.0 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.781 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.43 -26.87 68.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.534 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -68.26 -34.08 64.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.046 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.616 HG21 HG11 ' A' ' 49' ' ' VAL . 20.2 mt -71.41 -38.73 69.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.684 0.754 . . . . 0.0 109.787 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.31 -63.38 1.3 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.013 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -53.59 -36.21 61.68 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.462 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -55.95 -32.33 63.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -68.48 -57.69 5.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.671 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.77 -63.16 1.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.619 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.663 HG21 ' C ' ' A' ' 112' ' ' ILE . 68.9 mt -50.37 -34.36 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.914 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.83 -40.31 75.93 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.468 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -58.15 -36.63 83.06 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.466 ' HB1' ' OE1' ' A' ' 111' ' ' GLN . . . -68.71 -65.63 0.68 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.758 0.313 . . . . 0.0 110.383 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.517 179.88 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GDP . . . . . 0.631 HN21 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 120.993 0.425 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.425 HH21 HD21 ' A' ' 56' ' ' LEU . 4.6 mtm180 -140.04 136.63 33.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.702 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.587 ' HB3' HG22 ' A' ' 78' ' ' ILE . 1.9 tttt -102.51 133.43 47.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -110.16 129.49 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.429 -177.325 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.487 ' HB3' ' CE1' ' A' ' 81' ' ' TYR . . . -87.28 133.32 33.7 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 121.627 -0.67 . . . . 0.0 110.144 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.668 HD11 ' HB2' ' A' ' 58' ' ' LEU . 20.2 mt -98.24 133.69 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.15 0.5 . . . . 0.0 112.123 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.568 ' C ' HD23 ' A' ' 12' ' ' LEU . 3.8 tt -126.4 99.43 5.83 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.341 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -140.3 133.21 5.86 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.5 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.68 -179.03 0.16 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.982 0.42 . . . . 0.0 110.003 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -76.33 131.88 39.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.026 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.4 m 63.81 16.28 9.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.721 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 86' ' ' SER . 10.5 p -72.42 -13.15 16.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.393 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.68 23.12 29.17 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.128 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.4 pttm -69.65 -30.34 68.02 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.969 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.8 m -77.5 -34.44 54.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.434 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 61.2 m -65.29 -42.41 93.17 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.635 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.0 tp -77.8 -36.7 50.02 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.3 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.525 ' O ' HG12 ' A' ' 27' ' ' VAL . 97.2 m -55.45 -38.57 69.21 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.3 mp -73.82 -39.42 52.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.223 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.61 ' CG ' HD22 ' A' ' 153' ' ' ASN . 5.2 tt0 -70.29 -27.63 64.56 Favored 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.933 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 1.3 t80 -77.46 -60.26 2.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.4 0.619 . . . . 0.0 110.875 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.601 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.9 p -52.71 -45.92 49.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.043 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.601 ' N ' HG13 ' A' ' 27' ' ' VAL . 1.3 tm-20 -84.19 -24.61 30.04 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.474 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 78.77 19.61 72.81 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.748 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.546 ' NE2' ' O ' ' A' ' 31' ' ' PHE . 15.7 tp60 -154.26 134.06 12.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.161 -0.616 . . . . 0.0 112.258 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.546 ' O ' ' NE2' ' A' ' 30' ' ' GLN . 1.0 OUTLIER -65.54 93.81 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.453 178.576 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.611 HG22 ' N ' ' A' ' 33' ' ' ASP . 10.6 p -107.29 166.08 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.212 0.53 . . . . 0.0 110.485 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.611 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -44.66 -14.34 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.944 -178.642 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 32' ' ' VAL . 15.3 p 39.78 86.34 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.208 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -86.99 27.0 1.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.373 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 37' ' ' PRO . 3.8 t70 -115.92 92.02 33.18 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.246 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 36' ' ' ASP . 60.0 Cg_exo -54.5 -131.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.644 2.229 . . . . 0.0 112.407 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 38' ' ' THR . 13.4 t -112.86 50.11 0.9 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.338 0.59 . . . . 0.0 111.696 -179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.5 tp -84.26 158.39 3.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.409 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.546 ' CD ' ' H ' ' A' ' 40' ' ' GLU . 1.8 pm0 -85.52 124.22 31.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.819 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -170.51 -178.45 2.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.455 0.645 . . . . 0.0 112.348 -178.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.514 HG23 HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -129.93 131.93 46.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.22 179.737 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -108.47 171.33 7.48 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.464 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.531 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -145.3 150.95 37.55 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -178.585 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.596 ' C ' HD12 ' A' ' 46' ' ' LEU . 37.8 tptt -154.12 116.44 4.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.84 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.717 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.0 mp -105.85 125.01 50.48 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.203 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.872 HD12 ' CZ ' ' A' ' 160' ' ' PHE . 0.6 OUTLIER -145.76 165.58 10.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.799 0.333 . . . . 0.0 110.585 -179.822 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.4 m -117.7 123.82 47.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.878 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.813 HG11 HG21 ' A' ' 164' ' ' ILE . 5.8 p -127.15 132.12 70.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.67 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 70.59 7.35 6.18 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.05 -10.39 71.9 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -93.98 139.17 31.25 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -77.21 148.04 36.07 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.59 0.71 . . . . 0.0 111.41 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -139.35 124.47 18.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.215 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.767 ' C ' HD12 ' A' ' 56' ' ' LEU . 1.8 m-70 -117.32 114.15 23.17 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.767 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.2 mp -126.05 150.82 47.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.508 0.67 . . . . 0.0 111.67 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.29 133.15 36.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.941 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.917 ' N ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -114.64 144.28 43.68 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.639 -179.018 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.514 HG23 HG23 ' A' ' 42' ' ' THR . 0.3 OUTLIER -126.02 130.26 72.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.757 0.789 . . . . 0.0 112.89 -178.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -123.23 106.4 10.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.349 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.718 HG21 ' OH ' ' A' ' 74' ' ' TYR . 21.3 p -129.21 -166.86 1.7 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.302 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -148.6 23.69 1.0 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.102 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.431 ' O ' ' OG ' ' A' ' 68' ' ' SER . . . -94.62 -132.6 6.76 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.676 ' NE2' ' H ' ' A' ' 64' ' ' GLN . 0.9 OUTLIER -83.66 66.46 9.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.529 0.68 . . . . 0.0 110.356 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.695 ' O ' ' N ' ' A' ' 68' ' ' SER . 8.5 p-10 -138.57 -177.22 4.76 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.442 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.607 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 1.2 pm0 -37.95 -31.9 0.05 Allowed 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.183 0.516 . . . . 0.0 109.814 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.528 ' CG ' ' O ' ' A' ' 67' ' ' TYR . 2.6 t80 -54.27 -13.85 0.99 Allowed 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.897 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.695 ' N ' ' O ' ' A' ' 65' ' ' ASP . 16.4 p -165.5 -7.49 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.535 ' N ' ' O ' ' A' ' 65' ' ' ASP . 0.4 OUTLIER 45.13 115.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.925 0.869 . . . . 0.0 111.122 -177.766 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' A' ' 69' ' ' ILE . 0.8 OUTLIER -178.17 87.79 0.23 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.358 179.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.88 131.9 35.69 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.396 2.064 . . . . 0.0 112.559 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -172.89 -72.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.449 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.9 m -141.16 12.24 2.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.82 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.718 ' OH ' HG21 ' A' ' 61' ' ' THR . 0.3 OUTLIER -111.24 4.63 19.33 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.873 -179.526 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -82.28 -15.62 52.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.409 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.499 ' O ' ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER 26.87 -153.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 178.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.3 p30 -130.28 51.62 2.09 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.587 HG22 ' HB3' ' A' ' 8' ' ' LYS . 26.6 pt -75.55 173.85 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.315 -178.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -150.19 28.11 0.75 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.839 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.37 167.39 35.04 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.299 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.487 ' CE1' ' HB3' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -150.75 127.7 11.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.088 -0.556 . . . . 0.0 111.83 179.471 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.744 HG23 ' O ' ' A' ' 82' ' ' ILE . 13.2 tt -132.72 96.44 2.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.478 0.656 . . . . 0.0 109.35 177.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.806 HD23 ' N ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -98.17 117.66 33.05 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.089 -178.795 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -96.44 117.69 41.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.345 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.448 ' CZ ' ' CA ' ' A' ' 118' ' ' GLY . 35.7 p90 -111.22 144.19 40.77 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.568 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.62 ' HG ' ' H ' ' A' ' 89' ' ' SER . 1.3 p -86.95 138.23 31.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.73 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.573 HG21 ' N ' ' A' ' 124' ' ' HIS . 14.0 m -71.94 17.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.611 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.501 ' H ' ' C ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -138.11 -21.07 1.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.62 ' H ' ' HG ' ' A' ' 86' ' ' SER . 21.3 t -93.18 93.99 8.56 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.141 -176.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 90' ' ' ILE . 10.8 tp -60.57 -8.36 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 176.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.622 ' O ' HG13 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -77.48 -59.55 2.73 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.755 179.181 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.9 p -54.12 -29.39 44.81 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.335 0.588 . . . . 0.0 109.566 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.2 -39.87 47.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.669 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -68.59 -42.98 77.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.263 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 91' ' ' LYS . 2.3 m -67.38 -40.41 84.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.417 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.562 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.2 mt -55.05 -43.65 70.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 121.212 -0.195 . . . . 0.0 110.686 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.2 tttt -69.23 -35.03 75.74 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.239 0.543 . . . . 0.0 110.761 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.419 ' O ' ' C ' ' A' ' 99' ' ' ILE . 58.4 t -71.58 -65.63 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.319 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 100' ' ' HIS . 1.4 mp -38.02 -54.38 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.026 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.483 ' CE1' ' CG ' ' A' ' 141' ' ' TRP . 1.1 t-160 -46.4 -64.06 0.85 Allowed 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.457 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 100' ' ' HIS . . . -35.14 -58.45 0.8 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.467 ' O ' ' C ' ' A' ' 103' ' ' LEU . 16.5 tptp -69.82 -65.83 0.67 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.355 -0.422 . . . . 0.0 110.992 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.503 HD22 HD11 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -36.48 -63.02 0.42 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.021 0.438 . . . . 0.0 109.895 179.671 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.7 ' C ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -44.35 -50.83 8.95 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.481 ' N ' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -52.26 -31.3 31.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.373 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.481 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 3.9 ttm -65.68 -51.44 59.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.378 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.522 ' C ' ' H ' ' A' ' 109' ' ' LYS . 24.2 m -76.6 -13.78 14.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.83 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 63.39 -23.91 0.08 OUTLIER Glycine 0 CA--C 1.532 1.104 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.911 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 107' ' ' VAL . 3.6 tptp -171.77 -142.08 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.67 0.735 . . . . 0.0 111.444 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.505 ' H ' ' CG ' ' A' ' 109' ' ' LYS . 4.7 t 52.96 120.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.51 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -73.96 117.98 16.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.756 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.482 ' O ' ' CD1' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -108.57 132.02 21.4 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.569 179.553 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -48.2 123.04 8.32 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.384 1.39 . . . . 0.0 111.901 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.482 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.5 mp -123.91 130.83 73.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 6.7 tpt -128.4 117.27 21.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.793 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 mt -95.83 97.82 9.96 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.1 t -105.5 128.4 59.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 122.136 0.969 . . . . 0.0 111.446 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.448 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -100.25 111.84 4.28 Favored Glycine 0 C--N 1.308 -1.006 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.471 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 53.4 t30 -97.75 173.56 7.05 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.684 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.471 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 5.9 mtpp 61.96 58.38 1.91 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.909 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.534 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 0.5 OUTLIER -60.28 -25.51 65.78 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.568 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.641 ' CG ' HN21 ' A' ' 186' ' ' GDP . 4.2 p-10 -67.53 -9.87 46.5 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.204 -179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 125' ' ' MET . 11.2 mp -97.2 -25.35 15.32 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.573 ' N ' HG21 ' A' ' 87' ' ' VAL . 2.3 p-80 -36.94 -28.57 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.66 178.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.525 ' N ' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -44.39 -23.14 0.09 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.477 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -107.66 -40.68 5.24 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.69 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.462 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 22.1 ttm180 24.63 84.33 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.192 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 46.2 t -53.77 -35.35 26.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.308 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.4 tp -88.61 155.92 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.68 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.49 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 89.1 p -100.89 126.68 47.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.682 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -39.54 -33.29 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.796 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.6 mp0 -69.73 -65.3 0.73 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.73 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.49 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 62.4 mt-10 -41.41 -40.12 1.66 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.731 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.69 -37.54 67.25 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 132' ' ' GLU . 4.0 tmtt? -61.15 -55.32 33.71 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.66 -36.34 69.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.77 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.54 -61.78 1.9 Allowed 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.19 -37.36 54.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.109 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.01 -34.83 79.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.597 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.58 -46.4 86.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.891 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.483 ' CG ' ' CE1' ' A' ' 100' ' ' HIS . 66.5 m95 -90.58 4.79 50.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.523 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 62.69 31.01 16.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.637 0.732 . . . . 0.0 109.623 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -94.33 167.82 11.29 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.283 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -106.53 132.97 51.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.272 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.703 ' O ' HD22 ' A' ' 146' ' ' LEU . 6.4 t80 -96.89 121.59 38.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.478 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.703 HD22 ' O ' ' A' ' 145' ' ' PHE . 1.6 mm? -134.69 137.36 43.49 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.872 -176.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.462 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 2.4 mt-10 -125.4 111.56 15.27 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.537 ' OG ' HG21 ' A' ' 159' ' ' VAL . 20.8 p -137.43 -176.29 4.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.039 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.0 135.26 34.1 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.063 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.525 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -61.95 -29.47 70.26 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.25 0.548 . . . . 0.0 109.643 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -69.39 0.92 4.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.139 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -141.54 128.51 20.68 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.728 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.61 HD22 ' CG ' ' A' ' 25' ' ' GLN . 6.1 t-20 -77.52 -54.32 6.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.198 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 153' ' ' ASN . 1.1 mt-30 -36.75 -56.19 0.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.092 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.687 ' O ' HG23 ' A' ' 159' ' ' VAL . 50.5 p -56.14 -42.69 77.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.031 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 153' ' ' ASN . . . -57.7 -61.39 2.55 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.441 0.639 . . . . 0.0 110.196 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 59.7 t -42.55 -40.15 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.582 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -66.74 -36.61 82.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.783 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 155' ' ' THR . 25.7 t -66.14 -41.29 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.007 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.874 ' CZ ' HD11 ' A' ' 164' ' ' ILE . 22.7 t80 -59.66 -65.51 0.66 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.647 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.81 -55.82 2.91 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.789 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -51.83 -31.46 27.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.821 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -66.5 -37.21 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.416 -179.6 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.874 HD11 ' CZ ' ' A' ' 160' ' ' PHE . 15.5 mt -68.97 -31.97 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-O 121.421 0.629 . . . . 0.0 110.133 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.53 -59.79 4.68 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.719 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 114' ' ' ILE . 6.1 pt-20 -59.24 -30.25 68.12 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.006 -0.678 . . . . 0.0 109.515 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -60.46 -32.24 71.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.442 ' O ' ' OD1' ' A' ' 171' ' ' ASP . 0.0 OUTLIER -71.33 -41.4 69.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.04 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 15.7 tptt -70.19 -58.67 3.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.314 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 170' ' ' ILE . 1.7 mp -55.47 -52.17 49.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.321 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 172' ' ' GLY . 1.6 p-10 -67.58 -26.78 66.44 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.363 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 171' ' ' ASP . . . -60.28 -44.44 97.5 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.38 -67.97 0.46 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.806 0.336 . . . . 0.0 110.497 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.715 -179.795 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GDP . . . . . 0.641 HN21 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 120.974 0.416 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.402 ' NH2' ' OD1' ' A' ' 171' ' ' ASP . 0.0 OUTLIER -139.87 135.97 33.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.457 -179.392 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -104.16 122.39 45.24 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.771 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.7 OUTLIER -104.02 118.54 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-O 121.617 0.722 . . . . 0.0 109.917 -179.068 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.452 ' HB3' ' CE1' ' A' ' 81' ' ' TYR . . . -84.02 134.68 34.62 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 121.191 -0.943 . . . . 0.0 111.339 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.0 mt -95.36 126.88 47.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.705 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.2 tp -127.02 102.0 6.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.499 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -139.21 135.31 7.22 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -53.84 -161.04 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.418 0.628 . . . . 0.0 110.804 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -96.01 130.96 42.87 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.854 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.493 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 1.3 m 67.45 14.6 9.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.748 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.48 ' C ' ' NZ ' ' A' ' 120' ' ' LYS . 7.6 p -76.93 -12.76 14.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.483 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.21 12.35 34.01 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.42 ' CB ' ' NZ ' ' A' ' 19' ' ' LYS . 0.8 OUTLIER -46.82 -48.71 20.77 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.678 0.275 . . . . 0.0 111.122 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.588 ' O ' HD13 ' A' ' 24' ' ' ILE . 1.5 m -76.99 -26.45 53.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.924 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.444 ' N ' ' O1A' ' A' ' 186' ' ' GDP . 78.3 p -68.49 -49.4 59.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.549 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.6 tp -78.15 -30.7 49.37 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.271 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.533 ' O ' HG12 ' A' ' 27' ' ' VAL . 54.1 m -62.59 -47.86 81.95 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.588 HD13 ' O ' ' A' ' 20' ' ' SER . 1.5 mp -68.28 -34.87 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.981 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 150' ' ' ALA . 2.9 tt0 -74.2 -25.39 59.66 Favored 'General case' 0 C--O 1.215 -0.718 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.639 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 1.4 t80 -76.69 -57.97 3.55 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.473 0.654 . . . . 0.0 110.398 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.628 HG13 ' N ' ' A' ' 28' ' ' GLU . 11.5 p -57.17 -49.19 80.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.425 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.628 ' N ' HG13 ' A' ' 27' ' ' VAL . 1.2 tm-20 -80.13 -24.81 40.23 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.463 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 77.75 23.49 66.96 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.822 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.412 ' OE1' ' O ' ' A' ' 31' ' ' PHE . 1.7 pp0? -153.32 138.43 17.34 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 119.345 -0.942 . . . . 0.0 112.72 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.491 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 27.6 t80 -58.8 118.21 5.47 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.456 178.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.642 HG22 ' N ' ' A' ' 33' ' ' ASP . 12.4 p -94.04 166.48 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.917 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.642 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -49.16 -26.41 2.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.935 -179.536 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.445 ' H ' HG13 ' A' ' 32' ' ' VAL . 7.8 p 39.7 77.57 0.05 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.174 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -152.4 34.71 0.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.593 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.65 172.92 3.15 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.285 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -63.62 -147.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.247 1.965 . . . . 0.0 111.247 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 38' ' ' THR . 11.7 t -131.02 61.01 1.64 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.164 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.8 tp -82.93 158.5 3.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.255 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.419 ' O ' ' OD1' ' A' ' 41' ' ' ASN . 4.2 pt-20 -86.27 149.36 25.12 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.438 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 40' ' ' GLU . 1.8 m120 -170.94 179.03 3.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.543 0.687 . . . . 0.0 112.6 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.444 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 0.8 OUTLIER -127.09 145.89 50.57 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.165 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.529 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 7.3 m-85 -133.5 163.75 28.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.991 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.617 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -144.27 149.87 36.99 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.086 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -149.03 112.48 5.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.016 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.607 HD21 ' ND1' ' A' ' 55' ' ' HIS . 6.4 mp -108.02 120.95 43.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.068 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 pp -147.59 165.56 5.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.795 0.331 . . . . 0.0 111.009 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 m -112.46 126.77 55.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.637 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.614 HG23 HH22 ' A' ' 161' ' ' ARG . 7.6 p -124.07 133.83 68.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.809 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 63.5 3.85 1.59 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.114 0.483 . . . . 0.0 109.722 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 103.11 -14.05 55.52 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.64 ' NE2' ' H ' ' A' ' 53' ' ' GLU . 35.3 tp60 -90.1 141.28 28.84 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.64 ' H ' ' NE2' ' A' ' 52' ' ' GLN . 2.1 mt-10 -76.96 149.89 35.94 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.401 0.619 . . . . 0.0 111.051 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.564 ' CD1' HG12 ' A' ' 49' ' ' VAL . 12.3 m-85 -141.23 124.18 16.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.114 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.671 ' C ' HD12 ' A' ' 56' ' ' LEU . 9.7 t60 -117.69 113.89 22.54 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.671 HD12 ' C ' ' A' ' 55' ' ' HIS . 11.1 mp -120.66 140.81 51.06 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.695 0.76 . . . . 0.0 111.637 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.84 ' C ' HD13 ' A' ' 58' ' ' LEU . 2.6 mt-30 -133.07 123.39 25.68 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.251 -1.341 . . . . 0.0 109.502 178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.961 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.89 154.02 31.53 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.04 -178.656 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.92 145.13 36.13 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.264 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.66 103.27 10.53 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.708 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.68 HG22 ' CE1' ' A' ' 74' ' ' TYR . 68.8 p -59.46 -99.61 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.769 0.795 . . . . 0.0 110.45 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 61' ' ' THR . . . 70.24 -10.49 0.66 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.186 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 61' ' ' THR . . . -77.0 -10.57 86.19 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.573 HE22 ' CG ' ' A' ' 71' ' ' PRO . 20.9 mt-30 -142.49 -148.69 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.168 0.509 . . . . 0.0 110.138 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.619 ' O ' ' N ' ' A' ' 67' ' ' TYR . 2.5 p30 -76.86 -172.84 2.43 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.601 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.621 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -59.77 71.33 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.688 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.619 ' N ' ' O ' ' A' ' 65' ' ' ASP . 62.8 t80 57.94 64.68 1.47 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.937 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.577 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 1.1 m -40.97 134.68 1.91 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.55 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.788 ' N ' HD12 ' A' ' 69' ' ' ILE . 1.9 mp -88.7 83.28 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER 179.62 -54.62 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.862 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.573 ' CG ' HE22 ' A' ' 64' ' ' GLN . 83.8 Cg_exo -40.72 139.64 1.24 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.186 1.924 . . . . 0.0 112.316 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.57 -40.14 9.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.36 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 m -82.36 -20.22 37.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.365 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.68 ' CE1' HG22 ' A' ' 61' ' ' THR . 0.1 OUTLIER -109.6 35.58 3.28 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.37 0.605 . . . . 0.0 110.458 179.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 76' ' ' ILE . 8.7 t -153.98 -18.55 0.13 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.98 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.486 ' O ' ' O ' ' A' ' 75' ' ' SER . 0.0 OUTLIER 28.83 -155.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 178.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.591 ' O ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -119.36 -24.75 6.27 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.528 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.591 ' O ' ' O ' ' A' ' 77' ' ' ASP . 31.3 pt 29.65 -164.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 O-C-N 124.148 0.905 . . . . 0.0 112.902 177.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -152.0 16.76 0.66 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.584 ' O ' HD12 ' A' ' 78' ' ' ILE . . . -157.78 164.07 32.98 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.966 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.542 ' OH ' ' CG ' ' A' ' 67' ' ' TYR . 0.1 OUTLIER -152.29 122.86 7.33 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.672 -0.764 . . . . 0.0 110.589 178.107 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.623 HG23 ' O ' ' A' ' 82' ' ' ILE . 8.8 tt -122.6 98.5 5.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.981 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -97.37 126.57 42.69 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.174 -178.261 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -95.51 121.03 45.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.845 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.536 ' C ' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -110.06 147.5 33.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.276 -0.874 . . . . 0.0 108.994 179.356 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.688 ' HG ' ' H ' ' A' ' 89' ' ' SER . 0.3 OUTLIER -108.29 144.19 36.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.99 0.424 . . . . 0.0 112.051 -177.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.672 HG21 ' N ' ' A' ' 124' ' ' HIS . 14.2 m -81.45 15.86 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.255 179.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.7 -16.1 1.54 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -177.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.688 ' H ' ' HG ' ' A' ' 86' ' ' SER . 28.9 t -112.35 93.5 4.47 Favored 'General case' 0 CA--C 1.497 -1.085 0 CA-C-O 121.378 0.608 . . . . 0.0 110.304 -177.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.408 HD12 ' CG1' ' A' ' 128' ' ' VAL . 4.3 tp -54.84 -13.54 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.787 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.6 OUTLIER -79.1 -45.88 19.15 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.421 178.549 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.1 p -59.05 -46.71 87.56 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.748 ' CZ ' HD13 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -79.14 -32.91 44.55 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 119.0 -1.08 . . . . 0.0 112.215 -178.439 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -66.3 -47.18 74.43 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.908 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 91' ' ' LYS . 34.3 m -65.28 -34.82 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.457 -0.497 . . . . 0.0 109.881 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.0 mt -60.94 -36.83 74.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.701 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -70.52 -29.26 65.71 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.996 0.427 . . . . 0.0 109.94 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 99' ' ' ILE . 14.0 t -72.23 -66.63 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.4 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.487 HG22 ' N ' ' A' ' 100' ' ' HIS . 1.3 mp -38.55 -60.26 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.612 ' CE1' ' CG ' ' A' ' 141' ' ' TRP . 12.8 t-80 -43.05 -64.9 0.55 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.125 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -36.77 -66.51 0.48 Allowed Glycine 0 CA--C 1.518 0.233 0 CA-C-O 121.521 0.511 . . . . 0.0 112.047 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 103' ' ' LEU . 21.2 tptm -60.92 -61.08 2.84 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.765 -0.717 . . . . 0.0 110.527 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 102' ' ' LYS . 7.4 tp -36.14 -67.24 0.17 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.379 0.609 . . . . 0.0 109.6 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.727 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -42.88 -48.62 5.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.57 179.027 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.436 ' N ' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -59.39 -31.22 69.05 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.456 -179.179 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 41.7 ttp -69.57 -49.85 50.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.584 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.64 HG23 ' H ' ' A' ' 109' ' ' LYS . 4.4 m -76.99 -25.47 15.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.536 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 40.71 37.22 1.24 Allowed Glycine 0 CA--C 1.53 0.999 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.64 ' H ' HG23 ' A' ' 107' ' ' VAL . 0.1 OUTLIER -104.56 -156.19 0.56 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.262 0.553 . . . . 0.0 111.888 -178.583 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.453 HG23 ' H ' ' A' ' 110' ' ' VAL . 0.1 OUTLIER -82.62 -167.6 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.921 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.677 ' O ' ' HB2' ' A' ' 174' ' ' ALA . 18.5 mt-30 -68.98 119.82 13.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.678 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.6 mt -109.96 134.6 20.64 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.526 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -46.71 109.21 0.19 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.238 1.292 . . . . 0.0 112.295 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.5 mt -123.17 135.75 62.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.543 ' O ' HD12 ' A' ' 83' ' ' LEU . 2.4 tpp -137.65 123.59 20.17 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.394 0.616 . . . . 0.0 110.873 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.499 ' N ' ' SD ' ' A' ' 115' ' ' MET . 5.4 mt -97.88 107.3 19.76 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.623 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.7 t -103.23 127.74 56.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 121.863 0.84 . . . . 0.0 112.181 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.419 ' CA ' ' CE2' ' A' ' 85' ' ' TYR . . . -97.03 103.63 2.92 Favored Glycine 0 C--N 1.311 -0.831 0 N-CA-C 107.816 -2.113 . . . . 0.0 107.816 176.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.468 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.7 t30 -96.8 173.89 7.08 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.049 -177.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.48 ' NZ ' ' C ' ' A' ' 17' ' ' VAL . 7.1 mtpp 63.64 59.29 1.2 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.228 -178.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.432 ' H ' ' HB3' ' A' ' 149' ' ' SER . 0.0 OUTLIER -68.63 0.15 4.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.348 -178.449 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -82.59 -37.32 25.21 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.449 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.813 HD22 ' N ' ' A' ' 123' ' ' LEU . 1.0 OUTLIER -83.87 -18.11 38.58 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.081 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.672 ' N ' HG21 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -39.13 -27.92 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.002 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.504 ' N ' ' O ' ' A' ' 123' ' ' LEU . 9.5 mtt -42.1 -31.27 0.35 Allowed 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.41 ' N ' ' C ' ' A' ' 124' ' ' HIS . 1.3 pt-20 -87.8 -42.41 12.59 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.295 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 124' ' ' HIS . 6.0 tpt85 55.94 72.3 0.5 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.267 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.408 ' CG1' HD12 ' A' ' 90' ' ' ILE . 7.7 t -52.7 -64.35 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.57 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.748 HD13 ' CZ ' ' A' ' 93' ' ' PHE . 10.7 tp -86.89 153.22 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.518 ' HG ' ' HB2' ' A' ' 133' ' ' GLU . 35.8 p -88.24 137.67 32.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.278 0.561 . . . . 0.0 112.343 -178.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -53.5 -33.24 53.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.139 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mt-10 -69.06 -65.8 0.66 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.194 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.518 ' HB2' ' HG ' ' A' ' 130' ' ' SER . 45.3 mt-10 -42.83 -40.12 2.76 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.63 -35.02 62.67 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 132' ' ' GLU . 3.5 tptm -62.0 -57.29 12.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -55.28 -36.18 65.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.783 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.404 HD21 ' HE1' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -65.45 -61.13 2.28 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.419 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -52.56 -40.62 62.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.932 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.62 -30.86 71.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.654 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.8 p -63.72 -46.79 83.83 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.965 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.612 ' CG ' ' CE1' ' A' ' 100' ' ' HIS . 34.3 m95 -91.15 -0.58 57.73 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.778 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 3.5 m120 72.5 36.13 1.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.952 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -100.05 163.3 12.49 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.423 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.538 ' O ' ' SD ' ' A' ' 115' ' ' MET . . . -102.18 128.34 48.72 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.501 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.687 ' O ' HD22 ' A' ' 146' ' ' LEU . 6.2 t80 -98.09 118.43 34.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.755 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.687 HD22 ' O ' ' A' ' 145' ' ' PHE . 2.0 mm? -131.76 126.83 35.41 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -177.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.41 ' OE2' ' NH1' ' A' ' 127' ' ' ARG . 1.8 mt-10 -109.12 112.79 25.16 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.13 0.491 . . . . 0.0 110.197 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.516 ' OG ' HG21 ' A' ' 159' ' ' VAL . 4.1 p -136.43 -173.16 3.33 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.647 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.432 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -139.03 141.6 38.26 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.068 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.544 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -65.66 -49.15 69.66 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -49.42 -10.27 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.841 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.477 ' H ' ' C ' ' A' ' 150' ' ' ALA . 23.7 tt0 -129.04 127.27 41.23 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.813 0.339 . . . . 0.0 110.916 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.487 HD22 ' CG ' ' A' ' 25' ' ' GLN . 4.0 t-20 -77.78 -55.43 5.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.116 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 153' ' ' ASN . 10.3 tt0 -37.94 -53.13 1.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.932 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.535 ' O ' HG23 ' A' ' 159' ' ' VAL . 54.9 p -56.74 -41.54 77.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.97 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 153' ' ' ASN . . . -57.38 -62.94 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.624 0.726 . . . . 0.0 109.993 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.1 t -44.95 -37.55 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.443 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -62.29 -42.78 99.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.575 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 155' ' ' THR . 11.9 t -60.06 -45.28 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.696 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.518 ' O ' HG22 ' A' ' 163' ' ' ILE . 53.6 t80 -56.66 -65.38 0.62 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.084 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.614 HH22 HG23 ' A' ' 49' ' ' VAL . 6.1 ttm-85 -41.44 -58.05 2.0 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.178 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.79 -31.65 17.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.755 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.3 OUTLIER -69.18 -34.21 62.16 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.392 -179.758 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.541 HG21 HG21 ' A' ' 49' ' ' VAL . 12.6 mt -63.07 -38.07 81.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.937 0.875 . . . . 0.0 109.102 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -64.72 0.82 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.284 -1.325 . . . . 0.0 111.543 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.71 -33.37 70.11 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.464 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 163' ' ' ILE . . . -58.38 -31.48 67.7 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -67.86 -56.07 10.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.428 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 13.5 tttm -59.03 -63.74 1.19 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.954 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 72.2 mt -47.26 -37.15 4.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.59 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.402 ' OD1' ' NH2' ' A' ' 7' ' ' ARG . 11.6 t70 -69.25 -40.17 78.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.147 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -52.89 -40.42 57.48 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.37 -77.5 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.329 . . . . 0.0 110.26 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.677 ' HB2' ' O ' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.026 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GDP . . . . . 0.493 " H5'" ' HA ' ' A' ' 16' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 121.186 0.517 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.506 ' NH2' ' OD2' ' A' ' 171' ' ' ASP . 12.0 mtt180 -139.94 136.12 33.51 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.784 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.524 ' HB2' HG22 ' A' ' 78' ' ' ILE . 1.5 mttp -105.99 129.49 54.1 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.734 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -101.36 121.28 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-O 121.393 0.616 . . . . 0.0 110.647 -178.435 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.12 135.04 34.96 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.469 -0.77 . . . . 0.0 110.742 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.459 ' O ' HD12 ' A' ' 12' ' ' LEU . 19.9 mt -95.08 128.6 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 CA-C-O 121.759 0.79 . . . . 0.0 111.353 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.546 HD13 ' HE1' ' A' ' 81' ' ' TYR . 1.3 mp -127.26 94.52 4.02 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 113.975 -1.466 . . . . 0.0 110.252 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -140.54 136.01 7.38 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 -179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.494 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.1 OUTLIER -51.69 -161.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.395 0.617 . . . . 0.0 110.823 179.513 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.22 137.46 33.37 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.138 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.409 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 4.5 m 59.78 19.45 8.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.809 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 p -76.05 -21.64 15.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.876 0.369 . . . . 0.0 110.386 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.95 25.39 11.46 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -71.75 -32.09 67.35 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.353 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.433 ' O ' HD13 ' A' ' 24' ' ' ILE . 17.9 m -78.12 -35.83 48.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.777 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.469 ' OG ' ' N7 ' ' A' ' 186' ' ' GDP . 79.5 p -62.02 -48.3 80.91 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.478 HD12 ' HB3' ' A' ' 25' ' ' GLN . 15.5 tp -63.44 -53.34 53.75 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.656 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.557 ' O ' HG12 ' A' ' 27' ' ' VAL . 50.4 m -38.07 -40.82 0.52 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.433 HD13 ' O ' ' A' ' 20' ' ' SER . 1.3 mp -77.43 -40.8 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.053 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.585 ' OE1' ' N ' ' A' ' 31' ' ' PHE . 3.1 tp-100 -62.65 -41.06 98.84 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.535 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.512 ' C ' ' CD1' ' A' ' 26' ' ' PHE . 0.4 OUTLIER -76.67 -60.7 2.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.169 0.509 . . . . 0.0 111.828 -178.048 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.575 HG13 ' N ' ' A' ' 28' ' ' GLU . 13.2 p -45.51 -44.03 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.037 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.575 ' N ' HG13 ' A' ' 27' ' ' VAL . 2.1 mm-40 -92.01 -23.7 19.45 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.433 ' CA ' ' O ' ' A' ' 25' ' ' GLN . . . 71.34 26.02 74.26 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -148.99 142.03 24.84 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.585 ' N ' ' OE1' ' A' ' 25' ' ' GLN . 0.6 OUTLIER -78.13 93.65 4.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.924 177.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.621 HG22 ' N ' ' A' ' 33' ' ' ASP . 9.3 p -109.04 166.35 4.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.212 0.529 . . . . 0.0 110.869 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.621 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -50.06 -8.59 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.8 -178.766 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.493 ' H ' HG13 ' A' ' 32' ' ' VAL . 6.4 p 38.53 83.27 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.213 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -86.02 22.71 1.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.519 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 10.8 t0 -139.21 76.49 32.17 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.301 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.435 ' C ' ' H ' ' A' ' 39' ' ' ILE . 25.4 Cg_exo -64.1 -138.11 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 123.052 2.501 . . . . 0.0 112.026 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 38' ' ' THR . 14.9 t -74.93 47.41 0.34 Allowed 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.895 0.855 . . . . 0.0 110.513 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.435 ' H ' ' C ' ' A' ' 37' ' ' PRO . 1.5 tp -82.18 143.86 11.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 114.263 -1.335 . . . . 0.0 107.969 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.22 120.32 23.56 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.721 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 173.93 174.42 0.16 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 119.439 -0.904 . . . . 0.0 113.043 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.14 147.31 32.67 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.291 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -121.58 173.84 7.16 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.428 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.52 161.0 43.0 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -178.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -162.67 110.59 1.31 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.892 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.0 mp -106.9 119.69 40.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.664 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 pp -147.95 166.09 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.663 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.3 m -111.28 126.15 54.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.239 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.724 HG11 HG21 ' A' ' 164' ' ' ILE . 14.9 p -122.06 135.92 60.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.724 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 62.12 3.9 1.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.042 0.449 . . . . 0.0 109.839 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 49' ' ' VAL . . . 102.3 -13.31 57.08 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.671 ' NE2' ' H ' ' A' ' 53' ' ' GLU . 39.5 tp60 -91.49 141.75 28.39 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.671 ' H ' ' NE2' ' A' ' 52' ' ' GLN . 1.8 mt-10 -76.5 146.19 38.65 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.416 0.626 . . . . 0.0 111.229 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.598 ' CD1' HG12 ' A' ' 49' ' ' VAL . 11.7 m-85 -138.71 123.47 18.69 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.142 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.645 ' C ' HD12 ' A' ' 56' ' ' LEU . 1.6 m-70 -117.64 113.92 22.63 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.645 HD12 ' C ' ' A' ' 55' ' ' HIS . 10.9 mp -118.72 144.22 46.38 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.617 0.722 . . . . 0.0 112.374 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.781 ' C ' HD13 ' A' ' 58' ' ' LEU . 3.3 mt-30 -134.1 124.29 25.89 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.09 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.93 ' H ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -117.65 155.1 30.47 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 120.264 -0.574 . . . . 0.0 112.402 -178.214 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.82 144.82 35.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.429 ' C ' ' HG1' ' A' ' 61' ' ' THR . 0.4 OUTLIER -121.86 124.68 44.7 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.073 178.314 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.617 HG22 ' OD2' ' A' ' 65' ' ' ASP . 31.4 p 50.46 -113.2 0.66 Allowed 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.627 0.727 . . . . 0.0 110.381 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 41.36 34.65 0.36 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.727 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.36 -113.9 0.59 Allowed Glycine 0 CA--C 1.523 0.584 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.374 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.557 ' O ' ' CG ' ' A' ' 74' ' ' TYR . 19.4 mm100 -118.84 126.24 51.37 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.739 0.78 . . . . 0.0 110.286 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.617 ' OD2' HG22 ' A' ' 61' ' ' THR . 23.1 p-10 -139.52 -169.58 2.72 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.961 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.492 ' CD ' ' N ' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -50.7 -14.2 0.18 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.482 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.543 ' N ' ' C ' ' A' ' 65' ' ' ASP . 4.8 t80 -67.43 -29.47 68.97 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.222 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.529 ' OG ' ' NE2' ' A' ' 64' ' ' GLN . 7.1 p -138.99 167.73 21.41 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.869 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.671 HD11 ' HB3' ' A' ' 102' ' ' LYS . 9.7 tt -127.89 3.92 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.024 0.44 . . . . 0.0 110.859 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -103.81 103.68 38.38 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.44 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.96 122.78 8.81 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.291 1.994 . . . . 0.0 112.876 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.503 ' O ' ' CB ' ' A' ' 73' ' ' THR . 5.1 mm-40 -145.33 74.36 1.39 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.554 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.503 ' CB ' ' O ' ' A' ' 72' ' ' GLN . 0.6 OUTLIER 86.73 -22.97 0.15 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.336 -179.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.557 ' CG ' ' O ' ' A' ' 64' ' ' GLN . 19.3 t80 -63.88 -10.12 19.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.274 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 76' ' ' ILE . 4.0 p -78.21 46.08 0.59 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.501 HD12 ' CG2' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -51.78 -163.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.447 -179.377 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 2.9 p-10 -112.08 47.24 1.07 Allowed 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.524 HG22 ' HB2' ' A' ' 8' ' ' LYS . 31.7 pt -79.98 178.99 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.25 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -153.32 26.81 0.52 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.745 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.435 ' HA3' HD13 ' A' ' 9' ' ' ILE . . . -150.92 165.02 30.13 Favored Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.076 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.546 ' HE1' HD13 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -151.96 124.84 8.53 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.918 -0.641 . . . . 0.0 111.522 178.077 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.655 HG23 ' O ' ' A' ' 82' ' ' ILE . 12.0 tt -132.89 104.63 7.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.447 0.641 . . . . 0.0 109.693 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.563 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.7 OUTLIER -96.89 124.55 40.9 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.434 -178.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -97.86 133.58 39.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.112 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.574 ' CD1' ' CE2' ' A' ' 93' ' ' PHE . 26.4 p90 -137.16 145.48 43.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.717 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 89' ' ' SER . 1.0 OUTLIER -87.25 143.88 27.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.697 -179.417 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.512 HG21 ' N ' ' A' ' 124' ' ' HIS . 17.1 m -71.94 13.42 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.31 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.44 HG22 ' HG ' ' A' ' 86' ' ' SER . 0.6 OUTLIER -135.13 -19.28 1.74 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 120.911 0.386 . . . . 0.0 111.737 -178.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.52 ' C ' ' N ' ' A' ' 91' ' ' LYS . 23.0 t -89.28 92.65 9.25 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.05 -176.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.74 -9.69 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 176.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.78 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -76.86 -53.21 8.19 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 113.581 -1.645 . . . . 0.0 109.284 178.278 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.422 ' O ' HD12 ' A' ' 96' ' ' ILE . 25.6 p -59.6 -34.21 72.46 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.289 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.574 ' CE2' ' CD1' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -72.06 -56.71 5.15 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.173 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.502 ' O ' HG23 ' A' ' 98' ' ' VAL . 4.6 mm-40 -63.22 -40.51 97.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.031 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 91' ' ' LYS . 17.0 m -68.85 -33.95 61.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.676 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.422 HD12 ' O ' ' A' ' 92' ' ' SER . 2.4 mt -65.17 -40.86 90.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.335 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -70.22 -29.12 65.86 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.043 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 94' ' ' GLU . 54.1 t -74.84 -66.92 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.6 mm -41.76 -66.09 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.532 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.474 ' CE1' HD23 ' A' ' 104' ' ' LEU . 8.6 t-80 -42.24 -64.98 0.51 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.192 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 100' ' ' HIS . . . -35.06 -65.31 0.41 Allowed Glycine 0 CA--C 1.517 0.175 0 CA-C-O 121.337 0.41 . . . . 0.0 112.357 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.671 ' HB3' HD11 ' A' ' 69' ' ' ILE . 14.8 tptm -67.97 -63.53 1.04 Allowed 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.071 -0.565 . . . . 0.0 111.189 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.492 ' O ' HD13 ' A' ' 103' ' ' LEU . 0.5 OUTLIER -36.05 -58.3 0.66 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.047 0.451 . . . . 0.0 110.146 -179.426 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.698 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -51.39 -51.32 55.75 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.475 ' N ' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -52.09 -29.54 22.03 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.263 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.47 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 4.3 tpp -67.74 -53.63 25.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.711 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.429 HG23 ' H ' ' A' ' 109' ' ' LYS . 17.8 m -77.2 -20.27 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.698 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 42.27 38.16 2.66 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.232 178.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.429 ' H ' HG23 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -81.32 -159.47 0.27 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.396 0.598 . . . . 0.0 111.346 -179.379 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.73 -175.01 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.67 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.403 ' HB3' HG23 ' A' ' 170' ' ' ILE . 26.6 mt-30 -66.61 114.4 5.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.472 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.642 ' C ' HG21 ' A' ' 170' ' ' ILE . 1.1 pt -117.64 150.39 46.75 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.17 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -45.03 121.03 3.28 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.716 1.611 . . . . 0.0 112.014 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.472 ' HB ' ' HB2' ' A' ' 143' ' ' ALA . 1.4 mt -125.0 126.0 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.403 ' CE ' HD23 ' A' ' 146' ' ' LEU . 7.4 tpt -127.15 117.68 22.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.773 -178.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mt -96.19 97.91 9.91 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.0 t -105.07 126.57 60.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 122.249 1.023 . . . . 0.0 111.294 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.43 ' CA ' ' CZ ' ' A' ' 85' ' ' TYR . . . -97.83 107.81 3.53 Favored Glycine 0 C--N 1.308 -1.005 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.512 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 52.6 t30 -97.26 176.74 5.8 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.662 -177.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.512 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 41.2 mttt 62.75 60.76 1.25 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.689 0.757 . . . . 0.0 108.977 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.433 ' H ' ' HB3' ' A' ' 149' ' ' SER . 16.1 tttm -67.01 -24.12 65.99 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.657 ' CG ' HN21 ' A' ' 186' ' ' GDP . 1.3 p-10 -73.91 2.47 8.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 118.751 -1.179 . . . . 0.0 111.545 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 126' ' ' GLU . 8.1 mp -94.39 -25.77 16.8 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 176.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.55 ' C ' ' N ' ' A' ' 126' ' ' GLU . 7.6 t60 -27.12 -38.63 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.403 1.065 . . . . 0.0 111.457 178.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.515 ' N ' ' O ' ' A' ' 123' ' ' LEU . 2.8 mmt -46.98 -16.41 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.851 0.834 . . . . 0.0 108.777 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 123' ' ' LEU . 21.1 mm-40 -98.41 -57.53 2.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.994 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.466 ' CZ ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER 32.81 67.77 0.16 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.458 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.9 m -61.55 -32.1 52.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.828 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.5 tp -88.93 154.97 3.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.474 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.502 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 92.7 p -103.02 129.09 49.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.242 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -42.18 -35.32 0.92 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.564 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.6 mt-10 -66.34 -65.54 0.67 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.052 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.502 ' CD ' ' HG ' ' A' ' 130' ' ' SER . 63.6 mt-10 -41.29 -41.43 1.9 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.925 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.08 -35.91 64.33 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 132' ' ' GLU . 15.4 tttm -62.34 -54.94 33.15 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.066 -0.567 . . . . 0.0 109.601 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.87 69.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.561 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.73 -60.75 2.57 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 143' ' ' ALA . . . -54.54 -36.66 64.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.422 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -68.37 -31.77 71.39 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.1 p -63.88 -46.5 84.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.855 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -89.23 -3.53 58.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.935 0.398 . . . . 0.0 110.315 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 76.18 23.35 1.25 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.72 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 138' ' ' ALA . . . -90.59 168.13 12.04 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.83 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.41 134.13 50.91 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.045 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.621 ' O ' HD22 ' A' ' 146' ' ' LEU . 5.7 t80 -96.51 122.53 39.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.739 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.747 HD12 HG22 ' A' ' 159' ' ' VAL . 1.1 mm? -134.55 136.95 43.41 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.603 -176.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.466 ' CD ' ' CZ ' ' A' ' 127' ' ' ARG . 5.8 tt0 -123.48 112.23 17.25 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 24.2 p -138.99 -177.16 4.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.052 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.433 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -139.91 130.4 25.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.087 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 152' ' ' GLU . . . -49.24 -64.87 0.68 Allowed 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 150' ' ' ALA . 40.4 tttm -33.88 -30.7 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.217 179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 150' ' ' ALA . 34.3 mt-10 -111.71 103.63 11.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.57 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -64.9 -49.4 70.6 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.345 -179.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' A' ' 153' ' ' ASN . 4.1 mt-30 -37.27 -53.32 1.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.883 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.693 ' O ' HG23 ' A' ' 159' ' ' VAL . 80.8 p -58.16 -40.45 81.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.726 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 153' ' ' ASN . . . -58.2 -61.85 2.26 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.439 0.638 . . . . 0.0 109.978 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 55.1 t -41.32 -41.67 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.719 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.65 -39.53 93.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.528 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.747 HG22 HD12 ' A' ' 146' ' ' LEU . 29.5 t -63.04 -37.52 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.018 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.718 ' CE2' HD11 ' A' ' 164' ' ' ILE . 52.6 t80 -61.41 -65.18 0.73 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.753 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.45 -53.79 3.29 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.985 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -29.79 65.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.846 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.491 HG22 ' O ' ' A' ' 160' ' ' PHE . 0.1 OUTLIER -67.9 -33.89 64.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.387 -179.551 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.724 HG21 HG11 ' A' ' 49' ' ' VAL . 41.7 mt -69.85 -36.53 69.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 121.594 0.711 . . . . 0.0 109.784 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.28 -65.12 0.74 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.862 -178.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -58.06 -33.51 69.1 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.531 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 163' ' ' ILE . . . -58.17 -31.55 67.37 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -68.44 -57.11 6.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.617 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -54.88 -64.84 0.71 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.844 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.642 HG21 ' C ' ' A' ' 112' ' ' ILE . 96.6 mt -50.57 -34.51 12.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.007 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.506 ' OD2' ' NH2' ' A' ' 7' ' ' ARG . 1.2 t70 -67.26 -40.05 86.19 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -57.91 -31.88 65.39 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.37 -79.14 0.06 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 -0.12 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.86 179.689 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GDP . . . . . 0.657 HN21 ' CG ' ' A' ' 122' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 121.35 0.595 . . . . 0.0 110.54 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.509 ' NH2' ' OD2' ' A' ' 171' ' ' ASP . 0.0 OUTLIER -139.72 135.5 33.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.233 179.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.543 ' HB2' HG22 ' A' ' 78' ' ' ILE . 32.6 mttt -109.09 129.23 55.47 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.751 ' HB ' HD12 ' A' ' 58' ' ' LEU . 0.9 OUTLIER -102.96 125.06 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-O 121.282 0.563 . . . . 0.0 110.967 -177.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.03 133.08 34.68 Favored 'General case' 0 C--O 1.218 -0.566 0 O-C-N 121.463 -0.773 . . . . 0.0 111.303 -178.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.2 mt -95.81 133.97 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 121.795 0.807 . . . . 0.0 112.307 -179.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.584 HD11 ' HB3' ' A' ' 67' ' ' TYR . 1.1 tp -130.45 102.26 6.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.339 -1.301 . . . . 0.0 110.627 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . -141.67 135.75 6.97 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.4 OUTLIER -53.87 -164.44 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.349 0.595 . . . . 0.0 110.417 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.42 ' NH1' ' OG ' ' A' ' 16' ' ' SER . 9.1 ttt-85 -98.7 134.04 42.17 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.92 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.577 ' HA ' " H5'" ' A' ' 186' ' ' GDP . 1.3 m 67.47 19.85 9.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.572 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 p -87.3 -15.25 9.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.685 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.34 10.53 35.98 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -41.79 -55.53 2.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.015 0.436 . . . . 0.0 110.718 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -69.47 -31.13 69.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.386 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.569 ' OG ' ' H8 ' ' A' ' 186' ' ' GDP . 1.6 m -58.08 -44.03 87.35 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.117 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.7 tp -77.63 -48.41 16.91 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.167 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.507 ' O ' HG12 ' A' ' 27' ' ' VAL . 86.9 m -45.68 -54.67 7.45 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.547 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.455 HD11 ' CE2' ' A' ' 43' ' ' PHE . 1.4 mp -59.49 -42.61 88.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.079 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.622 ' NE2' ' ND2' ' A' ' 153' ' ' ASN . 0.0 OUTLIER -65.09 -33.39 75.91 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.919 -179.301 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.464 ' CD1' ' C ' ' A' ' 26' ' ' PHE . 1.6 t80 -76.83 -62.29 1.69 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.265 0.555 . . . . 0.0 111.858 -178.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.586 HG13 ' N ' ' A' ' 28' ' ' GLU . 14.9 p -48.6 -46.46 15.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.597 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.586 ' N ' HG13 ' A' ' 27' ' ' VAL . 12.4 mt-10 -85.33 -24.1 27.79 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.35 43.73 45.02 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.72 -174.22 3.65 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 121.566 0.698 . . . . 0.0 110.368 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.611 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -135.39 89.49 2.51 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.717 178.515 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.563 HG22 ' N ' ' A' ' 33' ' ' ASP . 10.5 p -107.98 166.13 4.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.633 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.563 ' N ' HG22 ' A' ' 32' ' ' VAL . 0.5 OUTLIER -66.26 -28.92 69.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.611 -179.096 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.539 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 3.9 p 34.94 51.4 0.52 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.085 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -88.6 64.43 7.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.868 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.75 176.68 1.51 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.731 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -65.42 -153.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.12 1.88 . . . . 0.0 111.169 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.741 HG23 ' O ' ' A' ' 38' ' ' THR . 11.3 t -131.69 64.9 1.58 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.923 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 tp -82.58 161.95 3.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.267 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -85.05 136.24 33.66 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.717 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -165.6 179.01 6.3 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 119.653 -0.819 . . . . 0.0 113.06 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.51 145.91 51.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.879 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.455 ' CE2' HD11 ' A' ' 24' ' ' ILE . 13.6 m-85 -129.08 166.48 19.18 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.724 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.574 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -146.89 153.28 39.95 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.565 -178.37 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.597 ' C ' HD12 ' A' ' 46' ' ' LEU . 29.4 tptt -156.82 112.03 2.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.455 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.74 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.7 mp -106.48 120.29 41.52 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.663 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.72 HD12 ' CZ ' ' A' ' 160' ' ' PHE . 0.8 OUTLIER -146.65 165.71 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.622 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 m -111.34 128.46 55.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.359 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.861 HG11 HG21 ' A' ' 164' ' ' ILE . 5.9 p -127.31 135.66 62.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.529 ' CG ' HG22 ' A' ' 49' ' ' VAL . 2.8 m120 63.16 12.83 6.36 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.28 -11.54 69.35 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -90.45 139.16 30.94 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -76.71 145.15 38.87 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.638 0.733 . . . . 0.0 111.32 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.552 ' CE2' HG23 ' A' ' 164' ' ' ILE . 10.3 m-85 -137.08 122.83 19.92 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.995 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.652 ' C ' HD12 ' A' ' 56' ' ' LEU . 66.6 m170 -116.9 113.61 22.7 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.652 HD12 ' C ' ' A' ' 55' ' ' HIS . 11.0 mp -119.57 143.4 47.64 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.657 0.741 . . . . 0.0 112.214 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.731 ' C ' HD13 ' A' ' 58' ' ' LEU . 2.4 mt-30 -135.32 124.86 25.04 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.698 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.916 ' N ' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -116.83 154.5 30.62 Favored 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 120.034 -0.666 . . . . 0.0 112.218 -178.452 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.17 145.93 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.87 -178.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.73 103.31 8.78 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.049 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.536 HG22 ' CE2' ' A' ' 74' ' ' TYR . 51.1 p -68.98 137.49 53.77 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.773 0.797 . . . . 0.0 111.562 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' A' ' 40' ' ' GLU . . . -144.71 13.85 1.53 Allowed 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.188 -1.369 . . . . 0.0 108.639 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.85 -2.4 30.35 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.523 ' N ' ' OE1' ' A' ' 64' ' ' GLN . 13.2 mp0 -142.14 -153.0 0.44 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.543 0.687 . . . . 0.0 111.107 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 67' ' ' TYR . 2.3 t70 -74.46 -177.38 3.08 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.507 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.546 ' N ' ' CG ' ' A' ' 65' ' ' ASP . 3.8 mp0 -43.39 -18.47 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.66 ' CD1' HD12 ' A' ' 99' ' ' ILE . 17.2 p90 -172.01 -22.73 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.751 -178.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.58 ' N ' ' CD1' ' A' ' 67' ' ' TYR . 1.4 m 41.36 93.02 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.536 0.208 . . . . 0.0 111.439 -178.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.798 HD13 ' H ' ' A' ' 70' ' ' PHE . 0.5 OUTLIER -56.94 156.53 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.355 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.798 ' H ' HD13 ' A' ' 69' ' ' ILE . 29.0 t80 58.82 65.89 2.67 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.89 0.376 . . . . 0.0 110.383 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -46.6 109.9 0.24 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.729 2.286 . . . . 0.0 111.988 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -97.7 -6.81 32.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.623 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.41 -26.83 2.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.569 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.536 ' CE2' HG22 ' A' ' 61' ' ' THR . 0.1 OUTLIER -83.64 101.6 11.62 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.515 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.0 m -86.93 51.9 2.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.8 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.414 ' HB ' HG23 ' A' ' 78' ' ' ILE . 0.9 OUTLIER -86.15 172.36 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 121.562 0.696 . . . . 0.0 112.056 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 5.1 p-10 -147.56 57.53 1.12 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.565 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.543 HG22 ' HB2' ' A' ' 8' ' ' LYS . 29.1 pt -79.01 -176.56 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -177.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -151.84 17.86 0.69 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.197 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -146.65 166.57 28.25 Favored Glycine 0 CA--C 1.518 0.232 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.38 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.68 121.69 7.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.951 -0.624 . . . . 0.0 110.763 178.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 82' ' ' ILE . 10.0 tt -123.9 103.31 12.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.97 ' H ' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -95.9 131.95 41.71 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.456 -0.897 . . . . 0.0 110.447 -178.266 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.483 ' O ' ' CD1' ' A' ' 96' ' ' ILE . 1.2 t -92.34 130.87 40.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.963 -178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -108.04 143.21 37.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.978 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.541 ' OG ' HG22 ' A' ' 88' ' ' THR . 47.8 t -109.88 130.21 55.55 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.889 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.547 HG21 ' N ' ' A' ' 124' ' ' HIS . 14.1 m -81.34 18.35 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.004 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.541 HG22 ' OG ' ' A' ' 86' ' ' SER . 1.4 t -143.54 -3.3 0.92 Allowed 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -177.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.495 ' C ' ' N ' ' A' ' 91' ' ' LYS . 1.0 OUTLIER -134.31 97.94 3.97 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 119.416 -0.914 . . . . 0.0 112.843 -175.566 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.569 HG22 ' HG3' ' A' ' 94' ' ' GLU . 18.1 mm -56.13 -10.9 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 114.155 -1.384 . . . . 0.0 107.859 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.729 ' O ' HG22 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -79.13 -42.03 27.2 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.091 178.686 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.62 -47.49 75.46 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.051 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.742 ' CD2' HD13 ' A' ' 129' ' ' ILE . 0.1 OUTLIER -76.3 -35.39 58.86 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 119.105 -1.038 . . . . 0.0 112.186 -178.034 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.569 ' HG3' HG22 ' A' ' 90' ' ' ILE . 14.0 mm-40 -66.46 -47.95 71.48 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.901 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 91' ' ' LYS . 32.6 m -64.17 -37.49 80.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.023 0.439 . . . . 0.0 110.292 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.483 ' CD1' ' O ' ' A' ' 84' ' ' VAL . 31.8 mt -69.02 -31.28 49.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.887 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.73 -26.42 63.38 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.18 0.514 . . . . 0.0 109.709 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 7.3 t -70.44 -64.98 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.755 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.66 HD12 ' CD1' ' A' ' 67' ' ' TYR . 1.8 tt -43.29 -47.95 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.647 178.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.58 ' NE2' ' CD1' ' A' ' 141' ' ' TRP . 15.1 t-80 -44.96 -64.79 0.63 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.852 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -39.43 -57.44 2.24 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 111.931 -0.468 . . . . 0.0 111.931 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 105' ' ' ASP . 13.5 tptp -62.96 -65.77 0.64 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.177 -0.511 . . . . 0.0 111.061 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.727 HD22 HD11 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -36.52 -56.69 0.8 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.731 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.73 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -46.34 -47.66 18.49 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.635 178.522 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 106' ' ' MET . 0.0 OUTLIER -56.83 -33.76 67.07 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.317 -179.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.529 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 2.4 tpp -67.99 -55.74 11.56 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.869 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.562 ' C ' ' H ' ' A' ' 109' ' ' LYS . 16.5 m -77.03 -12.82 14.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.016 -178.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.29 -24.87 0.04 OUTLIER Glycine 0 CA--C 1.534 1.227 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.853 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.57 ' CG ' ' H ' ' A' ' 110' ' ' VAL . 1.4 tptt -173.45 -128.73 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.856 0.828 . . . . 0.0 111.533 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.57 ' H ' ' CG ' ' A' ' 109' ' ' LYS . 7.8 t 51.1 118.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.909 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.44 ' HB3' HG23 ' A' ' 170' ' ' ILE . 27.3 mt-30 -76.14 131.6 39.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.086 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.627 ' C ' HG21 ' A' ' 170' ' ' ILE . 0.5 OUTLIER -136.17 154.6 77.45 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.407 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -49.89 110.14 0.35 Allowed 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.772 1.648 . . . . 0.0 112.546 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.485 ' CD1' ' O ' ' A' ' 112' ' ' ILE . 2.2 mp -121.67 127.84 75.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.574 ' O ' HD12 ' A' ' 83' ' ' LEU . 7.2 tpt -130.68 115.84 17.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.669 -178.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' A' ' 138' ' ' ALA . 28.2 mt -96.71 97.52 9.41 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.8 t -105.64 130.34 57.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.632 0.729 . . . . 0.0 110.977 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -102.02 116.33 5.49 Favored Glycine 0 C--N 1.306 -1.136 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.487 ' CG ' ' H ' ' A' ' 120' ' ' LYS . 51.7 t30 -97.04 173.92 7.02 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.557 -178.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.522 ' NZ ' ' O ' ' A' ' 16' ' ' SER . 18.0 mttt 60.2 58.25 2.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.545 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.46 ' O ' ' CD2' ' A' ' 124' ' ' HIS . 20.5 tttm -63.76 -29.5 70.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.955 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -70.96 -6.8 41.48 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.953 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 125' ' ' MET . 8.6 mp -94.31 -29.85 14.83 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.609 ' CD2' ' N ' ' A' ' 125' ' ' MET . 0.1 OUTLIER -38.61 -24.79 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.927 177.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.609 ' N ' ' CD2' ' A' ' 124' ' ' HIS . 19.1 mtp -44.73 -24.11 0.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.472 ' N ' ' C ' ' A' ' 124' ' ' HIS . 0.3 OUTLIER -101.83 -37.63 8.19 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.33 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.425 ' CZ ' ' OE2' ' A' ' 147' ' ' GLU . 1.2 tpt180 37.08 87.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.794 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.5 m -80.22 -32.36 13.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.15 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.742 HD13 ' CD2' ' A' ' 93' ' ' PHE . 11.1 tp -91.23 154.7 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.21 178.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.434 ' OG ' ' OE1' ' A' ' 133' ' ' GLU . 6.5 p -97.36 134.37 40.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.424 0.631 . . . . 0.0 112.226 -178.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -58.42 -30.63 67.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.095 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 135' ' ' LYS . 1.7 mp0 -68.53 -65.66 0.67 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.989 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.434 ' OE1' ' OG ' ' A' ' 130' ' ' SER . 43.5 mt-10 -41.42 -41.26 1.98 Allowed 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.83 -36.33 65.93 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 132' ' ' GLU . 3.5 tttm -60.92 -55.72 29.6 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.56 -33.98 66.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.289 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.61 -62.94 1.23 Allowed 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.832 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 143' ' ' ALA . . . -54.27 -33.67 59.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.655 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.43 -38.15 80.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.703 0.287 . . . . 0.0 110.872 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.41 -47.43 79.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.428 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.58 ' CD1' ' NE2' ' A' ' 100' ' ' HIS . 23.7 m95 -91.64 2.68 56.3 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.352 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 13.4 m120 60.67 35.56 19.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.099 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.507 ' O ' ' HB1' ' A' ' 138' ' ' ALA . . . -92.05 166.71 12.54 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.946 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -103.29 125.5 49.96 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.052 -0.659 . . . . 0.0 112.012 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.418 ' CD1' ' C ' ' A' ' 145' ' ' PHE . 6.7 t80 -98.13 121.22 39.79 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.977 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.31 125.98 15.1 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.418 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.425 ' OE2' ' CZ ' ' A' ' 127' ' ' ARG . 11.7 tt0 -102.01 110.8 22.86 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.406 ' OG ' HG21 ' A' ' 159' ' ' VAL . 0.1 OUTLIER -123.07 -176.52 3.44 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.245 -178.787 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.85 138.9 37.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.524 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.537 ' O ' ' NE2' ' A' ' 25' ' ' GLN . . . -71.88 -11.22 60.69 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.476 0.655 . . . . 0.0 109.361 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.54 -5.57 59.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.004 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.46 ' O ' ' OE1' ' A' ' 25' ' ' GLN . 51.9 mt-10 -138.97 125.91 21.06 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.474 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.622 ' ND2' ' NE2' ' A' ' 25' ' ' GLN . 4.2 m120 -75.51 -48.43 22.55 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 153' ' ' ASN . 0.0 OUTLIER -36.54 -56.88 0.79 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.998 0.427 . . . . 0.0 110.716 -179.166 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.719 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.2 p -52.57 -47.8 66.6 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.354 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 159' ' ' VAL . . . -55.38 -60.35 3.53 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.338 0.589 . . . . 0.0 110.178 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.1 t -41.98 -40.75 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.403 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.3 -32.53 72.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.994 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 155' ' ' THR . 22.0 t -73.78 -36.53 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 121.038 0.447 . . . . 0.0 109.996 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.793 ' CZ ' HD11 ' A' ' 164' ' ' ILE . 25.5 t80 -69.22 -35.63 76.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.038 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.478 HH22 HG23 ' A' ' 49' ' ' VAL . 23.9 ttm-85 -77.4 -45.21 26.6 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.135 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -34.39 74.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.067 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.479 HG23 ' N ' ' A' ' 164' ' ' ILE . 14.0 tt -68.83 -50.46 54.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.365 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.861 HG21 HG11 ' A' ' 49' ' ' VAL . 86.5 mt -50.76 -33.63 12.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 119.064 -1.055 . . . . 0.0 108.885 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.93 -63.61 1.16 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.861 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -57.77 -29.08 64.54 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 164' ' ' ILE . . . -60.63 -32.52 71.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.413 ' OE1' ' OH ' ' A' ' 54' ' ' TYR . 1.7 tp10 -68.93 -57.79 5.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.315 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -53.61 -62.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.689 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.627 HG21 ' C ' ' A' ' 112' ' ' ILE . 74.7 mt -51.89 -34.33 16.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.011 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.509 ' OD2' ' NH2' ' A' ' 7' ' ' ARG . 1.9 t70 -69.64 -38.49 77.19 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.679 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -63.21 -35.41 92.04 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.98 -65.48 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.348 . . . . 0.0 110.686 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.691 -179.928 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GDP . . . . . 0.577 " H5'" ' HA ' ' A' ' 16' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_